Citrus Sinensis ID: 020529
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | yes | no | 0.963 | 0.686 | 0.878 | 1e-164 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.775 | 0.595 | 0.710 | 1e-107 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.88 | 0.690 | 0.604 | 1e-100 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.692 | 0.456 | 0.599 | 1e-74 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.698 | 0.553 | 0.6 | 7e-74 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.68 | 0.451 | 0.592 | 5e-73 | |
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.8 | 0.349 | 0.509 | 2e-72 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.775 | 0.591 | 0.520 | 7e-70 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.689 | 0.549 | 0.553 | 3e-69 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.710 | 0.593 | 0.551 | 5e-69 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 578 bits (1490), Expect = e-164, Method: Compositional matrix adjust.
Identities = 283/322 (87%), Positives = 295/322 (91%), Gaps = 9/322 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWN RMKIAAG
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAG 193
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AAKGLE+LHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP GDKSHVSTRVMGT
Sbjct: 194 AAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGT 253
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS PHGEQNLV WARPLFNDRR
Sbjct: 254 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRR 313
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSH 240
KF KLADPRL+GR+P R LYQALAVASMCIQEQAATRPLI DVVTALSYLANQ YDP+
Sbjct: 314 KFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQAYDPSK- 372
Query: 241 RGAGDKDDRRNRD--GAR-IFKNDEGGGSGRRWDLEGSEKEDSPRETARILNRDLERERA 297
D RRNRD GAR I +ND+GGGSG ++DLEGSEKEDSPRETARILNRD+ RERA
Sbjct: 373 -----DDSRRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPRETARILNRDINRERA 427
Query: 298 VAEAKMWGENLREKRRQSAQGS 319
VAEAKMWGE+LREKRRQS QG+
Sbjct: 428 VAEAKMWGESLREKRRQSEQGT 449
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 389 bits (1000), Expect = e-107, Method: Compositional matrix adjust.
Identities = 179/252 (71%), Positives = 209/252 (82%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
LSL H NLV LIG+CA+GDQRLLVYE+MP GSLEDHLH LP K+ LDWNTRMKIAAGA
Sbjct: 152 LSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPSGKKPLDWNTRMKIAAGA 211
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 121
A+GLEYLHD+ PPVIYRD K SNILL E + PKLSDFGLAK+GP GDK+HVSTRVMGTY
Sbjct: 212 ARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVSTRVMGTY 271
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 181
GYCAP+YAMTGQLT KSD+YSFGVV LELITGRKAID+T+ +QNLV WARPLF DRR
Sbjct: 272 GYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWARPLFKDRRN 331
Query: 182 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSHR 241
F K+ DP L+G+YP+RGLYQALA+++MC+QEQ RP++ DVV AL++LA+ YDPNS
Sbjct: 332 FPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLALNFLASSKYDPNSPS 391
Query: 242 GAGDKDDRRNRD 253
+ K+ +RD
Sbjct: 392 SSSGKNPSFHRD 403
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 364 bits (935), Expect = e-100, Method: Compositional matrix adjust.
Identities = 191/316 (60%), Positives = 221/316 (69%), Gaps = 30/316 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH +LVNLIGYCADGDQRLLVYE+M GSLEDHL DL PD+ LDW+TR++IA G
Sbjct: 127 MLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALG 186
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AA GLEYLHDKANPPVIYRD K++NILL+ F+ KLSDFGLAKLGPVGDK HVS+RVMGT
Sbjct: 187 AAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGT 246
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEY TGQLT KSDVYSFGVV LELITGR+ ID+TRP EQNLVTWA+P+F +
Sbjct: 247 YGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPS 306
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSH 240
+F +LADP LEG +P + L QA+AVA+MC+QE+A RPL+ DVVTAL +L P+
Sbjct: 307 RFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFLGTA---PDGS 363
Query: 241 RGAGDKDDRRNRDGARIFKNDEGGGSGRRWDLEGSEKEDSPRETARILNRDLERERAVAE 300
DD +DE + EDS ERERAVAE
Sbjct: 364 ISVPHYDDPPQ-------PSDE------------TSVEDSVAAE--------ERERAVAE 396
Query: 301 AKMWGENLREKRRQSA 316
A WG R R +
Sbjct: 397 AMEWGVASRAHSRNPS 412
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (715), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 139/232 (59%), Positives = 167/232 (71%), Gaps = 7/232 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIA 58
L L H NLV L+GYC + DQRLLVYEFMP GSLE+HL LP L W+ RMKIA
Sbjct: 199 FLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIA 253
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
GAAKGL +LH++A PVIYRDFK+SNILL+ ++ KLSDFGLAK P K+HVSTRVM
Sbjct: 254 LGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVM 313
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 178
GTYGY APEY MTG LT KSDVYSFGVV LE++TGR+++D RP+GE NLV WARP D
Sbjct: 314 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLD 373
Query: 179 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230
+R+F +L DPRLEG + I+G + +A+ C+ RP + DVV AL L
Sbjct: 374 KRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPL 425
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 277 bits (709), Expect = 7e-74, Method: Compositional matrix adjust.
Identities = 138/230 (60%), Positives = 164/230 (71%), Gaps = 3/230 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
L L H NLV LIGYC + D RLLVYEFM GSLE+HL L W+ RM IA G
Sbjct: 123 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFR--KTTAPLSWSRRMMIALG 180
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AAKGL +LH+ A PVIYRDFK+SNILL+ + KLSDFGLAK GP GD++HVSTRVMGT
Sbjct: 181 AAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 239
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGY APEY MTG LT +SDVYSFGVV LE++TGRK++D TRP EQNLV WARP ND+R
Sbjct: 240 YGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARPKLNDKR 299
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230
K ++ DPRLE +Y +R +A ++A C+ + RPL+ DVV L L
Sbjct: 300 KLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 274 bits (701), Expect = 5e-73, Method: Compositional matrix adjust.
Identities = 135/228 (59%), Positives = 166/228 (72%), Gaps = 7/228 (3%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH--DLPPDKEALDWNTRMKIAAGAA 62
L H NLV L+GYC + DQRLLVYEFMP GSLE+HL LP L W+ RMKIA GAA
Sbjct: 197 LLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIALGAA 251
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
KGL +LH++A PVIYRDFK+SNILL+ ++ KLSDFGLAK P K+HVSTRVMGTYG
Sbjct: 252 KGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYG 311
Query: 123 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 182
Y APEY MTG LT KSDVYSFGVV LE++TGR+++D RP+GE NLV WARP D+R+F
Sbjct: 312 YAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRF 371
Query: 183 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230
+L DPRLEG + ++G + +A+ C+ + RP + +VV L L
Sbjct: 372 YRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPL 419
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (696), Expect = 2e-72, Method: Compositional matrix adjust.
Identities = 140/275 (50%), Positives = 182/275 (66%), Gaps = 15/275 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLS LHH NLV LIG C +G R L+YE + GS+E HLH+ LDW+ R+KIA G
Sbjct: 396 MLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLHE-----GTLDWDARLKIALG 450
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AA+GL YLH+ +NP VI+RDFK+SN+LLE+ F PK+SDFGLA+ G + H+STRVMGT
Sbjct: 451 AARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLAREATEGSQ-HISTRVMGT 509
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
+GY APEYAMTG L VKSDVYS+GVV LEL+TGR+ +D ++P GE+NLVTWARPL +R
Sbjct: 510 FGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQPSGEENLVTWARPLLANRE 569
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSH 240
+L DP L G Y + + A+ASMC+ ++ + RP +G+VV AL + N ++
Sbjct: 570 GLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGEVVQALKLIYN-----DAD 624
Query: 241 RGAGD---KDDRRNRDGARIFKNDEGGGSGRRWDL 272
GD + D D A FK D W+L
Sbjct: 625 ETCGDYCSQKDSSVPDSAD-FKGDLAPSDSSWWNL 658
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 264 bits (674), Expect = 7e-70, Method: Compositional matrix adjust.
Identities = 137/263 (52%), Positives = 179/263 (68%), Gaps = 11/263 (4%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L L H NLV L+GYC +G+ RLLVYEFMP GSLE+HL + L W RMK+A GA
Sbjct: 141 LGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRR--GAQPLTWAIRMKVAIGA 198
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 121
AKGL +LHD A VIYRDFK++NILL+ F+ KLSDFGLAK GP GDK+HVST+VMGT+
Sbjct: 199 AKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHVSTQVMGTH 257
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 181
GY APEY TG+LT KSDVYSFGVV LEL++GR+A+D ++ EQ+LV WA P D+RK
Sbjct: 258 GYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWATPYLGDKRK 317
Query: 182 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSHR 241
++ D RL G+YP +G Y A ++A C+ A RP + +V+ L L ++ P +
Sbjct: 318 LFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQL--ESTKPGT-- 373
Query: 242 GAGDK----DDRRNRDGARIFKN 260
G G++ D R +G+ + K+
Sbjct: 374 GVGNRQAQIDSPRGSNGSIVQKS 396
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (668), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 129/233 (55%), Positives = 164/233 (70%), Gaps = 9/233 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPDKEALDWNTRMKI 57
L L H NLV LIGYC + + R+L+YE+M GS+E++L LP L W RMKI
Sbjct: 133 FLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVLLP-----LSWAIRMKI 187
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
A GAAKGL +LH+ A PVIYRDFK+SNILL+ ++ KLSDFGLAK GPVGDKSHVSTR+
Sbjct: 188 AFGAAKGLAFLHE-AKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPVGDKSHVSTRI 246
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 177
MGTYGY APEY MTG LT SDVYSFGVV LEL+TGRK++D +RP EQNL+ WA PL
Sbjct: 247 MGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQNLIDWALPLLK 306
Query: 178 DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230
+++K + DP++ YP++ + +A +A C+ RPL+ D+V +L L
Sbjct: 307 EKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSLEPL 359
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 5e-69, Method: Compositional matrix adjust.
Identities = 128/232 (55%), Positives = 164/232 (70%), Gaps = 1/232 (0%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L L H NLV LIGYC + + RLLVYEFM GSLE+HL + L WNTR+++A GA
Sbjct: 126 LGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGA 185
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 121
A+GL +LH+ A P VIYRDFK+SNILL+ ++ KLSDFGLA+ GP+GD SHVSTRVMGT
Sbjct: 186 ARGLAFLHN-AQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQ 244
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK 181
GY APEY TG L+VKSDVYSFGVV LEL++GR+AID +P GE NLV WARP ++R+
Sbjct: 245 GYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRR 304
Query: 182 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233
++ DPRL+G+Y + + +A CI A +RP + ++V + L Q
Sbjct: 305 LLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHIQ 356
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | ||||||
| 255547614 | 461 | receptor serine-threonine protein kinase | 1.0 | 0.704 | 0.899 | 1e-173 | |
| 224053527 | 462 | serine/threonine protein kinase PBS1 [Po | 1.0 | 0.703 | 0.884 | 1e-172 | |
| 351721508 | 449 | serine/threonine-protein kinase [Glycine | 0.984 | 0.712 | 0.901 | 1e-170 | |
| 356576935 | 465 | PREDICTED: serine/threonine-protein kina | 0.981 | 0.686 | 0.902 | 1e-170 | |
| 224075521 | 456 | serine/threonine protein kinase PBS1 [Po | 0.981 | 0.699 | 0.891 | 1e-170 | |
| 225425176 | 464 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.700 | 0.888 | 1e-169 | |
| 449445572 | 469 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.692 | 0.849 | 1e-169 | |
| 149939721 | 456 | avrPphB susceptible 1 [Arabidopsis thali | 0.963 | 0.686 | 0.878 | 1e-163 | |
| 15240038 | 456 | serine/threonine-protein kinase PBS1 [Ar | 0.963 | 0.686 | 0.878 | 1e-162 | |
| 149939759 | 456 | avrPphB susceptible 1 [Arabidopsis lyrat | 0.963 | 0.686 | 0.875 | 1e-162 |
| >gi|255547614|ref|XP_002514864.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223545915|gb|EEF47418.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 613 bits (1581), Expect = e-173, Method: Compositional matrix adjust.
Identities = 294/327 (89%), Positives = 310/327 (94%), Gaps = 2/327 (0%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP KE LDWNTRM+IAAG
Sbjct: 135 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPAKEPLDWNTRMRIAAG 194
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AAKGLEYLHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP GDKSHVSTRVMGT
Sbjct: 195 AAKGLEYLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGT 254
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR
Sbjct: 255 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 314
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSH 240
KFSKLADP+L+GRYP+RGLYQALAVASMCIQEQAA RPLIGDVVTALSYLANQ Y+PNS
Sbjct: 315 KFSKLADPQLQGRYPMRGLYQALAVASMCIQEQAAARPLIGDVVTALSYLANQAYEPNST 374
Query: 241 RGAGDKDDRRNRD--GARIFKNDEGGGSGRRWDLEGSEKEDSPRETARILNRDLERERAV 298
++DD+RNRD G ++ K++EGGGSGRRWDLEGSEKEDSPRET R+LNRDL+RERAV
Sbjct: 375 GHGRERDDKRNRDERGGQLSKSEEGGGSGRRWDLEGSEKEDSPRETVRMLNRDLDRERAV 434
Query: 299 AEAKMWGENLREKRRQSAQGSFDGTNG 325
AEAKMWGEN REKRRQSAQGSFDG+NG
Sbjct: 435 AEAKMWGENWREKRRQSAQGSFDGSNG 461
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053527|ref|XP_002297857.1| serine/threonine protein kinase PBS1 [Populus trichocarpa] gi|222845115|gb|EEE82662.1| serine/threonine protein kinase PBS1 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 609 bits (1571), Expect = e-172, Method: Compositional matrix adjust.
Identities = 291/329 (88%), Positives = 314/329 (95%), Gaps = 4/329 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP+KE LDWNTRMKIAAG
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPEKEPLDWNTRMKIAAG 193
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AAKGLEYLHDKA+PPVIYRDFKSSNILLEEGF+PKLSDFGLAKLGP GDKSHVSTRVMGT
Sbjct: 194 AAKGLEYLHDKASPPVIYRDFKSSNILLEEGFNPKLSDFGLAKLGPTGDKSHVSTRVMGT 253
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST+PHG+QNLV WARPLFNDRR
Sbjct: 254 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTQPHGQQNLVAWARPLFNDRR 313
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPN-- 238
KFSKLADPRL+GRYP+RGLYQALAVASMCIQEQAA RPLIGDVVTALSYLANQ Y+PN
Sbjct: 314 KFSKLADPRLQGRYPMRGLYQALAVASMCIQEQAAARPLIGDVVTALSYLANQAYEPNGH 373
Query: 239 SHRGAGDKDDRRNRD--GARIFKNDEGGGSGRRWDLEGSEKEDSPRETARILNRDLERER 296
HRG+GD+D++R RD G ++ +N+EGGGSGRRWDL+GSEKEDSPRETA++LNRDL+RER
Sbjct: 374 GHRGSGDRDEKRQRDERGGQLSRNEEGGGSGRRWDLDGSEKEDSPRETAKMLNRDLDRER 433
Query: 297 AVAEAKMWGENLREKRRQSAQGSFDGTNG 325
AVAEAKMWGEN REK+RQ+AQGSFDG+NG
Sbjct: 434 AVAEAKMWGENWREKQRQNAQGSFDGSNG 462
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351721508|ref|NP_001235164.1| serine/threonine-protein kinase [Glycine max] gi|223452434|gb|ACM89544.1| serine/threonine-protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 604 bits (1557), Expect = e-170, Method: Compositional matrix adjust.
Identities = 293/325 (90%), Positives = 306/325 (94%), Gaps = 5/325 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE LDWNTRMKIA G
Sbjct: 127 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEPLDWNTRMKIAVG 186
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AAKGLEYLHDKANPPVIYRDFKSSNILL+EG+HPKLSDFGLAKLGPVGDKSHVSTRVMGT
Sbjct: 187 AAKGLEYLHDKANPPVIYRDFKSSNILLDEGYHPKLSDFGLAKLGPVGDKSHVSTRVMGT 246
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST+P GEQNLVTWARPLFNDRR
Sbjct: 247 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTQPQGEQNLVTWARPLFNDRR 306
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSH 240
KFSKLADPRL+GR+P+RGLYQALAVASMCIQE AATRPLIGDVVTALSYLANQ YDPN +
Sbjct: 307 KFSKLADPRLQGRFPMRGLYQALAVASMCIQESAATRPLIGDVVTALSYLANQAYDPNGY 366
Query: 241 RGAGDKDDRRNRD--GARIFKNDEGGGSGRRWDLEGSEKEDSPRETARILNRDLERERAV 298
RG+ DD+RNRD G RI KNDE GGSGRRWDLEGSEK+DSPRETARILNRDL+RERAV
Sbjct: 367 RGS--SDDKRNRDDKGGRISKNDEAGGSGRRWDLEGSEKDDSPRETARILNRDLDRERAV 424
Query: 299 AEAKMWGENLREKRRQS-AQGSFDG 322
AEAKMWGENLR+KR+QS QGS D
Sbjct: 425 AEAKMWGENLRQKRKQSLQQGSLDA 449
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356576935|ref|XP_003556585.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 602 bits (1553), Expect = e-170, Method: Compositional matrix adjust.
Identities = 295/327 (90%), Positives = 309/327 (94%), Gaps = 8/327 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMP GSLEDHLHDLPPDKE LDWNTRMKIAAG
Sbjct: 143 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPFGSLEDHLHDLPPDKEPLDWNTRMKIAAG 202
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AAKGLEYLHDKANPPVIYRDFKSSNILL+EG+HPKLSDFGLAKLGPVGDKSHVSTRVMGT
Sbjct: 203 AAKGLEYLHDKANPPVIYRDFKSSNILLDEGYHPKLSDFGLAKLGPVGDKSHVSTRVMGT 262
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF+DRR
Sbjct: 263 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFSDRR 322
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSH 240
KF KLADP+L+GRYP+RGLYQALAVASMCIQEQAA RPLIGDVVTALS+LANQ YD H
Sbjct: 323 KFPKLADPQLQGRYPMRGLYQALAVASMCIQEQAAARPLIGDVVTALSFLANQAYD---H 379
Query: 241 RGAGDKDDRRNRD--GARIFKNDEGGGSGRRWDLEGSEKEDSPRETARIL-NRDLERERA 297
RGAG DD++NRD G RI KND GGGSGRRWDLEGSEK+DSPRETAR+L NRDL+RERA
Sbjct: 380 RGAG--DDKKNRDDKGGRILKNDVGGGSGRRWDLEGSEKDDSPRETARMLNNRDLDRERA 437
Query: 298 VAEAKMWGENLREKRRQSAQGSFDGTN 324
VAEAK+WGEN REKRRQSAQGSFDG+N
Sbjct: 438 VAEAKIWGENWREKRRQSAQGSFDGSN 464
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224075521|ref|XP_002304664.1| serine/threonine protein kinase PBS1 [Populus trichocarpa] gi|222842096|gb|EEE79643.1| serine/threonine protein kinase PBS1 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 602 bits (1553), Expect = e-170, Method: Compositional matrix adjust.
Identities = 288/323 (89%), Positives = 308/323 (95%), Gaps = 4/323 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP+KE LDWNTRMKIAAG
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPEKEPLDWNTRMKIAAG 193
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AA+GLEYLHDKA+PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP GDKSHVSTRVMGT
Sbjct: 194 AARGLEYLHDKASPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGT 253
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS+RPHGEQNLVTW RPLFNDRR
Sbjct: 254 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSSRPHGEQNLVTWTRPLFNDRR 313
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSH 240
KFSKLADPRL+GRYP+RGLYQALAVASMCIQEQAA RPLIGDVVTALSYLANQ Y+PN H
Sbjct: 314 KFSKLADPRLQGRYPMRGLYQALAVASMCIQEQAAARPLIGDVVTALSYLANQAYEPNGH 373
Query: 241 --RGAGDKDDRRNRD--GARIFKNDEGGGSGRRWDLEGSEKEDSPRETARILNRDLERER 296
RG GD+D++R+R+ G ++ +N+EGGGSGR+WDL+GSEKEDSPRETAR+LNRDL+RER
Sbjct: 374 GYRGLGDRDEKRHREERGGQLSRNEEGGGSGRKWDLDGSEKEDSPRETARMLNRDLDRER 433
Query: 297 AVAEAKMWGENLREKRRQSAQGS 319
AVAEAKMWGEN REKRRQSAQGS
Sbjct: 434 AVAEAKMWGENWREKRRQSAQGS 456
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225425176|ref|XP_002265076.1| PREDICTED: serine/threonine-protein kinase PBS1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 600 bits (1548), Expect = e-169, Method: Compositional matrix adjust.
Identities = 295/332 (88%), Positives = 311/332 (93%), Gaps = 7/332 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADG+QRLLVYEFMPLGSLEDHL DLPPDKE LDWNTRMKIAAG
Sbjct: 133 MLSLLHHPNLVNLIGYCADGEQRLLVYEFMPLGSLEDHLLDLPPDKEPLDWNTRMKIAAG 192
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AAKGLEYLHDKA+PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT
Sbjct: 193 AAKGLEYLHDKASPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 252
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST PHGEQNLVTWARPLFNDRR
Sbjct: 253 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTLPHGEQNLVTWARPLFNDRR 312
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNS- 239
KF+KLADPRL GRYP+RGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ+YDPN+
Sbjct: 313 KFAKLADPRLHGRYPMRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQSYDPNAA 372
Query: 240 ----HRGAG--DKDDRRNRDGARIFKNDEGGGSGRRWDLEGSEKEDSPRETARILNRDLE 293
+RG+G D+ R AR+ +N++GGGSGRRWDLEGSE+EDSPRETAR+LNRDL+
Sbjct: 373 HGHIYRGSGDRDERRNREERSARVTRNEDGGGSGRRWDLEGSEREDSPRETARMLNRDLD 432
Query: 294 RERAVAEAKMWGENLREKRRQSAQGSFDGTNG 325
RERAVAEAKMWGEN REKRRQSAQGSFDGTNG
Sbjct: 433 RERAVAEAKMWGENWREKRRQSAQGSFDGTNG 464
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445572|ref|XP_004140546.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] gi|449487387|ref|XP_004157601.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 599 bits (1544), Expect = e-169, Method: Compositional matrix adjust.
Identities = 288/339 (84%), Positives = 310/339 (91%), Gaps = 14/339 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH++PP+KE LDWNTRMKIAAG
Sbjct: 131 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHEIPPEKEPLDWNTRMKIAAG 190
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AA+GLEYLHDKANPPVIYRDFKSSNILL+EG+HPKLSDFGLAKLGPVGDKSHVSTRVMGT
Sbjct: 191 AARGLEYLHDKANPPVIYRDFKSSNILLDEGYHPKLSDFGLAKLGPVGDKSHVSTRVMGT 250
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR+AIDSTRP GEQNLVTWARP FNDRR
Sbjct: 251 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRRAIDSTRPQGEQNLVTWARPFFNDRR 310
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNS- 239
+FSKLADP+L+GRYP+RGLYQALAVASMC QEQAA RPLIGDVVTALSYLANQ+YDP+S
Sbjct: 311 RFSKLADPQLQGRYPMRGLYQALAVASMCTQEQAAARPLIGDVVTALSYLANQSYDPSSP 370
Query: 240 ----------HRGAGDKDDRRNRD---GARIFKNDEGGGSGRRWDLEGSEKEDSPRETAR 286
RG+GD+D+RRNRD G + KN+EGG SGRRW L+G EK+DSPRETAR
Sbjct: 371 SGTAAAGTAAQRGSGDRDERRNRDEKGGGGMVKNEEGGASGRRWPLDGPEKDDSPRETAR 430
Query: 287 ILNRDLERERAVAEAKMWGENLREKRRQSAQGSFDGTNG 325
ILNRDL+RERAVAEAKMWGEN REKRRQS QGSFDG+NG
Sbjct: 431 ILNRDLDRERAVAEAKMWGENWREKRRQSTQGSFDGSNG 469
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|149939721|gb|ABR46067.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939753|gb|ABR46083.1| avrPphB susceptible 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1491), Expect = e-163, Method: Compositional matrix adjust.
Identities = 283/322 (87%), Positives = 295/322 (91%), Gaps = 9/322 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWN RMKIAAG
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAG 193
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AAKGLE+LHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP GDKSHVSTRVMGT
Sbjct: 194 AAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGT 253
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS PHGEQNLV WARPLFNDRR
Sbjct: 254 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRR 313
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSH 240
KF KLADPRL+GR+P R LYQALAVASMCIQEQAATRPLI DVVTALSYLANQ YDP+
Sbjct: 314 KFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQAYDPSK- 372
Query: 241 RGAGDKDDRRNRD--GAR-IFKNDEGGGSGRRWDLEGSEKEDSPRETARILNRDLERERA 297
D RRNRD GAR I +ND+GGGSG ++DLEGSEKEDSPRETARILNRD+ RERA
Sbjct: 373 -----DDSRRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPRETARILNRDINRERA 427
Query: 298 VAEAKMWGENLREKRRQSAQGS 319
VAEAKMWGE+LREKRRQS QG+
Sbjct: 428 VAEAKMWGESLREKRRQSEQGT 449
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15240038|ref|NP_196820.1| serine/threonine-protein kinase PBS1 [Arabidopsis thaliana] gi|45477166|sp|Q9FE20.1|PBS1_ARATH RecName: Full=Serine/threonine-protein kinase PBS1; AltName: Full=AvrPphB susceptible protein 1 gi|11559838|gb|AAG38109.1|AF314176_1 protein serine/threonine kinase PBS1 [Arabidopsis thaliana] gi|13937147|gb|AAK50067.1|AF372927_1 AT5g13160/T19L5_120 [Arabidopsis thaliana] gi|9955560|emb|CAC05444.1| protein kinase-like [Arabidopsis thaliana] gi|18700256|gb|AAL77738.1| AT5g13160/T19L5_120 [Arabidopsis thaliana] gi|149939719|gb|ABR46066.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939723|gb|ABR46068.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939725|gb|ABR46069.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939727|gb|ABR46070.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939729|gb|ABR46071.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939731|gb|ABR46072.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939733|gb|ABR46073.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939735|gb|ABR46074.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939737|gb|ABR46075.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939739|gb|ABR46076.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939741|gb|ABR46077.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939743|gb|ABR46078.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939745|gb|ABR46079.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939747|gb|ABR46080.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939749|gb|ABR46081.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939751|gb|ABR46082.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939755|gb|ABR46084.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|149939757|gb|ABR46085.1| avrPphB susceptible 1 [Arabidopsis thaliana] gi|332004475|gb|AED91858.1| serine/threonine-protein kinase PBS1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1490), Expect = e-162, Method: Compositional matrix adjust.
Identities = 283/322 (87%), Positives = 295/322 (91%), Gaps = 9/322 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWN RMKIAAG
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAG 193
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AAKGLE+LHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP GDKSHVSTRVMGT
Sbjct: 194 AAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGT 253
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS PHGEQNLV WARPLFNDRR
Sbjct: 254 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRR 313
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSH 240
KF KLADPRL+GR+P R LYQALAVASMCIQEQAATRPLI DVVTALSYLANQ YDP+
Sbjct: 314 KFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQAYDPSK- 372
Query: 241 RGAGDKDDRRNRD--GAR-IFKNDEGGGSGRRWDLEGSEKEDSPRETARILNRDLERERA 297
D RRNRD GAR I +ND+GGGSG ++DLEGSEKEDSPRETARILNRD+ RERA
Sbjct: 373 -----DDSRRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPRETARILNRDINRERA 427
Query: 298 VAEAKMWGENLREKRRQSAQGS 319
VAEAKMWGE+LREKRRQS QG+
Sbjct: 428 VAEAKMWGESLREKRRQSEQGT 449
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|149939759|gb|ABR46086.1| avrPphB susceptible 1 [Arabidopsis lyrata] gi|149939761|gb|ABR46087.1| avrPphB susceptible 1 [Arabidopsis lyrata] gi|149939763|gb|ABR46088.1| avrPphB susceptible 1 [Arabidopsis lyrata] gi|149939765|gb|ABR46089.1| avrPphB susceptible 1 [Arabidopsis lyrata] gi|149939767|gb|ABR46090.1| avrPphB susceptible 1 [Arabidopsis lyrata] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1486), Expect = e-162, Method: Compositional matrix adjust.
Identities = 282/322 (87%), Positives = 295/322 (91%), Gaps = 9/322 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLSLLHH NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWN RMKIAAG
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAG 193
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AAKGLE+LHDKANPPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP GDKSHVSTRVMGT
Sbjct: 194 AAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGT 253
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS PHGEQNLV WARPLFNDRR
Sbjct: 254 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRR 313
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSH 240
KF KLADPRL+GR+P R LYQALAVASMCIQEQAATRPLI DVVTALSYLANQ YDP+
Sbjct: 314 KFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQGYDPSK- 372
Query: 241 RGAGDKDDRRNRD--GAR-IFKNDEGGGSGRRWDLEGSEKEDSPRETARILNRDLERERA 297
D +RNRD GAR I +ND+GGGSG ++DLEGSEKEDSPRETARILNRD+ RERA
Sbjct: 373 -----DDSKRNRDERGARLITRNDDGGGSGSKFDLEGSEKEDSPRETARILNRDINRERA 427
Query: 298 VAEAKMWGENLREKRRQSAQGS 319
VAEAKMWGE+LREKRRQS QG+
Sbjct: 428 VAEAKMWGESLREKRRQSEQGT 449
|
Source: Arabidopsis lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 325 | ||||||
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.935 | 0.666 | 0.863 | 6.8e-143 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.926 | 0.586 | 0.688 | 3.4e-109 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.689 | 0.592 | 0.830 | 3.4e-100 | |
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.732 | 0.616 | 0.707 | 1.7e-91 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.710 | 0.544 | 0.711 | 7.5e-89 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.667 | 0.524 | 0.732 | 2.7e-88 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.670 | 0.560 | 0.715 | 4.9e-85 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.68 | 0.580 | 0.705 | 7.2e-84 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.704 | 0.588 | 0.685 | 3.1e-83 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.695 | 0.622 | 0.690 | 4.5e-82 |
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1397 (496.8 bits), Expect = 6.8e-143, P = 6.8e-143
Identities = 272/315 (86%), Positives = 287/315 (91%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWN RMKIAAGAAKGLE+LHDKAN
Sbjct: 147 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNMRMKIAAGAAKGLEFLHDKAN 206
Query: 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRDFKSSNILL+EGFHPKLSDFGLAKLGP GDKSHVSTRVMGTYGYCAPEYAMTGQ
Sbjct: 207 PPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAMTGQ 266
Query: 134 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 193
LTVKSDVYSFGVVFLELITGRKAIDS PHGEQNLV WARPLFNDRRKF KLADPRL+GR
Sbjct: 267 LTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARPLFNDRRKFIKLADPRLKGR 326
Query: 194 YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSHRGAGDKDD-RRNR 252
+P R LYQALAVASMCIQEQAATRPLI DVVTALSYLANQ YDP+ KDD RRNR
Sbjct: 327 FPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQAYDPS-------KDDSRRNR 379
Query: 253 D--GARIF-KNDEGGGSGRRWDLEGSEKEDSPRETARILNRDLERERAVAEAKMWGENLR 309
D GAR+ +ND+GGGSG ++DLEGSEKEDSPRETARILNRD+ RERAVAEAKMWGE+LR
Sbjct: 380 DERGARLITRNDDGGGSGSKFDLEGSEKEDSPRETARILNRDINRERAVAEAKMWGESLR 439
Query: 310 EKRRQSAQGSFDGTN 324
EKRRQS QG+ + +
Sbjct: 440 EKRRQSEQGTSESNS 454
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1079 (384.9 bits), Expect = 3.4e-109, P = 3.4e-109
Identities = 223/324 (68%), Positives = 253/324 (78%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYCADGDQRLLVYE+MPLGSLEDHLHDLPPDKE LDW+TRM IAAGAAKGLEYLHDKAN
Sbjct: 144 IGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLDWSTRMTIAAGAAKGLEYLHDKAN 203
Query: 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRD KSSNILL +G+HPKLSDFGLAKLGPVGDK+HVSTRVMGTYGYCAPEYAMTGQ
Sbjct: 204 PPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDKTHVSTRVMGTYGYCAPEYAMTGQ 263
Query: 134 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 193
LT+KSDVYSFGVVFLELITGRKAID+ R GE NLV WARPLF DRRKF K+ADP L+GR
Sbjct: 264 LTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVAWARPLFKDRRKFPKMADPSLQGR 323
Query: 194 YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPN------SHRGAGD-- 245
YP+RGLYQALAVA+MC+QEQAATRPLIGDVVTAL+YLA+QT+DPN S G+G
Sbjct: 324 YPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYLASQTFDPNAPSGQNSRSGSGPPF 383
Query: 246 ---KDDRRNR-DGARIFKNDEGGGSGRRWDLEGSEKEDSP----RETARILNRDLE--RE 295
+DDRR+ DG+ + D + R + K +SP R+ R +N E E
Sbjct: 384 IRTRDDRRSLGDGSSL---DSPAETRSRLGSPATHK-NSPDYRRRDMVREVNAGSEGGSE 439
Query: 296 RAVAEAKMWGENLREKRRQSAQGS 319
+ WG + E + +S +GS
Sbjct: 440 TGGGSGRKWGLSDLEGQ-ESQRGS 462
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 994 (355.0 bits), Expect = 3.4e-100, P = 3.4e-100
Identities = 186/224 (83%), Positives = 203/224 (90%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYCADGDQRLLVYE+MPLGSLEDHLHD+ P K+ LDWNTRMKIAAGAAKGLEYLHDK
Sbjct: 134 IGYCADGDQRLLVYEYMPLGSLEDHLHDISPGKQPLDWNTRMKIAAGAAKGLEYLHDKTM 193
Query: 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRD K SNILL++ + PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ
Sbjct: 194 PPVIYRDLKCSNILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 253
Query: 134 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 193
LT+KSDVYSFGVV LE+ITGRKAIDS+R GEQNLV WARPLF DRRKFS++ADP L+G+
Sbjct: 254 LTLKSDVYSFGVVLLEIITGRKAIDSSRSTGEQNLVAWARPLFKDRRKFSQMADPMLQGQ 313
Query: 194 YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDP 237
YP RGLYQALAVA+MC+QEQ RPLI DVVTALSYLA+Q +DP
Sbjct: 314 YPPRGLYQALAVAAMCVQEQPNLRPLIADVVTALSYLASQKFDP 357
|
|
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 912 (326.1 bits), Expect = 1.7e-91, P = 1.7e-91
Identities = 169/239 (70%), Positives = 207/239 (86%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-LDWNTRMKIAAGAAKGLEYLHDKA 72
+GYCADGDQR+LVYE+M GSLEDHL +L +K+ LDW+TRMK+AAGAA+GLEYLH+ A
Sbjct: 143 VGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAAGAARGLEYLHETA 202
Query: 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG 132
+PPVIYRDFK+SNILL+E F+PKLSDFGLAK+GP G ++HVSTRVMGTYGYCAPEYA+TG
Sbjct: 203 DPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMGTYGYCAPEYALTG 262
Query: 133 QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 192
QLTVKSDVYSFGVVFLE+ITGR+ ID+T+P EQNLVTWA PLF DRRKF+ +ADP LEG
Sbjct: 263 QLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLFKDRRKFTLMADPLLEG 322
Query: 193 RYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSHRGAGDKDDRRN 251
+YPI+GLYQALAVA+MC+QE+AATRP++ DVVTAL YLA + + G++++ +
Sbjct: 323 KYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYLAVTKTEEDGQTVEGEEEEEED 381
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 887 (317.3 bits), Expect = 7.5e-89, P = 7.5e-89
Identities = 165/232 (71%), Positives = 191/232 (82%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73
IG+CA+G QRLLVYE+MPLGSL++HLHDLP K L WNTRMKIAAGAA+GLEYLHD
Sbjct: 159 IGFCAEGVQRLLVYEYMPLGSLDNHLHDLPSGKNPLAWNTRMKIAAGAARGLEYLHDTMK 218
Query: 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRD K SNIL++EG+H KLSDFGLAK+GP G ++HVSTRVMGTYGYCAP+YA+TGQ
Sbjct: 219 PPVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSETHVSTRVMGTYGYCAPDYALTGQ 278
Query: 134 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 193
LT KSDVYSFGVV LELITGRKA D+TR Q+LV WA PLF DR+ F K+ DP LEG
Sbjct: 279 LTFKSDVYSFGVVLLELITGRKAYDNTRTRNHQSLVEWANPLFKDRKNFKKMVDPLLEGD 338
Query: 194 YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSHRGAGD 245
YP+RGLYQALA+A+MC+QEQ + RP+I DVV AL +LA+ YD SHR D
Sbjct: 339 YPVRGLYQALAIAAMCVQEQPSMRPVIADVVMALDHLASSKYD-RSHRQKQD 389
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 844 (302.2 bits), Expect = 2.7e-88, Sum P(2) = 2.7e-88
Identities = 159/217 (73%), Positives = 184/217 (84%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYCADGDQRLLVYE+M GSLEDHL DL PD+ LDW+TR++IA GAA GLEYLHDKAN
Sbjct: 140 IGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPLDWDTRIRIALGAAMGLEYLHDKAN 199
Query: 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRD K++NILL+ F+ KLSDFGLAKLGPVGDK HVS+RVMGTYGYCAPEY TGQ
Sbjct: 200 PPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSRVMGTYGYCAPEYQRTGQ 259
Query: 134 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 193
LT KSDVYSFGVV LELITGR+ ID+TRP EQNLVTWA+P+F + +F +LADP LEG
Sbjct: 260 LTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLVTWAQPVFKEPSRFPELADPSLEGV 319
Query: 194 YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230
+P + L QA+AVA+MC+QE+A RPL+ DVVTAL +L
Sbjct: 320 FPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGFL 356
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 851 (304.6 bits), Expect = 4.9e-85, P = 4.9e-85
Identities = 156/218 (71%), Positives = 184/218 (84%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYC + +QR+LVYEFMP GSLEDHL DLP +LDW TRM+I GAAKGLEYLHD A+
Sbjct: 146 IGYCVEDEQRVLVYEFMPNGSLEDHLFDLPEGSPSLDWFTRMRIVHGAAKGLEYLHDYAD 205
Query: 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRDFK+SNILL+ F+ KLSDFGLA+LGP K HVSTRVMGTYGYCAPEYAMTGQ
Sbjct: 206 PPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEGKDHVSTRVMGTYGYCAPEYAMTGQ 265
Query: 134 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 193
LT KSDVYSFGVV LE+I+GR+AID RP EQNL++WA PL DRR F+++ DP L+G
Sbjct: 266 LTAKSDVYSFGVVLLEIISGRRAIDGDRPTEEQNLISWAEPLLKDRRMFAQIVDPNLDGN 325
Query: 194 YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231
YP++GL+QALA+A+MC+QE+A TRPL+GDVVTAL +LA
Sbjct: 326 YPVKGLHQALAIAAMCLQEEAETRPLMGDVVTALEFLA 363
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 840 (300.8 bits), Expect = 7.2e-84, P = 7.2e-84
Identities = 156/221 (70%), Positives = 182/221 (82%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYC GDQRLLVYE+MP+GSLEDHL DL ++E L WNTRMKIA GAA+G+EYLH AN
Sbjct: 138 IGYCTSGDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAVGAARGIEYLHCTAN 197
Query: 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRD KS+NILL++ F PKLSDFGLAKLGPVGD++HVSTRVMGTYGYCAPEYAM+G+
Sbjct: 198 PPVIYRDLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMGTYGYCAPEYAMSGK 257
Query: 134 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 193
LTVKSD+Y FGVV LELITGRKAID + GEQNLVTW+RP D++KF L DP L G+
Sbjct: 258 LTVKSDIYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKDQKKFGHLVDPSLRGK 317
Query: 194 YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234
YP R L A+A+ +MC+ E+A RP IGD+V AL YLA Q+
Sbjct: 318 YPRRCLNYAIAIIAMCLNEEAHYRPFIGDIVVALEYLAAQS 358
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 834 (298.6 bits), Expect = 3.1e-83, P = 3.1e-83
Identities = 157/229 (68%), Positives = 189/229 (82%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYC DGDQRLLV+EFMPLGSLEDHL D+ ++ LDWN+R++IA GAAKGLEYLH+KAN
Sbjct: 132 IGYCLDGDQRLLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRIRIALGAAKGLEYLHEKAN 191
Query: 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRDFKSSNILL F KLSDFGLAKLG VGD +VS+RV+GTYGYCAPEY TGQ
Sbjct: 192 PPVIYRDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQNVSSRVVGTYGYCAPEYHKTGQ 251
Query: 134 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 193
LTVKSDVYSFGVV LELITG++ ID+TRP EQNLVTWA+P+F + +F +LADP L+G
Sbjct: 252 LTVKSDVYSFGVVLLELITGKRVIDTTRPCHEQNLVTWAQPIFREPNRFPELADPLLQGE 311
Query: 194 YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNSHRG 242
+P + L QA+A+A+MC+QE+ RPLI DVVTALS+++ +T P+ G
Sbjct: 312 FPEKSLNQAVAIAAMCLQEEPIVRPLISDVVTALSFMSTETGSPSGLTG 360
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 823 (294.8 bits), Expect = 4.5e-82, P = 4.5e-82
Identities = 156/226 (69%), Positives = 183/226 (80%)
Query: 14 IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73
IGYCADGDQRLLVYE+MPLGSLEDHL DL P ++ LDWNTR+KIA GAAKG+EYLHD+A+
Sbjct: 108 IGYCADGDQRLLVYEYMPLGSLEDHLLDLEPGQKPLDWNTRIKIALGAAKGIEYLHDEAD 167
Query: 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ 133
PPVIYRD KSSNILL+ + KLSDFGLAKLGPVGD HVS+RVMGTYGYCAPEY TG
Sbjct: 168 PPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPVGDTLHVSSRVMGTYGYCAPEYQRTGY 227
Query: 134 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGR 193
LT KSDVYSFGVV LELI+GR+ ID+ RP EQNLVTWA P+F D ++ +LADP L G
Sbjct: 228 LTNKSDVYSFGVVLLELISGRRVIDTMRPSHEQNLVTWALPIFRDPTRYWQLADPLLRGD 287
Query: 194 YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDPNS 239
YP + L QA+AVA+MC+ E+ RPL+ DV+TALS+L + N+
Sbjct: 288 YPEKSLNQAIAVAAMCLHEEPTVRPLMSDVITALSFLGASSNSSNT 333
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FE20 | PBS1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8788 | 0.9630 | 0.6864 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.00010502 | serine/threonine protein kinase PBS1 (462 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 325 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-42 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-38 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-37 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-26 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-22 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-20 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-19 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-19 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-19 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-15 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 6e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-13 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-13 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-12 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-12 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 9e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-11 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-11 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-11 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-11 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 8e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-10 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-10 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 3e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-10 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-10 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-10 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-10 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 9e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-07 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-07 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 5e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-06 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-05 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 5e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-04 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 2e-42
Identities = 55/152 (36%), Positives = 79/152 (51%), Gaps = 10/152 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L+H N+V L G D + LV E+ GSL+D L + L + ++I
Sbjct: 44 ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGK---LSEDEILRILLQ 100
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
+GLEYLH +I+RD K NILL + KL+DFGL+KL + + ++G
Sbjct: 101 ILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVG 155
Query: 120 TYGYCAPE-YAMTGQLTVKSDVYSFGVVFLEL 150
T Y APE G + KSD++S GV+ EL
Sbjct: 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 53/153 (34%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H N+V L+G C G+ +V E+MP G L D L E L +++A
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AKG+EYL K ++RD + N L+ E K+SDFGL++ D
Sbjct: 111 IAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
+ APE G+ T KSDV+SFGV+ E+ T
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-38
Identities = 49/153 (32%), Positives = 76/153 (49%), Gaps = 9/153 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H N+V L+G C + + +V E+M G L +L + L + + A
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD-KSHVSTRVMG 119
A+G+EYL K I+RD + N L+ E K+SDFGL++ D ++
Sbjct: 111 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-- 165
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE G+ T KSDV+SFGV+ E+ T
Sbjct: 166 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 51/153 (33%), Positives = 79/153 (51%), Gaps = 8/153 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H N+V L+G C + + ++V E+MP G L D+L + L + + A
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK--NRPKELSLSDLLSFALQ 111
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD-KSHVSTRVMG 119
A+G+EYL K I+RD + N L+ E K+SDFGL++ D ++
Sbjct: 112 IARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-- 166
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE G+ T KSDV+SFGV+ E+ T
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 7e-37
Identities = 63/155 (40%), Positives = 82/155 (52%), Gaps = 10/155 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N+V LI D D LV E+ G L D+L P L + KIA
Sbjct: 51 ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAKKIALQ 106
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+GLEYLH +I+RD K NILL+E K++DFGLAK + S ++T V GT
Sbjct: 107 ILRGLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GT 161
Query: 121 YGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
Y APE + G K DV+S GV+ EL+TG+
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 54/157 (34%), Positives = 76/157 (48%), Gaps = 8/157 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL-----HDLPPDKEALDWNTRM 55
++ L H N+V L+G C + + LV E+M G L D+L P+K L +
Sbjct: 49 VMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLL 108
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
A AKG+EYL K ++RD + N L+ E K+SDFGL++ D T
Sbjct: 109 SFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE G T KSDV+SFGV+ E+ T
Sbjct: 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 6e-35
Identities = 55/154 (35%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N+V L D D+ LV E+ G L D L E R
Sbjct: 50 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE---AR-FYLRQ 105
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
LEYLH K +++RD K NILL+E H KL+DFGLA+ + ++T V GT
Sbjct: 106 ILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GT 159
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
Y APE + D++S GV+ EL+TG+
Sbjct: 160 PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 13/158 (8%)
Query: 1 MLSLLHHSNLVNLIGYC--ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEAL--DWNTRMK 56
+LS L H N+V G + + + E++ GSL L E + + TR
Sbjct: 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY-TRQI 110
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
+ +GL YLH +++RD K +NIL++ KL+DFG AK + +
Sbjct: 111 L-----EGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGS 162
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
V GT + APE + +D++S G +E+ TG+
Sbjct: 163 VRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 1e-24
Identities = 52/160 (32%), Positives = 73/160 (45%), Gaps = 21/160 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAA 59
+L H N+V G D+ +V EF GSL+D L E+ +IA
Sbjct: 50 ILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES-------QIAY 102
Query: 60 ---GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
KGLEYLH +I+RD K++NILL KL DFGL+ S R
Sbjct: 103 VCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSA-----QLSDTKAR 154
Query: 117 --VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
++GT + APE K+D++S G+ +EL G+
Sbjct: 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-23
Identities = 50/152 (32%), Positives = 75/152 (49%), Gaps = 11/152 (7%)
Query: 5 LHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 62
L H N+V G C R L+ E++P GSL D+L ++ ++ + ++
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQIC 119
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST--RVMGT 120
KG++YL + I+RD + NIL+E K+SDFGLAK+ P +
Sbjct: 120 KGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ Y APE T + + SDV+SFGV EL T
Sbjct: 177 FWY-APECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 98.3 bits (243), Expect = 3e-23
Identities = 61/160 (38%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 62
SL H N+V L + D LV E++ GSLED L K L + + I A
Sbjct: 53 SLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKK-IGRKGPLSESEALFILAQIL 111
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAK-LGPVGDKSHV---STRV 117
LEYLH K +I+RD K NILL +G KL DFGLAK L G S + +
Sbjct: 112 SALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTS 168
Query: 118 MGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGR 154
+GT GY APE + + SD++S G+ EL+TG
Sbjct: 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-22
Identities = 50/162 (30%), Positives = 85/162 (52%), Gaps = 8/162 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+++ + H ++V L+G C Q L+ + MPLG L D++ + K+ + +
Sbjct: 62 VMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AKG+ YL +K +++RD + N+L++ H K++DFGLAKL V +K + +
Sbjct: 118 IAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVP 174
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTR 161
+ A E + T KSDV+S+GV EL+T G K +
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 4e-22
Identities = 55/154 (35%), Positives = 83/154 (53%), Gaps = 13/154 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H LV L C++ + +V E+M GSL D L + + L + +AA A+G
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEG 115
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 121
+ YL + I+RD + NIL+ E K++DFGLA+L + D + R G
Sbjct: 116 MAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARL--IED-DEYTAR-EGAKFPI 168
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154
+ APE A G+ T+KSDV+SFG++ E++T GR
Sbjct: 169 KWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-22
Identities = 60/157 (38%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L H N+V G C +R LV E++P GSL D+L +E LD + A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYA 114
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
+ KG+EYL K ++RD + NIL+E K+ DFGL K+ P DK + R
Sbjct: 115 SQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREP 170
Query: 119 G---TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
G + Y APE + +V SDV+SFGVV EL T
Sbjct: 171 GESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (227), Expect = 2e-21
Identities = 57/158 (36%), Positives = 75/158 (47%), Gaps = 17/158 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK-I 57
+LS ++H +V L + A + LV E+ P G L HL E R +
Sbjct: 46 ILSRINHPFIVKL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE-----RARFY 98
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
AA LEYLH +IYRD K NILL +G H KL+DFGLAK S +T
Sbjct: 99 AAEIVLALEYLHSLG---IIYRDLKPENILLDADG-HIKLTDFGLAKELSSEG-SRTNTF 153
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y APE + D +S GV+ E++TG+
Sbjct: 154 C-GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 3e-20
Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 17/154 (11%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H NLV L+G G+ +V E+M GSL D+L + + ++ A +G
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEG 114
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK---LGPVGDKSHVSTRVMGTY 121
+EYL +K ++RD + N+L+ E K+SDFGLAK G K V
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK------- 164
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154
+ APE + + KSDV+SFG++ E+ + GR
Sbjct: 165 -WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (218), Expect = 4e-20
Identities = 56/167 (33%), Positives = 77/167 (46%), Gaps = 34/167 (20%)
Query: 2 LSLLHHSNLVNLIGY---CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDW-NTRM-- 55
L +LH N ++G+ + + E+M GSL+ L KE R+
Sbjct: 50 LDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL------KEVQGRIPERILG 103
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
KIA KGL YLH+K +I+RD K SNIL+ KL DFG VS
Sbjct: 104 KIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFG------------VSG 149
Query: 116 RVM--------GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+++ GT Y APE +VKSD++S G+ +EL TGR
Sbjct: 150 QLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 4e-20
Identities = 65/225 (28%), Positives = 102/225 (45%), Gaps = 18/225 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H N+V LIG C L++E++ +L + L +L W R KIA G AK
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNL-------SWERRRKIAIGIAKA 792
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
L +LH + +P V+ + I+++ P L L L K +S+ Y
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYV 845
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK 184
APE T +T KSD+Y FG++ +EL+TG+ D+ ++V WAR ++D
Sbjct: 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWARYCYSDCH-LDM 903
Query: 185 LADPRLEGRYPI--RGLYQALAVASMCIQEQAATRPLIGDVVTAL 227
DP + G + + + + +A C RP DV+ L
Sbjct: 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 5e-20
Identities = 44/171 (25%), Positives = 74/171 (43%), Gaps = 29/171 (16%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------HDLPPDKEALDWNTRM 55
L L+H N++ + + +V E+ G L + P+++ LDW ++
Sbjct: 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
L+YLH + +++RD K NI L KL DFG++K+ + ++
Sbjct: 113 ------CLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAK 161
Query: 116 RVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160
V+GT Y +PE Y KSD++S G V EL T + +
Sbjct: 162 TVVGTPYYLSPELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGE 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 9e-20
Identities = 49/148 (33%), Positives = 82/148 (55%), Gaps = 7/148 (4%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H +L++L C+ G+ ++ E M GSL L P+ + L + + +A A+G
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEG 116
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
+ YL ++ I+RD + NIL+ E K++DFGLA+L + + ++S+ Y +
Sbjct: 117 MAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWT 171
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELIT 152
APE A G + KSDV+SFG++ E+ T
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-19
Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 15/162 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEA 48
++S L H N+V L+G C +++E++ G L + L P K +
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
LD + + IA A G+EYL ++ ++RD + N L+ EG K+SDFGL++
Sbjct: 121 LDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177
Query: 109 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150
D V ++ + + PE + G+ T +SD++SFGVV E+
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 5e-19
Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 13/154 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H L+ L C + +V E M GSL ++L AL + +AA A G
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASG 115
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 121
+ YL + I+RD + N+L+ E K++DFGLA++ K + G
Sbjct: 116 MAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARV----IKEDIYEAREGAKFPI 168
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154
+ APE A+ + ++KSDV+SFG++ E++T GR
Sbjct: 169 KWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 8e-19
Identities = 51/154 (33%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L L H N+V IG D ++ E+ GSL + P E+L ++
Sbjct: 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV---- 108
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMGT 120
+GL YLH++ VI+RD K++NIL + KL+DFG+A KL V V+GT
Sbjct: 109 LQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGT 162
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ APE + SD++S G +EL+TG
Sbjct: 163 PYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 9e-19
Identities = 49/162 (30%), Positives = 74/162 (45%), Gaps = 13/162 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR------ 54
+L+ H N+V G C +GD ++V+E+M G L L PD L
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 55 ----MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 110
++IA A G+ YL A+ ++RD + N L+ K+ DFG+++ D
Sbjct: 121 LSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDY 177
Query: 111 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
V M + PE M + T +SDV+SFGVV E+ T
Sbjct: 178 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 9e-19
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 2 LSLLH---HSNLVNLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI 57
L L +V G + +G+ + V E+M GSL D L + E I
Sbjct: 50 LKTLRSCESPYVVKCYGAFYKEGEISI-VLEYMDGGSLADLLKKVGKIPE----PVLAYI 104
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTR 116
A KGL+YLH K + +I+RD K SN+L+ K++DFG++K L D+ + T
Sbjct: 105 ARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TF 160
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
V GT Y +PE + +D++S G+ LE G+
Sbjct: 161 V-GTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 50/156 (32%), Positives = 69/156 (44%), Gaps = 12/156 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AA 59
+L L+H LVNL D + LV + + G L HL E ++K
Sbjct: 53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEE-----QVKFWIC 107
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
LEYLH K +I+RD K NILL+E H ++DF +A + T G
Sbjct: 108 EIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSG 161
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155
T GY APE +V D +S GV E + G++
Sbjct: 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 51/155 (32%), Positives = 78/155 (50%), Gaps = 11/155 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L+H N+V G C++ + L+ E++PLGSL D+L K L+ + A
Sbjct: 59 ILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFA 113
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-VSTRV 117
+G+ YLH + I+RD + N+LL+ K+ DFGLAK P G + + V
Sbjct: 114 QQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ A E + + SDV+SFGV EL+T
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 6e-18
Identities = 52/157 (33%), Positives = 72/157 (45%), Gaps = 16/157 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD--LPPDKEALDWNTRMKIA 58
M SL H NL+ L G ++V E PLGSL D L L + + ++IA
Sbjct: 50 MHSL-DHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA 107
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST--- 115
G+ YL K I+RD + NILL K+ DFGL + P + +V
Sbjct: 108 ----NGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+V + +CAPE T + SDV+ FGV E+ T
Sbjct: 161 KV--PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-18
Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALD---------- 50
+L++L H ++V G C +G L+V+E+M G L L PD + L
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 51 -WNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 109
+ IA+ A G+ YL A+ ++RD + N L+ +G K+ DFG+++ D
Sbjct: 120 TLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 176
Query: 110 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
V R M + PE + + T +SD++SFGVV E+ T
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 9e-18
Identities = 55/159 (34%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL-HDLPPDKEALDWNTRMKIAA 59
+S +H N+V GD+ LV ++ GSL D + P LD +
Sbjct: 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG--GLDEAIIATVLK 109
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSH-VSTRV 117
KGLEYLH I+RD K+ NILL E K++DFG+ A L GD++ V
Sbjct: 110 EVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF 166
Query: 118 MGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGR 154
+GT + APE M K+D++SFG+ +EL TG
Sbjct: 167 VGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 45/172 (26%), Positives = 71/172 (41%), Gaps = 25/172 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ L H ++ L D + V E+ P G L ++ +LD AA
Sbjct: 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG----SLDEKCTRFYAAE 110
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL---------GPVGDKS 111
LEYLH K +I+RD K NILL++ H K++DFG AK+ +
Sbjct: 111 ILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 112 HVSTR---------VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
S +GT Y +PE SD+++ G + +++TG+
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 52/166 (31%), Positives = 87/166 (52%), Gaps = 10/166 (6%)
Query: 1 MLSL--LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
ML++ L H+ +V L+G C G LV + PLGSL DH+ +++LD +
Sbjct: 60 MLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWC 115
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
AKG+ YL + +++R+ + NILL+ +++DFG+A L DK + +
Sbjct: 116 VQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPH 163
+ A E + G+ T +SDV+S+GV E+++ G + RPH
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-17
Identities = 56/156 (35%), Positives = 90/156 (57%), Gaps = 10/156 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L ++ + +V E+M GSL D L D + AL + +AA
Sbjct: 54 IMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMG 119
A G+ Y+ ++ N I+RD +S+NIL+ +G K++DFGLA+L + D + + +
Sbjct: 111 VAAGMAYI-ERMN--YIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTARQGAKF 165
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154
+ APE A+ G+ T+KSDV+SFG++ EL+T GR
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-17
Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 21/160 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+LS L H N+V +G + D + E +P GSL L E + +I
Sbjct: 55 LLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-- 112
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-- 118
GLEYLHD+ ++RD K +NIL++ KL+DFG+AK V
Sbjct: 113 --LGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAK 159
Query: 119 ---GTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
G+ + APE G + +D++S G LE+ TG+
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-17
Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 20/155 (12%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
+ H NLV L+G C ++ EFM G+L D+L + +++ ++ + +A +
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSA 116
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL-------GPVGDKSHVSTRV 117
+EYL K I+RD + N L+ E K++DFGL++L G K +
Sbjct: 117 MEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--- 170
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE + ++KSDV++FGV+ E+ T
Sbjct: 171 -----WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-17
Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 34/223 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIA 58
+L+ L S ++ D + +V E+ G L L P E W +
Sbjct: 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFF 107
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
GL +LH K +++RD KS N+ L+ + K+ D G+AKL + D ++ + ++
Sbjct: 108 IQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIV 162
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 178
GT Y +PE KSDV++ GVV E TG+ D+ N +
Sbjct: 163 GTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA------NNQGALILKI--- 213
Query: 179 RRKFSKLADPRLEGRY-PIRGLY-QALA-VASMCIQEQAATRP 218
+ G + P+ +Y Q LA + C+ + RP
Sbjct: 214 -----------IRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 8e-17
Identities = 46/166 (27%), Positives = 85/166 (51%), Gaps = 21/166 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEALDWNTRMK 56
+L LL H N++ + ++V E+ P G+L +++ L + L + ++
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP---KLSDFGLAKLGPVGDKSHV 113
+A L ++H K +++RD K+ NILL++ H K+ DFG++K+ + KS
Sbjct: 112 LA------LHHVHTKL---ILHRDLKTQNILLDK--HKMVVKIGDFGISKI--LSSKSKA 158
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159
T V+GT Y +PE KSD+++ G V EL + ++A ++
Sbjct: 159 YT-VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 9e-17
Identities = 46/147 (31%), Positives = 70/147 (47%), Gaps = 6/147 (4%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 66
H N+V LIG C +V E +P GSL L K L ++++ AA G+E
Sbjct: 51 HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGME 107
Query: 67 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 126
YL K I+RD + N L+ E K+SDFG+++ G + + AP
Sbjct: 108 YLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP 164
Query: 127 EYAMTGQLTVKSDVYSFGVVFLELITG 153
E G+ T +SDV+S+G++ E +
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 15/159 (9%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
LS +V L Y G + L LV E++P G L L ++ +LD + A
Sbjct: 47 LSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAE 101
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS------ 114
LEYLH + +I+RD K NIL++ H KL+DFGL+K+G V + +++
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
R++GT Y APE + + D +S G + E + G
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 15/164 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEA 48
+L+ L H ++V G C DGD ++V+E+M G L L PD K
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 119
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
L + + IA+ A G+ YL A+ ++RD + N L+ K+ DFG+++
Sbjct: 120 LGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 176
Query: 109 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
D V M + PE M + T +SDV+SFGV+ E+ T
Sbjct: 177 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 48/157 (30%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 2 LSLLHHSN---LVNLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI 57
L ++H +V+ G + + + + EFM GSL+ P + KI
Sbjct: 54 LQIMHECRSPYIVSFYGAFLNENNI-CMCMEFMDCGSLDRIYKKGGP----IPVEILGKI 108
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
A +GL YL++ +++RD K SNIL+ KL DFG++ G + + ++
Sbjct: 109 AVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVS--GELINS--IADTF 162
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+GT Y +PE G+ TVKSDV+S G+ +EL G+
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-16
Identities = 50/154 (32%), Positives = 73/154 (47%), Gaps = 13/154 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H NLV L G C +V E+M G L ++L + K +W M + +
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDM--CSDVCEA 112
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 121
+EYL I+RD + N L+ E K+SDFGLA+ V D + S+ GT
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPV 165
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155
+ PE + + KSDV+SFGV+ E+ + K
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 53/157 (33%), Positives = 74/157 (47%), Gaps = 24/157 (15%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWN-TRMK---IAAG 60
H N+V+ GD+ +V E+M GSL D + N RM IA
Sbjct: 72 CKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD----------IITQNFVRMNEPQIAYV 121
Query: 61 AA---KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTR 116
+GLEYLH + VI+RD KS NILL + KL+DFG A+L K +
Sbjct: 122 CREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---S 175
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
V+GT + APE K D++S G++ +E+ G
Sbjct: 176 VVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 6e-16
Identities = 51/173 (29%), Positives = 69/173 (39%), Gaps = 26/173 (15%)
Query: 6 HHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRM------KI 57
+V G D + E+ GSL+ K+ R+ KI
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY------KKVKKRGGRIGEKVLGKI 110
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTR 116
A KGL YLH + +I+RD K SNILL KL DFG++ +L +
Sbjct: 111 AESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT--- 164
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 169
GT Y APE ++ SDV+S G+ LE+ R P GE L
Sbjct: 165 --GTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-16
Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 12/153 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H LV L + ++ E+M GSL D L P+ L N + +AA A+G
Sbjct: 58 LQHPRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEG 114
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY--G 122
+ ++ K I+RD +++NIL+ E K++DFGLA+L + + + R +
Sbjct: 115 MAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARL---IEDNEYTAREGAKFPIK 168
Query: 123 YCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154
+ APE G T+KSDV+SFG++ E++T GR
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 1e-15
Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-LDWNTRMKIAA 59
M L +H N+VNL+G C G L++ E+ G L + L +E+ L + +
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR---KRESFLTLEDLLSFSY 148
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV---STR 116
AKG+ +L K I+RD + N+LL G K+ DFGLA+ + D ++V + R
Sbjct: 149 QVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNAR 204
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ + APE T +SDV+S+G++ E+ +
Sbjct: 205 L--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 49/156 (31%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L+H N+V G C + L+ EF+P GSL+++L P +K ++ ++K A
Sbjct: 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYA 115
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-- 116
KG++YL + ++RD + N+L+E K+ DFGL K DK + + +
Sbjct: 116 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDD 171
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ + APE + + + SDV+SFGV EL+T
Sbjct: 172 LDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-15
Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 12/161 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK---------EALDW 51
+L+ L H ++V G C +GD ++V+E+M G L L PD L
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 52 NTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 111
+ + IA A G+ YL A+ ++RD + N L+ E K+ DFG+++ D
Sbjct: 120 SQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
V M + PE M + T +SDV+S GVV E+ T
Sbjct: 177 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-15
Identities = 47/165 (28%), Positives = 80/165 (48%), Gaps = 16/165 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-------------KE 47
+++ LHH N+V L+G +++E++ G L + L P K
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 48 ALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 107
+LD + IA A G+EYL ++ +++D + NIL+ E H K+SD GL++
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 108 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
D V + + + PE M G+ + SD++SFGVV E+ +
Sbjct: 177 ADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 6e-15
Identities = 52/153 (33%), Positives = 87/153 (56%), Gaps = 9/153 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L ++ + +V EFM GSL D L + D + L + +AA
Sbjct: 54 IMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMG 119
A G+ Y+ ++ N I+RD +++NIL+ + K++DFGLA+L + D + + +
Sbjct: 111 IADGMAYI-ERMN--YIHRDLRAANILVGDNLVCKIADFGLARL--IEDNEYTARQGAKF 165
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE A+ G+ T+KSDV+SFG++ EL+T
Sbjct: 166 PIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 50/153 (32%), Positives = 71/153 (46%), Gaps = 11/153 (7%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA---LDWNTRMKI---AA 59
HH +V L+G + G L+V E M G L+ +L P+ E L T K AA
Sbjct: 69 HH--VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
A G+ YL K ++RD + N ++ E K+ DFG+ + D + +
Sbjct: 127 EIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE G T KSDV+SFGVV E+ T
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-14
Identities = 50/152 (32%), Positives = 81/152 (53%), Gaps = 14/152 (9%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
LHH NLV L+G + +V E M G+L + L + + ++ + A+G
Sbjct: 56 LHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEG 112
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG-DKSHVSTRVMGTYGY 123
+EYL K +++RD + NIL+ E K+SDFGLA++G +G D S + + +
Sbjct: 113 MEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------W 163
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154
APE + + KSDV+S+GV+ E+ + GR
Sbjct: 164 TAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 68/243 (27%), Positives = 102/243 (41%), Gaps = 45/243 (18%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDH--LHDLPPDKEALDWNTRMKIA 58
ML L H NLVNLI + LV+EF+ DH L DL LD + K
Sbjct: 53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFV------DHTVLDDLEKYPNGLDESRVRKYL 106
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRV 117
+G+E+ H + +I+RD K NIL+ + KL DFG A+ L G+ V T
Sbjct: 107 FQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDY 160
Query: 118 MGTYGYCAPEYAMTGQLTVKS-------DVYSFGVVFLELITGR------KAIDS----T 160
+ T Y APE L V D+++ G + E++TG ID
Sbjct: 161 VATRWYRAPE------LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214
Query: 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLY-----QALAVASMCIQEQAA 215
+ G NL+ + +F F+ + P ++ P+ + L +A C++
Sbjct: 215 KCLG--NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPD 272
Query: 216 TRP 218
RP
Sbjct: 273 DRP 275
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 45/160 (28%), Positives = 67/160 (41%), Gaps = 20/160 (12%)
Query: 20 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79
D LV E++ G + L E DW + A G+E LH + +I+R
Sbjct: 69 KDYLYLVMEYLNGGDCASLIKTLGGLPE--DWAK--QYIAEVVLGVEDLHQRG---IIHR 121
Query: 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSD 139
D K N+L+++ H KL+DFGL++ G + + +GT Y APE + SD
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSD 175
Query: 140 VYSFGVVFLELITGRKAIDSTRP-HGEQNLVTWARPLFND 178
+S G V E + G P H E + L
Sbjct: 176 WWSLGCVIFEFLFG------YPPFHAETPDAVFDNILSRR 209
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 13/157 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
++ H N+++L+G C + L+V +M G L + + + D +
Sbjct: 49 IMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGL 105
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS----T 115
AKG+EYL A+ ++RD + N +L+E F K++DFGLA+ + DK + S T
Sbjct: 106 QVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHT 160
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ A E T + T KSDV+SFGV+ EL+T
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 47/158 (29%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 1 MLSLLHHSNLVNLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+++ L+H +++ ++G C D L V E+M GS+ L KEA+ N ++
Sbjct: 56 LMARLNHPHIIRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAVIINYTEQLL- 113
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEE-GFHPKLSDFGLA-KLGPVGDKS-HVSTR 116
+GL YLH+ +I+RD K +N+L++ G +++DFG A +L G + +
Sbjct: 114 ---RGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
++GT + APE Q DV+S G V +E+ T +
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-14
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N+V +G C D + + EF+P GS+ L+ P E + +I G
Sbjct: 55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDG 114
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK----LGPVGDKSHVSTR 116
A YLH+ V++RD K +N++L KL DFG A+ +G G S++
Sbjct: 115 VA----YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 162
+ GT + APE KSD++S G E+ TG+ + S
Sbjct: 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-14
Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 8/154 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L + +V+L D LV M G L+ H++++ + + AA
Sbjct: 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQ 103
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
GLE+LH + ++YRD K N+LL++ + ++SD GLA G K GT
Sbjct: 104 IICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GT 157
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GY APE D ++ G E+I GR
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 64/243 (26%), Positives = 110/243 (45%), Gaps = 36/243 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDL-----------PPDKE 47
+LS L N++ L+G C D D ++ E+M G L L H L PP
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 48 --ALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 105
A+ +++ + +A A G++YL ++ ++RD + N L+ E K++DFG+++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188
Query: 106 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 165
GD + R + + A E + G+ T SDV++FGV E++ K +P+GE
Sbjct: 189 YAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE----QPYGE 244
Query: 166 ---QNLVTWARPLFNDRRKFSKLADPRLEGRYPI--RGLYQALAVASMCIQEQAATRPLI 220
+ ++ A F D+ + L R P +GLY+ + C RP
Sbjct: 245 LTDEQVIENAGEFFRDQGRQVYL------FRPPPCPQGLYELML---QCWSRDCRERPSF 295
Query: 221 GDV 223
D+
Sbjct: 296 SDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 3e-14
Identities = 46/164 (28%), Positives = 68/164 (41%), Gaps = 27/164 (16%)
Query: 2 LSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
L L H N+V L + +V+E+M HDL L + +K
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD--------HDL----TGLLDSPEVKFTE 99
Query: 60 GAAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 111
K GL+YLH +++RD K SNIL+ KL+DFGLA+ S
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNS 155
Query: 112 HVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
T + T Y PE + + + D++S G + EL G+
Sbjct: 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 5e-14
Identities = 50/156 (32%), Positives = 69/156 (44%), Gaps = 16/156 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
L +H +V L Y D++ +Y E+ G L L D + D T
Sbjct: 47 LEECNHPFIVKL--YRTFKDKKY-IYMLMEYCLGGELWTILRD----RGLFDEYTARFYI 99
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
A EYLH++ +IYRD K N+LL+ + KL DFG AK G K+
Sbjct: 100 ACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FC 153
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y APE + D +S G++ EL+TGR
Sbjct: 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 10/154 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L + ++ E+M GSL D L K L + +A
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP--KLIDFSAQ 111
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A+G+ Y+ K I+RD +++N+L+ E K++DFGLA+ V + + + R
Sbjct: 112 IAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLAR---VIEDNEYTAREGAK 165
Query: 121 Y--GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ + APE G T+KSDV+SFG++ E++T
Sbjct: 166 FPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 8e-14
Identities = 50/158 (31%), Positives = 70/158 (44%), Gaps = 22/158 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH--DLPPDKEALDWNTRMKIA 58
+L + H LVNL G D LV E++P G L HL P+ A A
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA------RFYA 107
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
A LEYLH ++YRD K N+LL+ + K++DFG AK V R
Sbjct: 108 AQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTY 156
Query: 119 ---GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
GT Y APE ++ D ++ G++ E++ G
Sbjct: 157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAA 62
L H +V LIG C G+ +LV E PLG L +L P + + ++ A
Sbjct: 53 LDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------A 105
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
G+ YL K ++RD + N+LL K+SDFG+++ G + +T T G
Sbjct: 106 MGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAG 158
Query: 123 -----YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE G+ + KSDV+S+GV E +
Sbjct: 159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 7/161 (4%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H LV L G C + LV+EFM G L D+L + T + + +G
Sbjct: 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR---AQRGKFSQETLLGMCLDVCEG 112
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
+ YL VI+RD + N L+ E K+SDFG+ + + D+ ST +
Sbjct: 113 MAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWS 168
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 165
+PE + + KSDV+SFGV+ E+ + K R + E
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE 209
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 49/160 (30%), Positives = 83/160 (51%), Gaps = 15/160 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N+V +G D D + E++P GS+ L++ +E L N +I
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL-- 116
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR---- 116
KGL YLH++ +I+RD K +NIL++ K+SDFG++K + S +
Sbjct: 117 --KGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK--KLEANSLSTKTNGAR 169
Query: 117 --VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ G+ + APE T K+D++S G + +E++TG+
Sbjct: 170 PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEA 48
+ L HH N++NL+G C L E+ P G+L D L L D
Sbjct: 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 108
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
L + AA A+G++YL K I+RD + NIL+ E + K++DFGL++ G
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----G 161
Query: 109 DKSHVSTRVMGTYG--YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ +V + MG + A E T SDV+S+GV+ E+++
Sbjct: 162 QEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 52/173 (30%), Positives = 89/173 (51%), Gaps = 16/173 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED---HLHDLPPDKEALDWNTRMKI 57
+LSLL H N++ + D + L+ E+ G+L D ++E + W +
Sbjct: 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
+A + Y+H KA +++RD K+ NI L + KL DFG++K+ +G + ++ V
Sbjct: 112 SA-----VSYIH-KAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETV 161
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT 170
+GT Y +PE + KSD+++ G V EL+T ++ D+T P NLV
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLVV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEA 48
+ L HH N++NL+G C + + E+ P G+L D L L D
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
L ++ A+ A G++YL +K I+RD + N+L+ E K++DFGL++ G
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----G 168
Query: 109 DKSHVSTRVMGTYG--YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
++ +V + MG + A E T KSDV+SFGV+ E+++
Sbjct: 169 EEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 2e-13
Identities = 49/165 (29%), Positives = 68/165 (41%), Gaps = 29/165 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMP---LGSLEDHLHDLPPDK-EALDWNTRMK 56
+L L H N+VNL + LV+E++ L LE LPPD + W
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL--- 109
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
+ + Y H +I+RD K NIL+ E KL DFG A+ S ++
Sbjct: 110 -----LQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY 161
Query: 117 VMGTYGYCAPEYAMTGQLTVKS-------DVYSFGVVFLELITGR 154
V T Y APE L V DV++ G + EL+ G
Sbjct: 162 V-ATRWYRAPE------LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 47/115 (40%), Positives = 61/115 (53%), Gaps = 9/115 (7%)
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
KIA K LEYLH K + VI+RD K SN+L+ KL DFG++ G + D S T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVD-SVAKT 161
Query: 116 RVMGTYGYCAPEY---AMTGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 166
G Y APE + + VKSDV+S G+ +EL TGR DS + +Q
Sbjct: 162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 50/157 (31%), Positives = 81/157 (51%), Gaps = 14/157 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+++ L HSNLV L+G + L +V E+M GSL D+L + L + +K +
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSL 109
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVM 118
+ +EYL +AN ++RD + N+L+ E K+SDFGL K D + +
Sbjct: 110 DVCEAMEYL--EANN-FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK-- 164
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154
+ APE + + KSDV+SFG++ E+ + GR
Sbjct: 165 ----WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 46/172 (26%), Positives = 79/172 (45%), Gaps = 23/172 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--------------------H 40
+L ++H +++ L G C+ LL+ E+ GSL L +
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 41 DLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 100
PD+ AL + A ++G++YL A +++RD + N+L+ EG K+SDFG
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 101 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
L++ D ++ + A E T +SDV+SFGV+ E++T
Sbjct: 173 LSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 45/134 (33%), Positives = 65/134 (48%), Gaps = 9/134 (6%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
+ V EF+ G L H+ D K D AA GL++LH K +IYRD
Sbjct: 69 EHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRD 121
Query: 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDV 140
K N++L+ H K++DFG+ K GD ++ GT Y APE + T D
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLKYTFSVDW 179
Query: 141 YSFGVVFLELITGR 154
+SFGV+ E++ G+
Sbjct: 180 WSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 21/170 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---------------- 44
+++ H N+V L+G CA G L++E+M G L + L P
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 45 --DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 102
+ L ++ IA A G+ YL ++ ++RD + N L+ E K++DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 103 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ D S + PE + T +SDV+++GVV E+ +
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-13
Identities = 52/152 (34%), Positives = 84/152 (55%), Gaps = 10/152 (6%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H LV L ++ + +V E+M GSL D L + L + +AA A G
Sbjct: 58 LRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASG 114
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMGTYGY 123
+ Y+ ++ N ++RD +++NIL+ E K++DFGLA+L + D + + + +
Sbjct: 115 MAYV-ERMN--YVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKW 169
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154
APE A+ G+ T+KSDV+SFG++ EL T GR
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 5e-13
Identities = 51/148 (34%), Positives = 77/148 (52%), Gaps = 12/148 (8%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 66
H N+VN + GD+ +V E++ GSL D + + D+ + R + A LE
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA-----LE 129
Query: 67 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCA 125
+LH VI+RD KS NILL KL+DFG A++ P ++S ST V GT + A
Sbjct: 130 FLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMA 183
Query: 126 PEYAMTGQLTVKSDVYSFGVVFLELITG 153
PE K D++S G++ +E++ G
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 6e-13
Identities = 36/99 (36%), Positives = 52/99 (52%), Gaps = 7/99 (7%)
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVST 115
I KGLEYLH I+RD K+ NILL E KL+DFG++ +L K +
Sbjct: 104 ILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-- 158
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
V+GT + APE K+D++S G+ +E+ G+
Sbjct: 159 -VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 39/104 (37%), Positives = 56/104 (53%), Gaps = 11/104 (10%)
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVS 114
K+ K L YL +K VI+RD K SNILL+ + KL DFG++ +L V K+
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAK-- 171
Query: 115 TRVMGTYGYCAPEY----AMTGQLTVKSDVYSFGVVFLELITGR 154
TR G Y APE + +++DV+S G+ +EL TG+
Sbjct: 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 16/162 (9%)
Query: 5 LHHSNLVNLIGYCADGDQRLL-VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK 63
L+H N+V L+ L V+E++P +L + L AL ++
Sbjct: 35 LYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAA----DGALPAGETGRLMLQVLD 90
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEE---GFHPKLSDFGLAKLGP-VGDKSHV----ST 115
L H++ +++RD K NI++ + H K+ DFG+ L P V D +T
Sbjct: 91 ALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157
V+GT YCAPE +T SD+Y++G++FLE +TG++ +
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 16/158 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L+H N++ L+ LV+EFM D + + L +
Sbjct: 51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSH-VSTRV 117
+GL + H +++RD K N+L+ KL+DFGLA+ PV +H V TR
Sbjct: 107 LLQGLAFCH-SHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR- 162
Query: 118 MGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154
Y APE + + D++S G +F EL++ R
Sbjct: 163 ----WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 56/160 (35%), Positives = 79/160 (49%), Gaps = 22/160 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDH--LHDLPPDKEALDWNTRMKIA 58
ML L H NLVNLI + LV+E+ DH L++L + + + KI
Sbjct: 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKII 106
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKS-HVST 115
+ + + H K N I+RD K NIL+ + KL DFG A++ GP D + +V+T
Sbjct: 107 WQTLQAVNFCH-KHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT 163
Query: 116 RVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITG 153
R Y APE + G Q DV++ G VF EL+TG
Sbjct: 164 R-----WYRAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 49/165 (29%), Positives = 70/165 (42%), Gaps = 24/165 (14%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L LL H NLV G ++ + E+ G+LE+ L LD +
Sbjct: 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQL 108
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 121
+GL YLH +++RD K +NI L+ KL DFG A K +T MG
Sbjct: 109 LEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAV------KLKNNTTTMGEE 159
Query: 122 G--------YCAPEYAMTGQLTVK---SDVYSFGVVFLELITGRK 155
Y APE G+ +D++S G V LE+ TG++
Sbjct: 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 15/158 (9%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR------------ 54
H N++NL+G C +V E+ G+L D L P E +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 114
+ A A+G+E+L K I+RD + N+L+ E K++DFGLA+ D +
Sbjct: 135 VSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
T + APE T +SDV+SFGV+ E+ T
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 49/149 (32%), Positives = 70/149 (46%), Gaps = 14/149 (9%)
Query: 7 HSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLH-DLPPDKEALDWNTRMKIAAGAAKG 64
H LVNL C + + V E+ G L H+H D+ + A + AA G
Sbjct: 61 HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA------VFYAACVVLG 113
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
L+YLH+ ++YRD K N+LL+ K++DFGL K G +G ST GT +
Sbjct: 114 LQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-FCGTPEFL 168
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELITG 153
APE T D + GV+ E++ G
Sbjct: 169 APEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-12
Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 11/153 (7%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE-----ALDWNTRM-KIAA 59
HH +V L+G + G L++ E M G L+ +L L P+ E A +M ++A
Sbjct: 69 HH--VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG 126
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
A G+ YL+ AN ++RD + N ++ E F K+ DFG+ + D + +
Sbjct: 127 EIADGMAYLN--AN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ +PE G T SDV+SFGVV E+ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-12
Identities = 56/226 (24%), Positives = 96/226 (42%), Gaps = 27/226 (11%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H LV L G C +V EFM G L L+ L + L + + + +G
Sbjct: 56 LSHPKLVQLYGVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEG 112
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMGTYGY 123
+EYL + I+RD + N L+ K+SDFG+ + V D + S+ +
Sbjct: 113 MEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY--VLDDEYTSSSGAKFPVKW 167
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKF 182
PE + + KSDV+SFGV+ E+ T G+ + + +++ +
Sbjct: 168 SPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS----------RG 217
Query: 183 SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228
+L P+L +Y+ V C E+ RP +++ A++
Sbjct: 218 FRLYRPKLASMT----VYE---VMYSCWHEKPEGRPTFAELLRAIT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-12
Identities = 48/143 (33%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 66
H N+V LIG C QR +Y M L D L L K+ L +K A AA G+
Sbjct: 51 HPNIVKLIGVCT---QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMA 107
Query: 67 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 126
YL K I+RD + N L+ E K+SDFG+++ G S + + + AP
Sbjct: 108 YLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAP 163
Query: 127 EYAMTGQLTVKSDVYSFGVVFLE 149
E G+ + +SDV+S+G++ E
Sbjct: 164 EALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 1 MLSLLHHSNLVNLIGY---CADGDQRLLVYEFMPLGSLEDHLHDLP----PDKEALDWNT 53
+ S+ H N+I Y DG++ +V E+ P G L + E W
Sbjct: 53 LASVNHP----NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 54 RMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV 113
+++ +GL+ LH++ +++RD KS+NILL K+ D G++K+ K ++
Sbjct: 109 FIQLL----RGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNM 157
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ +GT Y APE + KSD++S G + E+ T
Sbjct: 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 54/162 (33%), Positives = 84/162 (51%), Gaps = 19/162 (11%)
Query: 2 LSLLHHSNLVNLIGY----CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA--LDWNTRM 55
L +LH N ++G+ +DG+ + + E M GSL+ L K+A + N
Sbjct: 50 LKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL------KKAGRIPENILG 102
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
KI+ +GL YL +K +++RD K SNIL+ KL DFG++ G + D S ++
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLID-SMANS 157
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157
V GT Y +PE TV+SD++S G+ +E+ GR I
Sbjct: 158 FV-GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L + ++ EFM GSL D L K+ L + +A
Sbjct: 54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMG 119
A+G+ ++ + I+RD +++NIL+ K++DFGLA++ + D + +
Sbjct: 111 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKF 165
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154
+ APE G T+KSDV+SFG++ +E++T GR
Sbjct: 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 36/93 (38%), Positives = 54/93 (58%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL+Y+H V++RD K SNIL+ E K+ DFGLA++ +VSTR
Sbjct: 119 RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 123 YCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGR 154
Y APE +T Q V+ D++S G +F E++ G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 41/102 (40%), Positives = 53/102 (51%), Gaps = 8/102 (7%)
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
KIA K L YL K +I+RD K SNILL+ + KL DFG++ G + D S T
Sbjct: 111 KIAVATVKALNYL--KEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVD-SIAKT 165
Query: 116 RVMGTYGYCAPEYAMTGQLT---VKSDVYSFGVVFLELITGR 154
R G Y APE V+SDV+S G+ E+ TG+
Sbjct: 166 RDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 36/99 (36%), Positives = 57/99 (57%), Gaps = 9/99 (9%)
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
AA GL++LH++ +IYRD K N+LL+ H K++DFG+ K G +G V+T
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTST 155
Query: 118 M-GTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
GT Y APE ++ Q + D ++ GV+ E++ G+
Sbjct: 156 FCGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 9/157 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL-----HDLPPDKEALDWNTRM 55
M L H N+V L+G C + + ++ E+ LG L+ L D L ++
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKV 120
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
+ A G+++L +N ++RD + N L+ K+S L+K + +
Sbjct: 121 ALCTQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLR 176
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ + APE + KSDV+SFGV+ E+ T
Sbjct: 177 NALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 6e-12
Identities = 43/155 (27%), Positives = 71/155 (45%), Gaps = 22/155 (14%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAK 63
H N++ L G +++ E+M GSL+ L +D + + G A
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIAS 117
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG- 122
G++YL + ++RD + NIL+ K+SDFGL++ + D T T G
Sbjct: 118 GMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYT----TKGG 168
Query: 123 -----YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE + T SDV+SFG+V E+++
Sbjct: 169 KIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 6e-12
Identities = 40/95 (42%), Positives = 52/95 (54%), Gaps = 5/95 (5%)
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
A A L++LH +IYRD K NILL+E H KL+DFGL+K +K S
Sbjct: 105 AELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FC 159
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
GT Y APE T +D +SFGV+ E++TG
Sbjct: 160 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 8e-12
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 25/163 (15%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEALDWNTR 54
H N++NL+G C ++ E+ G+L ++L P +E L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 114
+ A A+G+EYL A+ I+RD + N+L+ E K++DFGLA+ D H+
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHID 194
Query: 115 TRVMGTYG-----YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
T G + APE T +SDV+SFGV+ E+ T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 29/236 (12%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-DLPPDKEALDWNTRMKIAAGAAK 63
L+H N++ +G C + LLV EF PLG L+++L + + + ++A A
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 123
GL +LH +A+ I+ D N L K+ D+GLA D +
Sbjct: 112 GLLWLH-QAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 124 CAPEYA-------MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP---HGEQNLVTWAR 173
APE + T KS+++S GV EL T + +P ++ ++
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPYPDLSDEQVLKQVV 223
Query: 174 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229
R + KL P+L+ +Y R Y+ + + TRP +V L+Y
Sbjct: 224 -----REQDIKLPKPQLDLKYSDR-WYEVMQFCWL----DPETRPTAEEVHELLTY 269
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-12
Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPD---------KEA 48
+ L HH N++NL+G C L E+ P G+L D L L D
Sbjct: 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
L + AA A+G++YL K I+RD + NIL+ E + K++DFGL++ G
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----G 173
Query: 109 DKSHVSTRVMGTYG--YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ +V + MG + A E T SDV+S+GV+ E+++
Sbjct: 174 QEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 9e-12
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 5/97 (5%)
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
AA GL++LH K ++YRD K NILL+ H K++DFG+ K +GD +
Sbjct: 102 AAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTF 156
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y APE + + D +SFGV+ E++ G+
Sbjct: 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-12
Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L H N+V LIG C Q+ +Y M L D L L + L +++
Sbjct: 46 ILKQYSHPNIVRLIGVCT---QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVEN 102
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AA G+EYL K I+RD + N L+ E K+SDFG+++ G +
Sbjct: 103 AAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLE 149
+ APE G+ + +SDV+SFG++ E
Sbjct: 160 VKWTAPEALNYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 48/159 (30%), Positives = 84/159 (52%), Gaps = 8/159 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+++ + H +LV L+G C +L V + MP G L D++H+ K+ + +
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AKG+ YL ++ +++RD + N+L++ H K++DFGLA+L +K + +
Sbjct: 118 IAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 174
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158
+ A E + T +SDV+S+GV EL+T G K D
Sbjct: 175 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE------ALDWNTRMKIAA 59
HH +V L+G + G L+V E M G L+ +L L P+ E +++AA
Sbjct: 69 HH--VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA 126
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
A G+ YL+ K ++RD + N ++ F K+ DFG+ + D + +
Sbjct: 127 EIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE G T SD++SFGVV E+ +
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 58/196 (29%), Positives = 90/196 (45%), Gaps = 31/196 (15%)
Query: 25 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84
++ E++ GS D L P D+ + I KGL+YLH + I+RD K++
Sbjct: 79 IIMEYLGGGSALDLLEPGPLDETQI-----ATILREILKGLDYLHSEKK---IHRDIKAA 130
Query: 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFG 144
N+LL E KL+DFG+A G + D +GT + APE K+D++S G
Sbjct: 131 NVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLG 188
Query: 145 VVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY--PIRGLYQA 202
+ +EL G PH E + + + LF K P LEG Y P++ +A
Sbjct: 189 ITAIELAKGEP------PHSELHPM---KVLF----LIPKNNPPTLEGNYSKPLKEFVEA 235
Query: 203 LAVASMCIQEQAATRP 218
C+ ++ + RP
Sbjct: 236 ------CLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-11
Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 19/164 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLED------------HLHDLPPDKEA 48
++S L + N++ L+G C D ++ E+M G L H +++P +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP----S 125
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
+ + +A A G++YL A+ ++RD + N L+ + K++DFG+++ G
Sbjct: 126 VSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182
Query: 109 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
D + R + + A E + G+ T SDV++FGV E+ T
Sbjct: 183 DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 52/173 (30%), Positives = 72/173 (41%), Gaps = 37/173 (21%)
Query: 4 LLHHSNLVNLIGY---------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR 54
L +SN N+ + + DQ LV E GS+ D + K R
Sbjct: 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKR 109
Query: 55 MK------IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPV 107
+K I +GL YLH+ VI+RD K NILL + KL DFG+ A+L
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQL--- 163
Query: 108 GDKSHVSTR--VMGTYGYCAPE-----YAMTGQLTVKSDVYSFGVVFLELITG 153
S + R +GT + APE +SDV+S G+ +EL G
Sbjct: 164 --DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 36/92 (39%), Positives = 55/92 (59%), Gaps = 7/92 (7%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 123
GL++LH K +IYRD K N+LL++ H K++DFG+ K G+ ++ GT Y
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 124 CAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
APE + GQ +S D +SFGV+ E++ G+
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 49/154 (31%), Positives = 75/154 (48%), Gaps = 10/154 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVY-EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+L L H +V G C D+ L ++ E+MP GS++D L E + TR K
Sbjct: 57 LLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETV---TR-KYTR 111
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVM 118
+G+EYLH +++RD K +NIL + + KL DFG +K L + V
Sbjct: 112 QILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT 168
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
GT + +PE K+DV+S G +E++T
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 45/151 (29%), Positives = 78/151 (51%), Gaps = 14/151 (9%)
Query: 13 LIGYCADGDQRLLVYEFMPLGSLEDHLH---DLPPDKEALDWNTRMKIAAGAAKGLEYLH 69
L+G C +L V + MP G L D++ D ++ L+W ++ AKG+ YL
Sbjct: 74 LLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 70 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 129
+ +++RD + N+L++ H K++DFGLA+L + + + + + A E
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 130 MTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159
+ + T +SDV+S+GV EL+T G K D
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 2e-11
Identities = 48/168 (28%), Positives = 73/168 (43%), Gaps = 38/168 (22%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L L H N+V L+ + LV+E+ DL K+ LD ++
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCD--------MDL---KKYLD-KRPGPLSPNL 99
Query: 62 AK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV 113
K GL Y H +++RD K NIL+ KL+DFGLA+ + +++
Sbjct: 100 IKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY- 155
Query: 114 STRVMGTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITGR 154
+ V+ T Y APE Y V D++S G +F E+ITG+
Sbjct: 156 THEVV-TLWYRAPEILLGSKHY----STAV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 46/139 (33%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D+ V E++ G L H+ + KE + AA A GL +LH K +IYRD
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEP----HAVFYAAEIAIGLFFLHSKG---IIYRD 126
Query: 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAPEYAMTGQLTVKSD 139
K N++L+ H K++DFG+ K G K +TR GT Y APE D
Sbjct: 127 LKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 140 VYSFGVVFLELITGRKAID 158
++FGV+ E++ G+ D
Sbjct: 184 WWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEALDWNTR 54
H N++NL+G C ++ E+ G+L ++L P +E L +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 114
+ A A+G+EYL A+ I+RD + N+L+ E K++DFGLA+ D +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
T + APE T +SDV+SFGV+ E+ T
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 46/134 (34%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D LV M G L+ H++++ D + AA GLE LH + ++YRD
Sbjct: 73 DALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRER---IVYRD 127
Query: 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDV 140
K NILL++ H ++SD GLA P G+ + RV GT GY APE + T D
Sbjct: 128 LKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERYTFSPDW 184
Query: 141 YSFGVVFLELITGR 154
+ G + E+I G+
Sbjct: 185 WGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 47/160 (29%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA---LDWNTRMKI 57
++S +H N+V L+G C + + ++ E M G L +L D ++ L + I
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI 111
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-----KLSDFGLAKLGPVGDKSH 112
AKG YL I+RD + N L+ E + K+ DFGLA+ D
Sbjct: 112 CLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ + APE + G+ T +SDV+SFGV+ E++T
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 2e-11
Identities = 52/150 (34%), Positives = 80/150 (53%), Gaps = 12/150 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L + N+VN + GD+ +V E++ GSL D + + D+ + R + A
Sbjct: 73 LKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQA----- 127
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGY 123
LE+LH AN VI+RD KS N+LL KL+DFG A++ P ++S ST V GT +
Sbjct: 128 LEFLH--ANQ-VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYW 181
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
APE K D++S G++ +E++ G
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 10/158 (6%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------DLPPDKEALDWNTR 54
LS L N+ L+G C ++ E+M G L L L + ++L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 114
+ +A A G+ YL + ++RD + N L+ + + K++DFG+++ D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
R + A E + G+ T KSDV++FGV E++T
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 8 SNLVNLIGY--CADGDQRL-LVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAA 62
SN L+G C + RL V EF+ G L H+ P++ A ++ + +A
Sbjct: 53 SNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA---- 108
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
L +LH++ +IYRD K N+LL+ H KL+D+G+ K G + ST GT
Sbjct: 109 --LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-IRPGDTTST-FCGTPN 161
Query: 123 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID--STRPHGEQN 167
Y APE D ++ GV+ E++ GR D + +QN
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 45/158 (28%), Positives = 73/158 (46%), Gaps = 15/158 (9%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTR 54
H N++NL+G C ++ E+ G+L ++L P E + +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 114
+ A+G+EYL A+ I+RD + N+L+ E K++DFGLA+ D +
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
T + APE T +SDV+SFGV+ E+ T
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 49/154 (31%), Positives = 68/154 (44%), Gaps = 10/154 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL-VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+LSL + + + C RL V EF+ G L H+ D AA
Sbjct: 48 ILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAA 103
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
L +LHDK +IYRD K N+LL+ H KL+DFG+ K G + + ST G
Sbjct: 104 EITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG-IFNGKTTST-FCG 158
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
T Y APE D ++ GV+ E++ G
Sbjct: 159 TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 4e-11
Identities = 44/127 (34%), Positives = 63/127 (49%), Gaps = 15/127 (11%)
Query: 28 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNIL 87
EFM GSL D +P + L +IA KGL YL + +++RD K SN+L
Sbjct: 79 EFMDGGSL-DVYRKIP--EHVLG-----RIAVAVVKGLTYLW---SLKILHRDVKPSNML 127
Query: 88 LEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVF 147
+ KL DFG++ + ++ +GT Y APE Q + SDV+S G+ F
Sbjct: 128 VNTRGQVKLCDFGVST----QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISF 183
Query: 148 LELITGR 154
+EL GR
Sbjct: 184 MELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 2 LSLLHHSNLVNLIGYC----ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI 57
L +LH N ++G+ +DG+ + + E M GSL+ L + E + K+
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKEAKRIPEEI----LGKV 108
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
+ +GL YL +K +++RD K SNIL+ KL DFG++ G + D ++
Sbjct: 109 SIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 177
+GT Y +PE +V+SD++S G+ +EL GR I P ++ + RP+ +
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIFGRPVVD 220
Query: 178 --DRRKFSKLADPRLEGRYPIRG 198
+ S PR GR P+ G
Sbjct: 221 GEEGEPHSISPRPRPPGR-PVSG 242
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 42/151 (27%), Positives = 75/151 (49%), Gaps = 13/151 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H LV L G C +V E+M G L ++L + + + +++ +G
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEG 112
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 121
+ YL K I+RD + N L+++ K+SDFGL++ V D + S+ +G+
Sbjct: 113 MAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPV 165
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ PE + + + KSDV++FGV+ E+ +
Sbjct: 166 RWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 46/162 (28%), Positives = 84/162 (51%), Gaps = 14/162 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH---DLPPDKEALDWNTRMKI 57
+++ + + ++ L+G C +L + + MP G L D++ D + L+W ++
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI-- 118
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
AKG+ YL ++ +++RD + N+L++ H K++DFGLAKL +K + +
Sbjct: 119 ----AKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGG 171
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158
+ A E + T +SDV+S+GV EL+T G K D
Sbjct: 172 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------DLPPD-----KEALDWNTR 54
H N++NL+G C ++ E+ G+L + L D D +E L +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 114
+ A A+G+EYL + I+RD + N+L+ E K++DFGLA+ D +
Sbjct: 137 VSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ + APE T +SDV+SFG++ E+ T
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 48/156 (30%), Positives = 73/156 (46%), Gaps = 9/156 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---ALDWNTRMKI 57
++S +H N+V LIG + R ++ E M G L+ L + P E +L +
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKLGPVGDKSHVS 114
A AKG +YL + I+RD + N LL G K++DFG+A+
Sbjct: 122 ARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150
R M + PE + G T K+DV+SFGV+ E+
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 41/159 (25%), Positives = 80/159 (50%), Gaps = 10/159 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLP-----PDKEALDWNT 53
++S L N++ L+ C D ++ E+M G L L H+ D + ++T
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 54 RMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV 113
+ +A A G++YL ++ ++RD + N L+ + + K++DFG+++ GD +
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRI 188
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
R + + + E + G+ T SDV++FGV E++T
Sbjct: 189 QGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 65
HH N+V++ GD+ +V EF+ G+L D + ++E + + + L
Sbjct: 77 HHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRAL 131
Query: 66 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 125
YLH++ VI+RD KS +ILL KLSDFG V + ++GT + A
Sbjct: 132 SYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMA 186
Query: 126 PEYAMTGQLTVKSDVYSFGVVFLELITG 153
PE + D++S G++ +E+I G
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 6e-11
Identities = 48/145 (33%), Positives = 70/145 (48%), Gaps = 8/145 (5%)
Query: 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 69
+VNL D LV M G L+ H++++ + + AA GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH 119
Query: 70 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA 129
+ +YRD K NILL++ H ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 REN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 130 MTGQLTVKSDVYSFGVVFLELITGR 154
+ T+ D + G + E+I G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 6e-11
Identities = 49/163 (30%), Positives = 71/163 (43%), Gaps = 34/163 (20%)
Query: 5 LHHSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHD-----LPPDKEALDWNTRMKI 57
L H N++ L+ + + LV+EFM LE + D P D ++ T
Sbjct: 59 LKHPNIIGLLDVFGHK--SNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT---- 111
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS-TR 116
+GLEYLH +++RD K +N+L+ KL+DFGLA +S S R
Sbjct: 112 ----LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA-------RSFGSPNR 157
Query: 117 VMG----TYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
M T Y APE V D++S G +F EL+
Sbjct: 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-11
Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 27/164 (16%)
Query: 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEALDWNTRMKIA 58
S L H N+V +G ++ + E +P GSL L L +++ + + T+ +
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL- 118
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLE--EGFHPKLSDFG----LAKLGPVGDKSH 112
+GL+YLHD +++RD K N+L+ G K+SDFG LA + P
Sbjct: 119 ----EGLKYLHDNQ---IVHRDIKGDNVLVNTYSGV-VKISDFGTSKRLAGINP------ 164
Query: 113 VSTRVMGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGR 154
+ GT Y APE G +D++S G +E+ TG+
Sbjct: 165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 8e-11
Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 38/177 (21%)
Query: 1 MLSLLHHSNLVNL--IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK-- 56
+L L H N+V + + ++ D+ +V E++ HDL K ++ MK
Sbjct: 57 ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE--------HDL---KSLME---TMKQP 102
Query: 57 IAAGAAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
K G+ +LHD +++RD K+SN+LL K+ DFGLA+ G
Sbjct: 103 FLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYG 157
Query: 109 DKSHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELIT------GRKAID 158
T+++ T Y APE + + + D++S G +F EL+T G+ ID
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 8e-11
Identities = 45/134 (33%), Positives = 66/134 (49%), Gaps = 8/134 (5%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D LV M G L+ H++ + + + + AA GLE LH + ++YRD
Sbjct: 73 DALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRD 127
Query: 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDV 140
K NILL++ H ++SD GLA P G + RV GT GY APE + T D
Sbjct: 128 LKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDW 184
Query: 141 YSFGVVFLELITGR 154
++ G + E+I G+
Sbjct: 185 WALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 9e-11
Identities = 56/205 (27%), Positives = 83/205 (40%), Gaps = 56/205 (27%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL----------LVYEFMP---LGSLEDHLHDLPPD-- 45
+L L+H N+VNL D L LV+E+M +G LE L D
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 46 ----KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 101
K+ L+ GL Y H K ++RD K SNILL KL+DFGL
Sbjct: 119 KSFMKQLLE-------------GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGL 162
Query: 102 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRKAIDST 160
A+L + + +V+ T Y PE + + + DV+S G + EL T
Sbjct: 163 ARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-------- 213
Query: 161 RPHGEQNLVTWARPLFNDRRKFSKL 185
+P+F ++ ++L
Sbjct: 214 -----------KKPIFQANQELAQL 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-10
Identities = 44/135 (32%), Positives = 66/135 (48%), Gaps = 17/135 (12%)
Query: 28 EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNIL 87
E+M GSL D L+ E + + +I KGL++L ++ N +I+RD K +N+L
Sbjct: 79 EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVL 135
Query: 88 LEEGFHPKLSDFGLAKLGPVGD--KSHVSTRVMGTYGYCAPEY----AMTGQLT--VKSD 139
+ KL DFG++ G+ S T + G Y APE T V+SD
Sbjct: 136 VNGNGQVKLCDFGVS-----GNLVASLAKTNI-GCQSYMAPERIKSGGPNQNPTYTVQSD 189
Query: 140 VYSFGVVFLELITGR 154
V+S G+ LE+ GR
Sbjct: 190 VWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 1e-10
Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 10/148 (6%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 65
H N+V + GD+ +V EF+ G+L D + ++E + + K L
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLAVLKAL 128
Query: 66 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 125
+LH + VI+RD KS +ILL KLSDFG V + ++GT + A
Sbjct: 129 SFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMA 183
Query: 126 PEYAMTGQLTVKSDVYSFGVVFLELITG 153
PE + D++S G++ +E++ G
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 46/134 (34%), Positives = 65/134 (48%), Gaps = 8/134 (5%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D LV M G L+ H++++ D + AA GLE L + ++YRD
Sbjct: 73 DALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRD 127
Query: 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDV 140
K NILL++ H ++SD GLA P G+ V RV GT GY APE + T D
Sbjct: 128 LKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVINNEKYTFSPDW 184
Query: 141 YSFGVVFLELITGR 154
+ G + E+I G+
Sbjct: 185 WGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY- 121
+GL+Y+H AN V++RD K SN+LL K+ DFGLA+ + D H T + Y
Sbjct: 117 RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLAR---IADPEHDHTGFLTEYV 170
Query: 122 ---GYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
Y APE + + K+ D++S G + E+++ R
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 17/196 (8%)
Query: 2 LSLLHHSNLVNLIGYC----ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI 57
L +LH N ++G+ +DG+ + + E M GSL+ L E + K+
Sbjct: 54 LQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQI----LGKV 108
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
+ KGL YL +K +++RD K SNIL+ KL DFG++ G + D ++
Sbjct: 109 SIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSF 162
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 177
+GT Y +PE +V+SD++S G+ +E+ GR I P ++ + + P+
Sbjct: 163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP--PDAKELELMFGCPVEG 220
Query: 178 DRRKFSKLADPRLEGR 193
D + PR GR
Sbjct: 221 DPAESETSPRPRPPGR 236
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 48/147 (32%), Positives = 72/147 (48%), Gaps = 18/147 (12%)
Query: 17 CADGDQRL-LVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73
C RL LV E++ G L H+ P++ A + + IA L +LH++
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA------LNFLHERG- 116
Query: 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK--LGPVGDKSHVSTRVMGTYGYCAPEYAMT 131
+IYRD K N+LL+ H KL+D+G+ K LGP GD ++ GT Y APE
Sbjct: 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GD---TTSTFCGTPNYIAPEILRG 170
Query: 132 GQLTVKSDVYSFGVVFLELITGRKAID 158
+ D ++ GV+ E++ GR D
Sbjct: 171 EEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 12/146 (8%)
Query: 9 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 68
N+VN + GD+ +V E++ GSL D + + +D + + LE+L
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFL 132
Query: 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPE 127
H VI+RD KS NILL KL+DFG A++ P K + ++GT + APE
Sbjct: 133 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPE 186
Query: 128 YAMTGQLTVKSDVYSFGVVFLELITG 153
K D++S G++ +E+I G
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 2e-10
Identities = 48/137 (35%), Positives = 69/137 (50%), Gaps = 18/137 (13%)
Query: 21 DQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANPPVI 77
D+ + + M G L HL H + + E M+ AA GLE++H++ V+
Sbjct: 70 DKLSFILDLMNGGDLHYHLSQHGVFSEAE-------MRFYAAEIILGLEHMHNRF---VV 119
Query: 78 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK 137
YRD K +NILL+E H ++SD GLA K H S +GT+GY APE G
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQKGVAYDS 175
Query: 138 S-DVYSFGVVFLELITG 153
S D +S G + +L+ G
Sbjct: 176 SADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 47/136 (34%), Positives = 70/136 (51%), Gaps = 16/136 (11%)
Query: 21 DQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78
D+ + + M G L HL H + +KE + T + + GLE++H++ V+Y
Sbjct: 70 DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL------GLEHMHNRF---VVY 120
Query: 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKS 138
RD K +NILL+E H ++SD GLA K H S +GT+GY APE G S
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQKGTAYDSS 176
Query: 139 -DVYSFGVVFLELITG 153
D +S G + +L+ G
Sbjct: 177 ADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 50/149 (33%), Positives = 71/149 (47%), Gaps = 16/149 (10%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 68
LV L Y D +L L+ +++ G L HL+ E+ R+ IA L++L
Sbjct: 67 LVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAE-IVLALDHL 121
Query: 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK--LGPVGDKSHVSTRVMGTYGYCAP 126
H +IYRD K NILL+ H L+DFGL+K L ++++ GT Y AP
Sbjct: 122 HQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAP 175
Query: 127 EYAMTGQLTVKS--DVYSFGVVFLELITG 153
E G D +S GV+ EL+TG
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 15/182 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
L L H N+V +G+ + + E++P GS+ L +E L ++
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL-- 118
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+GL YLH K +++RD K+ N+L++ K+SDFG++K + + + G+
Sbjct: 119 --EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173
Query: 121 YGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 178
+ APE + + K D++S G V LE+ GR RP ++ + L N
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIAAMFKLGNK 227
Query: 179 RR 180
R
Sbjct: 228 RS 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 27/227 (11%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 66
H N++ L G +++ E+M G+L+ +L D + + ++ G A G++
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMK 121
Query: 67 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL---GPVGDKSHVSTRVMGTYGY 123
YL D ++RD + NIL+ K+SDFGL+++ P G + ++ +
Sbjct: 122 YLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRW 176
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 183
APE + T SDV+SFG+V E+++ RP+ + + + + + R +
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMSF-----GERPYWDMSNHEVMKAINDGFRLPA 231
Query: 184 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230
+ P +YQ + C Q+ A RP D+V L L
Sbjct: 232 PMDCP--------SAVYQLML---QCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL----LVYEFMPLGSLEDHLHDLPPDKEA-LDWNTRM 55
L + +N++ + G+ D L L+ E+ G L + L DKE L + T++
Sbjct: 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-----DKEKDLSFKTKL 125
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
+A KGL L+ N P Y++ S + L+ E + K+ GL K+ +V+
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
V +Y ++ + T+K D+YS GVV E+ TG+
Sbjct: 184 MVYFSYKMLNDIFS---EYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 39/164 (23%), Positives = 74/164 (45%), Gaps = 15/164 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEA 48
M S L H N+V L+G +++ + L + L P K
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
L+ + I A G+E+L ++ V+++D + N+L+ + + K+SD GL +
Sbjct: 121 LEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 109 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
D + + + +PE M G+ ++ SD++S+GVV E+ +
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 38/130 (29%), Positives = 58/130 (44%), Gaps = 5/130 (3%)
Query: 25 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84
LV M G L H++++ + A GLE+LH + +IYRD K
Sbjct: 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPE 126
Query: 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFG 144
N+LL+ + ++SD GLA + D + GT G+ APE + D ++ G
Sbjct: 127 NVLLDNDGNVRISDLGLAV--ELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALG 184
Query: 145 VVFLELITGR 154
V E+I R
Sbjct: 185 VTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 44/168 (26%), Positives = 79/168 (47%), Gaps = 16/168 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD----LPPDKEALDWNTRMK 56
+L+ + H N+V + + +V E+ G L ++ L + + L W ++
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQIS 111
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVST 115
+ GL+++HD+ +++RD KS NI L + G KL DFG+A+ + D ++
Sbjct: 112 L------GLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAY 160
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 163
+GT Y +PE K+D++S G V EL T + + H
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 49/158 (31%), Positives = 71/158 (44%), Gaps = 26/158 (16%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
KGL+YLH + I+RD K++N+LL E KL+DFG+A G + D +GT
Sbjct: 112 KGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPF 166
Query: 123 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 182
+ APE K+D++S G+ +EL G P R LF
Sbjct: 167 WMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHP---------MRVLF----LI 213
Query: 183 SKLADPRLEGRY--PIRGLYQALAVASMCIQEQAATRP 218
K + P LEG+Y P + +A C+ + RP
Sbjct: 214 PKNSPPTLEGQYSKPFKEFVEA------CLNKDPRFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 23/162 (14%)
Query: 5 LHHSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHL-----HDLPPDKEALDWNT 53
H N++ LIG C + +++ FM G L L LP E L T
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLP---EKLPLQT 114
Query: 54 RMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD---K 110
+K A G+EYL +N I+RD + N +L E ++DFGL+K GD +
Sbjct: 115 LLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQ 171
Query: 111 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
++ + + A E T KSDV++FGV E+ T
Sbjct: 172 GRIAKMPVK---WIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-10
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 37/167 (22%)
Query: 1 MLSLLHHSNLVN-------------LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE 47
+L+ + H N+V ++ YC GD + ++ L P+
Sbjct: 51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDL---------MQKIKLQRGKLFPEDT 101
Query: 48 ALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--G 105
L W +M + G++++H+K V++RD KS NI L + KL DFG A+L
Sbjct: 102 ILQWFVQMCL------GVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152
Query: 106 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
P ++ T V GT Y PE KSD++S G + EL T
Sbjct: 153 PG---AYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 6/157 (3%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
L L H N+V D + L V E+ G L + +++ ++ +I
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 60 GAAKGLEYLHDKANPP--VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
L H++++P V++RD K +NI L+ + KL DFGLAK+ D S T V
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYV 171
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y +PE KSD++S G + EL
Sbjct: 172 -GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 20/157 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI- 57
+L + H ++ L + + DQR L + E++P G L +L + + ++ +
Sbjct: 54 VLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL------RNSGRFSNSTGLF 105
Query: 58 -AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
A+ LEYLH K ++YRD K NILL++ H KL+DFG AK + D++
Sbjct: 106 YASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK--KLRDRTWT--- 157
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
+ GT Y APE + D ++ G++ E++ G
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 1 MLSLLHHSNLVNLI-GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+LS H N+V L Y + +L+ EF G+L+ + +L + L +
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGALDSIMLEL---ERGLTEPQIRYVCR 110
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
+ L +LH VI+RD K+ NILL KL+DFG++ + + +G
Sbjct: 111 QMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIG 165
Query: 120 TYGYCAPEYAMTGQLT-----VKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 167
T + APE K+D++S G+ +EL PH E N
Sbjct: 166 TPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP------PHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 12/146 (8%)
Query: 9 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 68
N+VN + GD+ +V E++ GSL D + + +D + + L++L
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFL 131
Query: 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMGTYGYCAPE 127
H VI+RD KS NILL KL+DFG A++ P ++S ST V GT + APE
Sbjct: 132 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPE 185
Query: 128 YAMTGQLTVKSDVYSFGVVFLELITG 153
K D++S G++ +E++ G
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 37/232 (15%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALD----WNTRMKIAAG 60
L H N+V + D+ +V + + L +H + L K+ WN +++
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS--TRVM 118
L YLH + +++RD +NI+L E ++DFGLAK K S T V+
Sbjct: 126 ----LRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK-----QKQPESKLTSVV 174
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 178
GT Y PE K+DV++FG + ++ T + ST N+++ A +
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST------NMLSLATKIVE- 227
Query: 179 RRKFSKLADPRLEGRYP--IRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228
+ +P EG Y + + + C+ A RP I V +S
Sbjct: 228 -----AVYEPLPEGMYSEDVTDVITS------CLTPDAEARPDIIQVSAMIS 268
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 5e-10
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 17/158 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---PDKEALDWNTRMKIA 58
L H +V L+ G +LV E+MP L + L D P+ + + RM +
Sbjct: 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSY-MRMLL- 109
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
KG+ Y+H +++RD K +N+L+ K++DFGLA+L + S +V
Sbjct: 110 ----KGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV- 161
Query: 119 GTYGYCAPEYAMTGQLTVKS--DVYSFGVVFLELITGR 154
T Y APE + G D+++ G +F EL+ G
Sbjct: 162 ATRWYRAPEL-LYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 52/160 (32%), Positives = 73/160 (45%), Gaps = 25/160 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIA- 58
ML H N+V G D+ +V E+ GSL+D P E IA
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ-------IAY 105
Query: 59 --AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVST 115
KGL YLH+ I+RD K +NILL E KL+DFG+ A+L + ++
Sbjct: 106 VCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL-----TATIAK 157
Query: 116 R--VMGTYGYCAPEYA---MTGQLTVKSDVYSFGVVFLEL 150
R +GT + APE A G K D+++ G+ +EL
Sbjct: 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-10
Identities = 42/97 (43%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
I GA +GL YLH + I+RD K+ NILL E KL+DFG A L S ++
Sbjct: 120 ICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSF 171
Query: 117 VMGTYGYCAPE--YAM-TGQLTVKSDVYSFGVVFLEL 150
V GT + APE AM GQ K DV+S G+ +EL
Sbjct: 172 V-GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 32/94 (34%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL+YLH+ +I+RD K SN+LL + K++DFGLA+ G + T + T
Sbjct: 119 RGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKVVTLW 173
Query: 123 YCAPE--YAMTGQLTVKSDVYSFGVVFLELITGR 154
Y APE T T D+++ G + EL+ +
Sbjct: 174 YRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 10/162 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+LS + G G + ++ E++ GS D L P D+ + T +K
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQI--ATMLK---E 109
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
KGL+YLH + I+RD K++N+LL E KL+DFG+A G + D +GT
Sbjct: 110 ILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGT 164
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 162
+ APE K+D++S G+ +EL G P
Sbjct: 165 PFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 20/160 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L H +V G D +++ L E+MP GS++D L AL N +
Sbjct: 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYT 112
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK------LGPVGDKSH 112
+G+ YLH +++RD K +NIL + + KL DFG +K + G KS
Sbjct: 113 RQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS- 168
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
V GT + +PE K+DV+S +E++T
Sbjct: 169 ----VTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 8e-10
Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 17/157 (10%)
Query: 6 HHSNLVNLIGYCADGDQRLL-VYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAA 62
+H LV L C + RL V E++ G L H+ P++ A ++ + +A
Sbjct: 54 NHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA---- 108
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG-PVGDKSHVSTRVMGTY 121
L YLH++ +IYRD K N+LL+ H KL+D+G+ K G GD ++ GT
Sbjct: 109 --LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTP 160
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158
Y APE D ++ GV+ E++ GR D
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 8e-10
Identities = 35/97 (36%), Positives = 48/97 (49%), Gaps = 5/97 (5%)
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
AA L +LH VIYRD K NILL+ H KL+DFG+ K G + +T
Sbjct: 102 AAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTF 156
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y APE + D ++ GV+ E++ G+
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-10
Identities = 46/154 (29%), Positives = 66/154 (42%), Gaps = 11/154 (7%)
Query: 7 HSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIA 58
H N++ LIG C + +++ FM G L L L + L +K
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
A G+EYL K+ I+RD + N +L E + ++DFGL+K GD
Sbjct: 119 TDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAK 175
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ A E T KSDV+SFGV E+ T
Sbjct: 176 MPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 58/195 (29%), Positives = 85/195 (43%), Gaps = 18/195 (9%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDL-PPDKEALDWNTRMKIAAGAAK 63
L HSNL+ +G C + LLV EF PLG L+ +L + D T ++A A
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 123
GL +LH K N I+ D N LL K+ D+GL+ D ++ +
Sbjct: 112 GLLHLH-KNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRW 168
Query: 124 CAPEYA--MTGQLTV-----KSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 176
APE + G L V +S+V+S GV EL R ++ ++T +
Sbjct: 169 IAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF--ELGSQPYRHLSDEQVLT-----Y 221
Query: 177 NDRRKFSKLADPRLE 191
R + KL PRL+
Sbjct: 222 TVREQQLKLPKPRLK 236
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 54/152 (35%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L L H N + G LV E+ LGS D L K+ L I GA
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGA 130
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 121
+GL YLH +I+RD K+ NILL E KL+DFG A KS + +GT
Sbjct: 131 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTP 181
Query: 122 GYCAPEYAMT---GQLTVKSDVYSFGVVFLEL 150
+ APE + GQ K DV+S G+ +EL
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 16/156 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
LS + G G + ++ E+ GS D L D+ + + R +
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL--- 108
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR---V 117
GLEYLH++ I+RD K++NILL E KL+DFG++ G + ++
Sbjct: 109 --LGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTF 158
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
+GT + APE K+D++S G+ +EL G
Sbjct: 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 8/155 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N+V L + L++EF+ + L+ +L LP + +D
Sbjct: 52 LLKELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQY-MDAELVKSYLYQ 109
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+G+ + H + V++RD K N+L++ KL+DFGLA+ G V T + T
Sbjct: 110 ILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVT 164
Query: 121 YGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
Y APE + + D++S G +F E+ T +
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 43/173 (24%), Positives = 84/173 (48%), Gaps = 34/173 (19%)
Query: 1 MLSLLHHSNLVN--------------LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 46
+LS L H N+V ++G+C GD +Y L++ L P+
Sbjct: 52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPEN 102
Query: 47 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 106
+ ++W ++ +A L+YLH+K +++RD K+ N+ L K+ D G+A++
Sbjct: 103 QVVEWFVQIAMA------LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV-- 151
Query: 107 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159
+ ++ +++ ++GT Y +PE KSDV++ G E+ T + A ++
Sbjct: 152 LENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-09
Identities = 50/162 (30%), Positives = 73/162 (45%), Gaps = 20/162 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L H +V G D +R L E MP GS++D L AL N K
Sbjct: 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYT 112
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK------LGPVGDKSH 112
+G+ YLH +++RD K +NIL + + KL DFG +K L G KS
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS- 168
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
V GT + +PE K+D++S G +E++T +
Sbjct: 169 ----VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 42/143 (29%), Positives = 72/143 (50%), Gaps = 12/143 (8%)
Query: 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH 69
+V +IG C + + +LV E G L L K+ + + +++ + G++YL
Sbjct: 57 IVRMIGVC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLE 112
Query: 70 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTY--GYCAP 126
K ++RD + N+LL + K+SDFGL+K LG D S+ R G + + AP
Sbjct: 113 GKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAP 167
Query: 127 EYAMTGQLTVKSDVYSFGVVFLE 149
E + + +SDV+S+G+ E
Sbjct: 168 ECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 10/146 (6%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 68
+VNL Y + L LV M G L+ H++++ + L+ + +A G+ +L
Sbjct: 55 IVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHL 111
Query: 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 128
H ++YRD K N+LL++ + +LSD GLA G T+ GT GY APE
Sbjct: 112 HSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEI 165
Query: 129 AMTGQLTVKSDVYSFGVVFLELITGR 154
+ D ++ G E++ GR
Sbjct: 166 LKEEPYSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 22/154 (14%)
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
L+Y+H VI+RD K++NIL+ + KL DFG+A L + S + +GT +
Sbjct: 114 LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWM 168
Query: 125 APEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS 183
APE G+ K+D++S G+ E+ TG L+ ++P
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--------- 219
Query: 184 KLADPRLEGRYPIRGLYQALAVASMCIQEQAATR 217
PRLE + L + +A C+ E+ R
Sbjct: 220 ----PRLEDNGYSKLLREFVA---ACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 36/103 (34%), Positives = 58/103 (56%), Gaps = 17/103 (16%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL---GPVGDK----SHVST 115
+GL+Y+H AN VI+RD K SN+L+ E ++ DFG+A+ P K +V+T
Sbjct: 118 RGLKYIH-SAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 116 RVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAI 157
R Y APE ++ + T D++S G +F E++ GR+ +
Sbjct: 175 R-----WYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 43/139 (30%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D+ V E++ G L H+ + KE + AA + GL +LH + +IYRD
Sbjct: 74 DRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFFLHRRG---IIYRD 126
Query: 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAPEYAMTGQLTVKSD 139
K N++L+ H K++DFG+ K V V+TR GT Y APE D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKEHMV---DGVTTRTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 140 VYSFGVVFLELITGRKAID 158
+++GV+ E++ G+ D
Sbjct: 184 WWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 11/116 (9%)
Query: 44 PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103
P+ + LDW ++ +A L+++HD+ +++RD KS NI L + KL DFG+A+
Sbjct: 99 PEDQILDWFVQICLA------LKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIAR 149
Query: 104 LGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159
+ + ++ +GT Y +PE KSD+++ G V E+ T + A ++
Sbjct: 150 V--LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 65
H N+V + GD+ +V EF+ G+L D + ++E + + K L
Sbjct: 75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKAL 129
Query: 66 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 125
LH + VI+RD KS +ILL KLSDFG V + ++GT + A
Sbjct: 130 SVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMA 184
Query: 126 PEYAMTGQLTVKSDVYSFGVVFLELITG 153
PE + D++S G++ +E++ G
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 36/109 (33%), Positives = 59/109 (54%), Gaps = 5/109 (4%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL+YLH A +++RD K N+L+ K+ DFGLA++ + H++ V+ Y
Sbjct: 114 RGLKYLH-SAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 123 YCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVT 170
Y APE M + T D++S G +F EL+ R + P + +L+T
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 47/157 (29%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLV--YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L H +V G D ++ L E+MP GS++D L AL + K
Sbjct: 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYT 112
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-V 117
+G+ YLH +++RD K +NIL + + KL DFG +K S R V
Sbjct: 113 RQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV 169
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT + +PE K+DV+S G +E++T +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIA 58
+L L H +VN++ D ++ + EF+ G L HL P+ A ++ + +A
Sbjct: 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA 130
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
EYLH K +IYRD K N+LL+ H K++DFG AK V D++ +
Sbjct: 131 ------FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK--KVPDRTFT---LC 176
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
GT Y APE + D ++ GV+ E I G
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 22/175 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++S L H +LV L G C D+ ++V E++ G L+ LH + +L W ++ +A
Sbjct: 54 LMSQLSHKHLVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQ 109
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILL-----EEGFHP--KLSDFGLAKLGPVGDKSHV 113
A L YL DK +++ + NIL+ EG+ P KLSD G+ V +
Sbjct: 110 LASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREER 164
Query: 114 STRVMGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 166
R+ + APE GQ LT+ +D +SFG LE+ + + ST E+
Sbjct: 165 VERI----PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 50/153 (32%), Positives = 79/153 (51%), Gaps = 12/153 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H N+V L ++ +LV+E+M L+ ++ D + ALD NT KG
Sbjct: 55 LKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYM-DTHGVRGALDPNTVKSFTYQLLKG 112
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LG-PVGDKSHVSTRVMGTYG 122
+ + H+ V++RD K N+L+ + KL+DFGLA+ G PV + S V+ T
Sbjct: 113 IAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVV-TLW 165
Query: 123 YCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
Y AP+ + + S D++S G + E+ITGR
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 4e-09
Identities = 42/148 (28%), Positives = 72/148 (48%), Gaps = 10/148 (6%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
H ++V LIG + + +V E PLG L +L +K +LD + + + +
Sbjct: 64 FDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTA 119
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-STRVMGTYGY 123
L YL K ++RD + N+L+ KL DFGL++ + D+S+ +++ +
Sbjct: 120 LAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKW 174
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELI 151
APE + T SDV+ FGV E++
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 16/155 (10%)
Query: 2 LSLLHHSNLVNLIGYCADG--DQRL---LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
L H N+V L+ CA D+ LV+E + L +L +PP L T
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPP--PGLPAETIKD 112
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS-T 115
+ +GL++LH +++RD K NIL+ G KL+DFGLA++ ++ T
Sbjct: 113 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALT 165
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150
V+ T Y APE + D++S G +F E+
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-09
Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 13/152 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L + +V +IG C + + +LV E LG L L +K + N ++
Sbjct: 49 VMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQK---NKHVTEKNI-TELVHQ 103
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMG 119
+ G++YL + ++RD + N+LL + K+SDFGL+K LG D+++ + G
Sbjct: 104 VSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALG--ADENYYKAKTHG 158
Query: 120 TY--GYCAPEYAMTGQLTVKSDVYSFGVVFLE 149
+ + APE + + KSDV+SFGV+ E
Sbjct: 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
LEYLH + V+YRD K N++L++ H K++DFGL K G + D + + T GT Y
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYL 162
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELITGR 154
APE D + GVV E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 55/158 (34%), Positives = 73/158 (46%), Gaps = 28/158 (17%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAA 59
L L H N + G LV E+ LGS D L H P + ++IAA
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQE--------VEIAA 119
Query: 60 ---GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL-GPVGDKSHVST 115
GA +GL YLH + +I+RD K+ NILL E KL DFG A + P +
Sbjct: 120 VTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------AN 169
Query: 116 RVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLEL 150
+GT + APE + GQ K DV+S G+ +EL
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 9e-09
Identities = 46/169 (27%), Positives = 69/169 (40%), Gaps = 19/169 (11%)
Query: 9 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLE 66
N+V L Y D LV + G L H+ P++ W M +A L+
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------LD 99
Query: 67 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG-LAKLGPVGDKSHVSTRVMGTYGYCA 125
LH + ++ RD +NILL++ H +L+ F +++ D V YCA
Sbjct: 100 ALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150
Query: 126 PEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 174
PE + T D +S G + EL+TG K + P G T P
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPSGINTHTTLNIP 198
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 9e-09
Identities = 36/96 (37%), Positives = 45/96 (46%), Gaps = 5/96 (5%)
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
AA A L YLH +IYRD K NILL+ H L+DFGL K G K+ ++
Sbjct: 102 AAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTF 156
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
GT Y APE D + G V E++ G
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
A L+YLH + N V+YRD K N++L++ H K++DFGL K G + D + + T
Sbjct: 101 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-F 156
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y APE D + GVV E++ GR
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 34/90 (37%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
L YLH V+YRD K N++L++ H K++DFGL K G + D + + T GT Y
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCGTPEYL 162
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELITGR 154
APE D + GVV E++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 47/130 (36%), Positives = 59/130 (45%), Gaps = 11/130 (8%)
Query: 25 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANPPVIYRDFKS 83
LV F+ G L HL +E +R + A LE LH K N VIYRD K
Sbjct: 70 LVLAFINGGELFHHLQ-----REGRFDLSRARFYTAELLCALENLH-KFN--VIYRDLKP 121
Query: 84 SNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSF 143
NILL+ H L DFGL KL + GT Y APE + T D ++
Sbjct: 122 ENILLDYQGHIALCDFGLCKLNM--KDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTL 179
Query: 144 GVVFLELITG 153
GV+ E++TG
Sbjct: 180 GVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-LDWNTRMKIAA 59
M+ HSN+V G D+ + EF GSL+D H P E+ + + +R +
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-- 116
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
+GL YLH K ++RD K +NILL + H KL+DFG++ + +G
Sbjct: 117 ---QGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS--AQITATIAKRKSFIG 168
Query: 120 TYGYCAPEYAMT---GQLTVKSDVYSFGVVFLEL 150
T + APE A G D+++ G+ +EL
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 57/171 (33%), Positives = 79/171 (46%), Gaps = 17/171 (9%)
Query: 3 SLLHHSNLVNLIG--YCAD---GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI 57
SL +H N+V G Y AD G Q LV E GS+ + + L + LD I
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTR 116
GA GL++LH N +I+RD K +NILL KL DFG+ A+L + + S
Sbjct: 134 LYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-- 188
Query: 117 VMGTYGYCAPEYAMTGQ-----LTVKSDVYSFGVVFLELITGRKAIDSTRP 162
+GT + APE Q + DV+S G+ +EL G + P
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 51/152 (33%), Positives = 69/152 (45%), Gaps = 16/152 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L + H N + G LV E+ LGS D L K+ L I GA
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLE---VHKKPLQEVEIAAITHGA 134
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 121
+GL YLH +I+RD K+ NILL E KL+DFG A + + + +GT
Sbjct: 135 LQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI------ASPANSFVGTP 185
Query: 122 GYCAPEYAMT---GQLTVKSDVYSFGVVFLEL 150
+ APE + GQ K DV+S G+ +EL
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDW-NTRMKIAA 59
+L + H +V+LI G + L+ E++ G L HL ++E + +T +
Sbjct: 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLS 107
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
+ LE+LH + +IYRD K NILL+ H KL+DFGL K V+ G
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCG 162
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
T Y APE M D +S G + +++TG
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 38/96 (39%), Positives = 54/96 (56%), Gaps = 7/96 (7%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL+Y+H AN V++RD K SN+LL K+ DFGLA+ +K T + T
Sbjct: 119 RGLKYIH-SAN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 123 YCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAI 157
Y APE + + T DV+S G +F EL+ GRK +
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 26/166 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L+H N+V L+ ++ LV+EF+ DL K+ +D + I
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFLH--------QDL---KKFMDASPLSGIPLP 100
Query: 61 AAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 112
K GL + H V++RD K N+L+ KL+DFGLA+ V +++
Sbjct: 101 LIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157
Query: 113 VSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAI 157
V T Y APE + + + D++S G +F E++T R+A+
Sbjct: 158 THEVV--TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 41/157 (26%), Positives = 70/157 (44%), Gaps = 10/157 (6%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 65
H N+V + G++ ++ EF+ G+L D + ++E + + + L
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQI-----ATVCESVLQAL 130
Query: 66 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCA 125
YLH + VI+RD KS +ILL KLSDFG + ++GT + A
Sbjct: 131 CYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFC--AQISKDVPKRKSLVGTPYWMA 185
Query: 126 PEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 162
PE + D++S G++ +E++ G S P
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-08
Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 15/151 (9%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKG 64
H N+++L G ++V E+M GSL+ L HD L + + G A G
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL-----VGMLRGIASG 118
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG---TY 121
++YL D ++RD + NIL+ K+SDFGL+++ + D + G
Sbjct: 119 MKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPI 173
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE + T SDV+S+G+V E+++
Sbjct: 174 RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 4e-08
Identities = 36/97 (37%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY- 121
+GL+YLH AN VI+RD K SNIL+ K+ DFGLA+ D + Y
Sbjct: 114 RGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEKGFLTEYV 167
Query: 122 ---GYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
Y APE ++ K+ D++S G +F EL+T +
Sbjct: 168 VTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 45/169 (26%), Positives = 67/169 (39%), Gaps = 40/169 (23%)
Query: 16 YCADGDQRLL--VYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 71
Y + D+ L V E+MP G L + L D+ P++ A + + +A + L ++H
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIH-- 124
Query: 72 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-------------------- 111
RD K NIL++ H KL+DFGL K
Sbjct: 125 -------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 112 --HVSTRVM-----GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
H RV GT Y APE ++ D +S GV+ E++ G
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 52/223 (23%), Positives = 90/223 (40%), Gaps = 19/223 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L+H N++ + + ++ +V E G L + K + T K
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+E++H + V++RD K +N+ + KL D GL + K+ + ++GT
Sbjct: 115 LCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGT 169
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
Y +PE KSD++S G + E+ A+ S + NL + +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLC-------Q 218
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 223
K + P L + L + + SMCI RP IG V
Sbjct: 219 KIEQCDYPPLPTEHYSEKLRE---LVSMCIYPDPDQRPDIGYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-08
Identities = 42/139 (30%), Positives = 65/139 (46%), Gaps = 11/139 (7%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80
D+ V E++ G L + + KE + AA A GL +LH K +IYRD
Sbjct: 74 DRLYFVMEYVNGGDLMYQIQQVGRFKEP----HAVFYAAEIAIGLFFLHSKG---IIYRD 126
Query: 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAPEYAMTGQLTVKSD 139
K N++L+ H K++DFG+ K V+T+ GT Y APE D
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKENMW---DGVTTKTFCGTPDYIAPEIIAYQPYGKSVD 183
Query: 140 VYSFGVVFLELITGRKAID 158
++FGV+ E++ G+ +
Sbjct: 184 WWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 6e-08
Identities = 43/135 (31%), Positives = 64/135 (47%), Gaps = 11/135 (8%)
Query: 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEYLHDKANPPVIYR 79
D+ V E++ G L HL +E + R + A L+YLH ++YR
Sbjct: 68 DRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYR 119
Query: 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSD 139
D K N++L++ H K++DFGL K G + D + + T GT Y APE D
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKT-FCGTPEYLAPEVLEDNDYGRAVD 177
Query: 140 VYSFGVVFLELITGR 154
+ GVV E++ GR
Sbjct: 178 WWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 49/154 (31%), Positives = 67/154 (43%), Gaps = 11/154 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AA 59
+L + H LV L ++ V +F+ G L HL +E R + AA
Sbjct: 49 LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQ-----RERSFPEPRARFYAA 103
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
A L YLH + ++YRD K NILL+ H L+DFGL K G +S +T G
Sbjct: 104 EIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
T Y APE D + G V E++ G
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 31/83 (37%), Positives = 44/83 (53%)
Query: 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT 135
+I+RD KS+NILL KL DFG +K+ V GT Y APE +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 136 VKSDVYSFGVVFLELITGRKAID 158
K+D++S GV+ EL+T ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 14/158 (8%)
Query: 2 LSLLHHSNLVNLIGYCA----DGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
L H N+V L C D + +L LV+E + L +L +P + + T
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKD 114
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
+ +GL++LH V++RD K NIL+ KL+DFGLA++ T
Sbjct: 115 MMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTS 168
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
V+ T Y APE + D++S G +F E+ +
Sbjct: 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 9e-08
Identities = 51/176 (28%), Positives = 74/176 (42%), Gaps = 53/176 (30%)
Query: 4 LLHHSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L H N+V L+ A+ D+ + LV+E+M E LH + I A
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAV--------------IRANI 103
Query: 62 -------------AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL---G 105
K L+Y+H N VI+RD K SNILL KL+DFGLA+
Sbjct: 104 LEDVHKRYIMYQLLKALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160
Query: 106 PVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGV-------VFLELITGR 154
++ V T + T Y APE + + S Y+ GV + E++ G+
Sbjct: 161 EENPENPVLTDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL+Y+H A +I+RD K SNI + E K+ DFGLA+ +V+TR
Sbjct: 129 RGLKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 123 YCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154
Y APE + D++S G + EL+TG+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 49/177 (27%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 1 MLSLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM 55
+L L H N+V LI + +R VY P HDL L N +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-----HDL----SGLLENPSV 110
Query: 56 KIAAGAAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--- 104
K+ K G+ YLH+ +++RD K++NIL++ K++DFGLA+
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 105 ------GPVGDKSHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
G G + T ++ T Y PE + + T D++ G VF E+ T R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 50/180 (27%), Positives = 74/180 (41%), Gaps = 21/180 (11%)
Query: 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEY 67
LV L+ D + L E++P G L++L + A + M A A L Y
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 68 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE 127
+H RD K N L++ H KL+DFGL+K S V+G+ Y APE
Sbjct: 123 IH---------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPE 168
Query: 128 YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWA----RPLFNDRRKF 182
D +S G + E + G + P+ +NL W RP+++D R
Sbjct: 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN 228
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 35/92 (38%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 123
LE+LH +IYRD K NILL+ H L+DFGL+K D+ + GT Y
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK-EFHEDEVERAYSFCGTIEY 172
Query: 124 CAPEYAMTGQLTVKS--DVYSFGVVFLELITG 153
AP+ G D +S GV+ EL+TG
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 36/98 (36%), Positives = 54/98 (55%), Gaps = 9/98 (9%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK---LGPVGDKSHVSTRVMGT 120
GL+Y+H AN V++RD K N+L+ K+ DFGLA+ P + + T + T
Sbjct: 117 GLKYIH-SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172
Query: 121 YGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRKAI 157
Y APE ++ Q K+ DV+S G + EL+ GRK +
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 34/119 (28%), Positives = 46/119 (38%), Gaps = 32/119 (26%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK-----SHVSTRVM 118
LEYLH ++YRD K NILL E H LSDF L+K V +R
Sbjct: 115 ALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 119 ----------------------GTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGR 154
GT Y APE ++G D ++ G++ E++ G
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 3e-07
Identities = 33/90 (36%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
LE+LH ++YRD K NILL+ H L DFGL+K +K+ + GT Y
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYL 163
Query: 125 APEYAMTGQ-LTVKSDVYSFGVVFLELITG 153
APE + + T D +S GV+ E+ G
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 45/163 (27%), Positives = 81/163 (49%), Gaps = 20/163 (12%)
Query: 1 MLSLLHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHD--LPPDKEALDWNTR--M 55
+L L H N++ ++ C DG+ ++Y +M G+L+ L L +T+ +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGP-----VGD 109
+A A G+ YLH + VI++D + N +++E K++D L++ L P +GD
Sbjct: 121 HMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 110 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ + M A E + + + SDV+SFGV+ EL+T
Sbjct: 178 NENRPVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-07
Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 9/149 (6%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 66
H N+++L G +++ EFM G+L+ L + + + G A G++
Sbjct: 64 HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ---NDGQFTVIQLVGMLRGIAAGMK 120
Query: 67 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG---TYGY 123
YL + ++RD + NIL+ K+SDFGL++ T +G +
Sbjct: 121 YLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRW 177
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
APE + T SDV+S+G+V E+++
Sbjct: 178 TAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 55/192 (28%), Positives = 81/192 (42%), Gaps = 22/192 (11%)
Query: 6 HHSNLVNLIGY------CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
HH N+ G DQ LV EF GS+ D + + + DW I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICR 128
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLG-PVGDKSHVSTRV 117
+GL +LH VI+RD K N+LL E KL DFG+ A+L VG ++
Sbjct: 129 EILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN----TF 181
Query: 118 MGTYGYCAPEYAMTGQ-----LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWA 172
+GT + APE + +SD++S G+ +E+ G + P L+
Sbjct: 182 IGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN 241
Query: 173 RPLFNDRRKFSK 184
P +K+SK
Sbjct: 242 PPPKLKSKKWSK 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 4e-07
Identities = 34/96 (35%), Positives = 44/96 (45%), Gaps = 5/96 (5%)
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
AA A + YLH +IYRD K NILL+ H L+DFGL K G + ++
Sbjct: 102 AAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTF 156
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
GT Y APE D + G V E++ G
Sbjct: 157 CGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-07
Identities = 50/170 (29%), Positives = 73/170 (42%), Gaps = 22/170 (12%)
Query: 6 HHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
HH N+ G DQ LV EF GS+ D + + + +W I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICR 118
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLG-PVGDKSHVSTRV 117
+GL +LH VI+RD K N+LL E KL DFG+ A+L VG ++
Sbjct: 119 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN----TF 171
Query: 118 MGTYGYCAPEYAMTGQ-----LTVKSDVYSFGVVFLELITGRKAIDSTRP 162
+GT + APE + KSD++S G+ +E+ G + P
Sbjct: 172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 32/108 (29%), Positives = 57/108 (52%), Gaps = 6/108 (5%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL Y H + V++RD K N+L+ E KL+DFGLA+ V K++ + V T
Sbjct: 115 RGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLW 169
Query: 123 YCAPEYAM-TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 169
Y P+ + + + + + D++ G +F E+ +GR + E +L+
Sbjct: 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-07
Identities = 55/195 (28%), Positives = 83/195 (42%), Gaps = 29/195 (14%)
Query: 19 DGDQRLLVYEFMPLGSLEDHL--HDLPPDKE-ALDWNTRMKIAAGAAKGLEYLHDKANPP 75
D D LV E+ P G L L ++ D++ A + + +A + + Y+H
Sbjct: 72 DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH------ 125
Query: 76 VIYRDFKSSNILLEEGFHPKLSDFG-LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT--- 131
RD K N+L++ H KL+DFG A+L +K S +GT Y APE T
Sbjct: 126 ---RDIKPENVLIDRTGHIKLADFGSAARLT--ANKMVNSKLPVGTPDYIAPEVLTTMNG 180
Query: 132 ---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP 188
G V+ D +S GV+ E+I GR P E + N +R DP
Sbjct: 181 DGKGTYGVECDWWSLGVIAYEMIYGRS------PFHEGTSAKTYNNIMNFQRFLKFPEDP 234
Query: 189 RLEGRYPIRGLYQAL 203
++ + L Q+L
Sbjct: 235 KVSSDF--LDLIQSL 247
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 15/158 (9%)
Query: 1 MLSLLHHSNLVNL--IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI 57
+L L+H N+V L + + + +L LV+EF+ L L+ ++ P LD
Sbjct: 51 LLKELNHPNIVRLLDVVHS---ENKLYLVFEFLDL-DLKKYMDSSPLT--GLDPPLIKSY 104
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
+G+ Y H V++RD K N+L++ KL+DFGLA+ G T
Sbjct: 105 LYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHE 159
Query: 118 MGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 154
+ T Y APE + Q + D++S G +F E++ R
Sbjct: 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 5e-07
Identities = 44/156 (28%), Positives = 65/156 (41%), Gaps = 11/156 (7%)
Query: 5 LHHSNLVNLIGYC--ADGDQRL----LVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK 56
H N++ LIG + RL ++ FM G L L + + L T ++
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
A G+EYL K I+RD + N +L E ++DFGL+K GD
Sbjct: 118 FMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCA 174
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ A E T SDV++FGV E++T
Sbjct: 175 SKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 5/150 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L+H N++ + ++ +V E G L + K + T K
Sbjct: 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
LE++H + V++RD K +N+ + KL D GL + K+ + ++GT
Sbjct: 115 LCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGT 169
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150
Y +PE KSD++S G + E+
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 9/99 (9%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL+Y+H + +I+RD K SN+ + E K+ DFGLA+ +V+TR
Sbjct: 131 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 182
Query: 123 YCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160
Y APE + D++S G + EL+TGR T
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 6e-07
Identities = 52/170 (30%), Positives = 72/170 (42%), Gaps = 15/170 (8%)
Query: 3 SLLHHSNLVNLIG--YCAD---GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI 57
+L H N+V G Y D GDQ LV E GS+ D + E ++ I
Sbjct: 70 ALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYI 129
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
A GL++LH I+RD K +NILL KL DFG++ +
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTS 184
Query: 118 MGTYGYCAPEY-AMTGQL----TVKSDVYSFGVVFLELITGRKAIDSTRP 162
+GT + APE A QL + DV+S G+ +EL G + P
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 6e-07
Identities = 47/146 (32%), Positives = 64/146 (43%), Gaps = 35/146 (23%)
Query: 1 MLSLLHHSNLVNLIGYC---ADGDQR-----LLVYEFMPLGSLEDHLHDLPPDKEALDWN 52
+L LL H N+VNLI C A R LV+EF HDL L N
Sbjct: 64 ILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE--------HDLA----GLLSN 111
Query: 53 TRMKIAAGAAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK- 103
+K K GL Y+H +++RD K++NIL+ + KL+DFGLA+
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARA 168
Query: 104 --LGPVGDKSHVSTRVMGTYGYCAPE 127
L + + RV+ T Y PE
Sbjct: 169 FSLSKNSKPNRYTNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 6e-07
Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG---SLEDHLHDLPPDKEALDWNTRMKI 57
+L L H+N+V L + LV+E++ ++ H L P+ L
Sbjct: 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------F 108
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
+GL Y+H + +++RD K N+L+ + KL+DFGLA+ V SH +
Sbjct: 109 LFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNE 163
Query: 118 MGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGRKA 156
+ T Y P+ + + + + D++ G +F+E+I G A
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 46/160 (28%), Positives = 74/160 (46%), Gaps = 24/160 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQ-RL-LVYEFMPLGSLEDHLHDLPPD-KEALDWNTRMKI 57
+ L H N++ LI D RL LV+E M + +L++L K L
Sbjct: 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSY 105
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK----SHV 113
K L+++H + +RD K NIL+++ KL+DFG + + K ++
Sbjct: 106 MYQLLKSLDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYI 159
Query: 114 STRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELIT 152
STR Y APE +T G K D+++ G VF E+++
Sbjct: 160 STR-----WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 7/127 (5%)
Query: 27 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNI 86
Y+ +++ L D E L + A+G+E+L A+ ++RD + N+
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 87 LLEEGFHPKLSDFGLAKLGPVGDKSHVST-RVMGTYGYCAPEYAMTGQLTVKSDVYSFGV 145
LL +G K+ DFGLA+ + D ++VS + APE T SDV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 146 VFLELIT 152
+ E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 31/102 (30%), Positives = 48/102 (47%), Gaps = 16/102 (15%)
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG-------------PVGDKS 111
LEYLH N +++RD K N+L+ H KL+DFGL+K+G +
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
+ +V GT Y APE + D ++ G++ E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 8e-07
Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 19/146 (13%)
Query: 16 YCADGDQRLL--VYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAAGAAKGLEYLHDKA 72
+ A D + L V E+MP G L + + + P+K A + + +A A + ++H
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH--- 165
Query: 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMGTYGYCAPEYAMT 131
RD K N+LL++ H KL+DFG K+ G T V GT Y +PE +
Sbjct: 166 ------RDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAV-GTPDYISPEVLKS 217
Query: 132 ----GQLTVKSDVYSFGVVFLELITG 153
G + D +S GV E++ G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 39/119 (32%), Positives = 60/119 (50%), Gaps = 16/119 (13%)
Query: 44 PDKEALD-WNTRMKI------AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKL 96
P +E D W + + + + A+G+E+L A+ I+RD + NILL E K+
Sbjct: 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKI 215
Query: 97 SDFGLAKLGPVGDKSHV---STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
DFGLA+ D +V S R+ + APE T +SDV+SFGV+ E+ +
Sbjct: 216 CDFGLAR-DIYKDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H+N+V L LV+E++ L+ +L D +++ +
Sbjct: 57 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC---GNSINMHNVKLFLFQ 112
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+GL Y H + V++RD K N+L+ E KL+DFGLA+ + K++ + V T
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--T 167
Query: 121 YGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
Y P+ + + + + D++ G +F E+ TGR
Sbjct: 168 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 20/157 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA-- 58
M+ H N+V G ++ + E+ GSL+D H P E ++IA
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSE-------LQIAYV 111
Query: 59 -AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTR 116
+GL YLH K ++RD K +NILL + KL+DFG+ AK+ K
Sbjct: 112 CRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKS 165
Query: 117 VMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLEL 150
+GT + APE A G D+++ G+ +EL
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 11/112 (9%)
Query: 45 DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104
D+ ALD + + AKG+ +L K I+RD + NILL G K+ DFGLA+
Sbjct: 207 DELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR- 262
Query: 105 GPVGDKSHVSTRVMGT----YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
D ++V V G + APE T +SDV+S+G++ E+ +
Sbjct: 263 DIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 1e-06
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 46/172 (26%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L H N+V L + D+ V+E+M E +L+ L D++ +
Sbjct: 52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRK------GKPFSESV 100
Query: 62 AK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK--- 110
+ GL ++H K +RD K N+L+ K++DFGLA+ + +
Sbjct: 101 IRSIIYQILQGLAHIH-KHG--FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPY 155
Query: 111 -SHVSTRVMGTYGYCAPEYAMTGQLTVKS-------DVYSFGVVFLELITGR 154
+VSTR Y APE + ++S D+++ G + EL T R
Sbjct: 156 TDYVSTR-----WYRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 2e-06
Identities = 30/107 (28%), Positives = 50/107 (46%), Gaps = 6/107 (5%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL YLH + +I+RD K+ NI + + + D G A+ PV + + + GT
Sbjct: 168 EGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVE 221
Query: 123 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 169
APE + K+D++S G+V E++ I P + V
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268
|
Length = 357 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 30/110 (27%), Positives = 54/110 (49%), Gaps = 6/110 (5%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL Y+H + +++RD K N+L+ KL+DFGLA+ + +++ S V T
Sbjct: 114 RGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLW 168
Query: 123 YCAPEYAM-TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 171
Y P+ + + D++ G +F+E++ G+ A EQ W
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 29/91 (31%), Positives = 50/91 (54%), Gaps = 12/91 (13%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS-TRVMGTY 121
+G+++LH +++RD K NIL+ K++DFGLA++ ++ T V+ T
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVVVTL 170
Query: 122 GYCAPEYAMTGQLTVKS--DVYSFGVVFLEL 150
Y APE + Q + + D++S G +F EL
Sbjct: 171 WYRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+LS L H +V + D ++ E+ L+ L +L + L N +
Sbjct: 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
G+ Y+H + +++RD K+ NI L+ K+ DFG+++L + ++T GT
Sbjct: 115 LLLGVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGT 168
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150
Y +PE KSD++S G + E+
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 33/109 (30%), Positives = 56/109 (51%), Gaps = 5/109 (4%)
Query: 45 DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104
+ AL + + + A G+E+L A+ ++RD + N+L+ EG K+ DFGLA+
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLAR- 287
Query: 105 GPVGDKSHVST-RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ D +++S + APE T SDV+SFG++ E+ T
Sbjct: 288 DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 7/91 (7%)
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
LE+LH ++YRD K NILL+ H L+DFGL+K +K + GT Y
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYM 173
Query: 125 APEY--AMTGQLTVKSDVYSFGVVFLELITG 153
APE G D +S G++ EL+TG
Sbjct: 174 APEIIRGKGGHGKA-VDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 20/161 (12%)
Query: 1 MLSLLHHSNLVNL--IGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRM-- 55
+L + H N+V L + + ++RL LV+E++ L L+ H+ D PD N R+
Sbjct: 54 LLKEMQHGNIVRLQDVVHS---EKRLYLVFEYLDL-DLKKHM-DSSPD---FAKNPRLIK 105
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-KLSDFGLAKLGPVGDKSHVS 114
+G+ Y H V++RD K N+L++ + KL+DFGLA+ G
Sbjct: 106 TYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTF 160
Query: 115 TRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
T + T Y APE + + + D++S G +F E++ +
Sbjct: 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV---STRVM 118
A+G+E+L A+ I+RD + NILL E K+ DFGLA+ D +V R+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 237
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE T +SDV+SFGV+ E+ +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 47/156 (30%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AA 59
+L + H LV L D+ V +++ G L HL +E R + AA
Sbjct: 49 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQ-----RERCFLEPRARFYAA 103
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK--LGPVGDKSHVSTRV 117
A L YLH ++YRD K NILL+ H L+DFGL K + G ++
Sbjct: 104 EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----TTSTF 156
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
GT Y APE D + G V E++ G
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 46/159 (28%), Positives = 67/159 (42%), Gaps = 24/159 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPDKEALDWNTRMKI 57
+L+ ++H VNL G D LV EF+ G L P D
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-------Y 136
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR- 116
AA EYL ++YRD K N+LL++ K++DFG AK+ V TR
Sbjct: 137 AAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRT 185
Query: 117 --VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
+ GT Y APE + +D ++ G+ E++ G
Sbjct: 186 YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 6/93 (6%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL Y H + +++RD K N+L+ E KL+DFGLA+ V K++ + V T
Sbjct: 114 RGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLW 168
Query: 123 YCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
Y P+ + + + + D++ G + E+ TGR
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV---STRVM 118
AKG+E+L A+ I+RD + NILL E K+ DFGLA+ D +V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 243
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE T++SDV+SFGV+ E+ +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-06
Identities = 48/162 (29%), Positives = 82/162 (50%), Gaps = 21/162 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
M+S L H +LV G C GD+ ++V E++ GSL+ +L +K ++ + ++++A
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK---NKNLINISWKLEVAKQ 108
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILL--EE----GFHP--KLSDFGLAKLGPVGDKSH 112
A L +L DK + + + + N+LL EE G P KLSD G++ V K
Sbjct: 109 LAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI--TVLPKEI 163
Query: 113 VSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITG 153
+ R+ + PE Q L++ +D +SFG E+ +G
Sbjct: 164 LLERI----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 6/93 (6%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL Y H + V++RD K N+L+ E KL+DFGLA+ V K++ + V T
Sbjct: 114 RGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLW 168
Query: 123 YCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
Y P+ + + + + D++ G +F E+ TGR
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 35/113 (30%), Positives = 61/113 (53%), Gaps = 11/113 (9%)
Query: 44 PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103
D LD + ++ ++ A+G+++L K I+RD + N+LL +G K+ DFGLA+
Sbjct: 204 EDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 104 LGPVGDKSHVSTRVMGT----YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ D ++V V G + APE TV+SDV+S+G++ E+ +
Sbjct: 261 -DIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
KGL+Y+H +I+RD K N+ + E K+ DFGLA+ +V TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 123 YCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 154
Y APE + T D++S G + E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 53/191 (27%), Positives = 85/191 (44%), Gaps = 36/191 (18%)
Query: 2 LSLLHHS-----NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
++ LH++ NL ++ Y GD L+ +F ED L P+ A + M
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAEMV 112
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
IA + L Y+H RD K NIL++ H +L+DFG + L + D + S+
Sbjct: 113 IAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSV 162
Query: 117 VMGTYGYCAPEY--AM---TGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 171
+GT Y +PE AM G+ + D +S GV E++ G P ++LV
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET------PFYAESLVET 216
Query: 172 ARPLFNDRRKF 182
+ N + +F
Sbjct: 217 YGKIMNHKERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-06
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 22/155 (14%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLED-HLHDLPPDKEALDWNTRMKIAAGAAKGL 65
H N+V + ++ EFM GSLE H+ D ++ D +A G+
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIAD---EQFLAD------VARQILSGI 181
Query: 66 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGTYGYC 124
YLH + +++RD K SN+L+ + K++DFG+++ L D + S +GT Y
Sbjct: 182 AYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYM 235
Query: 125 APEYAMT----GQLT-VKSDVYSFGVVFLELITGR 154
+PE T G D++S GV LE GR
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 6/95 (6%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS-TRVMGTY 121
+ L+Y+H AN V +RD K NIL K+ DFGLA++ + + T + T
Sbjct: 114 RALKYIH-TAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 122 GYCAPEY--AMTGQLTVKSDVYSFGVVFLELITGR 154
Y APE + + T D++S G +F E++TG+
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 28/77 (36%), Positives = 42/77 (54%)
Query: 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT 135
+++RD KS+NI L KL DFG +K V++ GT Y APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 136 VKSDVYSFGVVFLELIT 152
K+D++S GV+ EL+T
Sbjct: 250 KKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 39/149 (26%), Positives = 66/149 (44%), Gaps = 13/149 (8%)
Query: 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 66
HSN+V L G G+ ++V E+M G+L+ L + L M + G A G++
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMK 121
Query: 67 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG---Y 123
YL + +++ + +L+ K+S F + DKS M +
Sbjct: 122 YLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLW 174
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
APE + SDV+SFG+V E+++
Sbjct: 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 44/146 (30%), Positives = 67/146 (45%), Gaps = 19/146 (13%)
Query: 16 YCADGDQRLL--VYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAAGAAKGLEYLHDKA 72
+CA D + L V E+MP G L + + + P+K A + + +A A + +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIH--- 165
Query: 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMGTYGYCAPEYAMT 131
RD K N+LL++ H KL+DFG K+ G T V GT Y +PE +
Sbjct: 166 ------RDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAV-GTPDYISPEVLKS 217
Query: 132 ----GQLTVKSDVYSFGVVFLELITG 153
G + D +S GV E++ G
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 8e-06
Identities = 29/91 (31%), Positives = 48/91 (52%), Gaps = 6/91 (6%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 123
G+++LH + +I+RD K SNI+++ K+ DFGLA+ G ++ V+ Y Y
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 183
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
APE + D++S G + E+I G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 9e-06
Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 15/156 (9%)
Query: 1 MLSLLHHSNLVNLIG-YCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+L+ +H +V L+G + DG +++ EF P G+++ + +L D+ + ++ I
Sbjct: 62 ILATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAVDAIMLEL--DRGLTEPQIQV-ICR 117
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
+ L+YLH +I+RD K+ N+LL KL+DFG++ + S +G
Sbjct: 118 QMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIG 172
Query: 120 TYGYCAPEYAMTGQLT-----VKSDVYSFGVVFLEL 150
T + APE M + K+D++S G+ +E+
Sbjct: 173 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
GL+Y+H +I+RD K N+ + E K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 123 YCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
Y APE + ++ D++S G + E++TG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 49/193 (25%), Positives = 80/193 (41%), Gaps = 54/193 (27%)
Query: 1 MLSLLHHSNLVNLIGYC-ADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDW------- 51
+L L H N+V+L+ D+ + L++++ HDL W
Sbjct: 55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE--------HDL--------WQIIKFHR 98
Query: 52 -NTRMKIAAGAAK--------GLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKLSD 98
R+ I K G+ YLH V++RD K +NIL+ E K+ D
Sbjct: 99 QAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGD 155
Query: 99 FGLAKL--GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRK 155
GLA+L P+ + + V+ T Y APE + + K+ D+++ G +F EL+T
Sbjct: 156 LGLARLFNAPLKPLADLD-PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT--- 211
Query: 156 AIDSTRP--HGEQ 166
P G +
Sbjct: 212 ----LEPIFKGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 53/169 (31%), Positives = 74/169 (43%), Gaps = 28/169 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD--KEALDWNTRMKIA 58
+ H N++ G ++ FM GS L P+ EAL N I
Sbjct: 52 LSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----IL 107
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV---GDKSHV-- 113
GA +GL YLH I+R+ K+S+IL+ LS GL+ L + G K+ V
Sbjct: 108 FGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVY 162
Query: 114 -----STRVMGTYGYCAPEYA---MTGQLTVKSDVYSFGVVFLELITGR 154
ST V+ + +PE + G VKSD+YS G+ EL TGR
Sbjct: 163 DFPQFSTSVLP---WLSPELLRQDLYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 32/106 (30%), Positives = 46/106 (43%), Gaps = 5/106 (4%)
Query: 46 KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KL 104
L + I + L YLH + +I+RD K+ NI L+E + L DFG A KL
Sbjct: 179 SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 105 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150
D GT +PE K+D++S G+V E+
Sbjct: 236 DAHPDTPQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 46/174 (26%), Positives = 70/174 (40%), Gaps = 32/174 (18%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPL--GSLEDHLHDLPPDKEALDWNTRMKIAAGA- 61
L H +V + C+DGD VY MP G L KE+L K + GA
Sbjct: 59 LIHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAF 115
Query: 62 -------AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA------------ 102
+EY+H K V++RD K NILL + D+G A
Sbjct: 116 LSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 103 -KLGPVGDKSHVST---RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ T +++GT Y APE + + +D+Y+ GV+ +++T
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 27/80 (33%), Positives = 41/80 (51%), Gaps = 7/80 (8%)
Query: 25 LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84
LV E++ G ++ LH D +K + A L+YLH +I+RD K
Sbjct: 81 LVMEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPD 133
Query: 85 NILLEEGFHPKLSDFGLAKL 104
N+L+ H KL+DFGL+K+
Sbjct: 134 NMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 33/169 (19%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK------IA 58
+ H N++ L+ +GD LV + M DL K+ +D R+ I
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMA--------SDL---KKVVDRKIRLTESQVKCIL 125
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-------LGPVGDKS 111
GL LH ++RD +NI + K++DFGLA+ +
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 112 HVSTRVMGTYG-----YCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
+ R T Y APE M + D++S G +F EL+TG+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 10/97 (10%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMG- 119
+GL+Y+H AN V++RD K +N+ + E K+ DFGLA+ + P SH G
Sbjct: 125 RGLKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDP--HYSHKGYLSEGL 179
Query: 120 -TYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154
T Y +P ++ T D+++ G +F E++TG+
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 39/143 (27%), Positives = 62/143 (43%), Gaps = 22/143 (15%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 123
G+++LH +I+RD K SNI+++ K+ DFGLA+ S + T + T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 184
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELI------TGRKAIDSTR----------PHGEQN 167
APE + D++S G + E++ GR ID P +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 168 LVTWARPLFNDRRKFSKLADPRL 190
L R +R K++ L P+L
Sbjct: 245 LQPTVRNYVENRPKYAGLTFPKL 267
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 13/95 (13%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL+Y+H +I+RD K SN+ + E ++ DFGLA+ +V+TR
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----W 180
Query: 123 YCAPEYA---MTGQLTVKSDVYSFGVVFLELITGR 154
Y APE M TV D++S G + EL+ G+
Sbjct: 181 YRAPEIMLNWMHYNQTV--DIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 43/165 (26%), Positives = 72/165 (43%), Gaps = 31/165 (18%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWN-------- 52
+L ++H N+++L+ F P SLE+ D+ E +D N
Sbjct: 73 LLKCVNHKNIISLLNV------------FTPQKSLEE-FQDVYLVMELMDANLCQVIHME 119
Query: 53 ---TRMK-IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
RM + G+++LH +I+RD K SNI+++ K+ DFGLA+
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TA 173
Query: 109 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
+ + T + T Y APE + D++S G + EL+ G
Sbjct: 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 25/150 (16%)
Query: 9 NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 68
NL ++ Y GD L+ +F ED L P+ A + M +A + L Y+
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAEMVLAIDSVHQLGYV 124
Query: 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY 128
H RD K N+LL++ H +L+DFG + L + D + S +GT Y +PE
Sbjct: 125 H---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 129 --AM---TGQLTVKSDVYSFGVVFLELITG 153
AM G+ + D +S GV E++ G
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 26/93 (27%), Positives = 46/93 (49%), Gaps = 7/93 (7%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 121
KG+ + H V++RD K N+L++ + K++D GL + + KS+ T + T
Sbjct: 121 KGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTL 175
Query: 122 GYCAPEYAMTG-QLTVKSDVYSFGVVFLELITG 153
Y APE + + D++S G +F E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 42/137 (30%), Positives = 65/137 (47%), Gaps = 24/137 (17%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAKL-----GPVGDKSHVS 114
G+ YLH AN V++RD K +NIL+ E K++D G A+L P+ D V
Sbjct: 120 GIHYLH--ANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR 173
T+ Y APE + + K+ D+++ G +F EL+T H Q + +
Sbjct: 177 V----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSN 227
Query: 174 PLFNDR--RKFSKLADP 188
P +D+ R FS + P
Sbjct: 228 PFHHDQLDRIFSVMGFP 244
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 14/157 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMP---LGSLEDHLHDLPPDKEALDWNTRMKI 57
ML L N+V L + LV+E++ L LE+ + +PP+K R I
Sbjct: 53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEK------VRSYI 106
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
K + + H +++RD K N+L+ KL DFG A+ G ++ T
Sbjct: 107 YQ-LIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEY 161
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ T Y +PE + D++S G + EL G+
Sbjct: 162 VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 38/157 (24%), Positives = 65/157 (41%), Gaps = 16/157 (10%)
Query: 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL---HDLPPDKEALDWNTRMKIAAG 60
+L H N++ +G C + LLV+E+ LG L+ +L + + L ++A
Sbjct: 51 ILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACE 107
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A G+ ++H K N ++ D N L K+ D+G+ D
Sbjct: 108 IAAGVTHMH-KHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164
Query: 121 YGYCAPEYA-------MTGQLTVKSDVYSFGVVFLEL 150
+ APE +T + T S+V++ GV EL
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 123
G+++LH +I+RD K SNI+++ K+ DFGLA+ G ++ V+ Y Y
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-Y 191
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
APE + D++S G + E+I G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
M+ + H ++V L G C + ++V EF+ G L+ +H + L + K+A
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQ 113
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILL-------EEGFHPKLSDFGLAKLGPVGDKSHV 113
A L YL DK +++ + + NILL E G KLSD G+ V +
Sbjct: 114 LASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPI--TVLSRQEC 168
Query: 114 STRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLEL 150
R+ + APE + L++ +D +SFG E+
Sbjct: 169 VERI----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 17/157 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L+ H N+V L+ + ++ EF G+++ + +L + L +
Sbjct: 55 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQ 111
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR--VM 118
+ L YLH+ +I+RD K+ NIL KL+DFG++ + + R +
Sbjct: 112 TLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFI 164
Query: 119 GTYGYCAPEYAMTGQ-----LTVKSDVYSFGVVFLEL 150
GT + APE M K+DV+S G+ +E+
Sbjct: 165 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 44/156 (28%), Positives = 67/156 (42%), Gaps = 25/156 (16%)
Query: 32 LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEG 91
L ED L P+ A + M +A + L Y+H RD K N+LL+
Sbjct: 92 LSKFEDRL----PEDMARFYIAEMVLAIHSIHQLHYVH---------RDIKPDNVLLDMN 138
Query: 92 FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEY--AM---TGQLTVKSDVYSFGVV 146
H +L+DFG + L D + S+ +GT Y +PE AM G+ + D +S GV
Sbjct: 139 GHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVC 197
Query: 147 FLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKF 182
E++ G P ++LV + N +F
Sbjct: 198 MYEMLYGET------PFYAESLVETYGKIMNHEERF 227
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 40/138 (28%), Positives = 64/138 (46%), Gaps = 23/138 (16%)
Query: 25 LVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKS 83
+V E+MP G L + + + P+K A + + +A A + ++H RD K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---------RDVKP 170
Query: 84 SNILLEEGFHPKLSDFG----LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT----GQLT 135
N+LL++ H KL+DFG + K G V + V GT Y +PE + G
Sbjct: 171 DNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-----GTPDYISPEVLKSQGGDGYYG 225
Query: 136 VKSDVYSFGVVFLELITG 153
+ D +S GV E++ G
Sbjct: 226 RECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 4e-04
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++S + H +L + G C G + ++V EF+ G L+ L +K + ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQ 125
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNIL-----LEEGFHP--KLSDFGLAKLGPVGDKSHV 113
A L YL DK +++ + + NIL L EG P KLSD G++ + + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 114 STRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLEL 150
R+ + APE G L+ +D +SFG LE+
Sbjct: 182 E-RI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 4e-04
Identities = 41/137 (29%), Positives = 65/137 (47%), Gaps = 24/137 (17%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAKL-----GPVGDKSHVS 114
G+ YLH AN V++RD K +NIL+ E K++D G A+L P+ D V
Sbjct: 120 GIHYLH--ANW-VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR 173
T+ Y APE + + K+ D+++ G +F EL+T H Q + +
Sbjct: 177 V----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF-----HCRQEDIKTSN 227
Query: 174 PLFNDR--RKFSKLADP 188
P +D+ R F+ + P
Sbjct: 228 PYHHDQLDRIFNVMGFP 244
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 30/106 (28%), Positives = 47/106 (44%), Gaps = 10/106 (9%)
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK---LSDFGLAKLGPVGDKS 111
+ I + ++YLH+ +I+RD K+ NI + HP L DFG A PV +
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFIN---HPGDVCLGDFGAACF-PVDINA 237
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157
+ GT APE D++S G+V E+ T ++
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 41/163 (25%), Positives = 61/163 (37%), Gaps = 24/163 (14%)
Query: 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD--KEALDWNTRMKIAAGA 61
L H N++ + + +V M GS ED L P+ E I
Sbjct: 55 QLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF----ILKDV 110
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA--------KLGPVGDKSHV 113
L+Y+H K I+R K+S+ILL LS + + V D
Sbjct: 111 LNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167
Query: 114 STRVMGTYGYCAPEY---AMTGQLTVKSDVYSFGVVFLELITG 153
S + + + +PE + G KSD+YS G+ EL G
Sbjct: 168 SVKNL---PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 44/159 (27%), Positives = 68/159 (42%), Gaps = 26/159 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N+V L + LV+E+ DL K+ D + I
Sbjct: 52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYCD--------QDL---KKYFD-SCNGDIDPE 99
Query: 61 AAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 112
K GL + H V++RD K N+L+ + KL+DFGLA+ + + +
Sbjct: 100 IVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY 156
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLEL 150
S V+ T Y P+ +L S D++S G +F EL
Sbjct: 157 -SAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 32/117 (27%), Positives = 43/117 (36%), Gaps = 44/117 (37%)
Query: 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG-DKSHVST-------------------- 115
I+RD K N+LL+ H KLSDFGL G KSH +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 116 --------------RVM-----GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
R + GT Y APE + + D +S GV+ E++ G
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.002
Identities = 42/174 (24%), Positives = 61/174 (35%), Gaps = 44/174 (25%)
Query: 25 LVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 82
L+ EF+P G + L D ++ + +A A L ++H RD K
Sbjct: 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIH---------RDIK 128
Query: 83 SSNILLEEGFHPKLSDFGLA---------------KLGPVGD------------------ 109
N+LL+ H KLSDFGL P D
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188
Query: 110 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 163
+ ++ +GT Y APE M D +S GV+ E++ G S P
Sbjct: 189 RRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 16/26 (61%), Positives = 20/26 (76%)
Query: 77 IYRDFKSSNILLEEGFHPKLSDFGLA 102
I+RD K NIL++ G H KLSDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (90), Expect = 0.003
Identities = 44/175 (25%), Positives = 73/175 (41%), Gaps = 28/175 (16%)
Query: 5 LHHSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAA 62
L H N+V I + +Q+L ++ EF G L ++ ++ + + I
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 63 KGLEYLHDKANPP----VIYRDFKSSNILLEEGFH-----------------PKLSDFGL 101
L Y H+ + P V++RD K NI L G K+ DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 102 AKLGPVGDKSHVSTRVMGTYGYCAPEYAM--TGQLTVKSDVYSFGVVFLELITGR 154
+K + +H +GT Y +PE + T KSD+++ G + EL +G+
Sbjct: 189 SKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.96 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.96 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.95 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.94 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.94 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.88 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.83 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.69 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.67 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.65 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.6 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.59 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.57 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.47 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.45 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.38 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.38 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.29 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.25 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.18 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.03 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.91 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.87 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.86 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.8 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.75 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.74 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.66 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.65 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.5 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.5 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.38 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.33 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.13 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.05 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.64 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.58 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.19 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.16 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.13 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.11 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.05 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.85 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.66 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.56 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.4 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.22 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.2 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.7 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.29 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.2 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.77 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.73 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.58 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 94.5 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.39 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.33 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.32 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.18 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.1 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.91 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.24 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.15 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.05 | |
| PLN02236 | 344 | choline kinase | 92.89 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.67 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.66 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.34 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 91.53 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 90.74 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 90.47 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 89.68 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 89.61 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 87.71 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 87.57 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 86.64 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 86.55 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=370.07 Aligned_cols=228 Identities=59% Similarity=1.012 Sum_probs=202.5
Q ss_pred CcCCCCCCCccceeeEEEeCC-eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++|||||+|+|||.+.+ +.+||||||++|||.++|+..... +++|.+|++|+.++|.||+|||+...++||||
T Consensus 124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHr 201 (361)
T KOG1187|consen 124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHR 201 (361)
T ss_pred HHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecC
Confidence 478899999999999999988 599999999999999999873332 89999999999999999999999988899999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
||||+|||||+++++||+|||+++..+.. ..+..+...||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+.
T Consensus 202 DiKssNILLD~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~ 280 (361)
T KOG1187|consen 202 DIKSSNILLDEDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQ 280 (361)
T ss_pred CCCHHHeeECCCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCC
Confidence 99999999999999999999999765542 22222222899999999999999999999999999999999999999998
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccC-CCCCh-HHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLE-GRYPI-RGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..+.....++.|+++.+.+. .+.+++|+.+. +.++. ..+.++..++.+|++.+|..||+|.+|+++|+.+..
T Consensus 281 ~~~~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 281 SRPRGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CCCcccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 77777778999998888877 78999999987 67765 688899999999999999999999999999965543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=315.14 Aligned_cols=204 Identities=26% Similarity=0.406 Sum_probs=168.1
Q ss_pred CcCCCCCCCccceeeEEEeCC-eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivH 78 (325)
||+..+|||||.++|.|.... ...++||||++|||.+++.. ...+++...-+|+.+|++||.|||+ .+ |||
T Consensus 130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIH 202 (364)
T KOG0581|consen 130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIH 202 (364)
T ss_pred HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eee
Confidence 467889999999999999988 59999999999999999976 3669999999999999999999996 66 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|||||+|||++..|+|||||||.++..... ....+.||..|||||.+.+..|+.++||||||++++|+.+|+.|+.
T Consensus 203 RDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~ 278 (364)
T KOG0581|consen 203 RDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYP 278 (364)
T ss_pred ccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCC
Confidence 999999999999999999999999764332 4566889999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChH-HHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIR-GLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
...+. ..........++.+ +. ...|.+ .+.++..++..||++||.+||++.++++.-
T Consensus 279 ~~~~~-~~~~~~Ll~~Iv~~---------pp--P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 279 PPNPP-YLDIFELLCAIVDE---------PP--PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CcCCC-CCCHHHHHHHHhcC---------CC--CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 64211 11111111111111 11 122333 567889999999999999999999998753
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=321.10 Aligned_cols=213 Identities=33% Similarity=0.501 Sum_probs=175.3
Q ss_pred CcCCCCCCCccceeeEEEeCC-eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++|||||+++|+|.+.. ..++||||+++|+|.++++.. .+..+++..+++|+.+||+||.|||+++. ||||
T Consensus 92 il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHr 167 (362)
T KOG0192|consen 92 LLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHR 167 (362)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeec
Confidence 467899999999999999887 799999999999999999874 35679999999999999999999999984 8999
Q ss_pred CCCCCcEEEcCCC-eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc--cCCCCccccEEEehHHHHHHHhCCCC
Q 020529 80 DFKSSNILLEEGF-HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM--TGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 80 dik~~Nill~~~~-~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
||||+||||+.++ ++||+|||+++...... ...+...||+.|||||++. ...++.|+|||||||++|||+||+.|
T Consensus 168 DLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 168 DLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred ccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCC
Confidence 9999999999998 99999999998643221 2334478999999999999 66999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccCC
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTY 235 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~ 235 (325)
|....+... .. .+.....+...+......+..|+..||..||..||+..+++..|+.+.....
T Consensus 246 f~~~~~~~~---~~-------------~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 246 FEDLAPVQV---AS-------------AVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCCCHHHH---HH-------------HHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 987654111 10 0111111112222344678899999999999999999999999998876443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=318.20 Aligned_cols=197 Identities=26% Similarity=0.408 Sum_probs=166.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||++|+|||||++.++|...+..||||||+.||.|.+.+-+ ++.+.+..-..+++|++.||.|||+.| |+|||
T Consensus 229 ILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRD 301 (475)
T KOG0615|consen 229 ILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRD 301 (475)
T ss_pred HHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---ccccc
Confidence 58899999999999999999999999999999999999976 667888888999999999999999999 99999
Q ss_pred CCCCcEEEcCC---CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC---CCccccEEEehHHHHHHHhCC
Q 020529 81 FKSSNILLEEG---FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ---LTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 81 ik~~Nill~~~---~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvvl~elltg~ 154 (325)
|||+||||..+ ..+||+|||+|+... +.......+||+.|.|||++.+.. +..+.|+||+|||||-+++|.
T Consensus 302 iKPeNILl~~~~e~~llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~ 378 (475)
T KOG0615|consen 302 IKPENILLSNDAEDCLLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGY 378 (475)
T ss_pred CCcceEEeccCCcceEEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccC
Confidence 99999999766 689999999999643 344566789999999999998764 345789999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCC------hHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP------IRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~------~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+||........ +.+..+.+.|+ .+...+.++||.+||..||+.||++.|+++.
T Consensus 379 pPFS~~~~~~s-------------------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 379 PPFSEEYTDPS-------------------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred CCcccccCCcc-------------------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 99976543321 11111222222 1346788999999999999999999999874
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-45 Score=307.42 Aligned_cols=209 Identities=23% Similarity=0.334 Sum_probs=171.1
Q ss_pred CcCCCCCCCccceee-EEEeCCe-eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC-CCeE
Q 020529 1 MLSLLHHSNLVNLIG-YCADGDQ-RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN-PPVI 77 (325)
Q Consensus 1 iL~~l~Hpniv~l~~-~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~-~~iv 77 (325)
+|++|+|||||++++ .|.++.+ .++|||||.+|+|.++++.++..++.+++.++|+++.|++.||.++|.+-. ..|+
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 589999999999999 5655555 899999999999999999988889999999999999999999999999321 3499
Q ss_pred eCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 78 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 78 Hrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||||||.||+|+.+|.+||+||||++.+.. .........|||.||+||.+....|+.||||||+||++|||+.-++||
T Consensus 151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF 228 (375)
T KOG0591|consen 151 HRDIKPANIFLTANGVVKLGDFGLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPF 228 (375)
T ss_pred eccCcchheEEcCCCceeeccchhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCc
Confidence 999999999999999999999999997543 233456678999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCC-hHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP-IRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~-~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
.+.+ +...-+.+ ...--| .+| .-.+.++..||..|+..||..||+.-.++..+.
T Consensus 229 ~g~n------~~~L~~KI-------~qgd~~----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 229 YGDN------LLSLCKKI-------EQGDYP----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred cccc------HHHHHHHH-------HcCCCC----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 8752 22111111 111111 123 345788999999999999999999655555443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=321.30 Aligned_cols=201 Identities=24% Similarity=0.371 Sum_probs=171.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|.++|+|||||+++++|++.++.|||.|+|..++|..++.. ++++++.++..++.||+.||.|||+.+ |||||
T Consensus 71 IHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRD 143 (592)
T KOG0575|consen 71 IHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRD 143 (592)
T ss_pred HHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecc
Confidence 45789999999999999999999999999999999999975 677999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||..|+||+++.++||+|||||..... ........+|||.|.|||++.....+..+||||+|||+|-||.|++||+..
T Consensus 144 LKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk 221 (592)
T KOG0575|consen 144 LKLGNLFLNENMNVKIGDFGLATQLEY--DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK 221 (592)
T ss_pred cchhheeecCcCcEEecccceeeeecC--cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence 999999999999999999999976433 234566789999999999999999999999999999999999999999875
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
...+.. ..+...... .|...+..+.+||.++|+.+|.+|||+.+|+..=-
T Consensus 222 ~vkety------~~Ik~~~Y~------------~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 222 TVKETY------NKIKLNEYS------------MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred hHHHHH------HHHHhcCcc------------cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 422211 111111111 12233467889999999999999999999998643
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=294.21 Aligned_cols=199 Identities=26% Similarity=0.341 Sum_probs=166.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||..++||+||+++-.|++.+.+|||+||+.||.|..+|+. ...+++..+.-++..|+.||.|||+++ |||||
T Consensus 78 IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRD 150 (357)
T KOG0598|consen 78 ILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRD 150 (357)
T ss_pred HHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 57789999999999999999999999999999999999975 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||||.+|+++|+||||++... .....+..++||+.|||||++.+..++..+|.||||+++|||++|.+||...
T Consensus 151 lKPENILLd~~GHi~LtDFgL~k~~~--~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 151 LKPENILLDEQGHIKLTDFGLCKEDL--KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred CCHHHeeecCCCcEEEeccccchhcc--cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 99999999999999999999998633 2334556689999999999999999999999999999999999999999876
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC----CHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP----LIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP----s~~evl~ 225 (325)
+. ..+...+...+.. ..+.-....+.+++.++|+.+|.+|. ++.+|-+
T Consensus 229 ~~------~~~~~~I~~~k~~-----------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 229 DV------KKMYDKILKGKLP-----------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred cH------HHHHHHHhcCcCC-----------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 43 2233333332200 01111245678999999999999995 4555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=298.40 Aligned_cols=153 Identities=31% Similarity=0.505 Sum_probs=140.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||+.|+|||||.+++++..++..|||||||+||+|.+|++. +..+++.++..++.|++.||++||+++ |||||
T Consensus 62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRD 134 (429)
T KOG0595|consen 62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRD 134 (429)
T ss_pred HHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 58899999999999999999999999999999999999987 557999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC------CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCC
Q 020529 81 FKSSNILLEEG------FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 81 ik~~Nill~~~------~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|||+||||+.. -.+||+|||+|+.+.. .......+|++.|||||++...+|+.|+|+||+|++||+|++|+
T Consensus 135 LKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~ 211 (429)
T KOG0595|consen 135 LKPQNILLSTTARNDTSPVLKIADFGFARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGK 211 (429)
T ss_pred CCcceEEeccCCCCCCCceEEecccchhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCC
Confidence 99999999765 4689999999997653 33445678999999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 020529 155 KAIDSTRPH 163 (325)
Q Consensus 155 ~p~~~~~~~ 163 (325)
.||+...+.
T Consensus 212 ~Pf~a~t~~ 220 (429)
T KOG0595|consen 212 PPFDAETPK 220 (429)
T ss_pred CCccccCHH
Confidence 999866543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=301.88 Aligned_cols=209 Identities=31% Similarity=0.443 Sum_probs=173.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||++|+|+|||+++++|..++..|||||||+.|||.++|+. ..+..+.....+.++.|||.|++||++++ +||||
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRD 328 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRD 328 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchh
Confidence 57899999999999999998899999999999999999986 34667899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|.+.||||+++..+||+|||||+. ...+.......-.-...|.|||.+..+.++.|||||||||+|+||+| |+.|+..
T Consensus 329 LAARNiLV~~~~~vKIsDFGLAr~-~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 329 LAARNILVDEDLVVKISDFGLARL-IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred hhhhheeeccCceEEEcccccccc-cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 999999999999999999999994 33333334444445667999999999999999999999999999987 6777766
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
+...+. -+.++.-.+-..|...+..+.+|+..|++.+|++|||.+.+...|+.+..
T Consensus 408 msn~ev-----------------~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 408 MSNEEV-----------------LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCHHHH-----------------HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 542211 12222222333455566788999999999999999999999999987654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=293.03 Aligned_cols=207 Identities=28% Similarity=0.375 Sum_probs=163.5
Q ss_pred CcCCCCCCCccceeeEEEeCC--eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
||++|+|||||+++|...... .++++|||+++|||.+++.... ..|++..+..+..|++.||+|||+++ |||
T Consensus 67 iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH 140 (313)
T KOG0198|consen 67 ILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKG---IVH 140 (313)
T ss_pred HHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---Eec
Confidence 578899999999999855444 6899999999999999998732 26999999999999999999999999 999
Q ss_pred CCCCCCcEEEcC-CCeEEEecCCCCccCCC-CCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCC
Q 020529 79 RDFKSSNILLEE-GFHPKLSDFGLAKLGPV-GDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 79 rdik~~Nill~~-~~~~kL~Dfgla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||||+||||+. ++.+||+|||+++.... .........+.||+.|||||++..+ ....++|||||||+++||+||+.
T Consensus 141 ~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~ 220 (313)
T KOG0198|consen 141 CDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKP 220 (313)
T ss_pred cCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCC
Confidence 999999999999 79999999999986543 1222334457899999999999964 34459999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
||..... ...+...+.... ..| .+|.....+..+++.+|+..+|..|||+.++++..-
T Consensus 221 PW~~~~~-----~~~~~~~ig~~~------~~P----~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 221 PWSEFFE-----EAEALLLIGRED------SLP----EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred cchhhcc-----hHHHHHHHhccC------CCC----CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 9976411 111111111100 111 233344567889999999999999999999998763
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=288.29 Aligned_cols=212 Identities=26% Similarity=0.361 Sum_probs=166.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||++++..|..+..+++||+||.+||+.+++....+ ..+++..+..|+.++++||.|||.+| .|||||
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~--~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdv 152 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYP--DGLEEASIATILREVLKALDYLHQNG---HIHRDV 152 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcc--ccccHHHHHHHHHHHHHHHHHHHhcC---ceeccc
Confidence 5788999999999999999999999999999999999987543 45999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCC-CCCcc-ccccCCcCccCchhhccC--CCCccccEEEehHHHHHHHhCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGD-KSHVS-TRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~-~~~~~-~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|+.||||+.+|.|||+|||....+...+ ..... ..+.||++|||||++... .|+.|+|||||||...||.+|..||
T Consensus 153 KAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf 232 (516)
T KOG0582|consen 153 KAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF 232 (516)
T ss_pred ccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc
Confidence 9999999999999999999875433322 11112 557899999999995543 6999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..+.+....-+ .+... .+......+...-.......+.+++..||++||.+|||++++++.
T Consensus 233 ~k~pPmkvLl~-----tLqn~---pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 233 SKYPPMKVLLL-----TLQND---PPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccCChHHHHHH-----HhcCC---CCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 88766432111 11111 111111111111111234578899999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=294.85 Aligned_cols=205 Identities=24% Similarity=0.368 Sum_probs=169.5
Q ss_pred CcCCCC-CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++ ||||+++++++......|+||||+.||+|.+++.. ..++.+....+++.|++.||+|||+.+ |+||
T Consensus 72 ~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HR 144 (370)
T KOG0583|consen 72 ILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHR 144 (370)
T ss_pred HHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeC
Confidence 356777 99999999999999999999999999999999976 567999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCC-CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC-CC-ccccEEEehHHHHHHHhCCCC
Q 020529 80 DFKSSNILLEEG-FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ-LT-VKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 80 dik~~Nill~~~-~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~ksDvwSlGvvl~elltg~~p 156 (325)
||||+|||++.+ +++||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.|
T Consensus 145 DLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~P 222 (370)
T KOG0583|consen 145 DLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLP 222 (370)
T ss_pred CCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence 999999999999 999999999998754 2233456688999999999999977 75 789999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
|+.... ......+......++..+. ..++..|+.+||..+|..|+++.+|+ .-..+..
T Consensus 223 F~d~~~------~~l~~ki~~~~~~~p~~~~-----------S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 223 FDDSNV------PNLYRKIRKGEFKIPSYLL-----------SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred CCCccH------HHHHHHHhcCCccCCCCcC-----------CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 987322 1112222222222222221 45788999999999999999999999 4444443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=298.05 Aligned_cols=201 Identities=26% Similarity=0.378 Sum_probs=169.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+..+|+|||.+++.|..++.+++|||||+||+|.+.+.. ..+++.++..|+..++.||+|||.++ |+|||
T Consensus 323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrD 394 (550)
T KOG0578|consen 323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRD 394 (550)
T ss_pred HHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeec
Confidence 46788999999999999999999999999999999999954 45999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||.+||||..+|.+||+|||++..+... ......+.||+.|||||++....|+.|.||||||++++||+-|.+||-..
T Consensus 395 IKSDnILL~~~g~vKltDFGFcaqi~~~--~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE 472 (550)
T KOG0578|consen 395 IKSDNILLTMDGSVKLTDFGFCAQISEE--QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNE 472 (550)
T ss_pred cccceeEeccCCcEEEeeeeeeeccccc--cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCC
Confidence 9999999999999999999999754332 33566788999999999999999999999999999999999999999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.+.....++.- .+ .+++ ..+...+..+.+++.+||+.|+.+||++.|+|+.
T Consensus 473 ~PlrAlyLIa~-------ng-~P~l-------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 473 NPLRALYLIAT-------NG-TPKL-------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ChHHHHHHHhh-------cC-CCCc-------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 55433332211 10 1111 1223445678899999999999999999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=290.65 Aligned_cols=212 Identities=26% Similarity=0.380 Sum_probs=164.1
Q ss_pred cCCC-CCCCccceeeEEEeC-CeeEEEEecCCCCCHHHHhccCCC-----------------------------------
Q 020529 2 LSLL-HHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPP----------------------------------- 44 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------- 44 (325)
|+++ +||||++++++|... ...++||||+++|+|.+++.....
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (338)
T cd05102 64 LIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQAS 143 (338)
T ss_pred HHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCC
Confidence 4556 899999999998764 467899999999999999875321
Q ss_pred -----------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCC
Q 020529 45 -----------------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 101 (325)
Q Consensus 45 -----------------------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgl 101 (325)
...++++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~ 220 (338)
T cd05102 144 VLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGL 220 (338)
T ss_pred ccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccc
Confidence 0245888999999999999999999999 99999999999999999999999999
Q ss_pred CccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhcccccc
Q 020529 102 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRR 180 (325)
Q Consensus 102 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 180 (325)
++...............+++.|+|||++.+..++.++|||||||++|||++ |..||....... .+. . .+....
T Consensus 221 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~---~-~~~~~~ 294 (338)
T cd05102 221 ARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFC---Q-RLKDGT 294 (338)
T ss_pred ccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHH---H-HHhcCC
Confidence 975432222222233456788999999999999999999999999999997 999997643211 111 0 011100
Q ss_pred ccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 181 ~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.. ..+......+.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus 295 ------~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 295 ------RM----RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ------CC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00 1112234568899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=271.94 Aligned_cols=187 Identities=28% Similarity=0.392 Sum_probs=161.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||+.+.||+++++++.|.+....||||||++||.|..+++. ..++++..+..++.+|+.||+|||+.+ |++||
T Consensus 97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRD 169 (355)
T KOG0616|consen 97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRD 169 (355)
T ss_pred HHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeecc
Confidence 57889999999999999999999999999999999999986 566999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||||.+|.+||+|||+|+... ..+-..+||+.|+|||++....+...+|.|+|||++|||+.|.+||...
T Consensus 170 LKPENiLlD~~G~iKitDFGFAK~v~-----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 170 LKPENLLLDQNGHIKITDFGFAKRVS-----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred CChHHeeeccCCcEEEEeccceEEec-----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 99999999999999999999998632 2355678999999999999999999999999999999999999999877
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCC
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR 217 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R 217 (325)
++... ...++...-.++..+. ..+.+|+...|+.|-.+|
T Consensus 245 ~~~~i------Y~KI~~~~v~fP~~fs------------~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 245 NPIQI------YEKILEGKVKFPSYFS------------SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred ChHHH------HHHHHhCcccCCcccC------------HHHHHHHHHHHhhhhHhh
Confidence 65221 2223333333333333 457789999999999988
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=274.72 Aligned_cols=216 Identities=25% Similarity=0.343 Sum_probs=173.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||++|+|||||.++.+|......+||||||+ .++.+.|... ..+++...+.++++|++.|+.|+|+++ +||||
T Consensus 54 mLKqLkH~NLVnLiEVFrrkrklhLVFE~~d-hTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRD 126 (396)
T KOG0593|consen 54 MLKQLKHENLVNLIEVFRRKRKLHLVFEYCD-HTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRD 126 (396)
T ss_pred HHHhcccchHHHHHHHHHhcceeEEEeeecc-hHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eeccc
Confidence 5889999999999999999999999999997 5555556553 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+||||+.++.+||||||+|+.... .....+....|-+|+|||.+.+ -+|+...|||++||++.||++|.+-|.+
T Consensus 127 IKPENILit~~gvvKLCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG 204 (396)
T KOG0593|consen 127 IKPENILITQNGVVKLCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPG 204 (396)
T ss_pred CChhheEEecCCcEEeccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCC
Confidence 999999999999999999999997543 3445566778999999999988 5899999999999999999999999987
Q ss_pred CCCCCcchhhhh--------hhhccccccccccccCCcc------CCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 160 TRPHGEQNLVTW--------ARPLFNDRRKFSKLADPRL------EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 160 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~d~~l------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
....+....+.. -..++.....+..+.-|.. +..|| ....-+++|+..||+.||.+|++-++++.
T Consensus 205 ~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 205 RSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 765554333321 2233333333443333332 22333 23457889999999999999999999986
Q ss_pred H
Q 020529 226 A 226 (325)
Q Consensus 226 ~ 226 (325)
.
T Consensus 284 H 284 (396)
T KOG0593|consen 284 H 284 (396)
T ss_pred C
Confidence 4
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=293.73 Aligned_cols=199 Identities=24% Similarity=0.338 Sum_probs=167.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||+.|.||||+++|+++++..++|+|.||+++|-|.+++-. ++++++....+++.||+.|+.|+|..+ |+|||
T Consensus 65 iMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRD 137 (786)
T KOG0588|consen 65 IMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRD 137 (786)
T ss_pred HHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceecc
Confidence 57888999999999999999999999999999999999976 778999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+|+||+..+++||+|||.|.+-.. ...-..-+|.+.|.|||++.+.+| +.++||||+|||||.||||+.||+.
T Consensus 138 LKpENlLLd~~~nIKIADFGMAsLe~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 138 LKPENLLLDVKNNIKIADFGMASLEVP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred CCchhhhhhcccCEeeeccceeecccC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999975322 223345679999999999999987 5789999999999999999999984
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
.+ +......+..... ..|.....++.+|+.+||..||..|.|++||++..
T Consensus 215 dN------ir~LLlKV~~G~f------------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 215 DN------IRVLLLKVQRGVF------------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred cc------HHHHHHHHHcCcc------------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 32 2222222111111 12334456788999999999999999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=290.10 Aligned_cols=201 Identities=25% Similarity=0.334 Sum_probs=168.9
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|.+| .||.|++|+-.|.+...+|+|+||+++|+|.++|+. -..|++.....++.+|+.||+|||+.| |||||
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRD 199 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRD 199 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceecc
Confidence 4566 899999999999999999999999999999999987 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCC---------Ccc--ccccCCcCccCchhhccCCCCccccEEEehHHHHH
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKS---------HVS--TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~e 149 (325)
|||+||||+++++++|+|||.|+.+...... ... ..++||..|++||++.....+..+|||+|||+||.
T Consensus 200 lKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQ 279 (604)
T KOG0592|consen 200 LKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQ 279 (604)
T ss_pred CChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHH
Confidence 9999999999999999999999987643322 111 45889999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 150 LITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
|+.|.+||...++-- . .+.++.. .-.++......+.+|+.+.|..||++|+++.+|-+..
T Consensus 280 mlaG~PPFra~Neyl--i----FqkI~~l------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 280 MLAGQPPFRAANEYL--I----FQKIQAL------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HhcCCCCCccccHHH--H----HHHHHHh------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 999999998765311 1 1111111 1122334446788999999999999999998887764
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=280.77 Aligned_cols=203 Identities=22% Similarity=0.390 Sum_probs=163.2
Q ss_pred CcCCCCCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCC
Q 020529 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPP 75 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ 75 (325)
+|++++||||+++++++.+ ....++||||+++|+|.+++.. ...+++..++.++.+++.||.|||+. +
T Consensus 71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~--- 143 (283)
T PHA02988 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN--- 143 (283)
T ss_pred HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---
Confidence 3678999999999999877 3578999999999999999975 45689999999999999999999985 6
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc--CCCCccccEEEehHHHHHHHhC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg 153 (325)
++||||||+||++++++.+||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|
T Consensus 144 ~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g 218 (283)
T PHA02988 144 KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG 218 (283)
T ss_pred CCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHC
Confidence 889999999999999999999999998754321 123457889999999976 6889999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 154 RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
+.||....... +. ......... + ..+......+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 219 ~~Pf~~~~~~~---~~---~~i~~~~~~------~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 219 KIPFENLTTKE---IY---DLIINKNNS------L----KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCCCHHH---HH---HHHHhcCCC------C----CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 99997653221 11 111111000 0 112223456889999999999999999999999998764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=286.58 Aligned_cols=202 Identities=26% Similarity=0.406 Sum_probs=171.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++|+||||+.|.|+|.....+|+|||||..|-|...|+. ...+.......|..+||.|+.|||.+. ||||||
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDL 238 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDL 238 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---Hhhhcc
Confidence 7899999999999999999999999999999999999986 566888899999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
|+-||||..+..|||+|||.++..... ...-.+.||..|||||++...+.++|.|||||||||||||||..|+..-.
T Consensus 239 KSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd 315 (904)
T KOG4721|consen 239 KSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD 315 (904)
T ss_pred CCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc
Confidence 999999999999999999998753222 34456889999999999999999999999999999999999999985432
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
...+.|. +=...|.-..|.....-+.-|++.||+..|..||+..+|+..|.-
T Consensus 316 ----ssAIIwG------------VGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 316 ----SSAIIWG------------VGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred ----hheeEEe------------ccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 1122221 222233333444556677889999999999999999999999864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=299.32 Aligned_cols=205 Identities=22% Similarity=0.285 Sum_probs=165.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++|||||+++++|...+..|+||||+++|+|.+++........++++..+..++.|++.||.|||+.+ |+|||
T Consensus 118 ~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrD 194 (478)
T PTZ00267 118 CLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRD 194 (478)
T ss_pred HHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECC
Confidence 367889999999999999999999999999999999988654334567899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 195 lkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998654333223344567999999999999999999999999999999999999999654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.... ........ ...+ .+......+.+++.+||+.+|..||++.+++.
T Consensus 275 ~~~~------~~~~~~~~------~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 275 SQRE------IMQQVLYG------KYDP-----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CHHH------HHHHHHhC------CCCC-----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 2211 11111100 0000 11123356889999999999999999999875
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=286.84 Aligned_cols=202 Identities=25% Similarity=0.322 Sum_probs=171.9
Q ss_pred CcCCCCCCCccceeeEEEeCCe-eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQ-RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++|||||.+.+.|.+++. .|+||+||+||+|.+.+...+ ..-++++.+.+|+.|++.|+.|||++. |+||
T Consensus 56 lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHR 130 (426)
T KOG0589|consen 56 LLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHR 130 (426)
T ss_pred HHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcc
Confidence 4688999999999999998887 999999999999999998743 456999999999999999999999888 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+.|||+..+..|+|+|||+|+...... .....+.||+.|++||++.+.+|..|+|||||||++|||++-+++|..
T Consensus 131 DlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a 208 (426)
T KOG0589|consen 131 DLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA 208 (426)
T ss_pred cchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc
Confidence 999999999999999999999999754433 245567899999999999999999999999999999999999999987
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.+... + +..+. ... ....|...+..+..++..||..+|..||++.+++..
T Consensus 209 ~~m~~---L---i~ki~------~~~-----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 209 SNMSE---L---ILKIN------RGL-----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cchHH---H---HHHHh------hcc-----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 54321 1 11111 111 223344667889999999999999999999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=282.82 Aligned_cols=218 Identities=22% Similarity=0.299 Sum_probs=170.9
Q ss_pred cCCCC-CCCccceeeEEEeCC-eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLH-HSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~-Hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++|+ ||||+++.+++.+.+ .+|+|||||+ .+|.+++.+ ..+.+++..+..|++||+.||+|+|.+| +.||
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHR 134 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHR 134 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccc
Confidence 67888 999999999998887 9999999996 999999988 3678999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|+||+|||+.....+||+|||||+.... ....+..+.|-+|+|||++.. +.|+.+.|+|++|||++||.+-++-|.
T Consensus 135 DlKPENiLi~~~~~iKiaDFGLARev~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP 211 (538)
T KOG0661|consen 135 DLKPENILISGNDVIKIADFGLAREVRS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP 211 (538)
T ss_pred cCChhheEecccceeEeccccccccccc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence 9999999999999999999999986432 224456778999999998765 578999999999999999999999998
Q ss_pred CCCCCCcchhh-----hhhhhccccccc--------cccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 159 STRPHGEQNLV-----TWARPLFNDRRK--------FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~-----~~~~~~~~~~~~--------~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
+....+...-+ .-.+..+..... ++.+.--.+..-.+ ....++++|+..||.+||.+|||+.+.++
T Consensus 212 G~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 212 GASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred CCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 77654432111 001111111111 11111111111112 25678999999999999999999999998
Q ss_pred HHHhh
Q 020529 226 ALSYL 230 (325)
Q Consensus 226 ~L~~~ 230 (325)
.--+.
T Consensus 291 ~pffq 295 (538)
T KOG0661|consen 291 HPFFQ 295 (538)
T ss_pred Ccccc
Confidence 75433
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=281.98 Aligned_cols=199 Identities=25% Similarity=0.320 Sum_probs=162.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++...+..|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrD 120 (323)
T cd05571 48 VLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRD 120 (323)
T ss_pred HHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCC
Confidence 35788999999999999999999999999999999999875 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 121 lkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 121 LKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCHHHEEECCCCCEEEeeCCCCcccccC--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 9999999999999999999998753221 12233467999999999999999999999999999999999999999654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
.... +. ..+.... . .++......+.+++.+||+.||.+|| ++.++++.
T Consensus 199 ~~~~---~~---~~~~~~~--------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 199 DHEK---LF---ELILMEE--------I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CHHH---HH---HHHHcCC--------C----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3211 11 1111110 0 11223345688999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=273.39 Aligned_cols=205 Identities=26% Similarity=0.323 Sum_probs=169.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||+.+.||.|+.||+.|+.++..|+|||||+||+|..+++..+ .+.+++..+..++..|+.||+|||..| ||+||
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRD 204 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHMLG---IVYRD 204 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhhc---eeecc
Confidence 6889999999999999999999999999999999999998744 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCC---------------------------------C-----------------
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGD---------------------------------K----------------- 110 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~---------------------------------~----------------- 110 (325)
|||+||||.++|++.|+||.|+..+.... +
T Consensus 205 LKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~ 284 (459)
T KOG0610|consen 205 LKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELV 284 (459)
T ss_pred CCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhh
Confidence 99999999999999999999986543200 0
Q ss_pred ----CCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhcccccccccccc
Q 020529 111 ----SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA 186 (325)
Q Consensus 111 ----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (325)
...+..++||-.|+|||++.+...+.+.|+|+|||++||||.|.-||.+.+.... +..++
T Consensus 285 aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv 348 (459)
T KOG0610|consen 285 AEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIV 348 (459)
T ss_pred cCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHh
Confidence 0112236799999999999999999999999999999999999999988754322 22222
Q ss_pred CCccCCCCChHHHHHHHHHHHHchhhCCCCCCC----HHHHHHH
Q 020529 187 DPRLEGRYPIRGLYQALAVASMCIQEQAATRPL----IGDVVTA 226 (325)
Q Consensus 187 d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs----~~evl~~ 226 (325)
-..+.-.-....+..+.+||.+.|.+||++|-- +.||-+.
T Consensus 349 ~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 349 GQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred cCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence 222221112245678999999999999999988 7776543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=276.81 Aligned_cols=215 Identities=25% Similarity=0.405 Sum_probs=164.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC---------------CCCCCCHHHHHHHHHHHHHHH
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---------------DKEALDWNTRMKIAAGAAKGL 65 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~~l~~~~~~~i~~~l~~al 65 (325)
+|++++||||+++++++.+.+..++||||+.+++|.+++..... ....+++.++++++.|++.||
T Consensus 72 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 151 (304)
T cd05096 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGM 151 (304)
T ss_pred HHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 36788999999999999999999999999999999999865321 123478899999999999999
Q ss_pred HHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehH
Q 020529 66 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGV 145 (325)
Q Consensus 66 ~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGv 145 (325)
.|||+.+ |+||||||+|||++.++.+||+|||+++...............++..|+|||++....++.++||||||+
T Consensus 152 ~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 228 (304)
T cd05096 152 KYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV 228 (304)
T ss_pred HHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH
Confidence 9999999 9999999999999999999999999997543332222233445678899999999889999999999999
Q ss_pred HHHHHHhC--CCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHH
Q 020529 146 VFLELITG--RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 223 (325)
Q Consensus 146 vl~elltg--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ev 223 (325)
++|||+++ ..||...... .........+.......... .+......+.+|+.+|++.+|.+||++.+|
T Consensus 229 ~l~el~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 229 TLWEILMLCKEQPYGELTDE---QVIENAGEFFRDQGRQVYLF-------RPPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred HHHHHHHccCCCCCCcCCHH---HHHHHHHHHhhhcccccccc-------CCCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 99999874 5666543321 22222222111110000000 111233578899999999999999999999
Q ss_pred HHHHH
Q 020529 224 VTALS 228 (325)
Q Consensus 224 l~~L~ 228 (325)
++.|+
T Consensus 299 ~~~l~ 303 (304)
T cd05096 299 HAFLT 303 (304)
T ss_pred HHHHh
Confidence 98885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=278.96 Aligned_cols=198 Identities=26% Similarity=0.316 Sum_probs=160.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|||
T Consensus 46 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrD 118 (312)
T cd05585 46 VLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRD 118 (312)
T ss_pred HHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCC
Confidence 35678999999999999999999999999999999999975 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.++|+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 119 lkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 119 LKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred CCHHHeEECCCCcEEEEECcccccCccC--CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 9999999999999999999998753221 22234467999999999999999999999999999999999999999754
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC---HHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL---IGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs---~~evl~ 225 (325)
... ........... .++......+.+++.+||+.+|.+||+ +.+++.
T Consensus 197 ~~~------~~~~~~~~~~~------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 197 NVN------EMYRKILQEPL------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CHH------HHHHHHHcCCC------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 221 11111111111 112223356789999999999999986 455544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=278.43 Aligned_cols=215 Identities=22% Similarity=0.298 Sum_probs=167.4
Q ss_pred CcCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
||++|.||||++|.+...+. ...|||||||+ .+|.-++.. ..-.|++.++..++.||+.||+|+|.++ |+|
T Consensus 169 ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlH 241 (560)
T KOG0600|consen 169 ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLH 241 (560)
T ss_pred HHHhcCCCcccceeeEEEecCCceEEEEEeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eee
Confidence 68999999999999998876 68999999997 899998865 3456999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||||.+|||||.+|.+||+|||||+++....... .+..+-|.+|+|||++.+. .|+...|+||.||||.||++|++.|
T Consensus 242 RDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~ 320 (560)
T KOG0600|consen 242 RDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL 320 (560)
T ss_pred ccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence 9999999999999999999999999765544333 4445569999999999876 6999999999999999999999999
Q ss_pred CCCCCCCcchhhhhh-----hhccccccccc--cccCCccCCCCCh-------HHHHHHHHHHHHchhhCCCCCCCHHHH
Q 020529 158 DSTRPHGEQNLVTWA-----RPLFNDRRKFS--KLADPRLEGRYPI-------RGLYQALAVASMCIQEQAATRPLIGDV 223 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~--~~~d~~l~~~~~~-------~~~~~~~~l~~~cl~~~p~~RPs~~ev 223 (325)
.+....+....+--. ...+. ...++ ..+-+ ...|.. .....+++|+..+|..||.+|.|+.++
T Consensus 321 ~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp--~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a 397 (560)
T KOG0600|consen 321 QGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKP--QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA 397 (560)
T ss_pred CCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCC--CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHH
Confidence 886654433222100 00000 00111 11111 111111 124567899999999999999999999
Q ss_pred HHH
Q 020529 224 VTA 226 (325)
Q Consensus 224 l~~ 226 (325)
++.
T Consensus 398 L~s 400 (560)
T KOG0600|consen 398 LQS 400 (560)
T ss_pred hcC
Confidence 874
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=274.42 Aligned_cols=208 Identities=30% Similarity=0.470 Sum_probs=167.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHh
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLH 69 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~LH 69 (325)
|++++||||+++++++......+++|||+++++|.+++..... ....+++.+++.++.+++.||+|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5678999999999999999999999999999999999975321 1156889999999999999999999
Q ss_pred cCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHH
Q 020529 70 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 70 ~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~e 149 (325)
+.+ ++|+||||+||+++.++.++|+|||+++...............+++.|+|||++....++.++|||||||++||
T Consensus 142 ~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~e 218 (283)
T cd05048 142 SHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218 (283)
T ss_pred hCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHH
Confidence 999 99999999999999999999999999875433332223334456788999999988899999999999999999
Q ss_pred HHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 150 LIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 150 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
|++ |..||......+ +...... . .....+......+.+|+.+|++.+|.+||++.+|++.|.
T Consensus 219 l~~~g~~p~~~~~~~~---~~~~i~~----~----------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05048 219 IFSYGLQPYYGFSNQE---VIEMIRS----R----------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281 (283)
T ss_pred HHcCCCCCCCCCCHHH---HHHHHHc----C----------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence 998 999987654321 1111110 0 000112234467889999999999999999999999996
Q ss_pred h
Q 020529 229 Y 229 (325)
Q Consensus 229 ~ 229 (325)
.
T Consensus 282 ~ 282 (283)
T cd05048 282 S 282 (283)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=287.11 Aligned_cols=211 Identities=26% Similarity=0.419 Sum_probs=164.2
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC-------------------------------------
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------------------------------------- 43 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------------------------- 43 (325)
|+.+ +||||++++++|......++||||+++|+|.+++....
T Consensus 95 l~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred HHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 4567 89999999999999999999999999999999985421
Q ss_pred -----------------------------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeE
Q 020529 44 -----------------------------PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP 94 (325)
Q Consensus 44 -----------------------------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~ 94 (325)
....++++..+++|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~ 251 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVA 251 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeE
Confidence 01235889999999999999999999999 9999999999999999999
Q ss_pred EEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCCCCCCcchhhhhhh
Q 020529 95 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWAR 173 (325)
Q Consensus 95 kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 173 (325)
+|+|||+++...............+++.|+|||++....++.++|||||||++|||++ |+.||....... .+..
T Consensus 252 kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~--- 326 (374)
T cd05106 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYK--- 326 (374)
T ss_pred EEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHH---
Confidence 9999999975433222122223345678999999999999999999999999999997 999997543211 1100
Q ss_pred hccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 174 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 174 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
..... ..+ ..+......+.+++.+||+.+|.+||++.+|++.|+.+.
T Consensus 327 -~~~~~------~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 327 -MVKRG------YQM----SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred -HHHcc------cCc----cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 00000 000 011112356889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=273.84 Aligned_cols=211 Identities=27% Similarity=0.433 Sum_probs=168.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHh
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLH 69 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~LH 69 (325)
+++++||||+++++++...+..++||||+++++|.+++..... ....+++..++.++.+++.||+|||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 5788999999999999999999999999999999999975321 1234899999999999999999999
Q ss_pred cCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHH
Q 020529 70 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 70 ~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~e 149 (325)
+++ |+||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++||
T Consensus 141 ~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e 217 (291)
T cd05094 141 SQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWE 217 (291)
T ss_pred hCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHH
Confidence 999 99999999999999999999999999975433322222334556788999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 150 LIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 150 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
|++ |..||....... ..... ... .... .+......+.+++.+||+.+|++||++.+|++.|+
T Consensus 218 l~t~g~~p~~~~~~~~---~~~~~----~~~-~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 218 IFTYGKQPWFQLSNTE---VIECI----TQG-RVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred HHhCCCCCCCCCCHHH---HHHHH----hCC-CCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 998 999986543221 11110 000 0000 01122356889999999999999999999999999
Q ss_pred hhhc
Q 020529 229 YLAN 232 (325)
Q Consensus 229 ~~~~ 232 (325)
.+..
T Consensus 281 ~~~~ 284 (291)
T cd05094 281 ALGK 284 (291)
T ss_pred HHHh
Confidence 8864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=296.41 Aligned_cols=212 Identities=24% Similarity=0.261 Sum_probs=167.5
Q ss_pred CcCCCC-CCCccceeeEE-Ee------CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 020529 1 MLSLLH-HSNLVNLIGYC-AD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 72 (325)
Q Consensus 1 iL~~l~-Hpniv~l~~~~-~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~ 72 (325)
+|++|+ |||||.|++.. .. ..+.+|+||||.||+|-+++..+.. ..|++.++++|++++++||++||...
T Consensus 87 ~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~ 164 (738)
T KOG1989|consen 87 IMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLK 164 (738)
T ss_pred HHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCC
Confidence 467785 99999999942 11 2477999999999999999986443 34999999999999999999999986
Q ss_pred CCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCc-------cccccCCcCccCchhhc---cCCCCccccEEE
Q 020529 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-------STRVMGTYGYCAPEYAM---TGQLTVKSDVYS 142 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~ksDvwS 142 (325)
+||||||||-+||||+.+++.||||||.|........... .-...-|+.|+|||++. +...++|+|||+
T Consensus 165 -pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWA 243 (738)
T KOG1989|consen 165 -PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWA 243 (738)
T ss_pred -CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHH
Confidence 7799999999999999999999999999864322211100 01234799999999875 557899999999
Q ss_pred ehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHH
Q 020529 143 FGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGD 222 (325)
Q Consensus 143 lGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e 222 (325)
|||+||-||....||+...... +++....-.-.......+..||..||+.+|.+||++.+
T Consensus 244 LGclLYkLCy~t~PFe~sg~la--------------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 244 LGCLLYKLCYFTTPFEESGKLA--------------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred HHHHHHHHHHhCCCcCcCccee--------------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 9999999999999998764321 11111111112356788999999999999999999999
Q ss_pred HHHHHHhhhccCC
Q 020529 223 VVTALSYLANQTY 235 (325)
Q Consensus 223 vl~~L~~~~~~~~ 235 (325)
|+..+..++.+..
T Consensus 304 v~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 304 VLEEIFELANKPC 316 (738)
T ss_pred HHHHHHHHhcCCC
Confidence 9999988876543
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=285.06 Aligned_cols=209 Identities=27% Similarity=0.411 Sum_probs=163.3
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------------------------------
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------------------------------ 44 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------ 44 (325)
|+.+ +||||++++++|.+....++||||+++|+|.+++.....
T Consensus 92 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (375)
T cd05104 92 LSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM 171 (375)
T ss_pred HHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence 4566 899999999999999999999999999999999865221
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEc
Q 020529 45 -----------------------------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE 89 (325)
Q Consensus 45 -----------------------------------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~ 89 (325)
....+++..++.++.+++.||+|||+.+ |+||||||+|||++
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~ 248 (375)
T cd05104 172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLT 248 (375)
T ss_pred CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEE
Confidence 1235889999999999999999999999 99999999999999
Q ss_pred CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCCCCCCcchh
Q 020529 90 EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNL 168 (325)
Q Consensus 90 ~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 168 (325)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... .+
T Consensus 249 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~ 326 (375)
T cd05104 249 HGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KF 326 (375)
T ss_pred CCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HH
Confidence 999999999999976433322222223345678999999999999999999999999999998 888886543211 11
Q ss_pred hhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 169 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
..+... .. ... .+.....++.+|+..||+.+|++||++.+|++.|+.
T Consensus 327 ~~~~~~----~~---~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 327 YKMIKE----GY---RML-------SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HHHHHh----Cc---cCC-------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 111111 00 000 011123468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=281.05 Aligned_cols=200 Identities=29% Similarity=0.391 Sum_probs=172.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|.+++||||.++|+.|..+..+.++||||.||++.+++.. ...+++..+..|+..++.||.|||.++ .+|||
T Consensus 64 ~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrD 136 (467)
T KOG0201|consen 64 VLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRD 136 (467)
T ss_pred HHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eeccc
Confidence 46788999999999999999999999999999999999975 444588889999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+.|||+..+|.+||+|||++-...... .....+.||+.|||||++.+..|+.|+||||||++.+||++|.+|+...
T Consensus 137 IKaanil~s~~g~vkl~DfgVa~ql~~~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 137 IKAANILLSESGDVKLADFGVAGQLTNTV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred ccccceeEeccCcEEEEecceeeeeechh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 99999999999999999999996544332 2336788999999999999889999999999999999999999999888
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.+.....+ +++-.-|.+.+.+ ...+.+++..||.++|+.||++.++++.
T Consensus 215 hPmrvlfl-------------Ipk~~PP~L~~~~----S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 215 HPMRVLFL-------------IPKSAPPRLDGDF----SPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CcceEEEe-------------ccCCCCCcccccc----CHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 76432222 2455556666544 3558899999999999999999999875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=278.95 Aligned_cols=202 Identities=24% Similarity=0.333 Sum_probs=163.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+.+..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 127 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDL 127 (333)
T ss_pred HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678899999999999999999999999999999999975 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++.+||+|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 128 kp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 128 KPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred CHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 99999999999999999999975322 2334568999999999999999999999999999999999999997654
Q ss_pred CCCcch-hhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQN-LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...... +..|... +. .....++. ......+.+++.+||..+|.+||++.++++.
T Consensus 203 ~~~~~~~i~~~~~~-~~----~~~~~~~~------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 203 PNETWENLKYWKET-LQ----RPVYDDPR------FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred HHHHHHHHHhcccc-cc----CCCCCccc------cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 322111 1111100 00 00000100 1234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=293.52 Aligned_cols=213 Identities=28% Similarity=0.462 Sum_probs=176.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC----------CCCCCHHHHHHHHHHHHHHHHHHhc
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD----------KEALDWNTRMKIAAGAAKGLEYLHD 70 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~----------~~~l~~~~~~~i~~~l~~al~~LH~ 70 (325)
+|..|+|||||+|+|.|.+++..|||||||..|+|.++|....+. +.+|+..+.+.||.|||.|+.||-+
T Consensus 542 Lla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 542 LLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred HHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 367899999999999999999999999999999999999765431 3348899999999999999999999
Q ss_pred CCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHH
Q 020529 71 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 71 ~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~el 150 (325)
.. +|||||-..|+||+++..|||+||||++-.-..+.......-.-...|||||.|..++++.+||||||||||||+
T Consensus 622 ~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEI 698 (774)
T KOG1026|consen 622 HH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEI 698 (774)
T ss_pred Cc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhh
Confidence 98 999999999999999999999999999865555544444333445789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 151 IT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 151 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
++ |+.|+.+....+....+ -+..+ -.+|...+..+..|+..||+.+|++||+++||-.+|..
T Consensus 699 FsyG~QPy~glSn~EVIe~i----------------~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 699 FSYGKQPYYGLSNQEVIECI----------------RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred hccccCcccccchHHHHHHH----------------HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 85 78888775433221111 11112 24456677889999999999999999999999999988
Q ss_pred hhcc
Q 020529 230 LANQ 233 (325)
Q Consensus 230 ~~~~ 233 (325)
....
T Consensus 762 ~~~~ 765 (774)
T KOG1026|consen 762 WAQA 765 (774)
T ss_pred HHhc
Confidence 7653
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=271.76 Aligned_cols=210 Identities=27% Similarity=0.405 Sum_probs=165.9
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------------PDKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
++++ +||||+++++++..+...++||||+++++|..+++... .....+++..++.++.|++.||+||
T Consensus 69 l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 148 (293)
T cd05053 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148 (293)
T ss_pred HHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4566 79999999999999999999999999999999996532 2245689999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ |+||||||+||+++.++.++|+|||+++...............++..|+|||++....++.++|||||||++|
T Consensus 149 H~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 225 (293)
T cd05053 149 ASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 225 (293)
T ss_pred HHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHH
Confidence 9999 9999999999999999999999999998654332222223334567899999998889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||++ |..||........... .... .....+......+.+|+.+|+..+|++|||+.+|++.|
T Consensus 226 el~~~g~~p~~~~~~~~~~~~-------~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l 288 (293)
T cd05053 226 EIFTLGGSPYPGIPVEELFKL-------LKEG----------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288 (293)
T ss_pred HHhcCCCCCCCCCCHHHHHHH-------HHcC----------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 9997 8888865432111110 0000 00011223345788999999999999999999999999
Q ss_pred Hhhh
Q 020529 228 SYLA 231 (325)
Q Consensus 228 ~~~~ 231 (325)
+.+.
T Consensus 289 ~~~~ 292 (293)
T cd05053 289 DRML 292 (293)
T ss_pred HHhh
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=277.06 Aligned_cols=198 Identities=24% Similarity=0.325 Sum_probs=161.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++...+..|+||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||
T Consensus 49 l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDi 121 (328)
T cd05593 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDL 121 (328)
T ss_pred HHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccc
Confidence 6778999999999999999999999999999999998865 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 122 kp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 122 KLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred CHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 999999999999999999998753221 112234569999999999999999999999999999999999999996543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
... + ......... .++......+.+++.+||+.+|.+|| ++.++++.
T Consensus 200 ~~~---~---~~~~~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 200 HEK---L---FELILMEDI------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHH---H---HHHhccCCc------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 211 1 111111110 11222345688999999999999997 89998864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=271.83 Aligned_cols=211 Identities=27% Similarity=0.429 Sum_probs=167.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC---------CCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---------DKEALDWNTRMKIAAGAAKGLEYLHDKA 72 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~l~~~~~~~i~~~l~~al~~LH~~~ 72 (325)
|++++||||+++++++...+..++||||+++++|.+++..... ....+++.+++.++.|++.||+|||+.+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5688999999999999999999999999999999999975321 1235899999999999999999999999
Q ss_pred CCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh
Q 020529 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt 152 (325)
++||||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++++|++
T Consensus 141 ---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t 217 (288)
T cd05093 141 ---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217 (288)
T ss_pred ---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999975433222222233445778999999998899999999999999999998
Q ss_pred -CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 153 -GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
|..||....... .... +.. . . . ... +......+.+|+.+||+.+|.+||++.+|++.|+.+.
T Consensus 218 ~g~~p~~~~~~~~---~~~~---i~~-~-~---~--~~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 218 YGKQPWYQLSNNE---VIEC---ITQ-G-R---V--LQR----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred CCCCCCCCCCHHH---HHHH---HHc-C-C---c--CCC----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 899986543221 1110 000 0 0 0 001 1112346889999999999999999999999999887
Q ss_pred c
Q 020529 232 N 232 (325)
Q Consensus 232 ~ 232 (325)
.
T Consensus 281 ~ 281 (288)
T cd05093 281 K 281 (288)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=272.74 Aligned_cols=211 Identities=25% Similarity=0.398 Sum_probs=167.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHH
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--------------------DKEALDWNTRMKIAAGA 61 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~l 61 (325)
|+.++||||++++++|...+..++|+||+.+++|.+++...+. ....+++.+++.++.++
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 6788999999999999999999999999999999999865321 12458899999999999
Q ss_pred HHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEE
Q 020529 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVY 141 (325)
Q Consensus 62 ~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvw 141 (325)
+.||+|||+.+ ++||||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||
T Consensus 137 ~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 137 SRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred HHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 99999999999 999999999999999999999999999754332222222334467789999999888999999999
Q ss_pred EehHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 142 SFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 142 SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
|||++++||++ |..||....+.. +..+.... .....+......+.+++..||+.+|.+||++
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~--------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~ 276 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPER---LFNLLKTG--------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTF 276 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhCC--------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 99999999998 999986543221 11111100 0011122234578899999999999999999
Q ss_pred HHHHHHHHhhhc
Q 020529 221 GDVVTALSYLAN 232 (325)
Q Consensus 221 ~evl~~L~~~~~ 232 (325)
.+|++.|+.+..
T Consensus 277 ~~i~~~l~~~~~ 288 (290)
T cd05045 277 ADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHHHh
Confidence 999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=270.15 Aligned_cols=208 Identities=28% Similarity=0.484 Sum_probs=165.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.+.||||+++++++. +...++|+||+++++|.+++.. ....+++..++.|+.|++.||+|||+.+ ++||||
T Consensus 63 l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dl 135 (279)
T cd05111 63 MGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNL 135 (279)
T ss_pred HhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---Eecccc
Confidence 46789999999999986 4557889999999999999975 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 136 kp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 136 AARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999986543332223344557788999999998899999999999999999998 99999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
.+.....+. .... ....+. .....+..++.+|+..+|.+||++.|+++.|..+...
T Consensus 216 ~~~~~~~~~-------~~~~---~~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 216 RPHEVPDLL-------EKGE---RLAQPQ-------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CHHHHHHHH-------HCCC---cCCCCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 432211111 1110 011111 1224567899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=276.10 Aligned_cols=196 Identities=28% Similarity=0.370 Sum_probs=159.7
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..|+||||+.+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||
T Consensus 71 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~d 143 (329)
T PTZ00263 71 ILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRD 143 (329)
T ss_pred HHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 36788999999999999999999999999999999999975 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 144 lkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 144 LKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred CCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999754321 22356899999999999999999999999999999999999999654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
.+.. ....+..... .++......+.+|+.+||+.||.+||+ +.+++..
T Consensus 219 ~~~~------~~~~i~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 219 TPFR------IYEKILAGRL------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CHHH------HHHHHhcCCc------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 3211 1111111110 011112346789999999999999997 5777654
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=271.48 Aligned_cols=204 Identities=26% Similarity=0.366 Sum_probs=162.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..++||||+++++|..++... ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 53 il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~d 127 (285)
T cd05631 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRD 127 (285)
T ss_pred HHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCC
Confidence 367789999999999999999999999999999999888642 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.++|+|||++....... ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 128 ikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 128 LKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred CCHHHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997643221 223456899999999999999999999999999999999999999865
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
......... ..... .. ...++......+.+|+.+||+.+|.+||+ ++++++.
T Consensus 205 ~~~~~~~~~--~~~~~----------~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 205 KERVKREEV--DRRVK----------ED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred CcchhHHHH--HHHhh----------cc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 432111100 00000 00 01122233457889999999999999997 7787764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=277.07 Aligned_cols=214 Identities=22% Similarity=0.312 Sum_probs=162.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivHr 79 (325)
+|++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+. + |+||
T Consensus 56 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~ 128 (331)
T cd06649 56 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHR 128 (331)
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcC
Confidence 36788999999999999999999999999999999999975 44689999999999999999999985 5 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
||||+|||++.++.++|+|||++...... ......|++.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 129 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 129 DVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred CCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998754221 22345689999999999999999999999999999999999999965
Q ss_pred CCCCCcchhhhhhhhccccccc--------------------------------cccccCCccCCCCChHHHHHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRK--------------------------------FSKLADPRLEGRYPIRGLYQALAVAS 207 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~d~~l~~~~~~~~~~~~~~l~~ 207 (325)
.......... ..+....... ...+...............++.+|+.
T Consensus 205 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 282 (331)
T cd06649 205 PDAKELEAIF--GRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVN 282 (331)
T ss_pred CCHHHHHHHh--cccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHH
Confidence 4321110000 0000000000 00000000000001123457889999
Q ss_pred HchhhCCCCCCCHHHHHHHH
Q 020529 208 MCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 208 ~cl~~~p~~RPs~~evl~~L 227 (325)
+||+.||++||++.+|++..
T Consensus 283 ~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 283 KCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred HHccCCcccCCCHHHHhcCh
Confidence 99999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=275.40 Aligned_cols=199 Identities=26% Similarity=0.353 Sum_probs=161.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||++++++|..++..|+||||+++++|.+++.. ...+.+..+..++.|++.||.|||+.+ |+|||
T Consensus 53 il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 125 (323)
T cd05584 53 ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRD 125 (323)
T ss_pred HHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 36789999999999999999999999999999999999965 456889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~ 203 (323)
T cd05584 126 LKPENILLDAQGHVKLTDFGLCKESIHE--GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAE 203 (323)
T ss_pred CCHHHeEECCCCCEEEeeCcCCeecccC--CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999998743221 12233456999999999999888999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
.... ....+..... ..+......+.+++.+||+.+|.+|| ++.+++..
T Consensus 204 ~~~~------~~~~~~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 204 NRKK------TIDKILKGKL------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CHHH------HHHHHHcCCC------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 3211 1111111100 11222335678999999999999999 78887763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=277.13 Aligned_cols=198 Identities=25% Similarity=0.320 Sum_probs=160.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrd 80 (325)
|+.++||||+++++++...+..|+||||+++++|..++.. ...+++..+..++.|++.||.|||+ .+ |+|||
T Consensus 49 l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrD 121 (325)
T cd05594 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRD 121 (325)
T ss_pred HHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecC
Confidence 5678999999999999999999999999999999998865 4568999999999999999999997 68 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 122 ikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 122 LKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred CCCCeEEECCCCCEEEecCCCCeecCCC--CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 9999999999999999999998743221 11223456999999999999999999999999999999999999999654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
....... .+..... .++......+.+++.+||+.||.+|+ ++.++++.
T Consensus 200 ~~~~~~~------~i~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 200 DHEKLFE------LILMEEI------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CHHHHHH------HHhcCCC------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 3211111 1111100 11222345678999999999999996 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=268.99 Aligned_cols=208 Identities=25% Similarity=0.417 Sum_probs=165.7
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhc
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP----------PDKEALDWNTRMKIAAGAAKGLEYLHD 70 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~l~~~~~~~i~~~l~~al~~LH~ 70 (325)
+|+.++||||+++++++......++||||+++++|.+++.... .....+++..+..++.+++.||.|||+
T Consensus 61 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 140 (280)
T cd05049 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS 140 (280)
T ss_pred HHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh
Confidence 3677899999999999999999999999999999999997532 223458899999999999999999999
Q ss_pred CCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHH
Q 020529 71 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 71 ~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~el 150 (325)
.+ ++||||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||+++||
T Consensus 141 ~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~ 217 (280)
T cd05049 141 QH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217 (280)
T ss_pred CC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHH
Confidence 99 999999999999999999999999998754322222223344467889999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 151 IT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 151 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
++ |..||....... ...... .. . . ...+......+.+++.+||+.+|.+||++.||++.|+
T Consensus 218 ~~~g~~p~~~~~~~~---~~~~~~---~~--~-~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 218 FTYGKQPWYGLSNEE---VIECIT---QG--R-L--------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HhcCCCCCCCCCHHH---HHHHHH---cC--C-c--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 98 999986543221 111111 00 0 0 0011123457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=270.14 Aligned_cols=207 Identities=23% Similarity=0.410 Sum_probs=162.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------KEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
++.++||||+++++++.++...++||||+++++|.+++...... ...+++..++.++.+++.||.|||+.+
T Consensus 63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--- 139 (277)
T cd05062 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--- 139 (277)
T ss_pred HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56789999999999999999999999999999999998753321 234688999999999999999999998
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~ 154 (325)
++|+||||+||++++++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 140 ~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~ 219 (277)
T cd05062 140 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219 (277)
T ss_pred cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999875433322222222345778999999999899999999999999999999 68
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
.||...... ...... . .. ... ..+......+.+++.+||+.+|.+||++.|+++.|+
T Consensus 220 ~p~~~~~~~---~~~~~~---~-~~-~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 220 QPYQGMSNE---QVLRFV---M-EG-GLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCCCCCCHH---HHHHHH---H-cC-CcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 888654321 111110 0 00 000 011122356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=273.13 Aligned_cols=209 Identities=25% Similarity=0.419 Sum_probs=164.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||++++++|... ..++|++|+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||
T Consensus 63 l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dl 135 (316)
T cd05108 63 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDL 135 (316)
T ss_pred HHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eecccc
Confidence 5788999999999999765 56799999999999999976 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+|||++.++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||...
T Consensus 136 kp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 136 AARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred chhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999986543322222222334678999999999999999999999999999997 99998754
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
.... +... ..... .. ..+......+..++.+|+..+|.+||++.+|+..|..+....
T Consensus 216 ~~~~---~~~~----~~~~~---~~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 216 PASE---ISSI----LEKGE---RL-------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CHHH---HHHH----HhCCC---CC-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 2211 1111 11100 00 001122346789999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=277.01 Aligned_cols=199 Identities=25% Similarity=0.317 Sum_probs=161.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||++++++|...+..|+||||+++++|..++.. ...+++..++.++.|++.||+|||+.+ |+|||
T Consensus 48 ~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 120 (323)
T cd05595 48 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRD 120 (323)
T ss_pred HHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 35778999999999999999999999999999999998865 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 121 lkp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 198 (323)
T cd05595 121 IKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred CCHHHEEEcCCCCEEecccHHhccccCC--CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998743221 11223456999999999999999999999999999999999999999654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
...... ........ .++......+.+++.+||+.+|.+|| ++.++++.
T Consensus 199 ~~~~~~------~~~~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 199 DHERLF------ELILMEEI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CHHHHH------HHHhcCCC------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 322111 01111100 11222345678999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=266.99 Aligned_cols=205 Identities=22% Similarity=0.333 Sum_probs=162.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++..++..++||||+++++|.+++.. ....+++..++.++.+++.||+|||+.+ ++||||
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~di 133 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGL 133 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeeccc
Confidence 5678999999999999999999999999999999999975 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++|||||||+++|+++ |..||...
T Consensus 134 kp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 134 AAHKVLVNSDLVCKISGFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cHhhEEEcCCCcEEECCCcccccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 9999999999999999999876432111 111112335678999999999999999999999999999875 99999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
.... +.... ... ... ..+......+.+++..|++.+|.+||++.+|++.|..+
T Consensus 213 ~~~~---~~~~~----~~~------~~~----~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 213 SGQD---VIKAV----EDG------FRL----PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CHHH---HHHHH----HCC------CCC----CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 3221 11111 000 000 11122345688999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=277.04 Aligned_cols=196 Identities=23% Similarity=0.296 Sum_probs=160.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||+++++++.+.+..|+||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+|||
T Consensus 84 ~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 156 (340)
T PTZ00426 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRD 156 (340)
T ss_pred HHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccC
Confidence 35678999999999999999999999999999999999975 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 157 Lkp~NILl~~~~~ikL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 157 LKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred CCHHHEEECCCCCEEEecCCCCeecCC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 999999999999999999999975422 123457999999999999988999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
.+... ...+..... .++......+.+++.+||+.+|.+|+ ++.++++.
T Consensus 232 ~~~~~------~~~i~~~~~------------~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 232 EPLLI------YQKILEGII------------YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CHHHH------HHHHhcCCC------------CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 32111 011111100 11122234678999999999999995 88888764
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=273.78 Aligned_cols=203 Identities=25% Similarity=0.380 Sum_probs=159.3
Q ss_pred CCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 3 SLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 3 ~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
..+ +||||++++++|.+....|+||||+++++|..++.. ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 50 ~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 122 (329)
T cd05588 50 ETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDL 122 (329)
T ss_pred HhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 345 799999999999999999999999999999998865 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||+...
T Consensus 123 kp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 200 (329)
T cd05588 123 KLDNVLLDAEGHIKLTDYGMCKEGIRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200 (329)
T ss_pred CHHHeEECCCCCEEECcCccccccccC--CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccc
Confidence 999999999999999999998642211 122334679999999999999999999999999999999999999997533
Q ss_pred CCC--cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC------HHHHHH
Q 020529 162 PHG--EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL------IGDVVT 225 (325)
Q Consensus 162 ~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs------~~evl~ 225 (325)
... ......+....+... .. ..|......+.+++.+||+.+|.+||+ +.++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~---------~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 201 MSDNPDQNTEDYLFQVILEK---------QI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ccccccccchHHHHHHHHcC---------CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 221 111111111111110 00 112223456889999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=264.87 Aligned_cols=205 Identities=24% Similarity=0.363 Sum_probs=160.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||++++++|......++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+.+ |+|||
T Consensus 46 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~d 119 (252)
T cd05084 46 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRD 119 (252)
T ss_pred HHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 36788999999999999999999999999999999999865 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.++|+|||++................++..|+|||.+....++.++||||||+++|||++ |..||..
T Consensus 120 l~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 120 LAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred cchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999875332111111111123456999999999899999999999999999997 8888865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
......... +. .......+......+.+++.+||+.+|++||++.+|++.|.
T Consensus 200 ~~~~~~~~~-------~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 200 LSNQQTREA-------IE----------QGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCHHHHHHH-------HH----------cCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 432111000 00 00011112223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=272.47 Aligned_cols=193 Identities=28% Similarity=0.313 Sum_probs=157.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++.+.+..++||||+.+++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||
T Consensus 50 ~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~di 122 (323)
T cd05575 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDL 122 (323)
T ss_pred HhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCC
Confidence 4678999999999999999999999999999999999865 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 123 kp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 123 KPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred CHHHeEECCCCcEEEeccCCCcccccC--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 999999999999999999998753221 222344679999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
.. .....+.... ..+ +......+.+++.+||+.+|.+||++.
T Consensus 201 ~~------~~~~~i~~~~--------~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 201 TA------EMYDNILNKP--------LRL----KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HH------HHHHHHHcCC--------CCC----CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 21 1111111110 001 112245688999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=271.97 Aligned_cols=196 Identities=26% Similarity=0.377 Sum_probs=155.5
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
++||||+++++++...+..++||||+++++|..++.. ...+++..+..++.+++.||.|||+.+ |+||||||+
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~ 125 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD 125 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHH
Confidence 4899999999999999999999999999999998865 456999999999999999999999999 999999999
Q ss_pred cEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 85 Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
||+++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 126 Nili~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~ 203 (329)
T cd05618 126 NVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203 (329)
T ss_pred HEEECCCCCEEEeeCCccccccCC--CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcC
Confidence 999999999999999998743211 122334679999999999999999999999999999999999999996432211
Q ss_pred --cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 165 --EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 165 --~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
......+....+... . ..+|......+.+++.+||+.||.+||++
T Consensus 204 ~~~~~~~~~~~~~i~~~---------~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 204 NPDQNTEDYLFQVILEK---------Q--IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CcccccHHHHHHHHhcC---------C--CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111111111111100 0 01222334567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=269.79 Aligned_cols=217 Identities=22% Similarity=0.252 Sum_probs=160.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||+++++++..++..++||||++++.+..+... ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~d 125 (287)
T cd07848 53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRD 125 (287)
T ss_pred HHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 35788999999999999999999999999987766654432 346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||+++.++.+||+|||++........ .......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 126 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 126 IKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred CCHHHEEEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999976432221 1223456899999999999989999999999999999999999999764
Q ss_pred CCCCcch-hhhhhhhc-------cccccccccccCCccC------CCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQN-LVTWARPL-------FNDRRKFSKLADPRLE------GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~-~~~~~~~~-------~~~~~~~~~~~d~~l~------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
....... +.....+. +.....+.....+... ..+.......+.+|+.+||+.||.+||++.++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 205 SEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 3221110 00000000 0000000001001110 0111123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=261.02 Aligned_cols=203 Identities=24% Similarity=0.358 Sum_probs=165.5
Q ss_pred CcCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
||+++ -||||+.+.++|+.+...++|||.|+.|.|.++|.. .-.+++....+|+.|+..|++|||..+ ||||
T Consensus 75 ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHR 147 (411)
T KOG0599|consen 75 ILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHR 147 (411)
T ss_pred HHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhc
Confidence 46666 799999999999999999999999999999999975 677999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC------CCCccccEEEehHHHHHHHhC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG------QLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvvl~elltg 153 (325)
||||+|||++++.+++|+|||+++....+. .-...+||++|+|||.+... .|+...|+|++||++|-|+.|
T Consensus 148 DLKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaG 224 (411)
T KOG0599|consen 148 DLKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAG 224 (411)
T ss_pred ccChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcC
Confidence 999999999999999999999998765443 34567899999999998643 578899999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 154 RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
.+||......- +..++..+. ..+-.|.. .+.+..+.+||.+||+.||.+|.|++|++..-
T Consensus 225 cpPFwHRkQml-------MLR~ImeGk--yqF~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 225 CPPFWHRKQML-------MLRMIMEGK--YQFRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred CCchhHHHHHH-------HHHHHHhcc--cccCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 99996532111 111111110 01111111 13356788999999999999999999999764
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=264.16 Aligned_cols=206 Identities=25% Similarity=0.381 Sum_probs=163.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++......++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl 130 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDL 130 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeeccc
Confidence 56789999999999999999999999999999999998652 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||++++++.++|+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 131 kp~nil~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 131 AARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred CcceEEEcCCCcEEeCCCcccccccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999976432211 11112234567999999999999999999999999999998 89998654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
... .+. ..... ...+ ..+......+.+++.+||+.+|++||++.++++.|+.+
T Consensus 210 ~~~---~~~---~~~~~-------~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 210 DLS---QVY---ELLEK-------GYRM----ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CHH---HHH---HHHHC-------CCCC----CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 221 111 11000 0001 11222345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=273.38 Aligned_cols=196 Identities=26% Similarity=0.341 Sum_probs=160.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.++...++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 126 (291)
T cd05612 54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRD 126 (291)
T ss_pred HHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 36788999999999999999999999999999999999975 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 127 lkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 127 LKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred CCHHHeEECCCCCEEEEecCcchhccC-----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875422 122356899999999999989999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
..... ...+..... .++......+.+|+.+||+.||.+||+ +.++++.
T Consensus 202 ~~~~~------~~~i~~~~~------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 202 NPFGI------YEKILAGKL------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred CHHHH------HHHHHhCCc------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 32111 111111110 111122346789999999999999995 7887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=280.17 Aligned_cols=198 Identities=27% Similarity=0.369 Sum_probs=171.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|++.|+|||||.++++|+...+.++|.||+. |+|..+|.. ...++++.+..|+.+++.||.|||+.+ |+|||
T Consensus 54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~-g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd 125 (808)
T KOG0597|consen 54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAV-GDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRD 125 (808)
T ss_pred HHHhcCCcchhhHHHhhcccceEEEEehhhh-hhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---ccccc
Confidence 5788999999999999999999999999997 599999976 667999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
+||.||||+.++.+||||||+|+... ....+.+.+.||+-|||||+..+..|+..+|+||||||+||+++|++||...
T Consensus 126 ~kPqniLl~~~~~~KlcdFg~Ar~m~--~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~ 203 (808)
T KOG0597|consen 126 MKPQNILLEKGGTLKLCDFGLARAMS--TNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR 203 (808)
T ss_pred CCcceeeecCCCceeechhhhhhhcc--cCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH
Confidence 99999999999999999999998643 3556778889999999999999999999999999999999999999999643
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
. +...++.+..+.. .+|......+..++...|.+||..|.+..+++..
T Consensus 204 s------i~~Lv~~I~~d~v------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 204 S------ITQLVKSILKDPV------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred H------HHHHHHHHhcCCC------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 2 3333333333221 1233556678899999999999999999998865
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=268.04 Aligned_cols=209 Identities=28% Similarity=0.460 Sum_probs=164.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHH
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-------------DKEALDWNTRMKIAAGAAKGLEY 67 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~l~~~~~~~i~~~l~~al~~ 67 (325)
+|+.++||||+++++++..+...++||||+++++|.+++..... ....+++.+++.++.+++.||+|
T Consensus 60 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~ 139 (283)
T cd05090 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEY 139 (283)
T ss_pred HHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence 36789999999999999999999999999999999999854221 12358899999999999999999
Q ss_pred HhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHH
Q 020529 68 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVF 147 (325)
Q Consensus 68 LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl 147 (325)
||+.+ |+||||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++
T Consensus 140 lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il 216 (283)
T cd05090 140 LSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVL 216 (283)
T ss_pred HHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHH
Confidence 99999 999999999999999999999999999764333322333344567789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 148 LELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 148 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+||++ |..||...... .+...... .. . . ..+......+.+++.+|++.+|.+||++.+|++.
T Consensus 217 ~el~~~g~~p~~~~~~~---~~~~~~~~----~~----~--~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 217 WEIFSFGLQPYYGFSNQ---EVIEMVRK----RQ----L--L----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHcCCCCCCCCCCHH---HHHHHHHc----CC----c--C----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 99998 98898654321 11111100 00 0 0 0111223567899999999999999999999998
Q ss_pred HHh
Q 020529 227 LSY 229 (325)
Q Consensus 227 L~~ 229 (325)
|..
T Consensus 280 l~~ 282 (283)
T cd05090 280 LRS 282 (283)
T ss_pred hhc
Confidence 863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=272.75 Aligned_cols=197 Identities=27% Similarity=0.377 Sum_probs=158.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++.+++..|+||||+++++|..+++. ..+++..++.++.+++.||+|||+.+ |+||||
T Consensus 56 ~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdl 127 (324)
T cd05589 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDL 127 (324)
T ss_pred ccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCC
Confidence 4577899999999999999999999999999999988853 45999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.+||+|||+++..... ........|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 128 kp~Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 128 KLDNLLLDTEGFVKIADFGLCKEGMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CHHHeEECCCCcEEeCcccCCccCCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998643221 122344679999999999999999999999999999999999999997643
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
.... ...+..... .++......+.+++.+||+.+|.+|| ++.++++.
T Consensus 206 ~~~~------~~~i~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 206 EEEV------FDSIVNDEV------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred HHHH------HHHHHhCCC------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 2111 111111100 11222345678999999999999999 46666553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=267.92 Aligned_cols=207 Identities=23% Similarity=0.313 Sum_probs=163.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++.+++......++||||+++++|..++.........+++..++.++.|++.||.|||+.+ |+|||
T Consensus 46 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 122 (280)
T cd05608 46 ILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRD 122 (280)
T ss_pred HHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 367889999999999999999999999999999999888654344567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||+++.++.++|+|||++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 123 lkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 123 LKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred CCHHHEEECCCCCEEEeeCccceecCCCC--ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987543322 1233457899999999999999999999999999999999999999754
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
..... ......... .... .++......+.+++..||+.+|.+|| +++++++.
T Consensus 201 ~~~~~--~~~~~~~~~----------~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 201 GEKVE--NKELKQRIL----------NDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred Ccchh--HHHHHHhhc----------ccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 32111 000011111 0000 12223445788999999999999999 66777753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=264.15 Aligned_cols=206 Identities=23% Similarity=0.395 Sum_probs=164.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.+++.||+|||+.+ |+|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di 132 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDL 132 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 5788999999999999999999999999999999999975 2346899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++++|++ |..||...
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~ 212 (266)
T cd05033 133 AARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred CcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC
Confidence 99999999999999999999987542222222223345678999999998899999999999999999998 99998553
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
... .+...... . ...+ .+......+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 213 ~~~---~~~~~~~~----~-----~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 213 SNQ---DVIKAVED----G-----YRLP-----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CHH---HHHHHHHc----C-----CCCC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 211 11111110 0 0000 1112345688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=252.11 Aligned_cols=214 Identities=23% Similarity=0.329 Sum_probs=167.3
Q ss_pred cCCCCCCCccceeeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
-++++||||++++++...+ ...|++++|...|||.+.+....-.+..+++..+++|+.++++||++||+.. +|+
T Consensus 72 ~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~y 150 (302)
T KOG2345|consen 72 HRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPY 150 (302)
T ss_pred HHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-Ccc
Confidence 3678999999999987433 4589999999999999999987777778999999999999999999999986 579
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCc-------cccccCCcCccCchhhcc---CCCCccccEEEehHH
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-------STRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVV 146 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvv 146 (325)
.||||||+|||+...+.++|.|||.+...+..-.... -.....|..|+|||.+.- ...++++|||||||+
T Consensus 151 AH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCt 230 (302)
T KOG2345|consen 151 AHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCT 230 (302)
T ss_pred cccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHH
Confidence 9999999999999999999999999976543221111 112457889999998764 457899999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 147 FLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 147 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
||+|+.|..||+..-..+. ++. ..+.++.+.-.-....+..+.+++..||+.||.+||++.+++..
T Consensus 231 LYa~mf~~sPfe~~~~~Gg-Sla-------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 231 LYAMMFGESPFERIYQQGG-SLA-------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred HHHHHHcCCcchHHhhcCC-eEE-------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9999999999976433221 110 01111111100011245778999999999999999999999998
Q ss_pred HHhh
Q 020529 227 LSYL 230 (325)
Q Consensus 227 L~~~ 230 (325)
+..+
T Consensus 297 ~d~L 300 (302)
T KOG2345|consen 297 LDDL 300 (302)
T ss_pred HHhh
Confidence 8765
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=266.90 Aligned_cols=207 Identities=26% Similarity=0.402 Sum_probs=164.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------KEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
|+.++||||+++++++......++||||+++++|.+++...... ...+++..++.++.+++.||.|||+.+
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 139 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--- 139 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 56789999999999999999999999999999999999764322 234789999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~ 154 (325)
|+||||||+||+++.++.+||+|||+++...............++..|+|||.+....++.++|||||||++|||++ |.
T Consensus 140 i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 219 (277)
T cd05032 140 FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAE 219 (277)
T ss_pred ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCC
Confidence 99999999999999999999999999875433322222333456788999999998899999999999999999998 88
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
.||....... +..+.. .. ... ..+......+.+++.+||+.+|++||++.++++.|+
T Consensus 220 ~p~~~~~~~~---~~~~~~----~~-~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 220 QPYQGLSNEE---VLKFVI----DG-GHL---------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCccCCHHH---HHHHHh----cC-CCC---------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 8886543221 111111 00 000 111223467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=269.64 Aligned_cols=193 Identities=25% Similarity=0.292 Sum_probs=157.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++.+.+..++||||+++++|..++.. ...+++..+..++.|++.||.|||+.+ |+||||
T Consensus 50 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dl 122 (321)
T cd05603 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDL 122 (321)
T ss_pred HHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccC
Confidence 5678999999999999999999999999999999988864 456889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 123 kp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 123 KPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred CHHHeEECCCCCEEEccCCCCccCCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 999999999999999999998743211 122344678999999999999899999999999999999999999996543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
.. .....+.... ...+......+.+++.+||+.+|.+||++.
T Consensus 201 ~~------~~~~~i~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 201 VS------QMYDNILHKP------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HH------HHHHHHhcCC------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 11 1111111110 011223345788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=269.69 Aligned_cols=204 Identities=32% Similarity=0.530 Sum_probs=155.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++...+..++||||+++|+|.++|... ....+++.+++.|+.|++.||.|||+.+ ++|++|
T Consensus 55 l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l 129 (259)
T PF07714_consen 55 LRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNL 129 (259)
T ss_dssp HHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred ccccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccc---cccccc
Confidence 56789999999999999888899999999999999999873 2456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
+++||+++.++.+||+|||++................+...|+|||++....++.++||||||++++||++ |+.|+...
T Consensus 130 ~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 130 SPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999976522222222333456778999999999999999999999999999999 67887554
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
.. ..+. ..+ ..... . ..+......+.+++..||..+|.+||++.+|++.|
T Consensus 210 ~~---~~~~---~~~-~~~~~---~-------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 210 DN---EEII---EKL-KQGQR---L-------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp CH---HHHH---HHH-HTTEE---T-------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc---cccc---ccc-ccccc---c-------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 21 1111 111 11100 0 01112235678999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=274.05 Aligned_cols=195 Identities=27% Similarity=0.325 Sum_probs=158.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..|+||||+.+++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 123 (318)
T cd05582 51 ILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRD 123 (318)
T ss_pred HHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCC
Confidence 36788999999999999999999999999999999999865 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||+++.++.++|+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 124 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 201 (318)
T cd05582 124 LKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201 (318)
T ss_pred CCHHHeEECCCCcEEEeeccCCcccCCC--CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC
Confidence 9999999999999999999998753222 12233467899999999999888999999999999999999999999754
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGD 222 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e 222 (325)
.... . ...+..... ..+......+.+++.+||+.+|.+||++.+
T Consensus 202 ~~~~---~---~~~i~~~~~------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 202 DRKE---T---MTMILKAKL------------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHH---H---HHHHHcCCC------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 3211 1 111111110 112222356789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=267.12 Aligned_cols=208 Identities=22% Similarity=0.346 Sum_probs=164.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHh
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------------PDKEALDWNTRMKIAAGAAKGLEYLH 69 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~l~~al~~LH 69 (325)
+++++||||+++++++......++++||+.+++|.+++.... .....+++..++.++.|++.||.|||
T Consensus 62 ~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred HhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 567899999999999999999999999999999999985321 11345889999999999999999999
Q ss_pred cCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHH
Q 020529 70 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 70 ~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~e 149 (325)
+.+ |+||||||+||+++.++.+||+|||+++...............+++.|+|||.+....++.++|||||||+++|
T Consensus 142 ~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 218 (283)
T cd05091 142 SHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWE 218 (283)
T ss_pred HcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHH
Confidence 999 99999999999999999999999999876433322222233456788999999988899999999999999999
Q ss_pred HHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 150 LIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 150 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
|++ |..||...... .+. ..+.... ...++......+.+++..|++.+|.+||++.+|+..|+
T Consensus 219 l~~~g~~p~~~~~~~---~~~---~~i~~~~-----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 219 VFSYGLQPYCGYSNQ---DVI---EMIRNRQ-----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHcCCCCCCCCCCHH---HHH---HHHHcCC-----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 998 88888654321 111 1111100 00112234456889999999999999999999999986
Q ss_pred h
Q 020529 229 Y 229 (325)
Q Consensus 229 ~ 229 (325)
.
T Consensus 282 ~ 282 (283)
T cd05091 282 T 282 (283)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=271.92 Aligned_cols=196 Identities=26% Similarity=0.278 Sum_probs=158.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||
T Consensus 50 l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDl 122 (325)
T cd05602 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDL 122 (325)
T ss_pred HHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 4678999999999999999999999999999999999975 455888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++.++|+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 123 kp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (325)
T cd05602 123 KPENILLDSQGHIVLTDFGLCKENIEH--NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200 (325)
T ss_pred CHHHeEECCCCCEEEccCCCCcccccC--CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC
Confidence 999999999999999999998743221 222345679999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 224 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl 224 (325)
... ....+.... . ..+......+.+++.+||+.+|.+||++.+.+
T Consensus 201 ~~~------~~~~i~~~~----~--------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 201 TAE------MYDNILNKP----L--------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred HHH------HHHHHHhCC----c--------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 211 111111110 0 01112235678999999999999999987544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=266.75 Aligned_cols=214 Identities=24% Similarity=0.397 Sum_probs=165.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-------DKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
|++++||||+++++++..+...++||||+++++|.+++..... ....+++..++.++.+++.||+|||+.+
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~-- 150 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN-- 150 (296)
T ss_pred HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--
Confidence 6788999999999999999999999999999999999976431 1236899999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh--
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-- 152 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-- 152 (325)
|+|+||||+||+++.++.++|+|||+++...............+++.|+|||++....++.++|||||||++|||++
T Consensus 151 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 229 (296)
T cd05051 151 -FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLC 229 (296)
T ss_pred -ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcC
Confidence 99999999999999999999999999875433332233344556788999999998889999999999999999998
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
+..||..... ..........+..... ......+.....++.+++.+||+.+|.+||++.+|++.|+
T Consensus 230 ~~~p~~~~~~---~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 230 REQPYEHLTD---QQVIENAGHFFRDDGR-------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCCCCcCh---HHHHHHHHhccccccc-------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 6677754321 1122111111111100 0000111123357899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=269.07 Aligned_cols=212 Identities=25% Similarity=0.393 Sum_probs=167.4
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~l~~al~~L 68 (325)
++.+ +||||+++++++......++||||+++++|.+++....+. ...+++.+++.++.|++.||.||
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L 153 (304)
T cd05101 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL 153 (304)
T ss_pred HHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence 4566 7999999999999999999999999999999999764321 23588999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ |+||||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++||||||+++|
T Consensus 154 H~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 230 (304)
T cd05101 154 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 230 (304)
T ss_pred HHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHH
Confidence 9999 9999999999999999999999999998654333222233344667899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
+|++ |..||....... +..... ... .. ..+......+.+|+.+||..+|.+||++.+|++.|
T Consensus 231 el~~~g~~p~~~~~~~~------~~~~~~-~~~---~~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l 293 (304)
T cd05101 231 EIFTLGGSPYPGIPVEE------LFKLLK-EGH---RM-------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293 (304)
T ss_pred HHHcCCCCCcccCCHHH------HHHHHH-cCC---cC-------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 9998 778875542211 111111 000 00 01123345788999999999999999999999999
Q ss_pred Hhhhcc
Q 020529 228 SYLANQ 233 (325)
Q Consensus 228 ~~~~~~ 233 (325)
..+...
T Consensus 294 ~~~~~~ 299 (304)
T cd05101 294 DRILTL 299 (304)
T ss_pred HHHHHh
Confidence 887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=272.89 Aligned_cols=212 Identities=26% Similarity=0.406 Sum_probs=164.5
Q ss_pred cCCC-CCCCccceeeEEEe-CCeeEEEEecCCCCCHHHHhccCCCC----------------------------------
Q 020529 2 LSLL-HHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPD---------------------------------- 45 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------- 45 (325)
++++ +||||++++++|.. +...+++|||+++++|.+++......
T Consensus 64 ~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (337)
T cd05054 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSA 143 (337)
T ss_pred HHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCcccccc
Confidence 4556 89999999998864 45788999999999999998642210
Q ss_pred -----------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCC
Q 020529 46 -----------------------KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 102 (325)
Q Consensus 46 -----------------------~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla 102 (325)
..++++..+..++.+++.||+|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a 220 (337)
T cd05054 144 SSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLA 220 (337)
T ss_pred ccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccc
Confidence 136899999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhccccccc
Q 020529 103 KLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRK 181 (325)
Q Consensus 103 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (325)
+...............++..|+|||++.+..++.++|||||||+++||++ |..||......+ .+.. .+....
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~----~~~~~~- 293 (337)
T cd05054 221 RDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCR----RLKEGT- 293 (337)
T ss_pred hhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHH----HHhccC-
Confidence 76533322222333456778999999999999999999999999999998 999986543221 1111 111100
Q ss_pred cccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 182 FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 182 ~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
....+......+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 294 ---------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 294 ---------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred ---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 001112234578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=275.06 Aligned_cols=195 Identities=25% Similarity=0.305 Sum_probs=159.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|....+|+||+|+-.|.+.+++||||||++||++..+|.. ...|++..+..++.+++.||..||..| +|||||
T Consensus 195 L~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDI 267 (550)
T KOG0605|consen 195 LAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDI 267 (550)
T ss_pred hhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccC
Confidence 4556899999999999999999999999999999999976 677999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCC----------------------CCCCC----cc-------------------cc
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPV----------------------GDKSH----VS-------------------TR 116 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~----------------------~~~~~----~~-------------------~~ 116 (325)
||+|+|||..|++||+||||+.-... .+... .. ..
T Consensus 268 KPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~S 347 (550)
T KOG0605|consen 268 KPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYS 347 (550)
T ss_pred ChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhc
Confidence 99999999999999999999853211 00000 00 02
Q ss_pred ccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCc-chhhhhhhhccccccccccccCCccCCCCC
Q 020529 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWARPLFNDRRKFSKLADPRLEGRYP 195 (325)
Q Consensus 117 ~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 195 (325)
..|||.|+|||++.+..|+..+|+||||||+||||.|.+||....+... ..+..|...+... .-
T Consensus 348 tVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP-----~~---------- 412 (550)
T KOG0605|consen 348 TVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFP-----EE---------- 412 (550)
T ss_pred ccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC-----Cc----------
Confidence 4599999999999999999999999999999999999999998877554 3455554222211 10
Q ss_pred hHHHHHHHHHHHHchhhCCCCCCC
Q 020529 196 IRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 196 ~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
.....++.+||.+||. ||..|--
T Consensus 413 ~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 413 VDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred CcccHHHHHHHHHHhc-CHHHhcC
Confidence 1123678899999999 9999976
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=270.31 Aligned_cols=204 Identities=28% Similarity=0.373 Sum_probs=160.9
Q ss_pred CcCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
||++|+|||||+|+.+..+ .+..|||+|||..|.+.. .+..+.-+++.++++++.+++.||+|||.++ |||
T Consensus 161 ilKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w----~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiH 233 (576)
T KOG0585|consen 161 ILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW----CPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIH 233 (576)
T ss_pred HHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCcccc----CCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eec
Confidence 5889999999999999876 468899999999888743 2333334999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC---CccccccCCcCccCchhhccCC----CCccccEEEehHHHHHHH
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS---HVSTRVMGTYGYCAPEYAMTGQ----LTVKSDVYSFGVVFLELI 151 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvvl~ell 151 (325)
|||||+|+||+++|++||+|||.+...+.+... .......||+.|+|||...++. -+.+.||||+||+||.|+
T Consensus 234 RDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll 313 (576)
T KOG0585|consen 234 RDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL 313 (576)
T ss_pred cccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh
Confidence 999999999999999999999999865433211 1223467999999999987743 367899999999999999
Q ss_pred hCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 152 TGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
.|+.||-..... ... .++++..|.-....+....+.+||.++|++||..|.++.+|....
T Consensus 314 fG~~PF~~~~~~------~l~----------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 314 FGQLPFFDDFEL------ELF----------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred hccCCcccchHH------HHH----------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 999999654321 111 222233332222224456788999999999999999999998765
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=262.55 Aligned_cols=205 Identities=27% Similarity=0.428 Sum_probs=165.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||+++++++.+....++||||+++++|.+++.... ...+++..++.++.+++.||.|||+.+ |+|+|
T Consensus 55 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~d 129 (261)
T cd05148 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRD 129 (261)
T ss_pred HHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 3678899999999999999999999999999999999997632 345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.+||+|||++....... .......+++.|+|||++....++.++||||||+++++|++ |+.||..
T Consensus 130 l~~~nilv~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~ 207 (261)
T cd05148 130 LAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207 (261)
T ss_pred cCcceEEEcCCceEEEccccchhhcCCcc--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999999999999997643221 11223346778999999998899999999999999999998 8999965
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
..... ....... ......+......+.+++.+||+.+|.+||++.++++.|+.
T Consensus 208 ~~~~~---~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 208 MNNHE---VYDQITA--------------GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCHHH---HHHHHHh--------------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 43211 1111110 00011122334567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=264.30 Aligned_cols=220 Identities=26% Similarity=0.393 Sum_probs=165.2
Q ss_pred cCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|+.++||||+++++++... ...++||||+++++|.+++.. ..+++..++.++.+++.||.|||+.+ |+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~ 131 (283)
T cd05080 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHR 131 (283)
T ss_pred HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 6788999999999998653 467899999999999999964 34999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCC-ccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.++|+|||+++......... ......++..|+|||++....++.++||||||++++||++|..|+.
T Consensus 132 dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 211 (283)
T cd05080 132 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211 (283)
T ss_pred ccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999997654322211 1122335667999999988889999999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
..... ......+....... ..+....+.......+......+.+++..|++.+|++||++.+|++.|+.+.
T Consensus 212 ~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 212 SPPKK-FEEMIGPKQGQMTV-VRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCcch-hhhhhcccccccch-hhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 53221 11111111100000 0111111111112223334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=270.35 Aligned_cols=195 Identities=28% Similarity=0.422 Sum_probs=157.5
Q ss_pred CCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCC
Q 020529 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKS 83 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~ 83 (325)
.++||||+++++++...+..++||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp 124 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKL 124 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCH
Confidence 35899999999999999999999999999999999865 446899999999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCC
Q 020529 84 SNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 163 (325)
Q Consensus 84 ~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~ 163 (325)
+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 125 ~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~ 202 (316)
T cd05592 125 DNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED 202 (316)
T ss_pred HHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999997532222 2234457999999999999999999999999999999999999999764321
Q ss_pred CcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH-HHHH
Q 020529 164 GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG-DVVT 225 (325)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~-evl~ 225 (325)
. + ...+.... + .++......+.+++.+||+.+|.+||++. ++++
T Consensus 203 ~---~---~~~i~~~~--------~----~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 203 E---L---FDSILNDR--------P----HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred H---H---HHHHHcCC--------C----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 1 1 11111110 0 11222335678999999999999999975 4443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=283.58 Aligned_cols=187 Identities=28% Similarity=0.443 Sum_probs=160.7
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
+||.|++++..|...++.|+||||+.||++..+.+ ...+++..+.-++..|+.||.|||+++ |||||||.+|
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdN 498 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDN 498 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhh
Confidence 69999999999999999999999999999655554 356999999999999999999999999 9999999999
Q ss_pred EEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCc
Q 020529 86 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 165 (325)
Q Consensus 86 ill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~ 165 (325)
||||..|++||+|||+++... .....+.+++||+.|+|||++....|+...|.|||||+|||||.|..||.+....+.
T Consensus 499 iLLD~eGh~kiADFGlcKe~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~ 576 (694)
T KOG0694|consen 499 LLLDTEGHVKIADFGLCKEGM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV 576 (694)
T ss_pred eEEcccCcEEecccccccccC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 999999999999999998743 233467789999999999999999999999999999999999999999987643221
Q ss_pred chhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 166 QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
.+ .++.+ ...||...+.+.+.|+.++|..+|++|--+
T Consensus 577 Fd------sI~~d------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 577 FD------SIVND------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HH------HHhcC------------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 11111 224566677889999999999999999877
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=270.53 Aligned_cols=199 Identities=25% Similarity=0.345 Sum_probs=157.1
Q ss_pred CCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 3 SLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 3 ~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
.++ +||||+++++++.+.+..|+||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||
T Consensus 50 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDl 122 (327)
T cd05617 50 EQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDL 122 (327)
T ss_pred HhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 344 799999999999999999999999999999998865 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 123 kp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 123 KLDNVLLDADGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred CHHHEEEeCCCCEEEeccccceeccCC--CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence 999999999999999999998742211 122344679999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
.........+........ .. ..|......+.+++.+||+.||.+|+++.
T Consensus 201 ~~~~~~~~~~~~~~~~~~---------~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 201 DNPDMNTEDYLFQVILEK---------PI--RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCcccccHHHHHHHHHhC---------CC--CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 322222222211111110 00 11222335678999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=269.61 Aligned_cols=195 Identities=26% Similarity=0.374 Sum_probs=158.3
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
.+||||+++++++.+.+..|+||||+++++|..++.. ...+++..+..++.+++.||.|||+.+ |+||||||+
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~ 125 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLD 125 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 3899999999999999999999999999999999865 456899999999999999999999999 999999999
Q ss_pred cEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 85 Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
||+++.++.++|+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 126 Nill~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~ 203 (321)
T cd05591 126 NILLDAEGHCKLADFGMCKEGILN--GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203 (321)
T ss_pred HeEECCCCCEEEeecccceecccC--CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999998753222 122334568999999999999999999999999999999999999997654221
Q ss_pred cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-------CHHHHHHH
Q 020529 165 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-------LIGDVVTA 226 (325)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-------s~~evl~~ 226 (325)
+ ...+.... . .++......+.+++..||+.+|.+|| ++.++++.
T Consensus 204 ---~---~~~i~~~~-----~-------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 204 ---L---FESILHDD-----V-------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred ---H---HHHHHcCC-----C-------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1 11111111 0 01112235678999999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=261.51 Aligned_cols=203 Identities=26% Similarity=0.404 Sum_probs=161.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++......++||||+++++|.++++.. ...+++..++.++.+++.||+|||+.+ |+|+|
T Consensus 52 ~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 125 (256)
T cd05114 52 VMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRD 125 (256)
T ss_pred HHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 367889999999999999999999999999999999998752 235899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 126 l~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred cCcceEEEcCCCeEEECCCCCccccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999999999875432211 11222335667999999998889999999999999999999 8999865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
.... ...... ... .....+. .....+.+++.+|++.+|.+||++.++++.|
T Consensus 205 ~~~~---~~~~~i---~~~----~~~~~~~-------~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 205 KSNY---EVVEMI---SRG----FRLYRPK-------LASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHH---HHHHHH---HCC----CCCCCCC-------CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 4321 111111 100 0011111 1234688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.99 Aligned_cols=190 Identities=27% Similarity=0.381 Sum_probs=155.1
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
.+||||+++++++...+..|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~ 125 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLD 125 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHH
Confidence 3799999999999999999999999999999999875 456899999999999999999999999 999999999
Q ss_pred cEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 85 Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
|||++.++.++|+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 126 NIli~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~ 203 (320)
T cd05590 126 NVLLDHEGHCKLADFGMCKEGIFN--GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203 (320)
T ss_pred HeEECCCCcEEEeeCCCCeecCcC--CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH
Confidence 999999999999999998743221 122344579999999999999999999999999999999999999997643211
Q ss_pred cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 165 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
....+..... .++......+.+++.+||+.||.+||++.
T Consensus 204 ------~~~~i~~~~~------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 204 ------LFEAILNDEV------------VYPTWLSQDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred ------HHHHHhcCCC------------CCCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 1111111110 01112235678999999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=251.92 Aligned_cols=219 Identities=25% Similarity=0.358 Sum_probs=171.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+.+++.|...+...||+|||+ .+|+..+++ ....++...+..++.++++||+|||++. |+||||
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDl 127 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDL 127 (318)
T ss_pred HHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccC
Confidence 678999999999999999999999999997 899999987 6678999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||.|+|++.+|.+||+|||+++.+........ ...-|-+|+|||.+.+. .|+...|+||.|||+.||+-+.+-|.+.
T Consensus 128 KPnNLLis~~g~lKiADFGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 128 KPNNLLISSDGQLKIADFGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred CccceEEcCCCcEEeecccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 99999999999999999999998765543332 23678899999999876 6899999999999999999999888765
Q ss_pred CCCCcchhh----------hhh-hhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 161 RPHGEQNLV----------TWA-RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 161 ~~~~~~~~~----------~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
...+....+ .|- ...+.+-..+.....+.+..-++ ....++++|+..|+..||.+|+++.+++++=.+
T Consensus 206 sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf 284 (318)
T KOG0659|consen 206 SDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFP-AASSDALDLLSKMLTYNPKKRITASQALKHPYF 284 (318)
T ss_pred chHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccc-cccHHHHHHHHhhhccCchhcccHHHHhcchhh
Confidence 543332211 110 00000111111122222222222 334567999999999999999999999987544
Q ss_pred h
Q 020529 230 L 230 (325)
Q Consensus 230 ~ 230 (325)
.
T Consensus 285 ~ 285 (318)
T KOG0659|consen 285 K 285 (318)
T ss_pred h
Confidence 3
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=262.05 Aligned_cols=205 Identities=26% Similarity=0.369 Sum_probs=162.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++...+..++||||+++++|.+++.... ...+++..++.++.+++.||.|||+.+ |+|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 129 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDL 129 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence 567899999999999999999999999999999999997632 346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||+++...... .........+..|+|||++....++.++||||||++++||++ |+.||...
T Consensus 130 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 208 (261)
T cd05068 130 AARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208 (261)
T ss_pred CcceEEEcCCCCEEECCcceEEEccCCc-ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999999997654221 111112223457999999998899999999999999999999 99998654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
.... +..... .. .. ...+......+.+++.+|++.+|.+||++.++++.|+.
T Consensus 209 ~~~~---~~~~~~----~~---~~-------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 209 TNAE---VLQQVD----QG---YR-------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CHHH---HHHHHH----cC---CC-------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 3211 111000 00 00 01111234578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=260.18 Aligned_cols=206 Identities=30% Similarity=0.411 Sum_probs=167.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-----KEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
++.++||||+++++++..+...++||||+++++|.+++...... ...+++..++.++.+++.||+|||+.+ +
T Consensus 50 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i 126 (262)
T cd00192 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---F 126 (262)
T ss_pred HhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---c
Confidence 56789999999999999999999999999999999999874222 367999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~ 155 (325)
+|+||||+||+++.++.++|+|||++................++..|+|||.+....++.++||||||+++++|++ |..
T Consensus 127 ~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 206 (262)
T cd00192 127 VHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGAT 206 (262)
T ss_pred ccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999987554432233344567889999999998899999999999999999999 599
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||...... .+.... .. . . ....+......+.+++.+||+.+|.+||++.+++..|
T Consensus 207 p~~~~~~~---~~~~~~---~~-~---~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 207 PYPGLSNE---EVLEYL---RK-G---Y-------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCCCHH---HHHHHH---Hc-C---C-------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 99765221 111111 10 0 0 0011222346788999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=262.42 Aligned_cols=209 Identities=26% Similarity=0.385 Sum_probs=163.6
Q ss_pred cCCCCCCCccceeeEEEeCCe------eEEEEecCCCCCHHHHhccCCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQ------RLLVYEFMPLGSLEDHLHDLPP--DKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
|+.++||||+++++++..... .++|+||+++++|..++...+. ....+++..++.++.|++.||.|||+.+
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~- 133 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN- 133 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 567899999999999866554 7999999999999999865322 2346899999999999999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT- 152 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt- 152 (325)
++||||||+||++++++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++
T Consensus 134 --i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~ 211 (273)
T cd05035 134 --FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211 (273)
T ss_pred --eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhC
Confidence 99999999999999999999999999976543332222223345678999999988899999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
|..||...... .+..+.. .. ..+ ..+......+.+++.+||+.+|++||++.+|++.|+.+
T Consensus 212 g~~p~~~~~~~---~~~~~~~---~~-------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 212 GQTPYPGVENH---EIYDYLR---HG-------NRL----KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCCCCCCCCHH---HHHHHHH---cC-------CCC----CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88888654321 1111110 00 000 11223345788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=268.30 Aligned_cols=213 Identities=25% Similarity=0.406 Sum_probs=166.1
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
++++ +||||++++++|.+....++||||+++++|.+++..... ....+++.++..++.|++.||.||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 150 (314)
T cd05099 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150 (314)
T ss_pred HHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence 4556 699999999999999999999999999999999976432 124589999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ ++||||||+||+++.++.+||+|||+++...............+++.|+|||++....++.++||||||+++|
T Consensus 151 H~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~ 227 (314)
T cd05099 151 ESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMW 227 (314)
T ss_pred HHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHH
Confidence 9999 9999999999999999999999999997643322211122223456799999999889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
+|++ |..||....... +... ...... ...+......+.+++.+||..+|.+||++.++++.|
T Consensus 228 el~~~g~~p~~~~~~~~---~~~~----~~~~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 228 EIFTLGGSPYPGIPVEE---LFKL----LREGHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred HHHhCCCCCCCCCCHHH---HHHH----HHcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999 888886543221 1111 000000 011122335678999999999999999999999999
Q ss_pred HhhhccC
Q 020529 228 SYLANQT 234 (325)
Q Consensus 228 ~~~~~~~ 234 (325)
..+....
T Consensus 291 ~~~~~~~ 297 (314)
T cd05099 291 DKVLAAV 297 (314)
T ss_pred HHHHHHh
Confidence 9887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=265.13 Aligned_cols=207 Identities=25% Similarity=0.353 Sum_probs=161.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
|+.++||||+++++++.+....++||||+++++|.+++..... ....+++..++.++.+++.||+|||+.+ ++|
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH 139 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIH 139 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eee
Confidence 5788999999999999999999999999999999999976432 1235899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCC---eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CC
Q 020529 79 RDFKSSNILLEEGF---HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154 (325)
Q Consensus 79 rdik~~Nill~~~~---~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~ 154 (325)
+||||+||+++.++ .+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |.
T Consensus 140 ~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~ 219 (277)
T cd05036 140 RDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219 (277)
T ss_pred cccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999998654 599999999976422211111122233567999999999999999999999999999997 99
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
.||........... +... .....+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 220 ~pf~~~~~~~~~~~------~~~~-----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 220 MPYPGRTNQEVMEF------VTGG-----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CCCCCCCHHHHHHH------HHcC-----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 99876433211111 0000 001112223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=278.49 Aligned_cols=211 Identities=23% Similarity=0.343 Sum_probs=165.0
Q ss_pred cCCCC-CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------------------------------
Q 020529 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------------------------------ 44 (325)
Q Consensus 2 L~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------ 44 (325)
|+++. ||||++++++|.+....|||||||++|+|.++++....
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 94 MTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred HHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 56674 99999999999999999999999999999999865210
Q ss_pred --------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 45 --------------------------------------------------------DKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 45 --------------------------------------------------------~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
....+++..++.++.|++.||+||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 013588899999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ |+||||||+|||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|
T Consensus 254 H~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ 330 (400)
T cd05105 254 ASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330 (400)
T ss_pred HhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHH
Confidence 9999 9999999999999999999999999997643332222233345678899999999989999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||++ |..||........ +.. .+... ... ..+......+.+++.+||+.+|++||++.+|+++|
T Consensus 331 ellt~g~~P~~~~~~~~~--~~~----~~~~~------~~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l 394 (400)
T cd05105 331 EIFSLGGTPYPGMIVDST--FYN----KIKSG------YRM----AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394 (400)
T ss_pred HHHHCCCCCCcccchhHH--HHH----HHhcC------CCC----CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHH
Confidence 9997 8899865432111 110 01000 000 01112345788999999999999999999999999
Q ss_pred Hhhh
Q 020529 228 SYLA 231 (325)
Q Consensus 228 ~~~~ 231 (325)
+.+.
T Consensus 395 ~~l~ 398 (400)
T cd05105 395 ESLL 398 (400)
T ss_pred HHHc
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=262.77 Aligned_cols=207 Identities=26% Similarity=0.383 Sum_probs=163.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
|+.++||||+++++++......++||||+++++|.+++..... ....+++.+++.++.+++.||+|||+.+ ++|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H 129 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIH 129 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 6788999999999999999999999999999999999975322 2245889999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCC-----eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-
Q 020529 79 RDFKSSNILLEEGF-----HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT- 152 (325)
Q Consensus 79 rdik~~Nill~~~~-----~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt- 152 (325)
+||||+||+++.++ .++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++
T Consensus 130 ~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~ 209 (269)
T cd05044 130 RDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTL 209 (269)
T ss_pred CCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHc
Confidence 99999999999877 899999999875433322222223345778999999999999999999999999999998
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
|..||...... ...... .... ....+......+.+++.+||..+|.+||++.+|++.|.
T Consensus 210 g~~p~~~~~~~---~~~~~~----~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 210 GQQPYPALNNQ---EVLQHV----TAGG----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCCCCcccCHH---HHHHHH----hcCC----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 99998643321 111110 0000 00111223457789999999999999999999999885
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=268.73 Aligned_cols=216 Identities=22% Similarity=0.321 Sum_probs=159.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++...+..++||||++ ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|||
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~d 128 (288)
T cd07871 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRD 128 (288)
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 3678899999999999999999999999997 599998865 2345789999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+|||++.++.+||+|||+++....... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 129 lkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 129 LKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred CCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999875332221 2233467899999999875 4689999999999999999999999976
Q ss_pred CCCCCcchhhh-hh-------hhccccccccccccCCccCCCC----ChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 160 TRPHGEQNLVT-WA-------RPLFNDRRKFSKLADPRLEGRY----PIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 160 ~~~~~~~~~~~-~~-------~~~~~~~~~~~~~~d~~l~~~~----~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
........... .. ++.+.....+.....+...... ......++.+|+.+||+.||.+|||+.|+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 207 STVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 54322111110 00 0000001111111111110000 0112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=266.39 Aligned_cols=215 Identities=21% Similarity=0.309 Sum_probs=157.1
Q ss_pred cCCCCCCCccceeeEEEe-----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
|+.++||||++++++|.. ....++||||++ ++|.+++.... ...+++.+++.++.|++.||.|||+.+ |
T Consensus 58 l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---i 131 (290)
T cd07862 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---V 131 (290)
T ss_pred hcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 345689999999999852 456899999996 79999987532 345899999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
+||||||+|||++.++.+||+|||+++..... .......||+.|+|||++....++.++|||||||++|||++|++|
T Consensus 132 iH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~ 208 (290)
T cd07862 132 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 208 (290)
T ss_pred eeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999999754322 223445689999999999988999999999999999999999999
Q ss_pred CCCCCCCCcc-hhhhhhhhcccccc----cc-ccccCCccCC---CCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 157 IDSTRPHGEQ-NLVTWARPLFNDRR----KF-SKLADPRLEG---RYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~~~----~~-~~~~d~~l~~---~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|......+.. .+............ .+ ...+.+.... .........+.+++.+||+.+|++||++.++++
T Consensus 209 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 209 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 9765432211 11110000000000 00 0000000000 000112345679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=274.26 Aligned_cols=202 Identities=25% Similarity=0.313 Sum_probs=161.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|..++||||+++++++.+++..|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dl 127 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDI 127 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 5678999999999999999999999999999999999976 356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCC---------------------------CCCccccccCCcCccCchhhccCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGD---------------------------KSHVSTRVMGTYGYCAPEYAMTGQL 134 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~ 134 (325)
||+|||++.++.+||+|||++....... .........||+.|+|||++.+..+
T Consensus 128 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 207 (350)
T cd05573 128 KPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY 207 (350)
T ss_pred CHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCC
Confidence 9999999999999999999997643322 0012234569999999999999999
Q ss_pred CccccEEEehHHHHHHHhCCCCCCCCCCCCcc-hhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhC
Q 020529 135 TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQ 213 (325)
Q Consensus 135 ~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~ 213 (325)
+.++|||||||++|||++|+.||......... .+..|... ..-+. .......+.+++.+||. +
T Consensus 208 ~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~----------~~~p~-----~~~~~~~~~~li~~ll~-d 271 (350)
T cd05573 208 GLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKES----------LRFPP-----DPPVSPEAIDLICRLLC-D 271 (350)
T ss_pred CCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCc----------ccCCC-----CCCCCHHHHHHHHHHcc-C
Confidence 99999999999999999999999765422111 11111000 00000 00124567899999997 9
Q ss_pred CCCCCC-HHHHHHH
Q 020529 214 AATRPL-IGDVVTA 226 (325)
Q Consensus 214 p~~RPs-~~evl~~ 226 (325)
|.+||+ +.++++.
T Consensus 272 p~~R~~s~~~ll~h 285 (350)
T cd05573 272 PEDRLGSFEEIKSH 285 (350)
T ss_pred hhhcCCCHHHHhcC
Confidence 999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=261.63 Aligned_cols=205 Identities=24% Similarity=0.366 Sum_probs=163.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++...+..++||||+++++|.+++.... ...+++..++.++.+++.||+|||+.+ ++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl 129 (261)
T cd05072 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDL 129 (261)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccc
Confidence 567899999999999999999999999999999999997532 345889999999999999999999998 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||++........ .......++..|+|||++....++.++|||||||++|+|++ |..||...
T Consensus 130 ~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 130 RAANVLVSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred chhhEEecCCCcEEECCCccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 99999999999999999999976433221 11223345678999999998889999999999999999998 99998653
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
... ......... ...... ......+.+++.+|+..+|++||++.++++.|+.
T Consensus 209 ~~~---~~~~~~~~~----------~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 209 SNS---DVMSALQRG----------YRMPRM----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CHH---HHHHHHHcC----------CCCCCC----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 221 111111100 000011 1223568899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=267.84 Aligned_cols=208 Identities=25% Similarity=0.387 Sum_probs=164.4
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+++ +||||+++++++...+..++||||+++++|.++++... ...+++.+++.++.+++.||+|||+.+ |+|+|
T Consensus 92 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~d 166 (302)
T cd05055 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRD 166 (302)
T ss_pred HHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhh
Confidence 5677 79999999999999999999999999999999997522 234899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.++|+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||..
T Consensus 167 lkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 167 LAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred hccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 999999999999999999999975433322122223446778999999999999999999999999999998 9999865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
...... +..... .. .....+......+.+++.+||..+|++||++.+|++.|..+
T Consensus 247 ~~~~~~--~~~~~~----~~----------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 247 MPVDSK--FYKLIK----EG----------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCchHH--HHHHHH----cC----------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 432211 111110 00 00001112235688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=265.06 Aligned_cols=207 Identities=28% Similarity=0.464 Sum_probs=163.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC-----------CCCCCHHHHHHHHHHHHHHHHHHhc
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-----------KEALDWNTRMKIAAGAAKGLEYLHD 70 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~l~~~~~~~i~~~l~~al~~LH~ 70 (325)
|+.++||||+++++++.+....++||||+++++|.+++....+. ...+++.+++.++.|++.||+|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 57889999999999999999999999999999999999764321 1358999999999999999999999
Q ss_pred CCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHH
Q 020529 71 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 71 ~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~el 150 (325)
.+ ++||||||+|||+++++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||
T Consensus 141 ~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 217 (280)
T cd05092 141 LH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217 (280)
T ss_pred CC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHH
Confidence 99 999999999999999999999999998754332221222333456789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 151 IT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 151 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
++ |.+||............ .. . ... . .+......+.+|+.+||+.+|.+||++.+|++.|+
T Consensus 218 ~~~g~~p~~~~~~~~~~~~~------~~-~---~~~---~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 218 FTYGKQPWYQLSNTEAIECI------TQ-G---REL---E----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCCCCCCccCCHHHHHHHH------Hc-C---ccC---C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 98 89998654322111100 00 0 000 0 01122345789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=276.96 Aligned_cols=217 Identities=18% Similarity=0.201 Sum_probs=159.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++|+||||++++++|......++|+|++. ++|..++.. ...+++..++.|+.|++.||.|||+.+ |+|||
T Consensus 136 il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrD 207 (391)
T PHA03212 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRD 207 (391)
T ss_pred HHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 4678999999999999999999999999995 889888865 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.++|+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 208 iKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 208 IKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred CChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 99999999999999999999996432211 12233457999999999999999999999999999999999999876443
Q ss_pred CCCCc-----chhhhhhhhccccc--------ccccc---------ccCCccCCCCC--hHHHHHHHHHHHHchhhCCCC
Q 020529 161 RPHGE-----QNLVTWARPLFNDR--------RKFSK---------LADPRLEGRYP--IRGLYQALAVASMCIQEQAAT 216 (325)
Q Consensus 161 ~~~~~-----~~~~~~~~~~~~~~--------~~~~~---------~~d~~l~~~~~--~~~~~~~~~l~~~cl~~~p~~ 216 (325)
..... ..+.......-... ..+.. ...+....... ......+.+|+.+||+.||.+
T Consensus 287 ~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~ 366 (391)
T PHA03212 287 DGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHH 366 (391)
T ss_pred ccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhh
Confidence 21110 00000000000000 00000 00000000000 012356889999999999999
Q ss_pred CCCHHHHHHH
Q 020529 217 RPLIGDVVTA 226 (325)
Q Consensus 217 RPs~~evl~~ 226 (325)
|||+.|+++.
T Consensus 367 Rpta~elL~h 376 (391)
T PHA03212 367 RPSAEALLDF 376 (391)
T ss_pred CCCHHHHhcC
Confidence 9999999974
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=276.58 Aligned_cols=219 Identities=20% Similarity=0.225 Sum_probs=164.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++......|+|||++. ++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 139 il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrD 210 (392)
T PHA03207 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRD 210 (392)
T ss_pred HHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccC
Confidence 4678999999999999999999999999995 789998843 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.++|+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 211 lkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 211 VKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred CCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999997654433333334567999999999999999999999999999999999999999765
Q ss_pred CCCCcch-hhhhhhhcccccccccc-----------ccCCccCCCCC-------hHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 161 RPHGEQN-LVTWARPLFNDRRKFSK-----------LADPRLEGRYP-------IRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 161 ~~~~~~~-~~~~~~~~~~~~~~~~~-----------~~d~~l~~~~~-------~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
....... +......+......+.. .+.......+. ......+.+++.+||..+|.+||++.
T Consensus 291 ~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~ 370 (392)
T PHA03207 291 QVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQ 370 (392)
T ss_pred CCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHH
Confidence 4332111 11100000000000000 00000000010 01234677899999999999999999
Q ss_pred HHHHHH
Q 020529 222 DVVTAL 227 (325)
Q Consensus 222 evl~~L 227 (325)
|++..-
T Consensus 371 e~l~~p 376 (392)
T PHA03207 371 DILSLP 376 (392)
T ss_pred HHhhCc
Confidence 999864
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=272.03 Aligned_cols=195 Identities=26% Similarity=0.312 Sum_probs=157.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++..++..++||||+.+++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||
T Consensus 50 l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dl 122 (325)
T cd05604 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDL 122 (325)
T ss_pred HHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCC
Confidence 4678999999999999999999999999999999998865 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 123 kp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 123 KPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred CHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 999999999999999999998743221 122344679999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 223 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ev 223 (325)
... + ....... .+ ..+......+.+++.+||+.+|.+||++.+.
T Consensus 201 ~~~---~---~~~~~~~----------~~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 201 VAE---M---YDNILHK----------PL--VLRPGASLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred HHH---H---HHHHHcC----------Cc--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCC
Confidence 211 1 1111110 00 0111233567899999999999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=272.02 Aligned_cols=148 Identities=28% Similarity=0.410 Sum_probs=131.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivHrd 80 (325)
|++++||||++++++|.+++..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+. + |+|+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~d 129 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRD 129 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecC
Confidence 5788999999999999999999999999999999999975 44589999999999999999999975 6 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||++...... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 130 lkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999998653221 123356899999999999889999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=260.63 Aligned_cols=203 Identities=24% Similarity=0.370 Sum_probs=160.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.+.||||+++++++. .+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 50 l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl 121 (257)
T cd05116 50 MQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDL 121 (257)
T ss_pred HHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeeccc
Confidence 56789999999999986 4567899999999999999965 346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCc-cccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
||+||+++.++.++|+|||++........... .....+++.|+|||.+....++.++|||||||++|||++ |..||..
T Consensus 122 kp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 122 AARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred chhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999976433222111 122234578999999988889999999999999999998 9999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
..... +..... .. .....+......+.+++.+|++.+|.+||++.+|++.|..
T Consensus 202 ~~~~~---~~~~i~----~~----------~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 202 MKGNE---VTQMIE----SG----------ERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCHHH---HHHHHH----CC----------CCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 43321 111111 00 0001122234568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=262.00 Aligned_cols=212 Identities=22% Similarity=0.315 Sum_probs=168.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||+++++++.+.+..++|+||+++++|.+++.........+++..++.++.+++.||+|||+.+ ++|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 131 (267)
T cd08228 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRD 131 (267)
T ss_pred HHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCC
Confidence 367889999999999999999999999999999999998754444556899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++||||||++++||++|..||...
T Consensus 132 l~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 132 IKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred CCHHHEEEcCCCCEEECccccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 99999999999999999999987543221 1122345888999999999888999999999999999999999998543
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
... ...+...+. ....+.. .+......+.+++.+||+.+|.+||++.+|++.|..+.
T Consensus 210 ~~~----~~~~~~~~~-------~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 210 KMN----LFSLCQKIE-------QCDYPPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred ccc----HHHHHHHHh-------cCCCCCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 221 111111110 0000110 01123456889999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=269.31 Aligned_cols=203 Identities=24% Similarity=0.296 Sum_probs=159.2
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+.+ +||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|||
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrD 130 (332)
T cd05614 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRD 130 (332)
T ss_pred HHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecC
Confidence 4566 699999999999999999999999999999999865 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+|||++.++.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|..||..
T Consensus 131 lkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 131 IKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 999999999999999999999975433222 122345699999999998865 478899999999999999999999975
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
......... ....+.. .++.+ +......+.+++.+||+.||++|| ++.++++.
T Consensus 210 ~~~~~~~~~--~~~~~~~--------~~~~~----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 210 EGERNTQSE--VSRRILK--------CDPPF----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CCCCCCHHH--HHHHHhc--------CCCCC----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 432221111 1111111 11111 122335678999999999999999 66777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=261.86 Aligned_cols=207 Identities=28% Similarity=0.406 Sum_probs=161.0
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
++++ +||||++++++|......++||||+++++|.+++..... ....+++.+++.++.+++.||+||
T Consensus 49 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l 128 (270)
T cd05047 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128 (270)
T ss_pred HHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4567 899999999999999999999999999999999975321 123588999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ ++||||||+||+++.++.++|+|||++...... ........+..|+|||++....++.++||||||++++
T Consensus 129 H~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 202 (270)
T cd05047 129 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 202 (270)
T ss_pred HHCC---EeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHH
Confidence 9998 999999999999999999999999998532111 1111122356799999998889999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||++ |..||....... +.. .... . .....+......+.+|+.+|+..+|.+||++.++++.|
T Consensus 203 el~~~g~~pf~~~~~~~---~~~---~~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 265 (270)
T cd05047 203 EIVSLGGTPYCGMTCAE---LYE---KLPQ-G----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 265 (270)
T ss_pred HHHcCCCCCccccCHHH---HHH---HHhC-C----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHH
Confidence 9997 999986542211 111 0000 0 00001112234678999999999999999999999999
Q ss_pred Hhhh
Q 020529 228 SYLA 231 (325)
Q Consensus 228 ~~~~ 231 (325)
..+.
T Consensus 266 ~~~~ 269 (270)
T cd05047 266 NRML 269 (270)
T ss_pred HHhh
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=276.65 Aligned_cols=212 Identities=29% Similarity=0.441 Sum_probs=169.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++.+|-||+-++|||..... .+|+.+|.|.||..+||. ....|+..+.+.|+.|++.|+.|||.++ |||||
T Consensus 441 ~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrD 513 (678)
T KOG0193|consen 441 VLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRD 513 (678)
T ss_pred HHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhh
Confidence 4788999999999999998877 999999999999999998 4466999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC---CCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG---QLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||+.||||.+++.|||+||||+.....-..........|...|||||++.-. +|++.+||||||+|+|||+||..||
T Consensus 514 LKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 514 LKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred ccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 9999999999999999999999653332222223345588899999998743 7899999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..... ++.+....+.+.. ..+... ..+....+.+|+..|+..++++||...+|+..|+.+..
T Consensus 594 si~~~--dqIifmVGrG~l~-----pd~s~~------~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 594 SIQNR--DQIIFMVGRGYLM-----PDLSKI------RSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred CCCCh--hheEEEecccccC-----ccchhh------hccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 83322 2222111111111 111111 11345688899999999999999999999998887765
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=278.07 Aligned_cols=210 Identities=27% Similarity=0.402 Sum_probs=169.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++++++|||||++||++......++|||+|+||+|.++|.. ....++..+++.++.++|.||+|||+++ +||||
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k---~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRD 287 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKK---NKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRD 287 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHhHHHHHHHCC---Ccchh
Confidence 46789999999999999999999999999999999999987 3336999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|-+.|+|++.++.+||+||||++.... .........-...|+|||.+....++.++|||||||++||+++ |..|+.+
T Consensus 288 IAARNcL~~~~~~vKISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g 365 (474)
T KOG0194|consen 288 IAARNCLYSKKGVVKISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG 365 (474)
T ss_pred HhHHHheecCCCeEEeCccccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC
Confidence 999999999999999999999976431 1111111223467999999999999999999999999999998 7778876
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
.... .+..++ ... ..+...+......+..++.+|+..+|++||+|.+|.+.|+.+....
T Consensus 366 ~~~~---~v~~kI---~~~----------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 366 MKNY---EVKAKI---VKN----------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred CCHH---HHHHHH---Hhc----------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 5432 111111 111 1111222244567778889999999999999999999999887654
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=260.77 Aligned_cols=203 Identities=25% Similarity=0.400 Sum_probs=161.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+....++||||+.+++|.+++... ...+++..++.++.+++.||+|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 126 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDL 126 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 67889999999999999888999999999999999999752 236899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.+||+|||+++...... ........++..|+|||++....++.++||||||+++|+|++ |..||...
T Consensus 127 ~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 127 AARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred CcceEEEcCCCCEEECCCccceecCCCc-eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 9999999999999999999987543221 111222345678999999998889999999999999999998 99998654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
.... ... ....... . ..+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 206 ~~~~---~~~---~~~~~~~----~-------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 206 NNSE---TVE---KVSQGLR----L-------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CHHH---HHH---HHhcCCC----C-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 3211 111 1110000 0 001122467889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=268.24 Aligned_cols=212 Identities=26% Similarity=0.396 Sum_probs=165.5
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
++.+ +||||++++++|...+..++||||+++++|.+++...++ ....+++.+++.++.|++.||+||
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 156 (307)
T cd05098 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156 (307)
T ss_pred HHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4456 799999999999999999999999999999999976432 123589999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ ++||||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|
T Consensus 157 H~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 233 (307)
T cd05098 157 ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 233 (307)
T ss_pred HHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHH
Confidence 9999 9999999999999999999999999987543322111122223456899999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||++ |..||....... +.. . +.... ....+......+.+|+.+||..+|.+||++.+|++.|
T Consensus 234 el~~~g~~p~~~~~~~~---~~~---~-~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l 296 (307)
T cd05098 234 EIFTLGGSPYPGVPVEE---LFK---L-LKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296 (307)
T ss_pred HHHcCCCCCCCcCCHHH---HHH---H-HHcCC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9998 888886543211 111 0 00000 0011122345788999999999999999999999999
Q ss_pred Hhhhcc
Q 020529 228 SYLANQ 233 (325)
Q Consensus 228 ~~~~~~ 233 (325)
..+...
T Consensus 297 ~~~~~~ 302 (307)
T cd05098 297 DRILAL 302 (307)
T ss_pred HHHHHH
Confidence 987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=259.89 Aligned_cols=206 Identities=22% Similarity=0.366 Sum_probs=161.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++. ....++||||+++++|.+++.. ....+++..+++++.+++.||+|||+.+ ++|||
T Consensus 48 ~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 120 (257)
T cd05115 48 IMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRD 120 (257)
T ss_pred HHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecc
Confidence 367889999999999986 4578999999999999999865 2456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCc-cccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~ 158 (325)
|||+||+++.++.+||+|||++........... .....+++.|+|||++....++.++||||||+++|||++ |..||.
T Consensus 121 lkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 121 LAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred cchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 999999999999999999999975433222111 111223578999999988889999999999999999996 999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
...... +.... ... .....+......+.+++.+|+..+|++||++.+|.+.|..+
T Consensus 201 ~~~~~~---~~~~~----~~~----------~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 201 KMKGPE---VMSFI----EQG----------KRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred cCCHHH---HHHHH----HCC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 653221 11111 000 00111223346788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=264.46 Aligned_cols=206 Identities=22% Similarity=0.289 Sum_probs=161.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.++...++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 46 il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 120 (277)
T cd05607 46 ILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRD 120 (277)
T ss_pred HHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEcc
Confidence 367889999999999999999999999999999999888652 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||+++.++.++|+|||++...... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 121 ikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 121 MKPENVLLDDQGNCRLSDLGLAVELKDG---KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred CChHhEEEcCCCCEEEeeceeeeecCCC---ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998754322 1223456899999999999989999999999999999999999999654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
..... ........... .... . ......++.+|+.+||+.+|.+||++.|+++.+
T Consensus 198 ~~~~~--~~~~~~~~~~~------~~~~-~----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 198 KEKVA--KEELKRRTLED------EVKF-E----HQNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred cchhh--HHHHHHHhhcc------cccc-c----cccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 32111 11111111110 0000 0 012245678999999999999999998776433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=272.81 Aligned_cols=217 Identities=23% Similarity=0.357 Sum_probs=156.5
Q ss_pred CcCCCCCCCccceeeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
+|++++||||+++++++... ...|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+
T Consensus 52 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~--- 123 (338)
T cd07859 52 LLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN--- 123 (338)
T ss_pred HHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 36788999999999988543 25799999995 799998865 446899999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhcc--CCCCccccEEEehHHHHHHHh
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~ellt 152 (325)
|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 124 ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 124 VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc
Confidence 999999999999999999999999999754322211 11234568999999999876 678999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhh-h--------hhhccccc--ccccccc---CCccCCCCChHHHHHHHHHHHHchhhCCCCCC
Q 020529 153 GRKAIDSTRPHGEQNLVT-W--------ARPLFNDR--RKFSKLA---DPRLEGRYPIRGLYQALAVASMCIQEQAATRP 218 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~-~--------~~~~~~~~--~~~~~~~---d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP 218 (325)
|+.||............. . ...+.... ..+..+. ...+...++ .....+.+++.+||+.+|.+||
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~Rp 282 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFP-NADPLALRLLERLLAFDPKDRP 282 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcC-CCChHHHHHHHHHcCcCcccCC
Confidence 999996643211100000 0 00000000 0000000 000000000 1234578999999999999999
Q ss_pred CHHHHHHH
Q 020529 219 LIGDVVTA 226 (325)
Q Consensus 219 s~~evl~~ 226 (325)
++++|++.
T Consensus 283 t~~e~l~h 290 (338)
T cd07859 283 TAEEALAD 290 (338)
T ss_pred CHHHHhcC
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=268.05 Aligned_cols=194 Identities=27% Similarity=0.412 Sum_probs=156.9
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
++||||+++++++.+.+..++||||+++++|.+++.. ...+++.++..++.|++.||.|||+.+ |+||||||+
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~ 125 (316)
T cd05619 53 WEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLD 125 (316)
T ss_pred cCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHH
Confidence 5899999999999999999999999999999999965 346899999999999999999999999 999999999
Q ss_pred cEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 85 Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
|||++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 126 Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~ 203 (316)
T cd05619 126 NILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203 (316)
T ss_pred HEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999987432221 12334568999999999999899999999999999999999999997543211
Q ss_pred cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH-HHHH
Q 020529 165 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG-DVVT 225 (325)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~-evl~ 225 (325)
+... +... .+. ++......+.+++.+||+.+|.+||++. ++.+
T Consensus 204 ---~~~~---i~~~--------~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 204 ---LFQS---IRMD--------NPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred ---HHHH---HHhC--------CCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 1111 0000 011 1112235678999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=268.52 Aligned_cols=194 Identities=27% Similarity=0.423 Sum_probs=156.7
Q ss_pred CCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCC
Q 020529 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKS 83 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~ 83 (325)
.++||||+++++++.+.+..|+||||+.+++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp 124 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKL 124 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCH
Confidence 35899999999999999999999999999999999865 456899999999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCC
Q 020529 84 SNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 163 (325)
Q Consensus 84 ~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~ 163 (325)
+|||++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||......
T Consensus 125 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~ 202 (316)
T cd05620 125 DNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED 202 (316)
T ss_pred HHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999986432211 1234467999999999999999999999999999999999999999754321
Q ss_pred CcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH-HHH
Q 020529 164 GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG-DVV 224 (325)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~-evl 224 (325)
.+. ..+... .+ .++......+.+++.+||+.||.+||++. +++
T Consensus 203 ---~~~---~~~~~~--------~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 203 ---ELF---ESIRVD--------TP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred ---HHH---HHHHhC--------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 111 110000 01 11112335678999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=260.56 Aligned_cols=203 Identities=26% Similarity=0.370 Sum_probs=160.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++......++||||+++++|.+++... ...+++..++.++.+++.||+|||+.+ |+|||
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~d 125 (256)
T cd05059 52 VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125 (256)
T ss_pred HHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 357789999999999999999999999999999999998752 336899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.+||+|||+++...... ........++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 126 l~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred ccHhhEEECCCCcEEECCcccceeccccc-ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 99999999999999999999987543211 111122234457999999999999999999999999999998 7999875
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
..... ...... ..... ..+......+.+++.+||..+|++||++.+|++.|
T Consensus 205 ~~~~~---~~~~~~----------~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 205 FSNSE---VVESVS----------AGYRL----YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHH---HHHHHH----------cCCcC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 43221 111000 00000 11112345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=263.13 Aligned_cols=214 Identities=23% Similarity=0.412 Sum_probs=163.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-------KEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
|+.++||||+++++++...+..++||||+++++|.+++...... ...+++.+++.++.+++.||+|||+.+
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~-- 150 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN-- 150 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 56789999999999999999999999999999999999764321 234788999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh--
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-- 152 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-- 152 (325)
++|+||||+||+++.++.++|+|||+++...............+++.|++||+...+.++.++|||||||++|||++
T Consensus 151 -i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~ 229 (296)
T cd05095 151 -FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLC 229 (296)
T ss_pred -eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhC
Confidence 99999999999999999999999999875433222122233345678999999988899999999999999999998
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
|..||....... ........+.... .....+. +......+.+|+.+||+.+|.+||++.+|++.|.
T Consensus 230 ~~~p~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 230 KEQPYSQLSDEQ---VIENTGEFFRDQG--RQVYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCCCccccChHH---HHHHHHHHHhhcc--ccccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 667775443221 1111111111100 0000010 1122357889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=278.58 Aligned_cols=219 Identities=20% Similarity=0.232 Sum_probs=160.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++|+|||||++++++..++..++|||++. ++|..++.. ....+++..++.|+.|++.||.|||+.+ |+|||
T Consensus 213 iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrD 285 (461)
T PHA03211 213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRD 285 (461)
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECc
Confidence 4678999999999999999999999999995 789888865 2346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||+.++.++|+|||+++...............||..|+|||++.+..++.++|||||||++|||++|..++...
T Consensus 286 LKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~ 365 (461)
T PHA03211 286 IKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSA 365 (461)
T ss_pred CCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccC
Confidence 99999999999999999999997643332222333467999999999999999999999999999999999987665332
Q ss_pred CCCCc-----chhhhhhhhccccccccccccCC------------ccCCCCCh-------HHHHHHHHHHHHchhhCCCC
Q 020529 161 RPHGE-----QNLVTWARPLFNDRRKFSKLADP------------RLEGRYPI-------RGLYQALAVASMCIQEQAAT 216 (325)
Q Consensus 161 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~d~------------~l~~~~~~-------~~~~~~~~l~~~cl~~~p~~ 216 (325)
..... ..+.............+...... ........ .....+.+|+.+||+.||.+
T Consensus 366 ~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~ 445 (461)
T PHA03211 366 SRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGAR 445 (461)
T ss_pred CcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhh
Confidence 21110 11111111000000000000000 00000000 11236778999999999999
Q ss_pred CCCHHHHHHH
Q 020529 217 RPLIGDVVTA 226 (325)
Q Consensus 217 RPs~~evl~~ 226 (325)
|||+.||++.
T Consensus 446 RPsa~elL~h 455 (461)
T PHA03211 446 RPSAAELLRL 455 (461)
T ss_pred CcCHHHHhhC
Confidence 9999999874
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=268.41 Aligned_cols=203 Identities=25% Similarity=0.285 Sum_probs=159.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+.+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dl 128 (330)
T cd05601 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDI 128 (330)
T ss_pred HHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccC
Confidence 56789999999999999999999999999999999999762 356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc------cCCCCccccEEEehHHHHHHHhCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM------TGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
||+|||++.++.+||+|||++........ .......||+.|+|||++. ...++.++|||||||++|||++|+.
T Consensus 129 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~ 207 (330)
T cd05601 129 KPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207 (330)
T ss_pred chHheEECCCCCEEeccCCCCeECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCC
Confidence 99999999999999999999976433221 1233456899999999987 4567899999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
||........ ...+..... .....+ .......+.+|+..||+ +|.+||++.+++..
T Consensus 208 Pf~~~~~~~~------~~~i~~~~~-~~~~~~-------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 208 PFHEGTSAKT------YNNIMNFQR-FLKFPE-------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCCCCCHHHH------HHHHHcCCC-ccCCCC-------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 9975432211 111111000 000000 01223567889999998 99999999998854
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=262.61 Aligned_cols=208 Identities=24% Similarity=0.375 Sum_probs=162.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++... ..+++++|+++|+|.+++.. ....+++.+++.++.|++.||+|||+.+ |+||||
T Consensus 63 l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dl 135 (279)
T cd05109 63 MAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDL 135 (279)
T ss_pred HHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccc
Confidence 4678999999999999754 57899999999999999975 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.+||+|||+++...............+++.|+|||...+..++.++|||||||++|||++ |..||...
T Consensus 136 kp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 136 AARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred ccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999986543222111222334678999999998899999999999999999998 89998654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
... .+..+..... .+.. +......+.+++.+||+.+|+.||++.+++..|..+...
T Consensus 216 ~~~---~~~~~~~~~~----------~~~~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 216 PAR---EIPDLLEKGE----------RLPQ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CHH---HHHHHHHCCC----------cCCC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 321 1111111100 0000 112235678999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=260.07 Aligned_cols=210 Identities=21% Similarity=0.319 Sum_probs=167.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+++..++||||+++++|.+++.........+++.+++.++.+++.||.|||+.+ ++|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl 132 (267)
T cd08229 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDI 132 (267)
T ss_pred HHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 56789999999999999999999999999999999998754444566899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++....... .......|+..|+|||++....++.++||||||+++++|++|..||....
T Consensus 133 ~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 133 KPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred CHHHEEEcCCCCEEECcchhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9999999999999999999987543222 11233568889999999998889999999999999999999999986432
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
.. ...+.... .....+.+. +......+.+++.+|++.+|.+|||+.+|++.++.+
T Consensus 211 ~~----~~~~~~~~-------~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 211 MN----LYSLCKKI-------EQCDYPPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ch----HHHHhhhh-------hcCCCCCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 21 11111100 011111110 112345788999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=265.42 Aligned_cols=209 Identities=27% Similarity=0.387 Sum_probs=162.8
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
++++ +||||+++++++......++|+||+++++|.+++..... ....+++..++.++.|++.||+||
T Consensus 56 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 135 (297)
T cd05089 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL 135 (297)
T ss_pred HHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence 4566 799999999999999999999999999999999965321 123588999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ |+||||||+||+++.++.+||+|||++...... ........+..|+|||++....++.++|||||||++|
T Consensus 136 H~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 209 (297)
T cd05089 136 SEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLW 209 (297)
T ss_pred HHCC---cccCcCCcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHH
Confidence 9999 999999999999999999999999998632111 1111122345799999999888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||++ |..||....... +. .... ....+ ..+......+.+|+.+|++.+|.+||++++|++.|
T Consensus 210 el~t~g~~pf~~~~~~~---~~---~~~~-------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 272 (297)
T cd05089 210 EIVSLGGTPYCGMTCAE---LY---EKLP-------QGYRM----EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQL 272 (297)
T ss_pred HHHcCCCCCCCCCCHHH---HH---HHHh-------cCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9997 999996543221 11 1000 00001 11112335678999999999999999999999999
Q ss_pred Hhhhcc
Q 020529 228 SYLANQ 233 (325)
Q Consensus 228 ~~~~~~ 233 (325)
..+...
T Consensus 273 ~~~~~~ 278 (297)
T cd05089 273 SRMLEA 278 (297)
T ss_pred HHHHHh
Confidence 887754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=259.45 Aligned_cols=211 Identities=21% Similarity=0.304 Sum_probs=159.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||++++++|......|+||||+++++|.++++........+++..++.++.+++.||+|||+.+ ++||||
T Consensus 49 ~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~di 125 (268)
T cd05086 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDL 125 (268)
T ss_pred HhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 56789999999999999999999999999999999999764333445778888999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-------CCCCccccEEEehHHHHHHHh-C
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-------GQLTVKSDVYSFGVVFLELIT-G 153 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvvl~ellt-g 153 (325)
||+|||++.++.++|+|||++................++..|+|||++.. ..++.++||||||+++|||++ |
T Consensus 126 kp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 205 (268)
T cd05086 126 ALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENA 205 (268)
T ss_pred ccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCC
Confidence 99999999999999999999854222221122234567889999998753 245789999999999999997 4
Q ss_pred CCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 154 RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
..||....... ........ ....+.++.+... ....+.+++..|+ .+|.+||++.+|++.|.
T Consensus 206 ~~p~~~~~~~~------~~~~~~~~--~~~~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 206 AQPYSHLSDRE------VLNHVIKD--QQVKLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCCCCCHHH------HHHHHHhh--cccccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 66775432211 11111111 1122333433322 2346677889999 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=273.44 Aligned_cols=203 Identities=23% Similarity=0.331 Sum_probs=159.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||++++++|.+++..|+||||+.+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~D 126 (364)
T cd05599 54 ILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRD 126 (364)
T ss_pred HHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 36678999999999999999999999999999999999975 446999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCC------------------------------------ccccccCCcCcc
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH------------------------------------VSTRVMGTYGYC 124 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~------------------------------------~~~~~~gt~~y~ 124 (325)
|||+|||++.++.++|+|||+++......... ......||+.|+
T Consensus 127 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 206 (364)
T cd05599 127 IKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYI 206 (364)
T ss_pred CCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCcccc
Confidence 99999999999999999999986532211000 011246999999
Q ss_pred CchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcc-hhhhhhhhccccccccccccCCccCCCCChHHHHHHH
Q 020529 125 APEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQAL 203 (325)
Q Consensus 125 aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 203 (325)
|||++....++.++|||||||++|||++|..||......... .+..|.. ...-+. .......+.
T Consensus 207 aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~----------~~~~~~-----~~~~s~~~~ 271 (364)
T cd05599 207 APEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKE----------TLQFPD-----EVPLSPEAK 271 (364)
T ss_pred CHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCC----------ccCCCC-----CCCCCHHHH
Confidence 999999999999999999999999999999999765432111 1111110 000000 001234677
Q ss_pred HHHHHchhhCCCCCCC---HHHHHHH
Q 020529 204 AVASMCIQEQAATRPL---IGDVVTA 226 (325)
Q Consensus 204 ~l~~~cl~~~p~~RPs---~~evl~~ 226 (325)
+++.+|+. +|.+|++ +.++++.
T Consensus 272 ~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 272 DLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred HHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 89999996 8999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=261.20 Aligned_cols=209 Identities=25% Similarity=0.346 Sum_probs=160.5
Q ss_pred cCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
|+.++||||+++++++... ...++||||+.+++|.+++.... .....+++.+++.++.|++.||+|||+.+
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~- 132 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS- 132 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5678999999999987532 24689999999999999874321 22345899999999999999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT- 152 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt- 152 (325)
|+||||||+|||+++++.++|+|||+++...............+++.|+|||++....++.++||||||+++|||++
T Consensus 133 --i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~ 210 (272)
T cd05075 133 --FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210 (272)
T ss_pred --eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999986543322111223345678999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
|..||...... .+.. .+..... . ..+......+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 211 g~~p~~~~~~~---~~~~----~~~~~~~-~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 211 GQTPYPGVENS---EIYD----YLRQGNR-L---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCCCCCCCHH---HHHH----HHHcCCC-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 78888653221 1111 1111100 0 01112345688999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=266.76 Aligned_cols=214 Identities=22% Similarity=0.307 Sum_probs=157.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||+++++++.+....++||||+. ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+|||
T Consensus 56 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 128 (303)
T cd07869 56 LLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRD 128 (303)
T ss_pred HHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 3678899999999999999999999999995 788888765 2356899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+|||++.++.+||+|||+++..... ........|++.|+|||++.+. .++.++|||||||++|+|++|..||..
T Consensus 129 lkp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 129 LKPQNLLISDTGELKLADFGLARAKSVP--SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CCHHHEEECCCCCEEECCCCcceeccCC--CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998643222 1222345689999999998754 578899999999999999999999976
Q ss_pred CCCCCcchhhhhhhhccc--------cccccccccCCc-cCCCCCh---------HHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 160 TRPHGEQNLVTWARPLFN--------DRRKFSKLADPR-LEGRYPI---------RGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~d~~-l~~~~~~---------~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
...... .......... ....... +++. .....+. .....+.+|+.+||+.||.+|||+.
T Consensus 207 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~ 283 (303)
T cd07869 207 MKDIQD--QLERIFLVLGTPNEDTWPGVHSLPH-FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQ 283 (303)
T ss_pred CccHHH--HHHHHHHHhCCCChhhccchhhccc-cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHH
Confidence 432111 0000000000 0000000 0000 0000000 1124677999999999999999999
Q ss_pred HHHHH
Q 020529 222 DVVTA 226 (325)
Q Consensus 222 evl~~ 226 (325)
++++.
T Consensus 284 ~~l~h 288 (303)
T cd07869 284 AALSH 288 (303)
T ss_pred HHhcC
Confidence 99863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=261.73 Aligned_cols=211 Identities=24% Similarity=0.388 Sum_probs=166.4
Q ss_pred cCCCCCCCccceeeEEEe-CCeeEEEEecCCCCCHHHHhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPD----KEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
|++++||||+++++++.. ....+++++|+++++|.+++...+.. ...+++.+++.++.+++.||+|||+.+ +
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i 138 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---V 138 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---E
Confidence 567899999999999766 56789999999999999999764332 156899999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~ 155 (325)
+|+||||+||+++.++.+||+|||+++...............++..|+|||++....++.++||||||++++|+++ |+.
T Consensus 139 ~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 218 (280)
T cd05043 139 IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218 (280)
T ss_pred eecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCC
Confidence 9999999999999999999999999976433322222233446778999999998889999999999999999998 999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
||....+. .+..+... .. .... +......+.+++.+|+..+|++||++.+|++.|+.+..
T Consensus 219 p~~~~~~~---~~~~~~~~----~~------~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 219 PYVEIDPF---EMAAYLKD----GY------RLAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CcCcCCHH---HHHHHHHc----CC------CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 99764332 12111111 00 0000 11123467899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=269.44 Aligned_cols=193 Identities=26% Similarity=0.420 Sum_probs=157.0
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
+||||+++++++...+..|+||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~N 126 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDN 126 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHH
Confidence 799999999999999999999999999999999865 446999999999999999999999999 9999999999
Q ss_pred EEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCc
Q 020529 86 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 165 (325)
Q Consensus 86 ill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~ 165 (325)
|+++.++.++|+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 127 ill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-- 202 (318)
T cd05570 127 VLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-- 202 (318)
T ss_pred eEECCCCcEEecccCCCeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--
Confidence 999999999999999986422211 1223456899999999999999999999999999999999999999754321
Q ss_pred chhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH-----HHHHH
Q 020529 166 QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI-----GDVVT 225 (325)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~-----~evl~ 225 (325)
.+ ...+.... . .++......+.+|+.+||+.+|.+||++ .+++.
T Consensus 203 -~~---~~~i~~~~--------~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 203 -EL---FQSILEDE--------V----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -HH---HHHHHcCC--------C----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11 11111110 0 1112234567899999999999999999 77664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=267.11 Aligned_cols=212 Identities=25% Similarity=0.379 Sum_probs=165.9
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
++++ +||||++++++|......++||||+++++|.+++....+ ....+++.+++.++.|++.||+||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred HHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4566 799999999999999999999999999999999975321 123588999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ |+||||||+||+++.++.+||+|||+++...............++..|+|||++....++.++||||||+++|
T Consensus 151 H~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 227 (334)
T cd05100 151 ASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLW 227 (334)
T ss_pred HHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHH
Confidence 9999 9999999999999999999999999997543322111222233456799999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||++ |..||....... +...+.. . .....+......+.+++.+|++.+|.+||++.++++.|
T Consensus 228 el~~~g~~p~~~~~~~~------~~~~~~~-~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l 290 (334)
T cd05100 228 EIFTLGGSPYPGIPVEE------LFKLLKE-G----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290 (334)
T ss_pred HHHhcCCCCCCCCCHHH------HHHHHHc-C----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence 9998 888886543211 1111110 0 00011122345788999999999999999999999999
Q ss_pred Hhhhcc
Q 020529 228 SYLANQ 233 (325)
Q Consensus 228 ~~~~~~ 233 (325)
..+...
T Consensus 291 ~~~~~~ 296 (334)
T cd05100 291 DRVLTV 296 (334)
T ss_pred HHHhhh
Confidence 988743
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=260.64 Aligned_cols=211 Identities=29% Similarity=0.370 Sum_probs=159.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+++++||||+++++++.+....++||||+++++|.+++..... ....+++..+..++.|++.||+|||+.+ ++|+|
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 125 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSD 125 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---Eeccc
Confidence 5678999999999999999999999999999999999975332 2235678888999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-------CCCccccEEEehHHHHHHHh-
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-------QLTVKSDVYSFGVVFLELIT- 152 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDvwSlGvvl~ellt- 152 (325)
|||+||+++.++.++|+|||+++...............++..|+|||++... .++.++||||||++++||++
T Consensus 126 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05087 126 LALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFEL 205 (269)
T ss_pred cCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhC
Confidence 9999999999999999999998754332222223345578889999998642 35789999999999999996
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
|..||........ .... . ........++.+.. .....+.+++.+|+ .+|++||++.+|+..|+
T Consensus 206 g~~p~~~~~~~~~---~~~~---~--~~~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 206 GSQPYRHLSDEQV---LTYT---V--REQQLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCCCChHHH---HHHH---h--hcccCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 9999965432211 1100 0 00111222222221 12345677888998 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=263.97 Aligned_cols=214 Identities=21% Similarity=0.359 Sum_probs=162.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC--------CCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--------DKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
|++++||||+++++++......++||||+++++|.+++..... ....+++..++.++.+++.||+|||+.+
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~- 149 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN- 149 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 6789999999999999999999999999999999999864211 1124789999999999999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT- 152 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt- 152 (325)
++|+||||+||+++.++.+||+|||++................++..|+|||++....++.++|||||||++++|++
T Consensus 150 --i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~ 227 (295)
T cd05097 150 --FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTL 227 (295)
T ss_pred --eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHc
Confidence 99999999999999999999999999875433322222233445778999999998899999999999999999998
Q ss_pred -CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 153 -GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
+..||....... ................... .+......+.+|+.+|++.+|.+||++.+|++.|.
T Consensus 228 ~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 228 CKEQPYSLLSDEQ---VIENTGEFFRNQGRQIYLS-------QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CCCCCCcccChHH---HHHHHHHhhhhccccccCC-------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 556665433211 1111111111100000000 01112357899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=273.06 Aligned_cols=203 Identities=25% Similarity=0.322 Sum_probs=156.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||++++++|.+....|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrD 126 (377)
T cd05629 54 VLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRD 126 (377)
T ss_pred HHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 35678999999999999999999999999999999999975 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCC---------------------------------------------Cccc
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKS---------------------------------------------HVST 115 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~---------------------------------------------~~~~ 115 (325)
|||+|||++.++.++|+|||+++........ ....
T Consensus 127 lkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (377)
T cd05629 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAY 206 (377)
T ss_pred CCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccc
Confidence 9999999999999999999998632110000 0001
Q ss_pred cccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcc-hhhhhhhhccccccccccccCCccCCCC
Q 020529 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWARPLFNDRRKFSKLADPRLEGRY 194 (325)
Q Consensus 116 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 194 (325)
...||+.|+|||++.+..++.++|||||||++|||++|..||......... .+..|... ..+ +.
T Consensus 207 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--------~~~--p~----- 271 (377)
T cd05629 207 STVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET--------LYF--PD----- 271 (377)
T ss_pred ccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc--------cCC--CC-----
Confidence 246999999999999999999999999999999999999999764432111 11111100 000 00
Q ss_pred ChHHHHHHHHHHHHchhhCCCCC---CCHHHHHHH
Q 020529 195 PIRGLYQALAVASMCIQEQAATR---PLIGDVVTA 226 (325)
Q Consensus 195 ~~~~~~~~~~l~~~cl~~~p~~R---Ps~~evl~~ 226 (325)
.......+.+++.+||. +|.+| +++.+++..
T Consensus 272 ~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 272 DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 00123567889999997 66665 699998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=262.99 Aligned_cols=212 Identities=24% Similarity=0.363 Sum_probs=165.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------DKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
++.++||||+++++++.+....++||||+++++|.+++..... ....+++..+..++.+++.||.|||+.+
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--- 139 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--- 139 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5678999999999999999999999999999999999975321 1234677889999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~ 154 (325)
|+||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|||||||+++||++ |.
T Consensus 140 i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~ 219 (288)
T cd05061 140 FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAE 219 (288)
T ss_pred CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999875433322222223345678999999998899999999999999999998 78
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
.||......+ +.. .... ... + ..+......+.+++.+||+.+|.+||++.++++.|......
T Consensus 220 ~p~~~~~~~~---~~~---~~~~-~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 281 (288)
T cd05061 220 QPYQGLSNEQ---VLK---FVMD-GGY------L----DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP 281 (288)
T ss_pred CCCCCCCHHH---HHH---HHHc-CCC------C----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence 8886533211 111 0000 000 0 01112235788999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=272.08 Aligned_cols=204 Identities=25% Similarity=0.344 Sum_probs=157.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+|||
T Consensus 54 il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrD 126 (381)
T cd05626 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRD 126 (381)
T ss_pred HHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 36788999999999999999999999999999999999975 456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCC---------------------------------------------CCccc
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDK---------------------------------------------SHVST 115 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~---------------------------------------------~~~~~ 115 (325)
|||+|||++.++.+||+|||+++....... .....
T Consensus 127 lKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (381)
T cd05626 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206 (381)
T ss_pred CcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccc
Confidence 999999999999999999999753211000 00012
Q ss_pred cccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcc-hhhhhhhhccccccccccccCCccCCCC
Q 020529 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWARPLFNDRRKFSKLADPRLEGRY 194 (325)
Q Consensus 116 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 194 (325)
...||+.|+|||++.+..++.++|||||||++|||++|..||......... .+..|... ..-+.
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~----------~~~~~----- 271 (381)
T cd05626 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT----------LHIPP----- 271 (381)
T ss_pred cccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc----------cCCCC-----
Confidence 356999999999999889999999999999999999999999765432111 11111100 00000
Q ss_pred ChHHHHHHHHHHHH--chhhCCCCCCCHHHHHHH
Q 020529 195 PIRGLYQALAVASM--CIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 195 ~~~~~~~~~~l~~~--cl~~~p~~RPs~~evl~~ 226 (325)
......++.+++.+ |+..++..||++.+|+..
T Consensus 272 ~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 272 QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 01123467778877 556667779999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=271.35 Aligned_cols=147 Identities=24% Similarity=0.376 Sum_probs=128.7
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++......++||||+. ++|.+++.. ....+++..++.|+.|++.||.|||+.+ |+|||
T Consensus 110 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 182 (357)
T PHA03209 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRD 182 (357)
T ss_pred HHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 4678999999999999999999999999995 788888865 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+|||++.++.++|+|||+++.... ........||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus 183 lkp~Nill~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 183 VKTENIFINDVDQVCIGDLGAAQFPVV---APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred CCHHHEEECCCCCEEEecCcccccccc---CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999999999999999999999874221 11223456899999999999999999999999999999999865554
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=274.31 Aligned_cols=203 Identities=23% Similarity=0.292 Sum_probs=157.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+++..|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrD 126 (376)
T cd05598 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRD 126 (376)
T ss_pred HHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCC
Confidence 46788999999999999999999999999999999999975 445899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCC-----------------------------------------CCCccccccC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGD-----------------------------------------KSHVSTRVMG 119 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~-----------------------------------------~~~~~~~~~g 119 (325)
|||+|||++.++.++|+|||++..+.... .........|
T Consensus 127 lkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 206 (376)
T cd05598 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVG 206 (376)
T ss_pred CCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCC
Confidence 99999999999999999999975321000 0001123569
Q ss_pred CcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcch-hhhhhhhccccccccccccCCccCCCCChHH
Q 020529 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-LVTWARPLFNDRRKFSKLADPRLEGRYPIRG 198 (325)
Q Consensus 120 t~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 198 (325)
|+.|+|||++.+..++.++|||||||++|||++|+.||....+..... +..|.. ....+ .....
T Consensus 207 t~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~----------~~~~~-----~~~~~ 271 (376)
T cd05598 207 TPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWET----------TLHIP-----SQAKL 271 (376)
T ss_pred CccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCc----------cccCC-----CCCCC
Confidence 999999999999999999999999999999999999997654322111 111100 00000 01122
Q ss_pred HHHHHHHHHHchhhCCCCCC---CHHHHHHH
Q 020529 199 LYQALAVASMCIQEQAATRP---LIGDVVTA 226 (325)
Q Consensus 199 ~~~~~~l~~~cl~~~p~~RP---s~~evl~~ 226 (325)
...+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 272 s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 272 SREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 345667787765 5999999 88998865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=257.38 Aligned_cols=201 Identities=24% Similarity=0.309 Sum_probs=162.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+.+..++||||+++++|.+++.... ...+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl 127 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDI 127 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 678899999999999999999999999999999999997632 356899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||+++...... .......|++.|+|||+..+..++.++||||||+++++|++|+.||....
T Consensus 128 ~~~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 128 KSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred CcceEEEeCCCCEEEcccccceeccCcc--chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987543321 22234568899999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.. ..... ... .... .+ +......+.+++.+|++.+|++||++.++++.
T Consensus 206 ~~---~~~~~---~~~------~~~~-~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 206 QG---ALILK---IIR------GVFP-PV----SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred HH---HHHHH---HHc------CCCC-CC----ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11 11111 000 0011 11 11223568899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=271.60 Aligned_cols=202 Identities=21% Similarity=0.273 Sum_probs=159.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+....|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||
T Consensus 97 l~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDL 168 (370)
T cd05596 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDV 168 (370)
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 5678999999999999999999999999999999999864 34888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC----CCCccccEEEehHHHHHHHhCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG----QLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||+|||++.++.+||+|||++....... ........||+.|+|||++... .++.++|||||||++|||++|+.||
T Consensus 169 kp~NILl~~~~~~kL~DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf 247 (370)
T cd05596 169 KPDNMLLDKSGHLKLADFGTCMKMDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (370)
T ss_pred CHHHEEEcCCCCEEEEeccceeeccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence 9999999999999999999987543221 1122345799999999998754 4789999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCC--CCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPs~~evl~~ 226 (325)
........ ...+..... .+.-+ ........+.+++..||+.+|.+ ||++.++++.
T Consensus 248 ~~~~~~~~------~~~i~~~~~---~~~~~-----~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 248 YADSLVGT------YSKIMDHKN---SLTFP-----DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCHHHH------HHHHHcCCC---cCCCC-----CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 76432111 111111000 00000 01123467889999999999987 9999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=258.81 Aligned_cols=202 Identities=26% Similarity=0.326 Sum_probs=161.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+.+..++|+||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ |+|+||
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl 130 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDI 130 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5788999999999999999999999999999999999875 345889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCc-cccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
+|+||+++.++.++|+|||+++.......... .....|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 131 ~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 210 (263)
T cd06625 131 KGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210 (263)
T ss_pred CHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence 99999999999999999999875432211111 12345788999999999989999999999999999999999998653
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..... .. . .. ........+......+.+++..||..+|.+||++.++++.
T Consensus 211 ~~~~~--~~-~---~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 211 EAMAA--IF-K---IA----------TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred chHHH--HH-H---Hh----------ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 22110 00 0 00 0000111222334568899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=264.49 Aligned_cols=208 Identities=27% Similarity=0.389 Sum_probs=162.4
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
|.++ +||||+++++++.+++..++||||+++++|.++++.... ....+++.+++.++.|++.||+||
T Consensus 61 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 140 (303)
T cd05088 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 140 (303)
T ss_pred HHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence 4567 899999999999999999999999999999999975321 123589999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ |+||||||+|||++.++.++|+|||+++..... .......++..|+|||++....++.++|||||||+++
T Consensus 141 H~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 214 (303)
T cd05088 141 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 214 (303)
T ss_pred HhCC---ccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHH
Confidence 9999 999999999999999999999999998632111 1111123456799999998888999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||+| |..||....... ...... ... ....+......+.+|+.+|++.+|.+||++.++++.|
T Consensus 215 ellt~g~~p~~~~~~~~---~~~~~~----------~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l 277 (303)
T cd05088 215 EIVSLGGTPYCGMTCAE---LYEKLP----------QGY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 277 (303)
T ss_pred HHHhcCCCCcccCChHH---HHHHHh----------cCC----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9998 999986543211 111000 000 0001112234678999999999999999999999999
Q ss_pred Hhhhc
Q 020529 228 SYLAN 232 (325)
Q Consensus 228 ~~~~~ 232 (325)
..+..
T Consensus 278 ~~~~~ 282 (303)
T cd05088 278 NRMLE 282 (303)
T ss_pred HHHHH
Confidence 87654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=257.75 Aligned_cols=204 Identities=26% Similarity=0.429 Sum_probs=161.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.+.||||+++++++. .+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 50 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di 121 (257)
T cd05060 50 MAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDL 121 (257)
T ss_pred HHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCc
Confidence 56789999999999876 4567999999999999999975 336899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCc-cccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
||+||+++.++.++|+|||+++.......... .....++..|+|||.+....++.++||||||+++++|++ |..||..
T Consensus 122 ~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred ccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 99999999999999999999976533322111 112224567999999999999999999999999999998 9999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
.... .+..+..... .. ..+......+.+++.+|+..+|++||++.+|++.|..+
T Consensus 202 ~~~~---~~~~~~~~~~-------~~-------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 202 MKGA---EVIAMLESGE-------RL-------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCHH---HHHHHHHcCC-------cC-------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 4321 1222211100 00 01112335788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=272.51 Aligned_cols=202 Identities=23% Similarity=0.293 Sum_probs=155.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||++++++|.+++..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+|||
T Consensus 54 il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrD 126 (382)
T cd05625 54 ILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRD 126 (382)
T ss_pred HHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 36788999999999999999999999999999999999975 346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCC---------------------------------------------CCccc
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDK---------------------------------------------SHVST 115 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~---------------------------------------------~~~~~ 115 (325)
|||+|||++.++.+||+|||++........ .....
T Consensus 127 lKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (382)
T cd05625 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH 206 (382)
T ss_pred CCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccc
Confidence 999999999999999999999753210000 00012
Q ss_pred cccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcc-hhhhhhhhccccccccccccCCccCCCC
Q 020529 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWARPLFNDRRKFSKLADPRLEGRY 194 (325)
Q Consensus 116 ~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 194 (325)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....+.... .+..|.. ....+.
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~----------~~~~p~----- 271 (382)
T cd05625 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT----------SLHIPP----- 271 (382)
T ss_pred ccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCC----------CcCCCC-----
Confidence 346999999999999999999999999999999999999999765432111 1111100 000000
Q ss_pred ChHHHHHHHHHHHHchhhCCCCCCC---HHHHHH
Q 020529 195 PIRGLYQALAVASMCIQEQAATRPL---IGDVVT 225 (325)
Q Consensus 195 ~~~~~~~~~~l~~~cl~~~p~~RPs---~~evl~ 225 (325)
.......+.+++.+|+ .+|.+|++ +.+++.
T Consensus 272 ~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 272 QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 0112345667777765 59999997 777765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=259.25 Aligned_cols=206 Identities=26% Similarity=0.413 Sum_probs=162.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+.+..++||||+++++|.+++.. ....+++.+++.++.+++.||.|||+.+ ++|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl 133 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDL 133 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccc
Confidence 5788999999999999999999999999999999999965 2356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCc-cccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
||+||+++.++.++|+|||++........... ......++.|+|||++....++.++|||||||++|||++ |..||..
T Consensus 134 kp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~ 213 (268)
T cd05063 134 AARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD 213 (268)
T ss_pred chhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999875433221111 111223457999999998889999999999999999997 9999865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
..... +. ..+. ... ..+ .+......+.+++.+|++.+|++||++.+|++.|..+
T Consensus 214 ~~~~~---~~---~~i~-~~~-----~~~-----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 214 MSNHE---VM---KAIN-DGF-----RLP-----APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCHHH---HH---HHHh-cCC-----CCC-----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 43211 11 1111 000 000 1112235678999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=274.77 Aligned_cols=198 Identities=26% Similarity=0.426 Sum_probs=161.9
Q ss_pred CcCCCCCCCccceeeEEEeCC--eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
||+.|+||||+++|.++.+.. ...+|+|.+..|+|..|+.+ .+.++...+..|+.||++||.|||++. |||||
T Consensus 94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIH 168 (632)
T KOG0584|consen 94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIH 168 (632)
T ss_pred HHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccc
Confidence 588999999999999998765 47899999999999999987 556889999999999999999999986 78999
Q ss_pred CCCCCCcEEEcCC-CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 79 RDFKSSNILLEEG-FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 79 rdik~~Nill~~~-~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||||.+||||+.+ |.|||+|+|||.+.. ..+.. .+.|||.|||||+.. ..|.+..||||||++++||+|+..|+
T Consensus 169 RDLKCDNIFinG~~G~VKIGDLGLAtl~r---~s~ak-svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPY 243 (632)
T KOG0584|consen 169 RDLKCDNIFVNGNLGEVKIGDLGLATLLR---KSHAK-SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPY 243 (632)
T ss_pred cccccceEEEcCCcCceeecchhHHHHhh---ccccc-eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCCh
Confidence 9999999999755 799999999997632 23333 388999999999876 78999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhcccc--ccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFND--RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....... +..+.+... +..+..+-|| ++.+||.+||.. ..+||++.|+|+.
T Consensus 244 sEC~n~A-----QIYKKV~SGiKP~sl~kV~dP------------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 244 SECTNPA-----QIYKKVTSGIKPAALSKVKDP------------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hhhCCHH-----HHHHHHHcCCCHHHhhccCCH------------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 7654321 111222211 1223444444 567999999999 9999999999874
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=259.73 Aligned_cols=196 Identities=24% Similarity=0.413 Sum_probs=155.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++..+...++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dl 126 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNV 126 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 56789999999999999989999999999999999999762 335899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCe--------EEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHh
Q 020529 82 KSSNILLEEGFH--------PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 82 k~~Nill~~~~~--------~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~ellt 152 (325)
||+||+++.++. ++|+|||++.... ......++..|+|||++.+. .++.++||||||+++|||++
T Consensus 127 kp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~ 200 (258)
T cd05078 127 CAKNVLLIREEDRKTGNPPFIKLSDPGISITVL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200 (258)
T ss_pred ccceEEEecccccccCCCceEEecccccccccC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHc
Confidence 999999987764 6899999886432 12234578889999999874 57999999999999999999
Q ss_pred CC-CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 153 GR-KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 153 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
|. .|+....+..... ..... ..++.....++.+|+.+||+.+|++||++.++++.|+
T Consensus 201 g~~~~~~~~~~~~~~~-------~~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 201 GGDKPLSALDSQKKLQ-------FYEDR------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCCChhhccHHHHHH-------HHHcc------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 94 5554332211100 00000 1122223356889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=260.11 Aligned_cols=211 Identities=26% Similarity=0.351 Sum_probs=157.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++.++||||+++++++.+....++||||+++++|.+++...+.. ...+++...+.++.|++.||+|||+.+ |+|||
T Consensus 49 ~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 125 (269)
T cd05042 49 YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSD 125 (269)
T ss_pred HHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---Eeccc
Confidence 46789999999999999999999999999999999999764332 234578888999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-------CCCCccccEEEehHHHHHHHh-
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-------GQLTVKSDVYSFGVVFLELIT- 152 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ksDvwSlGvvl~ellt- 152 (325)
|||+|||++.++.+||+|||++................++..|+|||++.. ..++.++|||||||++|||++
T Consensus 126 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (269)
T cd05042 126 LALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTA 205 (269)
T ss_pred ccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhC
Confidence 999999999999999999999865332221112233445678999998753 356889999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
|..||........ +. ..... .......+.+. ......+..++..|+ .+|.+||++++|++.|.
T Consensus 206 ~~~p~~~~~~~~~--~~----~~~~~--~~~~~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 206 ADQPYPDLSDEQV--LK----QVVRE--QDIKLPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCCCcCCHHHH--HH----HHhhc--cCccCCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 7788865432110 00 00100 01122222222 123345667888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=280.77 Aligned_cols=217 Identities=23% Similarity=0.300 Sum_probs=159.0
Q ss_pred CcCCCCCCCccceeeEEEeC--------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 020529 1 MLSLLHHSNLVNLIGYCADG--------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 72 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~ 72 (325)
+|+.++||||+++++++... ...++||||++ ++|.+++.........+++..++.++.|++.||+|||+.+
T Consensus 112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~ 190 (440)
T PTZ00036 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF 190 (440)
T ss_pred HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 46788999999999887432 24679999997 6888877654334567999999999999999999999999
Q ss_pred CCCeEeCCCCCCcEEEcCCC-eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHH
Q 020529 73 NPPVIYRDFKSSNILLEEGF-HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~-~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~el 150 (325)
|+||||||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||
T Consensus 191 ---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el 264 (440)
T PTZ00036 191 ---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEM 264 (440)
T ss_pred ---EecCCcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999998665 79999999997543222 22345689999999998764 689999999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhcccc--------c-----cccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCC
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFND--------R-----RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR 217 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~-----~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R 217 (325)
++|.+||........ +.......-.. . ..+.......+...++.....++.+|+.+||+.+|.+|
T Consensus 265 ltG~~pf~~~~~~~~--~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R 342 (440)
T PTZ00036 265 ILGYPIFSGQSSVDQ--LVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342 (440)
T ss_pred HhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHC
Confidence 999999976543211 11111000000 0 00011111112222233344678999999999999999
Q ss_pred CCHHHHHHH
Q 020529 218 PLIGDVVTA 226 (325)
Q Consensus 218 Ps~~evl~~ 226 (325)
|++.++++.
T Consensus 343 ~ta~e~l~h 351 (440)
T PTZ00036 343 LNPIEALAD 351 (440)
T ss_pred cCHHHHhCC
Confidence 999999865
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=255.54 Aligned_cols=203 Identities=26% Similarity=0.383 Sum_probs=161.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++......++||||+++++|.+++.. ....+++.+++.++.+++.||.|||+.+ ++|+||
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl 119 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDL 119 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccc
Confidence 5678999999999999999999999999999999999865 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||++....... ........+++.|+|||++.+..++.++||||||+++|++++ |..||...
T Consensus 120 ~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 120 AARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred ChheEEEcCCCeEEECCCccceeccccc-cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999986532211 111122234667999999998899999999999999999998 99998654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
..... ..... .. .....+......+.+++.+|+..+|++||++.++++.|.
T Consensus 199 ~~~~~---~~~~~----~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 199 TNQQA---REQVE----KG----------YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHH---HHHHH----cC----------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 32211 10000 00 001112223467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=262.62 Aligned_cols=207 Identities=25% Similarity=0.440 Sum_probs=161.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------------CCCCCCHHHHHHHHHHHHH
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------------DKEALDWNTRMKIAAGAAK 63 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------~~~~l~~~~~~~i~~~l~~ 63 (325)
+++++||||+++++++.++...++||||+++++|.+++..... ....+++..++.++.+++.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 5678999999999999999999999999999999999975321 1235789999999999999
Q ss_pred HHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEe
Q 020529 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSF 143 (325)
Q Consensus 64 al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSl 143 (325)
||+|||+.+ ++||||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|||||
T Consensus 142 aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (288)
T cd05050 142 GMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAY 218 (288)
T ss_pred HHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHH
Confidence 999999999 99999999999999999999999999875432222122222334667999999998999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHH
Q 020529 144 GVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGD 222 (325)
Q Consensus 144 Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e 222 (325)
||++|||++ |..||....... ..... . ... .. ..+......+.+|+.+||+.+|.+||++.|
T Consensus 219 G~il~el~~~~~~p~~~~~~~~---~~~~~---~-~~~-~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 219 GVVLWEIFSYGMQPYYGMAHEE---VIYYV---R-DGN-VL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCHHH---HHHHH---h-cCC-CC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 999999997 888885443211 11110 0 000 00 111223457889999999999999999999
Q ss_pred HHHHHH
Q 020529 223 VVTALS 228 (325)
Q Consensus 223 vl~~L~ 228 (325)
|++.|+
T Consensus 282 l~~~l~ 287 (288)
T cd05050 282 INRILQ 287 (288)
T ss_pred HHHHhh
Confidence 999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=259.26 Aligned_cols=207 Identities=29% Similarity=0.433 Sum_probs=164.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.. ...++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 63 l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di 135 (279)
T cd05057 63 MASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDL 135 (279)
T ss_pred HHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeccc
Confidence 567899999999999987 788999999999999999975 2345899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||+++...............++..|+|||.+....++.++||||||++++|+++ |+.||...
T Consensus 136 ~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 136 AARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred CcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999986543322222222234567999999988889999999999999999998 99999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.... +.... .. . ... ..+......+.+++.+||..+|+.||++.++++.|..+..
T Consensus 216 ~~~~---~~~~~---~~-~---~~~-------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 216 PAVE---IPDLL---EK-G---ERL-------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CHHH---HHHHH---hC-C---CCC-------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 3221 11111 10 0 000 0111223467899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=256.36 Aligned_cols=209 Identities=22% Similarity=0.309 Sum_probs=167.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++|+||+++++++...+..++||||+++++|..++.........+++..++.++.+++.||+|||+.+ |+|+||
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl 132 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDI 132 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCc
Confidence 57889999999999999999999999999999999998765444566899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||+++...... .......++..|+|||++.+..++.++||||||+++++|++|..||....
T Consensus 133 ~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08224 133 KPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred ChhhEEECCCCcEEEeccceeeeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC
Confidence 9999999999999999999987543221 11233458889999999998889999999999999999999999986432
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCCh-HHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPI-RGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
. ........... .... ..+. .....+.+++.+||..+|.+||++.+|++.|..+
T Consensus 211 ~----~~~~~~~~~~~------~~~~-----~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 211 M----NLYSLCKKIEK------CDYP-----PLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred c----cHHHHHhhhhc------CCCC-----CCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 11111111110 0001 1111 2345788999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=258.64 Aligned_cols=196 Identities=22% Similarity=0.389 Sum_probs=154.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++......++||||+++++|..++.. ....+++..++.++.|++.||+|||+.+ |+||||
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dl 131 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNV 131 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCC
Confidence 5678999999999999999999999999999999998864 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCe-------EEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-cCCCCccccEEEehHHHHHHH-h
Q 020529 82 KSSNILLEEGFH-------PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELI-T 152 (325)
Q Consensus 82 k~~Nill~~~~~-------~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvvl~ell-t 152 (325)
||+|||++.++. ++++|||++..... .....++..|+|||++. +..++.++|||||||++|||+ +
T Consensus 132 kp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~ 205 (262)
T cd05077 132 CTKNILLAREGIDGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYN 205 (262)
T ss_pred CcccEEEecCCccCCCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhC
Confidence 999999987654 89999999864321 12345788899999886 467899999999999999998 5
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
|..|+..........+ ... . ... .......+.+|+.+||+.+|.+||++.+|++.|+
T Consensus 206 ~~~p~~~~~~~~~~~~-------~~~--~-~~~---------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 206 GEIPLKDKTLAEKERF-------YEG--Q-CML---------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCCCCCCcchhHHHHH-------Hhc--C-ccC---------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 7888764322111000 000 0 000 0112356789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=257.72 Aligned_cols=206 Identities=23% Similarity=0.391 Sum_probs=161.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.++...++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++|+||
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl 132 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDL 132 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeeccc
Confidence 56789999999999999999999999999999999998752 345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCcccccc---CCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM---GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAI 157 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~ 157 (325)
||+||+++.++.++|+|||+++............... .+..|+|||++.+..++.++|||||||+++|+++ |..||
T Consensus 133 ~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~ 212 (269)
T cd05065 133 AARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212 (269)
T ss_pred ChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCC
Confidence 9999999999999999999987543322111111111 2357999999999999999999999999999886 99998
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
...... ....+..... ... .+......+.+++..|++.+|.+||++.+|+..|+.+
T Consensus 213 ~~~~~~---~~~~~i~~~~----------~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 213 WDMSNQ---DVINAIEQDY----------RLP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCHH---HHHHHHHcCC----------cCC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 654321 1222211100 000 0112234678999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=256.52 Aligned_cols=205 Identities=28% Similarity=0.424 Sum_probs=163.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+ ...++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||
T Consensus 50 l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di 123 (257)
T cd05040 50 MHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDL 123 (257)
T ss_pred HhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---cccccc
Confidence 678999999999999988 889999999999999999976322 46899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCC-ccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
||+||+++.++.+||+|||+++......... ......++..|+|||++....++.++|||||||++++|++ |+.||..
T Consensus 124 ~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 124 AARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred CcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998654432211 1223457788999999998899999999999999999998 9999865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
..... +. ....... ... ..+......+.+++..|++.+|.+||++.+|++.|.
T Consensus 204 ~~~~~---~~---~~~~~~~---~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 204 LSGSQ---IL---KKIDKEG---ERL-------ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHH---HH---HHHHhcC---CcC-------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 43221 11 1111000 000 011123457889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=282.45 Aligned_cols=205 Identities=22% Similarity=0.258 Sum_probs=163.2
Q ss_pred cCCCCCCCccceeeEEEeCC--------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGD--------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
|..++|+||+++...+...+ ..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+
T Consensus 85 l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~- 163 (496)
T PTZ00283 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH- 163 (496)
T ss_pred HhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45779999999988765432 368999999999999999765444567999999999999999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhC
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg 153 (325)
|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 164 --IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 164 --MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred --EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999999999999999999999765433323334456799999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 154 RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+.||...... ......... ..+ ..+......+.+++.+||+.+|.+||++.+++..
T Consensus 242 ~~Pf~~~~~~------~~~~~~~~~------~~~-----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 242 KRPFDGENME------EVMHKTLAG------RYD-----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCCCCCHH------HHHHHHhcC------CCC-----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 9999754321 111111110 011 1122334578899999999999999999999864
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=259.97 Aligned_cols=195 Identities=24% Similarity=0.410 Sum_probs=154.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||++++++|.+....++||||+++++|..++.. ....+++..++.++.|++.||+|||+++ |+||||
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dl 143 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNV 143 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCC
Confidence 5788999999999999999999999999999999999865 2456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCC-------eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHH-h
Q 020529 82 KSSNILLEEGF-------HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELI-T 152 (325)
Q Consensus 82 k~~Nill~~~~-------~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~ell-t 152 (325)
||+||+++..+ .++|+|||++...... ....++..|+|||.+.. ..++.++||||||+++|||+ +
T Consensus 144 kp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~ 217 (274)
T cd05076 144 CAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFD 217 (274)
T ss_pred CcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999997643 4899999987542211 12346788999998865 56899999999999999995 7
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
|..||....+...... +..... .+......+.+++.+||+.+|.+||++.+|++.|
T Consensus 218 g~~p~~~~~~~~~~~~-------~~~~~~------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 218 GEVPLKERTPSEKERF-------YEKKHR------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCCCccccChHHHHHH-------HHhccC------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 8998876433221111 000000 0111123678999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=269.78 Aligned_cols=202 Identities=20% Similarity=0.284 Sum_probs=156.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++.+++..|+||||+++|+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDL 168 (370)
T cd05621 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDV 168 (370)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 5678999999999999999999999999999999999964 34889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC----CCccccEEEehHHHHHHHhCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ----LTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||+|||++.++.+||+|||++....... ........||+.|+|||++.+.. ++.++|||||||++|||++|+.||
T Consensus 169 Kp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf 247 (370)
T cd05621 169 KPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247 (370)
T ss_pred CHHHEEECCCCCEEEEecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence 9999999999999999999997643221 11223467999999999987643 788999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCC--CCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPs~~evl~~ 226 (325)
........ ...+......+ .. + ........+.+++..||..++.. ||++.++++.
T Consensus 248 ~~~~~~~~------~~~i~~~~~~~-~~--p-----~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 248 YADSLVGT------YSKIMDHKNSL-NF--P-----EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCCHHHH------HHHHHhCCccc-CC--C-----CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 75432111 11111100000 00 0 01122456778899999755543 8999999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=269.35 Aligned_cols=153 Identities=27% Similarity=0.354 Sum_probs=134.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||
T Consensus 55 l~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDl 127 (363)
T cd05628 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDI 127 (363)
T ss_pred HHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCC
Confidence 5678999999999999999999999999999999999975 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCC---------------------------------CccccccCCcCccCchh
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKS---------------------------------HVSTRVMGTYGYCAPEY 128 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~ 128 (325)
||+|||++.++.+||+|||+++........ .......||+.|+|||+
T Consensus 128 Kp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~ 207 (363)
T cd05628 128 KPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEV 207 (363)
T ss_pred CHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHH
Confidence 999999999999999999998753221100 00123579999999999
Q ss_pred hccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 129 AMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 129 ~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+.+..++.++|||||||++|||++|+.||....
T Consensus 208 ~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 208 FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred HcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=257.40 Aligned_cols=206 Identities=23% Similarity=0.371 Sum_probs=162.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++..++..++||||+++++|.+++.. ....+++.+++.++.+++.||+|||+.+ ++||||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dl 132 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDL 132 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeehhh
Confidence 5678999999999999999999999999999999999975 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCc-cccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
||+||+++.++.++|+|||++........... .....++..|+|||++.+..++.++||||||++++|+++ |..||..
T Consensus 133 kp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 133 AARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred chhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 99999999999999999999976543221111 111223567999999998899999999999999999886 9999865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
..... ....... ... . ..+......+.+++.+|++.+|.+||++.+|++.|..+
T Consensus 213 ~~~~~---~~~~~~~----~~~------~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 213 MSNQD---VIKAIEE----GYR------L----PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCHHH---HHHHHhC----CCc------C----CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 43221 1111110 000 0 00112235678999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=255.16 Aligned_cols=205 Identities=26% Similarity=0.387 Sum_probs=161.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++++++||||+++++++.+....++||||+++++|.+++.. ....+++..++.++.+++.||+|||+.+ ++|||
T Consensus 45 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~d 118 (251)
T cd05041 45 ILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118 (251)
T ss_pred HHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eehhh
Confidence 36788999999999999999999999999999999999965 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++++|++ |..||..
T Consensus 119 i~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred cCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 999999999999999999999975432211111122234567999999998899999999999999999999 7888865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
.......... .. . .....+......+.+++.+|+..+|.+||++.||++.|.
T Consensus 199 ~~~~~~~~~~---~~----~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 199 MSNQQTRERI---ES----G----------YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHH---hc----C----------CCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4322111110 00 0 000112223457889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=271.30 Aligned_cols=199 Identities=25% Similarity=0.355 Sum_probs=153.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||+++++++...+..++||||+++++|.... .+.+..+..++.|++.||+|||+.+ |+|||
T Consensus 125 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 193 (353)
T PLN00034 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRD 193 (353)
T ss_pred HHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecC
Confidence 367889999999999999999999999999999986432 3567788999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-----CCCCccccEEEehHHHHHHHhCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||+|||++.++.+||+|||+++..... ........||..|+|||++.. ...+.++|||||||++|||++|+.
T Consensus 194 lkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~ 271 (353)
T PLN00034 194 IKPSNLLINSAKNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF 271 (353)
T ss_pred CCHHHEEEcCCCCEEEcccccceecccc--cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999754322 112234568999999998743 234568999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
||..........+.. .... ...+ ..+......+.+|+.+||+.+|.+||++.||++.
T Consensus 272 pf~~~~~~~~~~~~~---~~~~-------~~~~----~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 272 PFGVGRQGDWASLMC---AICM-------SQPP----EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCCCCccHHHHHH---HHhc-------cCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 997432211111110 0000 0000 1112234578899999999999999999999874
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=255.33 Aligned_cols=202 Identities=28% Similarity=0.377 Sum_probs=158.9
Q ss_pred CcCCCCCCCccceeeEEE-eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++||||+++++++. .+...++||||+++++|.+++... ....+++..++.++.+++.||+|||+.+ ++||
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 126 (256)
T cd05082 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126 (256)
T ss_pred HHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eecc
Confidence 367889999999999764 456789999999999999998752 2235899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~ 158 (325)
||||+||+++.++.+||+|||+++..... .....++..|+|||++....++.++|||||||++|+|++ |+.||.
T Consensus 127 dlkp~nil~~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 127 DLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred ccchheEEEcCCCcEEecCCccceecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998753221 122334567999999998899999999999999999997 898886
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
..... .+...... ...+. .+......+.+++.+|++.+|.+||++.++++.|+.
T Consensus 202 ~~~~~---~~~~~~~~----------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 202 RIPLK---DVVPRVEK----------GYKMD----APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHH---HHHHHHhc----------CCCCC----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 43211 11111100 00011 111234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=255.46 Aligned_cols=207 Identities=26% Similarity=0.389 Sum_probs=158.3
Q ss_pred cCCCCCCCccceeeEEE-eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++.++||||+++++++. .+...++||||+.+++|.+++... ...+++..++.++.+++.||+|||+.+ ++|||
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 123 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRD 123 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 67889999999999875 455689999999999999999752 334678888999999999999999998 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCC--CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhC-CCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG-RKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg-~~p~ 157 (325)
|||+|||++.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||+++||++| .+||
T Consensus 124 lk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 203 (262)
T cd05058 124 LAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 203 (262)
T ss_pred cCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999998753321110 111233467789999999988999999999999999999995 5566
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
...... .+... .... . .+.. +...+..+.+++..||+.+|++||++.+|++.|+.+.
T Consensus 204 ~~~~~~---~~~~~---~~~~----~---~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 204 PDVDSF---DITVY---LLQG----R---RLLQ----PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCHH---HHHHH---HhcC----C---CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 543211 11111 1100 0 0000 1112346889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=255.04 Aligned_cols=195 Identities=26% Similarity=0.454 Sum_probs=156.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.. ...++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+|||
T Consensus 54 ~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~d 126 (259)
T cd05037 54 LMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGN 126 (259)
T ss_pred HHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeccc
Confidence 3678899999999999988 7789999999999999999762 226899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC-------eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC--CCCccccEEEehHHHHHHH
Q 020529 81 FKSSNILLEEGF-------HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELI 151 (325)
Q Consensus 81 ik~~Nill~~~~-------~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~ell 151 (325)
|||+||+++.++ .++|+|||++..... .....++..|+|||++... .++.++||||||+++++|+
T Consensus 127 lkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 127 VCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred CccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 999999999887 799999999875322 2223466789999998876 7899999999999999999
Q ss_pred h-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 152 T-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 152 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
+ |..||........... .. .. ... +......+.+++.+||..+|.+||++.+|++.|
T Consensus 201 ~~~~~p~~~~~~~~~~~~---~~----~~---~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 201 SNGEEPLSTLSSSEKERF---YQ----DQ---HRL---------PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hCCCCCcccCCchhHHHH---Hh----cC---CCC---------CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 9 5777755432211111 00 00 000 111125788999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=260.72 Aligned_cols=204 Identities=25% Similarity=0.345 Sum_probs=161.7
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||+++++.+..++..++||||+.+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|||
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~d 127 (285)
T cd05605 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRD 127 (285)
T ss_pred HHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecC
Confidence 357789999999999999999999999999999999888642 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||++++++.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 128 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 128 LKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred CCHHHEEECCCCCEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 99999999999999999999987543221 123346899999999999889999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
...... ......+.. ....++......+.+|+.+||+.||.+|| ++.++++.
T Consensus 205 ~~~~~~--~~~~~~~~~------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 205 KEKVKR--EEVERRVKE------------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred chhhHH--HHHHHHhhh------------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 321110 000000000 00112223345678999999999999999 78888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.46 Aligned_cols=188 Identities=24% Similarity=0.357 Sum_probs=154.1
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
+||||+++++++.+.+..++||||+++|+|..++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~N 131 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 131 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHH
Confidence 689999999999999999999999999999999865 456899999999999999999999999 9999999999
Q ss_pred EEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCc
Q 020529 86 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 165 (325)
Q Consensus 86 ill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~ 165 (325)
||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 132 ill~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~- 208 (323)
T cd05616 132 VMLDSEGHIKIADFGMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE- 208 (323)
T ss_pred eEECCCCcEEEccCCCceecCCC--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-
Confidence 99999999999999998743221 122334679999999999999999999999999999999999999997643211
Q ss_pred chhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 166 QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
+. ..+.... ..++......+.+++.+||+.+|.+|++.
T Consensus 209 --~~---~~i~~~~------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 209 --LF---QSIMEHN------------VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --HH---HHHHhCC------------CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11 1111110 01222334578899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=254.49 Aligned_cols=201 Identities=22% Similarity=0.307 Sum_probs=161.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++.+++..++||||+++++|.+++... ....+++..++.++.+++.||.|||+.+ |+|+||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl 126 (255)
T cd08219 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDI 126 (255)
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 57789999999999999999999999999999999988642 2345889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++...... ........|++.|+|||++.+..++.++|+||||+++++|++|..||....
T Consensus 127 ~p~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 127 KSKNIFLTQNGKVKLGDFGSARLLTSP--GAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred CcceEEECCCCcEEEcccCcceeeccc--ccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 999999999999999999998754322 122234568899999999999899999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... ....... . ..+ .+......+.+++.+||+.+|.+||++.+|+..
T Consensus 205 ~~~~------~~~~~~~--~----~~~-----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 205 WKNL------ILKVCQG--S----YKP-----LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHH------HHHHhcC--C----CCC-----CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 2110 0010000 0 000 111223467899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=263.31 Aligned_cols=194 Identities=23% Similarity=0.266 Sum_probs=153.7
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
.||||+++++++.+....|+||||+.+++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~N 126 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPEN 126 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHH
Confidence 799999999999999999999999999999999865 456899999999999999999999999 9999999999
Q ss_pred EEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 86 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 86 ill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
||++.++.++|+|||+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.......
T Consensus 127 ili~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~ 204 (330)
T cd05586 127 ILLDATGHIALCDFGLSKANLTD--NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ 204 (330)
T ss_pred eEECCCCCEEEecCCcCcCCCCC--CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH
Confidence 99999999999999998753222 1223446799999999998765 47999999999999999999999996543211
Q ss_pred cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC----CHHHHHH
Q 020529 165 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP----LIGDVVT 225 (325)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP----s~~evl~ 225 (325)
. ...+..... .+... .....+.+++.+||+.+|.+|| ++.++++
T Consensus 205 ~------~~~i~~~~~---~~~~~--------~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 205 M------YRNIAFGKV---RFPKN--------VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred H------HHHHHcCCC---CCCCc--------cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1 111111000 00000 1234677899999999999998 4666655
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=257.88 Aligned_cols=213 Identities=25% Similarity=0.433 Sum_probs=161.6
Q ss_pred CcCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
+|+.++||||+++++++.+. ...++||||+++++|.+++.. ....+++.+++.++.+++.||+|||+.+ ++|
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H 132 (284)
T cd05079 59 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVH 132 (284)
T ss_pred HHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 36788999999999998775 568999999999999999865 2345899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||||+||+++.++.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|||+++..|.
T Consensus 133 ~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 133 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 999999999999999999999999764332211 1122345677899999998888999999999999999999987654
Q ss_pred CCCCCC---------CcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 158 DSTRPH---------GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 158 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
...... .......+.. ..... .....+......+.+|+.+||+.+|.+||++.+|++.|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 281 (284)
T cd05079 213 SSPMTLFLKMIGPTHGQMTVTRLVR-VLEEG----------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE 281 (284)
T ss_pred ccccchhhhhcccccccccHHHHHH-HHHcC----------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence 321100 0000000000 00000 000111233467899999999999999999999999987
Q ss_pred hh
Q 020529 229 YL 230 (325)
Q Consensus 229 ~~ 230 (325)
.+
T Consensus 282 ~~ 283 (284)
T cd05079 282 AI 283 (284)
T ss_pred hh
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=254.10 Aligned_cols=218 Identities=25% Similarity=0.344 Sum_probs=165.0
Q ss_pred CcCCCCCCC-ccceeeEEEeCC------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 1 MLSLLHHSN-LVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 1 iL~~l~Hpn-iv~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
+|+.|+|+| ||.+++++...+ ..+|||||++ -+|..++...+.....++...+..++.|++.||+|||+++
T Consensus 63 llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~- 140 (323)
T KOG0594|consen 63 LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG- 140 (323)
T ss_pred HHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 477899999 999999998877 7889999996 8999999886543356888999999999999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHh
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~ellt 152 (325)
|+||||||.|||++++|.+||+|||+|+....... ..+...+|.+|+|||++.+. .|+...||||+||++.||++
T Consensus 141 --IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~ 216 (323)
T KOG0594|consen 141 --ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT 216 (323)
T ss_pred --eecccCCcceEEECCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh
Confidence 99999999999999999999999999986543332 24456689999999999987 79999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccc-ccccc---ccCCc--cCCCC-Ch-------HHHHHHHHHHHHchhhCCCCCC
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDR-RKFSK---LADPR--LEGRY-PI-------RGLYQALAVASMCIQEQAATRP 218 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~---~~d~~--l~~~~-~~-------~~~~~~~~l~~~cl~~~p~~RP 218 (325)
+++-|.+...... +....+.+-... ...+. +.+-. ..... +. .......+++.+||+.+|..|.
T Consensus 217 ~~~LFpG~se~~q--l~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~ 294 (323)
T KOG0594|consen 217 RRPLFPGDSEIDQ--LFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRI 294 (323)
T ss_pred CCCCCCCCcHHHH--HHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCc
Confidence 9988877554221 111110000000 00000 00000 00000 00 1113678999999999999999
Q ss_pred CHHHHHHH
Q 020529 219 LIGDVVTA 226 (325)
Q Consensus 219 s~~evl~~ 226 (325)
|+..++..
T Consensus 295 Sa~~al~h 302 (323)
T KOG0594|consen 295 SAKGALTH 302 (323)
T ss_pred CHHHHhcC
Confidence 99999986
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=271.12 Aligned_cols=211 Identities=26% Similarity=0.391 Sum_probs=164.2
Q ss_pred cCCCC-CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------------------------------
Q 020529 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------------------------------ 44 (325)
Q Consensus 2 L~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------ 44 (325)
|.++. ||||++++++|......++||||+++|+|.++++....
T Consensus 94 l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (401)
T cd05107 94 MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173 (401)
T ss_pred HHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhc
Confidence 55676 99999999999999999999999999999999975321
Q ss_pred ----------------------------------------------------------CCCCCCHHHHHHHHHHHHHHHH
Q 020529 45 ----------------------------------------------------------DKEALDWNTRMKIAAGAAKGLE 66 (325)
Q Consensus 45 ----------------------------------------------------------~~~~l~~~~~~~i~~~l~~al~ 66 (325)
....+++..++.++.+++.||+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 253 (401)
T cd05107 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGME 253 (401)
T ss_pred cCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 1134778889999999999999
Q ss_pred HHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHH
Q 020529 67 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146 (325)
Q Consensus 67 ~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvv 146 (325)
|||+.+ |+||||||+|||++.++.++|+|||+++...............+++.|+|||++....++.++|||||||+
T Consensus 254 ~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvi 330 (401)
T cd05107 254 FLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGIL 330 (401)
T ss_pred HHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHH
Confidence 999998 99999999999999999999999999975433222122223456788999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 147 FLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 147 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
++||++ |..||........ +. ..+.. ......+......+.+|+.+|+..+|..||++.+|++
T Consensus 331 l~e~l~~g~~P~~~~~~~~~--~~----~~~~~----------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 331 LWEIFTLGGTPYPELPMNEQ--FY----NAIKR----------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred HHHHHHcCCCCCCCCCchHH--HH----HHHHc----------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 8888865422110 00 00000 0000112223467889999999999999999999999
Q ss_pred HHHhhh
Q 020529 226 ALSYLA 231 (325)
Q Consensus 226 ~L~~~~ 231 (325)
.|+.+.
T Consensus 395 ~L~~~~ 400 (401)
T cd05107 395 LVGDLL 400 (401)
T ss_pred HHHHHh
Confidence 998753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=261.85 Aligned_cols=208 Identities=27% Similarity=0.431 Sum_probs=163.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||++++++|... ..++++||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+|+||
T Consensus 63 ~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~di 135 (303)
T cd05110 63 MASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDL 135 (303)
T ss_pred HHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eecccc
Confidence 5678999999999998754 56799999999999999875 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 136 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 136 AARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred ccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986543322222223345678999999998999999999999999999997 88888654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
... .+..+.. .... ... +......+..++..|+..+|.+||++.+|++.|..+...
T Consensus 216 ~~~---~~~~~~~----~~~~---~~~-------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 216 PTR---EIPDLLE----KGER---LPQ-------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CHH---HHHHHHH----CCCC---CCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 221 1111111 1100 000 111234678999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=254.73 Aligned_cols=205 Identities=29% Similarity=0.430 Sum_probs=160.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++. ....++||||+++++|.+++... ....+++.+++.++.+++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~d 127 (260)
T cd05070 54 IMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127 (260)
T ss_pred HHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 367899999999999885 45679999999999999999752 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++++|++ |..||..
T Consensus 128 i~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 128 LRSANILVGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred CccceEEEeCCceEEeCCceeeeeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999975432221 11122335668999999988899999999999999999999 8899865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
.... ........ . .....+......+.+|+.+|+..+|.+||++.++++.|+.
T Consensus 207 ~~~~---~~~~~~~~----~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 207 MNNR---EVLEQVER----G----------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCHH---HHHHHHHc----C----------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 4321 11111100 0 0001122334578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=258.50 Aligned_cols=222 Identities=27% Similarity=0.360 Sum_probs=159.2
Q ss_pred cCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++.. ....++||||+++++|.+++.. ....+++..++.++.+++.||+|||+.+ |+||
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~ 132 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHR 132 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 578899999999998754 3468999999999999999965 2345899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCc-cccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.++|+|||++........... .....++..|+|||++.+..++.++||||||++++||++|..++.
T Consensus 133 dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 133 DLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 9999999999999999999999986543322111 111223446999999998899999999999999999999877653
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
.....-...+......... ...+...+........+......+.+|+.+|+..+|++|||+.+|++.|+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 213 SPPAEFMRMMGNDKQGQMI-VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred Ccchhhhhhcccccccccc-hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 3211000000000000000 0000000000000011122345788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=254.26 Aligned_cols=205 Identities=28% Similarity=0.406 Sum_probs=161.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++|||++++++++. .+..++||||+.+++|.+++... ....+++..++.++.+++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~d 127 (260)
T cd05069 54 IMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127 (260)
T ss_pred HHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---Eeecc
Confidence 367889999999999875 45689999999999999999752 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 128 l~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 128 LRAANILVGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cCcceEEEcCCCeEEECCCccceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999975432221 11222346678999999998899999999999999999999 8999865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
..... ...+... . ..+ ..+......+.+++.+||..+|.+||++.+|++.|+.
T Consensus 207 ~~~~~---~~~~~~~----~------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 207 MVNRE---VLEQVER----G------YRM----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCHHH---HHHHHHc----C------CCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 43211 1111100 0 000 1112334578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=264.60 Aligned_cols=192 Identities=27% Similarity=0.392 Sum_probs=153.3
Q ss_pred cCCCCC-CCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHH-SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~H-pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|..++| ++|+++++++.+.+..|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 54 l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~d 126 (324)
T cd05587 54 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRD 126 (324)
T ss_pred HHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecC
Confidence 345544 5688899999999999999999999999999865 445899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 127 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~ 204 (324)
T cd05587 127 LKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204 (324)
T ss_pred CCHHHeEEcCCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986432221 1233456999999999999999999999999999999999999999754
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
.... +. ..+.... ..++......+.+++.+||+.+|.+|++.
T Consensus 205 ~~~~---~~---~~i~~~~------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 205 DEDE---LF---QSIMEHN------------VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CHHH---HH---HHHHcCC------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 3211 11 1111100 11122234567899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=245.63 Aligned_cols=200 Identities=21% Similarity=0.250 Sum_probs=160.1
Q ss_pred CCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCC
Q 020529 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 82 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik 82 (325)
+.|+|||||++.+.+.+....|||||+|.|++|..-+-. +.-.++..+-..+.||+.+|.|+|.++ |||||+|
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvk 137 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLK 137 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCC
Confidence 468999999999999999999999999999999877654 345788889999999999999999999 9999999
Q ss_pred CCcEEEcC---CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 83 SSNILLEE---GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 83 ~~Nill~~---~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|.|++|-. ..-+||+|||+|.... ....-....|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+
T Consensus 138 P~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 138 PENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred hhheeeeeccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 99999943 3469999999998655 23345567899999999999999999999999999999999999999977
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...... ...+... ..-+++... ........+|+.+||..||.+|.|+.|.++.
T Consensus 215 ~~~~rl------ye~I~~g----~yd~~~~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 215 EDQHRL------YEQIKAG----AYDYPSPEW----DTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ccHHHH------HHHHhcc----ccCCCCccc----CcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 432211 1111111 111111111 1224567899999999999999999998864
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=258.90 Aligned_cols=220 Identities=22% Similarity=0.266 Sum_probs=164.6
Q ss_pred CcCCCCCCCccceeeEEEeCC-----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
||+++.|||||+++-+|.... ...+|||||+ .+|.+.++.+...+..++.-.+.-+.+|+++||+|||+.+
T Consensus 70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--- 145 (364)
T KOG0658|consen 70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--- 145 (364)
T ss_pred HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---
Confidence 477899999999998885432 4579999997 8999999865555677888888999999999999999999
Q ss_pred eEeCCCCCCcEEEcCC-CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhC
Q 020529 76 VIYRDFKSSNILLEEG-FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 76 ivHrdik~~Nill~~~-~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg 153 (325)
|+||||||.|+|+|.+ |.+||||||.|+....+. .+.....|-.|+|||.+.+. .|+.+.||||.|||+.||+.|
T Consensus 146 IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g 222 (364)
T KOG0658|consen 146 ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKG 222 (364)
T ss_pred cccCCCChheEEEcCCCCeEEeccCCcceeeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcC
Confidence 9999999999999977 899999999998754332 33455667889999999876 699999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhhcccc-----------ccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHH
Q 020529 154 RKAIDSTRPHGEQNLVTWARPLFND-----------RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGD 222 (325)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e 222 (325)
++-|.+....+....+--+...-.. ...++.+.......-+......+.++|+.++|+.+|.+|.++.+
T Consensus 223 ~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~ 302 (364)
T KOG0658|consen 223 QPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALE 302 (364)
T ss_pred CcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHH
Confidence 9999875443322211111000000 00111111111111122234567889999999999999999999
Q ss_pred HHHHH
Q 020529 223 VVTAL 227 (325)
Q Consensus 223 vl~~L 227 (325)
++..-
T Consensus 303 ~l~h~ 307 (364)
T KOG0658|consen 303 ALAHP 307 (364)
T ss_pred Hhcch
Confidence 98753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=259.17 Aligned_cols=197 Identities=23% Similarity=0.371 Sum_probs=166.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|++.|+||||+.++.+|+..+...+||||..+|.|.+|+.. +..|++.+...++.||..|+.|+|.++ ++|||
T Consensus 106 IMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRD 178 (668)
T KOG0611|consen 106 IMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRD 178 (668)
T ss_pred HHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecc
Confidence 57899999999999999999999999999999999999976 667999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
||.+|||||.++++||+||||+.++... ...+.++|++-|.+||++.+.+| ++..|-|||||+||-|+.|..||++
T Consensus 179 LKLENILLD~N~NiKIADFGLSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 179 LKLENILLDQNNNIKIADFGLSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred cchhheeecCCCCeeeeccchhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 9999999999999999999999765432 34567899999999999999887 4789999999999999999999987
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..- ..++ +.+-. .....| .......-||.+||-.+|.+|.|+.+|...
T Consensus 256 ~Dh---k~lv---rQIs~-----GaYrEP--------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 256 RDH---KRLV---RQISR-----GAYREP--------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred chH---HHHH---HHhhc-----ccccCC--------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 531 1111 11111 111122 122356689999999999999999999865
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=295.28 Aligned_cols=215 Identities=30% Similarity=0.550 Sum_probs=174.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++|||||+++++|.+.+..++||||+++|+|.++++. ++|..+.+|+.+++.||+|||....++|+||||
T Consensus 737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dl 809 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNL 809 (968)
T ss_pred HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCC
Confidence 5788999999999999999999999999999999999953 899999999999999999999654444999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.+++. |+...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||+...
T Consensus 810 kp~Nil~~~~~~~~~~-~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~ 882 (968)
T PLN00113 810 SPEKIIIDGKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882 (968)
T ss_pred CHHhEEECCCCceEEE-eccccccc------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc
Confidence 9999999999888875 55543221 1122367899999999999999999999999999999999999996543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCC--CChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGR--YPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.....+..|++...... .....+|+.+... .+..+..++.+++.+|++.+|.+||++.+|++.|+.+..
T Consensus 883 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 883 -GVHGSIVEWARYCYSDC-HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred -CCCCcHHHHHHHhcCcc-chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 22345666765544332 2345566665443 334567788999999999999999999999999987754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=255.75 Aligned_cols=215 Identities=24% Similarity=0.339 Sum_probs=164.2
Q ss_pred CcCCCCCCCccceeeEEEe-----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
+|+.++|+||+.+++.+.. -+..|+|+|+| ..+|.+.++. ...|+...+..+++|+++||+|+|+.+
T Consensus 74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn--- 145 (359)
T KOG0660|consen 74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN--- 145 (359)
T ss_pred HHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---
Confidence 4678899999999999865 35789999999 5999999975 455999999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+|+|++.+..+||+|||||+...........+....|-+|.|||++.. ..|+...||||+|||+.||++|+
T Consensus 146 ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk 225 (359)
T KOG0660|consen 146 VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK 225 (359)
T ss_pred ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC
Confidence 99999999999999999999999999997643322233355678999999998765 47999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhh-----------------hhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCC
Q 020529 155 KAIDSTRPHGEQNLVTW-----------------ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR 217 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R 217 (325)
+-|.+........++.- +++.+..-...+.. .+...++ .....+++|+.+||..||.+|
T Consensus 226 plFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~---~f~~~fp-~a~p~AidLlekmL~fdP~kR 301 (359)
T KOG0660|consen 226 PLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQ---PFSSIFP-NANPLAIDLLEKMLVFDPKKR 301 (359)
T ss_pred CCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCC---CHHHHcC-CCCHHHHHHHHHHhccCcccc
Confidence 99977654433222211 11111110000000 0011111 223578899999999999999
Q ss_pred CCHHHHHHHH
Q 020529 218 PLIGDVVTAL 227 (325)
Q Consensus 218 Ps~~evl~~L 227 (325)
+|++|.++.-
T Consensus 302 ita~eAL~hP 311 (359)
T KOG0660|consen 302 ITAEEALAHP 311 (359)
T ss_pred CCHHHHhcCh
Confidence 9999998754
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=262.42 Aligned_cols=218 Identities=19% Similarity=0.207 Sum_probs=157.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||++++++|..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dl 127 (327)
T cd08227 53 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSV 127 (327)
T ss_pred HHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCC
Confidence 567899999999999999999999999999999999986422 235899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCC-----CccccccCCcCccCchhhcc--CCCCccccEEEehHHHHHHHhCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~ 154 (325)
||+||+++.++.++++||+........... .......++..|+|||++.+ ..++.++|||||||+++||++|+
T Consensus 128 kp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~ 207 (327)
T cd08227 128 KASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 207 (327)
T ss_pred ChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCC
Confidence 999999999999999999865432211110 01122346778999999876 45889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhcccc---c-----ccc-----ccccCC-----------------ccCCCCChHHHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFND---R-----RKF-----SKLADP-----------------RLEGRYPIRGLYQALA 204 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~---~-----~~~-----~~~~d~-----------------~l~~~~~~~~~~~~~~ 204 (325)
.||........ ........... . ..+ ....+. .....+.......+.+
T Consensus 208 ~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (327)
T cd08227 208 VPFKDMPATQM--LLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHH 285 (327)
T ss_pred CCCCCcchhHH--HHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHH
Confidence 99975332110 00000000000 0 000 000000 0000011122357889
Q ss_pred HHHHchhhCCCCCCCHHHHHHH
Q 020529 205 VASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 205 l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|+.+||+.||.+|||+.+|++.
T Consensus 286 li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 286 FVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred HHHHHHhhCchhcCCHHHHhcC
Confidence 9999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=252.86 Aligned_cols=204 Identities=26% Similarity=0.347 Sum_probs=162.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+....+++|||+.+++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~d 126 (262)
T cd06613 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRD 126 (262)
T ss_pred HHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecC
Confidence 36788999999999999999999999999999999999875 2356999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC---CCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG---QLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|+|+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++||||||+++++|++|..||
T Consensus 127 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~ 204 (262)
T cd06613 127 IKGANILLTEDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM 204 (262)
T ss_pred CChhhEEECCCCCEEECccccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 99999999999999999999987543221 122345688899999999877 8899999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
....+... ...... .....+.+ ..+......+.+++.+|+..+|..||++.+|+.
T Consensus 205 ~~~~~~~~--~~~~~~---------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 205 FDLHPMRA--LFLISK---------SNFPPPKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCCCHHHH--HHHHHh---------ccCCCccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 76432211 110000 00001111 112233567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=258.66 Aligned_cols=215 Identities=22% Similarity=0.300 Sum_probs=161.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrd 80 (325)
|++++||||++++++|.+++..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+ .+ ++|+|
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~d 125 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRD 125 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECC
Confidence 5678999999999999999999999999999999999975 3568999999999999999999997 47 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||+++.++.++|+|||++...... ......|+..|+|||++.+..++.++||||||+++++|++|+.||...
T Consensus 126 l~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 126 VKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred CChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999998653221 123456889999999998888999999999999999999999998654
Q ss_pred CCCCcchhhhhhhhccccccc----------------cccccCC---ccCCCCCh-HHHHHHHHHHHHchhhCCCCCCCH
Q 020529 161 RPHGEQNLVTWARPLFNDRRK----------------FSKLADP---RLEGRYPI-RGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~----------------~~~~~d~---~l~~~~~~-~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
..................... .....+. ......+. .....+.+++.+||..+|++||++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 281 (308)
T cd06615 202 DAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADL 281 (308)
T ss_pred chhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCH
Confidence 322111111000000000000 0000000 00000010 123468899999999999999999
Q ss_pred HHHHHHH
Q 020529 221 GDVVTAL 227 (325)
Q Consensus 221 ~evl~~L 227 (325)
.+|++..
T Consensus 282 ~~ll~~~ 288 (308)
T cd06615 282 KELTKHP 288 (308)
T ss_pred HHHhcCh
Confidence 9998864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=253.25 Aligned_cols=205 Identities=27% Similarity=0.367 Sum_probs=160.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++. ....++||||+++++|.+++... ....+++..++.++.+++.||+|||+.+ ++|+||
T Consensus 55 l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl 128 (262)
T cd05071 55 MKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 128 (262)
T ss_pred HHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 56789999999999875 45679999999999999999752 2345799999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||+++....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 129 ~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~ 207 (262)
T cd05071 129 RAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207 (262)
T ss_pred CcccEEEcCCCcEEeccCCceeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999975433221 11223346678999999998899999999999999999999 88888654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
..... . ..... . ... ..+......+.+++.+|++.+|.+||++.++++.|+..
T Consensus 208 ~~~~~---~---~~~~~-~------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 208 VNREV---L---DQVER-G------YRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ChHHH---H---HHHhc-C------CCC----CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 32111 0 00000 0 000 11123345688999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=256.96 Aligned_cols=221 Identities=27% Similarity=0.384 Sum_probs=163.1
Q ss_pred cCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|+.++||||+++++++.. ....++||||+++++|.+++... ...+++..++.++.+++.||+|||+.+ ++|+
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~ 133 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHR 133 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 578899999999999877 56889999999999999999762 335999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCC-ccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.++|+|||++.......... ......++..|+|||.+....++.++||||||++++||++|..|+.
T Consensus 134 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 213 (284)
T cd05038 134 DLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQ 213 (284)
T ss_pred CCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcc
Confidence 999999999999999999999998654222111 1112334567999999998899999999999999999999998875
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
............ .... .....+...+........+......+.+++.+||+.+|.+||++.+|+++|..+
T Consensus 214 ~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 214 SPPAEFLRMIGI-AQGQ-MIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccchhcccccc-cccc-ccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 532211000000 0000 000000000001111111122335788999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=255.83 Aligned_cols=202 Identities=23% Similarity=0.319 Sum_probs=158.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||++++++|......++|+||+++++|..++.. ...++++..++.++.|++.||.|||+.+ ++||||
T Consensus 56 l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl 129 (282)
T cd06643 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDL 129 (282)
T ss_pred HHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCC
Confidence 5678999999999999999999999999999999998764 2456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHHHHhCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
||+||+++.++.++|+|||++...... ........++..|+|||++. +..++.++|||||||++|||++|.+|
T Consensus 130 kp~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p 207 (282)
T cd06643 130 KAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207 (282)
T ss_pred CcccEEEccCCCEEEcccccccccccc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCC
Confidence 999999999999999999998653221 12233456899999999974 34578899999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|....... ........ . ..... .+......+.+++.+||+.+|.+||++.++++.
T Consensus 208 ~~~~~~~~--~~~~~~~~----~--~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 208 HHELNPMR--VLLKIAKS----E--PPTLA-------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred ccccCHHH--HHHHHhhc----C--CCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 86543211 11111000 0 00000 111223568899999999999999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=253.27 Aligned_cols=202 Identities=28% Similarity=0.452 Sum_probs=161.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||+++++++.+....++||||+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+|
T Consensus 53 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~d 127 (256)
T cd05039 53 VMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRD 127 (256)
T ss_pred HHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchh
Confidence 367889999999999999899999999999999999999752 2236899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.++|+|||+++...... ....++..|+|||++....++.++||||||++++++++ |..||..
T Consensus 128 i~p~Nili~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 202 (256)
T cd05039 128 LAARNVLVSEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred cccceEEEeCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999997642211 12234567999999998899999999999999999997 9999865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
.... .+...... . .....+......+.+++.+||..+|.+||++.+|++.|+.
T Consensus 203 ~~~~---~~~~~~~~----~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 203 IPLK---DVVPHVEK----G----------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCHH---HHHHHHhc----C----------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 4221 11111100 0 0001112234578899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=259.40 Aligned_cols=200 Identities=25% Similarity=0.354 Sum_probs=160.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.+.||||++++++|..+...++||||+++++|.+++.. ..+++.+++.++.|++.||+|||+.+ |+|+||
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dL 142 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 142 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999854 35889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus 143 kp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 143 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred CHHHEEEcCCCCEEECccccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987533221 11233468899999999998889999999999999999999999996543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+... +..+ .... .+.+ ..+......+.+++.+||..+|.+||++.+|+..
T Consensus 221 ~~~~--~~~~----~~~~-------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 221 PLRA--LYLI----ATNG-------TPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred HHHh--HHHH----hcCC-------CCCC--CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 3211 1100 0000 0000 0112233567889999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=254.40 Aligned_cols=201 Identities=26% Similarity=0.420 Sum_probs=161.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|||
T Consensus 59 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~d 131 (267)
T cd06628 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRD 131 (267)
T ss_pred HHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---ccccc
Confidence 36788999999999999999999999999999999999965 356899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCC----CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKS----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
|+|+||+++.++.++|+|||+++........ .......|+..|+|||++.+..++.++||||||+++++|++|+.|
T Consensus 132 i~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p 211 (267)
T cd06628 132 IKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211 (267)
T ss_pred CCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCC
Confidence 9999999999999999999998765421111 111234588899999999988899999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|....... .+.. ......+. .+......+.+++.+||+.+|.+||++.+|++
T Consensus 212 ~~~~~~~~--~~~~-----------~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 212 FPDCTQLQ--AIFK-----------IGENASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCccHHH--HHHH-----------HhccCCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 97542211 0000 00111111 12233467889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=242.44 Aligned_cols=198 Identities=26% Similarity=0.360 Sum_probs=166.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
-+.|+||||+++|+||.+....||++||...|+|...|...+ ...+++.....++.|+|.||.|+|.++ ||||||
T Consensus 76 qs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdi 150 (281)
T KOG0580|consen 76 QSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDI 150 (281)
T ss_pred ecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccCC---cccCCC
Confidence 467999999999999999999999999999999999998633 455899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|+|++..+.+||+|||-+-..+ .......+||..|++||+..+...+...|+|++|++.||++.|.+||+...
T Consensus 151 KpenlLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 151 KPENLLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred CHHHhccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 9999999999999999999885433 334556889999999999999999999999999999999999999998765
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..+. +....+ ..+. +|......+.++|..|+..+|.+|....||+..
T Consensus 227 ~~et--YkrI~k---------~~~~-------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 227 HSET--YKRIRK---------VDLK-------FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred hHHH--HHHHHH---------cccc-------CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2211 111111 1111 222334678899999999999999999999874
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=251.54 Aligned_cols=201 Identities=25% Similarity=0.333 Sum_probs=161.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+....|+++||+.+++|.+++.. ....+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl 125 (256)
T cd06612 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDI 125 (256)
T ss_pred HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999865 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++||||||+++++|++|+.||....
T Consensus 126 ~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 126 KAGNILLNEEGQAKLADFGVSGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred CcceEEECCCCcEEEcccccchhcccCc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999999987643322 12334558889999999999899999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
+....... .....+.+ ..+......+.+++..|++.+|++||++.+|++
T Consensus 204 ~~~~~~~~-------------~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 204 PMRAIFMI-------------PNKPPPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhhhhhh-------------ccCCCCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 32111000 00000001 011122356889999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=253.98 Aligned_cols=206 Identities=23% Similarity=0.355 Sum_probs=162.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+ ...++||||+++++|.+++.. ....+++.+++.++.+++.||+|||+.+ ++|+||
T Consensus 61 l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl 133 (270)
T cd05056 61 MRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDI 133 (270)
T ss_pred HHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 577899999999999875 457899999999999999975 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||+++...... ........++..|+|||.+....++.++||||||++++|+++ |..||...
T Consensus 134 ~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~ 212 (270)
T cd05056 134 AARNVLVSSPDCVKLGDFGLSRYLEDES-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGV 212 (270)
T ss_pred ChheEEEecCCCeEEccCceeeeccccc-ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999987543321 111222334567999999988889999999999999999986 99999655
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.... ...+.. ... ... .+......+.+++.+|+..+|.+||++.+++..|..+..
T Consensus 213 ~~~~---~~~~~~----~~~------~~~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 213 KNND---VIGRIE----NGE------RLP----MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CHHH---HHHHHH----cCC------cCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3221 111110 000 000 111223568899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=255.00 Aligned_cols=204 Identities=24% Similarity=0.329 Sum_probs=159.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++...+..++||||+++++|.++++. ...+++..+..++.|++.||.|||+.+ |+||||
T Consensus 60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 132 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDI 132 (267)
T ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999865 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
+|+||+++.++.++|+|||++....... .......|+..|+|||.+. ...++.++|||||||+++||++|..||.
T Consensus 133 ~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~ 210 (267)
T cd06646 133 KGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CHHHEEECCCCCEEECcCccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999999999999999999997543221 1123346888999999874 3457889999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
...+.... ..+... ....+.+.. .......+.+++.+||+.+|.+||++++|++.|
T Consensus 211 ~~~~~~~~--~~~~~~---------~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 211 DLHPMRAL--FLMSKS---------NFQPPKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccchhhhh--eeeecC---------CCCCCCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 54322111 000000 000111110 112335788999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=293.89 Aligned_cols=203 Identities=25% Similarity=0.333 Sum_probs=161.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|..|+|||||+++|+=.+.+..++.||||.+|+|.+++.. ....++.....+..|++.|++|||+.| |||||
T Consensus 1287 vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRD 1359 (1509)
T KOG4645|consen 1287 VLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRD 1359 (1509)
T ss_pred HHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecC
Confidence 46789999999999999999999999999999999999975 445777778888999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCC--CCccccccCCcCccCchhhccCC---CCccccEEEehHHHHHHHhCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDK--SHVSTRVMGTYGYCAPEYAMTGQ---LTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||.||+|+.+|.+|++|||.|........ ....+..+||+.|||||++.+.. -..+.||||||||++||+||+.
T Consensus 1360 IK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr 1439 (1509)
T KOG4645|consen 1360 IKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR 1439 (1509)
T ss_pred CCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC
Confidence 999999999999999999999976543321 11234678999999999998654 4578999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
||...... |+ +.- .+...-. .+.|......-.+++.+||+.||++|+++.++++.
T Consensus 1440 PW~~~dne-------~a--IMy---~V~~gh~----Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1440 PWAELDNE-------WA--IMY---HVAAGHK----PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred chhhccch-------hH--HHh---HHhccCC----CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 99654211 10 000 0011111 22344455667799999999999999999888763
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=260.20 Aligned_cols=157 Identities=25% Similarity=0.350 Sum_probs=128.1
Q ss_pred CcCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPP-----DKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
+|++++||||+++++++.. +...++||||+. ++|.+++..... ....+++..+..++.|++.||.|||+.+
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 128 (317)
T cd07868 51 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 128 (317)
T ss_pred HHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678999999999999854 457899999995 789888753211 1235899999999999999999999999
Q ss_pred CCeEeCCCCCCcEEE----cCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccC-CCCccccEEEehHHH
Q 020529 74 PPVIYRDFKSSNILL----EEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVF 147 (325)
Q Consensus 74 ~~ivHrdik~~Nill----~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl 147 (325)
|+||||||+|||+ +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++
T Consensus 129 --ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (317)
T cd07868 129 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred --EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHH
Confidence 9999999999999 45678999999999764332211 122345689999999998774 589999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 020529 148 LELITGRKAIDSTR 161 (325)
Q Consensus 148 ~elltg~~p~~~~~ 161 (325)
++|++|++||....
T Consensus 207 ~el~~g~~~f~~~~ 220 (317)
T cd07868 207 AELLTSEPIFHCRQ 220 (317)
T ss_pred HHHHhCCCCccCCc
Confidence 99999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=252.51 Aligned_cols=205 Identities=27% Similarity=0.395 Sum_probs=161.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++. .+..++||||+.+++|.+++... ....+++.+++.++.+++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~d 127 (260)
T cd05067 54 LMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRD 127 (260)
T ss_pred HHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccc
Confidence 367889999999999875 45789999999999999998652 2346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.++|+|||++....... ........++..|+|||++....++.++||||||++++||++ |+.||..
T Consensus 128 l~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 206 (260)
T cd05067 128 LRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206 (260)
T ss_pred ccHHhEEEcCCCCEEEccCcceeecCCCC-cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987543221 112223346678999999998899999999999999999999 9999975
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
..... +...... .... ..+......+.+++.+|+..+|++||++.+++..|+.
T Consensus 207 ~~~~~---~~~~~~~----------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 207 MTNPE---VIQNLER----------GYRM----PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CChHH---HHHHHHc----------CCCC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 43211 1111100 0000 1111223568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=263.15 Aligned_cols=203 Identities=20% Similarity=0.254 Sum_probs=156.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++.++...++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDL 168 (371)
T cd05622 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDV 168 (371)
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence 5678999999999999999999999999999999999864 34889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC----CCccccEEEehHHHHHHHhCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ----LTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||+|||++.++.+||+|||+++...... ........||+.|+|||++.... ++.++|||||||++|||++|..||
T Consensus 169 kp~NIll~~~~~ikL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 247 (371)
T cd05622 169 KPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247 (371)
T ss_pred CHHHEEECCCCCEEEEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence 9999999999999999999997643221 12233467999999999987543 789999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCC--CCCHHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVTAL 227 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPs~~evl~~L 227 (325)
........ ...+...... .... ........+.+++..||...+.+ ||++.+|++..
T Consensus 248 ~~~~~~~~------~~~i~~~~~~-~~~~-------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 248 YADSLVGT------YSKIMNHKNS-LTFP-------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCCHHHH------HHHHHcCCCc-ccCC-------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 76432111 1111111000 0000 01123456788999999844443 78999998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=266.90 Aligned_cols=202 Identities=23% Similarity=0.302 Sum_probs=155.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|..++||||+++++++.+.+..|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||
T Consensus 55 l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDL 127 (360)
T cd05627 55 LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDI 127 (360)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCC
Confidence 5678999999999999999999999999999999999975 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCC---------------------------------CccccccCCcCccCchh
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKS---------------------------------HVSTRVMGTYGYCAPEY 128 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~ 128 (325)
||+|||++.++.++|+|||+++........ .......||+.|+|||+
T Consensus 128 kp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 207 (360)
T cd05627 128 KPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV 207 (360)
T ss_pred CHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHH
Confidence 999999999999999999998643221100 01123569999999999
Q ss_pred hccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHH
Q 020529 129 AMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASM 208 (325)
Q Consensus 129 ~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 208 (325)
+.+..++.++|||||||++|||++|+.||....+..... .+...... ..+.+. ......+.+++.+
T Consensus 208 ~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~------~i~~~~~~--~~~p~~------~~~s~~~~~li~~ 273 (360)
T cd05627 208 FMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYR------KVMNWKET--LVFPPE------VPISEKAKDLILR 273 (360)
T ss_pred HcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHH------HHHcCCCc--eecCCC------CCCCHHHHHHHHH
Confidence 999999999999999999999999999997654322111 01100000 000010 0123467778888
Q ss_pred chhhCCCCCCC---HHHHHH
Q 020529 209 CIQEQAATRPL---IGDVVT 225 (325)
Q Consensus 209 cl~~~p~~RPs---~~evl~ 225 (325)
|+. +|..|++ +.++++
T Consensus 274 l~~-~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 274 FCT-DSENRIGSNGVEEIKS 292 (360)
T ss_pred hcc-ChhhcCCCCCHHHHhc
Confidence 764 9999986 455554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=250.82 Aligned_cols=217 Identities=22% Similarity=0.277 Sum_probs=169.1
Q ss_pred CcCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
||.+++|||||.+-.+... -+..|||||||. .+|..++... +.++...++..++.|+++||+|||... |+|
T Consensus 128 iLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilH 200 (419)
T KOG0663|consen 128 ILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILH 200 (419)
T ss_pred HHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEe
Confidence 4678899999999888654 357899999996 8999999874 357999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||||++|+|++..|.+||+|||||+.+.... ...+..+-|.+|+|||.+.+. .|+...|+||+|||+.||+++++-|
T Consensus 201 RDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf 278 (419)
T KOG0663|consen 201 RDLKTSNLLLSHKGILKIADFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF 278 (419)
T ss_pred cccchhheeeccCCcEEecccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999765442 334556679999999998876 6899999999999999999999999
Q ss_pred CCCCCCCcchhhh--------hhhhcccc-----ccccccccCCccCCCCChH-HHHHHHHHHHHchhhCCCCCCCHHHH
Q 020529 158 DSTRPHGEQNLVT--------WARPLFND-----RRKFSKLADPRLEGRYPIR-GLYQALAVASMCIQEQAATRPLIGDV 223 (325)
Q Consensus 158 ~~~~~~~~~~~~~--------~~~~~~~~-----~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~cl~~~p~~RPs~~ev 223 (325)
.+....+..+.+- -.++-+.. ...+....-..+++.++.. ....-++|+..+|..||.+|-|+.+.
T Consensus 279 ~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~ 358 (419)
T KOG0663|consen 279 PGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDG 358 (419)
T ss_pred CCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHh
Confidence 8876554432220 01111111 1112222222334444333 34677889999999999999999999
Q ss_pred HHH
Q 020529 224 VTA 226 (325)
Q Consensus 224 l~~ 226 (325)
++.
T Consensus 359 L~h 361 (419)
T KOG0663|consen 359 LKH 361 (419)
T ss_pred hcc
Confidence 874
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=254.54 Aligned_cols=204 Identities=27% Similarity=0.384 Sum_probs=163.2
Q ss_pred CCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCCC
Q 020529 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDF 81 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrdi 81 (325)
+.++||||+++++++.+++..++||||+++++|.+++.........+++..++.++.+++.||.|||+ .+ ++|+||
T Consensus 64 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl 140 (269)
T cd08528 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDL 140 (269)
T ss_pred hcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCC
Confidence 35799999999999999999999999999999999986544445669999999999999999999996 66 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|.||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 141 ~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 141 TPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred CHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 9999999999999999999997643322 2344568899999999998889999999999999999999999986432
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
... ....... ....+.... .....+.+++.+|++.+|++||++.||..+++
T Consensus 218 ~~~------~~~~~~~------~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 218 MLS------LATKIVE------AVYEPLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHH------HHHHHhh------ccCCcCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 111 1111110 000111111 12356789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=251.95 Aligned_cols=203 Identities=27% Similarity=0.439 Sum_probs=160.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++......++||||+.+++|.+++.. ....+++..++.++.+++.||+|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~d 125 (256)
T cd05112 52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125 (256)
T ss_pred HHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36788999999999999999999999999999999999875 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 126 l~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred cccceEEEcCCCeEEECCCcceeecccCc-ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 99999999999999999999987543221 111222335678999999998899999999999999999998 8999865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
..... +. ..+.. . .....+. .....+.+|+.+||+.+|.+||++.+|++.|
T Consensus 205 ~~~~~---~~---~~~~~-~---~~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 205 RSNSE---VV---ETINA-G---FRLYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHHH---HH---HHHhC-C---CCCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 43211 11 11100 0 0111111 1235688999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=256.38 Aligned_cols=204 Identities=26% Similarity=0.370 Sum_probs=161.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|+||+++++++.+.+..++||||+.+++|.+++... ....+++..++.++.|++.||.|||+.+ |+|||
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~d 127 (285)
T cd05630 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRD 127 (285)
T ss_pred HHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCC
Confidence 367889999999999999999999999999999999998642 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...
T Consensus 128 ikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 128 LKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred CCHHHEEECCCCCEEEeeccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986533221 122346899999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
......... ....... . ..++......+.+|+..||+.+|.+||+ +.++++.
T Consensus 205 ~~~~~~~~~---~~~~~~~---~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 205 KKKIKREEV---ERLVKEV---Q--------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred CccchHHHH---Hhhhhhh---h--------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 321110000 0000000 0 0111122346789999999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=254.47 Aligned_cols=214 Identities=22% Similarity=0.294 Sum_probs=155.5
Q ss_pred CCCCCCCccceeeEEEe-----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 3 SLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
+.++||||+++++++.. ....++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+.+ |+
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---iv 130 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IV 130 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 34579999999999864 345799999997 68999886532 245899999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 78 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 78 Hrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||||||+||+++.++.+||+|||+++..... .......||..|+|||++.+..++.++|||||||++|+|++|++||
T Consensus 131 H~dikp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f 207 (288)
T cd07863 131 HRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207 (288)
T ss_pred cCCCCHHHEEECCCCCEEECccCccccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCc
Confidence 9999999999999999999999999754322 1223456889999999999989999999999999999999999999
Q ss_pred CCCCCCCcc-hhhhhhhh----cccccccc-ccccCCccC---CCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 158 DSTRPHGEQ-NLVTWARP----LFNDRRKF-SKLADPRLE---GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~-~~~~~~~~----~~~~~~~~-~~~~d~~l~---~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
......... .+...... .+...... ...+.+... ..........+.+++.+||+.||.+||++.+++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 208 CGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 654322111 11110000 00000000 000000000 0001122356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=254.98 Aligned_cols=198 Identities=25% Similarity=0.336 Sum_probs=160.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++......++||||+++++|.+++.. ..+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl 127 (277)
T cd06642 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDI 127 (277)
T ss_pred HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCC
Confidence 5788999999999999999999999999999999999853 45899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||++++++.++|+|||++....... .......|+..|+|||++.+..++.++||||||++++||++|..|+....
T Consensus 128 ~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 128 KAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred ChheEEEeCCCCEEEccccccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999987543221 12233467889999999999899999999999999999999999986543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+... ..+ + .....+.+ +......+.+++.+|++.+|.+||++.+|++.
T Consensus 206 ~~~~---~~~----~------~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 206 PMRV---LFL----I------PKNSPPTL----EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred hhhH---Hhh----h------hcCCCCCC----CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2211 000 0 00111111 12234568899999999999999999999985
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=252.13 Aligned_cols=205 Identities=28% Similarity=0.429 Sum_probs=162.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++......++||||+++++|.+++.... ...+++.+++.++.+++.||.|||+.+ ++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di 129 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDL 129 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 678899999999999999899999999999999999997622 245899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++||||||+++++|++ |+.||...
T Consensus 130 ~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 130 AARNILVGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred chheEEEcCCCCEEECccccceeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987643211 111122334568999999998899999999999999999998 99998654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
... .......... .. ..+......+.+++.+|++.+|.+||++.++++.|+.
T Consensus 209 ~~~---~~~~~~~~~~-------~~-------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 209 TNR---EVLEQVERGY-------RM-------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CHH---HHHHHHHcCC-------CC-------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 321 1111110000 00 0111223568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=250.15 Aligned_cols=205 Identities=24% Similarity=0.382 Sum_probs=161.7
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|+||+++++++.+ ...++||||+++++|.+++... ....+++.+++.++.+++.||.|||+.+ ++|+|
T Consensus 54 ~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~d 127 (260)
T cd05073 54 VMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 127 (260)
T ss_pred HHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 3678899999999999887 7789999999999999999753 2345889999999999999999999998 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.++|+|||++........ .......++..|+|||++....++.++|||||||+++++++ |+.||..
T Consensus 128 l~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 128 LRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred cCcceEEEcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999875433221 11222345678999999998889999999999999999998 8999865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
.... .+..+... . ... ..+......+.+++.+|++.+|++||++.+|++.|+.
T Consensus 207 ~~~~---~~~~~~~~----~------~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 207 MSNP---EVIRALER----G------YRM----PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCHH---HHHHHHhC----C------CCC----CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 4321 11111110 0 000 0111233568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=252.08 Aligned_cols=202 Identities=25% Similarity=0.358 Sum_probs=158.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++...+..++||||+++++|.+++.. ...+++.+++.++.+++.||.|||+.+ ++|+||
T Consensus 60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 132 (267)
T cd06645 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDI 132 (267)
T ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5678999999999999999999999999999999999865 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+||+++.++.++|+|||++...... ........|++.|+|||++. ...++.++|||||||++|+|++|..||.
T Consensus 133 kp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 133 KGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred CHHHEEECCCCCEEECcceeeeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 999999999999999999998653221 12233456899999999874 4568899999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...+...... .... ....+.+.. .......+.+++.+||+.+|++||++.+|++
T Consensus 211 ~~~~~~~~~~--~~~~---------~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 211 DLHPMRALFL--MTKS---------NFQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccchhhHHh--hhcc---------CCCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 5432211100 0000 000011100 0012245789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=259.59 Aligned_cols=216 Identities=22% Similarity=0.345 Sum_probs=159.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++..++..++||||++ ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dl 130 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDL 130 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 567899999999999999999999999997 689888865 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.+||+|||+++...... .......+++.|+|||++.+ ..++.++|||||||++++|++|+.||...
T Consensus 131 kp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 131 KPQNLLINERGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred CHHHEEECCCCCEEECccccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999987533222 12223457899999998865 46889999999999999999999999765
Q ss_pred CCCCcchhhhhh--------hhccccccccccccCCccCC----CCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWA--------RPLFNDRRKFSKLADPRLEG----RYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~d~~l~~----~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...+........ ++.+.....+.....+.... .........+.+++.+||+.||.+|||+.|+++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 209 TVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 432221111000 00000000000000000000 0001123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=259.33 Aligned_cols=188 Identities=24% Similarity=0.367 Sum_probs=152.7
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
+||+|+++.+++.+.+..|+||||+++++|.+++.. ...+++.+++.++.|++.||.|||+.+ |+||||||+|
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~N 131 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDN 131 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHH
Confidence 578899999999999999999999999999999865 456999999999999999999999999 9999999999
Q ss_pred EEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCc
Q 020529 86 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 165 (325)
Q Consensus 86 ill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~ 165 (325)
||++.++.++|+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 132 ill~~~~~ikL~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~- 208 (323)
T cd05615 132 VMLDSEGHIKIADFGMCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE- 208 (323)
T ss_pred eEECCCCCEEEeccccccccCCC--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-
Confidence 99999999999999998753221 122334568999999999999999999999999999999999999997653211
Q ss_pred chhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 166 QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
+. ..+.... ..++......+.+++.+||+.+|.+|++.
T Consensus 209 --~~---~~i~~~~------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 209 --LF---QSIMEHN------------VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --HH---HHHHhCC------------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11 1111110 01122234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=250.96 Aligned_cols=202 Identities=24% Similarity=0.371 Sum_probs=163.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..++||||+++++|.+++...+ ...+++.+++.++.+++.||+|||+.+ ++|+|
T Consensus 52 ~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~d 126 (256)
T cd08221 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRD 126 (256)
T ss_pred HHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 3678899999999999999999999999999999999997632 345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|+|+||+++.++.+||+|||++........ ......|++.|+|||++.+..++.++||||||+++++|++|..||...
T Consensus 127 l~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08221 127 IKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT 204 (256)
T ss_pred CChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999876433221 223456899999999998888999999999999999999999998654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... ....+... . ..+ .+......+.+++.+|+..+|.+||++.++++.
T Consensus 205 ~~~~------~~~~~~~~--~----~~~-----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 205 NPLN------LVVKIVQG--N----YTP-----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CHHH------HHHHHHcC--C----CCC-----CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 3211 11111110 0 000 011234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=265.80 Aligned_cols=212 Identities=23% Similarity=0.310 Sum_probs=155.2
Q ss_pred cCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
++.++||||+++++++... ...++||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g--- 139 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--- 139 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5678999999999988643 35799999996 677777642 4889999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|+||||||+|||++.++.+||+|||+++.... ........||..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 140 ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 216 (355)
T cd07874 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 216 (355)
T ss_pred cccCCCChHHEEECCCCCEEEeeCcccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999975322 122334568999999999999899999999999999999999999
Q ss_pred CCCCCCCCCcch-hh---------------hhhhhccccccccccccCCcc--------CCCCChHHHHHHHHHHHHchh
Q 020529 156 AIDSTRPHGEQN-LV---------------TWARPLFNDRRKFSKLADPRL--------EGRYPIRGLYQALAVASMCIQ 211 (325)
Q Consensus 156 p~~~~~~~~~~~-~~---------------~~~~~~~~~~~~~~~~~d~~l--------~~~~~~~~~~~~~~l~~~cl~ 211 (325)
||.......... .. ..................+.. ....+......+.+|+.+||+
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 296 (355)
T cd07874 217 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296 (355)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhc
Confidence 997643211100 00 000000000000000000000 000111224567899999999
Q ss_pred hCCCCCCCHHHHHHH
Q 020529 212 EQAATRPLIGDVVTA 226 (325)
Q Consensus 212 ~~p~~RPs~~evl~~ 226 (325)
.||.+|||+.|+++.
T Consensus 297 ~dP~~Rps~~ell~h 311 (355)
T cd07874 297 IDPAKRISVDEALQH 311 (355)
T ss_pred CCchhcCCHHHHhcC
Confidence 999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=270.66 Aligned_cols=201 Identities=26% Similarity=0.367 Sum_probs=166.4
Q ss_pred CCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEAL--DWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+.|+|.|||+++|.|.++++.-+.||-++||||.++|+. .-.++ .+.+.-.+..||+.||.|||+.. |||||
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRD 700 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRD 700 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeecc
Confidence 578999999999999999999999999999999999986 45566 78899999999999999999999 99999
Q ss_pred CCCCcEEEcC-CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC--CCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~-~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||-+|||++- .|.+||+|||.++..... ...+..+.||.-|||||++..+ .|+..+|||||||.+.||.||++||
T Consensus 701 IKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF 778 (1226)
T KOG4279|consen 701 IKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPF 778 (1226)
T ss_pred ccCCcEEEeeccceEEecccccchhhccC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCe
Confidence 9999999975 578999999999764332 3345567899999999999876 4899999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
-....... .++.- .+. ......|.+...++..+|.+|+.++|.+||++.++++-
T Consensus 779 ~ElgspqA--------AMFkV--Gmy-----KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 779 VELGSPQA--------AMFKV--GMY-----KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred eecCChhH--------hhhhh--cce-----ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 65433211 01110 001 12334566778899999999999999999999999874
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=252.32 Aligned_cols=198 Identities=25% Similarity=0.325 Sum_probs=162.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.+.||||+++++++.++...++||||+++++|.+++.. .++++..+..++.+++.||+|||+.+ ++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl 127 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDI 127 (277)
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCC
Confidence 5678999999999999999999999999999999999854 35889999999999999999999998 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+|||||++|||++|..||....
T Consensus 128 ~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 128 KAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred ChhhEEEcCCCCEEEcccccceeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 9999999999999999999997543322 22233467889999999998889999999999999999999999987543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+....... .....+ ..+......+.+++.+||+.+|.+||++.+++..
T Consensus 206 ~~~~~~~~-------------~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 206 PMRVLFLI-------------PKNNPP----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHhHhhhh-------------hcCCCC----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 32111000 000011 1222345678899999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=255.22 Aligned_cols=204 Identities=27% Similarity=0.433 Sum_probs=161.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.+++.||++||+.+ |+|+||
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~di 124 (260)
T PF00069_consen 52 LRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDI 124 (260)
T ss_dssp HHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSB
T ss_pred cccccccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccc---cccccc
Confidence 4567999999999999999999999999998899999973 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-cCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.++|+|||++... ...........++..|+|||++. +..++.++||||||+++++|++|..||...
T Consensus 125 kp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 125 KPENILLDENGEVKLIDFGSSVKL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SGGGEEESTTSEEEESSGTTTEES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999998653 12223344567899999999998 788999999999999999999999999865
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.......... ..... .... ... ........+.+++..||+.+|++||++.++++
T Consensus 203 ~~~~~~~~~~---~~~~~-----~~~~-~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 203 NSDDQLEIIE---KILKR-----PLPS-SSQ--QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SHHHHHHHHH---HHHHT-----HHHH-HTT--SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhhhhhhh---hcccc-----cccc-ccc--ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2111111110 00000 0000 000 00011267899999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=261.43 Aligned_cols=212 Identities=27% Similarity=0.412 Sum_probs=161.0
Q ss_pred cCCC-CCCCccceeeEEEe-CCeeEEEEecCCCCCHHHHhccCCC-----------------------------------
Q 020529 2 LSLL-HHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPP----------------------------------- 44 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------- 44 (325)
|.++ +||||++++++|.. +...++||||+++|+|.++++....
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (343)
T cd05103 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITS 143 (343)
T ss_pred HHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccc
Confidence 4566 78999999998865 4567899999999999999865221
Q ss_pred ----------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEE
Q 020529 45 ----------------------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKL 96 (325)
Q Consensus 45 ----------------------------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL 96 (325)
....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl 220 (343)
T cd05103 144 SQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKI 220 (343)
T ss_pred ccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEE
Confidence 0134788899999999999999999999 999999999999999999999
Q ss_pred ecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhc
Q 020529 97 SDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPL 175 (325)
Q Consensus 97 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 175 (325)
+|||+++...............+++.|+|||++.+..++.++||||||+++++|++ |..||....... .+.. .
T Consensus 221 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~----~ 294 (343)
T cd05103 221 CDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCR----R 294 (343)
T ss_pred EecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHH----H
Confidence 99999976433222222223345678999999998899999999999999999997 888886542211 1110 0
Q ss_pred cccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 176 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 176 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..... .. ..+......+.+++..|++.+|.+||++.+|++.|+.+..
T Consensus 295 ~~~~~---~~-------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 295 LKEGT---RM-------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HhccC---CC-------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 10000 00 0011122467899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=253.82 Aligned_cols=200 Identities=25% Similarity=0.328 Sum_probs=156.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++...+..++||||+++++|..+. .+++..+..++.+++.||.|||+.+ |+|+||
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 121 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDV 121 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCC
Confidence 56789999999999999999999999999999996542 3688899999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++...... ......|+..|+|||++....++.++||||||+++|+|++|+.||....
T Consensus 122 kp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 122 KPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred CHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 999999999999999999998754221 2234578999999999998899999999999999999999999996533
Q ss_pred CCCcch-hhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQN-LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...... ...+....... ..+.+ ........+.+++.+|++.+|..||++.+++..
T Consensus 198 ~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 198 KNQGSLMPLQLLQCIVDE-------DPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ccccccchHHHHHHHhcc-------CCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 221110 00111000000 00111 011223467899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=282.76 Aligned_cols=212 Identities=28% Similarity=0.398 Sum_probs=170.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
+|+.+.|||||+++|.|.+....++++|||.+|+|..+|+..++ ....++....+.++.+||+|+.||+++. +|
T Consensus 748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fv 824 (1025)
T KOG1095|consen 748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FV 824 (1025)
T ss_pred HHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---Cc
Confidence 47889999999999999999999999999999999999988533 2456899999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCC
Q 020529 78 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKA 156 (325)
Q Consensus 78 Hrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p 156 (325)
||||.+.|+||++...+||+|||+|+-.-..+.......-+-...|||||.+..+.++.|+|||||||++|||+| |..|
T Consensus 825 HRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P 904 (1025)
T KOG1095|consen 825 HRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP 904 (1025)
T ss_pred CcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence 999999999999999999999999984333333222222233467999999999999999999999999999997 6777
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
|......+... .... .. +-..|......+.+++..||+.+|.+||+...|++.+..+..
T Consensus 905 Y~~~~n~~v~~------~~~~-gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 905 YPSRSNFEVLL------DVLE-GG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred CCCcchHHHHH------HHHh-CC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 76543221111 0011 11 112233455678899999999999999999999998887764
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=248.95 Aligned_cols=199 Identities=27% Similarity=0.428 Sum_probs=157.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++... ..++||||+++++|.+++... ....+++.+++.++.+++.||.|||+.+ ++||||
T Consensus 53 l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl 126 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDL 126 (254)
T ss_pred HHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 5788999999999998755 479999999999999999752 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||++...... ......+..|+|||++.+..++.++|+||||+++++|++ |+.||...
T Consensus 127 ~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 127 AARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred CcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 999999999999999999998753221 122334567999999988899999999999999999997 99998654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
.... +.... . .. . ....+......+.+++.+|++.+|..||++.+|++.|+
T Consensus 202 ~~~~---~~~~~---~-~~--~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 202 SLKE---VKECV---E-KG--Y--------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CHHH---HHHHH---h-CC--C--------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 3221 11110 0 00 0 00011123356789999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=252.40 Aligned_cols=199 Identities=28% Similarity=0.368 Sum_probs=161.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++.++...++|+||+++++|.+++.. .++++..++.++.|++.||.|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl 124 (274)
T cd06609 53 LSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDI 124 (274)
T ss_pred HHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 5678999999999999999999999999999999999965 26899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||+++...... .......++..|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 125 ~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 125 KAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred CHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 9999999999999999999997654321 22334568889999999999889999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+...... . .....+.+... .....+.+++.+||..+|++||+++++++.
T Consensus 203 ~~~~~~~------~-------~~~~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 203 PMRVLFL------I-------PKNNPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred hHHHHHH------h-------hhcCCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 2211000 0 00011111111 023467889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=258.81 Aligned_cols=156 Identities=25% Similarity=0.348 Sum_probs=127.0
Q ss_pred CcCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCC-----CCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPP-----DKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
+|++++||||+++++++.. +...++||||+. ++|.+++..... ....+++..++.++.|++.||.|||+.+
T Consensus 51 ~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~- 128 (317)
T cd07867 51 LLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW- 128 (317)
T ss_pred HHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678899999999999854 567899999996 688887753211 2235899999999999999999999999
Q ss_pred CCeEeCCCCCCcEEE----cCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccC-CCCccccEEEehHHH
Q 020529 74 PPVIYRDFKSSNILL----EEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVF 147 (325)
Q Consensus 74 ~~ivHrdik~~Nill----~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl 147 (325)
|+||||||+|||+ +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++
T Consensus 129 --ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 206 (317)
T cd07867 129 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 206 (317)
T ss_pred --EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHH
Confidence 9999999999999 56678999999999864332211 122345689999999998764 579999999999999
Q ss_pred HHHHhCCCCCCCC
Q 020529 148 LELITGRKAIDST 160 (325)
Q Consensus 148 ~elltg~~p~~~~ 160 (325)
|||+||++||...
T Consensus 207 ~el~tg~~~f~~~ 219 (317)
T cd07867 207 AELLTSEPIFHCR 219 (317)
T ss_pred HHHHhCCCCcccc
Confidence 9999999999654
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=263.34 Aligned_cols=196 Identities=30% Similarity=0.389 Sum_probs=165.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++|+|||++.+.|+|......+|||||| -||-.+++.- .++++-+..+..|+.+++.||+|||+.+ .|||||
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDi 152 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDI 152 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhc
Confidence 67899999999999999999999999999 4899999876 4678999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|+.||||++.|.|||+|||.|... .....++|||.|||||++. .+.|+.|+|||||||...||.-.++|+.
T Consensus 153 KAGNILLse~g~VKLaDFGSAsi~------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 153 KAGNILLSEPGLVKLADFGSASIM------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred cccceEecCCCeeeeccccchhhc------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 999999999999999999998652 3456688999999999975 4689999999999999999999999987
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.++.....+- +..--.|.|. ..+.+..+..++..||++-|.+|||.++++..
T Consensus 227 nMNAMSALYH-------------IAQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 227 NMNAMSALYH-------------IAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CchHHHHHHH-------------HHhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 7654321111 1111223332 22456778899999999999999999998865
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=253.82 Aligned_cols=216 Identities=22% Similarity=0.294 Sum_probs=157.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+++.||||+++++++.++...++||||+. ++|.+++..... ...+++..++.++.|++.||+|||+.+ |+|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl 127 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDL 127 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCC
Confidence 567899999999999999999999999997 789988865432 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.++|+|||++...... ........+++.|+|||++.+. .++.++||||||+++++|++|+.||...
T Consensus 128 ~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 128 KPQNLLIDNKGVIKLADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred CHHHEEEcCCCcEEECcccceeecCCC--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999998754322 1122334578899999988654 5788999999999999999999999754
Q ss_pred CCCCcc-hhhh-hhh---hc---ccccc----ccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQ-NLVT-WAR---PL---FNDRR----KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~-~~~~-~~~---~~---~~~~~----~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...... .... +.. .. ..... .+.......+. ........++.+++.+||+.||.+||++.+|+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 206 SEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLR-SAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhH-HhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 321110 0000 000 00 00000 00000000000 000112356779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=257.81 Aligned_cols=205 Identities=20% Similarity=0.204 Sum_probs=155.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+..++||||+++++++.+.+..++||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDl 128 (332)
T cd05623 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDI 128 (332)
T ss_pred HhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 4568999999999999999999999999999999999975 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHHHHhCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
||+|||++.++.++|+|||++....... ........||+.|+|||++. ...++.++|||||||++|||++|+.|
T Consensus 129 kp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~P 207 (332)
T cd05623 129 KPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207 (332)
T ss_pred CHHHEEECCCCCEEEeecchheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCC
Confidence 9999999999999999999986532221 12233457999999999986 34678999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCC--CCCCHHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAA--TRPLIGDVVTA 226 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~--~RPs~~evl~~ 226 (325)
|....... ....+......+ . -+.. .......+.+|+.+||..++. .|+++.++++.
T Consensus 208 f~~~~~~~------~~~~i~~~~~~~-~--~p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 208 FYAESLVE------TYGKIMNHKERF-Q--FPAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCCCHHH------HHHHHhCCCccc-c--CCCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 97543211 111111111000 0 0000 112245677888888865444 47899998876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=251.60 Aligned_cols=202 Identities=27% Similarity=0.355 Sum_probs=160.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.+++.||+|||+.+ |+|+||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 128 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDI 128 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 5778999999999999999999999999999999999965 345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCC----CCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDK----SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
+|+||+++.++.++|+|||++........ ........|+..|+|||++.+..++.++||||||+++++|++|..||
T Consensus 129 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~ 208 (265)
T cd06631 129 KGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208 (265)
T ss_pred CHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcc
Confidence 99999999999999999999875422111 11123356899999999999888999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
......... ... .. .....+.+ +......+.+++.+||+.+|.+||++.+|+.
T Consensus 209 ~~~~~~~~~--~~~----~~-----~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 209 ASMDRLAAM--FYI----GA-----HRGLMPRL----PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ccCChHHHH--HHh----hh-----ccCCCCCC----CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 654321110 000 00 00001111 1223456789999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=256.17 Aligned_cols=200 Identities=25% Similarity=0.375 Sum_probs=160.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++...+..++|+||+++++|..++.. ..+++.++..++.+++.||+|||+.+ ++|+||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL 141 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDI 141 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999854 35899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....
T Consensus 142 ~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred CHHHEEECCCCCEEEccCccchhccccc--ccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987533221 12233468889999999998889999999999999999999999997654
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+...... ..... .+.+ ..+......+.+++.+||..+|.+||++.+|+..
T Consensus 220 ~~~~~~~------~~~~~-------~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 220 PLRALYL------IATNG-------TPEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred HHHHHHH------HHhcC-------Cccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 3211110 00000 0000 0111223467789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=263.13 Aligned_cols=212 Identities=23% Similarity=0.292 Sum_probs=153.9
Q ss_pred cCCCCCCCccceeeEEEeCC------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
|+.++||||+++++++.... ..|+||||++ ++|.+.++. .+++..+..++.|++.||.|||+.+
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~--- 143 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG--- 143 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 56789999999999986543 5799999996 667776642 3888999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|+||||||+|||++.++.+||+|||+++.... ........||..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 144 ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~ 220 (359)
T cd07876 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSV 220 (359)
T ss_pred cccCCCCHHHEEECCCCCEEEecCCCcccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999975321 112234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcc------------hhh----hhhhhccccccccc-----cccCCccCC---CCChHHHHHHHHHHHHchh
Q 020529 156 AIDSTRPHGEQ------------NLV----TWARPLFNDRRKFS-----KLADPRLEG---RYPIRGLYQALAVASMCIQ 211 (325)
Q Consensus 156 p~~~~~~~~~~------------~~~----~~~~~~~~~~~~~~-----~~~d~~l~~---~~~~~~~~~~~~l~~~cl~ 211 (325)
||......... .+. .............. ..+..-... .........+.+|+.+||+
T Consensus 221 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 300 (359)
T cd07876 221 IFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLV 300 (359)
T ss_pred CCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhc
Confidence 99764321100 000 00000000000000 000000000 0001123567899999999
Q ss_pred hCCCCCCCHHHHHHH
Q 020529 212 EQAATRPLIGDVVTA 226 (325)
Q Consensus 212 ~~p~~RPs~~evl~~ 226 (325)
.||.+|||+.|+++.
T Consensus 301 ~dP~~R~t~~e~l~h 315 (359)
T cd07876 301 IDPDKRISVDEALRH 315 (359)
T ss_pred cCcccCCCHHHHhcC
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=252.92 Aligned_cols=204 Identities=26% Similarity=0.371 Sum_probs=160.7
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++|+||+++.+++..++..++||||+++++|..++... ....+++..+..++.|++.||.|||+.+ |+|||
T Consensus 53 il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~d 127 (285)
T cd05632 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRD 127 (285)
T ss_pred HHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 367889999999999999999999999999999999888652 2346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++|||||||++++|++|..||...
T Consensus 128 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 128 LKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred CCHHHEEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986533221 123356899999999999889999999999999999999999999754
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
..... ............ ..++......+.+|+..||+.+|.+||+ +.+++..
T Consensus 205 ~~~~~--~~~~~~~~~~~~------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 205 KEKVK--REEVDRRVLETE------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred CHHHH--HHHHHHhhhccc------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 32111 111111000000 0111223346789999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=249.02 Aligned_cols=201 Identities=22% Similarity=0.321 Sum_probs=159.5
Q ss_pred cCCCCCCCccceeeEEEe-CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+++++||||+++++.+.. ....|+||||+++++|.+++... ....+++.+++.++.+++.||++||+.+ ++|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~d 127 (257)
T cd08223 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRD 127 (257)
T ss_pred HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 577899999999998764 44679999999999999999752 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||+++.++.++|+|||++....... .......+++.|+|||++.+..++.++||||||+++++|++|+.||...
T Consensus 128 i~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 128 LKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred CCchhEEEecCCcEEEecccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999987543221 2233456889999999999999999999999999999999999998753
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
... ......... .. + ..+......+.+++.+|++.+|.+||++.++++.
T Consensus 206 ~~~------~~~~~~~~~------~~-~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 206 DMN------SLVYRIIEG------KL-P----PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CHH------HHHHHHHhc------CC-C----CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 211 111111110 00 0 1122334578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=252.43 Aligned_cols=208 Identities=23% Similarity=0.369 Sum_probs=161.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK-----EALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
+|++++||||+++++++.+....++||||+++++|.+++....... ..+++..++.++.+++.||+|||+.+
T Consensus 61 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--- 137 (275)
T cd05046 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--- 137 (275)
T ss_pred HHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---
Confidence 3678899999999999999899999999999999999997643211 26899999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~ 154 (325)
|+||||||+||+++.++.++|+|||+++...... ........++..|+|||.+.+..++.++||||||+++++|++ |.
T Consensus 138 i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~ 216 (275)
T cd05046 138 FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216 (275)
T ss_pred cccCcCccceEEEeCCCcEEEcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999986432211 112223345677999999988889999999999999999998 78
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
.||...... .+..... . ..+....+......+.+++.+||+.+|.+||++.+++..|.
T Consensus 217 ~p~~~~~~~---~~~~~~~---~----------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 217 LPFYGLSDE---EVLNRLQ---A----------GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCccccchH---HHHHHHH---c----------CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 888543221 1111110 0 00000011122357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=251.70 Aligned_cols=201 Identities=27% Similarity=0.364 Sum_probs=155.1
Q ss_pred cCCC-CCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 2 LSLL-HHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
|+++ +||||++++++|... ...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~-- 131 (272)
T cd06637 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK-- 131 (272)
T ss_pred HHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4455 799999999998753 4679999999999999998752 2345899999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHH
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~e 149 (325)
|+|+||||+||++++++.++|+|||++....... .......|++.|+|||++. ...++.++|||||||++||
T Consensus 132 -ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~e 208 (272)
T cd06637 132 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 208 (272)
T ss_pred -CccCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHH
Confidence 9999999999999999999999999987532211 1233466899999999986 3357889999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 150 LITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|++|..||....+....... . ....+.+ ........+.+|+.+||..+|.+||++.+|++
T Consensus 209 l~~g~~p~~~~~~~~~~~~~------~-------~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 209 MAEGAPPLCDMHPMRALFLI------P-------RNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHhCCCCccccCHHHHHHHH------h-------cCCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 99999999643321111000 0 0000000 01122346889999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=251.65 Aligned_cols=216 Identities=27% Similarity=0.316 Sum_probs=159.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++++++||||+++++++..+...++||||+++++|..++.. ...+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 53 ~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~d 125 (286)
T cd07847 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRD 125 (286)
T ss_pred HHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecC
Confidence 35788999999999999999999999999998888877653 345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+||+++.++.++|+|||++........ ......++..|+|||++.+ ..++.++||||||+++++|++|..||..
T Consensus 126 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 126 VKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred CChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999976433221 2223457888999999876 4578999999999999999999999976
Q ss_pred CCCCCcch-hhhhhhhccc-------cccccccccCCccCCCCC-----hHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 160 TRPHGEQN-LVTWARPLFN-------DRRKFSKLADPRLEGRYP-----IRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 160 ~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~d~~l~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
....+... +......... ..........+......+ ......+.+|+.+||+.+|.+||++.+++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 204 KSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 54322111 1110001000 000000111111111111 112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=253.57 Aligned_cols=216 Identities=26% Similarity=0.344 Sum_probs=160.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++..++..++||||++++.+..++.. ...+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl 126 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDI 126 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5678999999999999999999999999987666655543 345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
+|+||+++.++.++|+|||++........ .......++..|+|||++... .++.++||||||+++++|++|+.||...
T Consensus 127 ~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 127 KPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred CHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999876443322 123345678899999999888 8899999999999999999999999754
Q ss_pred CCCCcchhhhh-hhh-------cccccc-----ccccccCCc-cCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTW-ARP-------LFNDRR-----KFSKLADPR-LEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~-~~~-------~~~~~~-----~~~~~~d~~-l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...+....... ... .+.... .+....++. +...++......+.+++.+||..+|++||++.+|++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 206 SDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 32211100000 000 000000 000000000 011122223567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=285.12 Aligned_cols=205 Identities=21% Similarity=0.293 Sum_probs=156.9
Q ss_pred CcCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC----C
Q 020529 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN----P 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~----~ 74 (325)
+|++|+|||||+++++|.+ ....||||||+++++|.++|.........+++..++.|+.||+.||.|||..+. .
T Consensus 65 IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k 144 (1021)
T PTZ00266 65 VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGE 144 (1021)
T ss_pred HHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccC
Confidence 4678999999999998854 457899999999999999997644444579999999999999999999998542 2
Q ss_pred CeEeCCCCCCcEEEcC-----------------CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc--CCCC
Q 020529 75 PVIYRDFKSSNILLEE-----------------GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT--GQLT 135 (325)
Q Consensus 75 ~ivHrdik~~Nill~~-----------------~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~ 135 (325)
+||||||||+||||+. .+.+||+|||++...... .......||+.|+|||++.+ ..++
T Consensus 145 ~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s 221 (1021)
T PTZ00266 145 RVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYD 221 (1021)
T ss_pred CceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCC
Confidence 3999999999999964 235899999999754322 12334579999999999864 4588
Q ss_pred ccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCC
Q 020529 136 VKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAA 215 (325)
Q Consensus 136 ~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~ 215 (325)
.++||||||||||||++|..||...... ......+.. .....+ ......+.+||..||+.+|.
T Consensus 222 ~KSDVWSLG~ILYELLTGk~PF~~~~~~-----~qli~~lk~-------~p~lpi-----~~~S~eL~dLI~~~L~~dPe 284 (1021)
T PTZ00266 222 DKSDMWALGCIIYELCSGKTPFHKANNF-----SQLISELKR-------GPDLPI-----KGKSKELNILIKNLLNLSAK 284 (1021)
T ss_pred chhHHHHHHHHHHHHHHCCCCCCcCCcH-----HHHHHHHhc-------CCCCCc-----CCCCHHHHHHHHHHhcCChh
Confidence 9999999999999999999999653221 111111110 000001 11235688999999999999
Q ss_pred CCCCHHHHHH
Q 020529 216 TRPLIGDVVT 225 (325)
Q Consensus 216 ~RPs~~evl~ 225 (325)
+||++.+++.
T Consensus 285 eRPSa~QlL~ 294 (1021)
T PTZ00266 285 ERPSALQCLG 294 (1021)
T ss_pred HCcCHHHHhc
Confidence 9999999984
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=249.26 Aligned_cols=206 Identities=24% Similarity=0.372 Sum_probs=160.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++...+..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 134 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDL 134 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCC
Confidence 6778999999999999999999999999999999999976 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC--CCccccEEEehHHHHHHHhCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
+|+||+++.++.++|+|||+++...............|+..|+|||++.... ++.++|+||||++++++++|..||..
T Consensus 135 ~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 135 KADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 9999999999999999999997643322222233456889999999987654 78999999999999999999999854
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..... .+.. .... .....+.+.. .......+.+++..||..+|..||++.+|++.
T Consensus 215 ~~~~~--~~~~----~~~~--~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 215 EEAIA--AMFK----LGNK--RSAPPIPPDV----SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cchHH--HHHH----hhcc--ccCCcCCccc----cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 32110 0100 0000 0011111111 11234678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=252.74 Aligned_cols=202 Identities=23% Similarity=0.326 Sum_probs=157.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++..+...++||||+++++|..++.. ....+++..++.++.|++.||.|||+.+ |+||||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl 136 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDL 136 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCC
Confidence 5788999999999999999999999999999999988754 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHHHHhCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
||+||+++.++.++|+|||++...... ........+++.|+|||++. ...++.++|||||||++|||++|..|
T Consensus 137 kp~Nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 214 (292)
T cd06644 137 KAGNVLLTLDGDIKLADFGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214 (292)
T ss_pred CcceEEEcCCCCEEEccCccceecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC
Confidence 999999999999999999988643221 12223456888999999885 34568899999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|....+.. .+... .. ...+.+ ..+......+.+++.+||..+|++||++.+|++.
T Consensus 215 ~~~~~~~~--~~~~~----~~-------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 215 HHELNPMR--VLLKI----AK-------SEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CccccHHH--HHHHH----hc-------CCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 86543211 11111 00 000000 0111233568899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=264.92 Aligned_cols=217 Identities=23% Similarity=0.329 Sum_probs=158.9
Q ss_pred CcCCCCCCCccceeeEEEeCC-----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
+|+.++||||+++++++.... ..|+||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+
T Consensus 52 ~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~--- 123 (372)
T cd07853 52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG--- 123 (372)
T ss_pred HHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 357789999999999998776 7899999996 788888754 456999999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+|||++.++.+||+|||+++...... ........++..|+|||++.+. .++.++|||||||+++||++|+
T Consensus 124 ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 202 (372)
T cd07853 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202 (372)
T ss_pred eeCCCCChHHEEECCCCCEEeccccceeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCC
Confidence 9999999999999999999999999997543222 1122334578899999998774 4789999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhh--ccc-------c-cccc-ccccC-CccCC--CCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 155 KAIDSTRPHGEQNLVTWARP--LFN-------D-RRKF-SKLAD-PRLEG--RYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~--~~~-------~-~~~~-~~~~d-~~l~~--~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
.||....+......+..... ... . ...+ ..... +.... .........+.+|+.+||+.||.+||++
T Consensus 203 ~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~ 282 (372)
T cd07853 203 ILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA 282 (372)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH
Confidence 99976543321111100000 000 0 0000 00000 00000 0111224578899999999999999999
Q ss_pred HHHHHH
Q 020529 221 GDVVTA 226 (325)
Q Consensus 221 ~evl~~ 226 (325)
.++++.
T Consensus 283 ~e~l~h 288 (372)
T cd07853 283 ADALAH 288 (372)
T ss_pred HHHhcC
Confidence 999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=249.78 Aligned_cols=204 Identities=23% Similarity=0.365 Sum_probs=161.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+.+++|.+++.. ..++++..++.++.|++.||+|||+.+ ++|+||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i 129 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDV 129 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999975 346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCC-eEEEecCCCCccCCCCCC--CCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGF-HPKLSDFGLAKLGPVGDK--SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~-~~kL~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
+|+||+++.++ .++|+|||++........ ........|+..|+|||++.+..++.++||||||+++++|++|..||.
T Consensus 130 ~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 130 KGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred CHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 99999998776 699999999876443211 112234568899999999988889999999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
........... ... .........+......+.+++.+||..+|.+||++.++++
T Consensus 210 ~~~~~~~~~~~---~~~----------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 210 AEKHSNHLALI---FKI----------ASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCcchHHHH---HHH----------hccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 43321111110 000 0000011222234467889999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=248.03 Aligned_cols=203 Identities=30% Similarity=0.459 Sum_probs=160.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+.+..+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl 129 (258)
T smart00219 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN---FIHRDL 129 (258)
T ss_pred HHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC---eeeccc
Confidence 5678999999999999999999999999999999999976221 12899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||+++......... .....+++.|+|||.+....++.++||||||+++++|++ |..||...
T Consensus 130 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 130 AARNCLVGENLVVKISDFGLSRDLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred ccceEEEccCCeEEEcccCCceecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997654332211 112336789999999988889999999999999999998 78888653
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
... .+.... ... ... ..+......+.+++.+|+..+|.+||++.++++.|
T Consensus 209 ~~~---~~~~~~---~~~----~~~-------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 209 SNE---EVLEYL---KKG----YRL-------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CHH---HHHHHH---hcC----CCC-------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 211 111111 100 000 00112345688899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=249.37 Aligned_cols=201 Identities=25% Similarity=0.345 Sum_probs=156.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEAL--DWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l--~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+++++||||+++++++..++..++|+||+++++|.+++... ...+ ++..+..++.|++.||+|||+.+ |+||
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~ 132 (268)
T cd06624 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHR 132 (268)
T ss_pred HHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---Eeec
Confidence 56889999999999999999999999999999999999752 2334 88899999999999999999999 9999
Q ss_pred CCCCCcEEEcC-CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC--CCccccEEEehHHHHHHHhCCCC
Q 020529 80 DFKSSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 80 dik~~Nill~~-~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvvl~elltg~~p 156 (325)
||||+||+++. ++.++|+|||++....... .......|++.|+|||++.... ++.++||||||+++++|++|+.|
T Consensus 133 dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p 210 (268)
T cd06624 133 DIKGDNVLVNTYSGVVKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210 (268)
T ss_pred CCCHHHEEEcCCCCeEEEecchhheecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999976 6799999999986543221 1222345789999999986643 78999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|....... ...+...... .....+......+.+++.+||+.+|.+||++.+|+.
T Consensus 211 ~~~~~~~~---~~~~~~~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 211 FIELGEPQ---AAMFKVGMFK------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CccccChh---hhHhhhhhhc------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 86532211 1111110000 011122233456889999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=262.78 Aligned_cols=212 Identities=24% Similarity=0.313 Sum_probs=154.8
Q ss_pred cCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
++.++||||+++++++... ...|+||||++ ++|.+++.. .+++..+..++.|++.||+|||+.+
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~--- 146 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--- 146 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---
Confidence 5678999999999987543 35799999996 678877742 3889999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|+||||||+|||++.++.+||+|||+++.... ........||..|+|||++.+..++.++|||||||++|+|++|+.
T Consensus 147 ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 223 (364)
T cd07875 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 223 (364)
T ss_pred eecCCCCHHHEEECCCCcEEEEeCCCccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCC
Confidence 99999999999999999999999999975322 112234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhh-h--------h-------hhhcccccccccc-----ccCCcc---CCCCChHHHHHHHHHHHHchh
Q 020529 156 AIDSTRPHGEQNLV-T--------W-------ARPLFNDRRKFSK-----LADPRL---EGRYPIRGLYQALAVASMCIQ 211 (325)
Q Consensus 156 p~~~~~~~~~~~~~-~--------~-------~~~~~~~~~~~~~-----~~d~~l---~~~~~~~~~~~~~~l~~~cl~ 211 (325)
||...........+ . + ..........+.. .+...+ ...........+.+|+.+||+
T Consensus 224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 303 (364)
T cd07875 224 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 303 (364)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcC
Confidence 99764322110000 0 0 0000000000000 000000 000011123567899999999
Q ss_pred hCCCCCCCHHHHHHH
Q 020529 212 EQAATRPLIGDVVTA 226 (325)
Q Consensus 212 ~~p~~RPs~~evl~~ 226 (325)
.||.+|||+.++++.
T Consensus 304 ~dP~~R~t~~e~L~h 318 (364)
T cd07875 304 IDASKRISVDEALQH 318 (364)
T ss_pred cCcccCCCHHHHhcC
Confidence 999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=254.60 Aligned_cols=216 Identities=22% Similarity=0.331 Sum_probs=158.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++...+..++||||++ ++|.+++.. ....+++..++.++.+++.||+|||+.+ |+|+||
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dl 130 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDL 130 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCC
Confidence 578899999999999999999999999997 699998875 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.++|+|||++....... .......+++.|+|||++.+. .++.++|||||||++|+|++|++||...
T Consensus 131 kp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~ 208 (301)
T cd07873 131 KPQNLLINERGELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGS 208 (301)
T ss_pred CHHHEEECCCCcEEECcCcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999987533221 112234568899999998754 5788999999999999999999999765
Q ss_pred CCCCcchhh-hhh-------hhccccccccccccCCccCCCC----ChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLV-TWA-------RPLFNDRRKFSKLADPRLEGRY----PIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~-~~~-------~~~~~~~~~~~~~~d~~l~~~~----~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
......... ... ++.+.....+.....+.....+ .......+.+|+.+||+.||.+|||+.||++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 209 TVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred CHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 332111000 000 0000000000000001100000 11223467899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=249.58 Aligned_cols=203 Identities=23% Similarity=0.282 Sum_probs=162.6
Q ss_pred cCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----cCCCC
Q 020529 2 LSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH-----DKANP 74 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH-----~~~~~ 74 (325)
|++++||||+++++++.. +...+++|||+++++|.+++.........+++..++.++.+++.||.||| +.+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~-- 130 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT-- 130 (265)
T ss_pred HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--
Confidence 678899999999998754 45679999999999999999765444567999999999999999999999 777
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCC
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~ 154 (325)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++....++.++||||||+++++|++|.
T Consensus 131 -i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 207 (265)
T cd08217 131 -VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207 (265)
T ss_pred -ceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCC
Confidence 99999999999999999999999999986543221 123346899999999999988999999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.||..... ..+.... . .... ...+......+.+++.+|++.+|.+||++.+|++.
T Consensus 208 ~p~~~~~~---~~~~~~~---~-------~~~~----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 208 PPFTARNQ---LQLASKI---K-------EGKF----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CcccCcCH---HHHHHHH---h-------cCCC----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 99976431 1111111 0 0000 11222344678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=256.54 Aligned_cols=200 Identities=23% Similarity=0.344 Sum_probs=159.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++..++..++||||+++++|.+++.. ..+++.+++.++.+++.||+|||+.+ |+||||
T Consensus 73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dl 144 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDI 144 (292)
T ss_pred HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCC
Confidence 5678999999999999999999999999999999998853 34899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++...... ........|+..|+|||++....++.++||||||++++||++|+.||....
T Consensus 145 kp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 145 KSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred CHHHEEEcCCCCEEEccCcchhhcccc--cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998753322 112234568899999999988889999999999999999999999986533
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... +. - +.....+.+... ......+..++.+|+..+|.+||++.++++.
T Consensus 223 ~~~~--~~-~----------~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 223 PLQA--MR-R----------IRDNLPPRVKDS--HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHH--HH-H----------HHhcCCCccccc--cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2111 00 0 001111111110 1123467789999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=252.48 Aligned_cols=206 Identities=27% Similarity=0.342 Sum_probs=157.4
Q ss_pred cCCC-CCCCccceeeEEE-----eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLL-HHSNLVNLIGYCA-----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
++.+ +||||+++++++. .++..++||||+++++|.+++.........+++..+..++.+++.||.|||+.+
T Consensus 68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--- 144 (286)
T cd06638 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--- 144 (286)
T ss_pred HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 4556 6999999999884 345789999999999999988653333456899999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-----CCCCccccEEEehHHHHHH
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~el 150 (325)
++||||||+||+++.++.++|+|||+++...... .......|++.|+|||++.. ..++.++|||||||+++||
T Consensus 145 i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el 222 (286)
T cd06638 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222 (286)
T ss_pred ccccCCCHHhEEECCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHH
Confidence 9999999999999999999999999987543221 12233468999999998753 4578899999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
++|..||........ +.... . .......++. .....+.+++.+||+.+|.+||++.||++.+
T Consensus 223 ~~g~~p~~~~~~~~~--~~~~~----~--~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 223 GDGDPPLADLHPMRA--LFKIP----R--NPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hcCCCCCCCCchhHH--Hhhcc----c--cCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 999999875432111 11000 0 0001111111 1234688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=256.69 Aligned_cols=205 Identities=21% Similarity=0.221 Sum_probs=154.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||++++++|.+++..|+||||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 128 (331)
T cd05597 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDI 128 (331)
T ss_pred HHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCC
Confidence 4567999999999999999999999999999999999965 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-----CCCCccccEEEehHHHHHHHhCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
||+|||++.++.+||+|||++....... ........||+.|+|||++.. ..++.++|||||||++|+|++|+.|
T Consensus 129 kp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~P 207 (331)
T cd05597 129 KPDNVLLDKNGHIRLADFGSCLRLLADG-TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred CHHHEEECCCCCEEEEECCceeecCCCC-CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCC
Confidence 9999999999999999999986533221 112233569999999999873 4578899999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCC--CCCCCHHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQA--ATRPLIGDVVTA 226 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p--~~RPs~~evl~~ 226 (325)
|....... ....+......+ .+ +... ......+.+++.+||..++ ..||++.++++.
T Consensus 208 f~~~~~~~------~~~~i~~~~~~~-~~--~~~~----~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 208 FYAESLVE------TYGKIMNHKEHF-QF--PPDV----TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCCCHHH------HHHHHHcCCCcc-cC--CCcc----CCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 96543211 111111110000 00 0000 1123456778888775433 348899998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=250.65 Aligned_cols=211 Identities=25% Similarity=0.314 Sum_probs=162.0
Q ss_pred CcCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
+|++++||||++++++|.+. ...++||||+++++|.+++.........+++..+..++.+++.||+|||+.+ ++|
T Consensus 52 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H 128 (287)
T cd06621 52 INKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIH 128 (287)
T ss_pred HHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 36788999999999998653 4789999999999999987654444566899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||.
T Consensus 129 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (287)
T cd06621 129 RDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204 (287)
T ss_pred CCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986532211 123457889999999998899999999999999999999999997
Q ss_pred CCCCC--CcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPH--GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..... ....+..+..... . ..+.+. .. ........+.+++.+||..+|.+||++.||++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~--~---~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 205 PEGEPPLGPIELLSYIVNMP--N---PELKDE-PG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cccCCCCChHHHHHHHhcCC--c---hhhccC-CC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 65321 1112222211100 0 011000 00 001234568899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=254.36 Aligned_cols=200 Identities=25% Similarity=0.362 Sum_probs=160.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||++++++|..++..++||||+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++||||
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL 141 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDI 141 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999854 35889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++....... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||....
T Consensus 142 ~p~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~ 219 (297)
T cd06656 142 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (297)
T ss_pred CHHHEEECCCCCEEECcCccceEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987533221 12233468889999999998889999999999999999999999996643
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+...... .... . .+.+ ..+......+.+++.+||+.+|.+||++.+|++.
T Consensus 220 ~~~~~~~------~~~~--~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 220 PLRALYL------IATN--G-----TPEL--QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cchheee------eccC--C-----CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3211100 0000 0 0000 0111223457789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=248.47 Aligned_cols=201 Identities=26% Similarity=0.362 Sum_probs=154.1
Q ss_pred CcCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
+|++++||||+++++++.+ ....++++||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|
T Consensus 57 ~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H 129 (266)
T cd06651 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVH 129 (266)
T ss_pred HHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 3678899999999999875 3678899999999999999975 345899999999999999999999998 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
+||+|+||+++.++.++|+|||+++........ .......++..|+|||++.+..++.++|||||||+++||++|+.||
T Consensus 130 ~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf 209 (266)
T cd06651 130 RDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209 (266)
T ss_pred CCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCc
Confidence 999999999999999999999998754321111 1122345888999999999988999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
....... .+. ... .....+ ..+......+..++ .|+..+|.+||+++||++
T Consensus 210 ~~~~~~~--~~~----~~~------~~~~~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 210 AEYEAMA--AIF----KIA------TQPTNP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred cccchHH--HHH----HHh------cCCCCC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 6542111 000 000 000011 11222233455566 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=259.25 Aligned_cols=200 Identities=24% Similarity=0.244 Sum_probs=165.9
Q ss_pred CcCCCC-CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
||++|+ |||||.++++|++....++|||++.||.|.+.+... .+++..+..++.+++.++.|||+.+ |+||
T Consensus 88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHr 159 (382)
T KOG0032|consen 88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHR 159 (382)
T ss_pred HHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceec
Confidence 477887 999999999999999999999999999999999763 3999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCC----CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 80 DFKSSNILLEEG----FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 80 dik~~Nill~~~----~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
||||+|+|+... +.+|++|||++..... .......+||+.|+|||++....++..+||||+|+++|.|++|..
T Consensus 160 DlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 160 DLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred cCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCC
Confidence 999999999533 4799999999987543 345667889999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
||...........+ .... ..+.+ .+-......+.+++..||..||..|+++.++++
T Consensus 237 PF~~~~~~~~~~~i------~~~~---~~f~~-----~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 237 PFWGETEFEIFLAI------LRGD---FDFTS-----EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred CCcCCChhHHHHHH------HcCC---CCCCC-----CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 99876543222111 1000 01111 111233567889999999999999999999998
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=249.86 Aligned_cols=204 Identities=27% Similarity=0.373 Sum_probs=157.6
Q ss_pred cCCC-CCCCccceeeEEEeCC------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
++++ +||||+++++++.... ..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~-- 133 (275)
T cd06608 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK-- 133 (275)
T ss_pred HHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--
Confidence 4556 7999999999996544 589999999999999998764433567999999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-----CCCCccccEEEehHHHHH
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~e 149 (325)
++|+||+|+||+++.++.++|+|||++...... ........|+..|+|||++.. ..++.++||||||+++++
T Consensus 134 -i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~ 210 (275)
T cd06608 134 -VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210 (275)
T ss_pred -cccCCCCHHHEEEccCCeEEECCCccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHH
Confidence 999999999999999999999999998653322 122234568899999998754 346789999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 150 LITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|++|+.||....... .+... . ....+.+ ..+......+.+++.+||..||++||++.+|++
T Consensus 211 l~~g~~p~~~~~~~~--~~~~~----~-------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 211 LADGKPPLCDMHPMR--ALFKI----P-------RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHhCCCCccccchHH--HHHHh----h-------ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 999999996432211 11110 0 0000111 111223457889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=251.70 Aligned_cols=203 Identities=23% Similarity=0.328 Sum_probs=159.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++..+...++||||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ |+|+|
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~d 128 (280)
T cd06611 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRD 128 (280)
T ss_pred HHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 36788999999999999999999999999999999999865 2346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHHHHhCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||+||+++.++.++|+|||++...... ........+++.|+|||++. ...++.++||||||+++|+|++|+.
T Consensus 129 l~p~nili~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~ 206 (280)
T cd06611 129 LKAGNILLTLDGDVKLADFGVSAKNKST--LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206 (280)
T ss_pred CChhhEEECCCCCEEEccCccchhhccc--ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 9999999999999999999988653222 11223456899999999975 3457789999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
||....... .+..+ .. ...+.+ ..+......+.+++..||+.+|.+||++.+|++.
T Consensus 207 p~~~~~~~~--~~~~~----~~-------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 207 PHHELNPMR--VLLKI----LK-------SEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CcccCCHHH--HHHHH----hc-------CCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 997643221 11111 00 000111 0111223567899999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=256.62 Aligned_cols=205 Identities=20% Similarity=0.203 Sum_probs=155.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++.+.+..|+||||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||
T Consensus 55 l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDl 128 (331)
T cd05624 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDI 128 (331)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccC
Confidence 4567999999999999999999999999999999999975 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-----CCCCccccEEEehHHHHHHHhCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
||+|||++.++.+||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 129 kp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~P 207 (331)
T cd05624 129 KPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207 (331)
T ss_pred chHHEEEcCCCCEEEEeccceeeccCCC-ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCC
Confidence 9999999999999999999987543222 112234569999999999876 4678899999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCC--CCCHHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVTA 226 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPs~~evl~~ 226 (325)
|....... ....+......+ . +.+.+ ......+.+++.+||...+.+ |+++.++++.
T Consensus 208 f~~~~~~~------~~~~i~~~~~~~-~-~p~~~-----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 208 FYAESLVE------TYGKIMNHEERF-Q-FPSHI-----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ccCCCHHH------HHHHHHcCCCcc-c-CCCcc-----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 97543211 111111100000 0 00000 122456788999988865544 5678888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=251.32 Aligned_cols=209 Identities=24% Similarity=0.375 Sum_probs=164.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrd 80 (325)
++.++||||+++++++......++||||+++++|.+++.. ...+++..+..++.+++.||.|||+ .+ ++|+|
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~d 129 (284)
T cd06620 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRD 129 (284)
T ss_pred HHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccC
Confidence 5678999999999999999999999999999999999865 3468999999999999999999997 46 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|+|+||+++.++.++|+|||++...... ......|+..|+|||++.+..++.++|||||||++++|++|..||...
T Consensus 130 l~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~ 205 (284)
T cd06620 130 IKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFS 205 (284)
T ss_pred CCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999998643211 122356899999999998889999999999999999999999999865
Q ss_pred CCCCc-----chhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 161 RPHGE-----QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 161 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
..... ..+..+........ .+.+. .......+.+|+.+|++.+|.+||++.||++....+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 206 NIDDDGQDDPMGILDLLQQIVQEP-------PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred chhhhhhhhhhHHHHHHHHHhhcc-------CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 43211 11112222221110 01110 0113356889999999999999999999998765443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=247.77 Aligned_cols=200 Identities=26% Similarity=0.329 Sum_probs=160.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.++...++|+||+++++|.+++.. ...+++..+..++.+++.||+|||+.+ ++|+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl 119 (262)
T cd05572 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDL 119 (262)
T ss_pred HHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 5678999999999999999999999999999999999975 345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++....... ......|+..|++||.+....++.++|+||||+++|+|++|..||....
T Consensus 120 ~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 120 KPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred CHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 9999999999999999999997643322 2233467889999999988889999999999999999999999997654
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVT 225 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~ 225 (325)
... ........ +......++......+.+++.+||+.+|.+||+ +.|+++
T Consensus 197 ~~~----~~~~~~~~----------~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 197 EDP----MEIYNDIL----------KGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCH----HHHHHHHh----------ccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 211 11111111 001111122222467899999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=246.64 Aligned_cols=201 Identities=21% Similarity=0.314 Sum_probs=161.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++...+..++||||+.+++|.+++.... ...+++.+++.++.|++.||.|||+.+ ++|+|
T Consensus 52 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~ 126 (256)
T cd08218 52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRD 126 (256)
T ss_pred HHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 3678999999999999999999999999999999999986521 235789999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|+|+||+++.++.++|+|||++....... .......|++.|+|||+..+..++.++|+|||||++++|++|..||...
T Consensus 127 l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 127 IKSQNIFLTKDGTIKLGDFGIARVLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred CCHHHEEEcCCCCEEEeeccceeecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 99999999999999999999987543221 1122345888999999999889999999999999999999999998643
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
... ......... .. + ..+......+.+++.+||+.+|.+||++.+|++
T Consensus 205 ~~~------~~~~~~~~~------~~-~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 205 NMK------NLVLKIIRG------SY-P----PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CHH------HHHHHHhcC------CC-C----CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 211 111111110 00 0 112233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=248.00 Aligned_cols=210 Identities=24% Similarity=0.356 Sum_probs=160.6
Q ss_pred CcCCCCCCCccceeeEEEeCC------eeEEEEecCCCCCHHHHhccCCC--CCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPP--DKEALDWNTRMKIAAGAAKGLEYLHDKA 72 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~--~~~~l~~~~~~~i~~~l~~al~~LH~~~ 72 (325)
+|+.++||||+++++++.... ..+++++|+.+++|..++...+. ....+++..++.++.+++.||+|||+.+
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~ 133 (273)
T cd05074 54 CMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN 133 (273)
T ss_pred HHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 367889999999999986532 34788999999999988754221 2235899999999999999999999999
Q ss_pred CCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh
Q 020529 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt 152 (325)
|+||||||+||+++.++.++|+|||+++...............+++.|++||.+....++.++||||||+++|+|++
T Consensus 134 ---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~ 210 (273)
T cd05074 134 ---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210 (273)
T ss_pred ---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhh
Confidence 99999999999999999999999999976433222222223345678999999998889999999999999999999
Q ss_pred -CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 153 -GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 153 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
|..||...... .+..+... .. .. ..+......+.+++.+|++.+|++||++.+|++.|+.+
T Consensus 211 ~g~~p~~~~~~~---~~~~~~~~----~~---~~-------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 211 RGQTPYAGVENS---EIYNYLIK----GN---RL-------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCCCCCCCCCHH---HHHHHHHc----CC---cC-------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88888654321 11111110 00 00 01112335788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=251.58 Aligned_cols=205 Identities=28% Similarity=0.327 Sum_probs=157.1
Q ss_pred cCCC-CCCCccceeeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLL-HHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
++++ +||||+++++++... ...++||||+++++|.++++........+++..++.++.+++.||.|||+.+
T Consensus 72 l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--- 148 (291)
T cd06639 72 LQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--- 148 (291)
T ss_pred HHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 899999999998653 3689999999999999998654334556899999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC-----CCccccEEEehHHHHHH
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ-----LTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~ksDvwSlGvvl~el 150 (325)
++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++.... ++.++|||||||++|||
T Consensus 149 ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el 226 (291)
T cd06639 149 IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226 (291)
T ss_pred eeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHH
Confidence 99999999999999999999999999875432221 123346888999999876543 68899999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
++|+.||....... .+..+... ....+.+ +......+.+++.+|++.+|.+||++.++++.
T Consensus 227 ~~g~~p~~~~~~~~--~~~~~~~~------~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 227 GDGDPPLFDMHPVK--TLFKIPRN------PPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hhCCCCCCCCcHHH--HHHHHhcC------CCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 99999986543211 11111000 0011111 11233468899999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=251.25 Aligned_cols=216 Identities=22% Similarity=0.320 Sum_probs=156.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++++++||||+++++++.+.+..++||||++ ++|.+++... ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 56 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~d 128 (291)
T cd07844 56 LLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRD 128 (291)
T ss_pred HHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccc
Confidence 3678899999999999999999999999997 5999988752 346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+||+++.++.++|+|||+++...... .......++..|+|||++.+ ..++.++||||||+++++|++|+.||..
T Consensus 129 l~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 129 LKPQNLLISERGELKLADFGLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred CCHHHEEEcCCCCEEECccccccccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999986432211 11222346788999999875 4578999999999999999999999965
Q ss_pred CCCCCcc-hhhhhh-hh-------ccccccccccc-----cCCccCCCC-ChHHHHHHHHHHHHchhhCCCCCCCHHHHH
Q 020529 160 TRPHGEQ-NLVTWA-RP-------LFNDRRKFSKL-----ADPRLEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVV 224 (325)
Q Consensus 160 ~~~~~~~-~~~~~~-~~-------~~~~~~~~~~~-----~d~~l~~~~-~~~~~~~~~~l~~~cl~~~p~~RPs~~evl 224 (325)
....... ...... .. ........... ....+.... .......+.+++.+||+.+|.+||++.+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 207 STDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred CccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 4311100 000000 00 00000000000 000000000 011125778999999999999999999987
Q ss_pred H
Q 020529 225 T 225 (325)
Q Consensus 225 ~ 225 (325)
.
T Consensus 287 ~ 287 (291)
T cd07844 287 K 287 (291)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=278.37 Aligned_cols=213 Identities=20% Similarity=0.252 Sum_probs=162.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-------DKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+++++||||+++++++.+++..++||||++|++|.+++..... ....+++..++.++.+++.||+|||+.+
T Consensus 56 Ls~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G-- 133 (932)
T PRK13184 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG-- 133 (932)
T ss_pred HHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 5678999999999999999999999999999999999864211 1234677889999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCC----------------CCccccccCCcCccCchhhccCCCCccc
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK----------------SHVSTRVMGTYGYCAPEYAMTGQLTVKS 138 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~ks 138 (325)
|+||||||+||+++.++.++|+|||+++....... ........||+.|+|||++.+..++.++
T Consensus 134 -IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kS 212 (932)
T PRK13184 134 -VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST 212 (932)
T ss_pred -ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHh
Confidence 99999999999999999999999999976421110 0111235699999999999999999999
Q ss_pred cEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC
Q 020529 139 DVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 218 (325)
Q Consensus 139 DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP 218 (325)
|||||||+++||+||..||........ . . .. ...++..... .......+.+++.+||+.+|++||
T Consensus 213 DIWSLGVILyELLTG~~PF~~~~~~ki---~-~-~~---------~i~~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ 277 (932)
T PRK13184 213 DIYALGVILYQMLTLSFPYRRKKGRKI---S-Y-RD---------VILSPIEVAP-YREIPPFLSQIAMKALAVDPAERY 277 (932)
T ss_pred HHHHHHHHHHHHHHCCCCCCCcchhhh---h-h-hh---------hccChhhccc-cccCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999965322111 0 0 00 0001100000 012234577899999999999996
Q ss_pred C-HHHHHHHHHhhhc
Q 020529 219 L-IGDVVTALSYLAN 232 (325)
Q Consensus 219 s-~~evl~~L~~~~~ 232 (325)
+ +.++++.|+....
T Consensus 278 ss~eeLl~~Le~~lq 292 (932)
T PRK13184 278 SSVQELKQDLEPHLQ 292 (932)
T ss_pred CHHHHHHHHHHHHHh
Confidence 5 7777777776654
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=254.34 Aligned_cols=205 Identities=22% Similarity=0.308 Sum_probs=159.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++||||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 127 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDL 127 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999965 346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCC-------------CccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKS-------------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
||+||+++.++.++|+|||+++........ .......|+..|+|||.+....++.++||||||+++|
T Consensus 128 ~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~ 207 (305)
T cd05609 128 KPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILY 207 (305)
T ss_pred chHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHH
Confidence 999999999999999999998742211100 0111245788999999998888999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 149 ELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 149 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
||++|..||....... +...... .....+.... .....+.+++.+||+.+|.+||+..++.+.|+
T Consensus 208 el~~g~~pf~~~~~~~------~~~~~~~-----~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 208 EFLVGCVPFFGDTPEE------LFGQVIS-----DDIEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHhCCCCCCCCCHHH------HHHHHHh-----cccCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 9999999996542211 1111110 0011111111 12346789999999999999999766666664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=251.79 Aligned_cols=214 Identities=19% Similarity=0.212 Sum_probs=155.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+....++|+||+. ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl 125 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDL 125 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCC
Confidence 567899999999999999999999999996 688888764 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.++|+|||+++...... .......++..|+|||++.+. .++.++|||||||++++|++|..|+...
T Consensus 126 ~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 126 KPQNLLINKNGELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred CHHHEEEcCCCcEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 9999999999999999999987543221 112234578899999998765 4689999999999999999998886432
Q ss_pred CCCCcchhhhhh----------hhccccccccccc--cCCcc-CCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWA----------RPLFNDRRKFSKL--ADPRL-EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~----------~~~~~~~~~~~~~--~d~~l-~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.... ..+.... ++........... ..... ...........+.+++.+||+.+|.+|||+++++.
T Consensus 204 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 204 NDVD-DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCHH-HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 2211 0000000 0000000000000 00000 00011123457789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=254.54 Aligned_cols=200 Identities=23% Similarity=0.317 Sum_probs=159.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.+.||||+++++++..++..++||||+++++|..++.. ..+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl 143 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDI 143 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999998743 45899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 144 ~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 144 KSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred CHHHeEEccCCcEEEeechhHhhccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999986533221 12234568899999999998899999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... +. .... . ..+... ........+.+++..||+.+|.+||++.+|++.
T Consensus 222 ~~~~--~~-~~~~----~------~~~~~~--~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 222 PVQA--MK-RLRD----S------PPPKLK--NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHH--HH-HHhc----c------CCCCcc--ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 2111 10 0000 0 000000 011223467899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=245.25 Aligned_cols=207 Identities=30% Similarity=0.410 Sum_probs=163.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++.+..++..++|||++++++|.+++....+ ...+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l 128 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDI 128 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999976322 245899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCC--ccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSH--VSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
+|+||++++++.++|+|||++.......... ......|+..|+|||++... .++.++|+||||+++++|++|+.||.
T Consensus 129 ~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~ 208 (267)
T cd06610 129 KAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208 (267)
T ss_pred CHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcc
Confidence 9999999999999999999987654433221 23445689999999998877 78999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCC-ChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY-PIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
....... +...... . .+.+.... .......+.+++.+||+.+|.+||++.+|++
T Consensus 209 ~~~~~~~--~~~~~~~---~--------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 209 KYPPMKV--LMLTLQN---D--------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccChhhh--HHHHhcC---C--------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 6533211 1111110 0 01111000 0123467889999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=256.81 Aligned_cols=202 Identities=23% Similarity=0.337 Sum_probs=161.5
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|.+| .|.+|+++++|-..++.+||||||-+ .+|..+|..... ...+| .++.+..|++.|+.+.|.++ |||.|
T Consensus 413 L~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~--~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSD 485 (677)
T KOG0596|consen 413 LNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKS--IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSD 485 (677)
T ss_pred HHHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccC--CCchH-HHHHHHHHHHHHHHHHHHhc---eeecC
Confidence 4456 68999999999999999999999874 999999986321 22234 78889999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-----------CCCccccEEEehHHHHH
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-----------QLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~ksDvwSlGvvl~e 149 (325)
|||.|+|+-. |.+||+|||+|...............+||+.||+||.+... +.+.++||||||||||+
T Consensus 486 LKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYq 564 (677)
T KOG0596|consen 486 LKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQ 564 (677)
T ss_pred CCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHH
Confidence 9999998874 57999999999988777777777889999999999988643 25689999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChH-HHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 150 LITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIR-GLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|+.|+.||.... +.. ..+..+.||.-.-.||.- ....+++++..||+.||++||++.|+|+.
T Consensus 565 MvYgktPf~~~~-----n~~----------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 565 MVYGKTPFGQII-----NQI----------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHhcCCchHHHH-----HHH----------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 999999995421 111 123445555443333321 22338999999999999999999999874
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=248.98 Aligned_cols=194 Identities=27% Similarity=0.386 Sum_probs=158.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl 127 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDL 127 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCC
Confidence 6788999999999999999999999999999999999975 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++...... .....|++.|+|||.+.+...+.++||||||+++++|++|..||....
T Consensus 128 ~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 128 KPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred CHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998764322 234468899999999988889999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 225 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~ 225 (325)
... .. ........ .++......+.+++.+||+.+|.+|| +++|+++
T Consensus 203 ~~~---~~---~~~~~~~~------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 203 PIQ---IY---EKILEGKV------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred HHH---HH---HHHhcCCc------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111 00 00111000 11112235678999999999999999 6777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=252.40 Aligned_cols=221 Identities=21% Similarity=0.250 Sum_probs=159.4
Q ss_pred CcCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPD-KEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
+|++++||||+++++++.+. ...++||||+. ++|.+++...... ...+++..++.++.|++.||.|||+.+ |+
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~ 130 (316)
T cd07842 55 LLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VL 130 (316)
T ss_pred HHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---Ee
Confidence 36778999999999999888 88999999996 6787777543322 237899999999999999999999999 99
Q ss_pred eCCCCCCcEEEcC----CCeEEEecCCCCccCCCCCC-CCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHH
Q 020529 78 YRDFKSSNILLEE----GFHPKLSDFGLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELI 151 (325)
Q Consensus 78 Hrdik~~Nill~~----~~~~kL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~ell 151 (325)
||||||+||+++. ++.+||+|||++........ ........++..|+|||++.+. .++.++||||||+++++|+
T Consensus 131 h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 210 (316)
T cd07842 131 HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (316)
T ss_pred eCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999 89999999999976433222 1122345678899999988764 5789999999999999999
Q ss_pred hCCCCCCCCCCCCcc-------hhhhhhhhcc----------ccccccccccCCccCCCCC---------h--HHHHHHH
Q 020529 152 TGRKAIDSTRPHGEQ-------NLVTWARPLF----------NDRRKFSKLADPRLEGRYP---------I--RGLYQAL 203 (325)
Q Consensus 152 tg~~p~~~~~~~~~~-------~~~~~~~~~~----------~~~~~~~~~~d~~l~~~~~---------~--~~~~~~~ 203 (325)
+|+.||......... .+......+- ..........+......++ . .....+.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (316)
T cd07842 211 TLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290 (316)
T ss_pred hcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHH
Confidence 999999765433200 0000000000 0000000000000001111 0 2335688
Q ss_pred HHHHHchhhCCCCCCCHHHHHH
Q 020529 204 AVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 204 ~l~~~cl~~~p~~RPs~~evl~ 225 (325)
+++.+||+.+|++||++.+++.
T Consensus 291 ~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 291 DLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHhcCCcccCcCHHHHhc
Confidence 9999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=253.49 Aligned_cols=198 Identities=22% Similarity=0.319 Sum_probs=166.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++|||||++|.+......+|||.|+-++|+|.+|+-. ....+.+....+++.||+.|+.|+|... ||||||
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDL 144 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDL 144 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccC
Confidence 4567999999999999999999999999999999999976 4567999999999999999999999998 999999
Q ss_pred CCCcEEEc-CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCC-ccccEEEehHHHHHHHhCCCCCCC
Q 020529 82 KSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT-VKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 82 k~~Nill~-~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
||+||.+. +-|-+||.|||++..+..+. ..+..+|+..|-|||++.+..|. +..||||||||||-|++|++||+.
T Consensus 145 KPENVVFFEKlGlVKLTDFGFSNkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe 221 (864)
T KOG4717|consen 145 KPENVVFFEKLGLVKLTDFGFSNKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE 221 (864)
T ss_pred CcceeEEeeecCceEeeeccccccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence 99998765 55789999999997665543 34567899999999999999886 578999999999999999999988
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.+..+... .++| ..-..|.....+|.+||..||..||++|.+.+||+..
T Consensus 222 ANDSETLT----------------mImD--CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 222 ANDSETLT----------------MIMD--CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ccchhhhh----------------hhhc--ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 76433221 1111 1112345567899999999999999999999998763
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=245.11 Aligned_cols=198 Identities=27% Similarity=0.383 Sum_probs=159.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+....++|+||+++++|.+++.. ...+++..++.++.+++.||+|||+.+ |+|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 128 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDI 128 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999975 345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC-CCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
+|+||+++.++.+||+|||++....... ......|+..|+|||.+.... ++.++|+||||+++++|++|..||...
T Consensus 129 ~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 129 KGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred CHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 9999999999999999999987543222 233456889999999987776 899999999999999999999999654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
... .....+.. . ... + ..+......+.+++.+||+.+|.+||++.+++.
T Consensus 206 ~~~--~~~~~~~~--~---~~~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 206 EGV--AAVFKIGR--S---KEL-----P----PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cHH--HHHHHHHh--c---ccC-----C----CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 311 11111100 0 000 0 111122356788999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=244.38 Aligned_cols=200 Identities=24% Similarity=0.389 Sum_probs=159.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++..++..++||||+++++|.+++.... ...+++..++.++.+++.||+|||+.+ ++|+|
T Consensus 52 ~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~d 126 (256)
T cd08220 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRD 126 (256)
T ss_pred HHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 3678899999999999999999999999999999999997622 345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCC-CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEG-FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~-~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|+|+||+++.+ +.++|+|||++....... ......|+..|+|||.+.+..++.++||||||+++++|++|+.||..
T Consensus 127 l~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 127 LKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred CCHHHEEEcCCCCEEEEccCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 99999999855 468999999997543221 22235688899999999988899999999999999999999999865
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
..... .. ...... ... ..+......+.+++..||+.+|.+||++.+++.
T Consensus 204 ~~~~~---~~---~~~~~~--~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 204 ANLPA---LV---LKIMSG--TFA---------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CchHH---HH---HHHHhc--CCC---------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 43211 11 111100 000 011123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=267.65 Aligned_cols=209 Identities=20% Similarity=0.264 Sum_probs=151.9
Q ss_pred CCCCCccceeeEEEeC-CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCCCC
Q 020529 5 LHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFK 82 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrdik 82 (325)
.+|++|++++++|... .+.|+||+++ +++|.+++.. ...+++..+..|+.||+.||.|||+ .+ |||||||
T Consensus 188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlK 259 (467)
T PTZ00284 188 ADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLK 259 (467)
T ss_pred ccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence 3567799999998764 5789999998 6899998865 4569999999999999999999997 48 9999999
Q ss_pred CCcEEEcCCC----------------eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHH
Q 020529 83 SSNILLEEGF----------------HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146 (325)
Q Consensus 83 ~~Nill~~~~----------------~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvv 146 (325)
|+|||++.++ .+||+|||++... ........||+.|+|||++.+..++.++|||||||+
T Consensus 260 P~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvi 334 (467)
T PTZ00284 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCI 334 (467)
T ss_pred HHHEEEecCCcccccccccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHH
Confidence 9999998765 4999999987532 222345679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchhhh---------hhh--------hccccccccccccCCcc-----CCC-C-ChHHHHHH
Q 020529 147 FLELITGRKAIDSTRPHGEQNLVT---------WAR--------PLFNDRRKFSKLADPRL-----EGR-Y-PIRGLYQA 202 (325)
Q Consensus 147 l~elltg~~p~~~~~~~~~~~~~~---------~~~--------~~~~~~~~~~~~~d~~l-----~~~-~-~~~~~~~~ 202 (325)
+|||++|+.||+.........++. |.. .++.....+....++.. ... . .......+
T Consensus 335 l~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (467)
T PTZ00284 335 IYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLL 414 (467)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHH
Confidence 999999999997654322111111 100 00000000000001000 000 0 00012456
Q ss_pred HHHHHHchhhCCCCCCCHHHHHHH
Q 020529 203 LAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 203 ~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.+|+.+||+.||.+||++.|+++.
T Consensus 415 ~dli~~mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 415 CDLIYGLLHYDRQKRLNARQMTTH 438 (467)
T ss_pred HHHHHHhCCcChhhCCCHHHHhcC
Confidence 799999999999999999999974
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=248.42 Aligned_cols=203 Identities=28% Similarity=0.331 Sum_probs=157.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivHrd 80 (325)
++.++||||+++++++..+...++||||++ ++|.+++.........+++.+++.++.|++.||+|||++ + ++|||
T Consensus 54 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~d 129 (283)
T cd06617 54 MRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRD 129 (283)
T ss_pred HHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCC
Confidence 356789999999999999999999999996 789888876444456799999999999999999999987 7 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc----CCCCccccEEEehHHHHHHHhCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT----GQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
|||+||+++.++.+||+|||++...... .......|+..|+|||++.+ ..++.++|+||||+++|+|++|+.|
T Consensus 130 lkp~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 206 (283)
T cd06617 130 VKPSNVLINRNGQVKLCDFGISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206 (283)
T ss_pred CCHHHEEECCCCCEEEeecccccccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCC
Confidence 9999999999999999999998754221 12233468889999998865 4568899999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|...... ...+... .. ...+.+. .......+.+++.+||..+|.+||++.+|++.
T Consensus 207 ~~~~~~~-~~~~~~~----~~-------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 207 YDSWKTP-FQQLKQV----VE-------EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCccccC-HHHHHHH----Hh-------cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 8643211 0111100 00 0001110 01123568899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=268.99 Aligned_cols=221 Identities=19% Similarity=0.175 Sum_probs=155.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++||||+++++++...+..|+|++++. ++|..++..... .........+..|+.|++.||.|||+.+ ||||
T Consensus 216 il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHr 291 (501)
T PHA03210 216 ALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHR 291 (501)
T ss_pred HHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 3678899999999999999999999999995 778777654211 1223445677889999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCC-CC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA-ID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p-~~ 158 (325)
||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|..+ +.
T Consensus 292 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~ 370 (501)
T PHA03210 292 DIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIG 370 (501)
T ss_pred CCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCcc
Confidence 9999999999999999999999976533221 122345799999999999999999999999999999999998754 43
Q ss_pred CCCCCCcchhhhhhhhccccccccc-------cccCCc-c---CCCCC-----hHHHHHHHHHHHHchhhCCCCCCCHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFS-------KLADPR-L---EGRYP-----IRGLYQALAVASMCIQEQAATRPLIGD 222 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~d~~-l---~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPs~~e 222 (325)
.........+......+......+. ..++.. + ....+ ......+.+++.+||+.||++||++.|
T Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~e 450 (501)
T PHA03210 371 DGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAE 450 (501)
T ss_pred CCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHH
Confidence 3322221222111111000000000 000000 0 00000 011235677899999999999999999
Q ss_pred HHHH
Q 020529 223 VVTA 226 (325)
Q Consensus 223 vl~~ 226 (325)
++..
T Consensus 451 lL~h 454 (501)
T PHA03210 451 LLAL 454 (501)
T ss_pred HhhC
Confidence 9874
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=252.76 Aligned_cols=203 Identities=25% Similarity=0.295 Sum_probs=159.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+....|+||||+.+++|.+++...+ ...+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 129 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDL 129 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 567899999999999999999999999999999999987522 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCC---------------------------CccccccCCcCccCchhhccCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKS---------------------------HVSTRVMGTYGYCAPEYAMTGQL 134 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~ 134 (325)
||+||+++.++.++|+|||++......... .......|+..|+|||++.+..+
T Consensus 130 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~ 209 (316)
T cd05574 130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209 (316)
T ss_pred ChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC
Confidence 999999999999999999998754322110 01123468889999999999899
Q ss_pred CccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCC
Q 020529 135 TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQA 214 (325)
Q Consensus 135 ~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p 214 (325)
+.++||||||+++|+|++|..||........ +. ... .....-.........+.+++.+||+.+|
T Consensus 210 ~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~----~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 210 GSAVDWWTLGILLYEMLYGTTPFKGSNRDET--FS----NIL----------KKEVTFPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred CchHHHHHHHHHHHHHhhCCCCCCCCchHHH--HH----HHh----------cCCccCCCccccCHHHHHHHHHHccCCH
Confidence 9999999999999999999999975532211 10 001 0000000001134678999999999999
Q ss_pred CCCCC----HHHHHH
Q 020529 215 ATRPL----IGDVVT 225 (325)
Q Consensus 215 ~~RPs----~~evl~ 225 (325)
.+||+ +.+++.
T Consensus 274 ~~R~s~~~~~~~ll~ 288 (316)
T cd05574 274 SKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHCCCchhhHHHHHc
Confidence 99999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=249.75 Aligned_cols=199 Identities=23% Similarity=0.333 Sum_probs=159.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++...++.++|+||+++++|.+++.. ..+++..++.++.+++.||+|||+.+ ++||||
T Consensus 70 l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl 141 (285)
T cd06648 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDI 141 (285)
T ss_pred HHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999864 35899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++...... ........|++.|+|||++.+..++.++||||||+++++|++|..||....
T Consensus 142 ~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 142 KSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred ChhhEEEcCCCcEEEcccccchhhccC--CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 999999999999999999988653322 112233568999999999988889999999999999999999999986543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
+... ...... ...+.+.. +......+.+++.+||+.+|++||++.++++
T Consensus 220 ~~~~------~~~~~~-------~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 220 PLQA------MKRIRD-------NLPPKLKN--LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHH------HHHHHh-------cCCCCCcc--cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 2111 111110 00111110 1112356889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=257.79 Aligned_cols=209 Identities=20% Similarity=0.291 Sum_probs=153.4
Q ss_pred CcCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+|++++||||+++++++... ...|++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~-- 138 (343)
T cd07878 67 LLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG-- 138 (343)
T ss_pred HHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 36788999999999987543 3568999998 7899988753 45999999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhC
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg 153 (325)
|+||||||+||+++.++.+||+|||+++.... ......||..|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 139 -ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 212 (343)
T cd07878 139 -IIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212 (343)
T ss_pred -eecccCChhhEEECCCCCEEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHC
Confidence 99999999999999999999999999975432 1234568999999999877 5689999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhhcccccc----------------ccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCC
Q 020529 154 RKAIDSTRPHGEQNLVTWARPLFNDRR----------------KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR 217 (325)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R 217 (325)
+.||........ +..+....-.... .+.......+...+ ......+.+|+.+||+.||.+|
T Consensus 213 ~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 213 KALFPGNDYIDQ--LKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred CCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhc-cCCCHHHHHHHHHHcCCChhhC
Confidence 999965432111 1110000000000 00000000000000 0112346799999999999999
Q ss_pred CCHHHHHHH
Q 020529 218 PLIGDVVTA 226 (325)
Q Consensus 218 Ps~~evl~~ 226 (325)
||+.++++.
T Consensus 290 ~s~~ell~h 298 (343)
T cd07878 290 ISASEALAH 298 (343)
T ss_pred CCHHHHhcC
Confidence 999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=247.69 Aligned_cols=197 Identities=22% Similarity=0.283 Sum_probs=157.0
Q ss_pred CCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCC
Q 020529 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKS 83 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~ 83 (325)
..+||||+.+++++...+..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp 125 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKP 125 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCH
Confidence 35799999999999999999999999999999999865 456999999999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCCCCC
Q 020529 84 SNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDSTRP 162 (325)
Q Consensus 84 ~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~~~~ 162 (325)
+||+++.++.++|+|||++...... ......|+..|+|||.+.+ ..++.++|||||||++++|++|..||.....
T Consensus 126 ~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 126 ANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred HHEEECCCCCEEEccCCcceecccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 9999999999999999998643221 1223468999999999864 5688999999999999999999999975432
Q ss_pred CCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 163 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
.....+... ... ... ..+......+.+++.+||..+|.+|| ++.++++.
T Consensus 202 ~~~~~~~~~---~~~--------~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 202 KDKHEIDRM---TLT--------VNV----ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCHHHHHHH---hhc--------CCc----CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 211111100 000 011 12223346788999999999999999 58888775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=246.36 Aligned_cols=198 Identities=22% Similarity=0.255 Sum_probs=157.0
Q ss_pred CCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCC
Q 020529 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 82 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik 82 (325)
..++||||+++++++..++..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~ 124 (260)
T cd05611 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIK 124 (260)
T ss_pred hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCC
Confidence 455899999999999999999999999999999999965 346899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCC
Q 020529 83 SSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 162 (325)
Q Consensus 83 ~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~ 162 (325)
|+||+++.++.++|+|||+++.... .....|+..|+|||.+.+..++.++||||||+++++|++|..||.....
T Consensus 125 p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 125 PENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred HHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999999999999999999875322 2334688899999999888889999999999999999999999965432
Q ss_pred CCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 163 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
... . ......... ..+.. .......+.+++.+||+.+|++||++..+.+.|
T Consensus 199 ~~~---~---~~~~~~~~~----~~~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 199 DAV---F---DNILSRRIN----WPEEV----KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHH---H---HHHHhcccC----CCCcc----cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 111 0 000000000 00001 112235688999999999999999876555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=249.10 Aligned_cols=215 Identities=23% Similarity=0.264 Sum_probs=159.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++++++||||+++++++.+.+..++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+|+|
T Consensus 55 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 127 (298)
T cd07841 55 LLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRD 127 (298)
T ss_pred HHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecC
Confidence 367789999999999999999999999999 89999999752 236999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|+|+||+++.++.++|+|||+++....... ......+++.|+|||.+.+ ..++.++|||||||+++||++|.+||..
T Consensus 128 l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 128 LKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred CChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 999999999999999999999976443221 2233456788999998865 4578999999999999999999887765
Q ss_pred CCCCCcchhhhhhhhc-------cccccccccccCCccCCCC-----ChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPL-------FNDRRKFSKLADPRLEGRY-----PIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~d~~l~~~~-----~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...... +....... +.................. .......+.+++.+||+.+|.+||++.+|+..
T Consensus 206 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 206 DSDIDQ--LGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred CccHHH--HHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 432111 10000000 0000000000000000011 11234678899999999999999999999983
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=245.55 Aligned_cols=201 Identities=23% Similarity=0.333 Sum_probs=164.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+....++||||+++++|.+++.........+++..++.++.+++.||+|||+.+ ++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l 129 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDL 129 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 57789999999999999999999999999999999998765444567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||+++..... ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||....
T Consensus 130 ~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 130 KSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred CcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999765433 2223457889999999999899999999999999999999999997643
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
... +... .. ... ....+.....++.+++..||+.+|.+||++.++++.
T Consensus 206 ~~~---~~~~---~~--~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 206 MQD---LRYK---VQ--RGK---------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred HHH---HHHH---Hh--cCC---------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 211 1100 00 000 011122344678999999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=245.03 Aligned_cols=200 Identities=25% Similarity=0.293 Sum_probs=155.8
Q ss_pred cCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++.+. ...++||||+++++|.+++.. ...+++..++.++.+++.||+|||+.+ |+|+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~ 130 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHR 130 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecC
Confidence 5778999999999998763 467899999999999999865 345889999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.++|+|||+++........ .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 131 dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 210 (265)
T cd06652 131 DIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA 210 (265)
T ss_pred CCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCC
Confidence 99999999999999999999998754321111 11223458889999999988889999999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...... .+. . .. ........+......+.+++.+|+. +|..||++++|++
T Consensus 211 ~~~~~~--~~~---~-~~----------~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 211 EFEAMA--AIF---K-IA----------TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ccchHH--HHH---H-Hh----------cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 432111 000 0 00 0000111233445677889999985 9999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=249.82 Aligned_cols=219 Identities=22% Similarity=0.254 Sum_probs=161.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..+++|||+++++|.+++.... ...+++..+..++.+++.||+|||+.+ |+||||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dl 127 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSV 127 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 567899999999999999999999999999999999997532 245889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCC-----CccccccCCcCccCchhhccC--CCCccccEEEehHHHHHHHhCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~ 154 (325)
||+||+++.++.++|+|||.+......... .......++..|+|||++... .++.++|||||||+++||++|.
T Consensus 128 k~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~ 207 (314)
T cd08216 128 KASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207 (314)
T ss_pred CcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCC
Confidence 999999999999999999988654322211 112334577889999998763 5789999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhh----hccc-----c-cccccc----ccCCcc----CCCCChHHHHHHHHHHHHchhhCCCC
Q 020529 155 KAIDSTRPHGEQNLVTWAR----PLFN-----D-RRKFSK----LADPRL----EGRYPIRGLYQALAVASMCIQEQAAT 216 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~----~~~~-----~-~~~~~~----~~d~~l----~~~~~~~~~~~~~~l~~~cl~~~p~~ 216 (325)
.||....... .+..-.. ..+. . ...... ..++.. ...........+.+++..||+.+|.+
T Consensus 208 ~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 285 (314)
T cd08216 208 VPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPES 285 (314)
T ss_pred CCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCc
Confidence 9997543211 1100000 0000 0 000000 001100 00111233457889999999999999
Q ss_pred CCCHHHHHHHH
Q 020529 217 RPLIGDVVTAL 227 (325)
Q Consensus 217 RPs~~evl~~L 227 (325)
||++.++++.-
T Consensus 286 Rpt~~~ll~~p 296 (314)
T cd08216 286 RPSASQLLNHS 296 (314)
T ss_pred CcCHHHHhcCc
Confidence 99999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=246.51 Aligned_cols=203 Identities=27% Similarity=0.409 Sum_probs=161.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrd 80 (325)
+++++||||+++++++......++|+||+++++|.+++... ...+++..+..++.+++.||+|||+ .+ ++|+|
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~d 126 (265)
T cd06605 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRD 126 (265)
T ss_pred HHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCC
Confidence 56789999999999999999999999999999999999762 2678999999999999999999999 88 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++||||||+++++|++|..||...
T Consensus 127 l~~~ni~~~~~~~~~l~d~g~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 127 VKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred CCHHHEEECCCCCEEEeecccchhhHHH----HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999998643211 111266888999999999999999999999999999999999999654
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChH-HHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIR-GLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... ............. ..+. .+.. ....+.+++..|+..+|.+||++.+++..
T Consensus 203 ~~~~-~~~~~~~~~~~~~-------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 203 NDPP-DGIFELLQYIVNE-------PPPR----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred cccc-ccHHHHHHHHhcC-------CCCC----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 3211 1111111111110 0011 1111 34568899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=248.70 Aligned_cols=214 Identities=21% Similarity=0.310 Sum_probs=159.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++..+...++||||+ +++|.+++.. ...++++.+++.++.+++.||+|||+.+ ++|+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 125 (286)
T cd07832 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDL 125 (286)
T ss_pred HHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCc
Confidence 56789999999999999999999999999 9999999875 2356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.++|+|||++........ .......|+..|+|||++.+. .++.++||||||++++||++|.++|...
T Consensus 126 ~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 126 KPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred CHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 99999999999999999999876543321 112334688999999998654 4689999999999999999998877654
Q ss_pred CCCCcchhhhhhhhccc-----------cccccccccCCccC----CCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFN-----------DRRKFSKLADPRLE----GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~d~~l~----~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
..... ..+....+. ..........+... .....+....+.+++.+||..+|.+||++++++.
T Consensus 205 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 205 NDIEQ---LAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CHHHH---HHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 32111 000000000 00000000000000 0000122367889999999999999999999986
Q ss_pred H
Q 020529 226 A 226 (325)
Q Consensus 226 ~ 226 (325)
.
T Consensus 282 h 282 (286)
T cd07832 282 H 282 (286)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=250.69 Aligned_cols=215 Identities=25% Similarity=0.347 Sum_probs=158.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++..+...++||||+++++|..+... ...+++..++.++.+++.||+|||+.+ ++|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l 126 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDI 126 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999998888887654 345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
+|+||++++++.++|+|||++....... .......++..|+|||++.+ ..++.++||||||++++||++|++||...
T Consensus 127 ~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 127 KPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred CHHHEEECCCCcEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999987543322 22233557889999999875 35788999999999999999999988654
Q ss_pred CCCCc-chhhhhhhhccc-------cccccccccCCccCC-----CCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGE-QNLVTWARPLFN-------DRRKFSKLADPRLEG-----RYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~-~~~~~~~~~~~~-------~~~~~~~~~d~~l~~-----~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
..... ..+..+...... ..........+.... .........+.+++.+||+.+|.+||++.+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 32111 011111000000 000000000111000 001123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=244.00 Aligned_cols=202 Identities=25% Similarity=0.330 Sum_probs=163.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrd 80 (325)
+++++||||+++++++......++||||+++++|.+++.. ...+++..++.++.+++.||+|||+ .+ ++|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~ 125 (264)
T cd06623 53 LRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRD 125 (264)
T ss_pred HHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCC
Confidence 5678999999999999999999999999999999999975 3668999999999999999999999 98 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|+|+||+++.++.++|+|||++........ ......++..|+|||.+....++.++||||||+++|+|++|..||...
T Consensus 126 l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 126 IKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred CCHHHEEECCCCCEEEccCccceecccCCC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999999999875432221 223456888999999999999999999999999999999999999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChH-HHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIR-GLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.......+..+.. ....+.+ +.. ....+.+++..||..+|++||++.++++.
T Consensus 204 ~~~~~~~~~~~~~----------~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 204 GQPSFFELMQAIC----------DGPPPSL----PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCHHHHHHHHh----------cCCCCCC----CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 4311111111111 0001111 112 34678899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=248.90 Aligned_cols=215 Identities=23% Similarity=0.335 Sum_probs=158.7
Q ss_pred cCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++... ...|+||||++ ++|.+++... ...+++..++.++.|++.||+|||+.+ ++|+
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~ 130 (293)
T cd07843 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHR 130 (293)
T ss_pred HHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 5678999999999998877 89999999997 6999988752 336899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.++|+|||++....... .......+++.|+|||.+.+. .++.++||||||+++++|++|..||.
T Consensus 131 dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 131 DLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred cCCHHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999987644322 122334578889999988764 46899999999999999999999997
Q ss_pred CCCCCCcch-hhhhhh-------hcccc----c-cccccccCCccCCCCChH-HHHHHHHHHHHchhhCCCCCCCHHHHH
Q 020529 159 STRPHGEQN-LVTWAR-------PLFND----R-RKFSKLADPRLEGRYPIR-GLYQALAVASMCIQEQAATRPLIGDVV 224 (325)
Q Consensus 159 ~~~~~~~~~-~~~~~~-------~~~~~----~-~~~~~~~d~~l~~~~~~~-~~~~~~~l~~~cl~~~p~~RPs~~evl 224 (325)
......... +..... +.+.. . ..........+...++.. ....+.+++.+||+.+|++||++.|++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 209 GKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred CCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 643321110 000000 00000 0 000111111112222222 345678999999999999999999998
Q ss_pred H
Q 020529 225 T 225 (325)
Q Consensus 225 ~ 225 (325)
.
T Consensus 289 ~ 289 (293)
T cd07843 289 K 289 (293)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=243.51 Aligned_cols=193 Identities=22% Similarity=0.292 Sum_probs=156.2
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
+||||++++++|...+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~n 139 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLEN 139 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHH
Confidence 799999999999999999999999999999999975 337999999999999999999999999 9999999999
Q ss_pred EEEcCCC-eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 86 ILLEEGF-HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 86 ill~~~~-~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
|+++.++ .++|+|||++..... .....|+..|+|||++.+..++.++||||||+++++|++|..||......
T Consensus 140 il~~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~- 212 (267)
T PHA03390 140 VLYDRAKDRIYLCDYGLCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE- 212 (267)
T ss_pred EEEeCCCCeEEEecCccceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-
Confidence 9999998 999999999875322 12345889999999999989999999999999999999999999744322
Q ss_pred cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-HHHHHH
Q 020529 165 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-IGDVVT 225 (325)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-~~evl~ 225 (325)
......+.... .. .. ..+......+.+++.+||+.+|.+||+ +.++++
T Consensus 213 ~~~~~~~~~~~-~~-----~~-------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 213 ELDLESLLKRQ-QK-----KL-------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhhHHHHHHhh-cc-----cC-------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11122221111 00 00 011123456889999999999999996 588874
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=247.62 Aligned_cols=201 Identities=26% Similarity=0.370 Sum_probs=154.3
Q ss_pred cCCC-CCCCccceeeEEEe------CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 2 LSLL-HHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
++++ +||||+++++++.. ....|++|||+++++|.+++.... ...+++..++.++.|++.||+|||+.+
T Consensus 66 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~-- 141 (282)
T cd06636 66 LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK-- 141 (282)
T ss_pred HHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3445 79999999999853 467899999999999999987532 345889999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHH
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~e 149 (325)
|+|+||+|+||+++.++.++|+|||++....... .......|+..|+|||.+. ...++.++|||||||++||
T Consensus 142 -ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~e 218 (282)
T cd06636 142 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218 (282)
T ss_pred -cccCCCCHHHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHH
Confidence 9999999999999999999999999987532211 1223456889999999875 3467889999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 150 LITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|++|..||....+....... .....+.+. .......+.+++.+||+.+|.+||++.+|++
T Consensus 219 l~~g~~p~~~~~~~~~~~~~-------------~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 219 MAEGAPPLCDMHPMRALFLI-------------PRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHhCCCCccccCHHhhhhhH-------------hhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 99999999654322111100 000001110 1122357889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=244.95 Aligned_cols=196 Identities=24% Similarity=0.292 Sum_probs=157.2
Q ss_pred CCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCC
Q 020529 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKS 83 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~ 83 (325)
...||||+.+++++...+..++||||+.+++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p 125 (278)
T cd05606 53 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKP 125 (278)
T ss_pred hCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCH
Confidence 45799999999999999999999999999999998864 456999999999999999999999999 99999999
Q ss_pred CcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCCCC
Q 020529 84 SNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRP 162 (325)
Q Consensus 84 ~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~~~ 162 (325)
+||+++.++.++|+|||++...... ......|+..|+|||++..+ .++.++||||||+++++|++|+.||.....
T Consensus 126 ~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~ 201 (278)
T cd05606 126 ANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (278)
T ss_pred HHEEECCCCCEEEccCcCccccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCc
Confidence 9999999999999999998643221 12234689999999998754 689999999999999999999999976532
Q ss_pred CCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHH
Q 020529 163 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 225 (325)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~ 225 (325)
....... .... ...+ ..+......+.+++.+||..+|.+|| ++.++++
T Consensus 202 ~~~~~~~---~~~~--------~~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 202 KDKHEID---RMTL--------TMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred cchHHHH---HHhh--------ccCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2211110 0000 0011 11222346788999999999999999 9999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=247.39 Aligned_cols=203 Identities=24% Similarity=0.339 Sum_probs=157.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivHrd 80 (325)
|++++||||+++++++...+..++||||+++++|..++.... ....+++..+..++.+++.||.|||+. + |+|+|
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~d 128 (286)
T cd06622 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRD 128 (286)
T ss_pred HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCC
Confidence 567899999999999999999999999999999999886521 134689999999999999999999974 7 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC------CCccccEEEehHHHHHHHhCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ------LTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwSlGvvl~elltg~ 154 (325)
|||+||+++.++.++|+|||++...... ......+++.|+|||++.+.. ++.++|||||||++++|++|.
T Consensus 129 l~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~ 204 (286)
T cd06622 129 VKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204 (286)
T ss_pred CCHHHEEECCCCCEEEeecCCcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCC
Confidence 9999999999999999999998653221 222345788999999986543 488999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.||........... ...... ...+ ..+......+.+++.+||+.+|.+||++.+++..
T Consensus 205 ~pf~~~~~~~~~~~---~~~~~~-------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 205 YPYPPETYANIFAQ---LSAIVD-------GDPP----TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred CCCCCcchhhHHHH---HHHHhh-------cCCC----CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 99965322111000 000000 0001 1122344677899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=244.46 Aligned_cols=198 Identities=27% Similarity=0.328 Sum_probs=160.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.++...++|+||+.+++|..++.. ..++++..+..++.+++.||.|||+.+ ++|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl 126 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDI 126 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCC
Confidence 5788999999999999999999999999999999999965 356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||++++++.++|+|||++....... ......|+..|+|||++.+..++.++|+||||+++++|++|..||....
T Consensus 127 ~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 203 (258)
T cd05578 127 KPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203 (258)
T ss_pred CHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987543322 2234568889999999998889999999999999999999999997654
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH--HHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI--GDVV 224 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~--~evl 224 (325)
......+. ..... .....+......+.+++.+||+.+|.+||+. .|++
T Consensus 204 ~~~~~~~~----~~~~~-----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 204 RTIRDQIR----AKQET-----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccHHHHHH----HHhcc-----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 32111111 11100 0011122234678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=259.58 Aligned_cols=203 Identities=21% Similarity=0.315 Sum_probs=165.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||..+.|||||++++.|...+.+.|+.|||.||-+...+-. ....|.+.++.-++++++.||.|||+++ |||||
T Consensus 82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRD 155 (1187)
T KOG0579|consen 82 ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRD 155 (1187)
T ss_pred hhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhh
Confidence 57888999999999999989999999999999999988765 5677999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-----CCCCccccEEEehHHHHHHHhCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
||+.|||+.-+|.++|+|||++-. ..........+.||+.|||||++.. .+|+.++|||||||.|.||..+.+
T Consensus 156 LKAGNiL~TldGdirLADFGVSAK--n~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEP 233 (1187)
T KOG0579|consen 156 LKAGNILLTLDGDIRLADFGVSAK--NKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEP 233 (1187)
T ss_pred ccccceEEEecCcEeeeccccccc--chhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCC
Confidence 999999999999999999998753 2222334566899999999998754 479999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|....++... ++. +..--.|.|. -|......+.+++.+||..||..||+++++++.
T Consensus 234 PHhelnpMRV---------llK----iaKSePPTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 234 PHHELNPMRV---------LLK----IAKSEPPTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CccccchHHH---------HHH----HhhcCCCccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 8766544321 111 0111112221 133456678899999999999999999999875
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=251.58 Aligned_cols=219 Identities=21% Similarity=0.257 Sum_probs=158.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||++++++|..++..++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 53 ~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDl 127 (328)
T cd08226 53 SHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNI 127 (328)
T ss_pred HHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 456899999999999999999999999999999999987632 235899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCC-----ccccccCCcCccCchhhccC--CCCccccEEEehHHHHHHHhCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-----VSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~ 154 (325)
||+||+++.++.++++||+.+.......... ......++..|+|||++.+. .++.++|||||||+++||++|.
T Consensus 128 kp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~ 207 (328)
T cd08226 128 KASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207 (328)
T ss_pred CHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999997653221111000 01112345679999998764 4789999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhh---------cccc-------c---------------cccccccCCccCCCCChHHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARP---------LFND-------R---------------RKFSKLADPRLEGRYPIRGLYQAL 203 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~---------~~~~-------~---------------~~~~~~~d~~l~~~~~~~~~~~~~ 203 (325)
.||........ +...... .... . .....+.+..+...........+.
T Consensus 208 ~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (328)
T cd08226 208 VPFQDMLRTQM--LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285 (328)
T ss_pred CCCCCcChHHH--HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHH
Confidence 99975432111 0000000 0000 0 000011111122222234567889
Q ss_pred HHHHHchhhCCCCCCCHHHHHHHH
Q 020529 204 AVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 204 ~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
+|+.+||+.||.+|||+.++++.-
T Consensus 286 ~li~~~l~~dP~~Rpta~e~l~~~ 309 (328)
T cd08226 286 NLVELCLQQDPEKRPSASSLLSHA 309 (328)
T ss_pred HHHHHHccCCcccCCCHHHHhhCH
Confidence 999999999999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=244.42 Aligned_cols=203 Identities=25% Similarity=0.319 Sum_probs=159.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++...+..|+||||+++++|.+++.... ...+++..++.++.+++.||.|||+.+ ++|+|
T Consensus 46 ~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~d 120 (277)
T cd05577 46 ILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRD 120 (277)
T ss_pred HHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 3678899999999999999999999999999999999987522 246899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|+|+||+++.++.++|+|||++..... ........++..|+|||++.+..++.++||||||+++++|++|+.||...
T Consensus 121 i~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 121 LKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred CCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999999875432 11223345788999999998888999999999999999999999999664
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~ 225 (325)
....... ......... ...++......+.+++.+||+.+|.+|| ++.+++.
T Consensus 198 ~~~~~~~--~~~~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 198 KEKVEKE--ELKRRTLEM------------AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cccccHH--HHHhccccc------------cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 3311111 000111100 0011122345678999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=245.17 Aligned_cols=198 Identities=25% Similarity=0.324 Sum_probs=160.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++..+...++||||+++++|.+++.. ..+++..+..++.+++.|+.|||+.+ ++|+||
T Consensus 56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl 127 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDI 127 (277)
T ss_pred HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCC
Confidence 5678999999999999999999999999999999999853 35899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++++|++|..||....
T Consensus 128 ~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 128 KAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred CHHhEEECCCCCEEEeecccceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 9999999999999999999987543221 12233467889999999988889999999999999999999999986543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
... .. ..... ...+.+ +......+.+++.+|++.+|.+||++.++++.
T Consensus 206 ~~~---~~---~~~~~-------~~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 206 PMK---VL---FLIPK-------NNPPTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred hHH---HH---HHHhc-------CCCCCC----CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 211 00 00000 001111 11233567899999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=243.29 Aligned_cols=203 Identities=24% Similarity=0.345 Sum_probs=171.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|++++..|+||++||.|.....+.+|||||..||+.+.++. .+++|++.++..++...++||+|||... -||||
T Consensus 81 IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRD 154 (502)
T KOG0574|consen 81 IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRD 154 (502)
T ss_pred HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhh
Confidence 45678899999999999888899999999999999999986 5778999999999999999999999988 79999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+.||||+.+|+.||+|||++-. ..+.-.....+.||+.|||||++..-.|..++||||||+...||..|++|+..-
T Consensus 155 IKAGNILLNT~G~AKLADFGVAGQ--LTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 155 IKAGNILLNTDGIAKLADFGVAGQ--LTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred cccccEEEcccchhhhhhccccch--hhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 999999999999999999999964 333344566788999999999999999999999999999999999999999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.+.. .++.- +.-..|.+ +-|...+.++-++++.||.+.|++|-++-.+++.
T Consensus 233 HPMR---------AIFMI----PT~PPPTF--~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 233 HPMR---------AIFMI----PTKPPPTF--KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred cccc---------eeEec----cCCCCCCC--CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 4431 22211 22222222 3355667889999999999999999999988875
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=235.53 Aligned_cols=199 Identities=22% Similarity=0.258 Sum_probs=157.4
Q ss_pred CCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 6 HHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 6 ~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
.|||||.++++|+. ...+++|||+|.||.|.+.+++. ....+++.++-.|+.+|+.|+.|||+.+ |.||||
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDl 187 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDL 187 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccC
Confidence 69999999998754 45778999999999999999873 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcC---CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEE---GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~---~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+|+|... +..+||+|||+|+.-.. ........-|+.|+|||++-..+|+..+|+||+||++|-||+|.+||.
T Consensus 188 KpENLLyt~t~~na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 188 KPENLLYTTTSPNAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred ChhheeeecCCCCcceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCccc
Confidence 999999954 45799999999986321 222344567999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCCh----HHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPI----RGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...... +.--++..+. ... -.+|. ..+....++|+.+|..+|.+|.|+.+++..
T Consensus 265 S~hg~a---ispgMk~rI~---------~gq--y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 265 SNHGLA---ISPGMKRRIR---------TGQ--YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ccCCcc---CChhHHhHhh---------ccC--ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 754321 1111111111 111 11222 235677889999999999999999999864
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=240.41 Aligned_cols=202 Identities=25% Similarity=0.314 Sum_probs=162.9
Q ss_pred cCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+++++||||+++++.+.+. ...++|+||+++++|.+++.. ...+++..++.++.+++.||+|||+.+ ++|+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~ 125 (260)
T cd06606 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHR 125 (260)
T ss_pred HHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccc
Confidence 5678999999999999988 899999999999999999976 237999999999999999999999998 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
||+|+||+++.++.++|+|||.+................++..|+|||.+.....+.++||||||+++++|++|..||..
T Consensus 126 dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (260)
T cd06606 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE 205 (260)
T ss_pred CCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998765443321123345688899999999988899999999999999999999999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.... ...... ..........+......+.+++.+|++.+|.+||++.+++.
T Consensus 206 ~~~~-----~~~~~~----------~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 206 LGNP-----MAALYK----------IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCch-----HHHHHh----------ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 5410 000000 00011111122233467889999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=244.54 Aligned_cols=204 Identities=26% Similarity=0.368 Sum_probs=160.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++.+..+...|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ ++|+||
T Consensus 47 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di 119 (265)
T cd05579 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDL 119 (265)
T ss_pred HHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCC
Confidence 5678999999999999999999999999999999999976 236899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCC------CCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDK------SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
+|+||+++.++.++|+|||++........ ........++..|+|||++.....+.++||||||+++++|++|..
T Consensus 120 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~ 199 (265)
T cd05579 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIP 199 (265)
T ss_pred CHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 99999999999999999999875433211 112234557889999999988889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
||........ . ....... ..... .......+.+++.+|++.+|.+||++..|.+.|+
T Consensus 200 p~~~~~~~~~---~---~~~~~~~------~~~~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 200 PFHGETPEEI---F---QNILNGK------IEWPE----DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCCCCCHHHH---H---HHHhcCC------cCCCc----cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 9975432111 1 1111000 00000 0012457889999999999999999966666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=239.15 Aligned_cols=200 Identities=28% Similarity=0.373 Sum_probs=161.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++......++++||+++++|.+++... ...+++..+..++.+++.||++||+.+ ++|+||
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl 124 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDI 124 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCC
Confidence 56789999999999999999999999999999999998762 256999999999999999999999998 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||.+........ .....++..|+|||++....++.++||||||+++++|++|..||....
T Consensus 125 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 201 (253)
T cd05122 125 KAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP 201 (253)
T ss_pred CHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999999999876433221 345668899999999998889999999999999999999999987543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
....... ... ........+ ......+.+++..||+.+|++||++.+|++
T Consensus 202 ~~~~~~~---~~~-----~~~~~~~~~-------~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 202 PMKALFK---IAT-----NGPPGLRNP-------EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred hHHHHHH---HHh-----cCCCCcCcc-------cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2111000 000 000111111 011356889999999999999999999985
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=250.21 Aligned_cols=197 Identities=27% Similarity=0.356 Sum_probs=162.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||++++.|.||.+--.|+..+.+|||+..|+||+|.-+|... ....+++..+..++.+|+.||++||... ||+||
T Consensus 238 iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRD 312 (591)
T KOG0986|consen 238 ILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRD 312 (591)
T ss_pred HHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeecc
Confidence 578899999999988899999999999999999999988763 3467999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||||+.|+++|+|+|||..++.+. ......||.+|||||++....|+...|.|||||+||||+.|+.||...
T Consensus 313 LKPeNILLDd~GhvRISDLGLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 313 LKPENILLDDHGHVRISDLGLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CChhheeeccCCCeEeeccceEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 99999999999999999999997655433 223347999999999999999999999999999999999999999664
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
.......-+ -+.... + ...|+...+.++.+|+...|+.||.+|--
T Consensus 390 KeKvk~eEv--drr~~~---------~---~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 390 KEKVKREEV--DRRTLE---------D---PEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred hhhhhHHHH--HHHHhc---------c---hhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 332111000 011111 1 12345566788999999999999999854
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=243.96 Aligned_cols=210 Identities=22% Similarity=0.273 Sum_probs=155.0
Q ss_pred cCCC-CCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 2 LSLL-HHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
|.++ .||||+++++++.+. +..++||||+. ++|.+.+.. ....+++..++.++.+++.||+|||+.+ ++|
T Consensus 51 l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H 123 (282)
T cd07831 51 LRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFH 123 (282)
T ss_pred HhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 3455 599999999999887 88999999996 688888765 2356899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+|+||+++. +.++|+|||+++...... ......++..|+|||++.. ..++.++|||||||++|||++|..||
T Consensus 124 ~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~ 199 (282)
T cd07831 124 RDIKPENILIKD-DILKLADFGSCRGIYSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF 199 (282)
T ss_pred cccCHHHEEEcC-CCeEEEecccccccccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC
Confidence 999999999999 999999999997543221 1223457889999997654 45788999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhcccccc----------ccccccCCccCC----CCChHHHHHHHHHHHHchhhCCCCCCCHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRR----------KFSKLADPRLEG----RYPIRGLYQALAVASMCIQEQAATRPLIGDV 223 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~d~~l~~----~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ev 223 (325)
......+. ..+......... .......+.... .........+.+|+.+||+.+|.+||++.++
T Consensus 200 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 276 (282)
T cd07831 200 PGTNELDQ---IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA 276 (282)
T ss_pred CCCCHHHH---HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHH
Confidence 76543221 111111000000 000000000000 0011235788999999999999999999999
Q ss_pred HH
Q 020529 224 VT 225 (325)
Q Consensus 224 l~ 225 (325)
++
T Consensus 277 l~ 278 (282)
T cd07831 277 LR 278 (282)
T ss_pred hh
Confidence 86
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=241.03 Aligned_cols=203 Identities=25% Similarity=0.369 Sum_probs=158.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++...+..++|+||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+|+||
T Consensus 53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl 125 (264)
T cd06626 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDI 125 (264)
T ss_pred HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999975 345889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCc--cccccCCcCccCchhhccCC---CCccccEEEehHHHHHHHhCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV--STRVMGTYGYCAPEYAMTGQ---LTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvvl~elltg~~p 156 (325)
+|+||+++.++.++|+|||++........... .....++..|+|||++.... ++.++||||||++++++++|..|
T Consensus 126 ~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~p 205 (264)
T cd06626 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205 (264)
T ss_pred CHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 99999999999999999999876443322111 12356788999999988766 88999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|....... ...... . ....+.+.. .......+.+++.+||+.+|.+||++.+++.
T Consensus 206 f~~~~~~~--~~~~~~---~-------~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 206 WSELDNEF--QIMFHV---G-------AGHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ccCCcchH--HHHHHH---h-------cCCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 96542111 010000 0 000111100 0011356779999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=244.18 Aligned_cols=204 Identities=14% Similarity=0.165 Sum_probs=154.4
Q ss_pred CCCCCCCccceeeEEEeCC----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 3 SLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
..+.|+||+++++.+.... ..+++++++. .++.+.+.. ....++..+..|+.|++.||+|||+.+ |+|
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH 149 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISH 149 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 4578999999998765543 4578888884 678777754 233578889999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-----CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg 153 (325)
|||||+|||++.++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||+++||++|
T Consensus 150 rDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g 229 (294)
T PHA02882 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGI 229 (294)
T ss_pred CCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999765432211 112335699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcch-h--hhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 154 RKAIDSTRPHGEQN-L--VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 154 ~~p~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
..||.......... . .++...+. .+.+. .......+.+++..|+..+|.+||++.++++.|
T Consensus 230 ~~P~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 230 KLPWKGFGHNGNLIHAAKCDFIKRLH----------EGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred CCCCCccccchHHHHHhHHHHHHHhh----------hhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99997653222110 0 01111111 11100 011235688999999999999999999999876
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=245.72 Aligned_cols=201 Identities=25% Similarity=0.364 Sum_probs=161.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||++++++|...+..++|+||+++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL 141 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 141 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccC
Confidence 5778999999999999999999999999999999999864 34789999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++....... .......|++.|+|||++....++.++||||||++++++++|..||....
T Consensus 142 ~p~Nili~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 142 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred CHHHEEEcCCCCEEEccCcceecccccc--cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999886543322 12233468889999999988889999999999999999999999997654
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
........ .... .+.. ..+......+.+++..||..+|.+||++.+++..-
T Consensus 220 ~~~~~~~~------~~~~-------~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 220 PLRALYLI------ATNG-------TPEL--QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred hhhheeeh------hcCC-------CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 32211100 0000 0000 01112234678899999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=244.37 Aligned_cols=203 Identities=26% Similarity=0.353 Sum_probs=161.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++......++|+||+++++|.+++.... ..+++..++.++.+++.||+|||+.+ ++|+||
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl 142 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDI 142 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCC
Confidence 567899999999999999999999999999999999997622 37999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 143 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 143 KSDNILLSKDGSVKLADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred ChhhEEEcCCCCEEECccchhhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999886433221 12234457889999999988889999999999999999999999986543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
+... ...+. .. ....... +......+.+++..|++.+|..||++.+|++..
T Consensus 221 ~~~~--~~~~~----~~--~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 221 PLRA--LFLIT----TK--GIPPLKN-------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred HHHH--HHHHH----hc--CCCCCcc-------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 2111 11000 00 0000000 111235688999999999999999999998743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=243.30 Aligned_cols=195 Identities=24% Similarity=0.343 Sum_probs=156.0
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
.||||+++++++..+...++||||+++++|.+++.. ..+++..++.++.+++.||.|||+.+ |+|+||+|+|
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~n 131 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAAN 131 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHH
Confidence 499999999999999999999999999999999864 26899999999999999999999999 9999999999
Q ss_pred EEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 86 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 86 ill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
|+++.++.++|+|||++....... .......|+..|+|||++..+ .++.++||||||+++++|++|..||.......
T Consensus 132 i~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~ 209 (277)
T cd06917 132 ILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR 209 (277)
T ss_pred EEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 999999999999999987654332 122334688999999988754 46899999999999999999999997543221
Q ss_pred cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 165 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
... .. .....+.+... .....+.+++.+||+.+|.+||++.+++..
T Consensus 210 ~~~---~~----------~~~~~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 210 AMM---LI----------PKSKPPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred hhh---cc----------ccCCCCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 110 00 00011111110 134578899999999999999999999873
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=245.64 Aligned_cols=213 Identities=23% Similarity=0.296 Sum_probs=156.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+. ++|..++.... ...+++..++.++.+++.||+|||+.+ ++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l 126 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDL 126 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 578899999999999999999999999996 78999886532 346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC-CCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
+|+||+++.++.++|+|||++....... .......++..|+|||++.+.. ++.++||||||+++|+|+||+.||...
T Consensus 127 ~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 127 KPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred CHHHEEECCCCCEEEeeccchhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999987543221 1122335688899999887654 588999999999999999999999654
Q ss_pred CCCCcchhhhhhhhcccc--------------ccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFND--------------RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~--------------~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.... .+.......-.. ...+.......+.. ........+.+++.+||+.||.+||++.+++.
T Consensus 205 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 205 SEID--QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CHHH--HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 3211 111100000000 00000000000000 00012245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=246.89 Aligned_cols=197 Identities=29% Similarity=0.379 Sum_probs=155.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||++++++|.+.+..++||||+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||
T Consensus 69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl 141 (307)
T cd06607 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDI 141 (307)
T ss_pred HHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 577899999999999999999999999996 788887754 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
+|+||+++.++.++|+|||++..... .....+++.|+|||++. ...++.++||||||+++|||++|..||.
T Consensus 142 ~p~nIl~~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~ 215 (307)
T cd06607 142 KAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (307)
T ss_pred CcccEEECCCCCEEEeecCcceecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999865322 12346788999999874 4568899999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
........... ... ..+.+. +......+.+++.+||..+|.+||++.+|+...
T Consensus 216 ~~~~~~~~~~~------~~~-------~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 216 NMNAMSALYHI------AQN-------DSPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred CccHHHHHHHH------hcC-------CCCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 54321110000 000 001110 112345688999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=246.28 Aligned_cols=206 Identities=24% Similarity=0.285 Sum_probs=155.2
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEe
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIY 78 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivH 78 (325)
|.++ .||||+++++++......+++|||+. ++|.++..... .....+++..+..++.+++.||+|||+. + ++|
T Consensus 56 l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H 131 (288)
T cd06616 56 VMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIH 131 (288)
T ss_pred HHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eec
Confidence 3456 49999999999999999999999995 67766543211 1235699999999999999999999975 7 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC---CCCccccEEEehHHHHHHHhCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG---QLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||||+||+++.++.++|+|||+++..... .......|+..|+|||++.+. .++.++|||||||++++|++|+.
T Consensus 132 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 208 (288)
T cd06616 132 RDVKPSNILLDRNGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208 (288)
T ss_pred cCCCHHHEEEccCCcEEEeecchhHHhccC---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCC
Confidence 999999999999999999999998653221 122334688899999998876 68999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
||..... ...-...... ...+.+....+......+.+|+.+||+.+|.+||++.+|+..
T Consensus 209 p~~~~~~-----~~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 209 PYPKWNS-----VFDQLTQVVK-------GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred Cchhcch-----HHHHHhhhcC-------CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9965431 1100011000 001111111112344578899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=239.85 Aligned_cols=202 Identities=23% Similarity=0.338 Sum_probs=164.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++|||++++++.+..+...++|+||+++++|.+++.........+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 53 l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl 129 (258)
T cd08215 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDI 129 (258)
T ss_pred HHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccC
Confidence 56789999999999999999999999999999999999875434577999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++....... .......|++.|+|||......++.++|+||||+++++|++|..||....
T Consensus 130 ~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 130 KPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred ChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 9999999999999999999997643332 12334568889999999998899999999999999999999999986543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
... ........ .. ...+......+.+++.+||..+|.+||++.++++
T Consensus 208 ~~~------~~~~~~~~------~~-----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 208 LLE------LALKILKG------QY-----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred HHH------HHHHHhcC------CC-----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 211 11111100 00 0112233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=244.06 Aligned_cols=215 Identities=21% Similarity=0.270 Sum_probs=154.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++.+++..++..++||||+. ++|.+++.. ....+.+..+..++.|++.||+|||+.+ |+|+||
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl 129 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDL 129 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 567899999999999999999999999996 778777654 2345788899999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.++|+|||+++...... .......+++.|+|||++.+. .++.++|||||||++++|++|..||...
T Consensus 130 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 130 KPQNLLISYLGELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred ChHHEEEcCCCcEEEeccccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999987532221 122334578899999998764 5788999999999999999999999754
Q ss_pred CCCCcchhhhhhhhccccc------cccc----cccCCccCCCC-----ChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDR------RKFS----KLADPRLEGRY-----PIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~------~~~~----~~~d~~l~~~~-----~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
..........|...-.... ..++ ........... .......+.+++.+|++.+|.+|||+.+++.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 208 SDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 3321110000100000000 0000 00000000000 0011356778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-32 Score=246.47 Aligned_cols=217 Identities=25% Similarity=0.333 Sum_probs=154.7
Q ss_pred cCCCCCCCccceeeEEEeCC--------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGD--------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
+++++||||+++++++.... ..++||||+. ++|.+++.. ....+++.+++.++.|++.||+|||+.+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~- 139 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK- 139 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 57889999999999987654 4599999996 688888865 2346899999999999999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC--CccccccCCcCccCchhhccC-CCCccccEEEehHHHHHH
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~el 150 (325)
++|+||||+||+++.++.++|+|||++......... .......++..|+|||++.+. .++.++||||||+++|||
T Consensus 140 --i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el 217 (310)
T cd07865 140 --ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217 (310)
T ss_pred --eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHH
Confidence 999999999999999999999999999764332221 112234578889999988665 468899999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhccc-----cccc---cccccCCc-cCCCC-----ChHHHHHHHHHHHHchhhCCCC
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFN-----DRRK---FSKLADPR-LEGRY-----PIRGLYQALAVASMCIQEQAAT 216 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~---~~~~~d~~-l~~~~-----~~~~~~~~~~l~~~cl~~~p~~ 216 (325)
++|..||..................+. .... ......+. ..... +......+.+++.+||..+|.+
T Consensus 218 ~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~ 297 (310)
T cd07865 218 WTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAK 297 (310)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhh
Confidence 999999976543221111111100000 0000 00000000 00000 0011245678999999999999
Q ss_pred CCCHHHHHH
Q 020529 217 RPLIGDVVT 225 (325)
Q Consensus 217 RPs~~evl~ 225 (325)
||++.++++
T Consensus 298 R~t~~e~l~ 306 (310)
T cd07865 298 RIDADTALN 306 (310)
T ss_pred ccCHHHHhc
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=245.23 Aligned_cols=200 Identities=23% Similarity=0.310 Sum_probs=158.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++...+..++||||+++++|.+++.. ..+++..++.++.+++.||+|||+.+ ++|+||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl 142 (292)
T cd06657 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDI 142 (292)
T ss_pred HHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5678999999999999999999999999999999998753 35899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++....... .......|++.|+|||.+.+..++.++||||||+++++|++|..||....
T Consensus 143 ~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 143 KSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred CHHHEEECCCCCEEEcccccceeccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999886543221 12234568899999999988889999999999999999999999986532
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... ...... ...+.+.. .......+.+++.+||+.+|.+||++.+|+..
T Consensus 221 ~~~~---~~~~~~----------~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 221 PLKA---MKMIRD----------NLPPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHH---HHHHHh----------hCCcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 2111 111000 00011100 01123457789999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-32 Score=240.20 Aligned_cols=201 Identities=21% Similarity=0.312 Sum_probs=159.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++......++|+||+++++|.+++.... ...+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl 127 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDI 127 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccC
Confidence 577899999999999999999999999999999999997522 235899999999999999999999999 999999
Q ss_pred CCCcEEEcCCC-eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGF-HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~-~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||++++++ .++|+|||++...... ........|++.|+|||+.....++.++|+||||+++++|++|..||...
T Consensus 128 ~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 128 KSQNIFLSKNGMVAKLGDFGIARQLNDS--MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred CHHHEEEcCCCCeEEecccccchhccCC--cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 99999998885 5799999998754322 11223356889999999998888999999999999999999999998653
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.. ..+....... .+.+ .+......+.+++.+|+..+|.+||++.+|++.
T Consensus 206 ~~------~~~~~~~~~~------~~~~-----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 206 NL------HQLVLKICQG------YFAP-----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred cH------HHHHHHHhcc------cCCC-----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 21 1111111110 0110 111223578899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=239.28 Aligned_cols=185 Identities=23% Similarity=0.241 Sum_probs=149.3
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
..||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ |+||||||+
T Consensus 42 ~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~ 114 (237)
T cd05576 42 HCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPN 114 (237)
T ss_pred cCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHH
Confidence 4699999999999999999999999999999999865 345899999999999999999999999 999999999
Q ss_pred cEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 85 Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
||+++.++.++|+|||++...... .....++..|+|||.+....++.++||||+|+++|||++|+.|+.......
T Consensus 115 Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~ 189 (237)
T cd05576 115 NILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI 189 (237)
T ss_pred HEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc
Confidence 999999999999999987643221 223345677999999988889999999999999999999998775321100
Q ss_pred cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHH
Q 020529 165 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 223 (325)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ev 223 (325)
..... ...+......+.+++.+||+.||.+||++.+.
T Consensus 190 ------------------~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 190 ------------------NTHTT----LNIPEWVSEEARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred ------------------ccccc----cCCcccCCHHHHHHHHHHccCCHHHhcCCCcc
Confidence 00000 01111223567899999999999999997433
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=245.74 Aligned_cols=201 Identities=29% Similarity=0.402 Sum_probs=158.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++|||++++++++.++...++||||+. |+|.+++.. ...++++..+..++.+++.||.|||+.+ |+||||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL 151 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDI 151 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 567899999999999999999999999997 688887754 2456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
+|+||+++.++.++|+|||++..... .....|++.|+|||++. ...++.++|||||||++++|++|..||.
T Consensus 152 ~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 225 (317)
T cd06635 152 KAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 225 (317)
T ss_pred CcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999864322 22346888999999974 4568899999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
....... +..+.. .. .+.. ........+.+++.+||+.+|.+||++.+|++.+-.+.
T Consensus 226 ~~~~~~~--~~~~~~----~~-------~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 226 NMNAMSA--LYHIAQ----NE-------SPTL---QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CccHHHH--HHHHHh----cc-------CCCC---CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 5321110 111100 00 0000 01122346789999999999999999999998765543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=255.86 Aligned_cols=189 Identities=24% Similarity=0.286 Sum_probs=153.4
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
+||||+++.+.+.++.+.++|||++.|+-|.+.+.. .. .....+..|+++++.|+.|||+++ ||||||||+|
T Consensus 374 ~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~----~~-~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~N 445 (612)
T KOG0603|consen 374 DHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS----KP-EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGN 445 (612)
T ss_pred CCCcceeecceecCCceeeeeehhccccHHHHHHHh----cc-hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhh
Confidence 899999999999999999999999999988887754 22 233677789999999999999999 9999999999
Q ss_pred EEE-cCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 86 ILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 86 ill-~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
||+ +..++++|+|||.++..... ....+-|..|+|||+.....|+..+||||||++||+||+|+.||......
T Consensus 446 IL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~- 519 (612)
T KOG0603|consen 446 ILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG- 519 (612)
T ss_pred eeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-
Confidence 999 68999999999999864433 12234477899999999999999999999999999999999999765322
Q ss_pred cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 165 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
. .+. .....+.+....+..+.+|+.+||+.||.+||++.++...
T Consensus 520 ~-ei~-----------------~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 520 I-EIH-----------------TRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred H-HHH-----------------HhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1 110 0011111223445678899999999999999999999763
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=241.88 Aligned_cols=201 Identities=22% Similarity=0.321 Sum_probs=160.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++.+....++||||+++++|.+++.........+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l 132 (260)
T cd08222 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDL 132 (260)
T ss_pred HHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCC
Confidence 56789999999999999999999999999999999998765444567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++. +.++|+|||+++..... ........|++.|+|||......++.++|+||||+++++|++|..||....
T Consensus 133 ~~~nili~~-~~~~l~d~g~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~ 209 (260)
T cd08222 133 KAKNIFLKN-NLLKIGDFGVSRLLMGS--CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN 209 (260)
T ss_pred ChhheEeec-CCEeecccCceeecCCC--cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999975 56999999998764322 122334568889999999988888999999999999999999999986432
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
. ......... ...+. .+......+.+++.+|+..+|.+||++.++++
T Consensus 210 ~------~~~~~~~~~-------~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 210 F------LSVVLRIVE-------GPTPS----LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred H------HHHHHHHHc-------CCCCC----CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 111111110 01111 12233457889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=237.94 Aligned_cols=211 Identities=23% Similarity=0.318 Sum_probs=157.2
Q ss_pred CCCCCCCccceeeEEEeCCe-----eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 3 SLLHHSNLVNLIGYCADGDQ-----RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
+.+.||||+++++++...+. .+++|||+. ++|.+++.... ...+++..++.++.+++.||.|||+.+ ++
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~ 129 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IV 129 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ee
Confidence 45679999999999988776 899999997 68999886532 235899999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 78 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 78 Hrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|+||+|+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++|||||||++++|++|.+||
T Consensus 130 h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~ 206 (287)
T cd07838 130 HRDLKPQNILVTSDGQVKIADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLF 206 (287)
T ss_pred eccCChhhEEEccCCCEEEeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcc
Confidence 99999999999999999999999987643321 122334788899999999999999999999999999999999998
Q ss_pred CCCCCCCcchhhhhhhhccc------------cccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFN------------DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
......+. +......... ....+........ ..........+.+++..||+.+|.+||++.+++.
T Consensus 207 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 207 RGTSEADQ--LDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCChHHH--HHHHHHHcCCCChHhcCCCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 76443211 1111110000 0000000000000 0001123467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-32 Score=254.19 Aligned_cols=196 Identities=24% Similarity=0.353 Sum_probs=167.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.|+|||||+++.+......+|+||||+.+|.+.+|+.. ...+.+..+..++.|+..|++|||+++ |||||
T Consensus 108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrd 180 (596)
T KOG0586|consen 108 IMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRD 180 (596)
T ss_pred HHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccc
Confidence 46789999999999999999999999999999999999986 555777889999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
||++||||+.+.++||+|||++..+. ........+|++.|.|||++.+..+ ++.+|+||+|+++|-|+.|..||++
T Consensus 181 Lk~eNilL~~~mnikIaDfgfS~~~~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 181 LKAENILLDENMNIKIADFGFSTFFD---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred cchhhcccccccceeeeccccceeec---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC
Confidence 99999999999999999999998654 3445667889999999999998876 5789999999999999999999987
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCCh--HHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPI--RGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~--~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
... ..+-.+.+.+.+.. -...+|-+++.++|..+|.+|+++.++.+.
T Consensus 258 ~~l--------------------k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 258 QNL--------------------KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccc--------------------ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 542 22223333333322 235678899999999999999999998764
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=249.47 Aligned_cols=212 Identities=24% Similarity=0.310 Sum_probs=155.7
Q ss_pred cCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
+++++||||++++++|... ...|+||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g--- 138 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG--- 138 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 5678999999999988643 35799999996 689888853 2889999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|+||||||+||+++.++.++|+|||+++...... ......++..|+|||++.+..++.++|||||||++++|++|+.
T Consensus 139 i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 215 (353)
T cd07850 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTV 215 (353)
T ss_pred eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999999999997543221 1233457889999999999999999999999999999999999
Q ss_pred CCCCCCCCCcch-hhh--------h-------hhhccccc-----cccccccCCcc----CCCCChHHHHHHHHHHHHch
Q 020529 156 AIDSTRPHGEQN-LVT--------W-------ARPLFNDR-----RKFSKLADPRL----EGRYPIRGLYQALAVASMCI 210 (325)
Q Consensus 156 p~~~~~~~~~~~-~~~--------~-------~~~~~~~~-----~~~~~~~d~~l----~~~~~~~~~~~~~~l~~~cl 210 (325)
||.......... +.. + ........ ..+...+...+ ....+......+.+++.+||
T Consensus 216 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 295 (353)
T cd07850 216 LFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKML 295 (353)
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHc
Confidence 996543211000 000 0 00000000 00001111100 00001123556789999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 020529 211 QEQAATRPLIGDVVTA 226 (325)
Q Consensus 211 ~~~p~~RPs~~evl~~ 226 (325)
+.||++||++.|++..
T Consensus 296 ~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 296 VIDPEKRISVDDALQH 311 (353)
T ss_pred CCChhhCcCHHHHhcC
Confidence 9999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=241.90 Aligned_cols=216 Identities=23% Similarity=0.303 Sum_probs=157.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+.+..++||||++ ++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl 126 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDL 126 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCC
Confidence 567899999999999999999999999997 589888865322 346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.++|+|||++....... .......++..|++||++.+. .++.++||||||+++++|++|+.||...
T Consensus 127 ~p~ni~~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 204 (284)
T cd07836 127 KPQNLLINKRGELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGT 204 (284)
T ss_pred CHHHEEECCCCcEEEeecchhhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999987533221 112234578899999988664 5688999999999999999999999765
Q ss_pred CCCCcch-hhhhhhhcc-------ccccc----cccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQN-LVTWARPLF-------NDRRK----FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~-~~~~~~~~~-------~~~~~----~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...+... +........ ..... +....+... ..+.......+.+++.+|++.+|.+||++.+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 205 NNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 4321110 000000000 00000 000000000 0001122356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-33 Score=239.48 Aligned_cols=199 Identities=24% Similarity=0.317 Sum_probs=164.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+..+||.+..+.-.|...+++|+||||..||.|.-+|.. .+.+++.....+...|+.||.|||+++ ||+||
T Consensus 221 VL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRD 293 (516)
T KOG0690|consen 221 VLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRD 293 (516)
T ss_pred HHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeee
Confidence 36778999999998889999999999999999999999976 566888888899999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||.+|+|||++|++||+||||++... ........++||+.|+|||++....|+...|.|.+|||+|||++|+.||...
T Consensus 294 lKLENLlLDkDGHIKitDFGLCKE~I--~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 294 LKLENLLLDKDGHIKITDFGLCKEEI--KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred chhhhheeccCCceEeeecccchhcc--cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 99999999999999999999998633 2344567799999999999999999999999999999999999999999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
.......++ +...- .+|.....+...|+.-.|..||.+|.- +.||.+.
T Consensus 372 dh~kLFeLI------l~ed~------------kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 372 DHEKLFELI------LMEDL------------KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred chhHHHHHH------Hhhhc------------cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 332211111 11111 233334457788999999999999953 5666554
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=243.43 Aligned_cols=216 Identities=20% Similarity=0.257 Sum_probs=153.8
Q ss_pred cCCC-CCCCccceeeEEEeCCe-----eEEEEecCCCCCHHHHhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQ-----RLLVYEFMPLGSLEDHLHDLPPD-KEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
++++ +||||+++++++...+. .|+||||++ ++|.+++...... ...+++..++.++.|++.||.|||+.+
T Consensus 54 l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~-- 130 (295)
T cd07837 54 LQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG-- 130 (295)
T ss_pred HHHccCCCCccceeeeEeecCCCCCceEEEEeeccC-cCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4556 57999999999877655 799999997 5899988654322 356899999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcC-CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHh
Q 020529 75 PVIYRDFKSSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 75 ~ivHrdik~~Nill~~-~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~ellt 152 (325)
|+||||+|+||+++. ++.++|+|||+++....... ......+++.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 131 -i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 207 (295)
T cd07837 131 -VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207 (295)
T ss_pred -eeecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHc
Confidence 999999999999998 88999999999875432211 1122346788999998865 457899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhcccc-ccccccc---cC----CccC----CCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFND-RRKFSKL---AD----PRLE----GRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~d----~~l~----~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
|..||........ +.......... ....... .+ +... ..........+.+++.+||..+|.+||++
T Consensus 208 g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~ 285 (295)
T cd07837 208 KQPLFPGDSELQQ--LLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285 (295)
T ss_pred CCCCCCCCCHHHH--HHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCH
Confidence 9999975432211 00000000000 0000000 00 0000 00001234568899999999999999999
Q ss_pred HHHHH
Q 020529 221 GDVVT 225 (325)
Q Consensus 221 ~evl~ 225 (325)
.+++.
T Consensus 286 ~eil~ 290 (295)
T cd07837 286 KAALT 290 (295)
T ss_pred HHHhc
Confidence 99975
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=254.72 Aligned_cols=209 Identities=24% Similarity=0.374 Sum_probs=166.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+++.++|||+|+|+|+|......|+|+|||..|+|.+||+.+ .+.-++.-..+.++.||..|++||..++ +||||
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRD 390 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRD 390 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhh
Confidence 467899999999999999999999999999999999999874 3344666777889999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|.+.|+|+.++..+|++||||++++.... ............|.|||-+....++.|+|||+|||+||||.| |..|+.+
T Consensus 391 LAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 391 LAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhhhhccccccceEEeeccchhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999999754322 222222233567999999999999999999999999999986 5666643
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
-. +.+ +-.++....+-.-|..+...+.+|+..||+++|.+||+.+|+.+.++.+..
T Consensus 470 id------lSq-----------VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 470 ID------LSQ-----------VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred cc------HHH-----------HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 21 111 111222222223344566789999999999999999999999999876643
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=235.69 Aligned_cols=198 Identities=27% Similarity=0.370 Sum_probs=160.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++|||++++++++.+.+..++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+||||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 125 (254)
T cd06627 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDI 125 (254)
T ss_pred HHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCC
Confidence 5678999999999999999999999999999999999975 356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++........ ......++..|+|||...+..++.++|||+||+++++|++|..||....
T Consensus 126 ~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 126 KAANILTTKDGVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred CHHHEEECCCCCEEEeccccceecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999999999976443222 1234568889999999988888999999999999999999999986533
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.. ... +. . .. .. .+ ..+......+.+++.+||..+|++||++.+++.
T Consensus 204 ~~--~~~--~~-~-~~--~~-----~~----~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 204 PM--AAL--FR-I-VQ--DD-----HP----PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred HH--HHH--HH-H-hc--cC-----CC----CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11 001 10 0 00 00 01 111222457789999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=232.85 Aligned_cols=198 Identities=27% Similarity=0.397 Sum_probs=158.3
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
.+|+||+.+|||..+...++.||.| +..++.++.. .+.++++...-++...++.||.||-++.. |+|||+||+|
T Consensus 149 dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSN 222 (391)
T KOG0983|consen 149 DCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSN 222 (391)
T ss_pred CCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccc
Confidence 4799999999999999999999999 4788888876 45679999999999999999999998643 9999999999
Q ss_pred EEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC---CCCccccEEEehHHHHHHHhCCCCCCCCCC
Q 020529 86 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG---QLTVKSDVYSFGVVFLELITGRKAIDSTRP 162 (325)
Q Consensus 86 ill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvvl~elltg~~p~~~~~~ 162 (325)
||+|+.|++||||||++-... .....++..|-+.|||||.+... .|+.++||||||+.|+||.||..||.+...
T Consensus 223 ILlDe~GniKlCDFGIsGrlv---dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 223 ILLDERGNIKLCDFGISGRLV---DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred eEEccCCCEEeecccccceee---cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence 999999999999999985432 23455667899999999998754 688999999999999999999999987543
Q ss_pred CCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 163 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+ ..... .++.+. + |.|.+ ....+..+.+++..||++|+.+||...++++.
T Consensus 300 d--Fe~lt---kvln~e---P----P~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 300 D--FEVLT---KVLNEE---P----PLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred c--HHHHH---HHHhcC---C----CCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2 11110 011100 1 22221 11255678899999999999999999999874
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=241.52 Aligned_cols=213 Identities=26% Similarity=0.315 Sum_probs=157.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+++..++||||++ ++|.+++...+. ..+++..++.++.+++.||+|||+.+ ++|+||
T Consensus 52 l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl 125 (283)
T cd07835 52 LKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDL 125 (283)
T ss_pred HHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCC
Confidence 567899999999999999999999999995 799999875321 35899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
+|+||+++.++.++|+|||++....... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||...
T Consensus 126 ~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 203 (283)
T cd07835 126 KPQNLLIDREGALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD 203 (283)
T ss_pred CHHHEEEcCCCcEEEeecccccccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999987543221 112223468889999987664 5688999999999999999999999654
Q ss_pred CCCCcchhhhhhhhccccc--------------cccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDR--------------RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~--------------~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.... .+........... ..+.....+.. ..........+.+++.+|++.+|.+||++.+|++
T Consensus 204 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 204 SEID--QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CHHH--HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 3211 1111110000000 00000000000 0111123357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=259.59 Aligned_cols=210 Identities=23% Similarity=0.392 Sum_probs=173.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||-++.||||++|.|+........+|+|||.+|+|..+|+. ....+.+-+..-++++|+.|++||-+.+ +||||
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRD 756 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRD 756 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhh
Confidence 57789999999999999999999999999999999999986 3455999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccC--CcCccCchhhccCCCCccccEEEehHHHHHHH-hCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG--TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELI-TGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDvwSlGvvl~ell-tg~~p~ 157 (325)
|.+.|||++.+..+|++||||++......... .+..-| ...|-|||.+...+++.++||||||||+||.+ .|.+|+
T Consensus 757 LAARNILVNsnLvCKVsDFGLSRvledd~~~~-ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 757 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAA-YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred hhhhheeeccceEEEeccccceeecccCCCcc-ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 99999999999999999999999764443222 222222 35799999999999999999999999999987 588887
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
..+...+. +. -+....+-..|.+....+.+|+..||++|.++||...+|+.+|..+...+
T Consensus 836 WdmSNQdV---Ik--------------aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP 895 (996)
T KOG0196|consen 836 WDMSNQDV---IK--------------AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP 895 (996)
T ss_pred cccchHHH---HH--------------HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence 65543221 11 11112222334566778999999999999999999999999999988654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=248.44 Aligned_cols=218 Identities=21% Similarity=0.293 Sum_probs=157.3
Q ss_pred CcCCCCCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
+|++++||||+++++++.. ....++||||+. ++|.+++.. ...+++..++.++.|++.||+|||+.+ |
T Consensus 57 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i 128 (334)
T cd07855 57 ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---V 128 (334)
T ss_pred HHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 3678899999999998753 357899999995 799998865 345999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC--CccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg 153 (325)
+||||||+||+++.++.++|+|||+++........ .......|+..|+|||++.. ..++.++||||||++++||++|
T Consensus 129 vH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g 208 (334)
T cd07855 129 IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGR 208 (334)
T ss_pred ecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcC
Confidence 99999999999999999999999998754332211 11234568899999998865 4688999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhh-----cccc--ccccccccCC-ccCCCC-----ChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 154 RKAIDSTRPHGEQNLVTWARP-----LFND--RRKFSKLADP-RLEGRY-----PIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~-----~~~~--~~~~~~~~d~-~l~~~~-----~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
+.||.............-... .+.. ...+....+. ...... .......+.+++.+||+.+|.+||++
T Consensus 209 ~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 288 (334)
T cd07855 209 RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITV 288 (334)
T ss_pred CCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCH
Confidence 999966433211110000000 0000 0000000000 000000 01234678899999999999999999
Q ss_pred HHHHHH
Q 020529 221 GDVVTA 226 (325)
Q Consensus 221 ~evl~~ 226 (325)
++++..
T Consensus 289 ~~~l~~ 294 (334)
T cd07855 289 EQALQH 294 (334)
T ss_pred HHHHhC
Confidence 999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=243.05 Aligned_cols=214 Identities=24% Similarity=0.305 Sum_probs=159.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++..+...++||||++ ++|.+++.. ....+++..++.++.+++.||.|||+.+ |+|+||
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl 124 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDL 124 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCc
Confidence 567899999999999999999999999997 588888865 2356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...
T Consensus 125 ~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 202 (283)
T cd05118 125 KPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGK 202 (283)
T ss_pred CHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999987654332 122234578889999998876 7899999999999999999999999665
Q ss_pred CCCCcchhh-hh-hh------hcccc-----ccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLV-TW-AR------PLFND-----RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~-~~-~~------~~~~~-----~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...+..... .. .. ..+.. ...+........ ..........+.+++..||+.+|.+||++.+++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 203 SEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 432111000 00 00 00000 000000000000 0011123567889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=247.52 Aligned_cols=215 Identities=25% Similarity=0.296 Sum_probs=156.0
Q ss_pred cCCC-CCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 2 LSLL-HHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
++++ +||||++++++|.. ....++||||++ ++|..++.. ..+++..++.++.+++.||+|||+.+ |+|
T Consensus 60 l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H 130 (337)
T cd07852 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIH 130 (337)
T ss_pred HHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence 5677 99999999999864 346899999997 699998864 26889999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC---CccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS---HVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
+||||+||+++.++.++|+|||++......... .......|+..|+|||++.+ ..++.++||||||+++++|++|+
T Consensus 131 ~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~ 210 (337)
T cd07852 131 RDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210 (337)
T ss_pred CCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCC
Confidence 999999999999999999999999765433221 12234568999999998765 45789999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccccc-------cccccccC----C---ccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDR-------RKFSKLAD----P---RLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~d----~---~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
.||...................... .....+.+ . .+.... ......+.+++.+|++.+|.+||++
T Consensus 211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~ 289 (337)
T cd07852 211 PLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTA 289 (337)
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCH
Confidence 9996543221100000000000000 00000000 0 000000 1124578899999999999999999
Q ss_pred HHHHHH
Q 020529 221 GDVVTA 226 (325)
Q Consensus 221 ~evl~~ 226 (325)
.++++.
T Consensus 290 ~~il~~ 295 (337)
T cd07852 290 EEALEH 295 (337)
T ss_pred HHHhhC
Confidence 999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=241.86 Aligned_cols=197 Identities=29% Similarity=0.378 Sum_probs=155.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++|||++++++++......++||||+. ++|.+++.. ...++++.++..++.+++.||.|||+.+ ++||||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl 141 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDV 141 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 577899999999999999999999999996 688887754 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
+|+||+++.++.++|+|||++..... .....|+..|+|||++. ...++.++|||||||++++|++|..||.
T Consensus 142 ~p~nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 215 (308)
T cd06634 142 KAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (308)
T ss_pred CHHhEEECCCCcEEECCcccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCc
Confidence 99999999999999999999865322 22345788999999975 3567889999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
....... ...+... . .+... +......+.+|+.+||+.+|.+||++.+|+...
T Consensus 216 ~~~~~~~--~~~~~~~------~-----~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 216 NMNAMSA--LYHIAQN------E-----SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred cccHHHH--HHHHhhc------C-----CCCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 5322110 0000000 0 01100 112345678999999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=252.34 Aligned_cols=210 Identities=23% Similarity=0.273 Sum_probs=160.1
Q ss_pred CcCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+|++|+|||||++++.=.+. ....+|||||.||||...|.. |....+|++.+.+.++..++.||.|||+++
T Consensus 64 ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn~-- 140 (732)
T KOG4250|consen 64 ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRENG-- 140 (732)
T ss_pred HHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHcC--
Confidence 57899999999999885443 366899999999999999976 456778999999999999999999999999
Q ss_pred CeEeCCCCCCcEEEc--CCC--eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-cCCCCccccEEEehHHHHH
Q 020529 75 PVIYRDFKSSNILLE--EGF--HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 75 ~ivHrdik~~Nill~--~~~--~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~ksDvwSlGvvl~e 149 (325)
||||||||.||++. ++| ..||+|||+|+...... ..+.+.||..|++||+.. .+.|+..+|.|||||++|+
T Consensus 141 -IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~ 216 (732)
T KOG4250|consen 141 -IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYE 216 (732)
T ss_pred -ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHH
Confidence 99999999999984 333 57999999999754433 567788999999999998 4889999999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccC------------CCCChHHHHHHHHHHHHchhhCCCCC
Q 020529 150 LITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLE------------GRYPIRGLYQALAVASMCIQEQAATR 217 (325)
Q Consensus 150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~------------~~~~~~~~~~~~~l~~~cl~~~p~~R 217 (325)
++||..||..........-+.|... ......+.-...+... ..........+...+..+|..+|.+|
T Consensus 217 caTG~lPF~p~~~pk~~~~~~~~~~-tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~ 295 (732)
T KOG4250|consen 217 CATGELPFIPFGGPKNNKEIMWHII-TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKR 295 (732)
T ss_pred HhccCCCCCcCCCccccchhhhhhh-ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHh
Confidence 9999999976554433222222211 1111111111111111 11223345677778899999999999
Q ss_pred C
Q 020529 218 P 218 (325)
Q Consensus 218 P 218 (325)
.
T Consensus 296 ~ 296 (732)
T KOG4250|consen 296 G 296 (732)
T ss_pred C
Confidence 8
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=240.04 Aligned_cols=206 Identities=24% Similarity=0.298 Sum_probs=160.1
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+++ +||||+++++.+..+...++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|||
T Consensus 58 l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~d 130 (288)
T cd05583 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRD 130 (288)
T ss_pred HHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 4566 699999999999999999999999999999999864 346899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC--CCccccEEEehHHHHHHHhCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|+|.||+++.++.++|+|||+++....... .......|+..|+|||.+.+.. .+.++||||||+++++|++|..||.
T Consensus 131 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 131 IKLENILLDSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred CCHHHeEECCCCCEEEEECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 999999999999999999999875433221 1222345888999999987765 7889999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
...... ............. + ..+......+.+++.+||+.+|++|||+.+|.+.|+.
T Consensus 210 ~~~~~~--~~~~~~~~~~~~~--------~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 210 VDGEQN--SQSEISRRILKSK--------P----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred cCcccc--hHHHHHHHHHccC--------C----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 432211 1111111111110 1 1111223467899999999999999999988877753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=236.30 Aligned_cols=200 Identities=24% Similarity=0.286 Sum_probs=156.7
Q ss_pred cCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++.+. ...++|+||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ ++|+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~ 130 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHR 130 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecC
Confidence 5678999999999998764 467899999999999999865 345889999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCC-CCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.++|+|||+++....... ........|+..|+|||++.+..++.++|||||||++++|++|+.||.
T Consensus 131 dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 210 (264)
T cd06653 131 DIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210 (264)
T ss_pred CCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999975432111 111223568899999999998889999999999999999999999996
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...... .+.. ..........+......+.+++.+|++ +|..||++.+++.
T Consensus 211 ~~~~~~--~~~~--------------~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 211 EYEAMA--AIFK--------------IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ccCHHH--HHHH--------------HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 532211 1110 000001112233445678899999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=243.31 Aligned_cols=216 Identities=23% Similarity=0.298 Sum_probs=156.1
Q ss_pred cCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++... +..++||||+. ++|.+++... ...+++..++.++.|++.||+|||+.+ ++||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~ 132 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHR 132 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 5688999999999998765 56899999996 6898888652 356899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.++|+|||++........ ......++..|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 133 dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 133 DLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred CCCHHHEEECCCCCEEECccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999976543221 1222345778999999875 457899999999999999999999997
Q ss_pred CCCCCCcchhh-hhhh-------hcccccccccccc-CCccCCCC---ChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLV-TWAR-------PLFNDRRKFSKLA-DPRLEGRY---PIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~-~~~~-------~~~~~~~~~~~~~-d~~l~~~~---~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
........... .... +.+.......... ........ .......+.+++.+||+.||++||++.+++..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 211 GKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred CCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 64432211111 0000 0000000000000 00000000 00124567789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=241.28 Aligned_cols=217 Identities=21% Similarity=0.290 Sum_probs=155.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++++++||||+++++++.++...++||||++ ++|.+++.... ...+++..+..++.+++.||+|||+.+ ++|+|
T Consensus 54 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~d 127 (294)
T PLN00009 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRD 127 (294)
T ss_pred HHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 3678899999999999999999999999996 68888875422 234688899999999999999999999 99999
Q ss_pred CCCCcEEEcC-CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCC
Q 020529 81 FKSSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 81 ik~~Nill~~-~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|+|+||+++. ++.+||+|||++....... .......+++.|+|||++.+. .++.++||||||+++|+|++|..||.
T Consensus 128 l~p~nill~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 128 LKPQNLLIDRRTNALKLADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred CCcceEEEECCCCEEEEcccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999985 5679999999997543221 112334578899999988664 57899999999999999999999997
Q ss_pred CCCCCCcch-hhhhhh-h---ccccccc-------cccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQN-LVTWAR-P---LFNDRRK-------FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~-~~~~~~-~---~~~~~~~-------~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.....+... ...+.. + .+..... ........+. .........+.+++.+||+.+|.+||++.++++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 206 GDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred CCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 543221100 000000 0 0000000 0000000000 0011224567899999999999999999999873
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-32 Score=249.59 Aligned_cols=216 Identities=25% Similarity=0.391 Sum_probs=174.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|.+|+||||+.++|+|..++.+|+|+|||..|+|.+++...-. ..+.-..-..|+.||+.|++||.+.+ +||||
T Consensus 588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd 662 (807)
T KOG1094|consen 588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRD 662 (807)
T ss_pred HHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhcc
Confidence 47889999999999999999999999999999999999976311 11344556779999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHH--hCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELI--TGRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ell--tg~~p~~ 158 (325)
|.+.|+|++.++++||+|||.++-.-.++..++..+..-...|||+|.+.-++++.++|||+||+.+||++ +...||.
T Consensus 663 ~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~ 742 (807)
T KOG1094|consen 663 LATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYS 742 (807)
T ss_pred ccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchh
Confidence 99999999999999999999999766667667777777778999999999999999999999999999985 4567876
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
.... ..+++-...++.......-+.- |.-....+.+++..|+..+-.+||+.+++...|...+
T Consensus 743 ~lt~---e~vven~~~~~~~~~~~~~l~~-------P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 743 QLTD---EQVVENAGEFFRDQGRQVVLSR-------PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hhhH---HHHHHhhhhhcCCCCcceeccC-------CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 5432 2333334444443332222222 3344567889999999999999999999999987653
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=242.16 Aligned_cols=196 Identities=29% Similarity=0.387 Sum_probs=154.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++|||++++++++.+....++||||+. ++|.+++.. ...++++.+++.++.+++.||.|||+.+ ++|+||
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl 147 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDI 147 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 567899999999999999999999999996 688887754 2456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
+|+||+++.++.++|+|||++.... ......|+..|+|||++. ...++.++|||||||++++|++|..||.
T Consensus 148 ~p~nili~~~~~~kL~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 148 KAGNILLTEPGQVKLADFGSASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred ChhhEEECCCCCEEEeecCCCcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999986421 123456888999999974 4568889999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
......... ..... ...... . ......+.+++.+||+.+|.+||++.+++..
T Consensus 222 ~~~~~~~~~------~~~~~--~~~~~~----~----~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 222 NMNAMSALY------HIAQN--DSPTLQ----S----NEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCChHHHHH------HHHhc--CCCCCC----c----cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 643211110 00000 001111 1 1122457889999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=250.40 Aligned_cols=145 Identities=24% Similarity=0.319 Sum_probs=125.1
Q ss_pred CCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEE
Q 020529 8 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNIL 87 (325)
Q Consensus 8 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nil 87 (325)
-|+|++++||...++.|||+|.+ ..+|.+++... .-.+++...+..++.||+.||.+||+.+ |||+||||+|||
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENIL 321 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENIL 321 (586)
T ss_pred eeEEEeeeccccccceeeeehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhhee
Confidence 48999999999999999999999 59999999873 3456999999999999999999999999 999999999999
Q ss_pred EcCCC--eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCC
Q 020529 88 LEEGF--HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 163 (325)
Q Consensus 88 l~~~~--~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~ 163 (325)
|.... .+||+|||.+........ ...-+..|+|||++.+.+|+.+.|+||||||+.||++|.+-|.+.+..
T Consensus 322 L~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~ 394 (586)
T KOG0667|consen 322 LKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEY 394 (586)
T ss_pred eccCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHH
Confidence 96543 799999999976332221 233455699999999999999999999999999999998888765543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=240.69 Aligned_cols=216 Identities=22% Similarity=0.266 Sum_probs=157.5
Q ss_pred cCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+++++||||+++++++.+. ...++||||++ ++|.+++.. ....+++..++.++.+++.||+|||+.+ ++|+
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~ 124 (287)
T cd07840 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHR 124 (287)
T ss_pred HHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 5678999999999999887 89999999997 589988865 2246999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+|+||++++++.++|+|||++........ .......++..|+|||.+.+ ..++.++||||||++++||++|+.||.
T Consensus 125 dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 125 DIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred cCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999976433321 11233456788999998765 457899999999999999999999997
Q ss_pred CCCCCCcchhh-hhhhhcccccc-cccc-----------ccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 159 STRPHGEQNLV-TWARPLFNDRR-KFSK-----------LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~-~~~~~~~~~~~-~~~~-----------~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
........... ........... .+.. .....+...+.......+.+++.+||..+|.+||++.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 204 GSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred CCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 65432211110 00000000000 0000 00000000000112467889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=241.22 Aligned_cols=217 Identities=23% Similarity=0.295 Sum_probs=154.0
Q ss_pred cCCCCCCCccceeeEEEeCC--------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGD--------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
|++++||||+++++++.+.. ..++|+||+. ++|...+.. ....+++..+..++.+++.||+|||+.+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~- 135 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH- 135 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 57789999999999875433 4699999996 678877764 2346999999999999999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC---------CccccccCCcCccCchhhccC-CCCccccEEEe
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS---------HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSF 143 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSl 143 (325)
|+|+||||+||+++.++.++|+|||+++........ ...+...+++.|+|||++.+. .++.++|||||
T Consensus 136 --i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 213 (311)
T cd07866 136 --ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGI 213 (311)
T ss_pred --eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHH
Confidence 999999999999999999999999999754322211 111234578889999987654 57899999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCcchhh-hhhhhc----cccccccccccCCccCCCCC-------hHHHHHHHHHHHHchh
Q 020529 144 GVVFLELITGRKAIDSTRPHGEQNLV-TWARPL----FNDRRKFSKLADPRLEGRYP-------IRGLYQALAVASMCIQ 211 (325)
Q Consensus 144 Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~d~~l~~~~~-------~~~~~~~~~l~~~cl~ 211 (325)
||+++||++|++||............ ...... ......+....+.......+ ......+.+++.+||+
T Consensus 214 G~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 293 (311)
T cd07866 214 GCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293 (311)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcc
Confidence 99999999999999764432111110 000000 00000001100000000011 0122568899999999
Q ss_pred hCCCCCCCHHHHHH
Q 020529 212 EQAATRPLIGDVVT 225 (325)
Q Consensus 212 ~~p~~RPs~~evl~ 225 (325)
.+|.+||++.+++.
T Consensus 294 ~~p~~R~t~~ell~ 307 (311)
T cd07866 294 LDPYKRLTASDALE 307 (311)
T ss_pred cCcccCcCHHHHhc
Confidence 99999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=242.96 Aligned_cols=214 Identities=21% Similarity=0.312 Sum_probs=156.4
Q ss_pred cCCCCCCCccceeeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
|+.++||||+++++++... ...|+|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ +
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 129 (337)
T cd07858 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---V 129 (337)
T ss_pred HHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---E
Confidence 5678999999999988654 35799999995 789988865 456999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
+||||||+||+++.++.++|+|||+++...... .......++..|+|||.+.. ..++.++|||||||++++|++|+.
T Consensus 130 ~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 207 (337)
T cd07858 130 LHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP 207 (337)
T ss_pred ecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999997643321 12233457889999998865 468999999999999999999999
Q ss_pred CCCCCCCCCcchhh-hhhhh-------cccccc------ccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 156 AIDSTRPHGEQNLV-TWARP-------LFNDRR------KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 156 p~~~~~~~~~~~~~-~~~~~-------~~~~~~------~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
||............ ..... .+.... .......+.+.. ........+.+++.+||+.+|.+||++.
T Consensus 208 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ 286 (337)
T cd07858 208 LFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVE 286 (337)
T ss_pred CCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHH
Confidence 99654321110000 00000 000000 000000111000 0112346688999999999999999999
Q ss_pred HHHHH
Q 020529 222 DVVTA 226 (325)
Q Consensus 222 evl~~ 226 (325)
++++.
T Consensus 287 ell~h 291 (337)
T cd07858 287 EALAH 291 (337)
T ss_pred HHHcC
Confidence 99986
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=237.18 Aligned_cols=214 Identities=21% Similarity=0.301 Sum_probs=157.5
Q ss_pred cCCCC-CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+++++ ||||+++++++.+++..++||||+ +++|.+++.... ...+++..++.++.|++.+|.|||+.+ ++|+|
T Consensus 51 l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~d 124 (283)
T cd07830 51 LRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRD 124 (283)
T ss_pred HHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 45677 999999999999999999999999 789999887522 246899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|+|+||+++.++.++|+|||++....... ......++..|+|||++.. ..++.++||||||+++++|++|+.||..
T Consensus 125 l~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~ 201 (283)
T cd07830 125 LKPENLLVSGPEVVKIADFGLAREIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201 (283)
T ss_pred CChhhEEEcCCCCEEEeecccceeccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCC
Confidence 99999999999999999999987543221 1233457889999998754 4578999999999999999999999966
Q ss_pred CCCCCcch-hhhhhhhc----ccccc--------ccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 160 TRPHGEQN-LVTWARPL----FNDRR--------KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 160 ~~~~~~~~-~~~~~~~~----~~~~~--------~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
....+... ...+.... +.+.. .+.......+. .........+.+++.+|++.+|.+||++.|++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 202 SSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred CChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 54322110 00000000 00000 00000000000 000112467889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=232.52 Aligned_cols=194 Identities=30% Similarity=0.389 Sum_probs=157.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++.+..+...++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ ++|+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l 119 (250)
T cd05123 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDL 119 (250)
T ss_pred HHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 5678999999999999999999999999999999999975 336899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||||+++++|++|..||....
T Consensus 120 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 120 KPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999987543221 12334568889999999988889999999999999999999999996543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGD 222 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~e 222 (325)
. .... ....... ..++......+.+++.+||..+|..||++++
T Consensus 198 ~---~~~~---~~~~~~~------------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 198 R---KEIY---EKILKDP------------LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred H---HHHH---HHHhcCC------------CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2 1111 1111110 0112222457789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=244.74 Aligned_cols=213 Identities=20% Similarity=0.306 Sum_probs=154.2
Q ss_pred cCCCCCCCccceeeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
|++++||||+++++++... ...++|+||+. ++|.+++.. ..+++..++.++.|++.||+|||+.+ |
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---i 127 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---V 127 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 5778999999999987654 35799999996 688888753 45999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCC-CCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
+||||||+||+++.++.++|+|||++........ ........|+..|+|||++.+ ..++.++|||||||++++|++|+
T Consensus 128 vH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~ 207 (336)
T cd07849 128 LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207 (336)
T ss_pred eccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999875432211 111233568899999998755 46889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccccc--cccccccCC---------ccCCCCC-----hHHHHHHHHHHHHchhhCCCCCC
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDR--RKFSKLADP---------RLEGRYP-----IRGLYQALAVASMCIQEQAATRP 218 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~d~---------~l~~~~~-----~~~~~~~~~l~~~cl~~~p~~RP 218 (325)
.||....... ........+... ..+....+. ......+ ......+.+++.+||+.+|.+||
T Consensus 208 ~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 284 (336)
T cd07849 208 PLFPGKDYLH---QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284 (336)
T ss_pred CCCCCCCHHH---HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc
Confidence 9996532211 000000000000 000000000 0000000 11245688999999999999999
Q ss_pred CHHHHHHH
Q 020529 219 LIGDVVTA 226 (325)
Q Consensus 219 s~~evl~~ 226 (325)
++.++++.
T Consensus 285 t~~e~l~h 292 (336)
T cd07849 285 TVEEALAH 292 (336)
T ss_pred CHHHHhcC
Confidence 99999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=238.31 Aligned_cols=199 Identities=25% Similarity=0.368 Sum_probs=159.9
Q ss_pred cCCCC-CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+++++ ||||+++++++..++..++||||+.+++|.+++.. ...+++..++.++.+++.||.|||+.+ ++|+|
T Consensus 55 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~d 127 (280)
T cd05581 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRD 127 (280)
T ss_pred HHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecC
Confidence 45677 99999999999999999999999999999999976 346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCC------------------CccccccCCcCccCchhhccCCCCccccEEE
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKS------------------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYS 142 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwS 142 (325)
|+|+||+++.++.++|+|||++......... .......++..|+|||++....++.++||||
T Consensus 128 l~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~s 207 (280)
T cd05581 128 LKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWA 207 (280)
T ss_pred CCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHH
Confidence 9999999999999999999998754332211 1223345788999999998888999999999
Q ss_pred ehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH--
Q 020529 143 FGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI-- 220 (325)
Q Consensus 143 lGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~-- 220 (325)
||++++++++|..||....... .. ..... ....++......+.+++..||+.+|.+||++
T Consensus 208 lG~~l~~l~~g~~p~~~~~~~~---~~---~~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 269 (280)
T cd05581 208 LGCIIYQMLTGKPPFRGSNEYL---TF---QKILK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE 269 (280)
T ss_pred HHHHHHHHHhCCCCCCCccHHH---HH---HHHHh------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCccc
Confidence 9999999999999997653110 00 00000 0111122224568899999999999999999
Q ss_pred --HHHHH
Q 020529 221 --GDVVT 225 (325)
Q Consensus 221 --~evl~ 225 (325)
.++++
T Consensus 270 ~~~~ll~ 276 (280)
T cd05581 270 GYDELKA 276 (280)
T ss_pred CHHHHhc
Confidence 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=243.82 Aligned_cols=216 Identities=21% Similarity=0.265 Sum_probs=157.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++...+..++||||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl 145 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDL 145 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 577899999999999999999999999996 799999864 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCC------------CCCccccccCCcCccCchhhccC-CCCccccEEEehHHHH
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGD------------KSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFL 148 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~ 148 (325)
+|+||+++.++.++|+|||+++...... .........++..|+|||++.+. .++.++|||||||+++
T Consensus 146 ~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~ 225 (335)
T PTZ00024 146 SPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFA 225 (335)
T ss_pred cHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHH
Confidence 9999999999999999999987643110 01111223467889999998764 4689999999999999
Q ss_pred HHHhCCCCCCCCCCCCcch-hhhhhhhc----cccccccc------cccCCccCCCCChHHHHHHHHHHHHchhhCCCCC
Q 020529 149 ELITGRKAIDSTRPHGEQN-LVTWARPL----FNDRRKFS------KLADPRLEGRYPIRGLYQALAVASMCIQEQAATR 217 (325)
Q Consensus 149 elltg~~p~~~~~~~~~~~-~~~~~~~~----~~~~~~~~------~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R 217 (325)
+|++|..||......+... +....... +.....+. ....+.+.. ........+.+++.+||+.+|.+|
T Consensus 226 el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R 304 (335)
T PTZ00024 226 ELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLER 304 (335)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhc
Confidence 9999999997654321110 00000000 00000000 000000000 001224568899999999999999
Q ss_pred CCHHHHHHH
Q 020529 218 PLIGDVVTA 226 (325)
Q Consensus 218 Ps~~evl~~ 226 (325)
|++.+++..
T Consensus 305 ~s~~~~l~~ 313 (335)
T PTZ00024 305 ISAKEALKH 313 (335)
T ss_pred cCHHHHhcC
Confidence 999999974
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-31 Score=235.79 Aligned_cols=202 Identities=25% Similarity=0.330 Sum_probs=155.8
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+++ +||||+++++++..+...++||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ ++|||
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~d 130 (290)
T cd05613 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRD 130 (290)
T ss_pred HHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4566 699999999999999999999999999999999975 456889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC--CCCccccEEEehHHHHHHHhCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|+|+||+++.++.++|+|||++....... ........|+..|+|||++... .++.++||||||+++++|++|..||.
T Consensus 131 l~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 131 IKLENILLDSNGHVVLTDFGLSKEFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred CCHHHeEECCCCCEEEeeCccceeccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 99999999999999999999987543221 1122235588899999998753 46789999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~ 225 (325)
...... ....+........ + .++......+.+++.+||+.+|.+|| ++.+++.
T Consensus 210 ~~~~~~--~~~~~~~~~~~~~--------~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 210 VDGEKN--SQAEISRRILKSE--------P----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred cCCccc--cHHHHHHHhhccC--------C----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 532211 1111111111110 0 11222335678999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=245.76 Aligned_cols=200 Identities=27% Similarity=0.327 Sum_probs=168.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||...+.|+||++|-.|.+..+.||+||-|-||.|+..|++ +..++..+...++..++.|++|||.++ ||+||
T Consensus 473 Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRD 545 (732)
T KOG0614|consen 473 IMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRD 545 (732)
T ss_pred HHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceecc
Confidence 35567899999999999999999999999999999999987 667999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|++|+.+|.+||.|||+|+....+. .+-.++||+.|.|||++.....+.+.|.||||+++||||+|.+||.+.
T Consensus 546 LKPENllLd~~Gy~KLVDFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 546 LKPENLLLDNRGYLKLVDFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred CChhheeeccCCceEEeehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999999999999999999765443 456789999999999999999999999999999999999999999998
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
.+....+++--.-..+ .+|........+|+.+.+..+|.+|-- +.+|-+.
T Consensus 623 dpmktYn~ILkGid~i----------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 623 DPMKTYNLILKGIDKI----------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred chHHHHHHHHhhhhhh----------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 7765554431111111 122233456789999999999999976 5566554
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=235.14 Aligned_cols=214 Identities=26% Similarity=0.350 Sum_probs=158.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+....++||||++ ++|.+++... ...+++..++.++.+++.||+|||+.+ |+||||
T Consensus 52 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l 124 (282)
T cd07829 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDL 124 (282)
T ss_pred HHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 567899999999999999999999999997 6999999762 246999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
+|+||+++.++.++|+|||+++....... ......++..|+|||++... .++.++||||||++++||++|.+||...
T Consensus 125 ~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 125 KPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred ChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999876433221 12233457789999998776 7899999999999999999999999664
Q ss_pred CCCCcc-hhhhhhh-------hcccc----ccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQ-NLVTWAR-------PLFND----RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~-~~~~~~~-------~~~~~----~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...... .+..... ..... ...+............+ .....+.+++..||..+|.+||++.+|+.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 203 SEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcc-cccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 322110 0000000 00000 00000000000000001 12457899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=237.21 Aligned_cols=215 Identities=26% Similarity=0.315 Sum_probs=154.1
Q ss_pred cCCCCCCCccceeeEEEeCC----------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 020529 2 LSLLHHSNLVNLIGYCADGD----------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK 71 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~----------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~ 71 (325)
+++++||||+++++++.+.. ..++|+||++ ++|..++.. ....+++..++.++.|++.||+|||+.
T Consensus 60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~ 135 (302)
T cd07864 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD-HDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK 135 (302)
T ss_pred HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccC-ccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 56789999999999987654 7899999997 578777765 234689999999999999999999999
Q ss_pred CCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHH
Q 020529 72 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 72 ~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~el 150 (325)
+ |+|+||||+||++++++.+||+|||++........ .......++..|+|||.+.+. .++.++|||||||++++|
T Consensus 136 ~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el 211 (302)
T cd07864 136 N---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211 (302)
T ss_pred C---eecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHH
Confidence 9 99999999999999999999999999976443321 122233467789999987653 578899999999999999
Q ss_pred HhCCCCCCCCCCCCcchh-hhhhhhcc----ccccccccc--cCC------ccCCCCChHHHHHHHHHHHHchhhCCCCC
Q 020529 151 ITGRKAIDSTRPHGEQNL-VTWARPLF----NDRRKFSKL--ADP------RLEGRYPIRGLYQALAVASMCIQEQAATR 217 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~--~d~------~l~~~~~~~~~~~~~~l~~~cl~~~p~~R 217 (325)
++|++||........... ........ ......... .++ ...... ......+.+++..||+.+|.+|
T Consensus 212 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R 290 (302)
T cd07864 212 FTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKR 290 (302)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhC
Confidence 999999975432211100 00000000 000000000 000 000000 0124578899999999999999
Q ss_pred CCHHHHHH
Q 020529 218 PLIGDVVT 225 (325)
Q Consensus 218 Ps~~evl~ 225 (325)
|++.+|+.
T Consensus 291 p~~~~il~ 298 (302)
T cd07864 291 CTAEEALN 298 (302)
T ss_pred CCHHHHhc
Confidence 99999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=238.28 Aligned_cols=198 Identities=24% Similarity=0.358 Sum_probs=152.0
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCCCCCC
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSS 84 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrdik~~ 84 (325)
.||||++++++|.++...|+||||+. ++|.+++.. ....+++..+..++.+++.||+|||+ .+ |+||||+|+
T Consensus 72 ~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~ 144 (296)
T cd06618 72 DCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKR---IQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPS 144 (296)
T ss_pred CCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHH
Confidence 59999999999999999999999995 678877755 23479999999999999999999997 47 999999999
Q ss_pred cEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC----CCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ----LTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 85 Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||++++++.++|+|||++....... ......++..|+|||++.+.. ++.++||||||+++|+|++|+.||...
T Consensus 145 nill~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 221 (296)
T cd06618 145 NILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNC 221 (296)
T ss_pred HEEEcCCCCEEECccccchhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999986543221 122345788999999987654 788999999999999999999999653
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
... ...+.. ..... ...... .......+.+++.+||..+|.+||++.+++...
T Consensus 222 ~~~-~~~~~~----~~~~~--~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 222 KTE-FEVLTK----ILQEE--PPSLPP-------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred hhH-HHHHHH----HhcCC--CCCCCC-------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 211 111111 11100 000000 001235688999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=243.38 Aligned_cols=217 Identities=23% Similarity=0.280 Sum_probs=159.8
Q ss_pred cCCCCCCCccceeeEEEeCC-----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
|+.++||||+++++++.... ..|+||||+. ++|.+++.. ...+++..++.++.+++.||+|||+.+ |
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i 124 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---V 124 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 56789999999999988765 7899999997 689998865 347999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~ 154 (325)
+|+||||+||+++.++.++|+|||++......... .......++..|+|||++.+. .++.++||||||+++++|++|+
T Consensus 125 ~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~ 204 (330)
T cd07834 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204 (330)
T ss_pred ecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCC
Confidence 99999999999999999999999999865443210 112334578899999999888 8899999999999999999999
Q ss_pred CCCCCCCCCCcchhh-hhhhhccc------cccccccccC---Ccc---CCCCChHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 155 KAIDSTRPHGEQNLV-TWARPLFN------DRRKFSKLAD---PRL---EGRYPIRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~d---~~l---~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
.||...........+ ........ ........+. ... ...........+.+++..||+.+|.+||++.
T Consensus 205 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 284 (330)
T cd07834 205 PLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITAD 284 (330)
T ss_pred CCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHH
Confidence 999765432111000 00000000 0000000000 000 0000112345678999999999999999999
Q ss_pred HHHHH
Q 020529 222 DVVTA 226 (325)
Q Consensus 222 evl~~ 226 (325)
+++..
T Consensus 285 ~ll~~ 289 (330)
T cd07834 285 EALAH 289 (330)
T ss_pred HHHhC
Confidence 99975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=241.20 Aligned_cols=216 Identities=20% Similarity=0.238 Sum_probs=152.8
Q ss_pred cCCC-CCCCccceeeEEEeC----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLL-HHSNLVNLIGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
|+++ +||||+++++++... ...+++++|+. ++|.+++.. ...+++..++.++.|++.||.|||+.+ |
T Consensus 55 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---i 126 (332)
T cd07857 55 LRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---V 126 (332)
T ss_pred HHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 3456 699999999875432 45788999985 799998864 456999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC--CccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg 153 (325)
+||||||+||+++.++.++|+|||+++........ .......|+..|+|||++.+ ..++.++|||||||++++|++|
T Consensus 127 vH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g 206 (332)
T cd07857 127 LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206 (332)
T ss_pred ccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999754322211 11234568999999998766 4689999999999999999999
Q ss_pred CCCCCCCCCCCcch-hh--------hhhhhccccc-c----ccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC
Q 020529 154 RKAIDSTRPHGEQN-LV--------TWARPLFNDR-R----KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 154 ~~p~~~~~~~~~~~-~~--------~~~~~~~~~~-~----~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
..||.......... .. .+........ . .........+.. ........+.+++.+||+.+|.+||+
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t 285 (332)
T cd07857 207 KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRIS 285 (332)
T ss_pred CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCC
Confidence 99987543211000 00 0000000000 0 000000000000 00112356889999999999999999
Q ss_pred HHHHHHH
Q 020529 220 IGDVVTA 226 (325)
Q Consensus 220 ~~evl~~ 226 (325)
+.+++..
T Consensus 286 ~~~ll~~ 292 (332)
T cd07857 286 VEEALEH 292 (332)
T ss_pred HHHHhcC
Confidence 9998753
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=244.43 Aligned_cols=207 Identities=25% Similarity=0.364 Sum_probs=171.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+++.+.||||++++|.|.+. ...+|||.++.|.|..||+. .+..|+..+...+++||+.||+|||+.. +||||
T Consensus 444 iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRD 516 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRD 516 (974)
T ss_pred HHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhh
Confidence 46789999999999999865 57899999999999999987 5678999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHH-hCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELI-TGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ell-tg~~p~~~ 159 (325)
|...|||+....-+||+||||++..........+ +..-...|||||-+.-..++.++|||-|||.+|||+ .|..||.+
T Consensus 517 IAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqg 595 (974)
T KOG4257|consen 517 IAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQG 595 (974)
T ss_pred hhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccc
Confidence 9999999999999999999999976655544433 344456799999999999999999999999999986 68999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
-...+.. ..+..--+..+|+.++..+..|+.+||+.+|.+||...++...|..+..
T Consensus 596 vkNsDVI-----------------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 596 VKNSDVI-----------------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ccccceE-----------------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 4322110 0111112223455666778899999999999999999999998876654
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-31 Score=240.52 Aligned_cols=209 Identities=20% Similarity=0.319 Sum_probs=151.1
Q ss_pred cCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
|+.++||||+++++++... ...++|+||+. .+|..++. ..+++..+..++.+++.||+|||+.+
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~--- 137 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG--- 137 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999998654 34699999996 67877652 34899999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+||+++.++.++|+|||+++.... ......++..|+|||++.+ ..++.++|||||||+++||++|+
T Consensus 138 i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~ 212 (342)
T cd07879 138 IIHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212 (342)
T ss_pred cccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875322 1223457888999999876 46889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhh--------ccccc--cc----cccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 155 KAIDSTRPHGEQNLVTWARP--------LFNDR--RK----FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~--------~~~~~--~~----~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
.||................. ..... .. ........+...+ ......+.+++.+||+.+|.+||++
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~ 291 (342)
T cd07879 213 TLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTA 291 (342)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCH
Confidence 99976432111110000000 00000 00 0000000000000 0123467899999999999999999
Q ss_pred HHHHHH
Q 020529 221 GDVVTA 226 (325)
Q Consensus 221 ~evl~~ 226 (325)
.+|+..
T Consensus 292 ~e~l~h 297 (342)
T cd07879 292 TEALEH 297 (342)
T ss_pred HHHhcC
Confidence 999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=227.66 Aligned_cols=228 Identities=21% Similarity=0.240 Sum_probs=166.3
Q ss_pred CcCCCCCCCccceeeEEEe-CCeeEEEEecCCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPP-DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
+++.|+||||+.+..+|.. +...+|++||.. .+|.+.++-.+. ..+.++...+..|+.||+.|+.|||++- |+|
T Consensus 80 L~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlH 155 (438)
T KOG0666|consen 80 LLRELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLH 155 (438)
T ss_pred HHHHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eee
Confidence 3678999999999999876 788999999996 899999865322 3357999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCC----CeEEEecCCCCccCCCCCCCC-ccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHh
Q 020529 79 RDFKSSNILLEEG----FHPKLSDFGLAKLGPVGDKSH-VSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 79 rdik~~Nill~~~----~~~kL~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~ellt 152 (325)
|||||+|||+..+ |.|||+|||+++++...-... ....+.-|.+|+|||.+.+. .|+.+.|||+.|||+.||+|
T Consensus 156 RDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 156 RDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred ccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 9999999999777 899999999999877665554 33456789999999999876 68999999999999999999
Q ss_pred CCCCCCCCCCCCcc-------hhhhhhhhccc----cccccccccCC-----ccC-CCCChH-----------HHHHHHH
Q 020529 153 GRKAIDSTRPHGEQ-------NLVTWARPLFN----DRRKFSKLADP-----RLE-GRYPIR-----------GLYQALA 204 (325)
Q Consensus 153 g~~p~~~~~~~~~~-------~~~~~~~~~~~----~~~~~~~~~d~-----~l~-~~~~~~-----------~~~~~~~ 204 (325)
-.+-|.+....-.. .+.+....+-. +-..+..+.+- .++ ..+... .....++
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~ 315 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALD 315 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHH
Confidence 98877653322111 11110000000 00000000000 000 000000 0123678
Q ss_pred HHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 205 VASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 205 l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
|+.++|+.||.+|.|+++.++..-+...
T Consensus 316 LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred HHHHHhccCchhhccHHHHhcccccccC
Confidence 9999999999999999999998766544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=233.73 Aligned_cols=186 Identities=26% Similarity=0.386 Sum_probs=157.1
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
+-|.++++...|..-+++|+||||+.||+|--+++. -..+.+..+..++..|+.||-+||+++ ||+||||.+|
T Consensus 408 kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDN 480 (683)
T KOG0696|consen 408 KPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDN 480 (683)
T ss_pred CCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccc
Confidence 468889988889999999999999999999999876 344777788899999999999999999 9999999999
Q ss_pred EEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCc
Q 020529 86 ILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 165 (325)
Q Consensus 86 ill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~ 165 (325)
|+|+..|++||+|||+++.....+ ..+..+.||+.|+|||++...+|+...|.|||||+|||||.|.+||++....+.
T Consensus 481 vmLd~eGHiKi~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el 558 (683)
T KOG0696|consen 481 VMLDSEGHIKIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 558 (683)
T ss_pred eEeccCCceEeeecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 999999999999999998644333 345678999999999999999999999999999999999999999988643211
Q ss_pred chhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC
Q 020529 166 QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 218 (325)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP 218 (325)
+..+.+.. -.||...+.++++++...|.++|.+|.
T Consensus 559 ----------------F~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 559 ----------------FQAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----------------HHHHHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11111111 245666778899999999999999984
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=237.37 Aligned_cols=211 Identities=22% Similarity=0.321 Sum_probs=154.6
Q ss_pred CcCCCCCCCccceeeEEEe-CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++||||+++.++|.. ....++|+||+ +++|.+++.. .++++..+..++.|++.||.|||+.+ |+|+
T Consensus 62 ~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~ 132 (328)
T cd07856 62 LLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHR 132 (328)
T ss_pred HHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 3568899999999999865 56789999999 5799988853 35888899999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+|+||+++.++.++|+|||++..... ......++..|+|||++.+ ..++.++||||||+++++|++|+.||.
T Consensus 133 dl~p~Nili~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 133 DLKPSNILINENCDLKICDFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred CCCHHHEeECCCCCEEeCccccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999874321 1223457888999998766 568999999999999999999999996
Q ss_pred CCCCCCcch-hh--------hhhhhccccccccccccCCccCCCCCh-----HHHHHHHHHHHHchhhCCCCCCCHHHHH
Q 020529 159 STRPHGEQN-LV--------TWARPLFNDRRKFSKLADPRLEGRYPI-----RGLYQALAVASMCIQEQAATRPLIGDVV 224 (325)
Q Consensus 159 ~~~~~~~~~-~~--------~~~~~~~~~~~~~~~~~d~~l~~~~~~-----~~~~~~~~l~~~cl~~~p~~RPs~~evl 224 (325)
......... +. ++....... ........-......+. .....+.+++.+||+.+|.+||++.+++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 208 GKDHVNQFSIITDLLGTPPDDVINTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHHHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 543211100 00 011100000 00000000001111111 1236788999999999999999999997
Q ss_pred HH
Q 020529 225 TA 226 (325)
Q Consensus 225 ~~ 226 (325)
..
T Consensus 287 ~~ 288 (328)
T cd07856 287 AH 288 (328)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=244.98 Aligned_cols=203 Identities=27% Similarity=0.386 Sum_probs=166.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|.+|+||||++|||...+ ....||||+++.|||.+.|++ ..+..|-......++.|||.|+.||..++ +|||||
T Consensus 165 M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDL 238 (1039)
T KOG0199|consen 165 MLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDL 238 (1039)
T ss_pred HHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhh
Confidence 567999999999999987 677899999999999999987 34566888999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCcccc-ccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR-VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
-..|+||..-..|||+||||.+.++......+... ..-.+.|||||.+....++.++|||+|||.||||+| |..||-+
T Consensus 239 AARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 239 AARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred hhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 99999999888999999999987665443332211 223567999999999999999999999999999987 5789987
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
...... .+.+|..-+-.-|..+..++.+++..||..+|.+||+...|.+.+
T Consensus 319 ~~g~qI-----------------L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 319 CRGIQI-----------------LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCHHHH-----------------HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 654322 222222222223445678899999999999999999999998554
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=242.05 Aligned_cols=211 Identities=20% Similarity=0.297 Sum_probs=154.2
Q ss_pred cCCCCCCCccceeeEEEeCCe------eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQ------RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
+++++||||+++.+++...+. .++|+||+ +++|.+++.. ..+++..++.++.+++.||.|||+.+
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g--- 138 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG--- 138 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 577899999999998866554 89999999 6899999864 45999999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+||+++.++.++|+|||++...... .....++..|+|||++.+ ..++.++||||||+++++|++|+
T Consensus 139 i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~ 213 (343)
T cd07851 139 IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213 (343)
T ss_pred eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999754221 233457888999999865 36789999999999999999999
Q ss_pred CCCCCCCCCCcch-hhhh--------hhhccccc-cccccccCCccCCCC---ChHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 155 KAIDSTRPHGEQN-LVTW--------ARPLFNDR-RKFSKLADPRLEGRY---PIRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 155 ~p~~~~~~~~~~~-~~~~--------~~~~~~~~-~~~~~~~d~~l~~~~---~~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
.||.......... +... ......+. ..+...........+ .......+.+++.+||+.+|.+||++.
T Consensus 214 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ 293 (343)
T cd07851 214 TLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA 293 (343)
T ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH
Confidence 9996543221100 0000 00000000 000000000000000 011246788999999999999999999
Q ss_pred HHHHH
Q 020529 222 DVVTA 226 (325)
Q Consensus 222 evl~~ 226 (325)
+|+..
T Consensus 294 ell~h 298 (343)
T cd07851 294 EALAH 298 (343)
T ss_pred HHhcC
Confidence 99753
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=245.72 Aligned_cols=203 Identities=27% Similarity=0.372 Sum_probs=169.3
Q ss_pred cCCC-CCCCccceeeEEEe-----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLL-HHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
|+.+ .|||++.++++|.. ++++.||||||.+||..+++.... ...+.|..+..|++.++.|+.+||...
T Consensus 69 l~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk--- 143 (953)
T KOG0587|consen 69 LKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK--- 143 (953)
T ss_pred HHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---
Confidence 4455 79999999999854 578999999999999999998866 567999999999999999999999998
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-----CCCccccEEEehHHHHHH
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-----QLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvvl~el 150 (325)
++|||||-.||||..++.|||+|||++... ...........||+.|||||++... .|+..+|+||||++..||
T Consensus 144 viHRDikG~NiLLT~e~~VKLvDFGvSaQl--dsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEl 221 (953)
T KOG0587|consen 144 VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEM 221 (953)
T ss_pred eeeecccCceEEEeccCcEEEeeeeeeeee--ecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehh
Confidence 999999999999999999999999998653 3344556678899999999998764 367889999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.-|.+|+-.+.+.. .++ .-..+|.....-+..-..++.++|..||.+|...||++.++++.
T Consensus 222 adG~PPl~DmHPmr---------aLF------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 222 AEGAPPLCDMHPMR---------ALF------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred cCCCCCccCcchhh---------hhc------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 99999987765531 122 12223333333456778899999999999999999999998864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=236.46 Aligned_cols=211 Identities=21% Similarity=0.307 Sum_probs=153.0
Q ss_pred cCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
+++++||||+++++++... ...|++++++ +++|.+++.. ..+++..++.++.|++.||+|||+.+
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~--- 140 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--- 140 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999988643 3468888887 7899988853 35899999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+||+++.++.++|+|||+++.... ......++..|+|||++.+ ..++.++|||||||++++|++|+
T Consensus 141 ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred eeecCCChHHEEEcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999875321 2233567889999999866 46889999999999999999999
Q ss_pred CCCCCCCCCCcch-hhhhhh-------hccccc--cc----cccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 155 KAIDSTRPHGEQN-LVTWAR-------PLFNDR--RK----FSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 155 ~p~~~~~~~~~~~-~~~~~~-------~~~~~~--~~----~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
.||.......... +..... ..+... .. +......... .........+.+++..||+.+|.+||++
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~ 294 (345)
T cd07877 216 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITA 294 (345)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCH
Confidence 9996543221110 000000 000000 00 0000000000 0001123467899999999999999999
Q ss_pred HHHHHHH
Q 020529 221 GDVVTAL 227 (325)
Q Consensus 221 ~evl~~L 227 (325)
.+++..-
T Consensus 295 ~e~l~h~ 301 (345)
T cd07877 295 AQALAHA 301 (345)
T ss_pred HHHhcCh
Confidence 9998763
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=223.32 Aligned_cols=200 Identities=30% Similarity=0.353 Sum_probs=159.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++|+||+++++++......++++||+.+++|.+++.. ...+++..++.++.+++.++.|||+.+ ++|+||
T Consensus 41 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i 113 (244)
T smart00220 41 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDL 113 (244)
T ss_pred HHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCc
Confidence 4677999999999999999999999999998899999875 223899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+|.||+++.++.++|+|||++....... ......+++.|++||.+....++.++|||+||+++++|++|..||....
T Consensus 114 ~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~ 190 (244)
T smart00220 114 KPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD 190 (244)
T ss_pred CHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997644332 2334568889999999998889999999999999999999999986531
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
. ...+..+...... ..... .......+.+++.+|+..+|++||++.++++
T Consensus 191 ~--~~~~~~~~~~~~~---------~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 191 Q--LLELFKKIGKPKP---------PFPPP---EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred c--HHHHHHHHhccCC---------CCccc---cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 1 1111111110000 00000 0002357889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=237.06 Aligned_cols=210 Identities=22% Similarity=0.329 Sum_probs=153.2
Q ss_pred CcCCCCCCCccceeeEEEeCC------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+|++++||||+++++++.... ..++||||+ +++|..++.. ..+++..++.++.|++.||.|||+.+
T Consensus 67 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g-- 138 (343)
T cd07880 67 LLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG-- 138 (343)
T ss_pred HHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 367889999999999987543 458999999 7899988853 45899999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhC
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg 153 (325)
|+||||||+||+++.++.++|+|||++..... ......++..|+|||++.+ ..++.++||||||+++++|++|
T Consensus 139 -i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g 212 (343)
T cd07880 139 -IIHRDLKPGNLAVNEDCELKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212 (343)
T ss_pred -eecCCCCHHHEEEcCCCCEEEeeccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999875322 1233457889999999876 4588999999999999999999
Q ss_pred CCCCCCCCCCCcc-hhhh--------hhhhccccc-----cccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC
Q 020529 154 RKAIDSTRPHGEQ-NLVT--------WARPLFNDR-----RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 154 ~~p~~~~~~~~~~-~~~~--------~~~~~~~~~-----~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
..||......... .+.. +...+.... ..++......+ ..........+.+++.+||+.+|.+||+
T Consensus 213 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t 291 (343)
T cd07880 213 KPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRIT 291 (343)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCC
Confidence 9999754321100 0000 000000000 00000000000 0001122346789999999999999999
Q ss_pred HHHHHH
Q 020529 220 IGDVVT 225 (325)
Q Consensus 220 ~~evl~ 225 (325)
+.+++.
T Consensus 292 ~~~~l~ 297 (343)
T cd07880 292 AAEALA 297 (343)
T ss_pred HHHHhc
Confidence 999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-31 Score=225.19 Aligned_cols=208 Identities=25% Similarity=0.364 Sum_probs=157.2
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
.|+||+++++||+++...|||||.|.||+|.++++. +..+++.++.++...|+.||.+||.+| |.||||||+|
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPEN 206 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPEN 206 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccc
Confidence 599999999999999999999999999999999986 667999999999999999999999999 9999999999
Q ss_pred EEEcCCC---eEEEecCCCCccCCCC-CCCC----ccccccCCcCccCchhhcc-----CCCCccccEEEehHHHHHHHh
Q 020529 86 ILLEEGF---HPKLSDFGLAKLGPVG-DKSH----VSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 86 ill~~~~---~~kL~Dfgla~~~~~~-~~~~----~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~ellt 152 (325)
||...-. -+|||||.|..-.... +... ......|+..|||||+..- ..|+.++|.||||||+|=||+
T Consensus 207 iLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs 286 (463)
T KOG0607|consen 207 ILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS 286 (463)
T ss_pred eeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh
Confidence 9996544 4899999987532111 1111 1234568889999998743 358899999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCC--ChHH----HHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY--PIRG----LYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~----~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|.+||.+.-..+ -.|-+.-.- +..-..++....+|.| |..+ +.+..+++...|..++.+|-++..|+.
T Consensus 287 GYpPFvG~Cg~d----CGWdrGe~C-r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 287 GYPPFVGHCGAD----CGWDRGEVC-RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCCccCccCCc----CCccCCCcc-HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 999998754321 112111000 0011222223333333 3333 456778999999999999999998886
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=239.02 Aligned_cols=217 Identities=21% Similarity=0.321 Sum_probs=151.9
Q ss_pred CcCCCCCCCccceeeEEEeC--------------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 020529 1 MLSLLHHSNLVNLIGYCADG--------------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE 66 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~--------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~ 66 (325)
+|++++||||+++++++... ...++||||++ ++|.+++.. ..+++..++.++.|++.||.
T Consensus 55 ~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~ 128 (342)
T cd07854 55 IIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLK 128 (342)
T ss_pred HHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHH
Confidence 36788999999999876543 35789999996 689888853 35899999999999999999
Q ss_pred HHhcCCCCCeEeCCCCCCcEEEc-CCCeEEEecCCCCccCCCCCC-CCccccccCCcCccCchhhcc-CCCCccccEEEe
Q 020529 67 YLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSF 143 (325)
Q Consensus 67 ~LH~~~~~~ivHrdik~~Nill~-~~~~~kL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSl 143 (325)
|||+.+ |+||||||+||+++ .++.++|+|||+++....... ........++..|+|||++.. ..++.++|||||
T Consensus 129 ~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSl 205 (342)
T cd07854 129 YIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAA 205 (342)
T ss_pred HHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHH
Confidence 999999 99999999999997 456789999999875322111 111223457889999998654 567889999999
Q ss_pred hHHHHHHHhCCCCCCCCCCCCcchhhhhhhhcccc--cccc----cc-ccCCccCCCCC-----hHHHHHHHHHHHHchh
Q 020529 144 GVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND--RRKF----SK-LADPRLEGRYP-----IRGLYQALAVASMCIQ 211 (325)
Q Consensus 144 Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~----~~-~~d~~l~~~~~-----~~~~~~~~~l~~~cl~ 211 (325)
||++++|++|+.||....+...........+.... ...+ .. +.........+ ......+.+++.+||+
T Consensus 206 Gvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 285 (342)
T cd07854 206 GCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILT 285 (342)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhC
Confidence 99999999999999765432211111000000000 0000 00 00000000000 1223567899999999
Q ss_pred hCCCCCCCHHHHHHH
Q 020529 212 EQAATRPLIGDVVTA 226 (325)
Q Consensus 212 ~~p~~RPs~~evl~~ 226 (325)
.+|.+||++.+|+..
T Consensus 286 ~dP~~R~t~~ell~h 300 (342)
T cd07854 286 FNPMDRLTAEEALMH 300 (342)
T ss_pred CCchhccCHHHHhCC
Confidence 999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=227.40 Aligned_cols=205 Identities=26% Similarity=0.416 Sum_probs=158.6
Q ss_pred cCCCCCCCccceeeEEE-eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
-+.|.||-||++|+||. +.+..|-|.|||+|.+|.-||.. .+.+++.++..|+.||+.||.||.+.. +||||-|
T Consensus 521 HKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYD 595 (775)
T KOG1151|consen 521 HKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYD 595 (775)
T ss_pred hhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeec
Confidence 46789999999999986 45677999999999999999975 677999999999999999999999886 7799999
Q ss_pred CCCCcEEEcC---CCeEEEecCCCCccCCCCCCCC-----ccccccCCcCccCchhhccC----CCCccccEEEehHHHH
Q 020529 81 FKSSNILLEE---GFHPKLSDFGLAKLGPVGDKSH-----VSTRVMGTYGYCAPEYAMTG----QLTVKSDVYSFGVVFL 148 (325)
Q Consensus 81 ik~~Nill~~---~~~~kL~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvvl~ 148 (325)
|||.||||-. -|.+||.||||++++......+ .+....||++|++||++..+ +.+.|.||||+|||+|
T Consensus 596 LKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFy 675 (775)
T KOG1151|consen 596 LKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFY 675 (775)
T ss_pred cCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhh
Confidence 9999999954 4789999999999876544332 23457799999999988654 4688999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCCh--HHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 149 ELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPI--RGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 149 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~--~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.++.|+.||...... +++.... .++.. .++ .+|. ....+...+|.+||+..-.+|.+.-++..
T Consensus 676 QClYGrKPFGhnqsQ--QdILqeN-TIlkA----tEV-------qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 676 QCLYGRKPFGHNQSQ--QDILQEN-TILKA----TEV-------QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhhccCCCCCCchhH--HHHHhhh-chhcc----eec-------cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 999999999764321 1221110 00100 000 1111 22456788999999999999987766543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=229.38 Aligned_cols=222 Identities=28% Similarity=0.404 Sum_probs=166.5
Q ss_pred CCCCCCccceeeEEEeCC----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------C
Q 020529 4 LLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA------N 73 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~------~ 73 (325)
.|+|+||++++++-..+. ++.||++|.+.|||.+||.. ..++|....+|+..+++||+|||+.- .
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~K 334 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHK 334 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCC
Confidence 579999999999876555 88999999999999999964 56999999999999999999999854 3
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC-CC-----ccccEEEehHHH
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ-LT-----VKSDVYSFGVVF 147 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~ksDvwSlGvvl 147 (325)
++|+|||||+.||||.+++..-|+|||||..+..+......-...||..|||||++.+.- +. ...||||+|.||
T Consensus 335 p~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVL 414 (534)
T KOG3653|consen 335 PPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVL 414 (534)
T ss_pred CccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHH
Confidence 789999999999999999999999999998877665555556688999999999998752 22 468999999999
Q ss_pred HHHHhCCCCCCCCCCCCcc-hh---------hhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCC
Q 020529 148 LELITGRKAIDSTRPHGEQ-NL---------VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR 217 (325)
Q Consensus 148 ~elltg~~p~~~~~~~~~~-~~---------~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R 217 (325)
+||++....++...+.+.+ -+ .+-++..+......+.+.+.=.. ...+.-+.+.+..|+..||..|
T Consensus 415 WEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeAR 490 (534)
T KOG3653|consen 415 WEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEAR 490 (534)
T ss_pred HHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhh
Confidence 9999876544321111100 00 00011111111111222111111 1346678889999999999999
Q ss_pred CCHHHHHHHHHhhhccC
Q 020529 218 PLIGDVVTALSYLANQT 234 (325)
Q Consensus 218 Ps~~evl~~L~~~~~~~ 234 (325)
-|+.=|-+++..+....
T Consensus 491 LTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 491 LTAGCVEERMAELMMLW 507 (534)
T ss_pred hhhHHHHHHHHHHhccC
Confidence 99999999998887543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=263.17 Aligned_cols=199 Identities=15% Similarity=0.227 Sum_probs=142.9
Q ss_pred cCCCCC-CCccceeeEE-------EeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 2 LSLLHH-SNLVNLIGYC-------ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 2 L~~l~H-pniv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
++.++| +||++++++| .+....++++||+ +++|.++|.. ....+++.+++.++.||+.||+|||+++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g- 100 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG- 100 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 356778 7999999988 2334567788988 5899999975 2456999999999999999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCC-------------------eEEEecCCCCccCCCCCC--------------CCccccccCC
Q 020529 74 PPVIYRDFKSSNILLEEGF-------------------HPKLSDFGLAKLGPVGDK--------------SHVSTRVMGT 120 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~-------------------~~kL~Dfgla~~~~~~~~--------------~~~~~~~~gt 120 (325)
|+||||||+||||+..+ .+||+|||+++....... ........||
T Consensus 101 --IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 101 --IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred --eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCC
Confidence 99999999999996544 455566666543211000 0001124588
Q ss_pred cCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHH
Q 020529 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLY 200 (325)
Q Consensus 121 ~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 200 (325)
+.|+|||++.+..++.++|||||||+||||++|.+|+..... .+..+.. ....+.. .....
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~----------~~~~~~~-----~~~~~ 239 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH----------RVLPPQI-----LLNWP 239 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH----------hhcChhh-----hhcCH
Confidence 999999999999999999999999999999998887643210 0110100 0111111 01123
Q ss_pred HHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 201 QALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 201 ~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.+..++.+||+.+|.+||++.+|++.
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhhc
Confidence 45688899999999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=249.43 Aligned_cols=95 Identities=33% Similarity=0.459 Sum_probs=88.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++......||||||+.+++|.+++.. ...+++..++.|+.||+.||.|||..+ |+||||
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDL 130 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDL 130 (669)
T ss_pred HHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCc
Confidence 4678999999999999999999999999999999999975 345899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCc
Q 020529 82 KSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~ 103 (325)
||+||||+.++.++|+|||+++
T Consensus 131 KP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 131 KPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred cHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=221.89 Aligned_cols=207 Identities=19% Similarity=0.224 Sum_probs=152.2
Q ss_pred ccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEc
Q 020529 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE 89 (325)
Q Consensus 10 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~ 89 (325)
+|++.++|.-.++.|+|+|.+ |.|+.+++.. ..-.+++...+..+++|++.++++||+.+ ++|.||||+|||+.
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfv 226 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFV 226 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEe
Confidence 567778899999999999999 6899999976 34457899999999999999999999999 99999999999983
Q ss_pred --------------------CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHH
Q 020529 90 --------------------EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 90 --------------------~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~e 149 (325)
++..|+|+|||.|..... . ......|..|+|||++.+-.++.++||||+||||+|
T Consensus 227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e---~--hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~E 301 (415)
T KOG0671|consen 227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE---H--HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVE 301 (415)
T ss_pred ccceEEEeccCCccceeccCCCcceEEEecCCcceecc---C--cceeeeccccCCchheeccCcCCccCceeeeeEEEE
Confidence 134589999999975221 1 244567889999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhhh--------------hhhccccc----------cccccccCCc--c--CCCCChHHHHH
Q 020529 150 LITGRKAIDSTRPHGEQNLVTW--------------ARPLFNDR----------RKFSKLADPR--L--EGRYPIRGLYQ 201 (325)
Q Consensus 150 lltg~~p~~~~~~~~~~~~~~~--------------~~~~~~~~----------~~~~~~~d~~--l--~~~~~~~~~~~ 201 (325)
+.+|..-|......+..-+-+- ...++... +....+.++. + .-.....+..+
T Consensus 302 lytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 302 LYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred eeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 9999988865432111000000 00001000 0001111110 0 11112345678
Q ss_pred HHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 202 ALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 202 ~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
+++|+..||..||.+|+|+.|++..-
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALSHP 407 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhcCH
Confidence 99999999999999999999998753
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=242.72 Aligned_cols=205 Identities=25% Similarity=0.429 Sum_probs=160.6
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC---CC-------C--CCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---PD-------K--EALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~-------~--~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
+||||+.++|+|..++..++|+||+..|+|..+|+..+ .. . ..++....+.++.|||.|++||++..
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~- 438 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP- 438 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 79999999999999999999999999999999998755 00 0 23889999999999999999999998
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccC--CcCccCchhhccCCCCccccEEEehHHHHHHH
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG--TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELI 151 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~ksDvwSlGvvl~ell 151 (325)
+|||||-+.|||+.++..+||+|||+++........... .-.| ...|||||.+....++.|+|||||||+||||+
T Consensus 439 --~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eif 515 (609)
T KOG0200|consen 439 --CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIF 515 (609)
T ss_pred --ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHh
Confidence 999999999999999999999999999854433322211 1112 34599999999999999999999999999998
Q ss_pred h-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 152 T-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 152 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
| |..|+.+... ...+.. .+..+.. + ..|.....++..|+..|++.+|.+||+..++++.|+..
T Consensus 516 sLG~~PYp~~~~--~~~l~~----~l~~G~r---~-------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 516 TLGGTPYPGIPP--TEELLE----FLKEGNR---M-------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred hCCCCCCCCCCc--HHHHHH----HHhcCCC---C-------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 7 4666654211 111211 1111111 1 11223356778999999999999999999999999874
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=228.02 Aligned_cols=163 Identities=26% Similarity=0.372 Sum_probs=137.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|..-..+-||+||-.|.+++.+|+||+|++||++-.+|.. ..-|.+..+..++..+..|+++.|..| +|||||
T Consensus 683 LAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDi 755 (1034)
T KOG0608|consen 683 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDI 755 (1034)
T ss_pred HhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceeccc
Confidence 4444677899999999999999999999999999999976 556889999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCC-------CCCc---------------------------------cccccCCc
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGD-------KSHV---------------------------------STRVMGTY 121 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~-------~~~~---------------------------------~~~~~gt~ 121 (325)
||+|||||.+|++||.||||+.-+.... ..+. .....||+
T Consensus 756 KPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~ 835 (1034)
T KOG0608|consen 756 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTP 835 (1034)
T ss_pred CccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCC
Confidence 9999999999999999999986432100 0000 01245999
Q ss_pred CccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcc-hhhhh
Q 020529 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTW 171 (325)
Q Consensus 122 ~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~ 171 (325)
.|+|||++....++..+|.||.|||||||+.|+.||-...+.+.+ .++.|
T Consensus 836 nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 836 NYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred cccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeeh
Confidence 999999999999999999999999999999999999877766544 34444
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=218.08 Aligned_cols=194 Identities=24% Similarity=0.372 Sum_probs=157.6
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
-+||.+|-+...|.....+++|.||++||+|--+++. .+.++++.+..+...|+.||.|||+.| ||+||||.+
T Consensus 308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkld 380 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLD 380 (593)
T ss_pred cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeecccc
Confidence 4799999999999999999999999999999888865 556999999999999999999999999 999999999
Q ss_pred cEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 85 Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
||||+..|++||.|||.++... .....+..++||+.|.|||++.+..|....|.|+|||+++||+.|+.||+-.....
T Consensus 381 nvlldaeghikltdygmcke~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n 458 (593)
T KOG0695|consen 381 NVLLDAEGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN 458 (593)
T ss_pred ceEEccCCceeecccchhhcCC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence 9999999999999999998633 23445677899999999999999999999999999999999999999997533211
Q ss_pred -cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC
Q 020529 165 -EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 218 (325)
Q Consensus 165 -~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP 218 (325)
..+-.++.- +-++...+ +.|...+.+...+++..|.+||.+|.
T Consensus 459 ~d~ntedylf---------qvilekqi--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 459 PDMNTEDYLF---------QVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccchhHHHH---------HHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 111111111 11111111 23444556777899999999999884
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-31 Score=221.63 Aligned_cols=207 Identities=23% Similarity=0.296 Sum_probs=157.4
Q ss_pred CCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+.-+.||||++||.+...+...++||+|+ .||..+-.... -.+..+++...-+|....+.||.||-+.-. ||||||
T Consensus 118 ks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDv 194 (361)
T KOG1006|consen 118 KSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDV 194 (361)
T ss_pred hhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccC
Confidence 44578999999999988888999999996 88877643321 234568999999999999999999987643 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC--CCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
||+||||+..|.+||||||++-.. ......+...|-..|||||.+... .|..+|||||||+.|+|+.||..|+..
T Consensus 195 KPSNILldr~G~vKLCDFGIcGqL---v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 195 KPSNILLDRHGDVKLCDFGICGQL---VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred ChhheEEecCCCEeeecccchHhH---HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 999999999999999999998532 223445667788899999998754 488999999999999999999999876
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... +.+.......+. +.+..+ .-.......+..++..||.+|-+.||...++.++
T Consensus 272 w~sv----feql~~Vv~gdp---p~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 272 WDSV----FEQLCQVVIGDP---PILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HHHH----HHHHHHHHcCCC---CeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 5431 111111111111 111111 1112456778899999999999999999998765
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-29 Score=237.94 Aligned_cols=209 Identities=28% Similarity=0.417 Sum_probs=173.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|.+|.||||++++++|..+. .-||++||++|+|.+|++. .+..+.....+.|++||++|+.|||++. ++|||
T Consensus 751 ~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrd 823 (1177)
T KOG1025|consen 751 RMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRD 823 (1177)
T ss_pred HHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhh
Confidence 367899999999999998765 7899999999999999987 5667888999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|-..||||.+-.++|+.|||++++..............-.+.|||-|.+....++.++|||||||.+||||| |..|+++
T Consensus 824 LaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 824 LAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred hhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 999999999999999999999998766655444443344567999999999999999999999999999986 7888877
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
....+..++. ....+-..|.-...++..++.+||..|+..||+++++...+...+..
T Consensus 904 i~~~eI~dll-----------------e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 904 IPAEEIPDLL-----------------EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCHHHhhHHH-----------------hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 6544333222 11122233445567889999999999999999999999999877653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-29 Score=243.63 Aligned_cols=196 Identities=24% Similarity=0.296 Sum_probs=152.6
Q ss_pred CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcE
Q 020529 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNI 86 (325)
Q Consensus 7 Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Ni 86 (325)
.+=|+++.-.|.+..++|||||||+||+|..++..+ ..+++..+..++..++.||.-||+.| +|||||||+||
T Consensus 134 s~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNv 206 (1317)
T KOG0612|consen 134 SEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNV 206 (1317)
T ss_pred cHHHHHHHHHhcCccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCccee
Confidence 455677777789999999999999999999999762 26999999999999999999999999 99999999999
Q ss_pred EEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-----CCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 87 LLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 87 ll~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
|||..|++||+|||.+-.+...+ .-.+...+|||.|.+||++.. +.|+..+|.||+||++|||+.|.-||....
T Consensus 207 Lld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads 285 (1317)
T KOG0612|consen 207 LLDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS 285 (1317)
T ss_pred EecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence 99999999999999986654333 334555679999999999863 568999999999999999999999996543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCC--hHHHHHHHHHHHHchhhCCCCCCC---HHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP--IRGLYQALAVASMCIQEQAATRPL---IGDVVTAL 227 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~~~~l~~~cl~~~p~~RPs---~~evl~~L 227 (325)
++.-...+..-.. .-.+| ...+.++.+||...+. +|..|-. ++++-...
T Consensus 286 ------lveTY~KIm~hk~----------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 286 ------LVETYGKIMNHKE----------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred ------HHHHHHHHhchhh----------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 2222222222111 11122 2245677788887765 5666766 88887664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-29 Score=236.84 Aligned_cols=200 Identities=26% Similarity=0.364 Sum_probs=151.6
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
.|||||++++.-.+....|++.|.|. .+|.+++..-.........-..+.++.|++.||++||+.+ ||||||||.|
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQN 636 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQN 636 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCce
Confidence 79999999999999999999999995 9999999762111111111234678899999999999999 9999999999
Q ss_pred EEEcC---C--CeEEEecCCCCccCCCCCCCCc-cccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhC-CCCCC
Q 020529 86 ILLEE---G--FHPKLSDFGLAKLGPVGDKSHV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG-RKAID 158 (325)
Q Consensus 86 ill~~---~--~~~kL~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg-~~p~~ 158 (325)
|||+. + ..++|+|||+++..+.+..... .....||.+|+|||++.....+...||||||||+|+.++| ..||.
T Consensus 637 ILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFG 716 (903)
T KOG1027|consen 637 ILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFG 716 (903)
T ss_pred EEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCC
Confidence 99975 3 4689999999998765543332 3457799999999999999989999999999999999987 88986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..-. ...++ +.....+..+. +.... .+.+||..|+..+|..||++.+|+..
T Consensus 717 d~~~-R~~NI-------l~~~~~L~~L~--------~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 717 DSLE-RQANI-------LTGNYTLVHLE--------PLPDC-EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred chHH-hhhhh-------hcCccceeeec--------cCchH-HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 5321 11111 11111111111 11111 67899999999999999999999854
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-29 Score=208.80 Aligned_cols=224 Identities=22% Similarity=0.333 Sum_probs=164.9
Q ss_pred CcCCCCCCCccceeeEEEeC--------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 020529 1 MLSLLHHSNLVNLIGYCADG--------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 72 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~ 72 (325)
||..|+|+|++.++..|... ...||||.+|. .+|.-+|.. ....++..++.+++.+++.||.|+|...
T Consensus 69 iL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k 144 (376)
T KOG0669|consen 69 ILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK 144 (376)
T ss_pred HHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh
Confidence 46788999999999987432 34799999996 899999976 3456999999999999999999999999
Q ss_pred CCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCc--cccccCCcCccCchhhccC-CCCccccEEEehHHHHH
Q 020529 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV--STRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~e 149 (325)
|+|||+|++|||++.++.+||+|||+++.+........ .+...-|.+|++||.+.+. .++.+.|||..|||+.|
T Consensus 145 ---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimae 221 (376)
T KOG0669|consen 145 ---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAE 221 (376)
T ss_pred ---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHH
Confidence 99999999999999999999999999986544332221 2234458999999998875 68999999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhhhhhhcc-----cccc---cccccc-CCccCCCCC--hHHH------HHHHHHHHHchhh
Q 020529 150 LITGRKAIDSTRPHGEQNLVTWARPLF-----NDRR---KFSKLA-DPRLEGRYP--IRGL------YQALAVASMCIQE 212 (325)
Q Consensus 150 lltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~---~~~~~~-d~~l~~~~~--~~~~------~~~~~l~~~cl~~ 212 (325)
|.|+.+-+.+........++......+ .+-. ....+- .|...+.+. .+.+ .+.++|+.++|..
T Consensus 222 Mwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~ 301 (376)
T KOG0669|consen 222 MWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKL 301 (376)
T ss_pred HHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhcc
Confidence 999998887655443333332211111 1100 011110 111111111 1112 2677999999999
Q ss_pred CCCCCCCHHHHHHHHHhhh
Q 020529 213 QAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 213 ~p~~RPs~~evl~~L~~~~ 231 (325)
||.+|+++.+++...-+..
T Consensus 302 DP~kR~~ad~alnh~~F~k 320 (376)
T KOG0669|consen 302 DPTKRIDADQALNHDFFWK 320 (376)
T ss_pred CcccCcchHhhhchhhhhc
Confidence 9999999999998765544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=203.69 Aligned_cols=197 Identities=22% Similarity=0.343 Sum_probs=148.5
Q ss_pred CCCCccceeeE-EEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 6 HHSNLVNLIGY-CADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 6 ~Hpniv~l~~~-~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
.|.||+..|+. |+..+.+++++||++.|+|.+-+.. .++.+....+++.|++.||.|||+++ +||||||.+
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~e 150 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAE 150 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccc
Confidence 69999998865 6777899999999999999988853 56889999999999999999999999 999999999
Q ss_pred cEEEc-CC-CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-----CCCccccEEEehHHHHHHHhCCCCC
Q 020529 85 NILLE-EG-FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-----QLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 85 Nill~-~~-~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+- .+ ..+||||||+.+..+. ......-+..|++||+.... ...+.+|||.||+++|.+|||..||
T Consensus 151 NiLif~~df~rvKlcDFG~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PW 225 (378)
T KOG1345|consen 151 NILIFDADFYRVKLCDFGLTRKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPW 225 (378)
T ss_pred eEEEecCCccEEEeeecccccccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcc
Confidence 99993 33 4899999999875322 12222345569999987543 3467899999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.... .....+..|.+-.-.....++..+.+ ....++.+..+-|..++++|=-+.++.+
T Consensus 226 Qka~-~~d~~Y~~~~~w~~rk~~~~P~~F~~---------fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 226 QKAS-IMDKPYWEWEQWLKRKNPALPKKFNP---------FSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred hhhh-ccCchHHHHHHHhcccCccCchhhcc---------cCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 8543 34445555554433333333333322 2356788999999999999944444433
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=214.37 Aligned_cols=213 Identities=25% Similarity=0.336 Sum_probs=161.3
Q ss_pred CCCCCCccceeeEEEeC----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-----CCCC
Q 020529 4 LLHHSNLVNLIGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-----KANP 74 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-----~~~~ 74 (325)
.|+|+||+.|++.=..+ .+++||++|.+.|||.+||.. ..++....++++..+|.||+|||. +|.|
T Consensus 261 mLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKP 335 (513)
T KOG2052|consen 261 MLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKP 335 (513)
T ss_pred HhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCc
Confidence 46999999999885433 378999999999999999964 669999999999999999999995 5668
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCC-C-CCccccccCCcCccCchhhccC------CCCccccEEEehHH
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD-K-SHVSTRVMGTYGYCAPEYAMTG------QLTVKSDVYSFGVV 146 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~-~-~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvv 146 (325)
.|.|||||+.|||+.+++.+-|+|+|||-...... . ........||..|||||++... ..-..+||||||+|
T Consensus 336 aIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLV 415 (513)
T KOG2052|consen 336 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLV 415 (513)
T ss_pred hhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHH
Confidence 89999999999999999999999999996543331 1 1234456799999999998653 22356999999999
Q ss_pred HHHHHhC----------CCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCC-----hHHHHHHHHHHHHchh
Q 020529 147 FLELITG----------RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP-----IRGLYQALAVASMCIQ 211 (325)
Q Consensus 147 l~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~~~~l~~~cl~ 211 (325)
+||++-. +.||....+.+.. +.+. + .-+....++...| .+.+..+.+|+..|+.
T Consensus 416 lWEiarRc~~ggi~eey~~Pyyd~Vp~DPs-~eeM-r---------kVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~ 484 (513)
T KOG2052|consen 416 LWEIARRCESGGIVEEYQLPYYDVVPSDPS-FEEM-R---------KVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWY 484 (513)
T ss_pred HHHHHHHhhcCCEehhhcCCcccCCCCCCC-HHHH-h---------cceeecccCCCCCcccccCHHHHHHHHHHHHhhc
Confidence 9999653 3555443332211 1100 0 1111222222222 3567889999999999
Q ss_pred hCCCCCCCHHHHHHHHHhhhc
Q 020529 212 EQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 212 ~~p~~RPs~~evl~~L~~~~~ 232 (325)
.+|..|-|+--|-+.|.++..
T Consensus 485 ~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 485 ANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCchhhhHHHHHHHHHHHHhc
Confidence 999999999999999988874
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=198.85 Aligned_cols=169 Identities=21% Similarity=0.149 Sum_probs=127.0
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCC
Q 020529 33 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 112 (325)
Q Consensus 33 gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~ 112 (325)
|+|.+++.. .+.++++..++.|+.|++.||.|||+.+ ||+|||++.++.+++ ||+++.....
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 689999975 2456999999999999999999999886 999999999999999 9998754321
Q ss_pred ccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCC
Q 020529 113 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEG 192 (325)
Q Consensus 113 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 192 (325)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+..... .. ++.. .
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~-------~~-~~~~-~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMP-------AD-DPRD-R 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhc-------cC-Cccc-c
Confidence 1258899999999999999999999999999999999999986543211 11111111100 00 0000 0
Q ss_pred CCChHHHH--HHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 193 RYPIRGLY--QALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 193 ~~~~~~~~--~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..+..... .+.+++.+||..+|.+||++.++++.+..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 01112222 58999999999999999999999999876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=200.15 Aligned_cols=153 Identities=29% Similarity=0.341 Sum_probs=130.4
Q ss_pred CCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCC
Q 020529 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 82 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik 82 (325)
+...+|++|.+||.+.......++||.|+ .||..+-.........+++...-+|+..++.||.|||++-. |||||+|
T Consensus 100 r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvK 176 (282)
T KOG0984|consen 100 RTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVK 176 (282)
T ss_pred cCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCC
Confidence 34578999999999888889999999996 89988766554456779999999999999999999999864 9999999
Q ss_pred CCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC----CCCccccEEEehHHHHHHHhCCCCCC
Q 020529 83 SSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG----QLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 83 ~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|+|||++.+|++|+||||.+-... .....+...|-..|+|||.+... .|+.|+||||||+.++||.+++.|++
T Consensus 177 PsNiLIn~~GqVKiCDFGIsG~L~---dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 177 PSNILINYDGQVKICDFGISGYLV---DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred cceEEEccCCcEEEcccccceeeh---hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 999999999999999999985432 22234446688889999998653 68999999999999999999999997
Q ss_pred CCC
Q 020529 159 STR 161 (325)
Q Consensus 159 ~~~ 161 (325)
...
T Consensus 254 ~w~ 256 (282)
T KOG0984|consen 254 SWG 256 (282)
T ss_pred ccC
Confidence 654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=237.40 Aligned_cols=182 Identities=22% Similarity=0.332 Sum_probs=133.6
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCC-CHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecC
Q 020529 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEAL-DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 99 (325)
Q Consensus 21 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l-~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Df 99 (325)
-.+|+-||||+...|.+++++ +... .....|+++.+|+.||+|+|+.| ||||||||.||||+++..|||+||
T Consensus 669 ~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDF 741 (1351)
T KOG1035|consen 669 LILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDF 741 (1351)
T ss_pred eEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeeccc
Confidence 467899999987777777765 2222 57788999999999999999999 999999999999999999999999
Q ss_pred CCCccCC----C------------CCCCCccccccCCcCccCchhhccCC---CCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 100 GLAKLGP----V------------GDKSHVSTRVMGTYGYCAPEYAMTGQ---LTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 100 gla~~~~----~------------~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|+|.... . +......+...||..|+|||++.... |+.|+|+|||||||+||+. ||...
T Consensus 742 GLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts 818 (1351)
T KOG1035|consen 742 GLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS 818 (1351)
T ss_pred ccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch
Confidence 9998611 0 11111346678999999999987654 9999999999999999987 34332
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.+......-.+ ...++.- ..+..+....-..+|.++++.||++|||+.|+|.
T Consensus 819 --MERa~iL~~LR-----~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 819 --MERASILTNLR-----KGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred --HHHHHHHHhcc-----cCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11111111110 0111111 1122233445678999999999999999999986
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=220.56 Aligned_cols=200 Identities=23% Similarity=0.299 Sum_probs=158.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||..++||-||.+...|+..+..|.|||.+. |++.+++-. ..+.+|++.....++.||+.||.|||.++ |+|+|
T Consensus 616 ILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCD 689 (888)
T KOG4236|consen 616 ILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCD 689 (888)
T ss_pred HHHhcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeecc
Confidence 5789999999999999999999999999996 666665543 35778999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC---CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEG---FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~---~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+||||... .++||||||+|++.+. ......+.||+.|+|||++..+.|...-|+||.|||+|.-++|..||
T Consensus 690 LKPENVLLas~~~FPQvKlCDFGfARiIgE---ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPF 766 (888)
T KOG4236|consen 690 LKPENVLLASASPFPQVKLCDFGFARIIGE---KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPF 766 (888)
T ss_pred CCchheeeccCCCCCceeeccccceeecch---hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccC
Confidence 99999999544 4799999999997543 33455678999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...... .+-++.+ .-++.+.... +.....++||...|+..-.+|-+...-+.
T Consensus 767 NEdEdI--ndQIQNA----------aFMyPp~PW~----eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 767 NEDEDI--NDQIQNA----------AFMYPPNPWS----EISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCccch--hHHhhcc----------ccccCCCchh----hcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 654221 1111111 1111111111 22456789999999999999988776543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=209.69 Aligned_cols=213 Identities=24% Similarity=0.292 Sum_probs=157.6
Q ss_pred cCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
+..++|+||++++.+|.-. ...|+|||+|+ .+|.+.++ ..++-.++..|++|++.|+.|||+.+
T Consensus 69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~--- 138 (369)
T KOG0665|consen 69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG--- 138 (369)
T ss_pred hhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---
Confidence 4567999999999998644 36699999996 89998886 34788899999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|+||||||+||++..+..+||.|||+++.... ....+....|-.|.|||++.+..+...+||||+||++.||++|+.
T Consensus 139 IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~V 215 (369)
T KOG0665|consen 139 IIHRDLKPSNIVVNSDCTLKILDFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTV 215 (369)
T ss_pred eeecccCcccceecchhheeeccchhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceE
Confidence 99999999999999999999999999975322 234455667888999999999899999999999999999999998
Q ss_pred CCCCCCCCCc----------------chhhhhhhhcccccc-----cccccc-CCccCCCC--ChHHHHHHHHHHHHchh
Q 020529 156 AIDSTRPHGE----------------QNLVTWARPLFNDRR-----KFSKLA-DPRLEGRY--PIRGLYQALAVASMCIQ 211 (325)
Q Consensus 156 p~~~~~~~~~----------------~~~~~~~~~~~~~~~-----~~~~~~-d~~l~~~~--~~~~~~~~~~l~~~cl~ 211 (325)
-|.+....+. ..+...++.++.... .+.+.+ |....... +......+.+++.+||.
T Consensus 216 lf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLv 295 (369)
T KOG0665|consen 216 LFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLV 295 (369)
T ss_pred EecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhc
Confidence 7764221111 011111111111111 111111 11111111 11234567789999999
Q ss_pred hCCCCCCCHHHHHHHH
Q 020529 212 EQAATRPLIGDVVTAL 227 (325)
Q Consensus 212 ~~p~~RPs~~evl~~L 227 (325)
.+|++|-++.++|..-
T Consensus 296 i~pe~Risv~daL~HP 311 (369)
T KOG0665|consen 296 IDPEKRISVDDALRHP 311 (369)
T ss_pred cChhhcccHHHHhcCC
Confidence 9999999999998754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-27 Score=207.33 Aligned_cols=210 Identities=22% Similarity=0.318 Sum_probs=169.3
Q ss_pred cCCCCCCCccceeeEEEe-CCeeEEEEecCCCCCHHHHhccCCC----CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPP----DKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~----~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
|.-++||||.++.+.+.+ ....+.++.++.-|+|..+|.-++. ....++..+...++.|++.|++|||..+ |
T Consensus 341 ly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---V 417 (563)
T KOG1024|consen 341 LYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---V 417 (563)
T ss_pred HhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---c
Confidence 556789999999999755 5678999999999999999984433 2345677788899999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~ 155 (325)
||.||.+.|+++++..++||+|=.|++-.-..+.............||+||.+....|+..+|||||||++|||+| |+.
T Consensus 418 iHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~ 497 (563)
T KOG1024|consen 418 IHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKL 497 (563)
T ss_pred ccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCC
Confidence 9999999999999999999999999986655555544444556678999999999999999999999999999987 677
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
|+-.-.|.+...+ +.++.++ .-|.+.+.+++.++.-||...|++||+.++++..|.++-
T Consensus 498 PyaeIDPfEm~~y-------lkdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 498 PYAEIDPFEMEHY-------LKDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred CccccCHHHHHHH-------Hhcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 7654433332221 2222111 224466788999999999999999999999999998764
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=230.55 Aligned_cols=198 Identities=21% Similarity=0.238 Sum_probs=131.9
Q ss_pred EeCCeeEEEEecCCCCCHHHHhccCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 18 ADGDQRLLVYEFMPLGSLEDHLHDLPP----------------DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 18 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
......++||||+.+++|.+++..... .........+..++.|++.||.|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 356688999999999999999865210 0011223456789999999999999999 999999
Q ss_pred CCCcEEEcC-CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC----------------------CCCccc
Q 020529 82 KSSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG----------------------QLTVKS 138 (325)
Q Consensus 82 k~~Nill~~-~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~ks 138 (325)
||+|||++. ++.+||+|||+++...... ........+++.|+|||.+... .++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999986 5799999999997543322 2233456789999999965322 234567
Q ss_pred cEEEehHHHHHHHhCCCCCCCCCC-------CCcchhhhhhhhccccccccccccCCccCCCCC--hHHHHHHHHHHHHc
Q 020529 139 DVYSFGVVFLELITGRKAIDSTRP-------HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP--IRGLYQALAVASMC 209 (325)
Q Consensus 139 DvwSlGvvl~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~~~~~l~~~c 209 (325)
|||||||+||||+++..+++.... .....+..|...... ...+.+...+. ........+|+.+|
T Consensus 361 DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~d~~~~~~~dLi~~m 433 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEP-------RASPDLRRGFEVLDLDGGAGWELLKSM 433 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhcc-------ccchhhhhhhhhccccchHHHHHHHHH
Confidence 999999999999997665432100 000111222111100 00000000000 00112345899999
Q ss_pred hhhCCCCCCCHHHHHHH
Q 020529 210 IQEQAATRPLIGDVVTA 226 (325)
Q Consensus 210 l~~~p~~RPs~~evl~~ 226 (325)
|+.||.+|||+.++++.
T Consensus 434 L~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 434 MRFKGRQRISAKAALAH 450 (566)
T ss_pred ccCCcccCCCHHHHhCC
Confidence 99999999999999975
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=190.81 Aligned_cols=217 Identities=22% Similarity=0.278 Sum_probs=162.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.|+|.|||++++....++..-+|+|||+ .+|..++.. .+..++.+.+..++.|+++||.++|+++ +.|||
T Consensus 54 llkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrd 126 (292)
T KOG0662|consen 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRD 126 (292)
T ss_pred HHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhcc
Confidence 4678999999999999998999999999995 899999876 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC-CCccccEEEehHHHHHHHh-CCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELIT-GRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~ellt-g~~p~~ 158 (325)
+||.|+|++.+|.+||+|||+++.++.... -.....-|.+|.+|.++.+.+ |+...|+||.||++.|+.. |++-|.
T Consensus 127 lkpqnllin~ngelkladfglarafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 127 LKPQNLLINRNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred CCcceEEeccCCcEEecccchhhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 999999999999999999999987554321 122344689999999998864 7889999999999999985 555565
Q ss_pred CCCCCCcchhhhhhhhcccc--ccccccccCCccCCCCChH-HHH--------HHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFND--RRKFSKLADPRLEGRYPIR-GLY--------QALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~-~~~--------~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+....+...-+-|......+ -..+..+.|-.....|+.- .+. .=.+++.+.|.-+|..|.++++.++.
T Consensus 205 g~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 205 GNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 54433332222222111111 1122334444443344321 111 22368888899999999999988764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=193.01 Aligned_cols=168 Identities=34% Similarity=0.523 Sum_probs=147.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++|++|+++++++......++++||+++++|.+++... ...+++..++.++.+++.+|.+||+.+ ++|+||
T Consensus 45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl 118 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDL 118 (215)
T ss_pred HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCC
Confidence 56789999999999999999999999999999999999752 146899999999999999999999999 999999
Q ss_pred CCCcEEEcC-CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 82 KSSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~-~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
+|.||+++. ++.++|+|||.+........ ......+...|++||..... ..+.++|+|++|+++++|
T Consensus 119 ~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------- 187 (215)
T cd00180 119 KPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------- 187 (215)
T ss_pred CHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------
Confidence 999999999 89999999999875433221 22334578889999999887 888999999999999999
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ----------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 357799999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-28 Score=204.50 Aligned_cols=218 Identities=22% Similarity=0.320 Sum_probs=158.7
Q ss_pred CcCCCCCCCccceeeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
||..++|.|++..++...-. .+.|.|+|.|+ .+|..++-. ...++...+.-+++||++||+|||+.+
T Consensus 105 mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~--- 176 (449)
T KOG0664|consen 105 MLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN--- 176 (449)
T ss_pred HHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---
Confidence 45667999999998876543 35688999996 788888754 566889999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~ 154 (325)
|.||||||.|+|++.+..+|||||||++.-...+..+.+. ..-|..|+|||++++. .|+...||||.||++.||+..+
T Consensus 177 ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRr 255 (449)
T KOG0664|consen 177 ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRK 255 (449)
T ss_pred hhhccCCCccEEeccCceEEecccccccccchhhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhh
Confidence 9999999999999999999999999998654443333322 3357789999999986 6999999999999999999998
Q ss_pred CCCCCCCCCCcchhhhhhhhccc--------ccccc----ccccCCccCCCC----ChHHHHHHHHHHHHchhhCCCCCC
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFN--------DRRKF----SKLADPRLEGRY----PIRGLYQALAVASMCIQEQAATRP 218 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~----~~~~d~~l~~~~----~~~~~~~~~~l~~~cl~~~p~~RP 218 (325)
.-|...++.....++.-....-. ++... .....|.+.--| +..--.+.+.+..+++..+|..|.
T Consensus 256 ILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkri 335 (449)
T KOG0664|consen 256 ILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRI 335 (449)
T ss_pred hhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccc
Confidence 88887776554443321110000 00000 001111111111 112234566788899999999999
Q ss_pred CHHHHHHHH
Q 020529 219 LIGDVVTAL 227 (325)
Q Consensus 219 s~~evl~~L 227 (325)
+..+.+..+
T Consensus 336 s~~~A~~~~ 344 (449)
T KOG0664|consen 336 SVEEALQHR 344 (449)
T ss_pred cHhhhcccc
Confidence 988887655
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-26 Score=215.53 Aligned_cols=203 Identities=21% Similarity=0.247 Sum_probs=139.3
Q ss_pred CccceeeEEEe--------CCeeEEEEecCCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHH
Q 020529 9 NLVNLIGYCAD--------GDQRLLVYEFMPLGSLEDHLHDLPP--------------------DKEALDWNTRMKIAAG 60 (325)
Q Consensus 9 niv~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ 60 (325)
+++++++||.. ....+|||||+.+++|.++++.... ....+++..+..++.+
T Consensus 238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q 317 (507)
T PLN03224 238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ 317 (507)
T ss_pred hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence 34677787753 3567999999999999999875211 1123578889999999
Q ss_pred HHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC------
Q 020529 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL------ 134 (325)
Q Consensus 61 l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------ 134 (325)
++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... ........+++.|+|||.+.....
T Consensus 318 l~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~ 393 (507)
T PLN03224 318 VLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEELVMPQSCPRAPA 393 (507)
T ss_pred HHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhhhcCCCCCCccch
Confidence 999999999999 9999999999999999999999999996533221 111122335789999998754321
Q ss_pred ----------------CccccEEEehHHHHHHHhCCC-CCCCCCCCC------cchhhhhhhhccccccccccccCCccC
Q 020529 135 ----------------TVKSDVYSFGVVFLELITGRK-AIDSTRPHG------EQNLVTWARPLFNDRRKFSKLADPRLE 191 (325)
Q Consensus 135 ----------------~~ksDvwSlGvvl~elltg~~-p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~d~~l~ 191 (325)
..+.||||+||++++|++|.. |+....... ...+..|... ... ..+-.
T Consensus 394 ~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~~~------~~~~~-- 464 (507)
T PLN03224 394 PAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-KGQ------KYDFS-- 464 (507)
T ss_pred hhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-ccc------CCCcc--
Confidence 234799999999999999875 664321110 1111122110 000 00000
Q ss_pred CCCChHHHHHHHHHHHHchhhCC---CCCCCHHHHHHH
Q 020529 192 GRYPIRGLYQALAVASMCIQEQA---ATRPLIGDVVTA 226 (325)
Q Consensus 192 ~~~~~~~~~~~~~l~~~cl~~~p---~~RPs~~evl~~ 226 (325)
..........+|+.+||..+| .+|+|+.|+++.
T Consensus 465 --~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 465 --LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 011234567889999999766 689999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=212.55 Aligned_cols=146 Identities=26% Similarity=0.370 Sum_probs=129.6
Q ss_pred cCCCC---CCCccceeeEEEeCCeeEEEEecC-CCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 2 LSLLH---HSNLVNLIGYCADGDQRLLVYEFM-PLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 2 L~~l~---Hpniv~l~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
|..|+ |+||++++++|++++++||+||.. ++.+|.+++.. +..+++.....|+.||+.|+++||+++ ||
T Consensus 620 la~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---iv 692 (772)
T KOG1152|consen 620 LATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IV 692 (772)
T ss_pred HHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ce
Confidence 45555 999999999999999999999985 56799999975 677999999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCC
Q 020529 78 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 78 Hrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p 156 (325)
|||||-+||.++.+|-+||+|||.+-.. +......++||..|.|||++.+.+| +..-|||++|++||-++....|
T Consensus 693 hrdikdenvivd~~g~~klidfgsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 693 HRDIKDENVIVDSNGFVKLIDFGSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred ecccccccEEEecCCeEEEeeccchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 9999999999999999999999988542 3334566889999999999999876 5668999999999999998888
Q ss_pred CC
Q 020529 157 ID 158 (325)
Q Consensus 157 ~~ 158 (325)
|.
T Consensus 769 yy 770 (772)
T KOG1152|consen 769 YY 770 (772)
T ss_pred Cc
Confidence 74
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=207.22 Aligned_cols=203 Identities=25% Similarity=0.310 Sum_probs=160.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|++..+|||||.+++.+...+...++||||.+|+|++.-+. ..++++.++..++...+.||+|||+.+ -+|||
T Consensus 65 ~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRd 137 (829)
T KOG0576|consen 65 MLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRD 137 (829)
T ss_pred eeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---ccccc
Confidence 46778999999999999999999999999999999998875 677999999999999999999999999 89999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||-.||+++..|.+||+|||.+-.+ +........+.||+.|||||+.. .+.|..++|||++|+...|+---.+|.
T Consensus 138 iKGanilltd~gDvklaDfgvsaqi--tati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 138 IKGANILLTDEGDVKLADFGVSAQI--TATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred ccccceeecccCceeecccCchhhh--hhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 9999999999999999999998542 22334456789999999999875 457899999999999999998877775
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
....+.....+. -+..+ .-..+-|+ ..-...+-.+++.||..+|++||+++.++.
T Consensus 216 fdlhpmr~l~Lm--TkS~~----qpp~lkDk-------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 216 FDLHPMRALFLM--TKSGF----QPPTLKDK-------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cccchHHHHHHh--hccCC----CCCcccCC-------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 433322111100 00000 00112222 133456778999999999999999988765
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=202.92 Aligned_cols=210 Identities=20% Similarity=0.207 Sum_probs=153.8
Q ss_pred CCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEE
Q 020529 8 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNIL 87 (325)
Q Consensus 8 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nil 87 (325)
-|+++|+-.|...+++|||||-+ ..+|.+.|..+.. +-+|....+..++.|+..||..|-..+ |+|.||||+|||
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiL 568 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNIL 568 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceE
Confidence 36788888999999999999999 5899999987643 556888999999999999999999999 999999999999
Q ss_pred EcCCC-eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcc
Q 020529 88 LEEGF-HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 166 (325)
Q Consensus 88 l~~~~-~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~ 166 (325)
+++.- .+||||||.|....... .+ -..-+-.|.|||++.+.+|+...|+||.||.||||.||+..|.+.......
T Consensus 569 VNE~k~iLKLCDfGSA~~~~ene---it-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 569 VNESKNILKLCDFGSASFASENE---IT-PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred eccCcceeeeccCcccccccccc---cc-HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 98775 68999999986533221 11 112244699999999999999999999999999999999888764332221
Q ss_pred hhhhhhh-----hccccccccccc--------------------------cCC------ccC--CCCChH---HHHHHHH
Q 020529 167 NLVTWAR-----PLFNDRRKFSKL--------------------------ADP------RLE--GRYPIR---GLYQALA 204 (325)
Q Consensus 167 ~~~~~~~-----~~~~~~~~~~~~--------------------------~d~------~l~--~~~~~~---~~~~~~~ 204 (325)
.+..-.+ .++....-.... +.| .|. ..++.+ ...++.+
T Consensus 645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence 1111000 111110000111 111 111 123333 3567888
Q ss_pred HHHHchhhCCCCCCCHHHHHHH
Q 020529 205 VASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 205 l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|+..||..||.+|.+..+.|+.
T Consensus 725 LLdkml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHHHHhccChhhcCCHHHHhcC
Confidence 9999999999999999998864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=182.97 Aligned_cols=151 Identities=32% Similarity=0.389 Sum_probs=130.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++|+|++++++++......++++||+++++|.+++.... ..+++..++.++.+++.++.+||+.+ ++|+||
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di 124 (225)
T smart00221 51 LKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDL 124 (225)
T ss_pred HHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 456799999999999999999999999999889999997622 11899999999999999999999998 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhh-ccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA-MTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
+|.||+++.++.++|+|||++........ .......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 125 ~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 125 KPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 99999999999999999999876543321 122345678889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-24 Score=191.22 Aligned_cols=78 Identities=24% Similarity=0.405 Sum_probs=68.8
Q ss_pred CCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 6 HHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 6 ~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
.-.+||+|+++|.. +.+.|||+|++ |.+|..+|.. ..-+.++...+..|+.||+.||.|||.+.. |||.||
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~--s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDl 214 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKY--SNYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDL 214 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHH--hCCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCC
Confidence 34579999999965 56999999999 7999999976 345679999999999999999999999764 999999
Q ss_pred CCCcEEE
Q 020529 82 KSSNILL 88 (325)
Q Consensus 82 k~~Nill 88 (325)
||+||||
T Consensus 215 KPENvLl 221 (590)
T KOG1290|consen 215 KPENVLL 221 (590)
T ss_pred Ccceeee
Confidence 9999999
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=185.07 Aligned_cols=212 Identities=22% Similarity=0.291 Sum_probs=151.6
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
-+-||+++.+++...+..++|+||++.....++... ++...+..+++.++.||+++|.+| ||||||||+|
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsN 162 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSN 162 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccc
Confidence 578999999999999999999999999999998865 778899999999999999999999 9999999999
Q ss_pred EEEcCC-CeEEEecCCCCccCCC------------------CC------------------------CCCccccccCCcC
Q 020529 86 ILLEEG-FHPKLSDFGLAKLGPV------------------GD------------------------KSHVSTRVMGTYG 122 (325)
Q Consensus 86 ill~~~-~~~kL~Dfgla~~~~~------------------~~------------------------~~~~~~~~~gt~~ 122 (325)
+|.+.. +.-.|.|||||..... .. .........||+|
T Consensus 163 FL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~G 242 (418)
T KOG1167|consen 163 FLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPG 242 (418)
T ss_pred cccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCC
Confidence 999754 5688999999972110 00 0000012459999
Q ss_pred ccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCCCCCCcc--hhh-------------------hhhhhcc-c--
Q 020529 123 YCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ--NLV-------------------TWARPLF-N-- 177 (325)
Q Consensus 123 y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~--~~~-------------------~~~~~~~-~-- 177 (325)
|.|||++... ..+.+.||||.|||++.+++++.||-....+-.. .+. -|.+..+ .
T Consensus 243 fRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~ 322 (418)
T KOG1167|consen 243 FRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIP 322 (418)
T ss_pred CCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccH
Confidence 9999998765 5789999999999999999999999654322110 000 0110000 0
Q ss_pred -cccccccccCCccCC-CC--------ChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 178 -DRRKFSKLADPRLEG-RY--------PIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 178 -~~~~~~~~~d~~l~~-~~--------~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
....+..+.-..+.. .. ..-....+++|+.+||+.||.+|.++++.|+.-
T Consensus 323 e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 323 ELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred HHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 000011110000100 00 111234788999999999999999999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-23 Score=203.36 Aligned_cols=204 Identities=22% Similarity=0.252 Sum_probs=160.6
Q ss_pred CCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCC
Q 020529 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 82 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik 82 (325)
+.|+|||++..+..+.+....+-+||||++ +|..++.. ...+....+-.++.|++.||.|||+.| |.|||||
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK 447 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLK 447 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCc
Confidence 468999999888887776666666999998 99999865 346888889999999999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEecCCCCccCCCCCCC--CccccccCCcCccCchhhccCCCCc-cccEEEehHHHHHHHhCCCCCCC
Q 020529 83 SSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTGQLTV-KSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 83 ~~Nill~~~~~~kL~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-ksDvwSlGvvl~elltg~~p~~~ 159 (325)
++|+++..+|.+||+|||.+..+....+. .....+.|+-.|+|||++.+..|.+ ..||||.|+++..|++|+.||..
T Consensus 448 ~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~ 527 (601)
T KOG0590|consen 448 LENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKV 527 (601)
T ss_pred cccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccc
Confidence 99999999999999999999876655554 6677788999999999999998875 48999999999999999999987
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCC--ChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY--PIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
....+..... .....+.- ...+.. ..........++-++|+.+|.+|-++.+|++
T Consensus 528 a~~~~~~~~~--------~~~~~~~~---~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 528 AKKSDNSFKT--------NNYSDQRN---IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccccchhh--------hccccccc---cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 6554332100 00000000 000000 1122456678999999999999999999987
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-23 Score=169.79 Aligned_cols=212 Identities=20% Similarity=0.303 Sum_probs=152.7
Q ss_pred CcCCCC-CCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 1 MLSLLH-HSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 1 iL~~l~-Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
||..|. ||||+++++...+ .....|||||+++.+...+... |+--.+...+.+++.||.|+|+.| |+
T Consensus 85 IL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-------l~d~dIryY~~elLkALdyCHS~G---Im 154 (338)
T KOG0668|consen 85 ILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-------LTDYDIRYYIYELLKALDYCHSMG---IM 154 (338)
T ss_pred HHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh-------hchhhHHHHHHHHHHHHhHHHhcC---cc
Confidence 355664 9999999999876 4577899999999888887643 677778889999999999999999 99
Q ss_pred eCCCCCCcEEEcCCC-eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCC
Q 020529 78 YRDFKSSNILLEEGF-HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 78 Hrdik~~Nill~~~~-~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||+||.||+++... .++|+|+|||.++-.+....+ + ..+-.|--||.+-. ..|+.+-|+|||||+|..|+..+.
T Consensus 155 HRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV--R-VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrke 231 (338)
T KOG0668|consen 155 HRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV--R-VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 231 (338)
T ss_pred cccCCcceeeechhhceeeeeecchHhhcCCCceeee--e-eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccC
Confidence 999999999998654 799999999987654443322 1 23445678998764 457889999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccc-----cccccccCCccCC---CCCh------------H-HHHHHHHHHHHchhhCC
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDR-----RKFSKLADPRLEG---RYPI------------R-GLYQALAVASMCIQEQA 214 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~d~~l~~---~~~~------------~-~~~~~~~l~~~cl~~~p 214 (325)
||-..... ...++..++.+-++. ....-.+||.+.. +... . ...++++++.+.|..|-
T Consensus 232 pFFhG~dN-~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDH 310 (338)
T KOG0668|consen 232 PFFHGHDN-YDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDH 310 (338)
T ss_pred cccCCCCC-HHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcc
Confidence 98654322 223333332221110 0111112332211 1110 0 13578899999999999
Q ss_pred CCCCCHHHHHHH
Q 020529 215 ATRPLIGDVVTA 226 (325)
Q Consensus 215 ~~RPs~~evl~~ 226 (325)
.+|||+.|....
T Consensus 311 qeRlTakEam~H 322 (338)
T KOG0668|consen 311 QERLTAKEAMAH 322 (338)
T ss_pred ccccchHHHhcC
Confidence 999999998765
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-22 Score=184.53 Aligned_cols=216 Identities=27% Similarity=0.391 Sum_probs=163.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ..-.+++-....++.+++.||+|||...- ..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPI--GYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcc--eeeeee
Confidence 6789999999999999999999999999999999999976 45569999999999999999999998761 399999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-------CCCccccEEEehHHHHHHHhCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-------QLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~ksDvwSlGvvl~elltg~ 154 (325)
++.|++++..+.+||+|||+..+..............-..-|.|||.+... ..+.+.||||||++++|+++-.
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998765321111111222234568999998764 1477899999999999999999
Q ss_pred CCCCCCCCCCc-chhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 155 KAIDSTRPHGE-QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 155 ~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
.||+....... ..++..+.. .-...+-|.+.... +....++.++..|+..+|.+||++..|-..++.+
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred CccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 99987443332 222222221 00111122221100 2223688999999999999999999999888654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-21 Score=175.17 Aligned_cols=207 Identities=20% Similarity=0.196 Sum_probs=156.6
Q ss_pred CCccceeeEE-EeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcE
Q 020529 8 SNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNI 86 (325)
Q Consensus 8 pniv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Ni 86 (325)
+++..+++.+ ......++||+.+ |.+|.++....+ ...++..+++.|+.|++.+|++||+.| ++||||||+|+
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~ 153 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENF 153 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHe
Confidence 6888899888 4778899999999 899999986644 467999999999999999999999999 99999999999
Q ss_pred EEcCC-----CeEEEecCCCCc--cCCCCCCC-----Cc-cccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhC
Q 020529 87 LLEEG-----FHPKLSDFGLAK--LGPVGDKS-----HV-STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 87 ll~~~-----~~~kL~Dfgla~--~~~~~~~~-----~~-~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg 153 (325)
++... ..++|.|||+++ ........ .. ...+.||..|+++.++.+...+.+.|+||+++++.|++.|
T Consensus 154 ~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g 233 (322)
T KOG1164|consen 154 VVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKG 233 (322)
T ss_pred eecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcC
Confidence 99765 469999999998 32222211 11 2346699999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCc-chhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 154 RKAIDSTRPHGE-QNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 154 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..||........ ..+...... ..... +.......+.++...+-..+...+|....+...|.....
T Consensus 234 ~LPW~~~~~~~~~~~~~~~~~~---------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 234 SLPWEALEMTDLKSKFEKDPRK---------LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred CCCCccccccchHHHHHHHhhh---------hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 999966543222 111111110 01110 111223445566666666899999999999999887765
Q ss_pred cC
Q 020529 233 QT 234 (325)
Q Consensus 233 ~~ 234 (325)
..
T Consensus 300 ~~ 301 (322)
T KOG1164|consen 300 SE 301 (322)
T ss_pred hc
Confidence 43
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=166.36 Aligned_cols=198 Identities=21% Similarity=0.201 Sum_probs=142.2
Q ss_pred CCCCccceeeEEEeC---------------------------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHH
Q 020529 6 HHSNLVNLIGYCADG---------------------------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~ 58 (325)
+|||||+++.+|.+. ...|+||..++ .+|..|+-. ...+..+..-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc-----CCCchHHHHHHH
Confidence 799999999887543 35699999985 899999954 346677888899
Q ss_pred HHHHHHHHHHhcCCCCCeEeCCCCCCcEEE--cCCC--eEEEecCCCCccCCCCC----CCCccccccCCcCccCchhhc
Q 020529 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILL--EEGF--HPKLSDFGLAKLGPVGD----KSHVSTRVMGTYGYCAPEYAM 130 (325)
Q Consensus 59 ~~l~~al~~LH~~~~~~ivHrdik~~Nill--~~~~--~~kL~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~ 130 (325)
.|+++|+.|||.++ |.|||+|++|||| +.++ .+.|+|||++-...... ........-|.-..||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 9999999999998 4444 57899999985422211 111112344777889999986
Q ss_pred cCC------CCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHH
Q 020529 131 TGQ------LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALA 204 (325)
Q Consensus 131 ~~~------~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~ 204 (325)
..+ --.|+|.|+.|.+.||+++-..||...... ..+.. ..++---|.+ |......+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r-----------~Yqe~qLPal----p~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTR-----------TYQESQLPAL----PSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechh-----------hhhhhhCCCC----cccCChHHHH
Confidence 543 236899999999999999999999873321 11111 1111111222 2223345778
Q ss_pred HHHHchhhCCCCCCCHHHHHHHHH
Q 020529 205 VASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 205 l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
++...|+.||++||+..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999766666554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.9e-21 Score=161.89 Aligned_cols=200 Identities=22% Similarity=0.386 Sum_probs=155.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC-C
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR-D 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr-d 80 (325)
|+-+.||||+++++.|.......++..||+.|||...|+.. ..--.+..++.+++.++++|++|||+... ++-| -
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep--~ipr~~ 316 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFY 316 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhh
Confidence 56679999999999999999999999999999999999873 23346778899999999999999999763 4433 5
Q ss_pred CCCCcEEEcCCCeEEEe--cCCCCccCCCCCCCCccccccCCcCccCchhhccCCC---CccccEEEehHHHHHHHhCCC
Q 020529 81 FKSSNILLEEGFHPKLS--DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL---TVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~ksDvwSlGvvl~elltg~~ 155 (325)
|.+..|++|++...+|+ |--++ .......-.+.|++||.++..+- -..+|+|||.++++||.|...
T Consensus 317 lns~hvmidedltarismad~kfs---------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trev 387 (448)
T KOG0195|consen 317 LNSKHVMIDEDLTARISMADTKFS---------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREV 387 (448)
T ss_pred cccceEEecchhhhheecccceee---------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccc
Confidence 88999999999877764 22111 11122234678999999987654 357999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
||....+.+.- -++.-..++-..|+.....+..|+.-|+..||.+||....|+-.|+..
T Consensus 388 pfadlspmecg----------------mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 388 PFADLSPMECG----------------MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccCCchhhh----------------hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 99766553211 112222344455666677888999999999999999999999988764
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-19 Score=162.42 Aligned_cols=215 Identities=29% Similarity=0.385 Sum_probs=159.0
Q ss_pred cCCCCCC-CccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHS-NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hp-niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++.+.|+ ||+++++++......+++++++.+++|.+++...... ..+.......++.+++.++.|+|..+ ++|||
T Consensus 51 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd 126 (384)
T COG0515 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRD 126 (384)
T ss_pred HHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4567777 7999999997777789999999999999777642211 36899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC-eEEEecCCCCccCCCCCCCC----ccccccCCcCccCchhhcc---CCCCccccEEEehHHHHHHHh
Q 020529 81 FKSSNILLEEGF-HPKLSDFGLAKLGPVGDKSH----VSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 81 ik~~Nill~~~~-~~kL~Dfgla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~ellt 152 (325)
|||+||+++..+ .++++|||+++......... ......|+..|++||.+.. ...+...|+|++|++++++++
T Consensus 127 ~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~ 206 (384)
T COG0515 127 IKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT 206 (384)
T ss_pred CCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999998 79999999997544333221 3456779999999999988 578999999999999999999
Q ss_pred CCCCCCCCCCC-CcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 153 GRKAIDSTRPH-GEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 153 g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|..||...... ............... .................+.+++..|+..+|..|.++.+....
T Consensus 207 ~~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 207 GLPPFEGEKNSSATSQTLKIILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CCCCCCCCCccccHHHHHHHHHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 99996554321 001111111100000 000011100001223567899999999999999999887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=151.79 Aligned_cols=210 Identities=18% Similarity=0.197 Sum_probs=153.1
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
..+.|..++-|..++.+..||+|++ |.||++++.- ..+.++..++..||.|++.-++|+|++. +|+|||||+|
T Consensus 82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdN 154 (449)
T KOG1165|consen 82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDN 154 (449)
T ss_pred CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccc
Confidence 5688888888888888999999999 8999999865 3566999999999999999999999999 9999999999
Q ss_pred EEEcCC-----CeEEEecCCCCccCCCCCC-CC----ccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 86 ILLEEG-----FHPKLSDFGLAKLGPVGDK-SH----VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 86 ill~~~-----~~~kL~Dfgla~~~~~~~~-~~----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
+||..- ..+.++|||+|+.+..... .+ ......||..||+-..+.+.+.+.+.|+=|||-|+++.|-|..
T Consensus 155 FLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsL 234 (449)
T KOG1165|consen 155 FLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSL 234 (449)
T ss_pred eeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCC
Confidence 999643 3589999999998654432 22 2344669999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
||.+........ -...+- +.. ....-..|.. ..+.++..-+.-.-..+-.+-|+..-+...+..+..
T Consensus 235 PWQGLKA~tnK~---kYeKIG-e~K--r~T~i~~Lc~----g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld 301 (449)
T KOG1165|consen 235 PWQGLKADTNKE---KYEKIG-ETK--RSTPIEVLCE----GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD 301 (449)
T ss_pred ccccccCcchHH---HHHHhc-ccc--ccCCHHHHHh----cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 998764332111 000100 000 0000001111 223444444444555666677887776666555543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-19 Score=166.13 Aligned_cols=176 Identities=23% Similarity=0.346 Sum_probs=130.2
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCC
Q 020529 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 100 (325)
Q Consensus 21 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfg 100 (325)
.+.|+.|++|.-.+|.++|...+. ....++.....++.|++.|+.| ++ .+|+|+||.||+...+.++||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 367899999999999999975443 3346788889999999999999 77 8999999999999999999999999
Q ss_pred CCccCCCCC----CCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhC-CCCCCCCCCCCcchhhhhhhhc
Q 020529 101 LAKLGPVGD----KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG-RKAIDSTRPHGEQNLVTWARPL 175 (325)
Q Consensus 101 la~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~ 175 (325)
++....... .....+...||..||+||.+.+..|+.|+|||+||++|+||+.- .-+++..... ..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~----------~d 471 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL----------TD 471 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh----------hh
Confidence 987544333 12234567799999999999999999999999999999999982 2222111000 00
Q ss_pred cccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHH
Q 020529 176 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 223 (325)
Q Consensus 176 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ev 223 (325)
++ ...++|.....+| .-..|+.+++...|.+||++.++
T Consensus 472 ~r-----~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 472 IR-----DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred hh-----cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence 00 1112222222222 23478999999999999955444
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7e-20 Score=179.74 Aligned_cols=198 Identities=23% Similarity=0.225 Sum_probs=145.2
Q ss_pred CCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCC
Q 020529 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 82 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik 82 (325)
..++|||++++.-........|||-+|+. .+|.+.+.. +.-+...+.+.|+.|++.||..+|..+ |+|||||
T Consensus 76 ~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIK 147 (1431)
T KOG1240|consen 76 ALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIK 147 (1431)
T ss_pred HhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccc
Confidence 35699999999888777888899999995 789998865 555788899999999999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEecCCCCccCC-CCCCCCcc----ccccCCcCccCchhhccC----------C-CCccccEEEehHH
Q 020529 83 SSNILLEEGFHPKLSDFGLAKLGP-VGDKSHVS----TRVMGTYGYCAPEYAMTG----------Q-LTVKSDVYSFGVV 146 (325)
Q Consensus 83 ~~Nill~~~~~~kL~Dfgla~~~~-~~~~~~~~----~~~~gt~~y~aPE~~~~~----------~-~~~ksDvwSlGvv 146 (325)
.+|||+..=..+.|+||.--+..- ..+..... ..-..-.+|+|||.+... . ++++-||||+||+
T Consensus 148 sENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCV 227 (1431)
T KOG1240|consen 148 SENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCV 227 (1431)
T ss_pred cceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHH
Confidence 999999999999999998765321 11111111 112234579999986541 2 6778899999999
Q ss_pred HHHHHh-CCCCCCCCCCCCcchhhhhhhh-ccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHH
Q 020529 147 FLELIT-GRKAIDSTRPHGEQNLVTWARP-LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 224 (325)
Q Consensus 147 l~ellt-g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl 224 (325)
+.||++ |+++|+... +..+-.. .......+.++-|+ .+..|+..|++.||..|-++++++
T Consensus 228 iaELf~Eg~PlF~LSQ------L~aYr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL 289 (1431)
T KOG1240|consen 228 IAELFLEGRPLFTLSQ------LLAYRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYL 289 (1431)
T ss_pred HHHHHhcCCCcccHHH------HHhHhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHH
Confidence 999976 588886432 1111000 00001111222222 356899999999999999999999
Q ss_pred HH
Q 020529 225 TA 226 (325)
Q Consensus 225 ~~ 226 (325)
+.
T Consensus 290 ~~ 291 (1431)
T KOG1240|consen 290 QK 291 (1431)
T ss_pred Hh
Confidence 87
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.4e-18 Score=145.18 Aligned_cols=207 Identities=19% Similarity=0.186 Sum_probs=152.7
Q ss_pred CCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEE
Q 020529 8 SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNIL 87 (325)
Q Consensus 8 pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nil 87 (325)
.-|..+..|+.+..+..|||+.+ |.||++++.- ..+.++..+++.++-|++.-++|+|.++ +|||||||+|+|
T Consensus 71 ~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFL 143 (341)
T KOG1163|consen 71 VGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFL 143 (341)
T ss_pred CCCchhhhhccccccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCcccee
Confidence 34555667788888999999999 8999999876 3556999999999999999999999999 999999999999
Q ss_pred EcCC---CeEEEecCCCCccCCCCCCC-C----ccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 88 LEEG---FHPKLSDFGLAKLGPVGDKS-H----VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 88 l~~~---~~~kL~Dfgla~~~~~~~~~-~----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
..-+ .++.|+||||++.+-..... + ......||..|.+-..+.+...+.+.|+=|+|.+|.++.-|..||.+
T Consensus 144 MGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 144 MGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred eccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 9654 36899999999876543321 1 12345699999999988888899999999999999999999999988
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
........-. ..+.... ....-..|.. ..+.++.-.+.-|-...-.+-|+.--+.+.+.-+.
T Consensus 224 lka~tk~QKy---EkI~EkK---~s~~ie~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 224 LKAATKKQKY---EKISEKK---MSTPIEVLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred cchhhHHHHH---HHHHHhh---cCCCHHHHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 6543322111 1111000 0000111222 33445556677788888888888877777665544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.4e-19 Score=167.70 Aligned_cols=180 Identities=28% Similarity=0.320 Sum_probs=145.4
Q ss_pred CCC-CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCC
Q 020529 4 LLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 82 (325)
Q Consensus 4 ~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik 82 (325)
.++ ||.+|++.-.+..+...+++.+|..+|.|...+.. ...+++.........++.+++++|+.+ ++|||+|
T Consensus 52 ~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k 124 (612)
T KOG0603|consen 52 FVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYK 124 (612)
T ss_pred hccCCCceeeeeeeeccccchhHhhhhcccchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhccc
Confidence 344 99999998888889999999999999999988865 455778888888899999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCC
Q 020529 83 SSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 162 (325)
Q Consensus 83 ~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~ 162 (325)
++||+++.+|++++.|||+.+....... .+||+.|||||++. .....+|.||||++.+||+||..||...
T Consensus 125 ~enilld~~Ghi~~tdfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-- 194 (612)
T KOG0603|consen 125 LENVLLLLEGHIKLTDFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-- 194 (612)
T ss_pred ccceeecccCccccCCchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--
Confidence 9999999999999999999986433222 17999999999988 5678899999999999999999999760
Q ss_pred CCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 163 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
....+.. .....|......+..++..++..+|..|--.
T Consensus 195 --------~~~~Il~------------~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 195 --------TMKRILK------------AELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --------HHHHHhh------------hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 1111111 1112344455667788888888888888765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-19 Score=154.48 Aligned_cols=164 Identities=18% Similarity=0.240 Sum_probs=110.7
Q ss_pred eEEEEecCCCCCHHHHhcc---CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecC
Q 020529 23 RLLVYEFMPLGSLEDHLHD---LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 99 (325)
Q Consensus 23 ~~lv~e~~~~gsL~~~l~~---~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Df 99 (325)
.+++|+-+. ++|.+++.. .......+....++.+..|+++.+++||..| ++|+||+|+|++++.+|.++|+||
T Consensus 114 ~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcCh
Confidence 478888884 899888643 1222334556677888899999999999999 999999999999999999999999
Q ss_pred CCCccCCCCCCCCccccccCCcCccCchhhccC--------CCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhh
Q 020529 100 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--------QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 171 (325)
Q Consensus 100 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 171 (325)
+.+..... .... ...+..|.+||..... .++.+.|.|+||+++|.|.|+..||+...+......
T Consensus 190 ~~~~r~g~----~~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--- 261 (288)
T PF14531_consen 190 SSLVRAGT----RYRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--- 261 (288)
T ss_dssp GGEEETTE----EEEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---
T ss_pred HHHeecCc----eeec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---
Confidence 87754211 1111 3345779999977542 478899999999999999999999987643221110
Q ss_pred hhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCC
Q 020529 172 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR 217 (325)
Q Consensus 172 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R 217 (325)
....|. +....+..||..+|+.+|.+|
T Consensus 262 ------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 ------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 122333 556778899999999999987
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.4e-18 Score=155.70 Aligned_cols=115 Identities=17% Similarity=0.077 Sum_probs=88.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|+|+++.+.. .+..|+||||++|++|.. +.. . . ...++.+++.||.|||+.+ |+|||
T Consensus 74 iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~-~~~----~---~---~~~~~~~i~~aL~~lH~~g---IiHrD 136 (365)
T PRK09188 74 ALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHL-ARP----H---G---DPAWFRSAHRALRDLHRAG---ITHND 136 (365)
T ss_pred HHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHH-hCc----c---c---hHHHHHHHHHHHHHHHHCC---CeeCC
Confidence 4678899999964322 245799999999999963 211 1 1 1467889999999999999 99999
Q ss_pred C-CCCcEEEcCCCeEEEecCCCCccCCCCCCCCc------cccccCCcCccCchhhccC
Q 020529 81 F-KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV------STRVMGTYGYCAPEYAMTG 132 (325)
Q Consensus 81 i-k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 132 (325)
| ||+|||++.++.++|+|||+++.......... .+...+++.|.|||++...
T Consensus 137 L~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 137 LAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9 99999999999999999999986544321111 1356788899999998765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.2e-17 Score=136.81 Aligned_cols=143 Identities=19% Similarity=0.164 Sum_probs=106.1
Q ss_pred CcCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++| +|++|++++++ +..+++|+|+.|.+|.+.+.. ....++.+++.+|.++|+.| |+||
T Consensus 54 iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHr 115 (218)
T PRK12274 54 ALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHN 115 (218)
T ss_pred HHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccC
Confidence 36678 45889999886 346999999999898754321 11357789999999999999 9999
Q ss_pred CC-CCCcEEEcCCCeEEEecCCCCccCCCCCCC---Cc--------cccccCCcCccCchhhccC-CCC-ccccEEEehH
Q 020529 80 DF-KSSNILLEEGFHPKLSDFGLAKLGPVGDKS---HV--------STRVMGTYGYCAPEYAMTG-QLT-VKSDVYSFGV 145 (325)
Q Consensus 80 di-k~~Nill~~~~~~kL~Dfgla~~~~~~~~~---~~--------~~~~~gt~~y~aPE~~~~~-~~~-~ksDvwSlGv 145 (325)
|| ||+|||++.++.++|+|||++......... .. ......++.|++|+...-- ..+ ...+.++.|+
T Consensus 116 DL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~ 195 (218)
T PRK12274 116 DLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGK 195 (218)
T ss_pred CCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcc
Confidence 99 799999999999999999999854432211 00 1123367788888864332 233 4568889999
Q ss_pred HHHHHHhCCCCCCCCC
Q 020529 146 VFLELITGRKAIDSTR 161 (325)
Q Consensus 146 vl~elltg~~p~~~~~ 161 (325)
.+|.++|+..+.-..+
T Consensus 196 ~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 196 PVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHhccCCccccC
Confidence 9999999988765443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.1e-17 Score=138.44 Aligned_cols=121 Identities=12% Similarity=0.197 Sum_probs=92.7
Q ss_pred cCCCCCCCccceeeEEEeC--------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 2 LSLLHHSNLVNLIGYCADG--------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
+.+++||+|..+.+++... ...+|||||++|.+|.++.. ++. ....+++.+|..||+.+
T Consensus 89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g- 155 (232)
T PRK10359 89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG- 155 (232)
T ss_pred HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC-
Confidence 4567899999999986643 35789999999999988742 232 24569999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt 152 (325)
++||||||+||+++.++ ++|+|||.......... . .-+.....+..++|||+||+.+..+..
T Consensus 156 --i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a---~-----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 156 --MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKA---K-----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred --CccCCCChHHEEEeCCC-EEEEECCCcccccchhh---H-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99999999999999988 99999998764321110 0 113444456789999999999886654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4.1e-17 Score=142.04 Aligned_cols=201 Identities=22% Similarity=0.294 Sum_probs=143.6
Q ss_pred CCCCCCccceeeEEEeCC-----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 4 LLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
++-|.|||++..|+.+.+ +..+++|||..|+|.++|++.+.....+......+|+-||+.||.|||+.. |+|+|
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppiih 201 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPIIH 201 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccccc
Confidence 457999999999986643 578999999999999999987666777888899999999999999999986 77999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCC--CccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGL--AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgl--a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
+++..+.|++..++-+|+.--.- .................+.++|++||.-.....+..+|||+||+..++|.-+..-
T Consensus 202 gnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq 281 (458)
T KOG1266|consen 202 GNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQ 281 (458)
T ss_pred CCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheec
Confidence 99999999999999888752211 1100000011112334577899999998878888999999999999999887542
Q ss_pred -CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 157 -IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.........+ ...... +..+-++. -..++.+|++..|+.||+|.+++..
T Consensus 282 ~tnseS~~~~e--e~ia~~-------i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 282 STNSESKVEVE--ENIANV-------IIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred cCCCcceeehh--hhhhhh-------eeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence 2111110000 000011 11111111 1257888999999999999998765
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.7e-15 Score=150.98 Aligned_cols=139 Identities=20% Similarity=0.205 Sum_probs=115.8
Q ss_pred ccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEc
Q 020529 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE 89 (325)
Q Consensus 10 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~ 89 (325)
|+.+...+...+..++|++|.+-|+|.+++.. .+.++|..++.+..++++.|++||..+ |||+||||+|++|.
T Consensus 756 ~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~ 828 (974)
T KOG1166|consen 756 IMHISSAHVFQNASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLR 828 (974)
T ss_pred hHHHHHHHccCCcceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEee
Confidence 33334444556778999999999999999973 667999999999999999999999999 99999999999993
Q ss_pred -------CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 90 -------EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 90 -------~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
....++|+|||.+.-+..-........+.+|-.+-.+|+..+..++...|.|.|.-+++-||.|+.
T Consensus 829 ~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 829 REICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 234589999999854333223334456778999999999999999999999999999999999964
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-15 Score=127.95 Aligned_cols=92 Identities=13% Similarity=0.068 Sum_probs=70.5
Q ss_pred CCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEeCCC
Q 020529 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL-HDKANPPVIYRDF 81 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~L-H~~~~~~ivHrdi 81 (325)
.++.|+++.....+.. ...+|||||+++++|...+.. ..+++......++.+++.+|.|| |+.+ |+||||
T Consensus 74 ~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDl 144 (190)
T cd05147 74 KRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADL 144 (190)
T ss_pred HHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 3455566533332222 223899999988777654322 34688999999999999999999 6888 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCcc
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~ 104 (325)
||+||+++ ++.++|+|||++..
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CHHHEEEE-CCcEEEEEcccccc
Confidence 99999998 47899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=4e-15 Score=125.28 Aligned_cols=93 Identities=15% Similarity=0.089 Sum_probs=72.5
Q ss_pred CCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCCC
Q 020529 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDF 81 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrdi 81 (325)
.++.|++|.....+... ..+|||||++++++...+.. ...++...+..++.+++.+|.+||. .+ |+||||
T Consensus 74 ~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDl 144 (190)
T cd05145 74 KRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDL 144 (190)
T ss_pred HHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCC
Confidence 45567776544443332 34899999988755443221 2457888999999999999999999 88 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLG 105 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~ 105 (325)
||+||+++ ++.++|+|||++...
T Consensus 145 kP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 145 SEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred ChhhEEEE-CCCEEEEEcccceec
Confidence 99999999 789999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=3.5e-16 Score=152.21 Aligned_cols=200 Identities=27% Similarity=0.318 Sum_probs=154.8
Q ss_pred CCCccceeeEEEeCCeeEEEEecCCCCCHHHHh-ccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEeCCCCCC
Q 020529 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL-HDLPPDKEALDWNTRMKIAAGAAKGLEYLH-DKANPPVIYRDFKSS 84 (325)
Q Consensus 7 Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l-~~~~~~~~~l~~~~~~~i~~~l~~al~~LH-~~~~~~ivHrdik~~ 84 (325)
|+|++.+++...+.+..+++++|..++++..-+ +. .....+....-.++.|+..++.|+| ..+ +.|+||||+
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~---~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~ 153 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHP---DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPS 153 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccC---CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCc
Confidence 999999999999999999999999999998887 33 2324666677788999999999999 888 999999999
Q ss_pred cEEEcCCC-eEEEecCCCCccCCC-CCCCCccccccC-CcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 85 NILLEEGF-HPKLSDFGLAKLGPV-GDKSHVSTRVMG-TYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 85 Nill~~~~-~~kL~Dfgla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|.+++..+ .+++.|||+|..+.. ...........| ++.|.|||...+. ......|+||+|+++.-+++|..||+..
T Consensus 154 n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~ 233 (601)
T KOG0590|consen 154 NSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFP 233 (601)
T ss_pred cchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccc
Confidence 99999999 999999999987666 444444455667 9999999998874 5577899999999999999999999876
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.... .....|...- ..+... . -........+++.+++..+|..|.+.+++-.
T Consensus 234 ~~~~-~~~~~~~~~~----~~~~~~----~----~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 234 SRKD-GRYSSWKSNK----GRFTQL----P----WNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccc-ccceeecccc----cccccC----c----cccCChhhhhcccccccCCchhccccccccc
Confidence 5433 1122222110 000000 0 0122345678999999999999999888754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.4e-16 Score=151.98 Aligned_cols=146 Identities=24% Similarity=0.356 Sum_probs=109.8
Q ss_pred HHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-------------CccccccCCcCccCchh
Q 020529 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-------------HVSTRVMGTYGYCAPEY 128 (325)
Q Consensus 62 ~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-------------~~~~~~~gt~~y~aPE~ 128 (325)
+.+++|||..+ |+|||+||+|++|..-|++||.|||+.+........ .....++||+.|.|||+
T Consensus 153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 78999999999 999999999999999999999999999864321111 01134679999999999
Q ss_pred hccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHH
Q 020529 129 AMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASM 208 (325)
Q Consensus 129 ~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~ 208 (325)
+....|....|+|++|+|+||.+-|..||.+..+.+.. ..++.+...+.+- |.. ...++.+++..
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~visd~i~wpE~-dea--------~p~Ea~dli~~ 294 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVISDDIEWPEE-DEA--------LPPEAQDLIEQ 294 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhhhhhcccccc-CcC--------CCHHHHHHHHH
Confidence 99999999999999999999999999999887554321 1122222222222 222 22467889999
Q ss_pred chhhCCCCCCCHHHHHH
Q 020529 209 CIQEQAATRPLIGDVVT 225 (325)
Q Consensus 209 cl~~~p~~RPs~~evl~ 225 (325)
+|+.+|..|--....++
T Consensus 295 LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 295 LLRQNPLCRLGTGGALE 311 (1205)
T ss_pred HHHhChHhhcccchhhh
Confidence 99999999965444333
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.4e-15 Score=125.31 Aligned_cols=87 Identities=18% Similarity=0.210 Sum_probs=69.6
Q ss_pred CCCCccceeeEEEeCC---eeE-EEEec--CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHhcCCCCCeEe
Q 020529 6 HHSNLVNLIGYCADGD---QRL-LVYEF--MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL-EYLHDKANPPVIY 78 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~---~~~-lv~e~--~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al-~~LH~~~~~~ivH 78 (325)
.||||+++++++.++. ..+ +|+|| +.+++|.+++.. ..+++. ..++.+++.++ +|||+++ |+|
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---Ivh 128 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVT 128 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---Eee
Confidence 6899999999998863 333 78999 557999999964 235555 35678888887 9999999 999
Q ss_pred CCCCCCcEEEcC----CCeEEEecCCCC
Q 020529 79 RDFKSSNILLEE----GFHPKLSDFGLA 102 (325)
Q Consensus 79 rdik~~Nill~~----~~~~kL~Dfgla 102 (325)
|||||+|||++. ++.++|+||+.+
T Consensus 129 rDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 129 MELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred cCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 999999999974 347999995444
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.2e-13 Score=118.08 Aligned_cols=91 Identities=23% Similarity=0.362 Sum_probs=79.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+..++|++|.....++......++||||++|++|.+++... .+ .+..++.+++.+|.+||..+ ++|+|+
T Consensus 53 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl 121 (211)
T PRK14879 53 MSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDL 121 (211)
T ss_pred HHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 44567889888888877788889999999999999998641 12 78899999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCcc
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~ 104 (325)
+|.||+++ ++.++|+|||++..
T Consensus 122 ~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 122 TTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CcccEEEE-CCCEEEEECCcccC
Confidence 99999999 78899999998863
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.6e-13 Score=133.41 Aligned_cols=87 Identities=23% Similarity=0.340 Sum_probs=78.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++|++++..+.++......++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||
T Consensus 390 l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDl 454 (535)
T PRK09605 390 LSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDL 454 (535)
T ss_pred HHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCC
Confidence 567899999988888887778899999999999999884 34678999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCcc
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~ 104 (325)
||+||++ .++.++|+|||+++.
T Consensus 455 kp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 455 TTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ChHHEEE-ECCcEEEEeCccccc
Confidence 9999999 577899999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.3e-13 Score=114.24 Aligned_cols=88 Identities=24% Similarity=0.372 Sum_probs=73.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++|+++....-++......++||||++|++|.+++.. ... .++.+++.+|.+||+.+ ++|+|+
T Consensus 51 l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl 116 (199)
T TIGR03724 51 LSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEE----GND-------ELLREIGRLVGKLHKAG---IVHGDL 116 (199)
T ss_pred HHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHCC---eecCCC
Confidence 3456777766666666667778999999999999998754 110 78999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCcc
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~ 104 (325)
+|.||+++ ++.++|+|||++..
T Consensus 117 ~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 117 TTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CcceEEEE-CCcEEEEECCCCcC
Confidence 99999999 78999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.8e-12 Score=123.01 Aligned_cols=138 Identities=19% Similarity=0.226 Sum_probs=110.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.|+||||+++++.+...+..|+|+|.+. -|..++.. +....+...+.||+.||.|||+.+. ++|++|
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv 131 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKEEVCLGLFQILAALSFLNDDCN--LVHGNV 131 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCC--eeeccE
Confidence 678899999999999999999999999983 68888865 4467778889999999999986654 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~ 154 (325)
.-+.|++++.|..||++|.++........ ......--..|..|+.+.... -..|.|-|||+++|++.|.
T Consensus 132 ~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 132 CKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred eeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 99999999999999999999865433322 112222233477777654433 4569999999999999993
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.9e-13 Score=114.82 Aligned_cols=91 Identities=22% Similarity=0.181 Sum_probs=71.4
Q ss_pred cCCCCCCCc--cceeeEEEeCC----eeEEEEecCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 2 LSLLHHSNL--VNLIGYCADGD----QRLLVYEFMPL-GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 2 L~~l~Hpni--v~l~~~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+.+|+|++| +..+++..... ..++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||+.|
T Consensus 94 l~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G-- 162 (239)
T PRK01723 94 LAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG-- 162 (239)
T ss_pred HHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC--
Confidence 446777774 66677654322 23599999997 699998854 235543 3568999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
|+||||||.|||++.++.++|+|||.+..
T Consensus 163 -I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 163 -VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred -CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 99999999999999989999999998865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-12 Score=113.30 Aligned_cols=76 Identities=14% Similarity=0.153 Sum_probs=63.8
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCC
Q 020529 22 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 101 (325)
Q Consensus 22 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgl 101 (325)
..++||||+++.+|...+.. ...+...+...++.+++.+|.+||+.+. |+||||||+||+++ ++.++|+|||+
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIli~-~~~i~LiDFg~ 194 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNILVH-DGKVVIIDVSQ 194 (237)
T ss_pred CceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEEEE-CCCEEEEEChh
Confidence 35899999998888765422 2346666778999999999999998874 99999999999999 88999999999
Q ss_pred Ccc
Q 020529 102 AKL 104 (325)
Q Consensus 102 a~~ 104 (325)
+..
T Consensus 195 a~~ 197 (237)
T smart00090 195 SVE 197 (237)
T ss_pred hhc
Confidence 864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.3e-12 Score=119.17 Aligned_cols=195 Identities=25% Similarity=0.240 Sum_probs=142.2
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHhcCCCCCeEeCCC
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK----GLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~----al~~LH~~~~~~ivHrdi 81 (325)
.|+|.++....+..++..|+-+|++ +.+|.++.+. ....++....+.++.+... ||.++|... ++|-|+
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~ 248 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDL 248 (524)
T ss_pred ccccccccCcccccCCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---cccccc
Confidence 6899999889999999999999999 5999999886 2333666677777777777 999999999 999999
Q ss_pred CCCcEEEcCC-CeEEEecCCCCccCCCCCCCCc---cccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 82 KSSNILLEEG-FHPKLSDFGLAKLGPVGDKSHV---STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 82 k~~Nill~~~-~~~kL~Dfgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||.||++..+ ...+++|||++..+........ ..+..|...|++||.. .+-++..+|||++|.++++..++....
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccc
Confidence 9999999999 7899999999987554432221 2233677889999975 446789999999999999998885433
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
... ....|.. + .... +...+.......+...+..+++.+|..|++...+..
T Consensus 328 ~~g------~~~~W~~--~------r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 328 SVG------KNSSWSQ--L------RQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cCC------CCCCccc--c------cccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 211 0111211 1 1111 111122222344555899999999999998877765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.3e-12 Score=108.15 Aligned_cols=71 Identities=13% Similarity=0.087 Sum_probs=61.1
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCC
Q 020529 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 100 (325)
Q Consensus 21 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfg 100 (325)
...++||||+++++|..+... .....++.+++.++.++|+.+ |+||||||+||++++++.++|+|||
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~~~~liDfg 170 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDEKIYIIDWP 170 (198)
T ss_pred CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCCcEEEEECC
Confidence 345899999999998765421 234678899999999999999 9999999999999999999999999
Q ss_pred CCcc
Q 020529 101 LAKL 104 (325)
Q Consensus 101 la~~ 104 (325)
++..
T Consensus 171 ~~~~ 174 (198)
T cd05144 171 QMVS 174 (198)
T ss_pred cccc
Confidence 9854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.1e-11 Score=99.10 Aligned_cols=91 Identities=20% Similarity=0.225 Sum_probs=75.9
Q ss_pred CCCCC--CCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 3 SLLHH--SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 3 ~~l~H--pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+.++| +++++++.++...+..+++|||+++..+..+ +......++.+++.+|++||.....+++|+|
T Consensus 46 ~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~D 114 (155)
T cd05120 46 QLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGD 114 (155)
T ss_pred HHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecC
Confidence 34544 5888999888888889999999987777543 5567778899999999999986434499999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCcc
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
|+|.||++++.+.++|+|||++..
T Consensus 115 l~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 115 LHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCcceEEEECCcEEEEEecccccC
Confidence 999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.4e-11 Score=121.95 Aligned_cols=194 Identities=23% Similarity=0.276 Sum_probs=138.9
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
+||-++...-.+.-....+||++|+.+++|...|+..+ +.+..........+..+++|||... ++|+|++|.|
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~ 934 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDS 934 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccc
Confidence 44656655545555678899999999999999998733 3454444555666788999999998 8999999999
Q ss_pred EEEcCCCeEEEecCCCCccCCCC----C-------------------------CCCccccccCCcCccCchhhccCCCCc
Q 020529 86 ILLEEGFHPKLSDFGLAKLGPVG----D-------------------------KSHVSTRVMGTYGYCAPEYAMTGQLTV 136 (325)
Q Consensus 86 ill~~~~~~kL~Dfgla~~~~~~----~-------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~ 136 (325)
++...+++.++.||++....... + .........||+.|.+||...+.....
T Consensus 935 ~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs 1014 (1205)
T KOG0606|consen 935 LLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGS 1014 (1205)
T ss_pred hhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCC
Confidence 99999999999999854332211 0 001122356999999999999999999
Q ss_pred cccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCC
Q 020529 137 KSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT 216 (325)
Q Consensus 137 ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~ 216 (325)
.+|+|++|++++|.++|.+||....+..... .+.... ....+ -+......+.+++...+..+|.+
T Consensus 1015 ~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~------ni~~~~---~~~p~------g~~~~s~~aq~~~~~ll~~~~~q 1079 (1205)
T KOG0606|consen 1015 AADWWSSGVCLFEVLTGIPPFNAETPQQIFE------NILNRD---IPWPE------GPEEGSYEAQDLINRLLTEEPTQ 1079 (1205)
T ss_pred cchhhhhhhhhhhhhcCCCCCCCcchhhhhh------ccccCC---CCCCC------CccccChhhhhhhhhhhccCchh
Confidence 9999999999999999999998765532211 001000 00001 12233456678888899999999
Q ss_pred CCCHH
Q 020529 217 RPLIG 221 (325)
Q Consensus 217 RPs~~ 221 (325)
|-.+.
T Consensus 1080 r~~a~ 1084 (1205)
T KOG0606|consen 1080 RLGAK 1084 (1205)
T ss_pred ccCcc
Confidence 97766
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=6.3e-09 Score=94.48 Aligned_cols=202 Identities=16% Similarity=0.182 Sum_probs=129.4
Q ss_pred eEEEEecCCCCC-HHHHhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecC
Q 020529 23 RLLVYEFMPLGS-LEDHLHD--LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 99 (325)
Q Consensus 23 ~~lv~e~~~~gs-L~~~l~~--~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Df 99 (325)
.-++|+.+.+.- ...++.. ++..-.-++|...++.+..++.+.+.||+.| .+-+|++++|+|+++++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 567888886552 2222211 1223345899999999999999999999999 899999999999999999999986
Q ss_pred CCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHHHHhC-CCCCCCCCCCCc---chhhh
Q 020529 100 GLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITG-RKAIDSTRPHGE---QNLVT 170 (325)
Q Consensus 100 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg-~~p~~~~~~~~~---~~~~~ 170 (325)
+.-.+.. ......-..|...|.+||... +..-+...|.|.||+++++++.| +.||.+-..... -.-.+
T Consensus 162 Dsfqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 6544331 222223345888999999755 22446789999999999999877 899976321111 00001
Q ss_pred hhhhccccccccc-cccCCccCCCCChHH-HHHHHHHHHHchhhC--CCCCCCHHHHHHHHHhhhc
Q 020529 171 WARPLFNDRRKFS-KLADPRLEGRYPIRG-LYQALAVASMCIQEQ--AATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 171 ~~~~~~~~~~~~~-~~~d~~l~~~~~~~~-~~~~~~l~~~cl~~~--p~~RPs~~evl~~L~~~~~ 232 (325)
.+...+....... ....+. +..|... ...+-.|..+|+... +.-||+++-.+..|..+..
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P--~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPP--RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hhcceeeechhccCCCCCCC--CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 1111111111100 111111 1112111 235567888888754 5679999999999987764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.03 E-value=4.3e-10 Score=94.04 Aligned_cols=73 Identities=19% Similarity=0.198 Sum_probs=57.9
Q ss_pred eeEEEEecCCCCCHHH-HhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCCCCCCcEEEcCCCeEEEecC
Q 020529 22 QRLLVYEFMPLGSLED-HLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDF 99 (325)
Q Consensus 22 ~~~lv~e~~~~gsL~~-~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrdik~~Nill~~~~~~kL~Df 99 (325)
..++||||++++.+.. .+... ... .....++.+++.++.++|. .+ |+|+||||+||+++ ++.++|+||
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~~~~liDf 158 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DGKVYIIDV 158 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CCcEEEEEC
Confidence 4689999999854321 11110 011 5678899999999999999 88 99999999999999 889999999
Q ss_pred CCCcc
Q 020529 100 GLAKL 104 (325)
Q Consensus 100 gla~~ 104 (325)
|.+..
T Consensus 159 g~a~~ 163 (187)
T cd05119 159 PQAVE 163 (187)
T ss_pred ccccc
Confidence 99864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1e-09 Score=103.38 Aligned_cols=192 Identities=23% Similarity=0.224 Sum_probs=138.1
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
.|.|++.++..+..-.+.|+=-|||.++++...+. ....+++..++++..+++.++.++|+.. ++|+|+||+|
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psn 396 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSN 396 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccc
Confidence 68888998888887788888899999898877662 2445888899999999999999999999 9999999999
Q ss_pred EEEcCC-CeEEEecCCCCccCCCCCCCCccccccCCcCcc--CchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCC
Q 020529 86 ILLEEG-FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC--APEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 162 (325)
Q Consensus 86 ill~~~-~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~ 162 (325)
|++..+ +..++.|||+...+... ......+-++. ++.......+..+.|+||||.-+.+.+++..-....
T Consensus 397 i~i~~~~~~~~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-- 469 (524)
T KOG0601|consen 397 ILISNDGFFSKLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-- 469 (524)
T ss_pred eeeccchhhhhcccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccc--
Confidence 999886 78889999988532211 11222333344 555555667889999999999999999986422111
Q ss_pred CCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 163 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
..|. .+..-..+.+ + ....++..+...++..++..||.+.++.......
T Consensus 470 ------~~~~--------~i~~~~~p~~----~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 470 ------VQSL--------TIRSGDTPNL----P-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ------ccce--------eeecccccCC----C-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0110 0011111111 1 1225667788899999999999998887765543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.90 E-value=2e-09 Score=88.44 Aligned_cols=86 Identities=22% Similarity=0.215 Sum_probs=61.0
Q ss_pred CCCCCCccc-eeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEeCC
Q 020529 4 LLHHSNLVN-LIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA--NPPVIYRD 80 (325)
Q Consensus 4 ~l~Hpniv~-l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~--~~~ivHrd 80 (325)
.+.+.++++ ++.+. ....++||||++|.++... . . ....++.+++.+|+.||..+ ...++|+|
T Consensus 48 ~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD 113 (170)
T cd05151 48 LAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHND 113 (170)
T ss_pred HHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCC
Confidence 333344443 44433 3346899999998877543 0 0 11345678999999999987 22359999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCcc
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
++|.||+++ ++.++|+||+.+..
T Consensus 114 ~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 114 LLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCcCcEEEE-CCeEEEEecccccC
Confidence 999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.4e-08 Score=89.58 Aligned_cols=87 Identities=17% Similarity=0.167 Sum_probs=69.6
Q ss_pred ceeeEEEe-----CCeeEEEEecCCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 12 NLIGYCAD-----GDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 12 ~l~~~~~~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
..++++.. ....++|||++++. +|.+++.... ..+.+...+..++.+++..+..||..| |+|+|+++.|
T Consensus 94 ~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~N 168 (268)
T PRK15123 94 TGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICH 168 (268)
T ss_pred CeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhh
Confidence 44555543 23578999999875 8999985422 234566778899999999999999999 9999999999
Q ss_pred EEEcC-------CCeEEEecCCCCc
Q 020529 86 ILLEE-------GFHPKLSDFGLAK 103 (325)
Q Consensus 86 ill~~-------~~~~kL~Dfgla~ 103 (325)
||++. +..+.|+||+.++
T Consensus 169 iLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 169 FLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EEEeccccCCCCCceEEEEECCccc
Confidence 99975 4689999999875
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.87 E-value=7.7e-09 Score=86.71 Aligned_cols=74 Identities=15% Similarity=0.146 Sum_probs=57.2
Q ss_pred CeeEEEEecCCCCCHH-HHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hcCCCCCeEeCCCCCCcEEEcCCCeEEEec
Q 020529 21 DQRLLVYEFMPLGSLE-DHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL-HDKANPPVIYRDFKSSNILLEEGFHPKLSD 98 (325)
Q Consensus 21 ~~~~lv~e~~~~gsL~-~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~L-H~~~~~~ivHrdik~~Nill~~~~~~kL~D 98 (325)
...+|||||+.+..+. ..+.+ ..++......+..+++.+|..| |..+ |||+||++.||++. ++.+.|+|
T Consensus 97 ~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~NIL~~-~~~v~iID 167 (197)
T cd05146 97 KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEYNMLWH-DGKVWFID 167 (197)
T ss_pred cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEE-CCcEEEEE
Confidence 4568999999754332 12222 2345556677889999999999 8888 99999999999997 46799999
Q ss_pred CCCCc
Q 020529 99 FGLAK 103 (325)
Q Consensus 99 fgla~ 103 (325)
||.+-
T Consensus 168 F~qav 172 (197)
T cd05146 168 VSQSV 172 (197)
T ss_pred CCCce
Confidence 99874
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.86 E-value=4.4e-09 Score=99.50 Aligned_cols=77 Identities=22% Similarity=0.207 Sum_probs=60.5
Q ss_pred CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEec
Q 020529 20 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAK-GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 98 (325)
Q Consensus 20 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~-al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~D 98 (325)
....+|||||++|++|.++.... ....+ +..++..++. .+.++|..| ++|+|++|.||+++.++.++|+|
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liD 300 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALD 300 (437)
T ss_pred cCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEe
Confidence 44579999999999998876431 11122 3456666665 478899999 99999999999999999999999
Q ss_pred CCCCccC
Q 020529 99 FGLAKLG 105 (325)
Q Consensus 99 fgla~~~ 105 (325)
||++...
T Consensus 301 fG~~~~l 307 (437)
T TIGR01982 301 FGIVGRL 307 (437)
T ss_pred CCCeeEC
Confidence 9998653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.80 E-value=1.1e-08 Score=83.43 Aligned_cols=75 Identities=29% Similarity=0.450 Sum_probs=63.0
Q ss_pred eEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeE
Q 020529 15 GYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP 94 (325)
Q Consensus 15 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~ 94 (325)
=|..+.+...++|||++|..|.+++... ...++..+-.-+.-||..+ |||+||.++||.+..+. +
T Consensus 66 v~dvD~~~~~I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i 130 (204)
T COG3642 66 VYDVDPDNGLIVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-I 130 (204)
T ss_pred EEEEcCCCCEEEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-E
Confidence 3455677788999999999999898651 2557778888889999999 99999999999998765 9
Q ss_pred EEecCCCCcc
Q 020529 95 KLSDFGLAKL 104 (325)
Q Consensus 95 kL~Dfgla~~ 104 (325)
.++||||+..
T Consensus 131 ~~IDfGLg~~ 140 (204)
T COG3642 131 YFIDFGLGEF 140 (204)
T ss_pred EEEECCcccc
Confidence 9999999863
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.1e-08 Score=82.56 Aligned_cols=88 Identities=24% Similarity=0.301 Sum_probs=71.8
Q ss_pred ccceeeEEEeC----CeeEEEEecCCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 10 LVNLIGYCADG----DQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 10 iv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
+...+++.... ...++|+|++++. +|.+++.... .++......++.+++..++-||+.| |+|+|+++.
T Consensus 75 tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~ 147 (206)
T PF06293_consen 75 TPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPS 147 (206)
T ss_pred CCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcc
Confidence 44556665543 2458999999874 8999987522 2667778899999999999999999 999999999
Q ss_pred cEEEcCCC---eEEEecCCCCcc
Q 020529 85 NILLEEGF---HPKLSDFGLAKL 104 (325)
Q Consensus 85 Nill~~~~---~~kL~Dfgla~~ 104 (325)
|||++.+. .+.|+||+-++.
T Consensus 148 NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 148 NILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred cEEEeCCCCceeEEEEcchhcee
Confidence 99999887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.5e-09 Score=98.78 Aligned_cols=154 Identities=18% Similarity=0.205 Sum_probs=102.2
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCc-------cccccCCcCccCchh
Q 020529 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-------STRVMGTYGYCAPEY 128 (325)
Q Consensus 56 ~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~-------~~~~~gt~~y~aPE~ 128 (325)
.=+.+++.|+.|+|.... +||++|.|++|.++.++..||+.|+.+-.......... .....-...|.|||+
T Consensus 103 ~nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY 180 (700)
T ss_pred hhhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence 344567799999997654 99999999999999999999999998754332111111 111223457999999
Q ss_pred hccCCCCccccEEEehHHHHHHH-hCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHH
Q 020529 129 AMTGQLTVKSDVYSFGVVFLELI-TGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVAS 207 (325)
Q Consensus 129 ~~~~~~~~ksDvwSlGvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~ 207 (325)
+.....+.++|+||+|+++|-+. .|+.-+...+........ ...+..-...+..+...++.+=+.
T Consensus 181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred hccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHHHHHHHH
Confidence 99988899999999999999998 444433332211111111 111111111222334456778888
Q ss_pred HchhhCCCCCCCHHHHHH
Q 020529 208 MCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 208 ~cl~~~p~~RPs~~evl~ 225 (325)
+++..++..||++-++..
T Consensus 247 k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 247 KLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHhcCCcccCcchhhhhc
Confidence 999999999997666544
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=9.8e-08 Score=77.84 Aligned_cols=84 Identities=25% Similarity=0.322 Sum_probs=63.6
Q ss_pred EEEeCCeeEEEEecCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCC--
Q 020529 16 YCADGDQRLLVYEFMPL-GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF-- 92 (325)
Q Consensus 16 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~-- 92 (325)
++.+....+++|||++| .++.+++...-. ..........++..+-..|.-||..+ |||+||..+||+|..++
T Consensus 78 ~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~ 152 (229)
T KOG3087|consen 78 IFIDTYGGQIYMEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQ 152 (229)
T ss_pred EEEecCCCeEEEEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCc
Confidence 45566777899999985 478888765211 11222223678888999999999999 99999999999997665
Q ss_pred -eEEEecCCCCcc
Q 020529 93 -HPKLSDFGLAKL 104 (325)
Q Consensus 93 -~~kL~Dfgla~~ 104 (325)
.+.|+|||++..
T Consensus 153 ~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 153 ITPILIDFGLSSV 165 (229)
T ss_pred CceEEEeecchhc
Confidence 358999999853
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.1e-07 Score=88.62 Aligned_cols=132 Identities=18% Similarity=0.244 Sum_probs=99.3
Q ss_pred cCCCCCCCccceeeEEEe----CCeeEEEEecCCC-CCHHHHhccCC-----------CCCCCCCHHHHHHHHHHHHHHH
Q 020529 2 LSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPL-GSLEDHLHDLP-----------PDKEALDWNTRMKIAAGAAKGL 65 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~-gsL~~~l~~~~-----------~~~~~l~~~~~~~i~~~l~~al 65 (325)
.+++.|+|||++.++|.. +.-++|||+|.++ ++|.++--.-+ .....+++...|.++.|+..||
T Consensus 327 wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL 406 (655)
T KOG3741|consen 327 WKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAAL 406 (655)
T ss_pred HHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHH
Confidence 468899999999988762 4467999999874 46666543322 2234578899999999999999
Q ss_pred HHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehH
Q 020529 66 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGV 145 (325)
Q Consensus 66 ~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGv 145 (325)
.++|+.| +.-+-|.+.+|++..+.+++|+..|...+..... + |.+. --.+-|.=-||.
T Consensus 407 ~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~---------~-------~~le---~~Qq~D~~~lG~ 464 (655)
T KOG3741|consen 407 YSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP---------T-------EPLE---SQQQNDLRDLGL 464 (655)
T ss_pred HHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCC---------C-------cchh---HHhhhhHHHHHH
Confidence 9999999 8889999999999999999998777654322211 0 1111 134567778999
Q ss_pred HHHHHHhCCC
Q 020529 146 VFLELITGRK 155 (325)
Q Consensus 146 vl~elltg~~ 155 (325)
+++.|.||..
T Consensus 465 ll~aLAt~~~ 474 (655)
T KOG3741|consen 465 LLLALATGTE 474 (655)
T ss_pred HHHHHhhccc
Confidence 9999999964
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.7e-07 Score=90.30 Aligned_cols=77 Identities=16% Similarity=0.080 Sum_probs=52.8
Q ss_pred CCeeEEEEecCCCCCHHHHh--ccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCC----e
Q 020529 20 GDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF----H 93 (325)
Q Consensus 20 ~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~----~ 93 (325)
....+|||||++|+.+.++- .........+....+..+ +..+...| ++|+|+||.||+++.++ .
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~-------~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~ 302 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF-------FTQVFRDG---FFHADMHPGNIFVSYDPPENPR 302 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH-------HHHHHhCC---eeeCCCChHHeEEecCCCCCCe
Confidence 45678999999999998742 211001111222222223 34445678 99999999999999888 9
Q ss_pred EEEecCCCCccCC
Q 020529 94 PKLSDFGLAKLGP 106 (325)
Q Consensus 94 ~kL~Dfgla~~~~ 106 (325)
++++|||++....
T Consensus 303 i~llDFGivg~l~ 315 (537)
T PRK04750 303 YIALDFGIVGSLN 315 (537)
T ss_pred EEEEecceEEECC
Confidence 9999999987543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.5e-07 Score=78.26 Aligned_cols=92 Identities=24% Similarity=0.321 Sum_probs=70.7
Q ss_pred CCccceeeEEEeC---CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC------------
Q 020529 8 SNLVNLIGYCADG---DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA------------ 72 (325)
Q Consensus 8 pniv~l~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~------------ 72 (325)
.++.+++.+.... +..++||||++|.++.+.+.. ..++...+..++.+++.+|..||+..
T Consensus 57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~ 131 (223)
T cd05154 57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRP 131 (223)
T ss_pred CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCC
Confidence 4466677776653 256899999998888765521 34777788888889999998888521
Q ss_pred -----------------------------------------CCCeEeCCCCCCcEEEcC--CCeEEEecCCCCcc
Q 020529 73 -----------------------------------------NPPVIYRDFKSSNILLEE--GFHPKLSDFGLAKL 104 (325)
Q Consensus 73 -----------------------------------------~~~ivHrdik~~Nill~~--~~~~kL~Dfgla~~ 104 (325)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 132 GGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred CchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.38 E-value=9.6e-07 Score=73.91 Aligned_cols=98 Identities=27% Similarity=0.296 Sum_probs=75.5
Q ss_pred cCCCCC-CCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHH-SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~H-pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+.+++ +++++++|+|- .++|.||...+++...-... ..-...+|..|.+|+.+++..+.+|+......+.-.|
T Consensus 13 l~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcD 87 (188)
T PF12260_consen 13 LQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCD 87 (188)
T ss_pred HHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEee
Confidence 455655 69999999993 46789999877664320000 0112368999999999999999999986544599999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCcc
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
++++|+-+++++.+|++|.+.+..
T Consensus 88 v~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 88 VSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cchHHeEEeCCCcEEEEechhcch
Confidence 999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.2e-07 Score=75.89 Aligned_cols=73 Identities=21% Similarity=0.276 Sum_probs=48.9
Q ss_pred eeEEEEecCC--CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HhcCCCCCeEeCCCCCCcEEEcCCCeEEEec
Q 020529 22 QRLLVYEFMP--LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY-LHDKANPPVIYRDFKSSNILLEEGFHPKLSD 98 (325)
Q Consensus 22 ~~~lv~e~~~--~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~-LH~~~~~~ivHrdik~~Nill~~~~~~kL~D 98 (325)
..++||||++ |..+..+... .++......++.+++..+.. +|..| |+|+||.+.||+++++ .+.|+|
T Consensus 80 ~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 3479999998 6555544322 11133446677788885555 57888 9999999999999988 899999
Q ss_pred CCCCcc
Q 020529 99 FGLAKL 104 (325)
Q Consensus 99 fgla~~ 104 (325)
||.+..
T Consensus 150 f~qav~ 155 (188)
T PF01163_consen 150 FGQAVD 155 (188)
T ss_dssp GTTEEE
T ss_pred cCccee
Confidence 998753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=2.8e-06 Score=71.97 Aligned_cols=67 Identities=18% Similarity=0.216 Sum_probs=53.4
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCC
Q 020529 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 100 (325)
Q Consensus 21 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfg 100 (325)
...+|||||++|..|.++.. +++ .++..++.++..||+.| +.|+|++|.|+++..++ ++++||+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-EEEEECc
Confidence 45579999999988876542 222 24566778899999999 99999999999998655 9999998
Q ss_pred CCc
Q 020529 101 LAK 103 (325)
Q Consensus 101 la~ 103 (325)
..+
T Consensus 180 ~k~ 182 (229)
T PF06176_consen 180 GKR 182 (229)
T ss_pred ccc
Confidence 654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.2e-05 Score=67.87 Aligned_cols=78 Identities=15% Similarity=0.061 Sum_probs=64.5
Q ss_pred eeEEEEecCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCe--EEEec
Q 020529 22 QRLLVYEFMPL-GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFH--PKLSD 98 (325)
Q Consensus 22 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~--~kL~D 98 (325)
+.+||+|-+.+ .+|.+++... ...+.+...+..++.+++.+|+-||+.+ +.|+|+.+.||+++.++. +.|+|
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lID 173 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLD 173 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEE
Confidence 56899997743 5899888552 1234677888999999999999999999 999999999999986666 99999
Q ss_pred CCCCcc
Q 020529 99 FGLAKL 104 (325)
Q Consensus 99 fgla~~ 104 (325)
|.-++.
T Consensus 174 lEk~r~ 179 (216)
T PRK09902 174 LEKSRR 179 (216)
T ss_pred hhccch
Confidence 987654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.05 E-value=1e-06 Score=84.17 Aligned_cols=145 Identities=21% Similarity=0.164 Sum_probs=107.7
Q ss_pred CcCCCCCCC-ccceeeEEEeCCeeEEEEecCCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSN-LVNLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpn-iv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
+|.+++||| .+..++-+.......++++++.++ +....... ....+..-+...++..-.+++++||+.. -+|
T Consensus 286 LLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~ 359 (829)
T KOG0576|consen 286 LLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVH 359 (829)
T ss_pred HHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccC
Confidence 467899999 777777777778889999999766 22221111 1222444455667777889999999885 589
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
+| ||+..+ +..++.||+....+.... ......+++.++|||+.....+..+.|+|++++--.++.-|.+|-.
T Consensus 360 ~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 360 RD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 98 777665 678999999886543332 4455779999999999999999999999999998778877776654
Q ss_pred C
Q 020529 159 S 159 (325)
Q Consensus 159 ~ 159 (325)
.
T Consensus 432 ~ 432 (829)
T KOG0576|consen 432 S 432 (829)
T ss_pred C
Confidence 3
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.79 E-value=2.8e-05 Score=79.23 Aligned_cols=189 Identities=20% Similarity=0.170 Sum_probs=130.0
Q ss_pred cCCCCCCCccceeeEEEeCCe----eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 2 LSLLHHSNLVNLIGYCADGDQ----RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
+.++.|+|++.++.|..+... ..+..+++..-++...+.. ...++..+.+.+..++..||+|+|+.. +.
T Consensus 236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~~---l~ 308 (1351)
T KOG1035|consen 236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSLS---LE 308 (1351)
T ss_pred HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHhc---cc
Confidence 467899999999999755432 2455688888888888865 556889999999999999999999986 66
Q ss_pred eCCCCCC---cEEEcCCCeEEEe--cCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCc--cccEEEehHHHHHH
Q 020529 78 YRDFKSS---NILLEEGFHPKLS--DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV--KSDVYSFGVVFLEL 150 (325)
Q Consensus 78 Hrdik~~---Nill~~~~~~kL~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--ksDvwSlGvvl~el 150 (325)
|.-+..+ +.-.+..+.+..+ ||+..+..+....... ..-...+.++|......+.. ..|+|.+|..+..+
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHHHHHHHhhh
Confidence 6665555 3444555566665 8888776554433221 22344567787766655444 47999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
..|..+-.... ....+.+... .....+...+|+..+++.|+++.+++...
T Consensus 386 ~~~~~i~~~~~-------------------~~~~~l~~~~--------~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 386 SQGEDISEKSA-------------------VPVSLLDVLS--------TSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhcCccccccc-------------------chhhhhcccc--------chhhhhhhhhhcchhhhhccchhhhhhch
Confidence 98865432211 0011111111 01456788899999999999999999864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.64 E-value=7.1e-05 Score=65.12 Aligned_cols=70 Identities=19% Similarity=0.170 Sum_probs=52.4
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCC
Q 020529 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 100 (325)
Q Consensus 21 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfg 100 (325)
+.-.+||||++|--|...- ++....-.|+..|+.-+.-+-..| |||+|+.+-||+++++|.+.++||-
T Consensus 180 nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~~~vIDwP 247 (304)
T COG0478 180 NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGDIVVIDWP 247 (304)
T ss_pred ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCCEEEEeCc
Confidence 4557999999876554322 233344456666666666666778 9999999999999999999999996
Q ss_pred CC
Q 020529 101 LA 102 (325)
Q Consensus 101 la 102 (325)
-+
T Consensus 248 Q~ 249 (304)
T COG0478 248 QA 249 (304)
T ss_pred cc
Confidence 54
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00074 Score=58.31 Aligned_cols=30 Identities=17% Similarity=0.163 Sum_probs=26.4
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
+.++|+|+.|.||++++++ +.|+||+.+..
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 4589999999999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00052 Score=59.78 Aligned_cols=30 Identities=23% Similarity=0.218 Sum_probs=26.9
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
+.++|+|+.|.||+++++..+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 559999999999999998888899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.19 E-value=1.7e-05 Score=82.73 Aligned_cols=152 Identities=11% Similarity=-0.005 Sum_probs=111.1
Q ss_pred CCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeEeC
Q 020529 4 LLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA--NPPVIYR 79 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~--~~~ivHr 79 (325)
...|+++...+.=... ..+.+.+++|+.+|.+.+.+-.......+++...+.....+.+....-.|... ....+|+
T Consensus 1285 ~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~ 1364 (2724)
T KOG1826|consen 1285 EAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSK 1364 (2724)
T ss_pred hhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhh
Confidence 4577777766554432 34668899999999999998765444455655555554444456666655533 2447999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
++|+.|.+|..+..+++.++|+.++... .........+++-|+.|+....-.++.++|+|..|+.+|+...|..+|
T Consensus 1365 ~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1365 SLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred hhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9999999999999999999999983111 112233455778899999988889999999999999999998887665
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0012 Score=63.46 Aligned_cols=77 Identities=21% Similarity=0.209 Sum_probs=56.0
Q ss_pred CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHH-HHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEec
Q 020529 20 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG-LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 98 (325)
Q Consensus 20 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~a-l~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~D 98 (325)
.....|+|||++|..+.+...- ....++... |+..++.+ +..+-..| +.|.|.+|.||+++.++.+.+.|
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l---~~~g~d~k~---ia~~~~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lD 308 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAAL---KSAGIDRKE---LAELLVRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLD 308 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHH---HhcCCCHHH---HHHHHHHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEc
Confidence 5677899999999998887432 123455333 33333332 34444567 99999999999999999999999
Q ss_pred CCCCccC
Q 020529 99 FGLAKLG 105 (325)
Q Consensus 99 fgla~~~ 105 (325)
||+....
T Consensus 309 fGi~g~l 315 (517)
T COG0661 309 FGIVGRL 315 (517)
T ss_pred CcceecC
Confidence 9998654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0013 Score=67.48 Aligned_cols=32 Identities=22% Similarity=0.382 Sum_probs=25.7
Q ss_pred CeEeCCCCCCcEEEcCC-C-eEEEecCCCCccCC
Q 020529 75 PVIYRDFKSSNILLEEG-F-HPKLSDFGLAKLGP 106 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~-~-~~kL~Dfgla~~~~ 106 (325)
.+||+|+++.||+++.+ . .+-|.||+++....
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 49999999999999853 3 35799999987643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0011 Score=57.16 Aligned_cols=73 Identities=19% Similarity=0.235 Sum_probs=53.1
Q ss_pred eeEEEEecCCCCC-HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCCCCCCcEEEcCCCeEEEecC
Q 020529 22 QRLLVYEFMPLGS-LEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDF 99 (325)
Q Consensus 22 ~~~lv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrdik~~Nill~~~~~~kL~Df 99 (325)
...|||||+.... -.-.|. ..++.......+..+++..+.-|-. .+ +||+||..-|||+. ++.+.++||
T Consensus 140 ~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~ 210 (268)
T COG1718 140 NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH-DGEPYIIDV 210 (268)
T ss_pred CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE-CCeEEEEEC
Confidence 4479999995331 111111 1223333567788888899888887 66 99999999999999 889999999
Q ss_pred CCCc
Q 020529 100 GLAK 103 (325)
Q Consensus 100 gla~ 103 (325)
+-+-
T Consensus 211 ~QaV 214 (268)
T COG1718 211 SQAV 214 (268)
T ss_pred cccc
Confidence 9774
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0021 Score=55.71 Aligned_cols=31 Identities=26% Similarity=0.460 Sum_probs=26.4
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
+.++|+|+.+.||+++.+...-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 4599999999999998776667999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0025 Score=61.40 Aligned_cols=77 Identities=22% Similarity=0.214 Sum_probs=53.3
Q ss_pred CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcC----CCeEE
Q 020529 20 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEE----GFHPK 95 (325)
Q Consensus 20 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~----~~~~k 95 (325)
.....|+||||+|..+.+.-.- ....++...+..-+.++. +..+-..| ++|+|=+|.||++.. ++.+.
T Consensus 274 st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~--~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~iv 345 (538)
T KOG1235|consen 274 STKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAY--LEQIFKTG---FFHADPHPGNILVRPNPEGDEEIV 345 (538)
T ss_pred CcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHH--HHHHHhcC---CccCCCCCCcEEEecCCCCCccEE
Confidence 3467899999999877766332 234466654443333322 23334456 999999999999984 56899
Q ss_pred EecCCCCcc
Q 020529 96 LSDFGLAKL 104 (325)
Q Consensus 96 L~Dfgla~~ 104 (325)
|.|||+...
T Consensus 346 llDhGl~~~ 354 (538)
T KOG1235|consen 346 LLDHGLYAV 354 (538)
T ss_pred EEccccccc
Confidence 999999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.66 E-value=0.017 Score=48.76 Aligned_cols=82 Identities=23% Similarity=0.306 Sum_probs=60.1
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCC------CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMP------LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~------~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
..+.+|.+++|+.+++...-+|+|.+. ..+|.+++.. ..++. . +...+-.-..||-+.. |+.
T Consensus 74 ~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~---~~~~L~~f~~~l~~~~---Iv~ 141 (199)
T PF10707_consen 74 VDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-E---LRQALDEFKRYLLDHH---IVI 141 (199)
T ss_pred CcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-H---HHHHHHHHHHHHHHcC---Cee
Confidence 458899999999999988899999853 2378888843 34555 3 3334445567777777 999
Q ss_pred CCCCCCcEEEcCCC----eEEEec
Q 020529 79 RDFKSSNILLEEGF----HPKLSD 98 (325)
Q Consensus 79 rdik~~Nill~~~~----~~kL~D 98 (325)
+||+|.||++.... .+.|+|
T Consensus 142 ~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 142 RDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cCCCcccEEEEecCCCceEEEEEe
Confidence 99999999995432 466766
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.56 E-value=0.0053 Score=55.92 Aligned_cols=73 Identities=21% Similarity=0.156 Sum_probs=58.7
Q ss_pred CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecC
Q 020529 20 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDF 99 (325)
Q Consensus 20 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Df 99 (325)
..+.|++|++- |++|.- ...-.+.++..++.+.+..+.-|..+- ++-|||+.-.||||+ .|+|.|+||
T Consensus 298 ~~y~yl~~kdh-gt~is~--------ik~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI--------IKADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Cceeee--------eecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEe
Confidence 34667888876 566642 223578899999999988888887664 389999999999999 899999999
Q ss_pred CCCcc
Q 020529 100 GLAKL 104 (325)
Q Consensus 100 gla~~ 104 (325)
-++++
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99985
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.018 Score=51.78 Aligned_cols=28 Identities=14% Similarity=0.166 Sum_probs=22.6
Q ss_pred CCCeEeCCCCCCcEEEcCC-Ce-EEEecCC
Q 020529 73 NPPVIYRDFKSSNILLEEG-FH-PKLSDFG 100 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~-~~-~kL~Dfg 100 (325)
.+.++|||+.+.||+++.+ +. +.|.|..
T Consensus 192 ~psLlHGDlw~gNvl~~~~~~~i~~liDPa 221 (297)
T PRK10593 192 NCVLVHGNFTLRSMLKDPRSDQLLAMLNPG 221 (297)
T ss_pred CCeeEeCCCCcccEEECCCCCceEEEECch
Confidence 4679999999999999865 33 6788875
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.014 Score=52.86 Aligned_cols=42 Identities=24% Similarity=0.540 Sum_probs=33.3
Q ss_pred HHHHHhcCC-----CCCeEeCCCCCCcEEEcCCCeEEEecCCCCccC
Q 020529 64 GLEYLHDKA-----NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLG 105 (325)
Q Consensus 64 al~~LH~~~-----~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~ 105 (325)
-..+|+... .++++|+|+.+.||+++.+.-+=|.||+++.+.
T Consensus 183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 345555433 357999999999999999888999999998753
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.026 Score=49.51 Aligned_cols=30 Identities=20% Similarity=0.138 Sum_probs=26.0
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
..++|+|+.|.||++++++ +.|+||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 3489999999999999877 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.70 E-value=0.0038 Score=59.17 Aligned_cols=40 Identities=30% Similarity=0.450 Sum_probs=33.1
Q ss_pred CcCCCCCCCccceeeEEEeC-CeeEEEEecCCCCCHHHHhcc
Q 020529 1 MLSLLHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHD 41 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~ 41 (325)
+|+.++|+|++.++++.... .+..+|+|++ +.||++++..
T Consensus 35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 46788999999999997654 3578899999 5999999865
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.051 Score=48.84 Aligned_cols=31 Identities=29% Similarity=0.245 Sum_probs=27.0
Q ss_pred CCCeEeCCCCCCcEEEcCC----CeEEEecCCCCc
Q 020529 73 NPPVIYRDFKSSNILLEEG----FHPKLSDFGLAK 103 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~----~~~kL~Dfgla~ 103 (325)
...++|+|+.+.||+++++ +.+.|+||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 3459999999999999885 789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.20 E-value=0.017 Score=51.97 Aligned_cols=69 Identities=20% Similarity=0.176 Sum_probs=51.6
Q ss_pred CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCC
Q 020529 21 DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 100 (325)
Q Consensus 21 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfg 100 (325)
+.-|+|||+++|..|.+.-+- .+..+ +...++.-+--|-..| +||+|++--||++.+++.++++||-
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~v-------~d~~~---ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~dd~~i~vIDFP 247 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRHV-------EDPPT---LYDDLMGLIVRLANHG---LIHGDFNEFNIMVKDDDKIVVIDFP 247 (465)
T ss_pred cceeeHHHhhcccceeeeeec-------CChHH---HHHHHHHHHHHHHHcC---ceecccchheeEEecCCCEEEeech
Confidence 455899999988877654432 23333 4445555566777788 9999999999999999999999995
Q ss_pred CC
Q 020529 101 LA 102 (325)
Q Consensus 101 la 102 (325)
-.
T Consensus 248 Qm 249 (465)
T KOG2268|consen 248 QM 249 (465)
T ss_pred Hh
Confidence 43
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.054 Score=46.66 Aligned_cols=30 Identities=27% Similarity=0.252 Sum_probs=26.4
Q ss_pred CCeEeCCCCCCcEEEcC-CCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEE-GFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~-~~~~kL~Dfgla~ 103 (325)
..++|+|+.+.||+++. ++.+.|+||..+.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 34999999999999998 5789999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.73 E-value=0.054 Score=48.94 Aligned_cols=30 Identities=27% Similarity=0.269 Sum_probs=26.7
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
..+||+|+.+.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 459999999999999988877899999774
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.078 Score=47.00 Aligned_cols=49 Identities=22% Similarity=0.158 Sum_probs=36.4
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 55 ~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
.+.+..+-.++.-++..- .-++|+|+.|.|+++++.+.++|+||..|..
T Consensus 135 ~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 135 RKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 334455555555555540 1289999999999999999999999998864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.064 Score=45.64 Aligned_cols=30 Identities=30% Similarity=0.379 Sum_probs=21.1
Q ss_pred CCeEeCCCCCCcEEEc-CCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLE-EGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~-~~~~~kL~Dfgla~ 103 (325)
..++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred cEEEEeccccccceeeeccceeEEEecccce
Confidence 4599999999999999 66667899998774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.39 E-value=0.11 Score=47.13 Aligned_cols=30 Identities=30% Similarity=0.283 Sum_probs=25.8
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
..+||+|+.+.||+++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 359999999999999976656899999875
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.16 Score=43.63 Aligned_cols=93 Identities=23% Similarity=0.350 Sum_probs=56.2
Q ss_pred CCCccceeeEEEeCCeeEEEEecCCCCCHHH-----------HhccCCC--------------CCCCCCHHHHHH-----
Q 020529 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLED-----------HLHDLPP--------------DKEALDWNTRMK----- 56 (325)
Q Consensus 7 Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~-----------~l~~~~~--------------~~~~l~~~~~~~----- 56 (325)
--+|.+++.+..+.++.|+|+||++-+.+.. .||.... ...+-.|...+.
T Consensus 70 ti~VP~vi~~G~~~~~sylVle~L~~~~~d~~~~~~~GqqLA~LH~~~~~~~fG~d~dn~iG~t~QpN~W~~~Wa~Ffae 149 (286)
T COG3001 70 TITVPKVIAVGASRDHSYLVLEYLPTGPLDAHSAFILGQQLARLHQWGGQAQFGLDFDNYIGTTPQPNTWQRRWATFFAE 149 (286)
T ss_pred CccccceEEecCCCCeeEEEEeeccCCCCCchhHHHHHHHHHHHHhhcCccccCcccccccCCCCCCCCCcchHHHHHHH
Confidence 3467788888888999999999998765541 1222111 011122222111
Q ss_pred --HHHH----------------HHHHHHHHhcCC--CCCeEeCCCCCCcEEEcCCCeEEEecCC
Q 020529 57 --IAAG----------------AAKGLEYLHDKA--NPPVIYRDFKSSNILLEEGFHPKLSDFG 100 (325)
Q Consensus 57 --i~~~----------------l~~al~~LH~~~--~~~ivHrdik~~Nill~~~~~~kL~Dfg 100 (325)
|..| ++..|..|=..- .|+++|+||-..|+++..+| +.+.|-.
T Consensus 150 qRig~qlqlar~rg~~f~did~~~~~v~elL~~hqpqPsLlHGDLW~gN~a~~~~G-Pv~fDPA 212 (286)
T COG3001 150 QRIGWQLQLARERGLTFGDIDAIVEKIQELLADHQPQPSLLHGDLWSGNCAFGKDG-PVIFDPA 212 (286)
T ss_pred hhhhHHHHHHHHhCCCccCHHHHHHHHHHHHhcCCCCcceeecccccccccccCCC-Ceeeccc
Confidence 1111 333333333222 37899999999999999999 8887753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.32 E-value=0.11 Score=46.79 Aligned_cols=29 Identities=24% Similarity=0.330 Sum_probs=25.1
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
..+||+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 34999999999999987 568999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.18 E-value=0.045 Score=45.55 Aligned_cols=28 Identities=18% Similarity=0.211 Sum_probs=25.1
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
..+|+|+.|.||++.+++ ++|+||+.+.
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~ 105 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAG 105 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCccc
Confidence 479999999999998877 8899999885
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.10 E-value=0.083 Score=47.29 Aligned_cols=30 Identities=27% Similarity=0.263 Sum_probs=26.5
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
..+||+|+.|.||+++++..+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 349999999999999998778899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.91 E-value=0.038 Score=46.91 Aligned_cols=29 Identities=31% Similarity=0.362 Sum_probs=20.9
Q ss_pred CeEeCCCCCCcEEE-cCCCeEEEecCCCCc
Q 020529 75 PVIYRDFKSSNILL-EEGFHPKLSDFGLAK 103 (325)
Q Consensus 75 ~ivHrdik~~Nill-~~~~~~kL~Dfgla~ 103 (325)
.++|+|+.+.||++ +.++.++|+||..+.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 38999999999999 888999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.24 E-value=0.2 Score=45.70 Aligned_cols=46 Identities=22% Similarity=0.310 Sum_probs=32.8
Q ss_pred HHHHHHHHHHHhcCC----CCC---eEeCCCCCCcEEEcCCCe-EEEecCCCCc
Q 020529 58 AAGAAKGLEYLHDKA----NPP---VIYRDFKSSNILLEEGFH-PKLSDFGLAK 103 (325)
Q Consensus 58 ~~~l~~al~~LH~~~----~~~---ivHrdik~~Nill~~~~~-~kL~Dfgla~ 103 (325)
...+...+..+.+.- ... +||+|+.|.||+++.+.. +.++||+-+.
T Consensus 174 ~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 174 RAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred HHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 344455555555432 122 899999999999998874 8899999774
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.15 E-value=0.092 Score=44.87 Aligned_cols=40 Identities=23% Similarity=0.120 Sum_probs=33.7
Q ss_pred HHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCC
Q 020529 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA 102 (325)
Q Consensus 62 ~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla 102 (325)
+.+|.-.|+.. ...+|+|..|+||+.|+.|.+||.|-+..
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhh
Confidence 46788888654 34899999999999999999999998754
|
The function of this family is unknown. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.05 E-value=0.098 Score=46.58 Aligned_cols=31 Identities=26% Similarity=0.408 Sum_probs=26.0
Q ss_pred CCeEeCCCCCCcEEEcCCCe-EEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEGFH-PKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~-~kL~Dfgla~~ 104 (325)
+.++|+|+++.||+++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45999999999999997554 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=92.89 E-value=0.18 Score=46.37 Aligned_cols=30 Identities=20% Similarity=0.270 Sum_probs=26.1
Q ss_pred CCeEeCCCCCCcEEEcC-CCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEE-GFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~-~~~~kL~Dfgla~ 103 (325)
..++|+|+++.||++++ ++.+.|+||..+.
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 35999999999999986 4689999999875
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.67 E-value=0.14 Score=46.28 Aligned_cols=53 Identities=19% Similarity=0.127 Sum_probs=33.5
Q ss_pred HHHHHHHHHHHHHHHHHhcCC-CCCeEeCCCCCCcEEEcCCC------------------eEEEecCCCCcc
Q 020529 52 NTRMKIAAGAAKGLEYLHDKA-NPPVIYRDFKSSNILLEEGF------------------HPKLSDFGLAKL 104 (325)
Q Consensus 52 ~~~~~i~~~l~~al~~LH~~~-~~~ivHrdik~~Nill~~~~------------------~~kL~Dfgla~~ 104 (325)
+-+..++.|++.-.-...+.. -..++|.||||+|||+-... ..+|.||.+++.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 345567777766553443321 22399999999999994332 246777777764
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.66 E-value=0.12 Score=43.44 Aligned_cols=30 Identities=23% Similarity=0.254 Sum_probs=25.3
Q ss_pred CeEeCCCCCCcEEEcCCC-----eEEEecCCCCcc
Q 020529 75 PVIYRDFKSSNILLEEGF-----HPKLSDFGLAKL 104 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~-----~~kL~Dfgla~~ 104 (325)
.++|||+.+.||++..++ .+.|+||..++.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 499999999999997543 589999998863
|
subfamily of choline kinases |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.34 E-value=0.26 Score=44.58 Aligned_cols=31 Identities=16% Similarity=0.182 Sum_probs=27.8
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
..+||+|+.+.||+++.++.+.++||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3499999999999999998999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=91.53 E-value=0.36 Score=45.29 Aligned_cols=30 Identities=20% Similarity=0.295 Sum_probs=25.5
Q ss_pred CCCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
...++|||+.+.||++..+ .++++||.++.
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 3459999999999999876 59999998764
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=90.74 E-value=0.16 Score=46.14 Aligned_cols=53 Identities=19% Similarity=0.146 Sum_probs=32.2
Q ss_pred HHHHHHHHHHHHHHHHhcC-CCCCeEeCCCCCCcEEEcCC------------------CeEEEecCCCCccC
Q 020529 53 TRMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEG------------------FHPKLSDFGLAKLG 105 (325)
Q Consensus 53 ~~~~i~~~l~~al~~LH~~-~~~~ivHrdik~~Nill~~~------------------~~~kL~Dfgla~~~ 105 (325)
-+..++.|+|.-.--..+. +-..++|.||||+|||+-+. -.++|.||++++..
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3445666665432112222 11239999999999999432 23578899888753
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=90.47 E-value=0.24 Score=45.28 Aligned_cols=29 Identities=24% Similarity=0.261 Sum_probs=25.4
Q ss_pred CeEeCCCCCCcEEEcC-CCeEEEecCCCCc
Q 020529 75 PVIYRDFKSSNILLEE-GFHPKLSDFGLAK 103 (325)
Q Consensus 75 ~ivHrdik~~Nill~~-~~~~kL~Dfgla~ 103 (325)
-++|+|+.+.||++++ ++.++|+||..+-
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 3899999999999975 4689999999874
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.68 E-value=0.73 Score=42.04 Aligned_cols=28 Identities=25% Similarity=0.306 Sum_probs=23.6
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
..+||+|+.+.||+++ + .+.|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3489999999999995 4 57899999775
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.61 E-value=0.74 Score=48.65 Aligned_cols=30 Identities=37% Similarity=0.361 Sum_probs=25.5
Q ss_pred CeEeCCCCCCcEEEcCCC--eEE-EecCCCCcc
Q 020529 75 PVIYRDFKSSNILLEEGF--HPK-LSDFGLAKL 104 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~--~~k-L~Dfgla~~ 104 (325)
.+||+|+.+.||+++.+. .+. |+|||-+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 499999999999999875 555 999998754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=87.71 E-value=1 Score=41.57 Aligned_cols=29 Identities=24% Similarity=0.261 Sum_probs=24.5
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
..++|||+.+.||+++++. ++++|+.++.
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 3499999999999997764 7899998764
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=87.57 E-value=0.87 Score=42.60 Aligned_cols=29 Identities=17% Similarity=0.303 Sum_probs=25.0
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
..++||||.|.|||++++ .+|++|..++.
T Consensus 227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAf 255 (409)
T PRK12396 227 QALIHGDLHTGSVFVKND-STKVIDPEFAF 255 (409)
T ss_pred hhhccCcCCCCCEEecCC-ceEEEcccccc
Confidence 349999999999999986 49999988774
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=86.64 E-value=1.1 Score=42.08 Aligned_cols=38 Identities=11% Similarity=0.197 Sum_probs=28.2
Q ss_pred HHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 65 l~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
|++.--...+.++|||+.+.||+++.++ ++++|..++.
T Consensus 221 Lk~~f~~~~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 221 LKSMFCERAQALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred HHHHHHhcccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 3333333346699999999999999876 8888876653
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=86.55 E-value=0.48 Score=42.33 Aligned_cols=31 Identities=32% Similarity=0.340 Sum_probs=25.5
Q ss_pred CCeEeCCCCCCcEEEcCC--C---eEEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEG--F---HPKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~--~---~~kL~Dfgla~~ 104 (325)
..++|||++..|||+..+ + .+++.||.+++.
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 459999999999999654 3 589999988763
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 325 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-42 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-41 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 9e-17 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-14 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-14 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-14 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-14 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-14 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-14 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 9e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 8e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-11 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-11 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 9e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-10 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-10 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-10 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-10 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 9e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-10 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 9e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-09 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-09 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-09 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 4e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 6e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-09 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 8e-09 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-09 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 8e-09 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-09 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-09 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-09 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-09 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-09 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-08 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-08 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-08 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-08 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-08 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-08 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-08 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-08 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-08 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-08 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-08 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 5e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-08 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 7e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-07 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-07 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-07 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-07 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-07 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 5e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-07 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 6e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-07 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 7e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 7e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 9e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 9e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 9e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-06 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-06 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-06 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-06 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-06 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 4e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-06 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 6e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 7e-06 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 8e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 9e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-05 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-05 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-05 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-05 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-05 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 5e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 5e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-05 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-05 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-05 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 8e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 8e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 8e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-05 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 9e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 9e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-04 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-04 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-04 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-04 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 8e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 433 bits (1117), Expect = e-154
Identities = 88/231 (38%), Positives = 129/231 (55%), Gaps = 8/231 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+++ H NLV L+G+ +DGD LVY +MP GSL D L L W+ R KIA G
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPLSWHMRCKIAQG 141
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AA G+ +LH+ I+RD KS+NILL+E F K+SDFGLA+ ++ +++R++GT
Sbjct: 142 AANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
Y APE + G++T KSD+YSFGVV LE+ITG A+D R Q L+ + ++ +
Sbjct: 199 TAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLLDIKEEIEDEEK 255
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231
D ++ + +VAS C+ E+ RP I V L +
Sbjct: 256 TIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 425 bits (1095), Expect = e-151
Identities = 92/229 (40%), Positives = 135/229 (58%), Gaps = 4/229 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
LS H +LV+LIG+C + ++ +L+Y++M G+L+ HL+ ++ W R++I G
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AA+GL YLH +I+RD KS NILL+E F PK++DFG++K G D++H+ST V GT
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGT 204
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
GY PEY + G+LT KSDVYSFGVV E++ R AI + P NL WA +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNG 263
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229
+ ++ DP L + L + A C+ + RP +GDV+ L Y
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 411 bits (1058), Expect = e-145
Identities = 96/229 (41%), Positives = 138/229 (60%), Gaps = 4/229 (1%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
M+S+ H NL+ L G+C +RLLVY +M GS+ L + P + LDW R +IA G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+A+GL YLHD +P +I+RD K++NILL+E F + DFGLAKL D +HV+T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGT 198
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ--NLVTWARPLFND 178
G+ APEY TG+ + K+DV+ +GV+ LELITG++A D R + L+ W + L +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 179 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227
++ L D L+G Y + Q + VA +C Q RP + +VV L
Sbjct: 259 KK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 6e-74
Identities = 64/255 (25%), Positives = 91/255 (35%), Gaps = 26/255 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
L + H N++ IG G L+ F GSL D L + WN
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCH 125
Query: 57 IAAGAAKGLEYLH-------DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 109
IA A+GL YLH D P + +RD KS N+LL+ ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 110 KSHVSTRVMGTYGYCAPEYAMTG-----QLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164
+ + +GT Y APE ++ D+Y+ G+V EL + A D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 165 EQNL--VTWARPLFNDRRKF--SKLADPRLEGRYPIRGLYQALA-VASMCIQEQAATRPL 219
P D ++ K P L + L C A R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 220 IGDVVTALSYLANQT 234
G V ++ + T
Sbjct: 306 AGCVGERITQMQRLT 320
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-51
Identities = 55/266 (20%), Positives = 95/266 (35%), Gaps = 37/266 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM 55
+ L+ H N+ I + LLV E+ P GSL +L DW +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSSC 114
Query: 56 KIAAGAAKGLEYLH------DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK------ 103
++A +GL YLH D P + +RD S N+L++ +SDFGL+
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 104 LGPVGDKSHVSTRVMGTYGYCAPEYAM-------TGQLTVKSDVYSFGVVFLELITGRKA 156
L G++ + + +GT Y APE + D+Y+ G+++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 157 IDSTRPHGEQNL----VTWARPLFNDRRKF--SKLADPRLEGRYPIRGLYQALAVASM-- 208
+ E + P F D + + P+ + L ++
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 209 CIQEQAATRPLIGDVVTALSYLANQT 234
C + A R ++ L
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIW 320
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-50
Identities = 56/154 (36%), Positives = 84/154 (54%), Gaps = 4/154 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H N+V +G +V E++ GSL LH +E LD R+ +A
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYD 145
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AKG+ YLH++ NPP+++R+ KS N+L+++ + K+ DFGL++L S S GT
Sbjct: 146 VAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGT 202
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ APE KSDVYSFGV+ EL T +
Sbjct: 203 PEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 7e-48
Identities = 51/156 (32%), Positives = 72/156 (46%), Gaps = 9/156 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
LS ++H N+V L G C + LV E+ GSL + LH P M
Sbjct: 54 QLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
++G+ YLH +I+RD K N+LL G K+ DFG A D T G
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKG 165
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155
+ + APE + K DV+S+G++ E+IT RK
Sbjct: 166 SAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 1e-47
Identities = 47/163 (28%), Positives = 85/163 (52%), Gaps = 20/163 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++S L+H N+V L G + +V EF+P G L L D + W+ ++++
Sbjct: 76 IMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLD 130
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEG-----FHPKLSDFGLAKLGPVGDKSHVST 115
A G+EY+ ++ NPP+++RD +S NI L+ K++DFGL++ H +
Sbjct: 131 IALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVS 184
Query: 116 RVMGTYGYCAPEYAMTGQL---TVKSDVYSFGVVFLELITGRK 155
++G + + APE + + T K+D YSF ++ ++TG
Sbjct: 185 GLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 7e-47
Identities = 37/160 (23%), Positives = 69/160 (43%), Gaps = 17/160 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
L + H N++ ++G C + +MP GSL + LH+ +D + +K A
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFA 117
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
A+G+ +LH P + S +++++E ++S + S S M
Sbjct: 118 LDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRM 169
Query: 119 GTYGYCAPEYAMTGQ----LTVKSDVYSFGVVFLELITGR 154
+ APE A+ + +D++SF V+ EL+T
Sbjct: 170 YAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-46
Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ ++L H N++ L G C LV EF G L L + + + + A
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQ 113
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP--------KLSDFGLAKLGPVGDKSH 112
A+G+ YLHD+A P+I+RD KSSNIL+ + K++DFGLA+ ++
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTT 170
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ G Y + APE + SDV+S+GV+ EL+TG
Sbjct: 171 KMSAA-GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 6e-45
Identities = 52/157 (33%), Positives = 80/157 (50%), Gaps = 10/157 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L H N++ +GY Q +V ++ SL HLH + + + IA
Sbjct: 73 VLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQ 128
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A+G++YLH K +I+RD KS+NI L E K+ DFGLA SH ++ G+
Sbjct: 129 TARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 121 YGYCAPE---YAMTGQLTVKSDVYSFGVVFLELITGR 154
+ APE + + +SDVY+FG+V EL+TG+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-44
Identities = 56/258 (21%), Positives = 99/258 (38%), Gaps = 32/258 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
L+ H N++ I G Q L+ ++ GSL D+L LD + +K
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLK 138
Query: 57 IAAGAAKGLEYLH-----DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 111
+A + GL +LH + P + +RD KS NIL+++ ++D GLA
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNE 198
Query: 112 H--VSTRVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR-- 161
+GT Y PE Q + +D+YSFG++ E+ +
Sbjct: 199 VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258
Query: 162 --PHGEQNLVTWARPLFNDRRKF--SKLADPRLEGRYPIRGLYQALA-VASMCIQEQAAT 216
P+ + + + P + D R+ K P R+ + + + + C A+
Sbjct: 259 QLPYHD---LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315
Query: 217 RPLIGDVVTALSYLANQT 234
R V L+ ++
Sbjct: 316 RLTALRVKKTLAKMSESQ 333
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-44
Identities = 38/166 (22%), Positives = 62/166 (37%), Gaps = 19/166 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
H N+V +G C ++ +L + D K LD N +IA
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQE 138
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL---GPVGDKSHVSTRV 117
KG+ YLH ++++D KS N+ + G ++DFGL + G +
Sbjct: 139 IVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 118 MGTYGYCAPEYAMTGQL---------TVKSDVYSFGVVFLELITGR 154
G + APE + SDV++ G ++ EL
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-43
Identities = 42/180 (23%), Positives = 72/180 (40%), Gaps = 22/180 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
+L H N++ I Q L+ + +GSL D+L LD + ++
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLR 109
Query: 57 IAAGAAKGLEYLH-----DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 111
I A GL +LH + P + +RD KS NIL+++ ++D GLA +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 112 HV--STRVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 163
+ +GT Y APE + D+++FG+V E+ + +
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 4e-42
Identities = 43/181 (23%), Positives = 75/181 (41%), Gaps = 24/181 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
+L H N++ I + Q LV ++ GSL D+L+ + + +K
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 143
Query: 57 IAAGAAKGLEYLH-----DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG--D 109
+A A GL +LH + P + +RD KS NIL+++ ++D GLA
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 110 KSHVSTRVMGTYGYCAPEYAMTGQLTV-------KSDVYSFGVVFLELITGRKAIDSTRP 162
+GT Y APE + + + ++D+Y+ G+VF E+
Sbjct: 204 IDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
Query: 163 H 163
+
Sbjct: 263 Y 263
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-42
Identities = 44/168 (26%), Positives = 69/168 (41%), Gaps = 18/168 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H N++ IG + + E++ G+L + W+ R+ A
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKD 116
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL------------GPVG 108
A G+ YLH +I+RD S N L+ E + ++DFGLA+L
Sbjct: 117 IASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 109 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156
V+G + APE K DV+SFG+V E+I A
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-29
Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
H N+V LIG C +V E + G L + L T +++ AA G
Sbjct: 169 YSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAG 225
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
+EYL K I+RD + N L+ E K+SDFG+++ G + +
Sbjct: 226 MEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT 282
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELIT 152
APE G+ + +SDV+SFG++ E +
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFS 310
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 57/156 (36%), Positives = 80/156 (51%), Gaps = 11/156 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L H N+V G C +R L+ E++P GSL D+L KE +D ++
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYT 151
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
+ KG+EYL K I+RD + NIL+E K+ DFGL K+ P DK + +
Sbjct: 152 SQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEP 207
Query: 119 GTY--GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
G + APE + +V SDV+SFGVV EL T
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 57/156 (36%), Positives = 79/156 (50%), Gaps = 11/156 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L H N+V G C +R L+ E++P GSL D+L KE +D ++
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYT 120
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
+ KG+EYL K I+RD + NIL+E K+ DFGL K+ P DK +
Sbjct: 121 SQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEP 176
Query: 119 GTY--GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
G + APE + +V SDV+SFGVV EL T
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 6/148 (4%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
+ H NLV L+G C ++ EFM G+L D+L + +++ + + +A +
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 330
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
+EYL K I+R+ + N L+ E K++DFGL++L GD +
Sbjct: 331 MEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWT 386
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELIT 152
APE + ++KSDV++FGV+ E+ T
Sbjct: 387 APESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 49/156 (31%), Positives = 80/156 (51%), Gaps = 11/156 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L+H N+V G C + L+ EF+P GSL+++L +K ++ ++K A
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYA 132
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
KG++YL + ++RD + N+L+E K+ DFGL K DK + + +
Sbjct: 133 VQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDD 188
Query: 119 GTY--GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE M + + SDV+SFGV EL+T
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
+ + ++ L+G C L+ + MP G L D++ + K+ + + AKG
Sbjct: 74 VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKG 129
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
+ YL D+ +++RD + N+L++ H K++DFGLAKL +K + + +
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
A E + T +SDV+S+GV EL+T G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-27
Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L LH +V G ++ LV E++P G L D L + LD + + +
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYS 133
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
+ KG+EYL + ++RD + NIL+E H K++DFGLAKL P+ +V
Sbjct: 134 SQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR--- 187
Query: 119 GTYG-----YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
G + APE + +SDV+SFGVV EL T
Sbjct: 188 -EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 50/159 (31%), Positives = 77/159 (48%), Gaps = 19/159 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L+H +++ G C D LV E++PLGSL D+L + ++ + A
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFA 140
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
+G+ YLH + I+RD + N+LL+ K+ DFGLAK P G + + +
Sbjct: 141 QQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----V 193
Query: 119 GTYG-----YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
G + APE + SDV+SFGV EL+T
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 8/152 (5%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H+++V L+G C G LV +++PLGSL DH+ + AL + AKG
Sbjct: 72 LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKG 127
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
+ YL + +++R+ + N+LL+ +++DFG+A L P DK + + +
Sbjct: 128 MYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
A E G+ T +SDV+S+GV EL+T G +
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-26
Identities = 46/160 (28%), Positives = 71/160 (44%), Gaps = 17/160 (10%)
Query: 1 MLSLLHHSNLVNLIGYCAD---GDQRLLVY-EFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
ML L H N+V G + +++ E M G+L+ +L +
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRS 133
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHVS 114
KGL++LH + PP+I+RD K NI + G K+ D GLA L ++ +
Sbjct: 134 WCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATLK----RASFA 187
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
V+GT + APE + DVY+FG+ LE+ T
Sbjct: 188 KAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-26
Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L + +V E+M GSL D L + L + +AA
Sbjct: 232 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQ 288
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A G+ Y+ ++RD +++NIL+ E K++DFGLA+L ++
Sbjct: 289 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFP 344
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE A+ G+ T+KSDV+SFG++ EL T
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 49/155 (31%), Positives = 68/155 (43%), Gaps = 13/155 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H NL+ L G +V E PLGSL D L + T + A A+G
Sbjct: 78 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEG 133
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 121
+ YL K I+RD + N+LL K+ DFGL + P D +V +
Sbjct: 134 MGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPF 188
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
+CAPE T + SD + FGV E+ T G++
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-25
Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
+ + ++ L+G C L+ + MP G L D++ + K+ + + AKG
Sbjct: 74 VDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKG 129
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
+ YL D+ +++RD + N+L++ H K++DFGLAKL +K + + +
Sbjct: 130 MNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
A E + T +SDV+S+GV EL+T G K
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 19/157 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+++ L HSNLV L+G + L +V E+M GSL D+L + L + +K +
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSL 296
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV-- 117
+ +EYL ++RD + N+L+ E K+SDFGL K + + ++
Sbjct: 297 DVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPV 350
Query: 118 --MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
APE + + KSDV+SFG++ E+ +
Sbjct: 351 KWT------APEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L + +V E+M GSL D L + L + +AA
Sbjct: 315 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQ 371
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A G+ Y+ ++RD +++NIL+ E K++DFGLA+L ++
Sbjct: 372 IASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFP 427
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE A+ G+ T+KSDV+SFG++ EL T
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 12/155 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
H N++ L G G ++V E+M GSL+ L + + G G
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAG 163
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 121
+ YL D ++RD + N+L++ K+SDFGL+++ + D + G
Sbjct: 164 MRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRV--LEDDPDAAYTTTGGKIPI 218
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
+ APE + SDV+SFGVV E++ G +
Sbjct: 219 RWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 41/155 (26%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
H N++ L G + +++ E+M G+L+ L + + + G A G
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAG 159
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 121
++YL + ++RD + NIL+ K+SDFGL+++ + D + G
Sbjct: 160 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPI 214
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
+ APE + T SDV+SFG+V E++T G +
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 49/155 (31%), Positives = 73/155 (47%), Gaps = 14/155 (9%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H LV L G C + LV EFM G L D+L + T + + +G
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEG 116
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 121
+ YL + VI+RD + N L+ E K+SDFG+ + V D + T GT
Sbjct: 117 MAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQY--TSSTGTKFPV 169
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
+ +PE + + KSDV+SFGV+ E+ + G+
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-25
Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 30/160 (18%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
+ H NLV L+G C ++ EFM G+L D+L + +++ + + +A +
Sbjct: 66 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 123
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY- 123
+EYL K I+RD + N L+ E K++DFGL+ R+M Y
Sbjct: 124 MEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLS-------------RLMTGDTYT 167
Query: 124 -----------CAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
APE + ++KSDV++FGV+ E+ T
Sbjct: 168 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-24
Identities = 39/155 (25%), Positives = 73/155 (47%), Gaps = 14/155 (9%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H LV G C+ +V E++ G L ++L + L+ + +++ +G
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEG 116
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 121
+ +L I+RD + N L++ K+SDFG+ + V D + +GT
Sbjct: 117 MAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQY--VSSVGTKFPV 169
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
+ APE + + KSDV++FG++ E+ + G+
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 41/164 (25%), Positives = 71/164 (43%), Gaps = 21/164 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------HDLPPDKEALDWNTR 54
++ + ++V L+G + G L++ E M G L+ +L P +
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSH 112
+++A A G+ YL+ ++RD + N ++ E F K+ DFG+ + D +
Sbjct: 141 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 197
Query: 113 VSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ M +PE G T SDV+SFGVV E+ T
Sbjct: 198 GKGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H N+V++I + D LV E++ +L +++ L +T + G
Sbjct: 68 LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDG 123
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST-RVMGTYGY 123
+++ HD +++RD K NIL++ K+ DFG+AK + + S T V+GT Y
Sbjct: 124 IKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQY 178
Query: 124 CAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+PE A +D+YS G+V E++ G
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 11/154 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L + +V LIG C + +LV E G L L +E + + ++ + G
Sbjct: 67 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMG 122
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY--G 122
++YL +K ++RD + N+LL + K+SDFGL+K D S+ + R G +
Sbjct: 123 MKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLK 178
Query: 123 YCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
+ APE + + +SDV+S+GV E ++ G+K
Sbjct: 179 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-24
Identities = 42/182 (23%), Positives = 70/182 (38%), Gaps = 23/182 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
M L +H N++ L+ YC L+ F G+L + + L L + +
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
+ G +GLE +H +RD K +NILL + P L D G + +
Sbjct: 139 LLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQAL 195
Query: 117 VM-------GTYGYCAPE------YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH 163
+ T Y APE + + + ++DV+S G V ++ G D
Sbjct: 196 TLQDWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 164 GE 165
G+
Sbjct: 253 GD 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 12/155 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
H N++ L G ++V E+M GSL+ L + + G A G
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASG 159
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 121
++YL D ++RD + NIL+ K+SDFGL ++ + D + G
Sbjct: 160 MKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRV--LEDDPEAAYTTRGGKIPI 214
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
+ +PE + T SDV+S+G+V E+++ G +
Sbjct: 215 RWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 5e-24
Identities = 47/161 (29%), Positives = 78/161 (48%), Gaps = 20/161 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+++ L HSNLV L+G + L +V E+M GSL D+L + L + +K +
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSL 124
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV-- 117
+ +EYL ++RD + N+L+ E K+SDFGL K + + ++
Sbjct: 125 DVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPV 178
Query: 118 --MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
APE + + KSDV+SFG++ E+ + GR
Sbjct: 179 KWT------APEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 45/155 (29%), Positives = 77/155 (49%), Gaps = 13/155 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L + ++ EFM GSL D L + + +A
Sbjct: 236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQ 292
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A+G+ ++ + I+RD +++NIL+ K++DFGLA++ + D + T G
Sbjct: 293 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV--IEDNEY--TAREGA 345
Query: 121 ---YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE G T+KSDV+SFG++ +E++T
Sbjct: 346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 6e-24
Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L + +V +IG C + + +LV E LG L +L + +++ + G
Sbjct: 75 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMG 129
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY--G 122
++YL + ++RD + N+LL + K+SDFGL+K D+++ + G +
Sbjct: 130 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVK 185
Query: 123 YCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
+ APE + + KSDV+SFGV+ E + G+K
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-24
Identities = 38/151 (25%), Positives = 69/151 (45%), Gaps = 13/151 (8%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H LV L G C ++ E+M G L ++L + + +++ +
Sbjct: 76 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEA 132
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT---Y 121
+EYL K ++RD + N L+ + K+SDFGL++ T +G+
Sbjct: 133 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPV 185
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ PE M + + KSD+++FGV+ E+ +
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEA 48
M + H N++NL+G C ++ E+ G+L ++L +E
Sbjct: 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
+ + + A+G+EYL + I+RD + N+L+ E K++DFGLA+
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 109 D--KSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
D K + R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 211 DYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 49/155 (31%), Positives = 81/155 (52%), Gaps = 13/155 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L + ++ E+M GSL D L P L N + +AA
Sbjct: 61 LMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A+G+ ++ ++ I+RD +++NIL+ + K++DFGLA+L + D + T G
Sbjct: 118 IAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEY--TAREGA 170
Query: 121 ---YGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE G T+KSDV+SFG++ E++T
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 39/158 (24%), Positives = 68/158 (43%), Gaps = 21/158 (13%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L H ++V LIG + + ++ E P G L +L +K +L T + + K
Sbjct: 70 LDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKA 125
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG-- 122
+ YL ++RD NIL+ KL DFGL++ + D+ +
Sbjct: 126 MAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKAS-----VTR 175
Query: 123 ----YCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
+ +PE + T SDV+ F V E+++ G++
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-23
Identities = 31/161 (19%), Positives = 66/161 (40%), Gaps = 14/161 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA- 59
+++ + + + G + D+ ++YE+M S+ + +++
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 60 ---GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
Y+H++ N + +RD K SNIL+++ KLSDFG ++ +
Sbjct: 156 IIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV---DKKIKG- 209
Query: 117 VMGTYGYCAPEYAMTGQLTV---KSDVYSFGVVFLELITGR 154
GTY + PE + + + K D++S G+ +
Sbjct: 210 SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-23
Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
++ L+H N++ LIG + ++ +M G L + + +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGL 131
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
A+G+EYL ++ ++RD + N +L+E F K++DFGLA+ + D+ + S +
Sbjct: 132 QVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHR 186
Query: 120 --------TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
T A E T + T KSDV+SFGV+ EL+T
Sbjct: 187 HARLPVKWT----ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 2e-23
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 11/154 (7%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
L + +V LIG C + +LV E G L L +E + + ++ + G
Sbjct: 393 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMG 448
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY- 123
++YL +K ++R+ + N+LL + K+SDFGL+K D S+ + R G +
Sbjct: 449 MKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLK 504
Query: 124 -CAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
APE + + +SDV+S+GV E ++ G+K
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEA 48
+L+ L H ++V G C DGD ++V+E+M G L L K
Sbjct: 70 LLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
L + + IA+ A G+ YL + ++RD + N L+ K+ DFG+++
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186
Query: 109 D--KSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
D + T + M PE M + T +SDV+SFGV+ E+ T
Sbjct: 187 DYYRVGGHTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 46/174 (26%), Positives = 71/174 (40%), Gaps = 37/174 (21%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR------ 54
M L H N+VNL+G C G L++ E+ G L + L E
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 55 ----MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK 110
+ ++ A+G+ +L K I+RD + N+LL G K+ DFGLA+
Sbjct: 163 TRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARD------ 213
Query: 111 SHVSTRVMGTYGYC------------APEYAMTGQLTVKSDVYSFGVVFLELIT 152
+M Y APE TV+SDV+S+G++ E+ +
Sbjct: 214 ------IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-23
Identities = 41/165 (24%), Positives = 72/165 (43%), Gaps = 22/165 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR-----LLVYEFMPLGSLEDHL--HDLPPDKEALDWNT 53
+ H N++ L+G C + + +++ FM G L +L L + + T
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 54 RMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KS 111
+K A G+EYL ++ ++RD + N +L + ++DFGL+K GD +
Sbjct: 149 LLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205
Query: 112 HVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
++ + A E T KSDV++FGV E+ T
Sbjct: 206 GRIAKMPVKWI------AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 5e-23
Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 23/166 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHL--HDLPPDKEALDWN 52
+ H ++ L+G + +++ FM G L L + + L
Sbjct: 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 53 TRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--K 110
T ++ A G+EYL + I+RD + N +L E ++DFGL++ GD +
Sbjct: 138 TLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 111 SHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
++++ + A E TV SDV++FGV E++T
Sbjct: 195 QGCASKLPVKWL------ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-23
Identities = 49/168 (29%), Positives = 74/168 (44%), Gaps = 26/168 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEA 48
+ L HH N++NL+G C L E+ P G+L D L
Sbjct: 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
L + AA A+G++YL K I+RD + NIL+ E + K++DFGL++ V
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY 195
Query: 109 DKSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
K R+ M A E T SDV+S+GV+ E+++
Sbjct: 196 VKKT-MGRLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 7e-23
Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEA 48
M + H N++NL+G C ++ E+ G+L ++L +E
Sbjct: 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
+ + + A+G+EYL + I+RD + N+L+ E K++DFGLA+
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 109 D--KSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
D K + R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 257 DYYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-23
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
M+S L H +LV G C GD+ +LV EF+ GSL+ +L +K ++ ++++A
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQ 121
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP--------KLSDFGLAKLGPVGDKSH 112
A + +L + +I+ + + NILL KLSD G++ V K
Sbjct: 122 LAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDI 176
Query: 113 VSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELIT-GRK 155
+ R+ PE + + +D +SFG E+ + G K
Sbjct: 177 LQERIPWV----PPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 8e-23
Identities = 36/154 (23%), Positives = 54/154 (35%), Gaps = 16/154 (10%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD---LPPDKEALDWNTRMKIAAGA 61
L ++V + + Q + + L L L P A+ I
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPP-RAVA------IVRQI 143
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST-RVMGT 120
L+ H +RD K NIL+ L DFG+A D+ +GT
Sbjct: 144 GSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGT 198
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
Y APE T ++D+Y+ V E +TG
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGS 232
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-23
Identities = 43/170 (25%), Positives = 77/170 (45%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL------------HDLPPDKEA 48
+ + L H N+V L+G +++ + G L + L D K A
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA 124
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
L+ + + A A G+EYL V+++D + N+L+ + + K+SD GL +
Sbjct: 125 LEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 109 D--KSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
D K ++ + M APE M G+ ++ SD++S+GVV E+ +
Sbjct: 182 DYYKLLGNSLLPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-22
Identities = 47/169 (27%), Positives = 77/169 (45%), Gaps = 26/169 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR------ 54
+L++L H ++V G C +G L+V+E+M G L L PD + L
Sbjct: 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 55 -----MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD 109
+ +A+ A G+ YL ++RD + N L+ +G K+ DFG+++ D
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
Query: 110 --KSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ T + M PE + + T +SDV+SFGVV E+ T
Sbjct: 213 YYRVGGRTMLPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 1e-22
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
++ H N+++L+G C + L+V +M G L + + + + +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGL 135
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
AKG++YL K ++RD + N +L+E F K++DFGLA+ + V
Sbjct: 136 QVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHN 188
Query: 120 TYGYC------APEYAMTGQLTVKSDVYSFGVVFLELIT 152
G A E T + T KSDV+SFGV+ EL+T
Sbjct: 189 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 19/163 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---ALDWNTRMKI 57
++S +H N+V IG R ++ E M G L+ L + P +L + +
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 145
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKLGPVGDKSHVS 114
A A G +YL + I+RD + N LL G K+ DFG+A+ D S
Sbjct: 146 ARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAS 197
Query: 115 TRVMGTYGY-----CAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
G PE M G T K+D +SFGV+ E+ +
Sbjct: 198 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 95.8 bits (238), Expect = 1e-22
Identities = 24/201 (11%), Positives = 62/201 (30%), Gaps = 30/201 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGD--QRLLVYEFM--PLGSLEDHLHDLPPDKEALDWNTRMK 56
++ ++ + D R +Y M L + + L ++L + R++
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
+ + L LH +++ + +I+L++ L+ F +
Sbjct: 211 LTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV------RDGARVV 261
Query: 117 VMGTYGYCAPEYAMT-----------GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE 165
+ G+ PE +T D ++ G+V + P +
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD------LPITK 315
Query: 166 QNLVTWARPLFNDRRKFSKLA 186
+ + +F + +
Sbjct: 316 DAALGGSEWIFRSCKNIPQPV 336
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 18/153 (11%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
H ++V LIG + ++ E LG L L K +LD + + A +
Sbjct: 448 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTA 503
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG-- 122
L YL K ++RD + N+L+ KL DFGL++ + D ++ G
Sbjct: 504 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASK----GKL 554
Query: 123 ---YCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ APE + T SDV+ FGV E++
Sbjct: 555 PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
++ H N+++L+G C + L+V +M G L + + + + +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN---PTVKDLIGFGL 199
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
AKG+++L K ++RD + N +L+E F K++DFGLA+ + V +
Sbjct: 200 QVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 120 ------TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
A E T + T KSDV+SFGV+ EL+T
Sbjct: 257 KLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 44/171 (25%), Positives = 69/171 (40%), Gaps = 17/171 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ L +V L G +G + E + GSL + + E +
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR----ALYYLGQ 158
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAK-LGPVGDKSHVSTR-- 116
A +GLEYLH + +++ D K+ N+LL +G L DFG A L P G + T
Sbjct: 159 ALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 167
+ GT + APE M K D++S + L ++ G P +
Sbjct: 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC------HPWTQYF 260
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 27/170 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR------ 54
M + H N++NL+G C ++ E+ G+L ++L P +N
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 55 ------MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
+ A A+G+EYL K I+RD + N+L+ E K++DFGLA+
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 244
Query: 109 D--KSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
D K + R+ M APE T +SDV+SFGV+ E+ T
Sbjct: 245 DYYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-22
Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 29/172 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--------------HDLPPDK 46
+ L +H N+VNL+G C G L++ E+ G L + L + D+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 47 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 106
ALD + + AKG+ +L K I+RD + NILL G K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 107 VGD--KSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
+ R+ M APE T +SDV+S+G+ EL +
Sbjct: 197 NDSNYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-22
Identities = 41/158 (25%), Positives = 64/158 (40%), Gaps = 21/158 (13%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
H ++V LIG + ++ E LG L L LD + + A +
Sbjct: 73 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTA 128
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG-- 122
L YL K ++RD + N+L+ KL DFGL++ + D ++
Sbjct: 129 LAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKAS-----KGK 178
Query: 123 ----YCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRK 155
+ APE + T SDV+ FGV E++ G K
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 4e-22
Identities = 45/163 (27%), Positives = 68/163 (41%), Gaps = 19/163 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKE---ALDWNTRMKI 57
++S +H N+V IG R ++ E M G L+ L + P +L + +
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHV 186
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKLGPVGDKSHVS 114
A A G +YL + I+RD + N LL G K+ DFG+A+ D
Sbjct: 187 ARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAG 238
Query: 115 TRVMGTYGY-----CAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
G PE M G T K+D +SFGV+ E+ +
Sbjct: 239 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 7e-22
Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 18/158 (11%)
Query: 5 LHHSNLVNL--IGYCADGDQRLLVY---EFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
L+H +V + G A+ L Y E++ +L D +H + + +++ A
Sbjct: 69 LNHPAIVAVYDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIA 123
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR--- 116
A + L + H +I+RD K +NI++ K+ DFG+A+ + D + T+
Sbjct: 124 DACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR--AIADSGNSVTQTAA 178
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
V+GT Y +PE A + +SDVYS G V E++TG
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 95.3 bits (237), Expect = 7e-22
Identities = 37/155 (23%), Positives = 58/155 (37%), Gaps = 22/155 (14%)
Query: 5 LHHSNLVNLIGYCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+ H ++V + + D+ +V E++ SL+ P EA+
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA------YLL 189
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
L YLH ++Y D K NI+L E KL D G + ++ G
Sbjct: 190 EILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGYL----YG 239
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
T G+ APE TV +D+Y+ G L
Sbjct: 240 TPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDL 273
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-22
Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 28/171 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQ-RLLVYEFMPLGSLEDHL------------HDLPPDKE 47
++ + HH N+VNL+G C +++ EF G+L +L K+
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 48 ALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 107
L + + AKG+E+L + I+RD + NILL E K+ DFGLA+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 108 GD--KSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
R+ M APE T++SDV+SFGV+ E+ +
Sbjct: 201 DPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 9e-22
Identities = 37/158 (23%), Positives = 57/158 (36%), Gaps = 17/158 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---PDKEALDWNTRMKI 57
+ H V L +G L E SL+ H P+ + +
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGY------ 162
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
L +LH + +++ D K +NI L KL DFGL +G +
Sbjct: 163 LRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVE--LGTAGAGEVQE 217
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155
G Y APE + G +DV+S G+ LE+ +
Sbjct: 218 -GDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-21
Identities = 45/157 (28%), Positives = 66/157 (42%), Gaps = 17/157 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIA 58
+ S L H N++ L GY D + L+ E+ PLG++ L L ++
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT------ATYI 115
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
A L Y H K VI+RD K N+LL K++DFG + P +
Sbjct: 116 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTDL 167
Query: 119 -GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y PE K D++S GV+ E + G+
Sbjct: 168 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-21
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 6/164 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L H N+V D L V E+ G L + +++ LD +++
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 59 AGAAKGLEYLHDKANPP--VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
L+ H +++ V++RD K +N+ L+ + KL DFGLA++ + + +
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKT 175
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160
+GT Y +PE KSD++S G + EL +
Sbjct: 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF 219
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 3e-21
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 35/178 (19%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--------------------H 40
+L ++H +++ L G C+ LL+ E+ GSL L
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 41 DLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 100
PD+ AL + A ++G++YL + +++RD + NIL+ EG K+SDFG
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFG 195
Query: 101 LAKLGPVGD--KSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
L++ D R+ M A E T +SDV+SFGV+ E++T
Sbjct: 196 LSRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-21
Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 15/160 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL----HDLPPDKEALDWNTRMK 56
+L+ + H N+V + +V ++ G L + L + + LDW ++
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI- 134
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
L+++HD+ +++RD KS NI L + +L DFG+A++ + ++
Sbjct: 135 -----CLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARA 184
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156
+GT Y +PE KSD+++ G V EL T + A
Sbjct: 185 CIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 34/177 (19%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL-------------------HD 41
M L H N+VNL+G C L++E+ G L ++L +
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 42 LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 101
D L + + A AKG+E+L K+ ++RD + N+L+ G K+ DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 102 AKLGPVGD--KSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
A+ + R+ M APE G T+KSDV+S+G++ E+ +
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 39/166 (23%), Positives = 61/166 (36%), Gaps = 22/166 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD--KEALDWNTRMKIA 58
+ L +H N+V ++ +V FM GS +D + D E IA
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------IA 131
Query: 59 A---GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG-LAKLGPVGDKSHV- 113
G K L+Y+H ++R K+S+IL+ LS + G + V
Sbjct: 132 YILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
Query: 114 ---STRVMGTYGYCAPEYAMTGQL--TVKSDVYSFGVVFLELITGR 154
+ + +PE KSD+YS G+ EL G
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 43/182 (23%), Positives = 75/182 (41%), Gaps = 38/182 (20%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-------------LVYEFMPLGSLEDHLHD--LPPD 45
+L+ L+H +V + + + E+ G+L D +H L
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 46 KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL- 104
++ ++ + L Y+H + +I+RD K NI ++E + K+ DFGLAK
Sbjct: 115 RDEY-----WRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 105 ------------GPVGDKSHVSTRVMGTYGYCAPE-YAMTGQLTVKSDVYSFGVVFLELI 151
G ++++ + GT Y A E TG K D+YS G++F E+I
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 152 TG 153
Sbjct: 226 YP 227
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 34/271 (12%), Positives = 75/271 (27%), Gaps = 48/271 (17%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMP-------LGSLEDHLHDLPPDKEALDWNTR 54
L+ +I D ++ F L + + L ++L + R
Sbjct: 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHAR 213
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 114
+++ + L LH +++ + +I+L++ L+ F G S
Sbjct: 214 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGA----S 264
Query: 115 TRVMGTYGYCAPEY----------AMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164
G+ PE +T D ++ G+ + P+
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------LPNT 318
Query: 165 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 224
+ + + +F + + LEG ++ R L +
Sbjct: 319 DDAALGGSEWIFRSCKNIPQPVRALLEG----------------FLRYPKEDRLLPLQAM 362
Query: 225 TALSYLANQTYDPNSHRGAGDKDDRRNRDGA 255
Y +T + + GA
Sbjct: 363 ETPEYEQLRTELSAALPLYQTDGEPTREGGA 393
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-20
Identities = 44/178 (24%), Positives = 77/178 (43%), Gaps = 35/178 (19%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--------------------H 40
+++ + N+V L+G CA G L++E+M G L + L
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 41 DLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 100
P L ++ IA A G+ YL ++ ++RD + N L+ E K++DFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFG 219
Query: 101 LAKLGPVGD--KSHVSTRV----MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
L++ D K+ + + M PE + T +SDV+++GVV E+ +
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 42/159 (26%), Positives = 62/159 (38%), Gaps = 12/159 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ + V G + E M SL+ + + + + KIA
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVS 117
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMG 119
K LE+LH K + VI+RD K SN+L+ K+ DFG+ L G
Sbjct: 118 IVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL----VDDVAKDIDAG 171
Query: 120 TYGYCAPE----YAMTGQLTVKSDVYSFGVVFLELITGR 154
Y APE +VKSD++S G+ +EL R
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 27/166 (16%), Positives = 51/166 (30%), Gaps = 15/166 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDL-PPDKEALDWNTRMKIAA 59
L + + +LV E G+L + ++ ++ + + A
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-----------KLSDFGLAKLGPVG 108
+E +HD +I+ D K N +L GF L D G + +
Sbjct: 180 RMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF 236
Query: 109 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
K + T T G+ E + D + ++ G
Sbjct: 237 PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 50/243 (20%), Positives = 84/243 (34%), Gaps = 54/243 (22%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL----------------LVYEFMPLGSLEDHLHD--- 41
L+ L H N+V+ G D + EF G+LE +
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 42 -LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 100
AL+ ++ KG++Y+H K +I RD K SNI L + K+ DFG
Sbjct: 117 EKLDKVLALELFEQI------TKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFG 167
Query: 101 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160
L TR GT Y +PE + + D+Y+ G++ EL+
Sbjct: 168 LVT---SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV------- 217
Query: 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220
F + F+ L D + + + + + ++ RP
Sbjct: 218 -----------CDTAFETSKFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNT 262
Query: 221 GDV 223
++
Sbjct: 263 SEI 265
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-A 58
+L+ +H +V+L Y + L LV M G + H++++ D R
Sbjct: 238 ILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYT 295
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
A GLE+LH + +IYRD K N+LL++ + ++SD GLA G
Sbjct: 296 AQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA- 350
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT G+ APE + + D ++ GV E+I R
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 3e-20
Identities = 42/157 (26%), Positives = 64/157 (40%), Gaps = 17/157 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIA 58
+ S L H N++ + Y D + L+ EF P G L L ++ +
Sbjct: 67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS------ATFM 120
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
A L Y H++ VI+RD K N+L+ K++DFG + P + R M
Sbjct: 121 EELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP-----SLRRRTM 172
Query: 119 -GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y PE K D++ GV+ E + G
Sbjct: 173 CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-20
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 5/155 (3%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L L+H N++ + ++ +V E G L + K + T K
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 121
LE++H + V++RD K +N+ + KL D GL + K+ + ++GT
Sbjct: 146 CSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTP 200
Query: 122 GYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156
Y +PE KSD++S G + E+ +
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 6e-20
Identities = 45/155 (29%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L + +V G + + E M GSL+ L E K++
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE----QILGKVSIA 139
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVMG 119
KGL YL +K +++RD K SNIL+ KL DFG++ +L S ++ V G
Sbjct: 140 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFV-G 192
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
T Y +PE +V+SD++S G+ +E+ GR
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 52/158 (32%), Positives = 75/158 (47%), Gaps = 16/158 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPD--KEALDWNTRMKI 57
+L ++ +V+L Y + L LV M G L+ H++ + EA R
Sbjct: 237 ILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-----RAVF 290
Query: 58 -AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
AA GLE LH + ++YRD K NILL++ H ++SD GLA P G R
Sbjct: 291 YAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GR 345
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
V GT GY APE + T D ++ G + E+I G+
Sbjct: 346 V-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-19
Identities = 37/167 (22%), Positives = 62/167 (37%), Gaps = 22/167 (13%)
Query: 1 MLSLLHHSNL--VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
L+ L + + L Y +V E L L K+++D R
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYW 133
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
+ + +H +++ D K +N L+ +G KL DFG+A S V +
Sbjct: 134 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189
Query: 119 GTYGYCAPE-----------YAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y PE +++ KSDV+S G + + G+
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 4e-19
Identities = 34/169 (20%), Positives = 63/169 (37%), Gaps = 27/169 (15%)
Query: 3 SLLHHSNLVNLIGYCADGDQRLLVY---EFMPLGSLEDHL-----HDLPPDKEALDWNTR 54
+ + N +G ++ +Y + +L+D + + L +
Sbjct: 113 RRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQ 172
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK----------L 104
+ A+ +E+LH K +++RD K SNI K+ DFGL +
Sbjct: 173 I------AEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 105 GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
T +GT Y +PE + K D++S G++ EL+
Sbjct: 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 4e-19
Identities = 38/166 (22%), Positives = 63/166 (37%), Gaps = 21/166 (12%)
Query: 1 MLSLLHHS-NLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+ L HS ++ L Y +V E L L K+++D R
Sbjct: 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYWK 115
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
+ + +H +++ D K +N L+ +G KL DFG+A S V +G
Sbjct: 116 NMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVG 171
Query: 120 TYGYCAPE-----------YAMTGQLTVKSDVYSFGVVFLELITGR 154
T Y PE +++ KSDV+S G + + G+
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 5e-19
Identities = 22/160 (13%), Positives = 42/160 (26%), Gaps = 14/160 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGD--QRLLVYEFMP--LGSLEDHLHDLPPDKEALDWNTRMK 56
+++ L D LL+ L L L + +
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHI 198
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
+ A + L K +++ F N+ + L D VG + S+
Sbjct: 199 LTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASS- 252
Query: 117 VMGTYGYCAPEYAM--TGQLTVKSDVYSFGVVFLELITGR 154
Y E+ T T + + G+ +
Sbjct: 253 --VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 54/160 (33%), Positives = 76/160 (47%), Gaps = 19/160 (11%)
Query: 1 MLSLLHHSN---LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
MLSL+ + +V + Y +L + + M G L HL EA M+
Sbjct: 242 MLSLVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMR 295
Query: 57 I-AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
AA GLE++H++ V+YRD K +NILL+E H ++SD GLA K H
Sbjct: 296 FYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--A 349
Query: 116 RVMGTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
V GT+GY APE G S D +S G + +L+ G
Sbjct: 350 SV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-19
Identities = 44/158 (27%), Positives = 67/158 (42%), Gaps = 18/158 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAA 59
++ ++V G +V E+ GS+ D + E +IA
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTED-------EIAT 129
Query: 60 ---GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVST 115
KGLEYLH I+RD K+ NILL H KL+DFG+ +L K +
Sbjct: 130 ILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-- 184
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
V+GT + APE +D++S G+ +E+ G
Sbjct: 185 -VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 57/195 (29%), Positives = 87/195 (44%), Gaps = 31/195 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA- 59
++ + N+VN + GD+ +V E++ GSL D + + D+ +IAA
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG--------QIAAV 121
Query: 60 --GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTR 116
+ LE+LH VI+RD KS NILL KL+DFG A++ P K T
Sbjct: 122 CRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TM 176
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-------LV 169
V GT + APE K D++S G++ +E+I G P+ +N +
Sbjct: 177 V-GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP------PYLNENPLRALYLIA 229
Query: 170 TWARPLFNDRRKFSK 184
T P + K S
Sbjct: 230 TNGTPELQNPEKLSA 244
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 44/157 (28%), Positives = 75/157 (47%), Gaps = 18/157 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA- 59
++ H N+V + G++ ++ EF+ G+L D + + ++E +IA
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE--------QIATV 146
Query: 60 --GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTR 116
+ L YLH + VI+RD KS +ILL KLSDFG A++ K +
Sbjct: 147 CEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SL 201
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153
V GT + APE + D++S G++ +E++ G
Sbjct: 202 V-GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 45/160 (28%), Positives = 64/160 (40%), Gaps = 13/160 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA-LDWNTRMKIAA 59
++ +V G + E M S + + + + KI
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVM 118
K L +L + +I+RD K SNILL+ + KL DFG+ +L S TR
Sbjct: 133 ATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL----VDSIAKTRDA 186
Query: 119 GTYGYCAPE----YAMTGQLTVKSDVYSFGVVFLELITGR 154
G Y APE A V+SDV+S G+ EL TGR
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 37/173 (21%), Positives = 68/173 (39%), Gaps = 26/173 (15%)
Query: 2 LSLLHHSNLVNLIGYCADGD---------QRLLVY---EFMPLGSLEDHLHDLPPDKEAL 49
L+ L H +V + + ++ +Y + +L+D ++ +E
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEE-R 115
Query: 50 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL----- 104
+ + + I A+ +E+LH K +++RD K SNI K+ DFGL
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 105 -----GPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152
T +GT Y +PE + K D++S G++ EL+
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 2e-18
Identities = 36/167 (21%), Positives = 61/167 (36%), Gaps = 22/167 (13%)
Query: 1 MLSLLHHSNL--VNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
L+ L + + L Y +V E L L K+++D R
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK----KKSIDPWERKSYW 161
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
+ + +H +++ D K +N L+ +G KL DFG+A S V +
Sbjct: 162 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 217
Query: 119 GTYGYCAPE-----------YAMTGQLTVKSDVYSFGVVFLELITGR 154
G Y PE +++ KSDV+S G + + G+
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-18
Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWN-TRMKIAA 59
+S HH N+V+ D+ LV + + GS+ D + + E IA
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 60 ---GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVST 115
+GLEYLH I+RD K+ NILL E +++DFG+ A L GD +
Sbjct: 126 ILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 116 R--VMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
R +GT + APE + K+D++SFG+ +EL TG
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 4e-18
Identities = 56/198 (28%), Positives = 85/198 (42%), Gaps = 31/198 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA- 59
+LS + G + ++ E++ GS D L P D+ +IA
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET--------QIATI 124
Query: 60 --GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTR 116
KGL+YLH + I+RD K++N+LL E KL+DFG+ +L K +
Sbjct: 125 LREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--- 178
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 176
+GT + APE K+D++S G+ +EL G PH E + + + LF
Sbjct: 179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP------PHSELHPM---KVLF 229
Query: 177 NDRRKFSKLADPRLEGRY 194
K P LEG Y
Sbjct: 230 ----LIPKNNPPTLEGNY 243
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 5e-18
Identities = 46/168 (27%), Positives = 69/168 (41%), Gaps = 26/168 (15%)
Query: 1 MLSLLHHSNLVNLI------GYCADGDQRLLVYEFMPLGSLEDHLHDLP-----PDKEAL 49
++ L+H N+V+ A D LL E+ G L +L+ +
Sbjct: 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 50 DWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP---KLSDFGLAKLGP 106
+ + + L YLH+ +I+RD K NI+L+ G K+ D G AK
Sbjct: 125 ------TLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-- 173
Query: 107 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ + V GT Y APE + TV D +SFG + E ITG
Sbjct: 174 LDQGELCTEFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-18
Identities = 45/162 (27%), Positives = 71/162 (43%), Gaps = 19/162 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---PDKEALDWNTRMKI 57
+ L H N+V +G ++ + E +P GSL L D E +I
Sbjct: 72 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 58 AAGAAKGLEYLHDKANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHVST 115
+GL+YLHD +++RD K N+L+ G K+SDFG +K + + +
Sbjct: 132 ----LEGLKYLHDNQ---IVHRDIKGDNVLINTYSG-VLKISDFGTSKR--LAGINPCTE 181
Query: 116 RVMGTYGYCAPE---YAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y APE G +D++S G +E+ TG+
Sbjct: 182 TFTGTLQYMAPEIIDKGPRG-YGKAADIWSLGCTIIEMATGK 222
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-18
Identities = 49/192 (25%), Positives = 71/192 (36%), Gaps = 18/192 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L +V G + E M + + P E K+
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE----RILGKMTVA 132
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVSTRVMG 119
K L YL +K VI+RD K SNILL+E KL DFG+ +L R G
Sbjct: 133 IVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL----VDDKAKDRSAG 186
Query: 120 TYGYCAPE-----YAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ--NLVTWA 172
Y APE +++DV+S G+ +EL TG+ + + E ++
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE 246
Query: 173 RPLFNDRRKFSK 184
PL FS
Sbjct: 247 PPLLPGHMGFSG 258
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-18
Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 9/155 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AA 59
++S L H V L D ++ + G L ++ K T + A
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETCTRFYTA 137
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
LEYLH K +I+RD K NILL E H +++DFG AK+ K + +G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
T Y +PE SD+++ G + +L+ G
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 40/162 (24%), Positives = 65/162 (40%), Gaps = 16/162 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ H N++ D + + E +L++++ L+ T ++
Sbjct: 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQ---Q 126
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEE-----GFHPKLSDFGLAKLGPVGDKS-HVS 114
GL +LH +++RD K NIL+ +SDFGL K VG S
Sbjct: 127 TTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRR 183
Query: 115 TRVMGTYGYCAPEY---AMTGQLTVKSDVYSFGVVFLELITG 153
+ V GT G+ APE T D++S G VF +I+
Sbjct: 184 SGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 6e-17
Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 31/173 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL--LVYEFMPLGSLEDHLHDLP-----PDKEALDWNT 53
+L L+H N+V L + R L+ EF P GSL L + P+ E L
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL---- 115
Query: 54 RMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP----KLSDFGLAKLGPVGD 109
+ G+ +L + +++R+ K NI+ G KL+DFG A+ + D
Sbjct: 116 --IVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LED 168
Query: 110 KSHVSTRVMGTYGYCAPE--------YAMTGQLTVKSDVYSFGVVFLELITGR 154
+ GT Y P+ + D++S GV F TG
Sbjct: 169 DEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-17
Identities = 40/163 (24%), Positives = 72/163 (44%), Gaps = 23/163 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAA 59
+L+ H +V L+G + ++ EF P G+++ + +L E +I
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEP-------QIQV 121
Query: 60 ---GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDKSHVST 115
+ L +LH K +I+RD K+ N+L+ +L+DFG+ AK K
Sbjct: 122 VCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-- 176
Query: 116 RVMGTYGYCAPEYAMTGQLT-----VKSDVYSFGVVFLELITG 153
+GT + APE M + K+D++S G+ +E+
Sbjct: 177 -FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 8e-17
Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 22/174 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPL-----GSLEDHLHDLPPDKEALDWNT 53
M L H N+V + G + EF+ L G L + L + + L +T
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDT 137
Query: 54 RMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA---KLGPVGDK 110
+KI + ++++H + PP+I+RD K N+LL KL DFG A P
Sbjct: 138 VLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 111 SHVSTRVM-------GTYGYCAPE-YAMTGQLTV--KSDVYSFGVVFLELITGR 154
S ++ T Y PE + + K D+++ G + L +
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 9e-17
Identities = 43/173 (24%), Positives = 67/173 (38%), Gaps = 31/173 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL--LVYEFMPLGSLEDHLHDLP-----PDKEALDWNT 53
+L L+H N+V L + R L+ EF P GSL L + P+ E L
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL---- 115
Query: 54 RMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP----KLSDFGLAKLGPVGD 109
+ G+ +L + +++R+ K NI+ G KL+DFG A+ + D
Sbjct: 116 --IVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LED 168
Query: 110 KSHVSTRVMGTYGYCAPE--------YAMTGQLTVKSDVYSFGVVFLELITGR 154
+ GT Y P+ + D++S GV F TG
Sbjct: 169 DEQFVSLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-16
Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 16/157 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---PDKEALDWNTRMKIA 58
L H +++ L Y D + LV E G + +L + + EA
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR------HFM 118
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRV 117
G+ YLH +++RD SN+LL + K++DFGLA +L +K +
Sbjct: 119 HQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-- 173
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y +PE A ++SDV+S G +F L+ GR
Sbjct: 174 -GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-16
Identities = 37/241 (15%), Positives = 69/241 (28%), Gaps = 55/241 (22%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
L HS++V A+ D L+ E+ GSL D + + +
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILL-------------------EEGFHPKLSDFGL 101
+GL Y+H + +++ D K SNI + K+ D G
Sbjct: 124 VGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 102 AKLGPVGDKSHVSTRVMGTYGYCAPE-YAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160
S G + A E K+D+++ + +
Sbjct: 181 VTR-----ISSPQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA------- 227
Query: 161 RPHGEQNLVTWARPLFNDRRKFSKLAD---PRLEGRYPIRGLYQALAVASMCIQEQAATR 217
PL + ++ ++ PR+ + + + I R
Sbjct: 228 ------------EPLPRNGDQWHEIRQGRLPRIPQVLS----QEFTELLKVMIHPDPERR 271
Query: 218 P 218
P
Sbjct: 272 P 272
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 46/156 (29%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAA 59
L H ++V G+ D D +V E SL + + EA R
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----R-YYLR 148
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVM 118
G +YLH VI+RD K N+ L E K+ DFGLA K+ G++ V
Sbjct: 149 QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--- 202
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y APE + + DV+S G + L+ G+
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-16
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-A 58
++ L H LVNL Y ++ + +V + + G L HL + +K+
Sbjct: 68 IMQGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFKEETVKLFI 121
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
L+YL ++ +I+RD K NILL+E H ++DF +A + P + T +
Sbjct: 122 CELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMA 175
Query: 119 GTYGYCAPE--YAMTGQLTVKS-DVYSFGVVFLELITGR 154
GT Y APE + G + D +S GV EL+ GR
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 51/155 (32%), Positives = 68/155 (43%), Gaps = 12/155 (7%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AA 59
L H L L Y RL V E+ G L HL E R + A
Sbjct: 202 LQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-----RARFYGA 255
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
L+YLH + N V+YRD K N++L++ H K++DFGL K G + D + + T G
Sbjct: 256 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCG 311
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
T Y APE D + GVV E++ GR
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-15
Identities = 40/178 (22%), Positives = 62/178 (34%), Gaps = 29/178 (16%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA- 59
+ H N++ + E +L+D + E L +
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISL 120
Query: 60 --GAAKGLEYLHDKANPPVIYRDFKSSNILL-------------EEGFHPKLSDFGLAKL 104
A G+ +LH +I+RD K NIL+ E +SDFGL K
Sbjct: 121 LRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 105 GPVGDKSHVSTR--VMGTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITG 153
G S + GT G+ APE +LT D++S G VF +++
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 46/156 (29%), Positives = 65/156 (41%), Gaps = 15/156 (9%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIAA 59
L H ++V G+ D D +V E SL + + EA R
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA-----R-YYLR 122
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA-KLGPVGDKSHVSTRVM 118
G +YLH VI+RD K N+ L E K+ DFGLA K+ G++ V
Sbjct: 123 QIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC--- 176
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y APE + + DV+S G + L+ G+
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 44/161 (27%), Positives = 68/161 (42%), Gaps = 22/161 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N++ L + D LV E G L D + E AA
Sbjct: 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE--------VDAAR 130
Query: 61 AAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHV 113
+ G+ Y+H +++RD K N+LL + + ++ DFGL+ + S
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKK 184
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+GT Y APE + G K DV+S GV+ L++G
Sbjct: 185 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 51/156 (32%), Positives = 70/156 (44%), Gaps = 15/156 (9%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AA 59
L H L L Y RL V E+ G L HL E R + A
Sbjct: 59 LQNTRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE-----RARFYGA 112
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
LEYLH + V+YRD K N++L++ H K++DFGL K G + D + + T G
Sbjct: 113 EIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKT-FCG 167
Query: 120 TYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
T Y APE + ++ D + GVV E++ GR
Sbjct: 168 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 52/162 (32%), Positives = 68/162 (41%), Gaps = 28/162 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAA 59
L L H N + G LV E+ GS D L P +E +IAA
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEV-------EIAA 158
Query: 60 ---GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
GA +GL YLH +I+RD K+ NILL E KL DFG A S ++
Sbjct: 159 VTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPA 207
Query: 117 --VMGTYGYCAPEYAMTGQLT---VKSDVYSFGVVFLELITG 153
+GT + APE + K DV+S G+ +EL
Sbjct: 208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 26/168 (15%)
Query: 1 MLSLLHHSNLVNLIG-----YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTR 54
+ HH N+ G D +L LV EF GS+ D + + + +W
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--- 130
Query: 55 MKIAA---GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL-AKLGPVGDK 110
IA +GL +LH VI+RD K N+LL E KL DFG+ A+L +
Sbjct: 131 --IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR 185
Query: 111 SHVSTRVMGTYGYCAPEYAMTGQLT-----VKSDVYSFGVVFLELITG 153
+ +GT + APE + KSD++S G+ +E+ G
Sbjct: 186 RNT---FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 48/161 (29%), Positives = 68/161 (42%), Gaps = 22/161 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L LL H N++ L + D LV E G L D + E AA
Sbjct: 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE--------VDAAV 140
Query: 61 AAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHV 113
K G+ YLH +++RD K N+LL E+ K+ DFGL+ V +
Sbjct: 141 IIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQKK 194
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+GT Y APE + + K DV+S GV+ L+ G
Sbjct: 195 MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 47/161 (29%), Positives = 67/161 (41%), Gaps = 22/161 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N++ L D LV EF G L + + + E AA
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE--------CDAAN 150
Query: 61 AAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHV 113
K G+ YLH +++RD K NILL + K+ DFGL+ K +
Sbjct: 151 IMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSS---FFSKDYK 204
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+GT Y APE + + K DV+S GV+ L+ G
Sbjct: 205 LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-14
Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 17/149 (11%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEY 67
L ++ + L V E++ G L H+ + R AA GL++
Sbjct: 80 LTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS-----RATFYAAEIILGLQF 133
Query: 68 LHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 126
LH K ++YRD K NILL ++G H K++DFG+ K + + +T GT Y AP
Sbjct: 134 LHSKG---IVYRDLKLDNILLDKDG-HIKIADFGMCKEN-MLGDAKTNT-FCGTPDYIAP 187
Query: 127 EYAMTGQLTVKS-DVYSFGVVFLELITGR 154
E + GQ S D +SFGV+ E++ G+
Sbjct: 188 E-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 3e-14
Identities = 54/158 (34%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AA 59
L ++H +V L Y + +L L+ +F+ G L L E +K A
Sbjct: 80 LVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLA 133
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
A L++LH +IYRD K NILL EEG H KL+DFGL+K +K
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEK---KAYSF 186
Query: 119 -GTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
GT Y APE + + +S D +SFGV+ E++TG
Sbjct: 187 CGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 48/153 (31%), Positives = 69/153 (45%), Gaps = 17/153 (11%)
Query: 6 HHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAK 63
L L C RL V E++ G L H+ + KE AA A
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAI 453
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYG 122
GL +L K +IYRD K N++L+ H K++DFG+ K +T+ GT
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPD 507
Query: 123 YCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
Y APE + Q KS D ++FGV+ E++ G+
Sbjct: 508 YIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 40/156 (25%), Positives = 66/156 (42%), Gaps = 16/156 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AA 59
+L ++ LV L D +V E++ G + HL + + AA
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAA 148
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM- 118
EYLH +IYRD K N+L+++ + +++DFG AK V + T +
Sbjct: 149 QIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKR--VKGR----TWTLC 199
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT APE ++ D ++ GV+ E+ G
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 5e-14
Identities = 48/157 (30%), Positives = 66/157 (42%), Gaps = 17/157 (10%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AA 59
L + H +V+LI Y +L L+ E++ G L L E A
Sbjct: 75 LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED-----TACFYLA 128
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
+ L +LH K +IYRD K NI+L +G H KL+DFGL K T
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDGT---VTHTF 181
Query: 119 -GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT Y APE M D +S G + +++TG
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.3 bits (172), Expect = 8e-14
Identities = 36/126 (28%), Positives = 55/126 (43%), Gaps = 3/126 (2%)
Query: 27 YEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNI 86
E L +E+ K+ L + + AKG+E+L + I+RD + NI
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNI 224
Query: 87 LLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
LL E K+ DFGLA+ + APE T++SDV+SFGV+
Sbjct: 225 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284
Query: 147 FLELIT 152
E+ +
Sbjct: 285 LWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 15/41 (36%), Positives = 23/41 (56%), Gaps = 1/41 (2%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLV-YEFMPLGSLEDHLH 40
++ + HH N+VNL+G C L+V EF G+L +L
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 9e-14
Identities = 50/154 (32%), Positives = 70/154 (45%), Gaps = 19/154 (12%)
Query: 6 HHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAK 63
L L C RL V E++ G L H+ + KE AA A
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP-----HAVFYAAEIAI 132
Query: 64 GLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTY 121
GL +L K +IYRD K N++L EG H K++DFG+ K +T+ GT
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDGV---TTKTFCGTP 185
Query: 122 GYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
Y APE + Q KS D ++FGV+ E++ G+
Sbjct: 186 DYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 50/149 (33%), Positives = 67/149 (44%), Gaps = 17/149 (11%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEY 67
L L C RL V EF+ G L H+ EA R + AA L +
Sbjct: 86 LTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA-----RARFYAAEIISALMF 139
Query: 68 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAP 126
LHDK +IYRD K N+LL+ H KL+DFG+ K G +T GT Y AP
Sbjct: 140 LHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATFCGTPDYIAP 193
Query: 127 EYAMTGQLTVKS-DVYSFGVVFLELITGR 154
E + L + D ++ GV+ E++ G
Sbjct: 194 E-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 68.7 bits (169), Expect = 2e-13
Identities = 54/157 (34%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AA 59
MLS++ H ++ + G D Q ++ +++ G L L K N K AA
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-----KSQRFPNPVAKFYAA 113
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM- 118
LEYLH K +IYRD K NILL++ H K++DFG AK V D T +
Sbjct: 114 EVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY--VPDV----TYTLC 164
Query: 119 GTYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
GT Y APE ++ + KS D +SFG++ E++ G
Sbjct: 165 GTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 17/149 (11%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEY 67
LV L C + RL V E++ G L H+ E + +A + L Y
Sbjct: 72 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNY 125
Query: 68 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAP 126
LH++ +IYRD K N+LL+ H KL+D+G+ K G +T GT Y AP
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAP 179
Query: 127 EYAMTGQLTVKS-DVYSFGVVFLELITGR 154
E + G+ S D ++ GV+ E++ GR
Sbjct: 180 E-ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 3e-13
Identities = 49/149 (32%), Positives = 66/149 (44%), Gaps = 17/149 (11%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEY 67
LV L + +L V +++ G L HL E R + AA A L Y
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGY 154
Query: 68 LHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAP 126
LH ++YRD K NILL +G H L+DFGL K + S ST GT Y AP
Sbjct: 155 LHSLN---IVYRDLKPENILLDSQG-HIVLTDFGLCKEN-IEHNSTTST-FCGTPEYLAP 208
Query: 127 EYAMTGQLTVKS-DVYSFGVVFLELITGR 154
E + Q ++ D + G V E++ G
Sbjct: 209 E-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 47/156 (30%), Positives = 65/156 (41%), Gaps = 20/156 (12%)
Query: 6 HHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAK 63
LV L Y + +L L+ +++ G L HL + ++I
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS-----QRERFTEHEVQIYVGEIVL 170
Query: 64 GLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
LE+LH +IYRD K NILL G H L+DFGL+K + GT
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADETERAYDFC-GTIE 225
Query: 123 YCAPEYAMTGQL----TVKSDVYSFGVVFLELITGR 154
Y AP+ G V D +S GV+ EL+TG
Sbjct: 226 YMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 37/166 (22%), Positives = 59/166 (35%), Gaps = 26/166 (15%)
Query: 1 MLSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHL----HDLPPDKEALDWNTR 54
+L + L + A D + LV ++ G L L LP +
Sbjct: 127 VLVNGDSKWITTL--HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEE--------M 176
Query: 55 MKI-AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV 113
+ A ++ +H ++RD K NIL++ H +L+DFG
Sbjct: 177 ARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKS-----DVYSFGVVFLELITGR 154
S V GT Y +PE + D +S GV E++ G
Sbjct: 234 SVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 47/160 (29%), Positives = 67/160 (41%), Gaps = 22/160 (13%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L L H N++ L D +V E G L D + E AA
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--------HDAARI 126
Query: 62 AK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVS 114
K G+ Y+H +++RD K NILL E+ K+ DFGL+ + +
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMK 181
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
R+ GT Y APE + G K DV+S GV+ L++G
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 17/149 (11%)
Query: 10 LVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKI-AAGAAKGLEY 67
LV L C + RL V E++ G L H+ E + +A + L Y
Sbjct: 115 LVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE-----HARFYSAEISLALNY 168
Query: 68 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM-GTYGYCAP 126
LH++ +IYRD K N+LL+ H KL+D+G+ K G +T GT Y AP
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAP 222
Query: 127 EYAMTGQLTVKS-DVYSFGVVFLELITGR 154
E + G+ S D ++ GV+ E++ GR
Sbjct: 223 E-ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 42/163 (25%), Positives = 67/163 (41%), Gaps = 23/163 (14%)
Query: 1 MLSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK 56
+++ + +V L + A D +V E+MP G L + + +D+P +
Sbjct: 122 IMAFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--------WAR 171
Query: 57 I-AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
A L+ +H I+RD K N+LL++ H KL+DFG T
Sbjct: 172 FYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 116 RVMGTYGYCAPE----YAMTGQLTVKSDVYSFGVVFLELITGR 154
V GT Y +PE G + D +S GV E++ G
Sbjct: 229 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 1e-12
Identities = 44/167 (26%), Positives = 68/167 (40%), Gaps = 30/167 (17%)
Query: 1 MLSLLHHSNLVNLI----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRM 55
L H N+V L D + +L LV+E + DL LD
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD--------QDL---TTYLDKVPEP 115
Query: 56 KIAAGAAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 107
+ K GL++LH V++RD K NIL+ KL+DFGLA+
Sbjct: 116 GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IY 170
Query: 108 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ +++ V+ T Y APE + D++S G +F E+ +
Sbjct: 171 SFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 16/158 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H NLVNL+ C + LV+EF+ ++ D L P LD+ K
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFP---NGLDYQVVQKYLFQ 132
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSH-VSTRV 117
G+ + H +I+RD K NIL+ + KL DFG A+ P V+TR
Sbjct: 133 IINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR- 188
Query: 118 MGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
Y APE + + DV++ G + E+ G
Sbjct: 189 ----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 46/197 (23%), Positives = 66/197 (33%), Gaps = 47/197 (23%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ LHH N+ L D LV E G L D L+ D +K
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 61 -----------------------------AAK-------GLEYLHDKANPPVIYRDFKSS 84
+ L YLH++ + +RD K
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPE 197
Query: 85 NILLE--EGFHPKLSDFGLAKL---GPVGDKSHVSTRVMGTYGYCAPE--YAMTGQLTVK 137
N L + F KL DFGL+K G+ ++T+ GT + APE K
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPK 256
Query: 138 SDVYSFGVVFLELITGR 154
D +S GV+ L+ G
Sbjct: 257 CDAWSAGVLLHLLLMGA 273
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 2e-12
Identities = 46/164 (28%), Positives = 65/164 (39%), Gaps = 28/164 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
ML L H NLVNL+ + LV+E+ ++ L + + I
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ---RGVPEHLVKSITWQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSH-VSTRV 117
+ + + H I+RD K NIL+ + KL DFG A+L GP V+TR
Sbjct: 111 TLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR- 166
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGV-------VFLELITGR 154
Y +PE L V Y V VF EL++G
Sbjct: 167 ----WYRSPE------LLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 2e-12
Identities = 44/164 (26%), Positives = 71/164 (43%), Gaps = 19/164 (11%)
Query: 1 MLSLLHHSNLVNLIGY-CADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEALDWNTR 54
++ L H N+V L + + G+++ LV +++P ++ K+ L
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYV 158
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-KLSDFGLAKLGPVGDK--S 111
+ L Y+H + +RD K N+LL+ KL DFG AK G+ S
Sbjct: 159 KLYMYQLFRSLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 112 HVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
++ +R Y Y APE T DV+S G V EL+ G+
Sbjct: 216 YICSR----Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-12
Identities = 36/167 (21%), Positives = 56/167 (33%), Gaps = 28/167 (16%)
Query: 2 LSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHL----HDLPPDKEALDWNTRM 55
L + L + A D + LV E+ G L L +P +
Sbjct: 115 LVNGDRRWITQL--HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE--------MA 164
Query: 56 KI-AAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 114
+ A ++ +H ++RD K NILL+ H +L+DFG
Sbjct: 165 RFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL 221
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVY-------SFGVVFLELITGR 154
V GT Y +PE + Y + GV E+ G+
Sbjct: 222 VAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 31/155 (20%), Positives = 59/155 (38%), Gaps = 23/155 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK--EALDWNTRMKIA 58
+ ++NL + + +L+ E+ G + + E
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE--------NDV 133
Query: 59 AGAAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKS 111
K G+ YLH +++ D K NILL K+ DFG+++ +G
Sbjct: 134 IRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGHAC 188
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
+ + GT Y APE +T +D+++ G++
Sbjct: 189 ELREIM-GTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 65.6 bits (161), Expect = 2e-12
Identities = 43/168 (25%), Positives = 67/168 (39%), Gaps = 30/168 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N+V L + LV+EF DL K+ D + +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD--------QDL---KKYFD-SCNGDLDPE 101
Query: 61 AAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDK 110
K GL + H + V++RD K N+L+ KL++FGLA+ PV
Sbjct: 102 IVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158
Query: 111 SHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGRKAI 157
S V+ T Y P+ + D++S G +F EL + +
Sbjct: 159 SA---EVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 44/167 (26%), Positives = 71/167 (42%), Gaps = 30/167 (17%)
Query: 1 MLSLLHHSNLVNLI----GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRM 55
L H N+V L+ D + ++ LV+E + DL + LD
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD--------QDL---RTYLDKAPPP 115
Query: 56 KIAAGAAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 107
+ A K GL++LH +++RD K NIL+ G KL+DFGLA+
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IY 170
Query: 108 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ ++ V+ T Y APE + D++S G +F E+ +
Sbjct: 171 SYQMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 41/164 (25%), Positives = 67/164 (40%), Gaps = 19/164 (11%)
Query: 1 MLSLLHHSNLVNLIGY-----CADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTR 54
++ ++ H N+V+L + + L LV E++P ++ K+ +
Sbjct: 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLI 143
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-KLSDFGLAK-LGPVGDKSH 112
+ L Y+H + +RD K N+LL+ KL DFG AK L
Sbjct: 144 KLYMYQLLRSLAYIH-SIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200
Query: 113 -VSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
+ +R Y Y APE T D++S G V EL+ G+
Sbjct: 201 YICSR----Y-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 35/161 (21%), Positives = 58/161 (36%), Gaps = 34/161 (21%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM----- 55
+ + H N++ L LV++ M G L D+ T
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-------------FDYLTEKVTLSE 123
Query: 56 KIAAGAAK----GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS 111
K + + LH +++RD K NILL++ + KL+DFG + +
Sbjct: 124 KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGE 178
Query: 112 HVSTRVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVV 146
+ GT Y APE + D++S GV+
Sbjct: 179 KLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 4e-12
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 30/165 (18%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L LHH N+V+LI LV+EFM DL K+ LD + +
Sbjct: 72 LLKELHHPNIVSLIDVIHSERCLTLVFEFME--------KDL---KKVLD-ENKTGLQDS 119
Query: 61 AAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDK 110
K G+ + H +++RD K N+L+ KL+DFGLA+ PV
Sbjct: 120 QIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176
Query: 111 SHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
+H V+ T Y AP+ M + + + D++S G +F E+ITG+
Sbjct: 177 TH---EVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 48/166 (28%), Positives = 69/166 (41%), Gaps = 20/166 (12%)
Query: 1 MLSLLHHSNLVNLI------GYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNT 53
L++LHH N+V L G D L +V E++P +L + + A
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPIL 130
Query: 54 RMKIAAGAAKGLEYLHDK-ANPPVIYRDFKSSNILLEEGFHP-KLSDFGLAK-LGPVGDK 110
+ + LH N V +RD K N+L+ E KL DFG AK L P
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 111 SH-VSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
+ +R Y Y APE Q T D++S G +F E++ G
Sbjct: 189 VAYICSR----Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 19/160 (11%)
Query: 1 MLSLLHHSNLVNLIG-YCADGDQRL-----LVYEFMPLGSLEDHLHDLPPDKEALDWNTR 54
++ ++H N+++L+ + LV E M + +L + + LD
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVI--QMELDHERM 166
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 114
+ G+++LH A +I+RD K SNI+++ K+ DFGLA+ S +
Sbjct: 167 SYLLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMM 220
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
T + T Y APE + D++S G + E++ +
Sbjct: 221 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 6e-12
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
G+++LH A +I+RD K SNI+++ K+ DFGLA S + T + T
Sbjct: 138 CGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRY 191
Query: 123 YCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
Y APE + D++S G + E+I G
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 6e-12
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 30/164 (18%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L L H+N+V L LV+E++ DL K+ LD + I
Sbjct: 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD--------KDL---KQYLD-DCGNIINMHN 101
Query: 62 AK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKS 111
K GL Y H + V++RD K N+L+ E KL+DFGLA+ P
Sbjct: 102 VKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158
Query: 112 HVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
+ V+ T Y P+ + + + + D++ G +F E+ TGR
Sbjct: 159 N---EVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 6e-12
Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 42/171 (24%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L HSN+V L + +LV+E + DL K+ LD + +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD--------QDL---KKLLD-VCEGGLESV 100
Query: 61 AAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDK 110
AK G+ Y HD+ V++RD K N+L+ K++DFGLA+ PV
Sbjct: 101 TAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY 157
Query: 111 SHVSTRVMGTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITGR 154
+H ++ T Y AP+ Y + D++S G +F E++ G
Sbjct: 158 TH---EIV-TLWYRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 64.1 bits (157), Expect = 7e-12
Identities = 45/165 (27%), Positives = 71/165 (43%), Gaps = 25/165 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMP--LGSLEDHLHDLPPDKEALDWNTRMKIA 58
++ L H N+V L ++ LV+EFM L D + L+ N
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDS-RTVGNTPRGLELNLVKYFQ 114
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSHVSTR 116
+GL + H+ +++RD K N+L+ + KL DFGLA+ PV S
Sbjct: 115 WQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---E 168
Query: 117 VMGTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITGR 154
V+ T Y AP+ Y + D++S G + E+ITG+
Sbjct: 169 VV-TLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 8e-12
Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 21/154 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMKIA 58
+L L+H ++ + + D + +V E M G L D + + + + +M
Sbjct: 193 ILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM--- 248
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVST 115
++YLH+ +I+RD K N+LL EE K++DFG +K+ +G+ S + T
Sbjct: 249 ---LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRT 300
Query: 116 RVMGTYGYCAPE---YAMTGQLTVKSDVYSFGVV 146
GT Y APE T D +S GV+
Sbjct: 301 LC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 42/183 (22%), Positives = 75/183 (40%), Gaps = 51/183 (27%)
Query: 2 LSLLHHSNLVNLIG-YCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
L L H N+++L + + D+++ L++++ HDL + ++ K
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE--------HDL---WHIIKFHRASKANK 120
Query: 60 GAA---------------KGLEYLHDKANPPVIYRDFKSSNILLEEGFHP----KLSDFG 100
G+ YLH V++RD K +NIL+ K++D G
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 101 LAKL--GPVGDKSHVSTRVMGTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELI 151
A+L P+ + + V+ T+ Y APE Y T D+++ G +F EL+
Sbjct: 178 FARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELL 230
Query: 152 TGR 154
T
Sbjct: 231 TSE 233
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-12
Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 24/161 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--DKEALDWNTRMKIA 58
+ H N++ LI + + D+ LV+E M GS+ H+H + EA ++
Sbjct: 64 LYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV---VQDV 120
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP---KLSDFGLAK-LGPVGDKSHVS 114
A A L++LH+K + +RD K NIL E K+ DF L + GD S +S
Sbjct: 121 ASA---LDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174
Query: 115 TRVM----GTYGYCAPEYAMTGQLTVKS-----DVYSFGVV 146
T + G+ Y APE D++S GV+
Sbjct: 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 43/153 (28%), Positives = 61/153 (39%), Gaps = 18/153 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N++ + D +V E G L + + +AL A
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALS----EGYVAE 128
Query: 61 AAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHV 113
K L Y H + V+++D K NIL K+ DFGLA+L H
Sbjct: 129 LMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHS 183
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
+ GT Y APE +T K D++S GVV
Sbjct: 184 TNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVV 214
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 44/159 (27%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 2 LSLLHHSNLVNL--IGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIA 58
L L H N+V L + + D +V+E + G + + P + +A + + I
Sbjct: 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFY-FQDLIK 148
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
G+EYLH + +I+RD K SN+L+ E H K++DFG++ G + +S V
Sbjct: 149 -----GIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FKGSDALLSNTV- 198
Query: 119 GTYGYCAPEYAMTGQLTV---KSDVYSFGVVFLELITGR 154
GT + APE + DV++ GV + G+
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 1e-11
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 22/153 (14%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L + H N++ L + +L+ E + G L D L +KE+L T + A
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESL---TEDE-ATQF 113
Query: 62 AK----GLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAKLGPVGDKSHV 113
K G+ YLH K + + D K NI+L KL DFG+A + +
Sbjct: 114 LKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEF 168
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
GT + APE L +++D++S GV+
Sbjct: 169 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 48/171 (28%), Positives = 71/171 (41%), Gaps = 44/171 (25%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L L H N++ L+ LV++FM DL + + + + +
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFME--------TDL---EVIIK-DNSLVLTPSH 113
Query: 62 AK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKS 111
K GLEYLH +++RD K +N+LL+E KL+DFGLAK P +
Sbjct: 114 IKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170
Query: 112 H-VSTRVMGTYGYCAPE-------YAMTGQLTVKSDVYSFGVVFLELITGR 154
H V TR Y APE Y V D+++ G + EL+
Sbjct: 171 HQVVTR-----WYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 34/165 (20%), Positives = 58/165 (35%), Gaps = 42/165 (25%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ + H +++ LI LV++ M G L D+L
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-----------------TEKV 195
Query: 61 ------AAK-------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 107
+ +LH +++RD K NILL++ +LSDFG + +
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH--L 250
Query: 108 GDKSHVSTRVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVV 146
+ GT GY APE + D+++ GV+
Sbjct: 251 EPGEKLRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 40/151 (26%), Positives = 60/151 (39%), Gaps = 16/151 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--DKEALDWNTRMKIA 58
+ H N+V L D LV E + G L + + + EA M+
Sbjct: 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI---MRKL 115
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVST 115
A + ++HD V++RD K N+L + K+ DFG A+L P D + T
Sbjct: 116 VSA---VSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP-PDNQPLKT 168
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
T Y APE D++S GV+
Sbjct: 169 PC-FTLHYAAPELLNQNGYDESCDLWSLGVI 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 35/167 (20%), Positives = 68/167 (40%), Gaps = 32/167 (19%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L L H N++ L + L++E+ +DL K+ +D N + +
Sbjct: 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE--------NDL---KKYMDKNPDVSMRVIK 135
Query: 62 A------KGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-----KLSDFGLAKL--GPVG 108
+ G+ + H + ++RD K N+LL K+ DFGLA+ P+
Sbjct: 136 SFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192
Query: 109 DKSHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
+H ++ T Y PE + + + D++S ++ E++
Sbjct: 193 QFTH---EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 41/163 (25%), Positives = 65/163 (39%), Gaps = 22/163 (13%)
Query: 2 LSLLHHSNLVNL--IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
L L H N++ L + Y + + +V E+ G E + D P+K R +
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVCQ 110
Query: 60 GAAK------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV 113
GLEYLH + ++++D K N+LL G K+S G+A+
Sbjct: 111 AHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167
Query: 114 STRVMGTYGYCAPEYAMTGQL--TVKSDVYSFGVVFLELITGR 154
G+ + PE A K D++S GV + TG
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 40/152 (26%), Positives = 60/152 (39%), Gaps = 17/152 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--DKEALDWNTRMKIA 58
+L H N++ L DG +V E M G L D + ++EA +
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV---LFTI 125
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHP-KLSDFGLAKLGPVGDKSHVS 114
+EYLH + V++RD K SNIL ++ DFG AK + +
Sbjct: 126 TKT---VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLM 178
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
T T + APE D++S GV+
Sbjct: 179 TPC-YTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 44/153 (28%), Positives = 66/153 (43%), Gaps = 22/153 (14%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L + H N++ L + +L+ E + G L D L KE+L + A
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATSF 120
Query: 62 AK----GLEYLHDKANPPVIYRDFKSSNILLEEGFHP----KLSDFGLAKLGPVGDKSHV 113
K G+ YLH K + + D K NI+L + P KL DFGLA + D
Sbjct: 121 IKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEF 175
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
GT + APE L +++D++S GV+
Sbjct: 176 KNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 22/154 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L + H N++ L + +L+ E + G L D L KE+L + A
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKESL----SEEEATS 119
Query: 61 AAK----GLEYLHDKANPPVIYRDFKSSNILLEEGFHP----KLSDFGLAKLGPVGDKSH 112
K G+ YLH K + + D K NI+L + P KL DFGLA + D
Sbjct: 120 FIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVE 174
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
GT + APE L +++D++S GV+
Sbjct: 175 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 41/161 (25%), Positives = 64/161 (39%), Gaps = 24/161 (14%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGS-LEDHL--HDLPPDKEALDWNTRMK-- 56
LS + H+N++ ++ + LV E G L + H + A
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA-----SYIFR 137
Query: 57 -IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
+ + + YL K +I+RD K NI++ E F KL DFG A G +
Sbjct: 138 QLVSA----VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC 190
Query: 116 RVMGTYGYCAPEYAMTGQLTV--KSDVYSFGVVFLELITGR 154
GT YCAPE + G + +++S GV L+
Sbjct: 191 ---GTIEYCAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 45/152 (29%), Positives = 63/152 (41%), Gaps = 22/152 (14%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L L H N++ L D +V E G L D + E AA
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--------HDAARI 126
Query: 62 AK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVS 114
K G+ Y+H +++RD K NILL E+ K+ DFGL+ + +
Sbjct: 127 IKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMK 181
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
R+ GT Y APE + G K DV+S GV+
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVI 211
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 23/153 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM--KIA 58
+S+L H LVNL D ++ +++YEFM G L + + D + +M A
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKV---------ADEHNKMSEDEA 257
Query: 59 AGAAK----GLEYLHDKANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSH 112
+ GL ++H+ ++ D K NI+ + KL DFGL
Sbjct: 258 VEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGV 145
V GT + APE A + +D++S GV
Sbjct: 315 V---TTGTAEFAAPEVAEGKPVGYYTDMWSVGV 344
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-11
Identities = 45/173 (26%), Positives = 68/173 (39%), Gaps = 34/173 (19%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL--------LVYEFMPLGSLEDHLHDLPPDKEALDWN 52
+L LL H N+VNLI C LV++F HDL L N
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE--------HDL---AGLLS-N 116
Query: 53 TRMKIAAGAAK--------GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104
+K K GL Y+H +++RD K++N+L+ KL+DFGLA+
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 105 --GPVGDKSHVSTRVMGTYGYCAPEYAM-TGQLTVKSDVYSFGVVFLELITGR 154
+ + T + T Y PE + D++ G + E+ T
Sbjct: 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 39/153 (25%), Positives = 67/153 (43%), Gaps = 22/153 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L + H N+V L LV + + G L D + + E K A+
Sbjct: 59 VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTE--------KDASL 110
Query: 61 AAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHV 113
+ ++YLH+ +++RD K N+L EE ++DFGL+K+ +++ +
Sbjct: 111 VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGI 163
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
+ GT GY APE + D +S GV+
Sbjct: 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 35/157 (22%), Positives = 60/157 (38%), Gaps = 24/157 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPD----KEALDWN 52
++V ++ + L++ E M G L + + +EA +
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI- 133
Query: 53 TRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGD 109
M+ A +++LH + +RD K N+L E+ KL+DFG AK
Sbjct: 134 --MRDIGTA---IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
Query: 110 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
+ T T Y APE + D++S GV+
Sbjct: 186 ---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 47/164 (28%), Positives = 74/164 (45%), Gaps = 31/164 (18%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK--- 56
+ +L+H N+V L L+ E+ G + D+L H +KEA R K
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----RSKFRQ 122
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
I + ++Y H K +++RD K+ N+LL+ + K++DFG + VG K
Sbjct: 123 IVSA----VQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC- 174
Query: 117 VMGTYGYCAPE------YAMTGQLTVKSDVYSFGVVFLELITGR 154
G Y APE Y G + DV+S GV+ L++G
Sbjct: 175 --GAPPYAAPELFQGKKYD--GP---EVDVWSLGVILYTLVSGS 211
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 34/152 (22%), Positives = 66/152 (43%), Gaps = 19/152 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+++ LHH L+NL D + +L+ EF+ G L D + + +
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMS----EAEVIN 153
Query: 61 AAK----GLEYLHDKANPPVIYRDFKSSNILLE--EGFHPKLSDFGLAKLGPVGDKSHVS 114
+ GL+++H+ + +++ D K NI+ E + K+ DFGLA + +
Sbjct: 154 YMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIV 207
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
T + APE + +D+++ GV+
Sbjct: 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 5e-11
Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 30/165 (18%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK--- 56
+L+H N+V G+ +G+ + L E+ G L D + P+ +A +
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQ 113
Query: 57 -IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
+A + YLH + +RD K N+LL+E + K+SDFGLA + ++ +
Sbjct: 114 LMAG-----VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 116 RVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVVFLELITGR 154
++ GT Y APE + + DV+S G+V ++ G
Sbjct: 166 KMCGTLPYVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 5e-11
Identities = 33/93 (35%), Positives = 47/93 (50%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
KGL Y+H A +I+RD K N+ + E K+ DFGLA+ +V TR
Sbjct: 139 KGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 123 YCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
Y APE + T D++S G + E+ITG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 25/152 (16%), Positives = 58/152 (38%), Gaps = 23/152 (15%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM--KIAA 59
L++ H N+++L ++ ++++EF+ + + + + +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI---------NTSAFELNEREIV 105
Query: 60 GAAK----GLEYLHDKANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHV 113
L++LH + + D + NI+ K+ +FG A+ GD +
Sbjct: 106 SYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGV 145
+ Y APE ++ +D++S G
Sbjct: 163 ---LFTAPEYYAPEVHQHDVVSTATDMWSLGT 191
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 7e-11
Identities = 38/156 (24%), Positives = 60/156 (38%), Gaps = 24/156 (15%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL----HDLPPDKEALDWNTRMKI 57
+L H ++V L+ + +V+EFM L + E +
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--------AV 131
Query: 58 AAGAAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDK 110
A+ + L Y HD +I+RD K +LL E KL FG+A +G+
Sbjct: 132 ASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGES 186
Query: 111 SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
V+ +GT + APE DV+ GV+
Sbjct: 187 GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 43/153 (28%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N++ L + LV E + G L D + + E + AA
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE--------RDAAD 152
Query: 61 AAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHV 113
A K + YLH+ +++RD K N+L K++DFGL+K+ V + +
Sbjct: 153 AVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLM 207
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
T GT GYCAPE + D++S G++
Sbjct: 208 KTVC-GTPGYCAPEILRGCAYGPEVDMWSVGII 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 41/153 (26%), Positives = 65/153 (42%), Gaps = 22/153 (14%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L + H N++ L + +L+ E + G L D L +KE+L + A
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLT----EEEATEF 119
Query: 62 AK----GLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAKLGPVGDKSHV 113
K G+ YLH + + D K NI+L K+ DFGLA D +
Sbjct: 120 LKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNE 173
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
+ GT + APE L +++D++S GV+
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 21/152 (13%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L H N+V L + LV++ + G L + + E A+
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHC 110
Query: 62 AK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVS 114
+ + Y H +++R+ K N+LL +G KL+DFGLA V D
Sbjct: 111 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWH 165
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
GT GY +PE + D+++ GV+
Sbjct: 166 GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVI 196
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 30/165 (18%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK--- 56
+L+H N+V G+ +G+ + L E+ G L D + P+ +A +
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA-----QRFFHQ 113
Query: 57 -IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
+A + YLH + +RD K N+LL+E + K+SDFGLA + ++ +
Sbjct: 114 LMAG-----VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165
Query: 116 RVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVVFLELITGR 154
++ GT Y APE + + DV+S G+V ++ G
Sbjct: 166 KMCGTLPYVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGE 205
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+GL+Y+H A+ +I+RD K SN+ + E K+ DFGLA+ +V+TR
Sbjct: 143 RGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 123 YCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
Y APE + D++S G + EL+TGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 2e-10
Identities = 40/153 (26%), Positives = 57/153 (37%), Gaps = 22/153 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H N++ L D LV E G L + + +E AA
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRE--------SDAAR 110
Query: 61 AAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHV 113
K + Y H V +RD K N L KL DFGLA +
Sbjct: 111 IMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMM 165
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
T+V GT Y +P+ + G + D +S GV+
Sbjct: 166 RTKV-GTPYYVSPQ-VLEGLYGPECDEWSAGVM 196
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 31/93 (33%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
KGL+Y+H A V++RD K N+ + E K+ DFGLA+ +V TR
Sbjct: 137 KGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----- 188
Query: 123 YCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
Y APE ++ D++S G + E++TG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 29/95 (30%), Positives = 41/95 (43%), Gaps = 11/95 (11%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGT 120
GL LH+ A V++RD NILL + + DF LA+ +V+ R
Sbjct: 145 LGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW--- 198
Query: 121 YGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154
Y APE M T D++S G V E+ +
Sbjct: 199 --YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 15/99 (15%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS------HVSTR 116
+GL+Y+H AN V++RD K SN+LL K+ DFGLA++ +V+TR
Sbjct: 139 RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 117 VMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
Y APE + + T D++S G + E+++ R
Sbjct: 196 -----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 4e-10
Identities = 35/153 (22%), Positives = 65/153 (42%), Gaps = 23/153 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRM--KIA 58
+++ L H+NL+ L + +LV E++ G L D + +D + +
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI---------IDESYNLTELDT 189
Query: 59 AGAAK----GLEYLHDKANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSH 112
K G+ ++H +++ D K NIL + K+ DFGLA+ +
Sbjct: 190 ILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREK 244
Query: 113 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGV 145
+ GT + APE ++ +D++S GV
Sbjct: 245 LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 37/152 (24%), Positives = 60/152 (39%), Gaps = 21/152 (13%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGA 61
L H N+V L + LV++ + G L + + E A+
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE--------ADASHC 133
Query: 62 AK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVS 114
+ + Y H +++R+ K N+LL +G KL+DFGLA V D
Sbjct: 134 IQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWH 188
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
GT GY +PE + D+++ GV+
Sbjct: 189 GFA-GTPGYLSPEVLKKDPYSKPVDIWACGVI 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 12/89 (13%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
++YLH+ +I+RD K N+LL EE K++DFG +K+ +G+ S + T GT
Sbjct: 126 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GT 179
Query: 121 YGYCAPE---YAMTGQLTVKSDVYSFGVV 146
Y APE T D +S GV+
Sbjct: 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 37/157 (23%), Positives = 60/157 (38%), Gaps = 23/157 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPD----KEALDWN 52
++V ++ + L+V E + G L + D +EA +
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI- 166
Query: 53 TRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE---EGFHPKLSDFGLAKLGPVGD 109
MK A ++YLH + +RD K N+L KL+DFG AK +
Sbjct: 167 --MKSIGEA---IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 110 KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
++T T Y APE + D++S GV+
Sbjct: 219 S--LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVI 252
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 12/96 (12%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-KLSDFGLAKLGPVGDK--SHVSTRVMG 119
+ + ++H + +RD K N+L+ + KL DFG AK + +++ +R
Sbjct: 152 RAVGFIH-SLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR--- 205
Query: 120 TYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
+ Y APE + T D++S G VF ELI G+
Sbjct: 206 -F-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 12/101 (11%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA----KLGPVGDKSHVSTRVM 118
+ ++ LH +N VI+RD K SN+L+ K+ DFGLA + + M
Sbjct: 123 RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 119 GTY----GYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
+ Y APE +T + DV+S G + EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 33/165 (20%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK--- 56
L L H +++ L + +V E++ G L D++ H + EA R
Sbjct: 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA-----RRLFQQ 119
Query: 57 -IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
++A ++Y H V++RD K N+LL+ + K++DFGL+ + G+ S
Sbjct: 120 ILSA-----VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 171
Query: 116 RVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVVFLELITGR 154
G+ Y APE YA G + D++S GV+ L+ G
Sbjct: 172 ---GSPNYAAPEVISGRLYA--GP---EVDIWSCGVILYALLCGT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 36/153 (23%), Positives = 62/153 (40%), Gaps = 20/153 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ LL H N+V L ++ L+++ + G L + + E A+
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE--------ADASH 114
Query: 61 AAK----GLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHV 113
+ + + H V++R+ K N+LL +G KL+DFGLA V +
Sbjct: 115 CIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQA 169
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146
GT GY +PE D+++ GV+
Sbjct: 170 WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVI 202
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 6/95 (6%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMGT 120
+GL+Y+H AN V++RD K +N+ + E K+ DFGLA+ + P + + T
Sbjct: 131 RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 121 YGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
Y +P ++ T D+++ G +F E++TG+
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 3e-09
Identities = 19/150 (12%), Positives = 35/150 (23%), Gaps = 38/150 (25%)
Query: 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKG 64
+ + ++ L+V E++ GSL++ P A+ A
Sbjct: 88 IDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR------AMQSLAAA 141
Query: 65 LEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
+ H V S + + S G L
Sbjct: 142 ADAAHRA---GVALSIDHPSRVRV--------SIDGDVVLA--------------YPATM 176
Query: 125 APEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ D+ G L+ R
Sbjct: 177 PDA-------NPQDDIRGIGASLYALLVNR 199
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-09
Identities = 25/99 (25%), Positives = 47/99 (47%), Gaps = 12/99 (12%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDK--SHVSTRVMG 119
K L+Y H +++RD K N+++ E +L D+GLA+ G + V++R
Sbjct: 141 KALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 120 TYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGRKAI 157
+ PE + Q+ S D++S G + +I ++
Sbjct: 196 ---FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-09
Identities = 33/160 (20%), Positives = 62/160 (38%), Gaps = 20/160 (12%)
Query: 2 LSLLHHS--NLVNLIGYCADGDQRLLVYEF-MPLGSLEDHL--HDLPPDKEALDWNTRMK 56
L + ++ L+ + D +L+ E P+ L D + ++ A R
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA-----R-S 153
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVST 115
+ + + H+ V++RD K NIL+ KL DFG L + +
Sbjct: 154 FFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTD 207
Query: 116 RVMGTYGYCAPEYAMTGQLT-VKSDVYSFGVVFLELITGR 154
GT Y PE+ + + V+S G++ +++ G
Sbjct: 208 FD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 9e-09
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 33/165 (20%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK--- 56
L L H +++ L + +V E++ G L D++ + +KE+ R
Sbjct: 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES-----RRLFQQ 124
Query: 57 -IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVST 115
++ ++Y H V++RD K N+LL+ + K++DFGL+ + G+ S
Sbjct: 125 ILSG-----VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 176
Query: 116 RVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVVFLELITGR 154
G+ Y APE YA G + D++S GV+ L+ G
Sbjct: 177 ---GSPNYAAPEVISGRLYA--GP---EVDIWSSGVILYALLCGT 213
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 39/167 (23%), Positives = 62/167 (37%), Gaps = 35/167 (20%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHL--HDLPPDKEALDWNTRMK--- 56
L H N+V ++ E+ G L + + + EA R
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEA-----RFFFQQ 124
Query: 57 -IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP--KLSDFGLAKLGPVGDKSHV 113
++ + Y H + +RD K N LL+ P K+ DFG +K + +
Sbjct: 125 LLSG-----VSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 175
Query: 114 STRVMGTYGYCAPE------YAMTGQLTVKSDVYSFGVVFLELITGR 154
+ V GT Y APE Y G+ +DV+S GV ++ G
Sbjct: 176 -STV-GTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVGA 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 17/97 (17%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGY 123
+EY H +++RD K N+LL++ + K++DFGL+ + G+ S G+ Y
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 173
Query: 124 CAPE------YAMTGQLTVKSDVYSFGVVFLELITGR 154
APE YA G + DV+S G+V ++ GR
Sbjct: 174 AAPEVINGKLYA--GP---EVDVWSCGIVLYVMLVGR 205
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 6e-08
Identities = 24/93 (25%), Positives = 41/93 (44%), Gaps = 9/93 (9%)
Query: 64 GLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
+++ H + V++RD K NIL+ KL DFG L + GT
Sbjct: 151 AIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPYTDFD-GTRV 203
Query: 123 YCAPEYAMTGQLT-VKSDVYSFGVVFLELITGR 154
Y PE+ Q + + V+S G++ +++ G
Sbjct: 204 YSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 6e-08
Identities = 30/135 (22%), Positives = 55/135 (40%), Gaps = 32/135 (23%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLA----------------KLGP 106
G ++H+ + +I+RD K +N LL + K+ DFGLA +
Sbjct: 140 LGENFIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 107 VGDKSHVSTRVMGTY----GYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTR 161
G + + + ++ Y APE + + T D++S G +F EL+ ++ +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 162 PHGEQNLVTWARPLF 176
+ PLF
Sbjct: 257 TNR--------FPLF 263
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 28/112 (25%), Positives = 47/112 (41%), Gaps = 23/112 (20%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
K ++YLH +++RD K SNILL H K++DFGL++ + + +
Sbjct: 120 KVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 123 -------------------YCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
Y APE + T D++S G + E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 7e-07
Identities = 27/98 (27%), Positives = 44/98 (44%), Gaps = 13/98 (13%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHP------KLSDFGLAKLGPVGDKSHVSTR 116
GL+Y+H + +I+ D K N+L+E P K++D G A + + TR
Sbjct: 142 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 199
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
Y +PE + +D++S + ELITG
Sbjct: 200 E-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 8e-07
Identities = 31/140 (22%), Positives = 51/140 (36%), Gaps = 37/140 (26%)
Query: 63 KGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYG 122
G++Y+H A +++RD K +N L+ + K+ DFGLA+ + + +
Sbjct: 167 VGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 123 -------------------------YCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKA 156
Y APE + + T DV+S G +F EL+ K
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 157 IDSTRPHGEQNLVTWARPLF 176
+ PLF
Sbjct: 284 NVAYHADR--------GPLF 295
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 36/180 (20%), Positives = 52/180 (28%), Gaps = 61/180 (33%)
Query: 25 LVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKS 83
+V+E LG L + L KI +GL+YLH K +I+ D K
Sbjct: 122 MVFE--VLGHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKP 175
Query: 84 SNILLE-------------------------------------------------EGFHP 94
NILL E
Sbjct: 176 ENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKV 235
Query: 95 KLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
K++D G A + TR Y + E + +D++S + EL TG
Sbjct: 236 KIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 32/98 (32%), Positives = 43/98 (43%), Gaps = 14/98 (14%)
Query: 12 NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 70
+ + G +V E LG SLED L DL +L T + IA +EY+H
Sbjct: 69 QVYYFGPCGKYNAMVLEL--LGPSLED-LFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 71 KANPPVIYRDFKSSNILLEEGFHPK-----LSDFGLAK 103
K +IYRD K N L+ + + DF LAK
Sbjct: 124 KN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 45/153 (29%), Positives = 65/153 (42%), Gaps = 19/153 (12%)
Query: 12 NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 70
+ A+GD ++V E LG SLED L + K +L T + +A +EY+H
Sbjct: 69 TIRWCGAEGDYNVMVMEL--LGPSLED-LFNFCSRKFSL--KTVLLLADQMISRIEYIHS 123
Query: 71 KANPPVIYRDFKSSNILLEEGFHPK---LSDFGLAKL-GPVGDKSHVSTR----VMGTYG 122
K I+RD K N L+ G + DFGLAK H+ R + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 123 YCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 154
Y A G + + + D+ S G V + G
Sbjct: 181 Y-ASINTHLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 40/155 (25%), Positives = 64/155 (41%), Gaps = 21/155 (13%)
Query: 12 NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 70
N+ + +G +LV + LG SLED L DL K T A ++ +H+
Sbjct: 70 NVYYFGQEGLHNVLVIDL--LGPSLED-LLDLCGRK--FSVKTVAMAAKQMLARVQSIHE 124
Query: 71 KANPPVIYRDFKSSNILLEEGFHPK-----LSDFGLAKL-GPVGDKSHVSTR----VMGT 120
K+ ++YRD K N L+ + DFG+ K K H+ R + GT
Sbjct: 125 KS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 181
Query: 121 YGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 154
Y G + + + D+ + G VF+ + G
Sbjct: 182 ARY-MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 26/114 (22%), Positives = 43/114 (37%), Gaps = 20/114 (17%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHL----HDLPPDKEALDWN 52
++V ++ + L+V E + G L + ++EA +
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI- 122
Query: 53 TRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAK 103
MK A ++YLH + +RD K N+L KL+DFG AK
Sbjct: 123 --MKSIGEA---IQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 3e-05
Identities = 23/137 (16%), Positives = 36/137 (26%), Gaps = 19/137 (13%)
Query: 19 DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78
DQ +V EF G + + + T I L +
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASLR--FEH 185
Query: 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV------STRVMGTYGYC------AP 126
RD N+LL++ KL K + + + G
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245
Query: 127 EYAMTGQLTVKSDVYSF 143
E TG + D+Y
Sbjct: 246 EDLFTGDGDYQFDIYRL 262
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 19/153 (12%)
Query: 12 NLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD 70
N+ + +GD +LV + LG SLED L + K L T + +A +E++H
Sbjct: 67 NVRWFGVEGDYNVLVMDL--LGPSLED-LFNFCSRK--LSLKTVLMLADQMINRVEFVHS 121
Query: 71 KANPPVIYRDFKSSNILLEEGFHPK---LSDFGLAKL-GPVGDKSHVSTR----VMGTYG 122
K+ ++RD K N L+ G + DFGLAK H+ R + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 123 YCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 154
Y A G + + + D+ S G V + + G
Sbjct: 179 Y-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 9e-05
Identities = 23/106 (21%), Positives = 42/106 (39%), Gaps = 11/106 (10%)
Query: 2 LSLLHHSNLVNLIGY-CADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAA 59
L + +G+ R LV LG SL+ L P K L + +++A
Sbjct: 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSP--KHVLSERSVLQVAC 166
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPK--LSDFGLAK 103
LE+LH+ ++ + + NI ++ + L+ +G A
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 39.7 bits (93), Expect = 9e-04
Identities = 28/103 (27%), Positives = 47/103 (45%), Gaps = 14/103 (13%)
Query: 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP--KLSDFGLAKLGPVGDKSH- 112
K A + L+ LH +I+ D K NILL++ K+ DFG + + +
Sbjct: 204 KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCY--EHQRVYT 258
Query: 113 -VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ +R Y APE + + + D++S G + EL+TG
Sbjct: 259 YIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.98 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.98 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.67 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.45 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.12 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.83 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.64 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.63 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.53 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.98 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.95 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.75 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.6 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.43 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.21 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.08 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.46 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.12 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 94.28 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.57 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.75 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 92.36 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.64 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 91.59 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 91.02 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.96 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 90.88 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.18 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 89.35 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.02 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.71 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 86.34 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 83.66 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=361.22 Aligned_cols=213 Identities=28% Similarity=0.479 Sum_probs=165.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+ +..|||||||++|+|.++|+. ....+++..++.|+.|++.||+|||+++ |||||
T Consensus 85 il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRD 157 (307)
T 3omv_A 85 VLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRD 157 (307)
T ss_dssp HHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSC
T ss_pred HHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCc
Confidence 4789999999999999865 568999999999999999976 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc---CCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+||||++++.+||+|||+|+...............||+.|||||++.+ ..++.++|||||||++|||+||+.||
T Consensus 158 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf 237 (307)
T 3omv_A 158 MKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPY 237 (307)
T ss_dssp CCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence 999999999999999999999987554443444556789999999999964 46899999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
........ +.. .+.. ....|.+. ..+...+..+.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus 238 ~~~~~~~~--~~~----~~~~-----~~~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~ 300 (307)
T 3omv_A 238 SHINNRDQ--IIF----MVGR-----GYASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH 300 (307)
T ss_dssp TTCCCHHH--HHH----HHHT-----TCCCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred CCCChHHH--HHH----HHhc-----CCCCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 76543211 111 1111 11111111 1222344678899999999999999999999999988764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=364.20 Aligned_cols=213 Identities=28% Similarity=0.449 Sum_probs=167.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHh
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-----------DKEALDWNTRMKIAAGAAKGLEYLH 69 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~l~~~~~~~i~~~l~~al~~LH 69 (325)
+|++|+|||||+++++|.+.+..|||||||++|+|.++++.... ...+++|.+++.|+.|++.||+|||
T Consensus 96 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 47899999999999999999999999999999999999976432 2346999999999999999999999
Q ss_pred cCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHH
Q 020529 70 DKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 70 ~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~e 149 (325)
+.+ ||||||||+||||++++.+||+|||+++...........+...||+.|||||++.+..++.++|||||||++||
T Consensus 176 ~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~E 252 (329)
T 4aoj_A 176 GLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWE 252 (329)
T ss_dssp HTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHH
Confidence 999 99999999999999999999999999987554444445566789999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 150 LIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 150 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
|+| |+.||....... +...+ . ... . + ..|.....++.+|+.+||+.||++|||+.||++.|+
T Consensus 253 llt~G~~Pf~~~~~~~---~~~~i---~-~g~---~---~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~ 315 (329)
T 4aoj_A 253 IFTYGKQPWYQLSNTE---AIDCI---T-QGR---E---L----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQ 315 (329)
T ss_dssp HHTTSCCTTCSSCHHH---HHHHH---H-HTC---C---C----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHH
T ss_pred HHcCCCCCCCCCCHHH---HHHHH---H-cCC---C---C----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHH
Confidence 999 899997653221 11111 1 100 0 0 112233457889999999999999999999999999
Q ss_pred hhhcc
Q 020529 229 YLANQ 233 (325)
Q Consensus 229 ~~~~~ 233 (325)
.+...
T Consensus 316 ~l~~~ 320 (329)
T 4aoj_A 316 ALAQA 320 (329)
T ss_dssp HHHHS
T ss_pred HHhhC
Confidence 98764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=362.44 Aligned_cols=213 Identities=27% Similarity=0.411 Sum_probs=175.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP---------PDKEALDWNTRMKIAAGAAKGLEYLHDK 71 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~l~~~~~~~i~~~l~~al~~LH~~ 71 (325)
+|++|+|||||+++++|.+++..|||||||++|+|.++|+... .....++|..++.|+.|++.||+|||++
T Consensus 68 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 68 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4789999999999999999999999999999999999997632 1245699999999999999999999999
Q ss_pred CCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHH
Q 020529 72 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELI 151 (325)
Q Consensus 72 ~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ell 151 (325)
+ ||||||||+||||++++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+
T Consensus 148 ~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ell 224 (299)
T 4asz_A 148 H---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 224 (299)
T ss_dssp T---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHH
Confidence 9 9999999999999999999999999998654433333344567999999999999999999999999999999999
Q ss_pred h-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 152 T-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 152 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
| |+.||....... +... +.. .. ....|...+.++.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 225 t~G~~Pf~~~~~~~---~~~~---i~~-~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 225 TYGKQPWYQLSNNE---VIEC---ITQ-GR----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp TTTCCTTTTSCHHH---HHHH---HHH-TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHH---HHHH---HHc-CC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 8 899997654221 1111 111 00 0011223346788999999999999999999999999988
Q ss_pred hcc
Q 020529 231 ANQ 233 (325)
Q Consensus 231 ~~~ 233 (325)
...
T Consensus 288 ~~~ 290 (299)
T 4asz_A 288 AKA 290 (299)
T ss_dssp HHH
T ss_pred Hhc
Confidence 653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=361.42 Aligned_cols=210 Identities=25% Similarity=0.392 Sum_probs=173.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
+|++|+|||||+++|+|.+++..+||||||++|+|.++|....+ ....++|..++.|+.|||.||+||
T Consensus 82 il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL 161 (308)
T 4gt4_A 82 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYL 161 (308)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 36789999999999999999999999999999999999975322 134699999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+++ ||||||||+||||++++.+||+|||+++.....+.....+...||+.|+|||++.++.++.++|||||||++|
T Consensus 162 H~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~ 238 (308)
T 4gt4_A 162 SSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLW 238 (308)
T ss_dssp HHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred HhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHH
Confidence 9999 9999999999999999999999999998654444344455677999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||+| |..||...... .+...+. ... ....|...+..+.+|+.+||+.||.+|||+.||++.|
T Consensus 239 El~t~g~~Pf~~~~~~---~~~~~i~----~~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 239 EVFSYGLQPYCGYSNQ---DVVEMIR----NRQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp HHHTTTCCTTTTCCHH---HHHHHHH----TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHH---HHHHHHH----cCC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 9998 89999765422 1221111 110 0112333456788999999999999999999999999
Q ss_pred Hhh
Q 020529 228 SYL 230 (325)
Q Consensus 228 ~~~ 230 (325)
+.+
T Consensus 302 ~a~ 304 (308)
T 4gt4_A 302 RAW 304 (308)
T ss_dssp HTS
T ss_pred Hhc
Confidence 764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=355.22 Aligned_cols=210 Identities=19% Similarity=0.199 Sum_probs=170.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++|+|||||+++++|.+++..|||||||+||+|.+++.. ...+++..+..++.||+.||+|||+++ |||||
T Consensus 103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 175 (336)
T 4g3f_A 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGD 175 (336)
T ss_dssp TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 57899999999999999999999999999999999999976 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC-eEEEecCCCCccCCCCCCC---CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCC
Q 020529 81 FKSSNILLEEGF-HPKLSDFGLAKLGPVGDKS---HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 81 ik~~Nill~~~~-~~kL~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
|||+||||+.++ .+||+|||+++........ .....++||+.|||||++.+..++.++|||||||++|||+||+.|
T Consensus 176 lKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~P 255 (336)
T 4g3f_A 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255 (336)
T ss_dssp CCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCC
Confidence 999999999987 6999999999865432211 123346799999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
|...........+ ......+. ..+......+.+|+.+||+.||.+|||+.||++.|.....
T Consensus 256 f~~~~~~~~~~~i------~~~~~~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 256 WTQYFRGPLCLKI------ASEPPPIR---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp STTTCCSCCHHHH------HHSCCGGG---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHH------HcCCCCch---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 9875543321111 11111101 1122334578899999999999999999999999877654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=349.52 Aligned_cols=200 Identities=23% Similarity=0.309 Sum_probs=168.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++|+|||||+++++|.+.+..|||||||+||+|.+++.. ...+++..+..++.||+.||+|||+++ |+|||
T Consensus 85 il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRD 157 (311)
T 4aw0_A 85 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRD 157 (311)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCC
Confidence 47889999999999999999999999999999999999976 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||+.++.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 lKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 237 (311)
T 4aw0_A 158 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 237 (311)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998765444444556678999999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.... ....+..... .+|...+.++.+|+.+||+.||.+|||+.|++.
T Consensus 238 ~~~~------~~~~i~~~~~------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 238 NEGL------IFAKIIKLEY------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp SHHH------HHHHHHHTCC------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CHHH------HHHHHHcCCC------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 3211 1111111111 112233457889999999999999999998754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=352.12 Aligned_cols=201 Identities=22% Similarity=0.316 Sum_probs=166.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++|+|||||+++++|.+.+..|||||||+||+|.+++.. ..+++..+..++.||+.||+|||+++ |||||
T Consensus 124 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 195 (346)
T 4fih_A 124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 195 (346)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 46789999999999999999999999999999999999964 35999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||+.++.+||+|||+++..... ........||+.|||||++.+..|+.++|||||||++|||++|+.||...
T Consensus 196 lKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 273 (346)
T 4fih_A 196 IKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273 (346)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCHHHEEECCCCCEEEecCcCceecCCC--CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999999864322 22345678999999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
........ +.. ...+.+ ..+......+.+|+.+||+.||++|||+.|+++.
T Consensus 274 ~~~~~~~~------i~~-------~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 274 PPLKAMKM------IRD-------NLPPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CHHHHHHH------HHH-------SSCCCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHH------HHc-------CCCCCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 32211111 100 001111 1112334678899999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=354.47 Aligned_cols=202 Identities=21% Similarity=0.345 Sum_probs=166.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++|+|||||+++++|.+.+..|||||||+||+|.+++... ....+++..++.|+.||+.||+|||+++ |||||
T Consensus 76 il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 150 (350)
T 4b9d_A 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRD 150 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETT
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 467899999999999999999999999999999999999752 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||+.++.+||+|||+++.... .....+...||+.|||||++.+..|+.++|||||||++|||+||+.||...
T Consensus 151 lKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 228 (350)
T 4b9d_A 151 IKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG 228 (350)
T ss_dssp CCGGGEEECTTCCEEECSTTEESCCCH--HHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CCHHHEEECCCCCEEEcccccceeecC--CcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 999999999999999999999986421 112234567999999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... ....+.... + +. .+.....++.+|+.+||+.||.+|||+.|+++.
T Consensus 229 ~~~~------~~~~i~~~~--~-----~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 229 SMKN------LVLKIISGS--F-----PP----VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp SHHH------HHHHHHHTC--C-----CC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CHHH------HHHHHHcCC--C-----CC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3211 111111110 0 11 122334578899999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=344.13 Aligned_cols=200 Identities=26% Similarity=0.403 Sum_probs=158.6
Q ss_pred CcCCCCCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
+|++|+|||||+++++|.+ ....|||||||++|+|.+++.. ...+++..+..|+.||+.||+|||+++ ++|
T Consensus 78 il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~I 152 (290)
T 3fpq_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 152 (290)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCE
Confidence 4678999999999999865 3467999999999999999976 456999999999999999999999986 459
Q ss_pred EeCCCCCCcEEEc-CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 77 IYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 77 vHrdik~~Nill~-~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||||||+||||+ .++.+||+|||+|+.... .......||+.|||||++.+ .++.++|||||||++|||+||+.
T Consensus 153 iHRDlKp~NILl~~~~g~vKl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~ 227 (290)
T 3fpq_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp CCCCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecccChhheeEECCCCCEEEEeCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCC
Confidence 9999999999997 478999999999985322 23445789999999998865 69999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
||....... .+. ..+.... ..+.+ +.....++.+|+.+||+.||++|||+.|+++
T Consensus 228 Pf~~~~~~~--~~~---~~i~~~~------~~~~~----~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 228 PYSECQNAA--QIY---RRVTSGV------KPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTTTCSSHH--HHH---HHHTTTC------CCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCcHH--HHH---HHHHcCC------CCCCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 996543211 111 1111100 00011 1112246789999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=342.21 Aligned_cols=226 Identities=23% Similarity=0.281 Sum_probs=165.4
Q ss_pred cCCCCCCCccceeeEEEeCC----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----
Q 020529 2 LSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA----- 72 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~----- 72 (325)
+.+++|||||+++++|.+.+ ..|||||||++|+|.++++. .++++..+++++.|++.||+|||++.
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~ 125 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTC
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccC
Confidence 56789999999999998654 57999999999999999975 35999999999999999999999871
Q ss_pred CCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC--CccccccCCcCccCchhhccC------CCCccccEEEeh
Q 020529 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTG------QLTVKSDVYSFG 144 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlG 144 (325)
.++||||||||+||||+.++.+||+|||+++........ .......||+.|+|||++.+. .++.++||||||
T Consensus 126 ~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~G 205 (303)
T 3hmm_A 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp BCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred CCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHH
Confidence 234999999999999999999999999999865433221 123346799999999998764 467899999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCC-----hHHHHHHHHHHHHchhhCCCCCCC
Q 020529 145 VVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP-----IRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 145 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
|++|||+||.+|+......... ...+.............+....++...| .+....+.+|+.+||+.||.+|||
T Consensus 206 vvl~El~tg~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt 284 (303)
T 3hmm_A 206 LVFWEIARRCSIGGIHEDYQLP-YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCT-TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred HHHHHHHHCCCCCCcccccccc-chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC
Confidence 9999999999887543321110 0000000000000001111112222222 234567889999999999999999
Q ss_pred HHHHHHHHHhhhcc
Q 020529 220 IGDVVTALSYLANQ 233 (325)
Q Consensus 220 ~~evl~~L~~~~~~ 233 (325)
+.||++.|+.+...
T Consensus 285 ~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 285 ALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999988754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=341.14 Aligned_cols=198 Identities=26% Similarity=0.316 Sum_probs=163.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++|+|||||+++++|.+.+..|||||||+||+|.+++.. ...+++..+..++.|++.||+|||+++ |+|||
T Consensus 79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRD 151 (304)
T 3ubd_A 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRD 151 (304)
T ss_dssp CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCC
Confidence 57899999999999999999999999999999999999976 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+|+..... ........||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 152 lKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~ 229 (304)
T 3ubd_A 152 LKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229 (304)
T ss_dssp CCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHeEEcCCCCEEecccccceeccCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999854322 22334578999999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH-----HHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI-----GDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~-----~evl~ 225 (325)
.... ....+..... .+|...+.++.+|+.+||+.||.+|||+ +|+++
T Consensus 230 ~~~~------~~~~i~~~~~------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 230 DRKE------TMTMILKAKL------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp SHHH------HHHHHHHCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred CHHH------HHHHHHcCCC------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 3221 1111111111 1122234568899999999999999994 56654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=352.82 Aligned_cols=212 Identities=26% Similarity=0.379 Sum_probs=171.5
Q ss_pred cCCC-CCCCccceeeEEEeC-CeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEY 67 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~ 67 (325)
|+++ +|||||+++++|.+. +..|||||||++|+|.++|+.... .+..+++..++.++.|||.||+|
T Consensus 121 l~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 4566 459999999999764 578999999999999999975321 23558999999999999999999
Q ss_pred HhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHH
Q 020529 68 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVF 147 (325)
Q Consensus 68 LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl 147 (325)
||+++ ||||||||+||||++++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++
T Consensus 201 LH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l 277 (353)
T 4ase_A 201 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 277 (353)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHH
Confidence 99999 999999999999999999999999999875544444445567799999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 148 LELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 148 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|||+| |+.||....... .+.. .+.... ....|.....++.+|+.+||+.||.+|||+.+|++.
T Consensus 278 ~El~t~G~~Pf~~~~~~~--~~~~----~i~~g~----------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 278 WEIFSLGASPYPGVKIDE--EFCR----RLKEGT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHTTTSCCSSTTCCCSH--HHHH----HHHHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHH--HHHH----HHHcCC----------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 99998 899997654321 1111 111110 011222334578899999999999999999999999
Q ss_pred HHhhhc
Q 020529 227 LSYLAN 232 (325)
Q Consensus 227 L~~~~~ 232 (325)
|+.+..
T Consensus 342 L~~llq 347 (353)
T 4ase_A 342 LGNLLQ 347 (353)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998764
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=353.74 Aligned_cols=201 Identities=22% Similarity=0.314 Sum_probs=165.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
||++|+|||||+++++|.+.+..|||||||+||+|.+++.. ..+++..+..|+.||+.||+|||+++ |||||
T Consensus 201 il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRD 272 (423)
T 4fie_A 201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRD 272 (423)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccc
Confidence 46789999999999999999999999999999999999964 35999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||+.++.+||+|||+++..... .......+||+.|||||++.+..|+.++|||||||++|||++|+.||...
T Consensus 273 iKp~NILl~~~g~vKl~DFGla~~~~~~--~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 273 IKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp CSTTTEEECTTCCEEECCCTTCEECCSS--CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CCHHHEEEcCCCCEEEecCccceECCCC--CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999999864322 22345678999999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
........ +.. ...+.+. ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 351 ~~~~~~~~------i~~-------~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 351 PPLKAMKM------IRD-------NLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CHHHHHHH------HHH-------SCCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CHHHHHHH------HHc-------CCCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 32211111 110 0111111 111234578899999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=332.40 Aligned_cols=197 Identities=22% Similarity=0.326 Sum_probs=154.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||++++++.+.+..|+||||+ +|+|.+++.. ...+++..+..++.|++.||+|||+++ |+|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRD 137 (275)
T 3hyh_A 66 YLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRD 137 (275)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 367899999999999999999999999999 6899999976 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+||||+.++.+||+|||+|+..... .......||+.|+|||++.+..+ +.++|||||||++|+|+||+.||..
T Consensus 138 iKP~NILl~~~~~vkl~DFGla~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 138 LKPENLLLDEHLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp CCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CChHHeEECCCCCEEEeecCCCeecCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999764322 23345679999999999998876 5799999999999999999999975
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... .....+...... ++......+.+|+.+||+.||.+|||+.|+++.
T Consensus 215 ~~~~------~~~~~i~~~~~~------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 215 ESIP------VLFKNISNGVYT------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp SSHH------HHHHHHHHTCCC------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCHH------HHHHHHHcCCCC------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 4321 111111111111 112233567899999999999999999999874
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=323.05 Aligned_cols=202 Identities=21% Similarity=0.289 Sum_probs=147.9
Q ss_pred CcCCCCCCCccceeeEEEeCC------------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 1 MLSLLHHSNLVNLIGYCADGD------------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~------------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
+|++|+|||||+++++|.+.+ ..|+|||||++|+|.+++..... ....++..++.|+.||+.||+||
T Consensus 56 il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~yl 134 (299)
T 4g31_A 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFL 134 (299)
T ss_dssp HHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHH
Confidence 478899999999999987644 36999999999999999976322 22356778899999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC----------CccccccCCcCccCchhhccCCCCccc
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS----------HVSTRVMGTYGYCAPEYAMTGQLTVKS 138 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~ks 138 (325)
|+++ ||||||||+||||+.++.+||+|||+|+........ ...+...||+.|||||++.+..++.++
T Consensus 135 H~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~ 211 (299)
T 4g31_A 135 HSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV 211 (299)
T ss_dssp HHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHH
T ss_pred HHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHH
Confidence 9999 999999999999999999999999999865432211 112346799999999999999999999
Q ss_pred cEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC
Q 020529 139 DVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 218 (325)
Q Consensus 139 DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP 218 (325)
|||||||++|||++ ||.... ......... ....-|.. .......+.+|+.+||+.||.+||
T Consensus 212 DiwSlGvilyell~---Pf~~~~-----~~~~~~~~~-------~~~~~p~~----~~~~~~~~~~li~~~L~~dP~~Rp 272 (299)
T 4g31_A 212 DIFSLGLILFELLY---PFSTQM-----ERVRTLTDV-------RNLKFPPL----FTQKYPCEYVMVQDMLSPSPMERP 272 (299)
T ss_dssp HHHHHHHHHHHHHS---CCSSHH-----HHHHHHHHH-------HTTCCCHH----HHHHCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHHHHHHHcc---CCCCcc-----HHHHHHHHH-------hcCCCCCC----CcccCHHHHHHHHHHcCCChhHCc
Confidence 99999999999996 664211 000000000 00000000 112234567899999999999999
Q ss_pred CHHHHHH
Q 020529 219 LIGDVVT 225 (325)
Q Consensus 219 s~~evl~ 225 (325)
|+.|+++
T Consensus 273 s~~eil~ 279 (299)
T 4g31_A 273 EAINIIE 279 (299)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999986
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=314.36 Aligned_cols=228 Identities=41% Similarity=0.720 Sum_probs=196.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..++||||+++++|.+++.........+++..++.++.|++.||+|||+.+ |+|||
T Consensus 88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~d 164 (321)
T 2qkw_B 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRD 164 (321)
T ss_dssp GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCC
Confidence 467899999999999999999999999999999999999765444456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 165 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~ 244 (321)
T 2qkw_B 165 VKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS 244 (321)
T ss_dssp CCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS
T ss_pred CCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc
Confidence 99999999999999999999997654433333445566899999999999999999999999999999999999999887
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.+........|...... ...+...+++.+....+......+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 245 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 245 LPREMVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp SSSSCCCHHHHTHHHHT-TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcHHHHHHHHHhhhccc-cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 77666666666544332 234456667777777777888999999999999999999999999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=317.94 Aligned_cols=149 Identities=26% Similarity=0.350 Sum_probs=128.0
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+.+ +|||||+++++|.+.++.|||||||++++|.+++. .+++..+..++.|++.||+|||+++ |+|||
T Consensus 73 l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~g---IiHRD 142 (361)
T 4f9c_A 73 LTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFG---IVHRD 142 (361)
T ss_dssp HHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCc
Confidence 4455 79999999999999999999999999999999984 3899999999999999999999999 99999
Q ss_pred CCCCcEEEcCC-CeEEEecCCCCccCCCCCC--------------------------CCccccccCCcCccCchhhccC-
Q 020529 81 FKSSNILLEEG-FHPKLSDFGLAKLGPVGDK--------------------------SHVSTRVMGTYGYCAPEYAMTG- 132 (325)
Q Consensus 81 ik~~Nill~~~-~~~kL~Dfgla~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~- 132 (325)
|||+|||++.+ +.+||+|||+|+....... ....+...||+.|+|||++.+.
T Consensus 143 iKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 222 (361)
T 4f9c_A 143 VKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP 222 (361)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCS
T ss_pred CCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 99999999877 7999999999975432211 0112335799999999999876
Q ss_pred CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 133 QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 133 ~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
.++.++||||+||++|||++|+.||...
T Consensus 223 ~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 223 NQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred CCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 5899999999999999999999999654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=335.39 Aligned_cols=199 Identities=24% Similarity=0.276 Sum_probs=163.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++|||||+++++|.+.+..|||||||+||+|.++|.. ...+++..+..++.||+.||+|||+++ ||||||
T Consensus 246 l~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDL 318 (689)
T 3v5w_A 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDL 318 (689)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 4678999999999999999999999999999999999976 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||||+.+|++||+|||+|+..... .....+||+.|||||++.. ..|+.++|||||||++|||++|+.||...
T Consensus 319 KPeNILld~~G~vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 319 KPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred chHHeEEeCCCCEEecccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999864322 2344689999999999975 57999999999999999999999999754
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
.......+. ....... ..+|.....++.+|+.+||+.||.+|++ +.||++.
T Consensus 395 ~~~~~~~i~---~~i~~~~------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 395 KTKDKHEID---RMTLTMA------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp GCCCHHHHH---HHHHHCC------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ChHHHHHHH---HhhcCCC------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 332221111 1111111 0122233467889999999999999998 6787764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=322.07 Aligned_cols=214 Identities=22% Similarity=0.294 Sum_probs=159.8
Q ss_pred CcCCCCCCCccceeeEEEe------CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+|+.|+|||||++++++.. .+..|||||||+ |+|.+++.. ..++++..+..++.||+.||.|||+++
T Consensus 106 il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~-- 178 (398)
T 4b99_A 106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ-- 178 (398)
T ss_dssp HHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc--
Confidence 4678999999999998754 357899999995 789999975 567999999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCC--CCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHH
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELI 151 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~ell 151 (325)
||||||||+|||++.++.+||+|||+++...... .........||+.|+|||++.+. .++.++||||+||++|||+
T Consensus 179 -iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell 257 (398)
T 4b99_A 179 -VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257 (398)
T ss_dssp -CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred -CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence 9999999999999999999999999998653321 12234557899999999998875 5699999999999999999
Q ss_pred hCCCCCCCCCCCCcchhhhhhhhccccccccc------------cccCCccCCCCC-----hHHHHHHHHHHHHchhhCC
Q 020529 152 TGRKAIDSTRPHGEQNLVTWARPLFNDRRKFS------------KLADPRLEGRYP-----IRGLYQALAVASMCIQEQA 214 (325)
Q Consensus 152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~d~~l~~~~~-----~~~~~~~~~l~~~cl~~~p 214 (325)
+|++||.+.........+. ........... ..+.+ ....+ .....++.+|+.+||+.||
T Consensus 258 ~G~~pF~g~~~~~~l~~I~--~~~g~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 333 (398)
T 4b99_A 258 ARRQLFPGKNYVHQLQLIM--MVLGTPSPAVIQAVGAERVRAYIQSLPP--RQPVPWETVYPGADRQALSLLGRMLRFEP 333 (398)
T ss_dssp HTSCSSCCSSHHHHHHHHH--HHHCCCCGGGTC-----CHHHHHHSSCC--CCCCCHHHHSTTCCHHHHHHHHHHSCSST
T ss_pred HCCCCCCCCCHHHHHHHHH--HhcCCCChHHhhhhhhhhhhhhhhcCCC--cCCCCHHHhCCCCCHHHHHHHHHHCcCCh
Confidence 9999997654322111110 00000000000 00000 00001 1123578899999999999
Q ss_pred CCCCCHHHHHHH
Q 020529 215 ATRPLIGDVVTA 226 (325)
Q Consensus 215 ~~RPs~~evl~~ 226 (325)
.+|||+.|+++.
T Consensus 334 ~~R~ta~e~L~H 345 (398)
T 4b99_A 334 SARISAAAALRH 345 (398)
T ss_dssp TTSCCHHHHTTS
T ss_pred hHCcCHHHHhcC
Confidence 999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=307.40 Aligned_cols=226 Identities=42% Similarity=0.730 Sum_probs=193.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC---CCCCeE
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK---ANPPVI 77 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~---~~~~iv 77 (325)
+|++++||||++++++|.+.+..++||||+.+++|.+++.........+++..++.|+.+++.||+|||+. + |+
T Consensus 80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---iv 156 (326)
T 3uim_A 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---II 156 (326)
T ss_dssp GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EE
T ss_pred HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eE
Confidence 46789999999999999999999999999999999999988666667799999999999999999999999 7 99
Q ss_pred eCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 78 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 78 Hrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||||||+|||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus 157 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 235 (326)
T 3uim_A 157 HRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235 (326)
T ss_dssp CCCCSGGGEEECTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSB
T ss_pred eCCCchhhEEECCCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcc
Confidence 99999999999999999999999998654322 23344566999999999999999999999999999999999999999
Q ss_pred CCCC--CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 158 DSTR--PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 158 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
+... ......+..|....... ..+..+.+..+...++......+.+++..||+.+|.+|||+.+|++.|+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 236 DLARLANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp CHHHHTTTSCSBHHHHHTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred cccccccccchhHHHHHHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 6321 12334455566555543 3446677777888888888999999999999999999999999999998643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=331.95 Aligned_cols=203 Identities=23% Similarity=0.287 Sum_probs=164.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.|+|||||+++++|.+.+..|||||||+||+|.+++.. ....+++..+..++.||+.||.|||+++ |+|||
T Consensus 207 il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRD 280 (573)
T 3uto_A 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 280 (573)
T ss_dssp HHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 46789999999999999999999999999999999999965 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC--CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 81 FKSSNILLEEG--FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~--~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 281 lKp~Nill~~~~~~~vKl~DFG~a~~~~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp CCGGGEEESSSSCCCEEECCCSSCEECCTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CChhhccccCCCCCCEEEeeccceeEccCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 99999999854 79999999999865322 23345679999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
........ ..+...... +.+... ......+.+|+.+||+.||.+||++.|+++.
T Consensus 358 ~~~~~~~~------~~i~~~~~~----~~~~~~----~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 358 GENDDETL------RNVKSCDWN----MDDSAF----SGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp CSSHHHHH------HHHHTTCCC----CCSGGG----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CcCHHHHH------HHHHhCCCC----CCcccc----cCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 65432111 111111000 111111 1224568899999999999999999999873
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=305.21 Aligned_cols=224 Identities=27% Similarity=0.367 Sum_probs=171.4
Q ss_pred CcCCCCCCCccceeeEEEeCC----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----
Q 020529 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK----- 71 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~----- 71 (325)
+|++++||||+++++++.+.. ..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~ 145 (322)
T 3soc_A 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLK 145 (322)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEET
T ss_pred HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 478899999999999998754 46999999999999999975 3499999999999999999999998
Q ss_pred -----CCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-----CCCccccEE
Q 020529 72 -----ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-----QLTVKSDVY 141 (325)
Q Consensus 72 -----~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~ksDvw 141 (325)
+ |+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||
T Consensus 146 ~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw 222 (322)
T 3soc_A 146 DGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222 (322)
T ss_dssp TEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHH
T ss_pred cccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhH
Confidence 8 999999999999999999999999999765544433334456799999999999863 456789999
Q ss_pred EehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccc----cccccCCccCCCC-ChHHHHHHHHHHHHchhhCCCC
Q 020529 142 SFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRK----FSKLADPRLEGRY-PIRGLYQALAVASMCIQEQAAT 216 (325)
Q Consensus 142 SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~d~~l~~~~-~~~~~~~~~~l~~~cl~~~p~~ 216 (325)
||||++|||++|+.||..........+............. ......+.+...+ .......+.+|+.+||+.||.+
T Consensus 223 slG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 302 (322)
T 3soc_A 223 AMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302 (322)
T ss_dssp HHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhh
Confidence 9999999999999999875443322221111000000000 0111111111111 1234567899999999999999
Q ss_pred CCCHHHHHHHHHhhhc
Q 020529 217 RPLIGDVVTALSYLAN 232 (325)
Q Consensus 217 RPs~~evl~~L~~~~~ 232 (325)
|||+.+|++.|+.+..
T Consensus 303 Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 303 RLSAGCVGERITQMQR 318 (322)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHH
Confidence 9999999999998865
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=306.95 Aligned_cols=212 Identities=25% Similarity=0.385 Sum_probs=172.4
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
|+++ +||||++++++|.+.+..|+||||+++|+|.+++..... ....+++..++.++.|++.||+||
T Consensus 140 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 219 (370)
T 2psq_A 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219 (370)
T ss_dssp HHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4567 899999999999999999999999999999999986432 124589999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+++ |+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|
T Consensus 220 H~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ 296 (370)
T 2psq_A 220 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 296 (370)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred HhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHH
Confidence 9999 9999999999999999999999999998654443333344456788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||++ |..||....... +..... .. .....+......+.+|+.+||+.+|.+||++.+|++.|
T Consensus 297 ellt~g~~p~~~~~~~~---~~~~~~----~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L 359 (370)
T 2psq_A 297 EIFTLGGSPYPGIPVEE---LFKLLK----EG----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359 (370)
T ss_dssp HHHTTSCCSSTTCCGGG---HHHHHH----TT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCCCCCCCCHHH---HHHHHh----cC----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999 999997643221 111100 00 00111223345788999999999999999999999999
Q ss_pred Hhhhcc
Q 020529 228 SYLANQ 233 (325)
Q Consensus 228 ~~~~~~ 233 (325)
+.+...
T Consensus 360 ~~il~~ 365 (370)
T 2psq_A 360 DRILTL 365 (370)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 988753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=298.44 Aligned_cols=212 Identities=25% Similarity=0.356 Sum_probs=169.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 60 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~d 133 (310)
T 3s95_A 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRD 133 (310)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 36788999999999999999999999999999999999976 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCC------------ccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH------------VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|||+||+++.++.+||+|||+++......... ......||+.|+|||++.+..++.++||||||+++|
T Consensus 134 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~ 213 (310)
T 3s95_A 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213 (310)
T ss_dssp CSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHH
Confidence 99999999999999999999997653322111 111457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 149 ELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 149 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
||++|..|+............. .. ...+... +......+.+|+.+||+.||.+||++.+|++.|+
T Consensus 214 el~~g~~~~~~~~~~~~~~~~~-~~----------~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~ 278 (310)
T 3s95_A 214 EIIGRVNADPDYLPRTMDFGLN-VR----------GFLDRYC----PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE 278 (310)
T ss_dssp HHHHTCCSSTTTSCBCTTSSBC-HH----------HHHHHTC----CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHhcCCCCCcchhhhHHHHhhh-hh----------ccccccC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 9999999987654322211100 00 0000001 1112235789999999999999999999999999
Q ss_pred hhhcc
Q 020529 229 YLANQ 233 (325)
Q Consensus 229 ~~~~~ 233 (325)
.+...
T Consensus 279 ~l~~~ 283 (310)
T 3s95_A 279 TLRMH 283 (310)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 88653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=294.05 Aligned_cols=223 Identities=39% Similarity=0.633 Sum_probs=178.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ |+||||
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl 159 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDI 159 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCC
Confidence 567899999999999999999999999999999999987532 2356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.+||+|||+++...............||+.|+|||++.+ .++.++||||||+++|+|++|..||....
T Consensus 160 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 160 KSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred CHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 99999999999999999999976544333333445679999999998765 58899999999999999999999998754
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
... .+..+..........+...+++.+. ..+......+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus 239 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 239 EPQ--LLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SSS--BTTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred chH--HHHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 332 1222222222222233344444432 3455667889999999999999999999999999998753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=298.76 Aligned_cols=213 Identities=31% Similarity=0.449 Sum_probs=161.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Di 165 (309)
T 3p86_A 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNL 165 (309)
T ss_dssp HHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTH-HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTC
T ss_pred HHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCC
Confidence 5678999999999999999999999999999999999975211 123899999999999999999999986 45999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 166 kp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~ 243 (309)
T 3p86_A 166 KSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243 (309)
T ss_dssp CGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC
T ss_pred ChhhEEEeCCCcEEECCCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999753222 222345679999999999999999999999999999999999999997653
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
.......... .. .....+......+.+|+.+||+.+|.+||++.+|++.|+.+....
T Consensus 244 ~~~~~~~~~~------------~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 244 PAQVVAAVGF------------KC----KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp HHHHHHHHHH------------SC----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred HHHHHHHHHh------------cC----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 2211110000 00 001112233456889999999999999999999999999887654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=299.45 Aligned_cols=211 Identities=23% Similarity=0.369 Sum_probs=169.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.|+.+++.||+|||+.+ |+|||
T Consensus 103 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~D 176 (325)
T 3kul_A 103 IMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRD 176 (325)
T ss_dssp HHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCC
Confidence 36788999999999999999999999999999999999975 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~ 158 (325)
|||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.
T Consensus 177 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~ 256 (325)
T 3kul_A 177 LAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW 256 (325)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999865433221 12233456788999999999999999999999999999999 999996
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
...... +...... . .....+......+.+|+..||+.+|.+||++.+|++.|+.+....
T Consensus 257 ~~~~~~---~~~~~~~----------~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 257 NMTNRD---VISSVEE----------G----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp TSCHHH---HHHHHHT----------T----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred cCCHHH---HHHHHHc----------C----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 643221 1111000 0 011112233457889999999999999999999999999987643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=300.41 Aligned_cols=207 Identities=25% Similarity=0.399 Sum_probs=167.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||++++++|.++. .++|++|+.+++|.+++.. ....+++..++.|+.|++.||+|||+.+ |+||||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Di 143 (327)
T 3poz_A 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDL 143 (327)
T ss_dssp HHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCC
Confidence 56789999999999998765 7789999999999999976 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||...
T Consensus 144 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 223 (327)
T 3poz_A 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp CGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred ChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC
Confidence 99999999999999999999987554444334445567889999999999999999999999999999999 99999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.......... . ......+......+.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus 224 ~~~~~~~~~~-------~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 224 PASEISSILE-------K----------GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CGGGHHHHHH-------T----------TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CHHHHHHHHH-------c----------CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 4322111110 0 00111122334578899999999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=296.51 Aligned_cols=212 Identities=26% Similarity=0.398 Sum_probs=171.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHHH
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--------------------DKEALDWNTRMKIAAGA 61 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~l 61 (325)
|++++||||+++++++.+.+..++||||+++++|.+++..... ....+++..++.++.|+
T Consensus 80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 159 (314)
T 2ivs_A 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159 (314)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence 6788999999999999999999999999999999999986432 12348999999999999
Q ss_pred HHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEE
Q 020529 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVY 141 (325)
Q Consensus 62 ~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvw 141 (325)
+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||
T Consensus 160 ~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 236 (314)
T 2ivs_A 160 SQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW 236 (314)
T ss_dssp HHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHH
T ss_pred HHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHH
Confidence 99999999999 999999999999999999999999999765443332233445678899999999999999999999
Q ss_pred EehHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 142 SFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 142 SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
|||+++|||++ |..||........... ... . . ....+......+.+|+.+||+.||.+||++
T Consensus 237 slG~il~el~t~g~~p~~~~~~~~~~~~---~~~----~------~----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 299 (314)
T 2ivs_A 237 SFGVLLWEIVTLGGNPYPGIPPERLFNL---LKT----G------H----RMERPDNCSEEMYRLMLQCWKQEPDKRPVF 299 (314)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHT----T------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHH---hhc----C------C----cCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 99999999999 9999976543221111 100 0 0 011122334578899999999999999999
Q ss_pred HHHHHHHHhhhcc
Q 020529 221 GDVVTALSYLANQ 233 (325)
Q Consensus 221 ~evl~~L~~~~~~ 233 (325)
.+|++.|+.+...
T Consensus 300 ~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 300 ADISKDLEKMMVK 312 (314)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhh
Confidence 9999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=299.27 Aligned_cols=208 Identities=25% Similarity=0.398 Sum_probs=162.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||++++++|.... .++|++|+.+++|.+++.. ....+++..++.|+.|++.||.|||+.+ |+||||
T Consensus 71 l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 143 (327)
T 3lzb_A 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDL 143 (327)
T ss_dssp HTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCC
Confidence 67889999999999998765 7889999999999999976 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 144 kp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~ 223 (327)
T 3lzb_A 144 AARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223 (327)
T ss_dssp CGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred CHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999986544433333444567889999999999999999999999999999999 99999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
......... .. ......+......+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus 224 ~~~~~~~~~---~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 224 PASEISSIL---EK--------------GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CGGGHHHHH---HT--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CHHHHHHHH---Hc--------------CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 432211111 00 000111222345688999999999999999999999999988754
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=299.32 Aligned_cols=208 Identities=28% Similarity=0.467 Sum_probs=166.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++. +...++||||+.+++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||
T Consensus 69 l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Di 141 (325)
T 3kex_A 69 IGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNL 141 (325)
T ss_dssp HHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCcc
Confidence 46789999999999986 4568899999999999999976 2346899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+|||++.++.+||+|||+++...............|++.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 142 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 221 (325)
T 3kex_A 142 AARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221 (325)
T ss_dssp SSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred chheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCcccc
Confidence 99999999999999999999987655544444556678889999999999999999999999999999999 99999875
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
............. ... .+......+.+++.+||+.+|.+||++.+|++.|..+...
T Consensus 222 ~~~~~~~~~~~~~----------~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 222 RLAEVPDLLEKGE----------RLA-------QPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp CTTHHHHHHHTTC----------BCC-------CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CHHHHHHHHHcCC----------CCC-------CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 4332211111100 000 0111123467899999999999999999999999988643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=293.01 Aligned_cols=200 Identities=25% Similarity=0.348 Sum_probs=163.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++...+..++||||+++++|.+++.. ..+++..++.++.+++.||+|||+.+ |+||||
T Consensus 71 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dl 142 (297)
T 3fxz_A 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDI 142 (297)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCC
Confidence 5678999999999999999999999999999999999975 35899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++.+||+|||++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 143 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 220 (297)
T 3fxz_A 143 KSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (297)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CHHHEEECCCCCEEEeeCCCceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999987643322 23345679999999999999999999999999999999999999997643
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....... ..... .... ..+......+.+|+.+||+.||.+||++.++++.
T Consensus 221 ~~~~~~~------~~~~~--~~~~-------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 221 PLRALYL------IATNG--TPEL-------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp HHHHHHH------HHHHC--SCCC-------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred HHHHHHH------HHhCC--CCCC-------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 2211110 00000 0000 1122334568899999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=306.92 Aligned_cols=209 Identities=24% Similarity=0.363 Sum_probs=167.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||++++++|.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 165 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrD 238 (377)
T 3cbl_A 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRD 238 (377)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcc
Confidence 36789999999999999999999999999999999999975 2345899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+|||++.++.+||+|||+++...............+++.|+|||++....++.++|||||||++|||++ |..||..
T Consensus 239 lkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp CSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999975332211111122335678999999999999999999999999999998 9999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..... ..... .... ....+......+.+|+.+||+.+|.+|||+.+|++.|+.+..
T Consensus 319 ~~~~~---~~~~~----~~~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 319 LSNQQ---TREFV----EKGG----------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp SCHHH---HHHHH----HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH---HHHHH----HcCC----------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 43211 11111 0000 011122234568899999999999999999999999998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=301.91 Aligned_cols=213 Identities=26% Similarity=0.384 Sum_probs=173.2
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
|+++ +||||++++++|.+.+..++||||+++++|.+++..... ....+++..++.|+.|++.||+||
T Consensus 128 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 207 (382)
T 3tt0_A 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL 207 (382)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 4456 899999999999999999999999999999999986432 124599999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ |+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||+++
T Consensus 208 H~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 284 (382)
T 3tt0_A 208 ASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLW 284 (382)
T ss_dssp HHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHH
T ss_pred HhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHH
Confidence 9999 9999999999999999999999999998655443333444556788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
+|++ |..||...... .+...... . .....+......+.+|+.+||+.+|.+||++.+|++.|
T Consensus 285 ellt~g~~p~~~~~~~---~~~~~~~~----~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 347 (382)
T 3tt0_A 285 EIFTLGGSPYPGVPVE---ELFKLLKE----G----------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347 (382)
T ss_dssp HHHTTSCCSSTTCCHH---HHHHHHHT----T----------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHH---HHHHHHHc----C----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999 99999764321 11111110 0 00111122345788999999999999999999999999
Q ss_pred HhhhccC
Q 020529 228 SYLANQT 234 (325)
Q Consensus 228 ~~~~~~~ 234 (325)
+.+....
T Consensus 348 ~~~~~~~ 354 (382)
T 3tt0_A 348 DRIVALT 354 (382)
T ss_dssp HHHHHHS
T ss_pred HHHHHHH
Confidence 9987644
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=299.11 Aligned_cols=219 Identities=15% Similarity=0.155 Sum_probs=170.5
Q ss_pred cCCCCCCCccceeeEEEeC----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 2 LSLLHHSNLVNLIGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
++.++||||+++++++... ...||||||+ +++|.+++.. ....+++..++.|+.|++.||+|||+.+ |+
T Consensus 102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ii 174 (364)
T 3op5_A 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YV 174 (364)
T ss_dssp HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eE
Confidence 4678999999999998764 4689999999 9999999976 3456999999999999999999999999 99
Q ss_pred eCCCCCCcEEEc--CCCeEEEecCCCCccCCCCCCC-----CccccccCCcCccCchhhccCCCCccccEEEehHHHHHH
Q 020529 78 YRDFKSSNILLE--EGFHPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 78 Hrdik~~Nill~--~~~~~kL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~el 150 (325)
||||||+|||++ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 175 HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el 254 (364)
T 3op5_A 175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQW 254 (364)
T ss_dssp CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHH
Confidence 999999999999 8899999999999764332211 112345599999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
++|+.||....... .......... ...+..++++.+.. ......+.+|+..|++.+|.+||++.+|++.|..+
T Consensus 255 ~~g~~Pf~~~~~~~--~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 255 LTGHLPWEDNLKDP--KYVRDSKIRY--RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp HHSCCTTGGGTTCH--HHHHHHHHHH--HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred HhCCCCccccccCH--HHHHHHHHHh--hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 99999997543221 1111111111 11122222222210 12235688999999999999999999999999988
Q ss_pred hccC
Q 020529 231 ANQT 234 (325)
Q Consensus 231 ~~~~ 234 (325)
....
T Consensus 328 ~~~~ 331 (364)
T 3op5_A 328 LKAI 331 (364)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 7654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=302.10 Aligned_cols=210 Identities=22% Similarity=0.369 Sum_probs=159.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 99 ~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 172 (373)
T 2qol_A 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRD 172 (373)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCC
Confidence 36789999999999999999999999999999999999976 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCC-ccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~ 158 (325)
|||+|||++.++.+||+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 173 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~ 252 (373)
T 2qol_A 173 LAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW 252 (373)
T ss_dssp CCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTT
T ss_pred CCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998654322111 1222345778999999999999999999999999999998 999996
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
...... +...... . .....+......+.+|+..||+.+|.+||++.+|++.|+.+...
T Consensus 253 ~~~~~~---~~~~i~~----~----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 253 EMSNQD---VIKAVDE----G----------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp TCCHHH---HHHHHHT----T----------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCHHH---HHHHHHc----C----------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 543211 1111100 0 00111223346788999999999999999999999999988753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=298.86 Aligned_cols=212 Identities=23% Similarity=0.427 Sum_probs=169.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC--------------------CCCCCHHHHHHHHHHH
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD--------------------KEALDWNTRMKIAAGA 61 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~~l~~~~~~~i~~~l 61 (325)
|++++||||+++++++.+.+..++||||+++++|.+++...... ...+++..++.++.|+
T Consensus 104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 56789999999999999999999999999999999999764321 2579999999999999
Q ss_pred HHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEE
Q 020529 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVY 141 (325)
Q Consensus 62 ~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvw 141 (325)
+.||.|||+.+ |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||
T Consensus 184 ~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 260 (343)
T 1luf_A 184 AAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260 (343)
T ss_dssp HHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccH
Confidence 99999999999 999999999999999999999999999754332222233445688999999999999999999999
Q ss_pred EehHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 142 SFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 142 SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
|||+++|+|++ |..||....... +... +.. . .. ...+......+.+|+.+||+.+|.+||++
T Consensus 261 slG~il~el~t~g~~p~~~~~~~~---~~~~---~~~-~-~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 323 (343)
T 1luf_A 261 AYGVVLWEIFSYGLQPYYGMAHEE---VIYY---VRD-G-NI---------LACPENCPLELYNLMRLCWSKLPADRPSF 323 (343)
T ss_dssp HHHHHHHHHHTTTCCTTTTSCHHH---HHHH---HHT-T-CC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHhcCCCcCCCCChHH---HHHH---HhC-C-Cc---------CCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 99999999999 999997543211 1111 000 0 00 01122334578899999999999999999
Q ss_pred HHHHHHHHhhhcc
Q 020529 221 GDVVTALSYLANQ 233 (325)
Q Consensus 221 ~evl~~L~~~~~~ 233 (325)
.+|++.|+.+...
T Consensus 324 ~~~~~~L~~~~~~ 336 (343)
T 1luf_A 324 CSIHRILQRMCER 336 (343)
T ss_dssp HHHHHHHHHTTC-
T ss_pred HHHHHHHHHHHhh
Confidence 9999999988754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=291.13 Aligned_cols=215 Identities=18% Similarity=0.189 Sum_probs=171.1
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|++| +||||+++++++...+..++||||+ +++|.+++... ...+++..++.|+.|++.||+|||+.+ |+|||
T Consensus 58 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrD 130 (330)
T 2izr_A 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRD 130 (330)
T ss_dssp HHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccC
Confidence 4567 8999999999999999999999999 89999999762 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCe-----EEEecCCCCccCCCCCCCC-----ccccccCCcCccCchhhccCCCCccccEEEehHHHHHH
Q 020529 81 FKSSNILLEEGFH-----PKLSDFGLAKLGPVGDKSH-----VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 81 ik~~Nill~~~~~-----~kL~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~el 150 (325)
|||+|||++.++. +||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 131 lkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 210 (330)
T 2izr_A 131 VKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYF 210 (330)
T ss_dssp CCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHH
Confidence 9999999998887 9999999998643322211 12456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
++|+.||............... ..... ......+... .. .+.+++..||+.+|.+||++.+|++.|..+
T Consensus 211 l~g~~Pf~~~~~~~~~~~~~~i---~~~~~---~~~~~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 211 LRGSLPWQGLKADTLKERYQKI---GDTKR---ATPIEVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp HHSSCTTTTCCCSSHHHHHHHH---HHHHH---HSCHHHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred hcCCCCccccccccHHHHHHHH---Hhhhc---cCCHHHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 9999999876433322211111 10000 0000011111 12 788999999999999999999999999988
Q ss_pred hccC
Q 020529 231 ANQT 234 (325)
Q Consensus 231 ~~~~ 234 (325)
....
T Consensus 280 ~~~~ 283 (330)
T 2izr_A 280 FDRK 283 (330)
T ss_dssp HHHT
T ss_pred HHHc
Confidence 7654
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=287.97 Aligned_cols=208 Identities=26% Similarity=0.424 Sum_probs=168.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~di 132 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 132 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCc
Confidence 5788999999999999999999999999999999999975 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.+||+|||+++...... ........+|+.|+|||++.+..++.++||||||+++++|++ |+.||...
T Consensus 133 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~ 211 (269)
T 4hcu_A 133 AARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 211 (269)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred chheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999997543221 112233456788999999999999999999999999999999 99999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
.... +.. .+... ... ..+......+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 212 ~~~~---~~~---~~~~~----~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 212 SNSE---VVE---DISTG----FRL-------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CHHH---HHH---HHHTT----CCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CHHH---HHH---HHhcC----ccC-------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 3221 111 00000 000 11112245688999999999999999999999999988753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=300.80 Aligned_cols=212 Identities=27% Similarity=0.391 Sum_probs=168.2
Q ss_pred cCCC-CCCCccceeeEEEeCC-eeEEEEecCCCCCHHHHhccCCCC----------------------------------
Q 020529 2 LSLL-HHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPD---------------------------------- 45 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~---------------------------------- 45 (325)
|+++ +||||++++++|.+.+ ..++||||+++|+|.+++......
T Consensus 79 l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (359)
T 3vhe_A 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITS 158 (359)
T ss_dssp HHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------
T ss_pred HHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCc
Confidence 4456 7999999999998754 489999999999999999864321
Q ss_pred ----------------------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEe
Q 020529 46 ----------------------------KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLS 97 (325)
Q Consensus 46 ----------------------------~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~ 97 (325)
...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~ 235 (359)
T 3vhe_A 159 SQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKIC 235 (359)
T ss_dssp -------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEEC
T ss_pred cccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEE
Confidence 223899999999999999999999999 9999999999999999999999
Q ss_pred cCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhcc
Q 020529 98 DFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLF 176 (325)
Q Consensus 98 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 176 (325)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||........ +... +
T Consensus 236 Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~----~ 309 (359)
T 3vhe_A 236 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRR----L 309 (359)
T ss_dssp CCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHH----H
T ss_pred eccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHH----H
Confidence 9999986544433334455678999999999999999999999999999999998 9999976543211 1110 0
Q ss_pred ccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 177 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 177 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
... .....+......+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus 310 ~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 310 KEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 000 0001112233568899999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=294.23 Aligned_cols=197 Identities=21% Similarity=0.336 Sum_probs=163.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDl 140 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDL 140 (328)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCC
Confidence 5678999999999999999999999999999999999975 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCC-ccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT-VKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+|||++.++.+||+|||++...... .......||+.|+|||++.+..+. .++|||||||++|+|++|+.||...
T Consensus 141 kp~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 141 KAENLLLDADMNIKIADFGFSNEFTVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp CGGGEEECTTSCEEECSTTCCGGGSSS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEEcCCCCEEEeeccCceecCCC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999764332 234456799999999999988765 7999999999999999999999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... ....+..... ..|......+.+|+.+||+.||.+|||+.++++.
T Consensus 218 ~~~~------~~~~i~~~~~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 218 NLKE------LRERVLRGKY------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp SHHH------HHHHHHHCCC------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred CHHH------HHHHHHhCCC------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 3211 1111111110 1122234568899999999999999999999863
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=304.36 Aligned_cols=212 Identities=25% Similarity=0.356 Sum_probs=169.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
|++++||||+++++++.+....++||||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ |+|
T Consensus 128 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH 204 (367)
T 3l9p_A 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIH 204 (367)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeC
Confidence 5678999999999999999999999999999999999976432 2356999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCC---eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CC
Q 020529 79 RDFKSSNILLEEGF---HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154 (325)
Q Consensus 79 rdik~~Nill~~~~---~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~ 154 (325)
|||||+|||++.++ .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 205 rDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~ 284 (367)
T 3l9p_A 205 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 284 (367)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999998554 599999999975332222233344568999999999999999999999999999999998 99
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
.||....... +.... .. .. ....+......+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus 285 ~pf~~~~~~~---~~~~i---~~-~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 285 MPYPSKSNQE---VLEFV---TS-GG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CSSTTCCHHH---HHHHH---HT-TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCCCHHH---HHHHH---Hc-CC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 9997643221 11111 00 00 0011122335688999999999999999999999999988653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=295.71 Aligned_cols=203 Identities=25% Similarity=0.377 Sum_probs=164.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+++..|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 59 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dl 131 (323)
T 3tki_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDI 131 (323)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccc
Confidence 5678999999999999999999999999999999999975 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+|||++.++.+||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 132 kp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred chHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999976443333333445679999999999988775 78999999999999999999999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... .....|..... ...+ .......+.+|+.+||+.||.+|||+.|+++.
T Consensus 212 ~~~~-~~~~~~~~~~~--------~~~~------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 212 SDSC-QEYSDWKEKKT--------YLNP------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp CTTS-HHHHHHHTTCT--------TSTT------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred chHH-HHHHHHhcccc--------cCCc------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 4321 11211111100 0000 11233567899999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=289.75 Aligned_cols=210 Identities=24% Similarity=0.327 Sum_probs=163.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+.+..++||||+++++|.+++.. ..++++..++.++.|++.||+|||+.+ |+||||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dl 137 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDI 137 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5788999999999999999999999999999999999976 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.+||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 138 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~ 216 (294)
T 4eqm_A 138 KPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET 216 (294)
T ss_dssp CGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred CHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997643221 122334569999999999999999999999999999999999999997643
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-CHHHHHHHHHhhhc
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-LIGDVVTALSYLAN 232 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~ 232 (325)
.... . ...+... . +.+....+......+.+++.+||+.+|.+|| ++.++.+.|..+..
T Consensus 217 ~~~~--~----~~~~~~~--~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 217 AVSI--A----IKHIQDS--V-----PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHH--H----HHHHSSC--C-----CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred hHHH--H----HHHhhcc--C-----CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 2110 0 0000000 0 0000001112235688999999999999999 89999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=296.80 Aligned_cols=213 Identities=24% Similarity=0.383 Sum_probs=169.7
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC-------------------CCCCCHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD-------------------KEALDWNTRMKIAAGA 61 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~l~~~~~~~i~~~l 61 (325)
|+++ +||||+++++++...+..++||||+++++|.+++...... ...+++..++.++.|+
T Consensus 102 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 4567 8999999999999999999999999999999999764321 1348999999999999
Q ss_pred HHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEE
Q 020529 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVY 141 (325)
Q Consensus 62 ~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvw 141 (325)
+.||+|||+.+ |+||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++|||
T Consensus 182 ~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~ 258 (344)
T 1rjb_A 182 AKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 258 (344)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHH
Confidence 99999999999 999999999999999999999999999765433333334455678899999999999999999999
Q ss_pred EehHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 142 SFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 142 SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
|||+++|+|+| |..||....... .+...... . .....+......+.+|+..||+.||.+||++
T Consensus 259 slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~----~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 322 (344)
T 1rjb_A 259 SYGILLWEIFSLGVNPYPGIPVDA--NFYKLIQN----G----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 322 (344)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHT----T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHHcCCCCCcccCCcHH--HHHHHHhc----C----------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 99999999998 999997654321 11111110 0 0011122234578899999999999999999
Q ss_pred HHHHHHHHhhhcc
Q 020529 221 GDVVTALSYLANQ 233 (325)
Q Consensus 221 ~evl~~L~~~~~~ 233 (325)
.+|++.|..+...
T Consensus 323 ~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 323 PNLTSFLGCQLAD 335 (344)
T ss_dssp HHHHHHHHHHC--
T ss_pred HHHHHHHHHHHHH
Confidence 9999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=291.43 Aligned_cols=214 Identities=22% Similarity=0.322 Sum_probs=160.5
Q ss_pred cCCCCCCCccceeeEEEeCCee------EEEEecCCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
|++++||||+++++++...... ++||||+.+++|.+++.... .....+++..++.++.|++.||+|||+.+
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~- 157 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN- 157 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC-
Confidence 6788999999999999877655 99999999999999986432 12236999999999999999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT- 152 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt- 152 (325)
|+||||||+|||++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 158 --ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~ 235 (323)
T 3qup_A 158 --FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235 (323)
T ss_dssp --CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhC
Confidence 99999999999999999999999999986544433333444567889999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
|..||........... +.... ....+......+.+|+.+||+.||.+||++.++++.|+.+..
T Consensus 236 g~~p~~~~~~~~~~~~------~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 236 GQTPYAGIENAEIYNY------LIGGN-----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp SCCTTTTCCGGGHHHH------HHTTC-----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccccChHHHHHH------HhcCC-----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999976543221110 00000 001122334578899999999999999999999999999987
Q ss_pred cCC
Q 020529 233 QTY 235 (325)
Q Consensus 233 ~~~ 235 (325)
...
T Consensus 299 ~~~ 301 (323)
T 3qup_A 299 HLS 301 (323)
T ss_dssp C--
T ss_pred Hhh
Confidence 553
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=291.11 Aligned_cols=198 Identities=25% Similarity=0.320 Sum_probs=164.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..++.++.+++.||+|||+++ |+||||
T Consensus 59 l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDl 131 (337)
T 1o6l_A 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDI 131 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcC
Confidence 5678999999999999999999999999999999999975 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 132 kp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 209 (337)
T 1o6l_A 132 KLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209 (337)
T ss_dssp CGGGEEECTTSCEEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHEEECCCCCEEEeeccchhhcccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC
Confidence 999999999999999999999753222 223445679999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
... ....+..... .++......+.+|+.+||+.||.+|| ++.+|++.
T Consensus 210 ~~~------~~~~i~~~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 210 HER------LFELILMEEI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp HHH------HHHHHHHCCC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred HHH------HHHHHHcCCC------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 211 1111111110 11223345788999999999999999 89999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=291.44 Aligned_cols=213 Identities=27% Similarity=0.391 Sum_probs=171.2
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--------------DKEALDWNTRMKIAAGAAKGLE 66 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~l~~al~ 66 (325)
|+++ +||||+++++++.+.+..++||||+++++|.+++..... ....+++..++.++.|++.||.
T Consensus 80 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 4566 899999999999999999999999999999999976432 1235899999999999999999
Q ss_pred HHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHH
Q 020529 67 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146 (325)
Q Consensus 67 ~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvv 146 (325)
|||+.+ |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||++
T Consensus 160 ~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 236 (313)
T 1t46_A 160 FLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (313)
T ss_dssp HHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHH
Confidence 999999 99999999999999999999999999986544433333444567889999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 147 FLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 147 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
+++|++ |..||........ +...... ...+ ..+......+.+|+.+||+.||.+||++.+|++
T Consensus 237 l~ellt~g~~p~~~~~~~~~--~~~~~~~----------~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 237 LWELFSLGSSPYPGMPVDSK--FYKMIKE----------GFRM----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp HHHHHTTTCCSSTTCCSSHH--HHHHHHH----------TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCcccchhH--HHHHhcc----------CCCC----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999998 9999976543211 1111110 0001 111223457889999999999999999999999
Q ss_pred HHHhhhcc
Q 020529 226 ALSYLANQ 233 (325)
Q Consensus 226 ~L~~~~~~ 233 (325)
.|+.+...
T Consensus 301 ~L~~~~~~ 308 (313)
T 1t46_A 301 LIEKQISE 308 (313)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99987754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=285.72 Aligned_cols=208 Identities=21% Similarity=0.343 Sum_probs=167.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di 130 (268)
T 3sxs_A 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDL 130 (268)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSC
T ss_pred HHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCc
Confidence 5678999999999999999999999999999999999976 2345999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||++....... ........+|+.|+|||++.+..++.++||||||+++++|++ |..||...
T Consensus 131 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (268)
T 3sxs_A 131 AARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209 (268)
T ss_dssp SGGGEEECTTCCEEECCTTCEEECCTTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CcceEEECCCCCEEEccCccceecchhh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence 9999999999999999999997643322 122233456778999999999999999999999999999999 99999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
....... ..... ..... +......+.+++..||+.+|.+||++.+|++.|+.+..+
T Consensus 210 ~~~~~~~------~~~~~----~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 210 TNSEVVL------KVSQG----HRLYR-------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CHHHHHH------HHHTT----CCCCC-------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ChHHHHH------HHHcC----CCCCC-------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 3221110 00000 00111 112234688999999999999999999999999988653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=283.09 Aligned_cols=216 Identities=17% Similarity=0.179 Sum_probs=170.2
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++++ +|||++++++++.+....++||||+ +++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 59 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 131 (298)
T 1csn_A 59 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 131 (298)
T ss_dssp HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 3456 8999999999999999999999999 8999999986 2346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCe-----EEEecCCCCccCCCCCCC-----CccccccCCcCccCchhhccCCCCccccEEEehHHHHHH
Q 020529 81 FKSSNILLEEGFH-----PKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 81 ik~~Nill~~~~~-----~kL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~el 150 (325)
|||+||+++.++. +||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|||
T Consensus 132 lkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 211 (298)
T 1csn_A 132 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 211 (298)
T ss_dssp CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHH
Confidence 9999999987765 999999999865433221 123456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
++|+.||................. .. .....+.+.. .....+.+|+..||+.+|.+||++.+|++.|+.+
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~---~~---~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 212 LRGSLPWQGLKAATNKQKYERIGE---KK---QSTPLRELCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHH---HH---HHSCHHHHTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HcCCCCcchhhccccHHHHHHHHh---hc---cCccHHHHHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 999999987543322221111100 00 0000001111 1235688999999999999999999999999988
Q ss_pred hccC
Q 020529 231 ANQT 234 (325)
Q Consensus 231 ~~~~ 234 (325)
....
T Consensus 282 ~~~~ 285 (298)
T 1csn_A 282 LERL 285 (298)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 7643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=285.73 Aligned_cols=213 Identities=28% Similarity=0.457 Sum_probs=156.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++ .....++||||+++++|.+++.. ....+++..++.++.+++.||+|||+.+ |+|||
T Consensus 73 ~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~D 145 (289)
T 3og7_A 73 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRD 145 (289)
T ss_dssp HHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 36789999999999975 45568999999999999999965 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+||+++.++.+||+|||+++...............||+.|+|||++. ...++.++||||||+++++|++|+.||
T Consensus 146 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 225 (289)
T 3og7_A 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225 (289)
T ss_dssp CCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCc
Confidence 99999999999999999999997644333333344567999999999986 567889999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
....... .+...... ....+.+ ..........+.+|+..||+.+|.+||++.+|++.|+.+..
T Consensus 226 ~~~~~~~--~~~~~~~~---------~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 226 SNINNRD--QIIEMVGR---------GSLSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SSCCCHH--HHHHHHHH---------TSCCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cccchHH--HHHHHhcc---------cccCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 7643221 11111100 0001111 01112334678899999999999999999999999998753
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=283.33 Aligned_cols=204 Identities=29% Similarity=0.433 Sum_probs=157.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||+++++++.+.+..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+++..+|+||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~di 134 (271)
T 3dtc_A 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134 (271)
T ss_dssp HHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCC
T ss_pred HHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Confidence 4678999999999999999999999999999999999953 46999999999999999999999998555889999
Q ss_pred CCCcEEEcC--------CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhC
Q 020529 82 KSSNILLEE--------GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 82 k~~Nill~~--------~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg 153 (325)
||+||+++. ++.+||+|||+++..... ......||+.|+|||++.+..++.++||||||+++++|++|
T Consensus 135 kp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp SGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred chHHEEEecccccccccCcceEEccCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999986 678999999999754322 22245689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 154 RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
+.||.......... . ..........+......+.+++.+||+.+|.+||++.+|++.|+.+
T Consensus 211 ~~p~~~~~~~~~~~------~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 211 EVPFRGIDGLAVAY------G----------VAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp CCTTTTSCHHHHHH------H----------HHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred CCCCCCCCHHHHHH------h----------hhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 99997643211100 0 0000111112223345788999999999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=292.17 Aligned_cols=201 Identities=24% Similarity=0.304 Sum_probs=162.7
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||++++++|.+....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 68 il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 140 (361)
T 2yab_A 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFD 140 (361)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 36788999999999999999999999999999999999965 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC----eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCC
Q 020529 81 FKSSNILLEEGF----HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 81 ik~~Nill~~~~----~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
|||+|||++.++ .+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 141 lkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~P 217 (361)
T 2yab_A 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217 (361)
T ss_dssp CSGGGEEESCTTSSSCCEEECCCSSCEECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCS
T ss_pred CCHHHEEEeCCCCCccCEEEEecCCceEcCCC---CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999998777 7999999999764432 123446799999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|........ . ..+..... .+++... ......+.+|+.+||..||.+||++.++++
T Consensus 218 f~~~~~~~~---~---~~i~~~~~----~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 218 FLGDTKQET---L---ANITAVSY----DFDEEFF----SQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp SCCSSHHHH---H---HHHHTTCC----CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCHHHH---H---HHHHhcCC----CCCchhc----cCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 976432111 1 11111000 0011110 112356889999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=295.72 Aligned_cols=205 Identities=21% Similarity=0.249 Sum_probs=162.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..|+||||+++++|.+++.........+++..++.++.|++.||.|||+++ |+||||
T Consensus 80 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDl 156 (351)
T 3c0i_A 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDV 156 (351)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccC
Confidence 56789999999999999999999999999999999888653333456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCe---EEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFH---PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~---~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+|||++.++. +||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 157 kp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 157 KPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp SGGGEEECSSSTTCCEEECCCTTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ChHHeEEecCCCCCcEEEecCcceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 999999976654 999999999764332 222345679999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... .+. ..+..... ...+.... .....+.+|+.+||+.||.+||++.++++.
T Consensus 235 ~~~~----~~~---~~i~~~~~----~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 235 GTKE----RLF---EGIIKGKY----KMNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp SSHH----HHH---HHHHHTCC----CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcHH----HHH---HHHHcCCC----CCCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 6321 111 11111000 00000001 123568899999999999999999999874
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=285.10 Aligned_cols=206 Identities=23% Similarity=0.334 Sum_probs=156.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++. .+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||
T Consensus 70 l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 142 (281)
T 1mp8_A 70 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDI 142 (281)
T ss_dssp HHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccc
Confidence 56789999999999985 5578999999999999999976 2446999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.+||+|||+++...... ........+++.|+|||++....++.++||||||+++|||++ |..||...
T Consensus 143 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~ 221 (281)
T 1mp8_A 143 AARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221 (281)
T ss_dssp SGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred cHHHEEECCCCCEEECccccccccCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcC
Confidence 9999999999999999999997643322 112233457788999999999999999999999999999996 99999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..... .... .. . ... ..+......+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 222 ~~~~~---~~~i---~~-~------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 222 KNNDV---IGRI---EN-G------ERL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp CGGGH---HHHH---HT-T------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHH---HHHH---Hc-C------CCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 43211 1111 00 0 000 1122334578899999999999999999999999998764
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=291.00 Aligned_cols=222 Identities=27% Similarity=0.388 Sum_probs=163.8
Q ss_pred cCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++.. ....++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 138 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHR 138 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHH---CGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHh---cccccCHHHHHHHHHHHHHHHHHHhcCC---cccC
Confidence 678899999999999865 3568999999999999999976 2345999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||++++||++|..|+.
T Consensus 139 Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 139 DLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp CCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred CCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 99999999999999999999999865433221 12233457778999999999999999999999999999999998875
Q ss_pred CCCCCCcchhhhhhhhccccc---cccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 159 STRPHGEQNLVTWARPLFNDR---RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
..... ............ ...............+......+.+|+..||+.+|.+|||+.+|++.|+.+...
T Consensus 219 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 219 SPPAE----FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp SHHHH----HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CChHH----HHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 42110 000000000000 000000001111112233456788999999999999999999999999988653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=288.98 Aligned_cols=203 Identities=15% Similarity=0.242 Sum_probs=163.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||
T Consensus 55 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dl 128 (321)
T 1tki_A 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDI 128 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 5678999999999999999999999999999999999965 3346999999999999999999999999 999999
Q ss_pred CCCcEEEcC--CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 82 KSSNILLEE--GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~--~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
||+|||++. ++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 129 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 129 RPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp CGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CHHHEEEccCCCCCEEEEECCCCeECCCC---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 999999987 789999999999765332 233456799999999999988899999999999999999999999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
..... + ...+...... ++.... ......+.+|+.+||+.||.+|||+.|+++.-
T Consensus 206 ~~~~~---~---~~~i~~~~~~----~~~~~~----~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 206 ETNQQ---I---IENIMNAEYT----FDEEAF----KEISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp SSHHH---H---HHHHHHTCCC----CCHHHH----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCHHH---H---HHHHHcCCCC----CChhhh----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 43211 1 1111111000 000000 01235688999999999999999999999854
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=286.14 Aligned_cols=208 Identities=22% Similarity=0.358 Sum_probs=168.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||
T Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di 146 (283)
T 3gen_A 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDL 146 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSC
T ss_pred HhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCC
Confidence 5678999999999999999999999999999999999975 2346999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.+||+|||+++...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~ 225 (283)
T 3gen_A 147 AARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225 (283)
T ss_dssp SGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999997543221 112233456788999999999999999999999999999998 99999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
....... .+.. . .....+......+.+|+..||+.+|.+||++.++++.|..+...
T Consensus 226 ~~~~~~~------~~~~-------~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 226 TNSETAE------HIAQ-------G----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CHHHHHH------HHHT-------T----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ChhHHHH------HHhc-------c----cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 3221111 0000 0 00011112235688999999999999999999999999987653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=283.67 Aligned_cols=212 Identities=23% Similarity=0.317 Sum_probs=161.1
Q ss_pred CCCCCCccceeeEEEeC----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cC
Q 020529 4 LLHHSNLVNLIGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH--------DK 71 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH--------~~ 71 (325)
.++||||+++++++... ...++||||+++++|.++++. ..+++..++.++.|++.||+||| +.
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 132 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP 132 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 47999999999997543 468999999999999999953 46999999999999999999999 88
Q ss_pred CCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCC--ccccccCCcCccCchhhccC------CCCccccEEEe
Q 020529 72 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH--VSTRVMGTYGYCAPEYAMTG------QLTVKSDVYSF 143 (325)
Q Consensus 72 ~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSl 143 (325)
+ |+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||
T Consensus 133 ~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Dvwsl 209 (301)
T 3q4u_A 133 A---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAF 209 (301)
T ss_dssp E---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHH
T ss_pred C---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHH
Confidence 8 9999999999999999999999999997543322111 12334799999999999876 45579999999
Q ss_pred hHHHHHHHhC----------CCCCCCCCCCCcchhhhhhhhccccccccccccCCcc-CCCCChHHHHHHHHHHHHchhh
Q 020529 144 GVVFLELITG----------RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRL-EGRYPIRGLYQALAVASMCIQE 212 (325)
Q Consensus 144 Gvvl~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~~~~~l~~~cl~~ 212 (325)
||++|||++| ..||.......... ..... ..... ...+.+ ...++......+.+|+.+||+.
T Consensus 210 G~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~-~~~~~-~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 282 (301)
T 3q4u_A 210 GLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF-EDMRK-VVCVD-----QQRPNIPNRWFSDPTLTSLAKLMKECWYQ 282 (301)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH-HHHHH-HHTTS-----CCCCCCCGGGGGSHHHHHHHHHHHHHCCS
T ss_pred HHHHHHHHhhhcCccccccccccccccCCCCcch-hhhhH-HHhcc-----CCCCCCChhhccCccHHHHHHHHHHHhhc
Confidence 9999999999 77775543322111 11100 00000 001111 0111234567899999999999
Q ss_pred CCCCCCCHHHHHHHHHhh
Q 020529 213 QAATRPLIGDVVTALSYL 230 (325)
Q Consensus 213 ~p~~RPs~~evl~~L~~~ 230 (325)
||.+|||+.+|++.|+.+
T Consensus 283 dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 283 NPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SGGGSCCHHHHHHHHHHH
T ss_pred ChhhCCCHHHHHHHHhcc
Confidence 999999999999999865
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=286.60 Aligned_cols=200 Identities=22% Similarity=0.302 Sum_probs=163.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++...+..++||||+++++|.+++.. ..+++..++.++.+++.||.|||+.+ |+||||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dl 167 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDI 167 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 6788999999999999999999999999999999999854 45999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.+||+|||++...... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 168 kp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 168 KSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCSS--SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CHHHEEECCCCcEEEeeeeeeeecccC--ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999998764322 122345679999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
... ..... . ....+.+. .+......+.+++.+||+.||.+||++.+|++.
T Consensus 246 ~~~---~~~~~---~-------~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 246 PVQ---AMKRL---R-------DSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHH---HHHHH---H-------HSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHH---HHHHH---h-------cCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 211 11110 0 01111110 111234568899999999999999999999874
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=291.01 Aligned_cols=201 Identities=23% Similarity=0.297 Sum_probs=162.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 68 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dl 140 (326)
T 2y0a_A 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDL 140 (326)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCC
Confidence 5678999999999999999999999999999999999965 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCC----eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 82 KSSNILLEEGF----HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 82 k~~Nill~~~~----~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||+|||++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 141 kp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 217 (326)
T 2y0a_A 141 KPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 217 (326)
T ss_dssp CGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 99999998887 79999999997653322 233457999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
........ +. .+...... +.... .......+.+|+.+||+.||.+|||+.++++.
T Consensus 218 ~~~~~~~~--~~----~~~~~~~~----~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 218 LGDTKQET--LA----NVSAVNYE----FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp CCSSHHHH--HH----HHHHTCCC----CCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHHH--HH----HHHhcCCC----cCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 75432111 10 00000000 00000 01223567899999999999999999999874
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=288.42 Aligned_cols=209 Identities=27% Similarity=0.405 Sum_probs=167.7
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------------PDKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
|+++ +||||+++++++.+.+..++||||+++++|.+++.... .....+++..++.++.|++.||+||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 5678 89999999999999999999999999999999997643 2235799999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ |+||||||+||+++.++.+||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|
T Consensus 159 H~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 232 (327)
T 1fvr_A 159 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 232 (327)
T ss_dssp HHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HhCC---ccCCCCccceEEEcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHH
Confidence 9999 99999999999999999999999999874221 11223345788999999999989999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
+|++ |..||....... +. ..+.. .. ....+......+.+|+.+||+.+|.+||++.++++.|
T Consensus 233 ellt~g~~pf~~~~~~~---~~---~~~~~-------~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 295 (327)
T 1fvr_A 233 EIVSLGGTPYCGMTCAE---LY---EKLPQ-------GY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295 (327)
T ss_dssp HHHTTSCCTTTTCCHHH---HH---HHGGG-------TC----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHcCCCCCCCCCcHHH---HH---HHhhc-------CC----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9998 999997653211 11 11100 00 0111223345788999999999999999999999999
Q ss_pred Hhhhcc
Q 020529 228 SYLANQ 233 (325)
Q Consensus 228 ~~~~~~ 233 (325)
..+...
T Consensus 296 ~~~~~~ 301 (327)
T 1fvr_A 296 NRMLEE 301 (327)
T ss_dssp HHHHHS
T ss_pred HHHHHh
Confidence 988764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=306.95 Aligned_cols=207 Identities=24% Similarity=0.375 Sum_probs=168.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||++++++|.+....++||||+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||
T Consensus 270 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDl 344 (495)
T 1opk_A 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNL 344 (495)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 56789999999999999999999999999999999999763 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+|||++.++.+||+|||+++...... ........+++.|+|||++....++.++|||||||++|||++ |..||...
T Consensus 345 kp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~ 423 (495)
T 1opk_A 345 AARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423 (495)
T ss_dssp SGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998643221 122233456788999999999999999999999999999999 99999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
.... +...... ......+......+.+|+.+||+.+|.+||++.+|++.|+.+.
T Consensus 424 ~~~~---~~~~~~~--------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 424 DLSQ---VYELLEK--------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CGGG---HHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CHHH---HHHHHHc--------------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 4221 1111100 0111122233467889999999999999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=293.48 Aligned_cols=211 Identities=26% Similarity=0.399 Sum_probs=159.5
Q ss_pred CcCCCCCCCccceeeEEEe-CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++||||++++++|.+ .+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||
T Consensus 143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHr 216 (373)
T 3c1x_A 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHR 216 (373)
T ss_dssp TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 5788999999999999754 5678999999999999999975 3456899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCC--CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKA 156 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p 156 (325)
||||+|||++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |.+|
T Consensus 217 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p 296 (373)
T 3c1x_A 217 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296 (373)
T ss_dssp CCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred ccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCC
Confidence 99999999999999999999999754332211 12234567889999999999999999999999999999999 6778
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
|............ ... ..... +......+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus 297 ~~~~~~~~~~~~~------~~~----~~~~~-------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 297 YPDVNTFDITVYL------LQG----RRLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CTTSCSSCHHHHH------HTT----CCCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCCHHHHHHHH------HcC----CCCCC-------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 8665432211111 000 00011 1122356889999999999999999999999999887643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=285.99 Aligned_cols=212 Identities=23% Similarity=0.351 Sum_probs=161.3
Q ss_pred cCCCCCCCccceeeEEEeCC-----eeEEEEecCCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
|++++||||+++++++.+.. ..++||||+.+++|.+++.... .....+++..++.++.+++.||.|||+.+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-- 167 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN-- 167 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 56789999999999998754 3499999999999999985422 23466999999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-C
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-G 153 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g 153 (325)
|+||||||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 168 -ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 246 (313)
T 3brb_A 168 -FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRG 246 (313)
T ss_dssp -CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcC
Confidence 99999999999999999999999999976544332233344567889999999999999999999999999999999 8
Q ss_pred CCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 154 RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
..||........ .... ... . ....+......+.+++..||+.+|.+||++.+|++.|+.+...
T Consensus 247 ~~p~~~~~~~~~---~~~~---~~~-------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 247 MTPYPGVQNHEM---YDYL---LHG-------H----RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp CCSSTTCCGGGH---HHHH---HTT-------C----CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHH---HHHH---HcC-------C----CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 899876543211 1110 000 0 0011223345788999999999999999999999999988754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=293.11 Aligned_cols=200 Identities=26% Similarity=0.353 Sum_probs=163.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++|||||+++++|.+....|+||||+.+|+|..++.. ...+++..+..++.+++.||.|||+.+ |+|||
T Consensus 68 il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 140 (384)
T 4fr4_A 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRD 140 (384)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 36788999999999999999999999999999999999975 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc---CCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+||||+.++.+||+|||+++..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||
T Consensus 141 lkp~NIll~~~g~vkL~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf 217 (384)
T 4fr4_A 141 MKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217 (384)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred CcHHHeEECCCCCEEEeccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCC
Confidence 9999999999999999999999864322 23445679999999999874 45899999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-HHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-IGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-~~evl~ 225 (325)
..........+...... . ...++......+.+|+.+||+.+|.+||+ +.+|++
T Consensus 218 ~~~~~~~~~~~~~~~~~---~------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 218 HIRSSTSSKEIVHTFET---T------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCTTSCHHHHHHHHHH---C------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCCCCccHHHHHHHHhh---c------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 76543332222211110 0 01122233467889999999999999999 666654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=294.24 Aligned_cols=195 Identities=25% Similarity=0.369 Sum_probs=157.5
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
.+||||++++++|.+.+..|+||||+++|+|..++.. ...+++..+..++.+|+.||+|||+.+ |+||||||+
T Consensus 110 ~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~ 182 (396)
T 4dc2_A 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLD 182 (396)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG
T ss_pred CCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHH
Confidence 3899999999999999999999999999999999976 456999999999999999999999999 999999999
Q ss_pred cEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 85 Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
||||+.++.+||+|||+++.... .........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 183 NILl~~~g~ikL~DFGla~~~~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~ 260 (396)
T 4dc2_A 183 NVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260 (396)
T ss_dssp GEEECTTSCEEECCCTTCBCCCC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--
T ss_pred HEEECCCCCEEEeecceeeeccc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccccc
Confidence 99999999999999999975322 2223455789999999999999999999999999999999999999997543221
Q ss_pred cc--hhhh-hhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 165 EQ--NLVT-WARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 165 ~~--~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
.. .... ....+.... ..+|......+.+|+.+||+.||.+||++
T Consensus 261 ~~~~~~~~~~~~~i~~~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 261 NPDQNTEDYLFQVILEKQ------------IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCHHHHHHHHHHCC------------CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ccchhhHHHHHHHHhccc------------cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11 1111 111111111 01222334578899999999999999995
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=296.47 Aligned_cols=202 Identities=20% Similarity=0.266 Sum_probs=163.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..|+||||+.+++|.+++.. ...+++..+..++.|++.||.|||+++ |+||||
T Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDl 136 (444)
T 3soa_A 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNL 136 (444)
T ss_dssp HHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999976 456999999999999999999999999 999999
Q ss_pred CCCcEEEc---CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLE---EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~---~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+|||++ .++.+||+|||++...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 137 Kp~NIll~~~~~~~~vkL~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 137 KPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp SSTTEEESBSSTTCCEEECCCSSCBCCCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CHHHEEEeccCCCCcEEEccCceeEEecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 99999998 4678999999999764332 222344679999999999999999999999999999999999999996
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...... +. ..+.... .....+. . ......+.+|+.+||+.||.+||++.++++.
T Consensus 215 ~~~~~~---~~---~~i~~~~---~~~~~~~-~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 215 DEDQHR---LY---QQIKAGA---YDFPSPE-W----DTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CSSHHH---HH---HHHHHTC---CCCCTTT-T----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CccHHH---HH---HHHHhCC---CCCCccc-c----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 543211 11 1111100 0011110 0 1223568899999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=285.23 Aligned_cols=195 Identities=29% Similarity=0.405 Sum_probs=162.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+....|+||||+++++|.+++.. ...+++..+..++.+++.||.|||+.+ |+||||
T Consensus 60 l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDl 132 (318)
T 1fot_A 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDL 132 (318)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999976 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 133 kp~NIll~~~g~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 133 KPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp CGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ChheEEEcCCCCEEEeecCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999976432 2334679999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
... ....+..... .++......+.+++.+||+.+|.+|| ++.+|++.
T Consensus 208 ~~~------~~~~i~~~~~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 208 TMK------TYEKILNAEL------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp HHH------HHHHHHHCCC------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred HHH------HHHHHHhCCC------------CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 211 1111111110 11222345788999999999999999 88888864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=296.04 Aligned_cols=212 Identities=24% Similarity=0.380 Sum_probs=168.6
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhc
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP----------DKEALDWNTRMKIAAGAAKGLEYLHD 70 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------~~~~l~~~~~~~i~~~l~~al~~LH~ 70 (325)
|+++ +||||+++++++.+.+..++||||+++++|.+++..... ....+++..++.++.|++.||+|||+
T Consensus 103 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 4567 899999999999999999999999999999999865211 13458999999999999999999999
Q ss_pred CCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHH
Q 020529 71 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 71 ~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~el 150 (325)
.+ |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|
T Consensus 183 ~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 259 (333)
T 2i1m_A 183 KN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259 (333)
T ss_dssp TT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHH
Confidence 99 999999999999999999999999999764433332233445678899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 151 IT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 151 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
++ |..||........ +...... . ... ..+......+.+|+..||+.+|.+||++.+|++.|+.
T Consensus 260 ~t~g~~p~~~~~~~~~--~~~~~~~----~------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 323 (333)
T 2i1m_A 260 FSLGLNPYPGILVNSK--FYKLVKD----G------YQM----AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE 323 (333)
T ss_dssp TTTSCCSSTTCCSSHH--HHHHHHH----T------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HcCCCCCCcccchhHH--HHHHHhc----C------CCC----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence 98 9999976532211 1111110 0 000 1111223568899999999999999999999999988
Q ss_pred hhc
Q 020529 230 LAN 232 (325)
Q Consensus 230 ~~~ 232 (325)
+..
T Consensus 324 ~~~ 326 (333)
T 2i1m_A 324 QAQ 326 (333)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=282.02 Aligned_cols=215 Identities=25% Similarity=0.325 Sum_probs=162.4
Q ss_pred CCCCCCccceeeEEEeC----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC--------
Q 020529 4 LLHHSNLVNLIGYCADG----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-------- 71 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-------- 71 (325)
.++||||+++++++... ...++||||+++++|.+++.. ..+++..++.++.+++.||+|||+.
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~ 161 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKP 161 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC
Confidence 45999999999999887 788999999999999999965 3599999999999999999999998
Q ss_pred CCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCC--ccccccCCcCccCchhhccCCCCcc------ccEEEe
Q 020529 72 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH--VSTRVMGTYGYCAPEYAMTGQLTVK------SDVYSF 143 (325)
Q Consensus 72 ~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~k------sDvwSl 143 (325)
+ |+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++.+.....+ +|||||
T Consensus 162 ~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diwsl 238 (337)
T 3mdy_A 162 A---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238 (337)
T ss_dssp C---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHH
T ss_pred C---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHH
Confidence 7 9999999999999999999999999997543322211 1234579999999999988776665 999999
Q ss_pred hHHHHHHHhC----------CCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCC-ChHHHHHHHHHHHHchhh
Q 020529 144 GVVFLELITG----------RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY-PIRGLYQALAVASMCIQE 212 (325)
Q Consensus 144 Gvvl~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~l~~~cl~~ 212 (325)
||++|||++| ..||......... ..... .... .....+.+...+ +......+.+|+.+||+.
T Consensus 239 G~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~-~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 311 (337)
T 3mdy_A 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS-YEDMR-EIVC-----IKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311 (337)
T ss_dssp HHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCC-HHHHH-HHHT-----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCS
T ss_pred HHHHHHHHhccCcccccccccccHhhhcCCCCc-hhhhH-HHHh-----hhccCccccccchhhHHHHHHHHHHHHhhhh
Confidence 9999999999 4555433222111 00000 0000 000111111111 124567899999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhcc
Q 020529 213 QAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 213 ~p~~RPs~~evl~~L~~~~~~ 233 (325)
||.+||++.+|++.|+.+...
T Consensus 312 dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 312 NPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp SGGGSCCHHHHHHHHHHHHHT
T ss_pred ChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999988754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=282.96 Aligned_cols=222 Identities=19% Similarity=0.227 Sum_probs=169.7
Q ss_pred cCCCCCCCccceeeEEEeCC--eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++.... ..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 136 (319)
T 4euu_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHR 136 (319)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecC
Confidence 56789999999999998765 77999999999999999976322 234999999999999999999999999 9999
Q ss_pred CCCCCcEEE----cCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc--------cCCCCccccEEEehHHH
Q 020529 80 DFKSSNILL----EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM--------TGQLTVKSDVYSFGVVF 147 (325)
Q Consensus 80 dik~~Nill----~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~ksDvwSlGvvl 147 (325)
||||+|||+ +.++.+||+|||+++...... ......||+.|+|||++. +..++.++|||||||++
T Consensus 137 Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il 213 (319)
T 4euu_A 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (319)
T ss_dssp CCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHH
T ss_pred CCCHHHEEEeccCCCCceEEEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHH
Confidence 999999999 788889999999998643322 233456999999999986 56889999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhhhhhhhcccccc-----ccccc------c--CCccCCCCChHHHHHHHHHHHHchhhCC
Q 020529 148 LELITGRKAIDSTRPHGEQNLVTWARPLFNDRR-----KFSKL------A--DPRLEGRYPIRGLYQALAVASMCIQEQA 214 (325)
Q Consensus 148 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~------~--d~~l~~~~~~~~~~~~~~l~~~cl~~~p 214 (325)
|||++|+.||.......... .....+..... .+... . .......++......+.+++.+||+.||
T Consensus 214 ~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP 291 (319)
T 4euu_A 214 YHAATGSLPFRPFEGPRRNK--EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (319)
T ss_dssp HHHHHSSCSEECTTCGGGCH--HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHHHhCCCCCCCCCccchhH--HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCCh
Confidence 99999999997543322111 11111111000 00000 0 0111223345667788899999999999
Q ss_pred CCCCCHHHHHHHHHhhhc
Q 020529 215 ATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 215 ~~RPs~~evl~~L~~~~~ 232 (325)
.+||++.|+++.....+.
T Consensus 292 ~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 292 EKCWGFDQFFAETSDILH 309 (319)
T ss_dssp TTSCCHHHHHHHHHHHTC
T ss_pred hhhccHHHhhhccHHHhh
Confidence 999999999999986553
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=290.29 Aligned_cols=212 Identities=25% Similarity=0.382 Sum_probs=169.7
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------KEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~l~~al~~L 68 (325)
|+++ +||||+++++++.+.+..++||||+++++|.+++...... ...+++..++.++.|++.||+||
T Consensus 94 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 173 (334)
T 2pvf_A 94 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 173 (334)
T ss_dssp HHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4456 8999999999999999999999999999999999864321 23489999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ |+||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|
T Consensus 174 H~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 250 (334)
T 2pvf_A 174 ASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMW 250 (334)
T ss_dssp HHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred HhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHH
Confidence 9999 9999999999999999999999999997654333222334455788999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
+|++ |..||....... +...... . ..+ ..+......+.+|+.+||+.+|.+||++.+|++.|
T Consensus 251 ellt~g~~p~~~~~~~~---~~~~~~~----~------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 313 (334)
T 2pvf_A 251 EIFTLGGSPYPGIPVEE---LFKLLKE----G------HRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 313 (334)
T ss_dssp HHHTTSCCSSTTCCHHH---HHHHHHH----T------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCCcCcCCHHH---HHHHHhc----C------CCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 9999 999997643211 1111100 0 000 11223345788999999999999999999999999
Q ss_pred Hhhhcc
Q 020529 228 SYLANQ 233 (325)
Q Consensus 228 ~~~~~~ 233 (325)
+.+...
T Consensus 314 ~~l~~~ 319 (334)
T 2pvf_A 314 DRILTL 319 (334)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 988754
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=292.62 Aligned_cols=215 Identities=15% Similarity=0.129 Sum_probs=165.1
Q ss_pred cCCCCCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 2 LSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
++.++||||+++++++.. ....|+||||+ +++|.+++.. ...+++..++.|+.|++.||+|||+.+ |+
T Consensus 102 ~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---iv 173 (345)
T 2v62_A 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YV 173 (345)
T ss_dssp HHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred hccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 456799999999999988 77899999999 8999999976 337999999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCC--eEEEecCCCCccCCCCCC-----CCccccccCCcCccCchhhccCCCCccccEEEehHHHHHH
Q 020529 78 YRDFKSSNILLEEGF--HPKLSDFGLAKLGPVGDK-----SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 78 Hrdik~~Nill~~~~--~~kL~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~el 150 (325)
||||||+|||++.++ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||
T Consensus 174 H~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el 253 (345)
T 2v62_A 174 HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRW 253 (345)
T ss_dssp CSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 999999999999887 999999999976432211 1122456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
++|+.||........ .+......... .+......... .......+.+++..||+.+|.+||++.+|++.|+.+
T Consensus 254 l~g~~pf~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 254 LCGKLPWEQNLKDPV-AVQTAKTNLLD---ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHSSCTTGGGTTCHH-HHHHHHHHHHH---TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HhCCCCccccccccH-HHHHHHHhhcc---cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 999999964322111 11111000000 00000000000 002235788999999999999999999999999765
Q ss_pred h
Q 020529 231 A 231 (325)
Q Consensus 231 ~ 231 (325)
.
T Consensus 327 ~ 327 (345)
T 2v62_A 327 G 327 (345)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=278.43 Aligned_cols=206 Identities=22% Similarity=0.336 Sum_probs=163.9
Q ss_pred CcCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
+|++++||||+++++++.+. ...++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+|
T Consensus 60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H 136 (271)
T 3kmu_A 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPR 136 (271)
T ss_dssp GGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTT
T ss_pred HHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-Cceec
Confidence 46789999999999999876 7889999999999999999862 2235999999999999999999999876 45999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCc---cccEEEehHHHHHHHhCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTV---KSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---ksDvwSlGvvl~elltg~~ 155 (325)
|||||+||+++.++.++|+|||+.... ......||+.|+|||++.+..++. ++||||||+++|||++|+.
T Consensus 137 ~dikp~Nil~~~~~~~~l~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 209 (271)
T 3kmu_A 137 HALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV 209 (271)
T ss_dssp CCCSGGGEEECTTSCEEEEGGGSCCTT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred CCCccceEEEcCCcceeEEeccceeee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999999999999887532 122346899999999998765544 7999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
||........ ...... ....+ ..+......+.+++..||+.+|.+||++.+|++.|+.+..
T Consensus 210 p~~~~~~~~~------~~~~~~------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 210 PFADLSNMEI------GMKVAL------EGLRP----TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp TTTTSCHHHH------HHHHHH------SCCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CccccChHHH------HHHHHh------cCCCC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 9975432111 000000 00111 1222334578899999999999999999999999988753
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=294.73 Aligned_cols=198 Identities=27% Similarity=0.383 Sum_probs=158.3
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+++ +||||+++++++.+.+..|+||||+++++|.+++.. ...+++..++.++.+++.||+|||+.+ |+|||
T Consensus 77 l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 149 (353)
T 3txo_A 77 LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRD 149 (353)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccC
Confidence 3445 799999999999999999999999999999999976 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 150 lkp~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 150 LKLDNVLLDHEGHCKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHEEECCCCCEEEccccceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999753222 22344567999999999999999999999999999999999999999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH------HHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI------GDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~------~evl~~ 226 (325)
.... ....+..... .++......+.+|+.+||+.+|.+||++ .+|++.
T Consensus 228 ~~~~------~~~~i~~~~~------------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 228 NEDD------LFEAILNDEV------------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp SHHH------HHHHHHHCCC------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CHHH------HHHHHHcCCC------------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 3221 1111111110 1122234568899999999999999998 677653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=281.43 Aligned_cols=204 Identities=28% Similarity=0.494 Sum_probs=161.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.. ++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++|+||||
T Consensus 77 l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~di 150 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDL 150 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCC
T ss_pred HHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCC
Confidence 67889999999999987654 799999999999998875 3457999999999999999999999986 45999999
Q ss_pred CCCcEEEcCCCe-----EEEecCCCCccCCCCCCCCccccccCCcCccCchhhc--cCCCCccccEEEehHHHHHHHhCC
Q 020529 82 KSSNILLEEGFH-----PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM--TGQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 82 k~~Nill~~~~~-----~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~ksDvwSlGvvl~elltg~ 154 (325)
||+||+++.++. +||+|||+++... .......||+.|+|||++. ...++.++||||||+++|+|++|+
T Consensus 151 kp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 225 (287)
T 4f0f_A 151 RSPNIFLQSLDENAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225 (287)
T ss_dssp SGGGEEESCCCTTCSCCEEECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CcceEEEeccCCCCceeEEeCCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCC
Confidence 999999988776 9999999997422 2334467999999999983 456789999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
.||............ .. . .....+ ..+......+.+++..||+.||.+||++.+|++.|+.+
T Consensus 226 ~pf~~~~~~~~~~~~-~~---~------~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 226 GPFDEYSYGKIKFIN-MI---R------EEGLRP----TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp CTTTTCCCCHHHHHH-HH---H------HSCCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred CCCccccccHHHHHH-HH---h------ccCCCC----CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 999765432211111 00 0 001111 12223345788999999999999999999999999753
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=299.55 Aligned_cols=206 Identities=27% Similarity=0.371 Sum_probs=165.9
Q ss_pred CcCCCCCCCccceeeEEEeCC-eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++||||+++++++.+.. ..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||
T Consensus 239 ~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHr 313 (450)
T 1k9a_A 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313 (450)
T ss_dssp HHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCC
Confidence 367889999999999987765 789999999999999999762 2334799999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~ 158 (325)
||||+|||++.++.+||+|||+++..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 314 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 388 (450)
T 1k9a_A 314 DLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388 (450)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999753221 122357889999999999999999999999999999998 999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
.......... . ... .....+......+.+|+..||+.+|.+||++.+|++.|+.+...
T Consensus 389 ~~~~~~~~~~---i----~~~----------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 389 RIPLKDVVPR---V----EKG----------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TSCTTTHHHH---H----HTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHHHHHH---H----HcC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 6543221111 1 000 00111223346788999999999999999999999999988654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=298.83 Aligned_cols=199 Identities=26% Similarity=0.328 Sum_probs=163.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHr 79 (325)
+|+.++||||++++++|.+.+..|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+ |+||
T Consensus 201 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHr 273 (446)
T 4ejn_A 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYR 273 (446)
T ss_dssp CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCC
T ss_pred HHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEEC
Confidence 47889999999999999999999999999999999999976 4569999999999999999999998 88 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
||||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 274 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 274 DLKLENLMLDKDGHIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp CCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEECCCCCEEEccCCCceeccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 99999999999999999999999753222 2233456799999999999999999999999999999999999999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
..... + ...+..... .++......+.+|+.+||+.||.+|| ++.++++.
T Consensus 352 ~~~~~---~---~~~i~~~~~------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 352 QDHEK---L---FELILMEEI------------RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp SSHHH---H---HHHHHHCCC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CCHHH---H---HHHHHhCCC------------CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 43211 1 111111110 11222335688999999999999999 99999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=288.70 Aligned_cols=197 Identities=23% Similarity=0.302 Sum_probs=161.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||+++++++.+....++||||+ +|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dl 134 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDL 134 (336)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCC
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 67889999999999999999999999999 6899998875 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+|||++.++.+||+|||++...... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...
T Consensus 135 kp~NIll~~~~~~kl~DFG~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 135 KPENLLLDDNLNVKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp STTTEEECTTCCEEECCSSCTBTTTTS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred chhhEEEcCCCCEEEEEeccceeccCC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 999999999999999999999764332 22344579999999999988776 68999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
........+ . .. ....+......+.+|+.+||+.||.+|||+.|+++.-
T Consensus 212 ~~~~~~~~i------~----------~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 212 FIPNLFKKV------N----------SC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp SSTTCBCCC------C----------SS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred cHHHHHHHH------H----------cC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 322111000 0 00 0011222345688999999999999999999998754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=285.76 Aligned_cols=216 Identities=22% Similarity=0.282 Sum_probs=160.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||++ ++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||
T Consensus 73 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Di 145 (311)
T 3niz_A 73 LKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDL 145 (311)
T ss_dssp HHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 567899999999999999999999999997 688888875 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+|||++.++.+||+|||+++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 146 kp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 223 (311)
T 3niz_A 146 KPQNLLINSDGALKLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGV 223 (311)
T ss_dssp CGGGEEECTTCCEEECCCTTCEETTSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred chHhEEECCCCCEEEccCcCceecCCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999764322 222344568999999999876 56899999999999999999999999765
Q ss_pred CCCCcchhh-hhhhhc----ccccccc-------ccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLV-TWARPL----FNDRRKF-------SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~-~~~~~~----~~~~~~~-------~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
......... ...... +.....+ ...+..............++.+|+.+||+.||.+|||+.|+++.
T Consensus 224 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 224 TDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp STTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 443221111 000000 0000000 00000000000011223578899999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=282.48 Aligned_cols=209 Identities=23% Similarity=0.342 Sum_probs=168.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++ ..+..++||||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ |+||||
T Consensus 64 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 136 (287)
T 1u59_A 64 MHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDL 136 (287)
T ss_dssp HHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCC
Confidence 5678999999999999 55678999999999999999965 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
||+||+++.++.++|+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++ |+.||..
T Consensus 137 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 137 AARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999765332211 12233456889999999998899999999999999999998 9999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
..... +...... . . ....+......+.+++..||+.+|.+||++.+|++.|..+....
T Consensus 217 ~~~~~---~~~~i~~----~------~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 217 MKGPE---VMAFIEQ----G------K----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp CCTHH---HHHHHHT----T------C----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCHHH---HHHHHhc----C------C----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 54321 1111100 0 0 01112233467889999999999999999999999999887544
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=282.61 Aligned_cols=210 Identities=26% Similarity=0.398 Sum_probs=164.5
Q ss_pred cCCCCCCCccceeeEEE-eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|++++||||+++++++. ..+..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~d 153 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 153 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 57889999999999965 45688999999999999999975 3456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCC--CCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDK--SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~ 157 (325)
|||+||+++.++.+||+|||+++....... ........||+.|+|||++.+..++.++||||||+++++|++ |.+||
T Consensus 154 ikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 233 (298)
T 3f66_A 154 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233 (298)
T ss_dssp CSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999976433221 122334567889999999999999999999999999999999 56666
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
............ ... .... .+......+.+++.+||+.+|.+||++.+|++.|+.+....
T Consensus 234 ~~~~~~~~~~~~------~~~----~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 234 PDVNTFDITVYL------LQG----RRLL-------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TTSCTTTHHHHH------HTT----CCCC-------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ccCCHHHHHHHH------hcC----CCCC-------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 554332211110 000 0000 01122356889999999999999999999999999887643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=283.33 Aligned_cols=208 Identities=24% Similarity=0.367 Sum_probs=169.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++... ....+++..++.++.+++.||.|||+.+ |+||||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~di 137 (288)
T 3kfa_A 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDL 137 (288)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCC
Confidence 56789999999999999999999999999999999999763 2355999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 138 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 138 AARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp SGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997643322 223344557889999999999999999999999999999999 99999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
....... .... . .....+......+.+|+..||+.+|.+||++.+|++.|+.+..
T Consensus 217 ~~~~~~~---~~~~----------~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 217 DLSQVYE---LLEK----------D----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CGGGHHH---HHHT----------T----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHH---HHhc----------c----CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 4321111 1100 0 0111122334578899999999999999999999999987764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=288.08 Aligned_cols=209 Identities=24% Similarity=0.375 Sum_probs=162.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ |+||||
T Consensus 100 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 173 (333)
T 1mqb_A 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDL 173 (333)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCC
Confidence 5678999999999999999999999999999999999976 3456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
||+||+++.++.+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |..||..
T Consensus 174 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 174 AARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp CGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999764332211 12223446788999999999999999999999999999998 9999965
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
..... +.... . ... ....+......+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus 254 ~~~~~---~~~~~---~-~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 254 LSNHE---VMKAI---N-DGF----------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCHHH---HHHHH---H-TTC----------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCHHH---HHHHH---H-CCC----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 43211 11110 0 000 0011223345688999999999999999999999999987653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=280.50 Aligned_cols=208 Identities=26% Similarity=0.414 Sum_probs=168.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ |+||||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 130 (267)
T 3t9t_A 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 130 (267)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSC
T ss_pred HHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 5678999999999999999999999999999999999976 2356899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |+.||...
T Consensus 131 ~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 209 (267)
T 3t9t_A 131 AARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209 (267)
T ss_dssp CGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred chheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence 9999999999999999999997543211 112233457788999999999999999999999999999999 89999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
.... .. ..+... ... ..+......+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 210 ~~~~---~~---~~i~~~----~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 210 SNSE---VV---EDISTG----FRL-------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CHHH---HH---HHHHTT----CCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CHHH---HH---HHHhcC----CcC-------CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3211 11 111100 000 01112235688999999999999999999999999988753
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=281.19 Aligned_cols=210 Identities=24% Similarity=0.328 Sum_probs=165.8
Q ss_pred cCCCCCCCccceeeEEEeCCee-EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQR-LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~-~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|++++||||+++++++.+.+.. ++||||+.+++|.+++.. ....+++..++.++.+++.||+|||+.+ |+|||
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~d 149 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRD 149 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 5678999999999999876655 999999999999999976 3456899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCC--CCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCC-C
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGD--KSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA-I 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p-~ 157 (325)
|||+||+++.++.+||+|||+++...... .........+++.|+|||.+.+..++.++||||||+++|+|++|..| |
T Consensus 150 ikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~ 229 (298)
T 3pls_A 150 LAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY 229 (298)
T ss_dssp CSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred CCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCC
Confidence 99999999999999999999997543322 11223345678899999999999999999999999999999996554 4
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
....... +....... ... ..+......+.+++..||+.+|.+|||+.++++.|+.+....
T Consensus 230 ~~~~~~~---~~~~~~~~----------~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 230 RHIDPFD---LTHFLAQG----------RRL----PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp TTSCGGG---HHHHHHTT----------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ccCCHHH---HHHHhhcC----------CCC----CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 4332211 11111000 000 111223357889999999999999999999999999887643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=289.00 Aligned_cols=201 Identities=20% Similarity=0.264 Sum_probs=161.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..|+||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dl 154 (362)
T 2bdw_A 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNL 154 (362)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccC
Confidence 5678999999999999999999999999999999999965 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCC---CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEG---FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~---~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+|||++.+ +.+||+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 155 kp~NIll~~~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 155 KPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp SGGGEEESCSSTTCCEEECCCTTCBCCTTC---CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred chHHEEEecCCCCCCEEEeecCcceEecCC---cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999765 45999999999764422 22334679999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..... .+. ..+..... ....+. .......+.+|+.+||+.||.+||++.++++.
T Consensus 232 ~~~~~---~~~---~~i~~~~~---~~~~~~-----~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 232 DEDQH---RLY---AQIKAGAY---DYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CSSHH---HHH---HHHHHTCC---CCCTTG-----GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCHH---HHH---HHHHhCCC---CCCccc-----ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 54321 111 11110000 000000 01224568899999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=285.94 Aligned_cols=220 Identities=25% Similarity=0.392 Sum_probs=166.5
Q ss_pred cCCCCCCCccceeeEEEeC--CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADG--DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++.+. ...++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+ |+||
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~ 150 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHR 150 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccC
Confidence 5688999999999999876 678999999999999999965 2456999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.++|+|||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+.
T Consensus 151 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 151 DLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp CCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 99999999999999999999999765433221 22334568888999999999999999999999999999999998864
Q ss_pred CCCCCCcchhhhhhhhcccc--ccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 159 STRPHGEQNLVTWARPLFND--RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
..... ......+.... ...+............+......+.+|+.+||+.||.+|||+.+|++.|+.+.
T Consensus 231 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 231 SPMAL----FLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp SHHHH----HHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhhH----HhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 32100 00000000000 00000000011111122334467889999999999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=292.64 Aligned_cols=203 Identities=21% Similarity=0.265 Sum_probs=163.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+....++||||+.+++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 101 il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 174 (387)
T 1kob_A 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLD 174 (387)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 36789999999999999999999999999999999999975 3346999999999999999999999999 99999
Q ss_pred CCCCcEEEcC--CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 81 FKSSNILLEE--GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 81 ik~~Nill~~--~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|||+|||++. ++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus 175 lkp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 251 (387)
T 1kob_A 175 IKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 251 (387)
T ss_dssp CCGGGEEESSTTCCCEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cchHHeEEecCCCCceEEEecccceecCCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCC
Confidence 9999999974 467999999999864322 22334579999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...... .. ..+.... ..+++.. .......+.+|+.+||+.||.+||++.++++.
T Consensus 252 ~~~~~~---~~---~~i~~~~----~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 252 GEDDLE---TL---QNVKRCD----WEFDEDA----FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSHHH---HH---HHHHHCC----CCCCSST----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCHHH---HH---HHHHhCC----CCCCccc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 643211 11 1111100 0011111 11234578899999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=287.15 Aligned_cols=212 Identities=23% Similarity=0.381 Sum_probs=168.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------PDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+|++++||||+++++++.+.+..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+++
T Consensus 81 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 158 (322)
T 1p4o_A 81 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 158 (322)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3678899999999999999999999999999999999987521 11245799999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-C
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-G 153 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g 153 (325)
|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 159 -i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g 237 (322)
T 1p4o_A 159 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237 (322)
T ss_dssp -CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred -CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999975432222222334457889999999999999999999999999999999 8
Q ss_pred CCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 154 RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..||....... +... .... .. + ..+......+.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus 238 ~~p~~~~~~~~---~~~~---~~~~-----~~--~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 238 EQPYQGLSNEQ---VLRF---VMEG-----GL--L----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp CCTTTTSCHHH---HHHH---HHTT-----CC--C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCccccCCHHH---HHHH---HHcC-----Cc--C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 89987643211 1111 0000 00 0 1112334568899999999999999999999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=290.13 Aligned_cols=195 Identities=26% Similarity=0.281 Sum_probs=160.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
++.++||||++++++|.+.+..|+||||+++|+|.+++.. ...+++..++.++.+++.||+|||+++ |+||||
T Consensus 93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDl 165 (373)
T 2r5t_A 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDL 165 (373)
T ss_dssp BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 5678999999999999999999999999999999999975 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++++||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 166 kp~NIll~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~ 243 (373)
T 2r5t_A 166 KPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243 (373)
T ss_dssp CGGGEEECTTSCEEECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB
T ss_pred CHHHEEECCCCCEEEeeCccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999999999999999753222 223445679999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 223 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ev 223 (325)
... ....+..... .++......+.+|+.+||+.||.+||++.+.
T Consensus 244 ~~~------~~~~i~~~~~------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~ 287 (373)
T 2r5t_A 244 TAE------MYDNILNKPL------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDD 287 (373)
T ss_dssp HHH------HHHHHHHSCC------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTT
T ss_pred HHH------HHHHHHhccc------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCC
Confidence 211 1111111110 1112233568899999999999999998543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=284.95 Aligned_cols=217 Identities=20% Similarity=0.299 Sum_probs=162.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.........+++..++.++.+++.||.|||+.+ |+||||
T Consensus 86 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl 162 (310)
T 2wqm_A 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDI 162 (310)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCC
Confidence 56789999999999999999999999999999999999754334567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++...... ........|++.|+|||++.+..++.++||||||+++++|++|..||....
T Consensus 163 ~p~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 163 KPANVFITATGVVKLGDLGLGRFFSSK--TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp CGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred cHHHEEEcCCCCEEEEeccceeeecCC--CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999999998754322 122334568999999999999999999999999999999999999996543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccCCCC
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDP 237 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~~~~ 237 (325)
.. .......+... .+. +.. .......+.+|+.+||+.||.+||++.+|++.|+.+......|
T Consensus 241 ~~----~~~~~~~~~~~--~~~----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 241 MN----LYSLCKKIEQC--DYP----PLP----SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp CC----HHHHHHHHHTT--CSC----CCC----TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred hh----HHHHHHHhhcc--cCC----CCc----ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 21 11111111000 000 000 1122356889999999999999999999999999998765443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=281.76 Aligned_cols=206 Identities=23% Similarity=0.369 Sum_probs=165.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++ ..+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 72 l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~di 143 (291)
T 1xbb_A 72 MQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDL 143 (291)
T ss_dssp HHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCC
Confidence 5678999999999999 56678999999999999999976 455999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCC-ccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
||+||+++.++.+||+|||++.......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||..
T Consensus 144 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 144 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999999999997654332211 1223446788999999999899999999999999999999 9999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..... +...... . . ....+......+.+++..||+.||.+||++.+|++.|+.+..
T Consensus 224 ~~~~~---~~~~~~~----~------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 224 MKGSE---VTAMLEK----G------E----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp CCHHH---HHHHHHT----T------C----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHHH---HHHHHHc----C------C----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 53221 1111100 0 0 011122334678899999999999999999999999998764
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=279.54 Aligned_cols=216 Identities=21% Similarity=0.245 Sum_probs=159.7
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+++..++||||++ ++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 54 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~d 126 (292)
T 3o0g_A 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRD 126 (292)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHhcCCCCCEeeEEeEEEeCCEEEEEEecCC-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 3678999999999999999999999999997 567666654 2456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC-CCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+||+++.++.+||+|||+++..... ........||+.|+|||++.+.. ++.++|||||||++++|++|..|+..
T Consensus 127 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 127 LKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred CCHHHEEEcCCCCEEEeecccceecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 9999999999999999999999764322 22334457899999999998766 79999999999999999998888643
Q ss_pred CCCCCcchhhhhhhhcccc-cc---ccccccC---------CccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFND-RR---KFSKLAD---------PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~-~~---~~~~~~d---------~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..... ..+.......... .. ......+ ..............+.+|+.+||+.||.+|||+.|+++.
T Consensus 205 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 205 GNDVD-DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CSSHH-HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHH-HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 32111 1111110000000 00 0000000 000011112334678899999999999999999999863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=306.61 Aligned_cols=208 Identities=23% Similarity=0.342 Sum_probs=164.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.. +..++||||+.+|+|.+++.. ....+++..++.++.||+.||+|||+++ |+|||
T Consensus 389 il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrD 461 (613)
T 2ozo_A 389 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRN 461 (613)
T ss_dssp HHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCc
Confidence 3678999999999999976 568999999999999999975 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~ 158 (325)
|||+||||+.++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus 462 lkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 541 (613)
T 2ozo_A 462 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 541 (613)
T ss_dssp CSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999865432211 11222345688999999999999999999999999999998 999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
...... +..... .. .....+......+.+|+..||+.+|.+||++.+|++.|+.+..
T Consensus 542 ~~~~~~---~~~~i~----~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 542 KMKGPE---VMAFIE----QG----------KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp TCCSHH---HHHHHH----TT----------CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCHHH---HHHHHH----cC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 654322 111110 00 0011222344678899999999999999999999999988754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=287.42 Aligned_cols=198 Identities=25% Similarity=0.374 Sum_probs=157.8
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+++ +||||+++++++.+.+..|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||
T Consensus 63 l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 135 (345)
T 3a8x_A 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRD 135 (345)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecC
Confidence 3345 899999999999999999999999999999999975 356999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 136 lkp~NIll~~~g~~kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 136 LKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp CCGGGEEECTTSCEEECCGGGCBCSCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred CCHHHEEECCCCCEEEEeccccccccCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence 9999999999999999999999753222 22344567999999999999999999999999999999999999999754
Q ss_pred CCCCcc--hhhhhh-hhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 161 RPHGEQ--NLVTWA-RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 161 ~~~~~~--~~~~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
...... ...... ..+.... ..++......+.+|+.+||+.||.+||++
T Consensus 214 ~~~~~~~~~~~~~~~~~i~~~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 214 GSSDNPDQNTEDYLFQVILEKQ------------IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp TC-------CHHHHHHHHHHCC------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ccccccccccHHHHHHHHHcCC------------CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 322111 011111 1111110 01222334578899999999999999995
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=280.69 Aligned_cols=214 Identities=23% Similarity=0.325 Sum_probs=158.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..++||||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|||
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 125 (288)
T 1ob3_A 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125 (288)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 4778999999999999999999999999997 599999875 2356999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+||+++.++.+||+|||+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||..
T Consensus 126 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 126 LKPQNLLINREGELKIADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp CCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCHHHEEEcCCCCEEEeECccccccCcc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999754322 1123345689999999998764 589999999999999999999999976
Q ss_pred CCCCCcchhhhhhhhc-------cccccccccccCCccC-------CCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 160 TRPHGEQNLVTWARPL-------FNDRRKFSKLADPRLE-------GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~d~~l~-------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...... +....... +...... ...++.+. ..........+.+|+.+||+.||.+|||+.++++
T Consensus 204 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 204 VSEADQ--LMRIFRILGTPNSKNWPNVTEL-PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp SSHHHH--HHHHHHHHCCCCTTTSTTGGGS-TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHH--HHHHHHHHCCCChhhchhhhcc-cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 432211 11100000 0000000 00111110 0111123457889999999999999999999986
Q ss_pred H
Q 020529 226 A 226 (325)
Q Consensus 226 ~ 226 (325)
.
T Consensus 281 h 281 (288)
T 1ob3_A 281 H 281 (288)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=289.27 Aligned_cols=203 Identities=22% Similarity=0.317 Sum_probs=155.7
Q ss_pred cCCCCC--CCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHH--SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~H--pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++| |||+++++++.+....++|||+. +++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||
T Consensus 61 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHr 132 (343)
T 3dbq_A 61 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 132 (343)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHhhhhcCCceEEEeeeEeeCCEEEEEEeCC-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 455655 99999999999999999999955 7899999986 456999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-----------CCCCccccEEEehHHHH
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----------GQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvvl~ 148 (325)
||||+|||++ ++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|
T Consensus 133 Dikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ 211 (343)
T 3dbq_A 133 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 211 (343)
T ss_dssp CCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHH
T ss_pred CCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHH
Confidence 9999999997 67899999999986544433334455679999999999875 67899999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 149 ELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 149 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
||++|+.||...... .. .+....++.....++......+.+|+..||+.||.+|||+.++++..-
T Consensus 212 ell~g~~pf~~~~~~----~~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 212 YMTYGKTPFQQIINQ----IS-----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HHHHSSCTTTTCCSH----HH-----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHhCCCcchhhhhH----HH-----------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 999999999653211 00 011122222222233333457889999999999999999999998653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=290.71 Aligned_cols=204 Identities=21% Similarity=0.264 Sum_probs=152.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 70 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dl 142 (361)
T 3uc3_A 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDL 142 (361)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCC
T ss_pred HHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999999999999999999999999999975 446999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCe--EEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCcc-ccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFH--PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVK-SDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~--~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~k-sDvwSlGvvl~elltg~~p~~ 158 (325)
||+|||++.++. +||+|||+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.
T Consensus 143 kp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 143 KLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp CGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CHHHEEEcCCCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 999999987765 999999999743221 22344569999999999988877655 899999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
....... .......+......++ ........+.+|+.+||+.+|.+|||+.++++.-
T Consensus 220 ~~~~~~~--~~~~~~~~~~~~~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 220 DPEEPRD--YRKTIQRILSVKYSIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp ----CCC--HHHHHHHHHTTCCCCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CCccHHH--HHHHHHHHhcCCCCCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 6543222 1111111111110000 0112235688999999999999999999999864
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=286.44 Aligned_cols=213 Identities=27% Similarity=0.392 Sum_probs=168.6
Q ss_pred cCCC-CCCCccceeeEEEeCC-eeEEEEecCCCCCHHHHhccCCCC------------CCCCCHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGD-QRLLVYEFMPLGSLEDHLHDLPPD------------KEALDWNTRMKIAAGAAKGLEY 67 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~------------~~~l~~~~~~~i~~~l~~al~~ 67 (325)
|+++ +||||+++++++...+ ..++||||+++++|.+++...... ...+++..++.++.|++.||.|
T Consensus 84 l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 163 (316)
T 2xir_A 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 163 (316)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHH
Confidence 3456 7999999999987754 589999999999999999864321 2238999999999999999999
Q ss_pred HhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHH
Q 020529 68 LHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVF 147 (325)
Q Consensus 68 LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl 147 (325)
||+.+ |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++
T Consensus 164 lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 240 (316)
T 2xir_A 164 LASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240 (316)
T ss_dssp HHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHH
Confidence 99999 999999999999999999999999999865443333334456688999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 148 LELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 148 ~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|+|++ |..||........ +... +... ... ..+......+.+++..||+.+|.+||++.+|++.
T Consensus 241 ~~l~t~g~~p~~~~~~~~~--~~~~----~~~~------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 241 WEIFSLGASPYPGVKIDEE--FCRR----LKEG------TRM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHTTSCCSSTTCCCSHH--HHHH----HHHT------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhCCCCCCcccchhHH--HHHH----hccC------ccC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99998 9999976543211 1110 0000 000 1111223568899999999999999999999999
Q ss_pred HHhhhcc
Q 020529 227 LSYLANQ 233 (325)
Q Consensus 227 L~~~~~~ 233 (325)
|+.+...
T Consensus 305 L~~~~~~ 311 (316)
T 2xir_A 305 LGNLLQA 311 (316)
T ss_dssp HHHHHHH
T ss_pred HHHHHhh
Confidence 9988653
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=283.56 Aligned_cols=200 Identities=24% Similarity=0.405 Sum_probs=159.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dl 139 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNV 139 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCc
Confidence 5788999999999999999999999999999999999976 2344999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCe--------EEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHh
Q 020529 82 KSSNILLEEGFH--------PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 82 k~~Nill~~~~~--------~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~ellt 152 (325)
||+|||++.++. +||+|||++.... ......||+.|+|||++.+ ..++.++||||||+++|||++
T Consensus 140 kp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 213 (289)
T 4fvq_A 140 CAKNILLIREEDRKTGNPPFIKLSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213 (289)
T ss_dssp CGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred CcceEEEecCCcccccccceeeeccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence 999999998887 9999999986421 2234568899999999987 678999999999999999999
Q ss_pred CCC-CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 153 GRK-AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 153 g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
|.. |+...... ..... ......+.. .....+.+|+.+||+.||.+||++.+|++.|+.+.
T Consensus 214 g~~~~~~~~~~~---~~~~~----~~~~~~~~~------------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 214 GGDKPLSALDSQ---RKLQF----YEDRHQLPA------------PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp TTCCTTTTSCHH---HHHHH----HHTTCCCCC------------CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred CCCCCccccchH---HHHHH----hhccCCCCC------------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 654 44332211 11100 001101111 11234678999999999999999999999999876
Q ss_pred c
Q 020529 232 N 232 (325)
Q Consensus 232 ~ 232 (325)
.
T Consensus 275 ~ 275 (289)
T 4fvq_A 275 T 275 (289)
T ss_dssp -
T ss_pred C
Confidence 5
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=289.48 Aligned_cols=203 Identities=21% Similarity=0.253 Sum_probs=163.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||++++++|.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|||
T Consensus 139 ~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 212 (373)
T 2x4f_A 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLD 212 (373)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36789999999999999999999999999999999998865 2346999999999999999999999999 99999
Q ss_pred CCCCcEEE--cCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 81 FKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 81 ik~~Nill--~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|||+|||+ +.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 213 lkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 213 LKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp CCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 99999999 567899999999998654322 2234569999999999999899999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...... .+. .+...... +.+.... .....+.+|+.+||+.+|.+||++.++++.
T Consensus 290 ~~~~~~--~~~----~i~~~~~~----~~~~~~~----~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 290 GDNDAE--TLN----NILACRWD----LEDEEFQ----DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CSSHHH--HHH----HHHHTCCC----SCSGGGT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHH--HHH----HHHhccCC----CChhhhc----cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 653211 111 11111100 0001111 223578899999999999999999999984
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-38 Score=285.65 Aligned_cols=225 Identities=23% Similarity=0.324 Sum_probs=162.4
Q ss_pred cCCCCCCCccceeeEEEe-----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-----
Q 020529 2 LSLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK----- 71 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~----- 71 (325)
++.++||||+++++++.. ....++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~ 135 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGD 135 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGG
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhcccc
Confidence 456899999999986543 2366899999999999999965 3358999999999999999999999
Q ss_pred ----CCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCC------CCccccccCCcCccCchhhcc-------CCC
Q 020529 72 ----ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK------SHVSTRVMGTYGYCAPEYAMT-------GQL 134 (325)
Q Consensus 72 ----~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~ 134 (325)
+ |+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..+
T Consensus 136 ~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 212 (336)
T 3g2f_A 136 HYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212 (336)
T ss_dssp GCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH
T ss_pred ccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccc
Confidence 7 99999999999999999999999999976433211 112234569999999999987 456
Q ss_pred CccccEEEehHHHHHHHhCCCCCCCCCCCCcch-hhhh---hhhccccccc--cccccCCccCCCC--ChHHHHHHHHHH
Q 020529 135 TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN-LVTW---ARPLFNDRRK--FSKLADPRLEGRY--PIRGLYQALAVA 206 (325)
Q Consensus 135 ~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~-~~~~---~~~~~~~~~~--~~~~~d~~l~~~~--~~~~~~~~~~l~ 206 (325)
+.++|||||||++|||++|..||.......... .... ..+....... ......+.+...+ .......+.+|+
T Consensus 213 ~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (336)
T 3g2f_A 213 LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292 (336)
T ss_dssp HHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHH
T ss_pred ccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHH
Confidence 788999999999999999977764432222111 0000 0000000000 0000011111111 123456799999
Q ss_pred HHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 207 SMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 207 ~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
.+||+.||.+|||+.+|++.|+.+....
T Consensus 293 ~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 293 EDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp HHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 9999999999999999999999988654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=287.80 Aligned_cols=201 Identities=23% Similarity=0.295 Sum_probs=153.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||++++++|.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 102 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Di 174 (349)
T 2w4o_A 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDL 174 (349)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCC
Confidence 5678999999999999999999999999999999999975 456999999999999999999999999 999999
Q ss_pred CCCcEEEcC---CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEE---GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~---~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+|||++. ++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 175 kp~NIll~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp CGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CcccEEEecCCCCCCEEEccCccccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 999999975 889999999999754321 22344679999999999999999999999999999999999999996
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...... .+. ..+.... ..... .........+.+|+.+||+.||.+||++.++++
T Consensus 252 ~~~~~~--~~~---~~i~~~~---~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 252 DERGDQ--FMF---RRILNCE---YYFIS-----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp CTTCHH--HHH---HHHHTTC---CCCCT-----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcccH--HHH---HHHHhCC---CccCC-----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 543221 010 1111100 00000 111123457889999999999999999999986
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=282.02 Aligned_cols=198 Identities=22% Similarity=0.306 Sum_probs=157.1
Q ss_pred cCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++.+ ....++||||+++++|.+++. ...+++..++.++.|++.||+|||+.+ |+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~ 161 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHR 161 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecc
Confidence 568899999999999987 568899999999999987653 356999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC---CCccccEEEehHHHHHHHhCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ---LTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvvl~elltg~~p 156 (325)
||||+|||++.++.+||+|||+++..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.|
T Consensus 162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 239 (298)
T 2zv2_A 162 DIKPSNLLVGEDGHIKIADFGVSNEFKGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239 (298)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECSSS--SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCHHHEEECCCCCEEEecCCCccccccc--cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence 99999999999999999999999764322 12234467999999999987765 37889999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|...... .+...+..... .. + . .......+.+|+.+||+.||.+||++.+|++
T Consensus 240 f~~~~~~------~~~~~~~~~~~---~~--~-~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 240 FMDERIM------CLHSKIKSQAL---EF--P-D----QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCCSSHH------HHHHHHHHCCC---CC--C-S----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCccHH------HHHHHHhcccC---CC--C-C----ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 9654211 11111111000 00 0 0 1122356889999999999999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=287.56 Aligned_cols=196 Identities=22% Similarity=0.278 Sum_probs=163.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||+++++++.+....|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 94 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrD 166 (350)
T 1rdq_E 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRD 166 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccc
Confidence 36788999999999999999999999999999999999976 346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 167 lkp~NIll~~~g~~kL~DFg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 167 LKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CccceEEECCCCCEEEcccccceeccC-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 999999999999999999999976432 233457999999999999999999999999999999999999999754
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
.... ....+..... .++......+.+|+.+||+.||.+||+ +.+|++.
T Consensus 242 ~~~~------~~~~i~~~~~------------~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 242 QPIQ------IYEKIVSGKV------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp SHHH------HHHHHHHCCC------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CHHH------HHHHHHcCCC------------CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 3211 1111111110 112233457889999999999999998 8888764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=287.12 Aligned_cols=198 Identities=24% Similarity=0.345 Sum_probs=161.7
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+.+ +||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..++.++.+++.||.|||+.+ |+|||
T Consensus 74 l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrD 146 (353)
T 2i0e_A 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRD 146 (353)
T ss_dssp HTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecc
Confidence 4455 899999999999999999999999999999999975 346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 147 lkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 224 (353)
T 2i0e_A 147 LKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224 (353)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHEEEcCCCcEEEEeCCcccccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999753221 22344567999999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
.... ....+..... .++......+.+|+.+||+.+|.+||+ +.+|++.
T Consensus 225 ~~~~------~~~~i~~~~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 225 DEDE------LFQSIMEHNV------------AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp SHHH------HHHHHHHCCC------------CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CHHH------HHHHHHhCCC------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 3211 1111111110 122233467889999999999999995 5777654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=281.67 Aligned_cols=209 Identities=22% Similarity=0.300 Sum_probs=154.1
Q ss_pred CcCCCCCCCccceeeEEEeCCe----eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQ----RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
+|++++||||+++++++..... .|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+++ |
T Consensus 65 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 137 (311)
T 3ork_A 65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---I 137 (311)
T ss_dssp TCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 4778999999999999876543 4999999999999999975 456999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.
T Consensus 138 vH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 217 (311)
T 3ork_A 138 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217 (311)
T ss_dssp CCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999764332221 22334568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHH-HHHHhh
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV-TALSYL 230 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl-~~L~~~ 230 (325)
||........ ............. .. .......+.+|+.+||+.||.+||++.+++ ..+..+
T Consensus 218 pf~~~~~~~~------~~~~~~~~~~~~~----~~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 218 PFTGDSPVSV------AYQHVREDPIPPS----AR----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp SCCCSSHHHH------HHHHHHCCCCCHH----HH----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCCChHHH------HHHHhcCCCCCcc----cc----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 9976432111 0011110000000 00 011235688999999999999999766555 444443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=290.32 Aligned_cols=218 Identities=19% Similarity=0.209 Sum_probs=161.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++|||||+++++|.+.+..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 80 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDl 154 (389)
T 3gni_B 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSV 154 (389)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 567899999999999999999999999999999999997632 345999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCC-----CCccccccCCcCccCchhhcc--CCCCccccEEEehHHHHHHHhCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDK-----SHVSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~ 154 (325)
||+|||++.++.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 155 kp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~ 234 (389)
T 3gni_B 155 KASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234 (389)
T ss_dssp SGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCC
Confidence 99999999999999999998864321111 111233468999999999987 57899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhcccc---ccc------------------ccccc---CC------ccCCCCChHHHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFND---RRK------------------FSKLA---DP------RLEGRYPIRGLYQALA 204 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~---~~~------------------~~~~~---d~------~l~~~~~~~~~~~~~~ 204 (325)
.||......... .......... ... +.... .+ .....++......+.+
T Consensus 235 ~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 312 (389)
T 3gni_B 235 VPFKDMPATQML--LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312 (389)
T ss_dssp CTTTTCCSTTHH--HHC--------------------------------------------------------CCHHHHH
T ss_pred CCCCCCCHHHHH--HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHH
Confidence 999765432211 1100000000 000 00000 00 0000112223457889
Q ss_pred HHHHchhhCCCCCCCHHHHHHH
Q 020529 205 VASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 205 l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|+.+||+.||.+|||+.|+++.
T Consensus 313 li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 313 FVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHHHHhhcCcccCCCHHHHhcC
Confidence 9999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=290.66 Aligned_cols=194 Identities=26% Similarity=0.408 Sum_probs=159.9
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
++||||+++++++.+.+..|+||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~ 147 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLD 147 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGG
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChh
Confidence 3899999999999999999999999999999999975 356999999999999999999999999 999999999
Q ss_pred cEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 85 Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 148 NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~ 225 (345)
T 1xjd_A 148 NILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225 (345)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred hEEECCCCCEEEeEChhhhhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999999753322 223455679999999999999999999999999999999999999997643211
Q ss_pred cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH-HHHH
Q 020529 165 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG-DVVT 225 (325)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~-evl~ 225 (325)
+ ...+.... + .++......+.+|+.+||+.||.+||++. +|++
T Consensus 226 ---~---~~~i~~~~--------~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 226 ---L---FHSIRMDN--------P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ---H---HHHHHHCC--------C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---H---HHHHHhCC--------C----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 1 11111111 0 11222345788999999999999999997 6653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=288.55 Aligned_cols=207 Identities=22% Similarity=0.280 Sum_probs=142.1
Q ss_pred cCCCC-CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+++. ||||+++++++.+....|+||||+++++|.+++.. ...+++..++.|+.|++.||+|||+.+ |+|||
T Consensus 59 l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 131 (325)
T 3kn6_A 59 LKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRD 131 (325)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecC
Confidence 44565 99999999999999999999999999999999976 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC---eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEGF---HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~---~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+|||++.++ .+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 132 lkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf 209 (325)
T 3kn6_A 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPF 209 (325)
T ss_dssp CCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCHHHEEEecCCCcccEEEeccccceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCC
Confidence 999999997665 89999999997643322 2234456899999999999999999999999999999999999999
Q ss_pred CCCCCCCcc-hhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 158 DSTRPHGEQ-NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
......... ........+..... .+...........+.+|+..||+.||.+||++.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 210 QSHDRSLTCTSAVEIMKKIKKGDF--------SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp C-------CCCHHHHHHHHTTTCC--------CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCccccccccHHHHHHHHHcCCC--------CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 765432111 11111111111000 0000000122457889999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=301.20 Aligned_cols=208 Identities=24% Similarity=0.386 Sum_probs=165.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++. .+..++||||+.+|+|.+++... ....+++..++.++.|++.||+|||+++ |+|||
T Consensus 236 ~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrD 309 (454)
T 1qcf_A 236 VMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 309 (454)
T ss_dssp HHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 367899999999999986 56789999999999999999752 1235889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+|||++.++.+||+|||+++...... ........+++.|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 310 lkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 310 LRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp CSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998643211 111223446788999999999999999999999999999999 9999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..... +..... .. ... ..+......+.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus 389 ~~~~~---~~~~i~----~~---~~~-------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 389 MSNPE---VIRALE----RG---YRM-------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCHHH---HHHHHH----HT---CCC-------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCHHH---HHHHHH----cC---CCC-------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 43221 111110 00 000 1122334578899999999999999999999999988754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=284.10 Aligned_cols=198 Identities=27% Similarity=0.348 Sum_probs=159.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..|+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 75 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dl 147 (327)
T 3a62_A 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDL 147 (327)
T ss_dssp HHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccC
Confidence 5678999999999999999999999999999999999975 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 148 kp~Nill~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 225 (327)
T 3a62_A 148 KPENIMLNHQGHVKLTDFGLCKESIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN 225 (327)
T ss_dssp CTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CHHHeEECCCCcEEEEeCCcccccccC--CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999998753222 122344679999999999999999999999999999999999999997643
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
... ....+..... .++......+.+|+.+||+.+|.+|| ++.++++.
T Consensus 226 ~~~------~~~~i~~~~~------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 226 RKK------TIDKILKCKL------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHH------HHHHHHHTCC------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHH------HHHHHHhCCC------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 211 1111111110 11222345788999999999999999 77888764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=282.81 Aligned_cols=219 Identities=22% Similarity=0.307 Sum_probs=162.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP--PDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
+|++++||||+++++++.+.+..++||||++ ++|.+++.... .....+++..+..++.|++.||.|||+.+ |+|
T Consensus 56 ~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH 131 (317)
T 2pmi_A 56 LMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILH 131 (317)
T ss_dssp HHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eee
Confidence 3678999999999999999999999999997 79999986532 22346999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||
T Consensus 132 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf 209 (317)
T 2pmi_A 132 RDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF 209 (317)
T ss_dssp CCCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999999999999999997643221 223345689999999999764 6899999999999999999999999
Q ss_pred CCCCCCCcchhh-hhhh----hccccccccccccCCccC------------CCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 158 DSTRPHGEQNLV-TWAR----PLFNDRRKFSKLADPRLE------------GRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 158 ~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~d~~l~------------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
...........+ .... ..+........ ..+.+. ...+......+.+|+.+||+.||.+|||+
T Consensus 210 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 288 (317)
T 2pmi_A 210 PGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK-YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288 (317)
T ss_dssp CCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT-CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCCChHHHHHHHHHHhCCCChhHhhhhhhhhh-cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCH
Confidence 765432111110 0000 00000000000 000000 00011223578899999999999999999
Q ss_pred HHHHHH
Q 020529 221 GDVVTA 226 (325)
Q Consensus 221 ~evl~~ 226 (325)
.++++.
T Consensus 289 ~e~l~h 294 (317)
T 2pmi_A 289 KQALHH 294 (317)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=282.31 Aligned_cols=192 Identities=25% Similarity=0.317 Sum_probs=160.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCC-CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLG-SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++||||++++++|.+.+..++||||+.+| +|.+++.. ...+++..++.|+.|++.||.|||+.+ |+||
T Consensus 82 ~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~ 154 (335)
T 3dls_A 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHR 154 (335)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEe
Confidence 367889999999999999999999999998666 99999975 456999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.
T Consensus 155 Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 231 (335)
T 3dls_A 155 DIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231 (335)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEECCTT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCS
T ss_pred ccCHHHEEEcCCCcEEEeecccceECCCC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchh
Confidence 99999999999999999999999764332 22344679999999999988877 789999999999999999999996
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..... . ..... .+......+.+|+..||+.+|.+||++.+|++.
T Consensus 232 ~~~~~------------~------~~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 232 ELEET------------V------EAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SGGGG------------T------TTCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hHHHH------------H------hhccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 42110 0 00000 011123568899999999999999999999874
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=287.38 Aligned_cols=222 Identities=27% Similarity=0.402 Sum_probs=168.9
Q ss_pred cCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++.+ ....++||||+++++|.+++.. ..+++..++.++.+++.||+|||+.+ |+||
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~ 158 (318)
T 3lxp_A 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHR 158 (318)
T ss_dssp HHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCC
Confidence 567899999999999987 4678999999999999999965 34999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.+||+|||++......... .......||..|+|||++.+..++.++||||||+++++|++|..||.
T Consensus 159 Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 159 DLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp CCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 99999999999999999999999865443221 12334568888999999999999999999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
..... ......+....... ..+............+......+.+|+.+||+.+|.+||++.+|++.|+.+...
T Consensus 239 ~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 239 SPPTK-FLELIGIAQGQMTV-LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp SHHHH-HHHHHCSCCHHHHH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccchh-hhhhhcccccchhH-HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 43111 00000000000000 001111111111222334456789999999999999999999999999988754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=299.45 Aligned_cols=208 Identities=26% Similarity=0.379 Sum_probs=161.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+ +..++||||+++|+|.+++... ....+++..++.++.|++.||+|||+++ |+||||
T Consensus 233 l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDl 306 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 306 (452)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCC
Confidence 578899999999999876 6789999999999999999641 1245899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+|||++.++.+||+|||+++...... ........+++.|+|||++....++.++|||||||++|||++ |+.||...
T Consensus 307 kp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~ 385 (452)
T 1fmk_A 307 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385 (452)
T ss_dssp SGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ChhhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998643221 122233457889999999999999999999999999999999 99999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
.... +.... ... .....+......+.+|+.+||+.+|.+|||+.+|++.|+.+...
T Consensus 386 ~~~~---~~~~i----~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 386 VNRE---VLDQV----ERG----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CHHH---HHHHH----HTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CHHH---HHHHH----HcC----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 3211 11110 000 00111223345788999999999999999999999999887643
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=279.63 Aligned_cols=206 Identities=22% Similarity=0.311 Sum_probs=162.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.++ ..++||||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ |+||||
T Consensus 67 l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 139 (281)
T 3cc6_A 67 MKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDI 139 (281)
T ss_dssp HHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCC
Confidence 5678999999999998754 56899999999999999975 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.+||+|||++....... ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...
T Consensus 140 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~ 218 (281)
T 3cc6_A 140 AVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218 (281)
T ss_dssp SGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred ccceEEECCCCcEEeCccCCCccccccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence 9999999999999999999997643322 112334557889999999999999999999999999999998 99999754
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
......... . .. .. . ..+......+.+++.+||+.+|.+||++.+|++.|+.+..
T Consensus 219 ~~~~~~~~~---~----~~---~~---~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 219 ENKDVIGVL---E----KG---DR---L----PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CGGGHHHHH---H----HT---CC---C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ChHHHHHHH---h----cC---CC---C----CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 332211110 0 00 00 0 0111223568899999999999999999999999988754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=275.48 Aligned_cols=215 Identities=20% Similarity=0.265 Sum_probs=167.6
Q ss_pred cCCCCCCCccceeeEE-EeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++.++|+|++..+.++ ...+..++||||+ +++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|||
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 130 (296)
T 4hgt_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 130 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCC
Confidence 4567788777777665 6678889999999 8999999975 2446999999999999999999999999 99999
Q ss_pred CCCCcEEE---cCCCeEEEecCCCCccCCCCCCC-----CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh
Q 020529 81 FKSSNILL---EEGFHPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 81 ik~~Nill---~~~~~~kL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt 152 (325)
|||+|||+ +.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 131 lkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 210 (296)
T 4hgt_A 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp CSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhc
Confidence 99999999 78899999999999865433221 12335679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhh-hhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 153 GRKAIDSTRPHGEQNLVT-WARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
|+.||............. ........ ..+.+...+ ...+.+|+..||+.+|.+||++.+|++.|+.+.
T Consensus 211 g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~ 279 (296)
T 4hgt_A 211 GSLPWQGLKAATKRQKYERISEKKMST-------PIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SSCTTSSCCCSSSSSHHHHHHHHHHHS-------CHHHHTTTS----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred CCCCCcccchhhhhhhhhhhhcccccc-------hhhhhhccC----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHH
Confidence 999998755433322211 11110000 000011111 356889999999999999999999999999887
Q ss_pred ccC
Q 020529 232 NQT 234 (325)
Q Consensus 232 ~~~ 234 (325)
...
T Consensus 280 ~~~ 282 (296)
T 4hgt_A 280 HRQ 282 (296)
T ss_dssp HHH
T ss_pred HHh
Confidence 644
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=276.80 Aligned_cols=202 Identities=25% Similarity=0.362 Sum_probs=162.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+++..++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+|+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 131 (276)
T 2yex_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDI 131 (276)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCC
Confidence 5678999999999999999999999999999999999865 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.++|+|||++................||+.|+|||++.+..+ +.++||||||+++++|++|..||...
T Consensus 132 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 132 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred ChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999975433222223345678999999999987765 78999999999999999999999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.... ..+..|..... ... ........+.+|+.+||+.||.+||++.+|++
T Consensus 212 ~~~~-~~~~~~~~~~~--------~~~------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 212 SDSC-QEYSDWKEKKT--------YLN------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp CTTS-HHHHHHHTTCT--------TST------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chHH-HHHHHhhhccc--------ccC------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 4321 11222211100 000 01122356789999999999999999999976
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=288.47 Aligned_cols=224 Identities=27% Similarity=0.352 Sum_probs=167.7
Q ss_pred cCCCCCCCccceeeEEE--eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++. +....++||||+++++|.+++.. ....+++..++.|+.+++.||+|||+.+ |+||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~ 151 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR---CVHR 151 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCC
Confidence 57889999999999986 45678999999999999999975 2345999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++++|++|..||.
T Consensus 152 Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 152 DLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp CCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999865433221 12234558888999999999999999999999999999999999986
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
....... ....+... ......+............+......+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus 232 ~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 232 SPSAEFL-RMMGCERD-VPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp SHHHHHH-HHCC-----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred cccchhh-hhcccccc-cccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 4321100 00000000 0000000111111111222334456788999999999999999999999999987653
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=295.61 Aligned_cols=205 Identities=20% Similarity=0.198 Sum_probs=163.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||++++++|.+.+..||||||+++|+|.+++.. ....+++..+..++.+++.||.|||+.+ |+||||
T Consensus 128 l~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDL 201 (437)
T 4aw2_A 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDI 201 (437)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccc
Confidence 5578999999999999999999999999999999999976 2456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHHHHhCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
||+||||+.++.+||+|||+++...... ........||+.|+|||++. ...++.++|||||||++|||++|+.|
T Consensus 202 Kp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~P 280 (437)
T 4aw2_A 202 KPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280 (437)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCT
T ss_pred CHHHeeEcCCCCEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCC
Confidence 9999999999999999999997643322 22334467999999999987 45789999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCC--CCCHHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVTA 226 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPs~~evl~~ 226 (325)
|......... ..+..... ...-|... ......+.+|+.+||..+|++ ||++.||++.
T Consensus 281 f~~~~~~~~~------~~i~~~~~---~~~~p~~~----~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 281 FYAESLVETY------GKIMNHKE---RFQFPTQV----TDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp TCCSSHHHHH------HHHHTHHH---HCCCCSSC----CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred CCCCChhHHH------Hhhhhccc---cccCCccc----ccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 9764322111 11111100 00001110 122356889999999888888 9999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=280.93 Aligned_cols=202 Identities=27% Similarity=0.320 Sum_probs=155.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++.........+++..++.++.+++.||+|||+.+ |+||||
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~di 150 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDL 150 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCC
Confidence 67889999999999999999999999999999999998653323467999999999999999999999999 999999
Q ss_pred CCCcEEE---cCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill---~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+||++ +.++.+||+|||++...... .......||+.|+|||++. ..++.++||||||+++++|++|+.||.
T Consensus 151 kp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~ 226 (285)
T 3is5_A 151 KPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFT 226 (285)
T ss_dssp SGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEEecCCCCCCEEEEeeecceecCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCC
Confidence 9999999 45678999999999754322 2234566899999999875 568999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
............+... . ... ... .....+.+|+.+||+.||.+||++.||++
T Consensus 227 ~~~~~~~~~~~~~~~~------~----~~~-~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 227 GTSLEEVQQKATYKEP------N----YAV-ECR----PLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CSSHHHHHHHHHHCCC------C----CCC---C----CCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHhhhccCCc------c----ccc-ccC----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 6432211111100000 0 000 000 12346789999999999999999999986
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=275.52 Aligned_cols=198 Identities=25% Similarity=0.381 Sum_probs=141.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 138 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDL 138 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSC
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCC
Confidence 5788999999999999999999999999999999999975 3356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++....... .......||+.|+|||++.+..++.++||||||+++++|++|+.||....
T Consensus 139 ~p~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 216 (278)
T 3cok_A 139 TLSNLLLTRNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216 (278)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred CHHHEEEcCCCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence 9999999999999999999997643222 12234568999999999999899999999999999999999999997643
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...... ..... +. ..+......+.+++.+||+.||.+||++.+|++
T Consensus 217 ~~~~~~------~~~~~--------~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 217 VKNTLN------KVVLA--------DY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CC-----------CCSS--------CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHH------HHhhc--------cc----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 221110 00000 00 112223457889999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=282.06 Aligned_cols=191 Identities=20% Similarity=0.181 Sum_probs=152.5
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
.+||||++++++|.+++..++||||+ +++|.+++.. ....+++..++.|+.+++.||+|||+.+ |+||||||+
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~ 186 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPA 186 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHH
Confidence 48999999999999999999999999 6899999876 2456999999999999999999999999 999999999
Q ss_pred cEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCC
Q 020529 85 NILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHG 164 (325)
Q Consensus 85 Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~ 164 (325)
|||++.++.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||+++||++|..|+....
T Consensus 187 NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--- 259 (311)
T 3p1a_A 187 NIFLGPRGRCKLGDFGLLVELGTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--- 259 (311)
T ss_dssp GEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---
T ss_pred HEEECCCCCEEEccceeeeecccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---
Confidence 999999999999999998764322 23344569999999998876 78999999999999999999976654321
Q ss_pred cchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 165 EQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
........ ...+.+ +......+.+|+.+||+.||.+||++.++++
T Consensus 260 --~~~~~~~~----------~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 260 --GWQQLRQG----------YLPPEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp --HHHHHTTT----------CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --HHHHHhcc----------CCCccc----ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111000 001111 1122457889999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=286.54 Aligned_cols=201 Identities=23% Similarity=0.297 Sum_probs=159.3
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
+||||+++++++.+++..|+||||+++|+|.+++.. ...+++..+..++.+++.||.|||+.+ |+||||||+|
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~N 146 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSN 146 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGG
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHH
Confidence 899999999999999999999999999999999975 456999999999999999999999999 9999999999
Q ss_pred EEEcCC----CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 86 ILLEEG----FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 86 ill~~~----~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+... +.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 147 Il~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 224 (342)
T 2qr7_A 147 ILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224 (342)
T ss_dssp EEESSSSCSGGGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSST
T ss_pred EEEecCCCCcCeEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCC
Confidence 998433 359999999997643322 22344678999999999988889999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
......+.. .+..... .+...+.......+.+|+.+||+.||.+||++.+|++.
T Consensus 225 ~~~~~~~~~---~i~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 225 DDTPEEILA---RIGSGKF--------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp TSCHHHHHH---HHHHCCC--------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred cCCHHHHHH---HHccCCc--------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 222111111 1111000 01111112334678899999999999999999999875
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=289.20 Aligned_cols=206 Identities=20% Similarity=0.242 Sum_probs=155.3
Q ss_pred CCCCCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 3 SLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
+.++||||++++++|.. ....|+||||+++|+|.+++... ....+++..++.|+.|++.||.|||+.+ |+|
T Consensus 110 ~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 184 (400)
T 1nxk_A 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAH 184 (400)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 34589999999999875 56789999999999999999762 2346999999999999999999999999 999
Q ss_pred CCCCCCcEEEcC---CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 79 RDFKSSNILLEE---GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 79 rdik~~Nill~~---~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||||+|||++. ++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 185 rDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 261 (400)
T 1nxk_A 185 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_dssp CCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCcceEEEecCCCCccEEEEecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 999999999987 789999999999854322 22345678999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcc-hhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 156 AIDSTRPHGEQ-NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 156 p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||......... ..... +.... .....+. .......+.+|+.+||+.||.+||++.+|++.-
T Consensus 262 pf~~~~~~~~~~~~~~~---i~~~~---~~~~~~~-----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 262 PFYSNHGLAISPGMKTR---IRMGQ---YEFPNPE-----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp SCCCCTTCSSCCSHHHH---HHHTC---CCCCTTT-----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CCCCCccccccHHHHHH---HHcCc---ccCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 99765433211 01000 00000 0000000 012345688999999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=309.50 Aligned_cols=206 Identities=23% Similarity=0.365 Sum_probs=163.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++|||||+++++|.. +..++||||+.+++|.+++.. ...+++..++.|+.||+.||+|||+++ |+||||
T Consensus 424 l~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDL 495 (635)
T 4fl3_A 424 MQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDL 495 (635)
T ss_dssp HHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCC
Confidence 567899999999999964 457899999999999999975 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCC-CCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
||+||||+.++.+||+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus 496 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 575 (635)
T 4fl3_A 496 AARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575 (635)
T ss_dssp SGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999986543322 122333457889999999999999999999999999999998 9999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..... +..... .. .....+......+.+|+..||+.||.+||++.+|++.|+.+..
T Consensus 576 ~~~~~---~~~~i~----~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 576 MKGSE---VTAMLE----KG----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCHHH---HHHHHH----TT----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCHHH---HHHHHH----cC----------CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 54321 111110 00 0111222344678899999999999999999999999987653
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=274.20 Aligned_cols=215 Identities=20% Similarity=0.245 Sum_probs=167.0
Q ss_pred cCCCCCCCccceeeEE-EeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++.++|+|+++.+.++ ......++||||+ +++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d 130 (296)
T 3uzp_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 130 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCC
Confidence 4567888877777665 5677889999999 8999999975 2456999999999999999999999999 99999
Q ss_pred CCCCcEEE---cCCCeEEEecCCCCccCCCCCCC-----CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh
Q 020529 81 FKSSNILL---EEGFHPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 81 ik~~Nill---~~~~~~kL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt 152 (325)
|||+|||+ +.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 131 lkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 210 (296)
T 3uzp_A 131 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 210 (296)
T ss_dssp CCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHh
Confidence 99999999 58889999999999765433221 12345679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhh-hhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 153 GRKAIDSTRPHGEQNLV-TWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
|+.||............ .......... .+.+.. .....+.+++..||+.+|.+||++.+|++.|+.+.
T Consensus 211 g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 279 (296)
T 3uzp_A 211 GSLPWQGLKAATKRQKYERISEKKMSTP-------IEVLCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 279 (296)
T ss_dssp SSCTTSSCCCSSSSSHHHHHHHHHHHSC-------HHHHTT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHH
T ss_pred CCCCCCCcCchhhhhhhhhhcccccCCc-------hHHHHh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHH
Confidence 99999875443322221 1111111000 001111 12356889999999999999999999999999887
Q ss_pred ccC
Q 020529 232 NQT 234 (325)
Q Consensus 232 ~~~ 234 (325)
...
T Consensus 280 ~~~ 282 (296)
T 3uzp_A 280 HRQ 282 (296)
T ss_dssp HHT
T ss_pred Hhc
Confidence 654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=286.51 Aligned_cols=211 Identities=25% Similarity=0.382 Sum_probs=166.3
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP---DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
|++++||||+++++++.+....++||||+++++|.+++..... ....+++..++.++.+++.||.|||+.+ |+|
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H 163 (327)
T 2yfx_A 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIH 163 (327)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred HhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eec
Confidence 5678999999999999999999999999999999999986432 2245899999999999999999999999 999
Q ss_pred CCCCCCcEEEcC---CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CC
Q 020529 79 RDFKSSNILLEE---GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GR 154 (325)
Q Consensus 79 rdik~~Nill~~---~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~ 154 (325)
|||||+|||++. +..+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |.
T Consensus 164 ~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 243 (327)
T 2yfx_A 164 RDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY 243 (327)
T ss_dssp SCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999984 45699999999875433322223344568899999999999999999999999999999998 99
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.||...... .+...... . ..+ ..+......+.+|+.+||+.+|.+||++.+|++.|..+..
T Consensus 244 ~p~~~~~~~---~~~~~~~~---~-------~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 244 MPYPSKSNQ---EVLEFVTS---G-------GRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CSSTTCCHH---HHHHHHHT---T-------CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCHH---HHHHHHhc---C-------CCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 999754321 11111100 0 000 1112233568899999999999999999999999998765
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=276.15 Aligned_cols=197 Identities=27% Similarity=0.412 Sum_probs=160.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.+++.||+|||+.+ |+||||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dl 135 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDI 135 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCC
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccC
Confidence 6788999999999999999999999999999999999976 355999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 136 kp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 211 (279)
T 3fdn_A 136 KPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211 (279)
T ss_dssp CGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ChHhEEEcCCCCEEEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc
Confidence 999999999999999999998643221 2334578999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
..... ..+... ...++......+.+|+.+||+.+|.+||++.+|++.-
T Consensus 212 ~~~~~------~~~~~~------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 212 YQETY------KRISRV------------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp HHHHH------HHHHHT------------CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred HHHHH------HHHHhC------------CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 21111 000000 0011222335678999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=291.31 Aligned_cols=202 Identities=21% Similarity=0.313 Sum_probs=155.2
Q ss_pred cCCCC--CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLH--HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~--Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++|+ ||||+++++++...+..|+|||+ .+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||
T Consensus 108 l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHr 179 (390)
T 2zmd_A 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 179 (390)
T ss_dssp HHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCC
T ss_pred HHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 44554 69999999999999999999995 57999999986 346899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-----------CCCCccccEEEehHHHH
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----------GQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvvl~ 148 (325)
||||+|||++ ++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|
T Consensus 180 Dlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ 258 (390)
T 2zmd_A 180 DLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 258 (390)
T ss_dssp CCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHH
T ss_pred CCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHH
Confidence 9999999996 57899999999986544333333445679999999999875 36889999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||++|+.||...... ... +..+.++.....++......+.+|+.+||+.||.+||++.+|++..
T Consensus 259 ell~G~~Pf~~~~~~-----~~~----------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 259 YMTYGKTPFQQIINQ-----ISK----------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp HHHHSSCTTTTCCCH-----HHH----------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHCCCcchhhhHH-----HHH----------HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 999999999653211 000 1111122222222222345788999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=280.23 Aligned_cols=207 Identities=30% Similarity=0.423 Sum_probs=157.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc---CCCCCeEe
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD---KANPPVIY 78 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~---~~~~~ivH 78 (325)
|++++||||+++++++. +..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+ ++ |+|
T Consensus 55 l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH 128 (307)
T 2eva_A 55 LSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIH 128 (307)
T ss_dssp HHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSS-EECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCC
T ss_pred HhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCC-CCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eec
Confidence 56789999999999886 347999999999999999976321 2347899999999999999999999 66 999
Q ss_pred CCCCCCcEEEcCCCe-EEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 79 RDFKSSNILLEEGFH-PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 79 rdik~~Nill~~~~~-~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||||+||+++.++. +||+|||++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||
T Consensus 129 ~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~ 203 (307)
T 2eva_A 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203 (307)
T ss_dssp CCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTT
T ss_pred CCCChhHEEEeCCCCEEEEccccccccccc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 999999999988875 89999999864321 123346899999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
........ ...|. .. ....+.+ +......+.+|+.+||+.+|.+||++.+|++.|+.+....
T Consensus 204 ~~~~~~~~--~~~~~--~~-------~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 204 DEIGGPAF--RIMWA--VH-------NGTRPPL----IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp TTTCSSHH--HHHHH--HH-------TTCCCCC----BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred hhhCccHH--HHHHH--Hh-------cCCCCCc----ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 75432211 11111 00 0001111 1122356889999999999999999999999999887543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=293.43 Aligned_cols=198 Identities=23% Similarity=0.356 Sum_probs=163.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||+++++++.+.+..|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||
T Consensus 69 ~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrD 141 (476)
T 2y94_A 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRD 141 (476)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCccc
Confidence 36788999999999999999999999999999999999965 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..
T Consensus 142 Lkp~NIll~~~~~vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 142 LKPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp CSGGGEEECTTCCEEECCCSSCEECCTT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccHHHEEEecCCCeEEEeccchhhcccc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 9999999999999999999999864332 22344579999999999988765 6899999999999999999999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..... + ...+..... ..+......+.+|+.+||+.||.+|||+.+|++.
T Consensus 219 ~~~~~---~---~~~i~~~~~------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 219 DHVPT---L---FKKICDGIF------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp SSSHH---H---HHHHHTTCC------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCHHH---H---HHHHhcCCc------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 43211 1 111111000 0111223568899999999999999999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=281.38 Aligned_cols=211 Identities=22% Similarity=0.313 Sum_probs=160.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.+++.||+|||+.+ |+|||
T Consensus 82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~d 155 (319)
T 2y4i_B 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155 (319)
T ss_dssp GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 36788999999999999999999999999999999999976 3446999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCC---CCCccccccCCcCccCchhhcc---------CCCCccccEEEehHHHH
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGD---KSHVSTRVMGTYGYCAPEYAMT---------GQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~ksDvwSlGvvl~ 148 (325)
|||+||+++ ++.++|+|||+++...... .........||+.|+|||++.. ..++.++||||||+++|
T Consensus 156 lkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 234 (319)
T 2y4i_B 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234 (319)
T ss_dssp CCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHH
T ss_pred CChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHH
Confidence 999999998 6799999999987543221 1122234558999999999874 35788999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 149 ELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 149 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
||++|..||....... +. ..... ...+.+. +......+.+|+..||+.+|.+||++.+|++.|+
T Consensus 235 el~~g~~p~~~~~~~~---~~---~~~~~-------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~ 298 (319)
T 2y4i_B 235 ELHAREWPFKTQPAEA---II---WQMGT-------GMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLE 298 (319)
T ss_dssp HHHHSSCSSSSCCHHH---HH---HHHHT-------TCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHT
T ss_pred HHHhCCCCCCCCCHHH---HH---HHhcc-------CCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 9999999997643211 11 00000 0011110 0011235789999999999999999999999999
Q ss_pred hhhccC
Q 020529 229 YLANQT 234 (325)
Q Consensus 229 ~~~~~~ 234 (325)
.+....
T Consensus 299 ~l~~~~ 304 (319)
T 2y4i_B 299 KLPKRN 304 (319)
T ss_dssp TC----
T ss_pred HHHHhh
Confidence 877543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=276.96 Aligned_cols=211 Identities=22% Similarity=0.281 Sum_probs=158.5
Q ss_pred CCCCCCccceeeEEEeCC-----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 4 LLHHSNLVNLIGYCADGD-----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
.++||||++++++|.... ..++||||+. ++|.+++.... ...+++..++.++.|++.||+|||+.+ |+|
T Consensus 70 ~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH 143 (308)
T 3g33_A 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVH 143 (308)
T ss_dssp HHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred hcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 346999999999998765 5799999996 79999997632 234999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|||||+|||++.++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 144 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 220 (308)
T 3g33_A 144 RDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 220 (308)
T ss_dssp SCCCTTTEEECTTSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred CCCCHHHEEEcCCCCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999754322 23345679999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccc-ccccccc-------ccCCccC---CCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFN-DRRKFSK-------LADPRLE---GRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~-~~~~~~~-------~~d~~l~---~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
........ .......-. ....... .+.+... ..........+.+|+.+||+.||.+|||+.|+++
T Consensus 221 ~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 221 GNSEADQL--GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CSSHHHHH--HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHH--HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 65432211 110000000 0000000 0000000 0001123467889999999999999999999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=290.12 Aligned_cols=203 Identities=21% Similarity=0.270 Sum_probs=162.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++||||++++++|.+....|+||||+++|+|.+++.. ..+++..+..++.+++.||+|||+.+ |+||||
T Consensus 123 l~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDL 194 (410)
T 3v8s_A 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDV 194 (410)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccC
Confidence 5678999999999999999999999999999999999965 35899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC----CCccccEEEehHHHHHHHhCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ----LTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||+||||+.++.+||+|||+++...... ........||+.|+|||++.... ++.++|||||||++|||++|+.||
T Consensus 195 Kp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf 273 (410)
T 3v8s_A 195 KPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273 (410)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTT
T ss_pred CHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCC
Confidence 9999999999999999999997643322 11234567999999999998765 789999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCC--CCCHHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAAT--RPLIGDVVTAL 227 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~--RPs~~evl~~L 227 (325)
........ ...+...... +.-|. .......+.+|+.+||+.+|.+ ||++.||++.-
T Consensus 274 ~~~~~~~~------~~~i~~~~~~---~~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 274 YADSLVGT------YSKIMNHKNS---LTFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp CCSSHHHH------HHHHHTHHHH---CCCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred CCCChhhH------HHHHHhcccc---ccCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 76432211 1111111000 00000 0122357889999999999988 99999998763
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=278.98 Aligned_cols=202 Identities=25% Similarity=0.353 Sum_probs=162.9
Q ss_pred cCCCCCCCccceeeEEEe----------------CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 020529 2 LSLLHHSNLVNLIGYCAD----------------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 65 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~----------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al 65 (325)
|++++||||+++++++.. ....++||||+++++|.+++.... ...+++..++.++.|++.||
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l 135 (284)
T 2a19_B 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGV 135 (284)
T ss_dssp HHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHH
Confidence 567899999999999864 445799999999999999997521 34699999999999999999
Q ss_pred HHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehH
Q 020529 66 EYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGV 145 (325)
Q Consensus 66 ~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGv 145 (325)
.|||+.+ |+||||||+||+++.++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+
T Consensus 136 ~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 209 (284)
T 2a19_B 136 DYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGL 209 (284)
T ss_dssp HHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHH
T ss_pred HHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHH
Confidence 9999999 9999999999999999999999999997644322 233456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 146 VFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 146 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
++|+|++|..|+.... .... .+....+. ......+.+++.+||+.||.+||++.++++
T Consensus 210 il~~l~~~~~~~~~~~--------~~~~----------~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 267 (284)
T 2a19_B 210 ILAELLHVCDTAFETS--------KFFT----------DLRDGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILR 267 (284)
T ss_dssp HHHHHHSCCSSHHHHH--------HHHH----------HHHTTCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCCcchhHH--------HHHH----------Hhhccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 9999999988763210 0000 00011111 112345789999999999999999999999
Q ss_pred HHHhhhcc
Q 020529 226 ALSYLANQ 233 (325)
Q Consensus 226 ~L~~~~~~ 233 (325)
.|..+...
T Consensus 268 ~l~~~~~~ 275 (284)
T 2a19_B 268 TLTVWKKS 275 (284)
T ss_dssp HHHHHTC-
T ss_pred HHHHHhhC
Confidence 99987653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=284.27 Aligned_cols=205 Identities=15% Similarity=0.116 Sum_probs=165.4
Q ss_pred CCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCC
Q 020529 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-DKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 82 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik 82 (325)
...|+||+++++++...+..|+||||+++|+|.+++..... ....+++..++.|+.|++.||+|||+.+ |+|||||
T Consensus 123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiK 199 (365)
T 3e7e_A 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIK 199 (365)
T ss_dssp GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCS
T ss_pred hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCC
Confidence 34599999999999999999999999999999999975322 2456999999999999999999999999 9999999
Q ss_pred CCcEEEcC-----------CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHH
Q 020529 83 SSNILLEE-----------GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELI 151 (325)
Q Consensus 83 ~~Nill~~-----------~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ell 151 (325)
|+||||+. ++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+
T Consensus 200 p~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 279 (365)
T 3e7e_A 200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML 279 (365)
T ss_dssp GGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHH
T ss_pred HHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHH
Confidence 99999998 8999999999997543333334455677999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCC-CCHHHHHHHHHhh
Q 020529 152 TGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR-PLIGDVVTALSYL 230 (325)
Q Consensus 152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R-Ps~~evl~~L~~~ 230 (325)
+|+.||....... .. ....+. .++ ....+.+++..||+.+|.+| |++.++.+.|+.+
T Consensus 280 tg~~pf~~~~~~~---------------~~----~~~~~~-~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 280 FGTYMKVKNEGGE---------------CK----PEGLFR-RLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp HSSCCCEEEETTE---------------EE----ECSCCT-TCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred hCCCccccCCCCc---------------ee----echhcc-ccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence 9999985432110 00 001111 111 23456789999999999998 5688888888877
Q ss_pred hcc
Q 020529 231 ANQ 233 (325)
Q Consensus 231 ~~~ 233 (325)
...
T Consensus 338 l~~ 340 (365)
T 3e7e_A 338 FQQ 340 (365)
T ss_dssp HHH
T ss_pred HHH
Confidence 654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=286.60 Aligned_cols=220 Identities=17% Similarity=0.207 Sum_probs=168.0
Q ss_pred cCCCCCCCccc---------------eeeEEEe-CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 020529 2 LSLLHHSNLVN---------------LIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 65 (325)
Q Consensus 2 L~~l~Hpniv~---------------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al 65 (325)
|++++||||++ +++++.. +...++||||+ +++|.+++...+ ...+++..++.|+.|++.||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L 172 (352)
T 2jii_A 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDAL 172 (352)
T ss_dssp HHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHH
T ss_pred HHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHH
Confidence 45667887776 6778776 77899999999 899999998621 35699999999999999999
Q ss_pred HHHhcCCCCCeEeCCCCCCcEEEcCCC--eEEEecCCCCccCCCCCCC-----CccccccCCcCccCchhhccCCCCccc
Q 020529 66 EYLHDKANPPVIYRDFKSSNILLEEGF--HPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKS 138 (325)
Q Consensus 66 ~~LH~~~~~~ivHrdik~~Nill~~~~--~~kL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ks 138 (325)
.|||+++ |+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.+..++.++
T Consensus 173 ~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 249 (352)
T 2jii_A 173 EFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRS 249 (352)
T ss_dssp HHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHH
T ss_pred HHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchh
Confidence 9999999 99999999999999998 8999999999764322111 112345799999999999999999999
Q ss_pred cEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC
Q 020529 139 DVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 218 (325)
Q Consensus 139 DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP 218 (325)
|||||||++|||++|+.||....... ..+........... ..+.+.... .......+.+|+..||+.||.+||
T Consensus 250 Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rp 322 (352)
T 2jii_A 250 DLQSLGYCMLKWLYGFLPWTNCLPNT-EDIMKQKQKFVDKP---GPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKP 322 (352)
T ss_dssp HHHHHHHHHHHHHHSCCTTGGGTTCH-HHHHHHHHHHHHSC---CCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCC
T ss_pred hHHHHHHHHHHHHhCCCCcccCCcCH-HHHHHHHHhccCCh---hhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCC
Confidence 99999999999999999997654221 11111111111111 111111100 011235788999999999999999
Q ss_pred CHHHHHHHHHhhhccC
Q 020529 219 LIGDVVTALSYLANQT 234 (325)
Q Consensus 219 s~~evl~~L~~~~~~~ 234 (325)
++.+|++.|..+....
T Consensus 323 s~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 323 PYAMLRNNLEALLQDL 338 (352)
T ss_dssp CHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHhc
Confidence 9999999999887654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=277.47 Aligned_cols=209 Identities=19% Similarity=0.175 Sum_probs=157.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++...+..++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+||||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl 160 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDV 160 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCC
Confidence 6788999999999999999999999999999999999975 356999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.+||+|||++....... ........|++.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 161 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (309)
T 2h34_A 161 KPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ 239 (309)
T ss_dssp CGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH
T ss_pred ChHHEEEcCCCCEEEecCccCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch
Confidence 9999999999999999999987543322 122334568999999999999999999999999999999999999997542
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-CHHHHHHHHHhhhcc
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-LIGDVVTALSYLANQ 233 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-s~~evl~~L~~~~~~ 233 (325)
.. .+......... ... .. +......+.+++.+||+.+|.+|| ++.++++.|..+...
T Consensus 240 ~~---~~~~~~~~~~~----~~~----~~----~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 240 LS---VMGAHINQAIP----RPS----TV----RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp HH---HHHHHHHSCCC----CGG----GT----STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred HH---HHHHHhccCCC----Ccc----cc----CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 21 11111000000 000 01 112234678999999999999999 899999999876543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=296.77 Aligned_cols=205 Identities=23% Similarity=0.332 Sum_probs=166.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||++++++|.+....|+||||++||+|.+++.........+++..++.++.||+.||.|||+.+ |+||||
T Consensus 239 L~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDL 315 (543)
T 3c4z_A 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDL 315 (543)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCC
Confidence 56789999999999999999999999999999999999875544567999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 316 KP~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 316 KPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred ChHHEEEeCCCCEEEeecceeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 9999999999999999999998643322 22344579999999999999999999999999999999999999997653
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH-----HHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI-----GDVVT 225 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~-----~evl~ 225 (325)
.... .......+.... ..++......+.+|+.+||+.||.+||++ .+|++
T Consensus 394 ~~~~--~~~~~~~i~~~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 394 EKVE--NKELKQRVLEQA------------VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCCC--HHHHHHHHHHCC------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred cchh--HHHHHHHHhhcc------------cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 2211 111111111111 01222334678899999999999999975 56654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=278.73 Aligned_cols=200 Identities=24% Similarity=0.299 Sum_probs=161.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~di 141 (321)
T 2a2a_A 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDL 141 (321)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 5678999999999999999999999999999999999975 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCC----eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 82 KSSNILLEEGF----HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 82 k~~Nill~~~~----~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||+||+++.++ .+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 142 kp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 218 (321)
T 2a2a_A 142 KPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (321)
T ss_dssp SGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred ChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCC
Confidence 99999999887 79999999997643321 223456999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
....... .. ..+.... ...++.... .....+.+|+.+||+.||.+||++.++++
T Consensus 219 ~~~~~~~---~~---~~i~~~~----~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 219 LGDTKQE---TL---ANITSVS----YDFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCSSHHH---HH---HHHHTTC----CCCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCCCHHH---HH---HHHHhcc----cccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 7543211 11 1111000 000111111 12356889999999999999999999986
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=278.56 Aligned_cols=216 Identities=25% Similarity=0.311 Sum_probs=157.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..+..++.+++.||+|||+.+ |+||||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dl 128 (311)
T 4agu_A 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDV 128 (311)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence 5678999999999999999999999999999999998865 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.+||+|||++...... ........||+.|+|||++.+ ..++.++||||||+++++|++|..||...
T Consensus 129 kp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 206 (311)
T 4agu_A 129 KPENILITKHSVIKLCDFGFARLLTGP--SDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206 (311)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ChhhEEEcCCCCEEEeeCCCchhccCc--ccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999764322 222344568999999999876 56899999999999999999999999765
Q ss_pred CCCCcchhhhhh-hh-------ccccccccc--cccCCccCCCC---ChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWA-RP-------LFNDRRKFS--KLADPRLEGRY---PIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~-~~-------~~~~~~~~~--~~~d~~l~~~~---~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
............ .. .+.....+. ...++...... .......+.+|+.+||+.||.+|||+.++++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 432221111000 00 000000000 01111000000 01234568899999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=282.34 Aligned_cols=213 Identities=23% Similarity=0.332 Sum_probs=164.0
Q ss_pred cCCCCCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 2 LSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
|++++||||+++++++.. ....++||||+.+++|.+++.........+++..++.++.|++.||+|||+.+ |+
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---iv 156 (317)
T 2buj_A 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YA 156 (317)
T ss_dssp HHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 567899999999999863 34789999999999999999765444567999999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCC-------ccccccCCcCccCchhhccCC---CCccccEEEehHHH
Q 020529 78 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-------VSTRVMGTYGYCAPEYAMTGQ---LTVKSDVYSFGVVF 147 (325)
Q Consensus 78 Hrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~ksDvwSlGvvl 147 (325)
||||||+||+++.++.+||+|||++.......... ......||+.|+|||++.... ++.++||||||+++
T Consensus 157 H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 236 (317)
T 2buj_A 157 HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVL 236 (317)
T ss_dssp CCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHH
T ss_pred cCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999987532211110 012345799999999987554 68899999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 148 LELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 148 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
|+|++|+.||......... +...... . .....+......+.+++.+||+.||.+||++.+|++.|
T Consensus 237 ~el~~g~~p~~~~~~~~~~-~~~~~~~----~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 237 YAMMFGEGPYDMVFQKGDS-VALAVQN----Q----------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHHHSSCTTHHHHHTTSC-HHHHHHC----C------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhhhcccch-hhHHhhc----c----------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 9999999998542111110 1000000 0 00001112335788999999999999999999999999
Q ss_pred Hhhhc
Q 020529 228 SYLAN 232 (325)
Q Consensus 228 ~~~~~ 232 (325)
+.+..
T Consensus 302 ~~~~~ 306 (317)
T 2buj_A 302 EALQP 306 (317)
T ss_dssp HHTCC
T ss_pred hhcCC
Confidence 98754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=275.69 Aligned_cols=205 Identities=27% Similarity=0.368 Sum_probs=159.2
Q ss_pred cCCCCCCCccceeeEEEeC-CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|++++||||+++++++.+. +..++||||+++++|.+++... ....+++..++.++.+++.||.|||+.+ |+|||
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~d 142 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRD 142 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccC
Confidence 6788999999999997554 5789999999999999999752 1223889999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.++|+|||++...... .....+++.|+|||++.+..++.++||||||+++++|++ |+.||..
T Consensus 143 lkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 143 LAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp CSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred CCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998753221 223457889999999999999999999999999999998 9999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
..... +.... . ....+ ..+......+.+++..||+.+|.+||++.++++.|+.+...
T Consensus 218 ~~~~~---~~~~~---~-------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 218 IPLKD---VVPRV---E-------KGYKM----DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp SCGGG---HHHHH---T-------TTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHH---HHHHH---h-------cCCCC----CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 43221 11100 0 00011 11223345788999999999999999999999999988754
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=278.82 Aligned_cols=214 Identities=25% Similarity=0.345 Sum_probs=164.4
Q ss_pred CCCCCccceeeEEEeCC----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------cCC
Q 020529 5 LHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH--------DKA 72 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH--------~~~ 72 (325)
++||||+++++++.... ..++||||+++++|.+++.. ..+++..++.++.+++.||+||| +.+
T Consensus 93 l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ 167 (342)
T 1b6c_B 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA 167 (342)
T ss_dssp CCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE
T ss_pred cCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC
Confidence 79999999999998876 78999999999999999965 35899999999999999999999 778
Q ss_pred CCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCC--ccccccCCcCccCchhhccC------CCCccccEEEeh
Q 020529 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH--VSTRVMGTYGYCAPEYAMTG------QLTVKSDVYSFG 144 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlG 144 (325)
|+||||||+||+++.++.+||+|||++.......... ......||+.|+|||++.+. .++.++||||||
T Consensus 168 ---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG 244 (342)
T 1b6c_B 168 ---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 244 (342)
T ss_dssp ---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHH
T ss_pred ---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHH
Confidence 9999999999999999999999999997643322111 22345799999999998776 234789999999
Q ss_pred HHHHHHHhC----------CCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCC-ChHHHHHHHHHHHHchhhC
Q 020529 145 VVFLELITG----------RKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRY-PIRGLYQALAVASMCIQEQ 213 (325)
Q Consensus 145 vvl~elltg----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~l~~~cl~~~ 213 (325)
|++|||++| ..||........ ....+..... .....+.+...+ .......+.+|+.+||+.+
T Consensus 245 ~il~el~tg~~~~~~~~~~~~p~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 317 (342)
T 1b6c_B 245 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDP-SVEEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317 (342)
T ss_dssp HHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC-CHHHHHHHHT------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSS
T ss_pred HHHHHHHhccCcCCcccccccCccccCcCcc-cHHHHHHHHH------HHHhCCCCcccccchhHHHHHHHHHHHHhccC
Confidence 999999999 667755432211 1111111111 011111111111 1245678899999999999
Q ss_pred CCCCCCHHHHHHHHHhhhcc
Q 020529 214 AATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 214 p~~RPs~~evl~~L~~~~~~ 233 (325)
|.+||++.+|++.|+.+...
T Consensus 318 p~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 318 GAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp GGGSCCHHHHHHHHHHHHHT
T ss_pred hhhCCCHHHHHHHHHHHHHH
Confidence 99999999999999988764
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=275.22 Aligned_cols=208 Identities=25% Similarity=0.380 Sum_probs=165.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++. .+..++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||
T Consensus 62 l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~di 135 (279)
T 1qpc_A 62 MKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDL 135 (279)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 56789999999999986 45689999999999999999641 1125999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.+||+|||++....... ........++..|+|||++.+..++.++||||||++++||++ |+.||...
T Consensus 136 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 214 (279)
T 1qpc_A 136 RAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (279)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred CHhhEEEcCCCCEEECCCcccccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence 9999999999999999999997643322 112233457788999999998899999999999999999999 89999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
.... +.... .. .... ..+......+.+|+..||+.+|.+||++.+|++.|+.+...
T Consensus 215 ~~~~---~~~~~---~~-------~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 215 TNPE---VIQNL---ER-------GYRM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp CHHH---HHHHH---HT-------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHH---HHHHH---hc-------ccCC----CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 3211 11110 00 0001 11122345788999999999999999999999999988654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=277.33 Aligned_cols=209 Identities=26% Similarity=0.364 Sum_probs=163.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.. .++||||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ |+|+||
T Consensus 75 l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di 147 (291)
T 1u46_A 75 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDL 147 (291)
T ss_dssp HHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 56789999999999998765 8899999999999999975 2345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCC-ccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
||+||+++.++.+||+|||++.......... ......+|+.|+|||++.+..++.++||||||+++++|++ |+.||..
T Consensus 148 kp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 148 AARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp CGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999997654332211 2234557888999999999899999999999999999999 9999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
..... +. ..+..... .. ..+......+.+++.+||+.+|.+||++.+|++.|..+...
T Consensus 228 ~~~~~---~~---~~~~~~~~------~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 228 LNGSQ---IL---HKIDKEGE------RL----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp CCHHH---HH---HHHHTSCC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CCHHH---HH---HHHHccCC------CC----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 53211 11 11111000 00 11123346788999999999999999999999999887643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=284.15 Aligned_cols=198 Identities=29% Similarity=0.372 Sum_probs=159.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+. |+|.+++.. ....+++..++.++.+++.||.|||+.+ |+||||
T Consensus 108 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dl 180 (348)
T 1u5q_A 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDV 180 (348)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCC
T ss_pred HHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCC
Confidence 567899999999999999999999999997 788888864 2456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+|||++.++.+||+|||+++.... .....||+.|+|||++. ...++.++|||||||+++||++|+.||.
T Consensus 181 kp~NIll~~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 181 KAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp SGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CHHHEEECCCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999975422 23457999999999985 5678999999999999999999999996
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
....... + ..+.... .+.+. +......+.+|+.+||+.+|.+||++.++++..-
T Consensus 255 ~~~~~~~--~----~~~~~~~-------~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 255 NMNAMSA--L----YHIAQNE-------SPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp TSCHHHH--H----HHHHHSC-------CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred CCChHHH--H----HHHHhcC-------CCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 5432111 1 1111100 11110 1122356789999999999999999999987543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=282.83 Aligned_cols=208 Identities=24% Similarity=0.219 Sum_probs=156.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCC------------------------------------
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPD------------------------------------ 45 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------ 45 (325)
|++++||||+++++++.+.+..++||||+++++|.+++......
T Consensus 82 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (345)
T 3hko_A 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161 (345)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred HHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 56789999999999999999999999999999999998631110
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCC--eEEEecCCCCccCCCCC--CCCccccccCCc
Q 020529 46 KEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF--HPKLSDFGLAKLGPVGD--KSHVSTRVMGTY 121 (325)
Q Consensus 46 ~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~--~~kL~Dfgla~~~~~~~--~~~~~~~~~gt~ 121 (325)
...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++...... .........||+
T Consensus 162 ~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 238 (345)
T 3hko_A 162 DFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCG
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCc
Confidence 122467888999999999999999999 99999999999998776 89999999997543221 111234567999
Q ss_pred CccCchhhcc--CCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHH
Q 020529 122 GYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGL 199 (325)
Q Consensus 122 ~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 199 (325)
.|+|||++.+ ..++.++|||||||++|||++|+.||........ +. .+.... .....+. .....
T Consensus 239 ~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~----~~~~~~---~~~~~~~-----~~~~~ 304 (345)
T 3hko_A 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT--IS----QVLNKK---LCFENPN-----YNVLS 304 (345)
T ss_dssp GGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH----HHHHCC---CCTTSGG-----GGGSC
T ss_pred cccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH--HH----HHHhcc---cccCCcc-----cccCC
Confidence 9999999975 6789999999999999999999999976532211 11 111100 0000010 01123
Q ss_pred HHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 200 YQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 200 ~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..+.+|+..||+.+|.+||++.++++.
T Consensus 305 ~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 305 PLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 568899999999999999999999874
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=272.85 Aligned_cols=200 Identities=21% Similarity=0.237 Sum_probs=159.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl 132 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDL 132 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCC
Confidence 5688999999999999999999999999999999999875 456999999999999999999999999 999999
Q ss_pred CCCcEEE---cCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill---~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+||++ +.++.++|+|||++...... .......||+.|+|||++.+. ++.++||||||+++++|++|+.||.
T Consensus 133 kp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~ 208 (277)
T 3f3z_A 133 KPENFLFLTDSPDSPLKLIDFGLAARFKPG---KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFS 208 (277)
T ss_dssp SGGGEEESSSSTTCCEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEEecCCCCCcEEEEecccceeccCc---cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCC
Confidence 9999999 78889999999999764322 223445699999999988654 8999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....... .... ......... ... ......+.+|+.+||+.+|.+||++.++++.
T Consensus 209 ~~~~~~~--~~~~----~~~~~~~~~----~~~----~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 209 APTDSEV--MLKI----REGTFTFPE----KDW----LNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CSSHHHH--HHHH----HHCCCCCCH----HHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CCCHHHH--HHHH----HhCCCCCCc----hhh----hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 6432111 1100 000000000 000 0123578899999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=284.96 Aligned_cols=146 Identities=27% Similarity=0.351 Sum_probs=130.2
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
+.||||+++++++...+..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 93 ~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~ 166 (360)
T 3llt_A 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPE 166 (360)
T ss_dssp TTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred CCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcc
Confidence 45999999999999999999999999 899999997632 345999999999999999999999999 999999999
Q ss_pred cEEEcC-------------------------CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCcccc
Q 020529 85 NILLEE-------------------------GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSD 139 (325)
Q Consensus 85 Nill~~-------------------------~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksD 139 (325)
|||++. ++.+||+|||+++.... ......||+.|+|||++.+..++.++|
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~D 241 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWDVSSD 241 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCCCccc
Confidence 999975 78899999999975322 223457899999999999999999999
Q ss_pred EEEehHHHHHHHhCCCCCCCCC
Q 020529 140 VYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 140 vwSlGvvl~elltg~~p~~~~~ 161 (325)
||||||++|+|++|+.||....
T Consensus 242 iwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 242 MWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHHHHHHHHHHHCCCCCCCCc
Confidence 9999999999999999997643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=281.53 Aligned_cols=213 Identities=18% Similarity=0.260 Sum_probs=153.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..++||||+. ++|.+++.. ...+++..++.|+.|++.||.|||+.+ |+|||
T Consensus 86 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~D 157 (329)
T 3gbz_A 86 LLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRD 157 (329)
T ss_dssp HGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCC
Confidence 3678999999999999999999999999997 699999976 445999999999999999999999999 99999
Q ss_pred CCCCcEEE-----cCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCC
Q 020529 81 FKSSNILL-----EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 81 ik~~Nill-----~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~ 154 (325)
|||+|||+ +..+.+||+|||+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 158 lkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 235 (329)
T 3gbz_A 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235 (329)
T ss_dssp CCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEEecCCCCccceEEECcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 99999999 45566999999999764322 1223445689999999999875 4899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccc-ccc-------------ccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFN-DRR-------------KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~-~~~-------------~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
.||........ +.......-. ... .+.......+....+......+.+|+.+||+.||.+|||+
T Consensus 236 ~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 313 (329)
T 3gbz_A 236 PLFPGDSEIDQ--LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA 313 (329)
T ss_dssp CSSCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCcCCCCHHHH--HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCH
Confidence 99976432211 1111000000 000 0000000000000011123577899999999999999999
Q ss_pred HHHHH
Q 020529 221 GDVVT 225 (325)
Q Consensus 221 ~evl~ 225 (325)
.|+++
T Consensus 314 ~e~l~ 318 (329)
T 3gbz_A 314 KNALE 318 (329)
T ss_dssp HHHHT
T ss_pred HHHhC
Confidence 99986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=279.78 Aligned_cols=202 Identities=21% Similarity=0.288 Sum_probs=155.3
Q ss_pred CcCCCCCCCccceeeEEEeCC---------------------------------------------------------ee
Q 020529 1 MLSLLHHSNLVNLIGYCADGD---------------------------------------------------------QR 23 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~---------------------------------------------------------~~ 23 (325)
+|++++||||++++++|.+.. ..
T Consensus 57 ~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (332)
T 3qd2_B 57 ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYL 136 (332)
T ss_dssp HHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------------CCCEE
T ss_pred HHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceE
Confidence 367899999999999986543 37
Q ss_pred EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 24 LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 24 ~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
++||||+++++|.+++..... ....++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 137 ~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 212 (332)
T 3qd2_B 137 YIQMQLCRKENLKDWMNRRCS-LEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT 212 (332)
T ss_dssp EEEEECCCSSCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCCCCHHHHHhcccC-ccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCccc
Confidence 999999999999999986432 234677789999999999999999999 9999999999999999999999999998
Q ss_pred cCCCCCCC----------CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhh
Q 020529 104 LGPVGDKS----------HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR 173 (325)
Q Consensus 104 ~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~ 173 (325)
........ .......||+.|+|||++.+..++.++|||||||++|||++|..|+... .......
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~~~~- 286 (332)
T 3qd2_B 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRIITDV- 286 (332)
T ss_dssp ECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHHHHH-
T ss_pred ccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHHHHh-
Confidence 65433211 1223456999999999999999999999999999999999986654210 0000000
Q ss_pred hccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 174 PLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 174 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.....+. ........+.+|+.+||+.||.+||++.++++
T Consensus 287 ---------~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 287 ---------RNLKFPL----LFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ---------HTTCCCH----HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ---------hccCCCc----ccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 0000000 01123356789999999999999999999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=291.68 Aligned_cols=204 Identities=22% Similarity=0.195 Sum_probs=160.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|..++||||++++++|.+.+..|+||||+++|+|.+++.. ....+++..++.++.+++.||+|||+.+ |+||||
T Consensus 115 l~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDL 188 (412)
T 2vd5_A 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDI 188 (412)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccc
Confidence 4568999999999999999999999999999999999975 2346999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-------cCCCCccccEEEehHHHHHHHhCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-------TGQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~ksDvwSlGvvl~elltg~ 154 (325)
||+|||++.++++||+|||+++...... ........||+.|+|||++. ...++.++|||||||++|||++|+
T Consensus 189 Kp~NILld~~g~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 267 (412)
T 2vd5_A 189 KPDNILLDRCGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267 (412)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSS
T ss_pred CHHHeeecCCCCEEEeechhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCC
Confidence 9999999999999999999997643322 12233467999999999987 356899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCC---CCHHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATR---PLIGDVVTA 226 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~R---Ps~~evl~~ 226 (325)
.||......... ..+..... ...-|.. +......+.+|+.+||+ +|.+| |++.||++.
T Consensus 268 ~Pf~~~~~~~~~------~~i~~~~~---~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 268 TPFYADSTAETY------GKIVHYKE---HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CTTCCSSHHHHH------HHHHTHHH---HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CCCCCCCHHHHH------HHHHhccc---CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 999764322111 11111000 0001111 11223578899999999 99998 689998765
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=273.86 Aligned_cols=201 Identities=19% Similarity=0.253 Sum_probs=161.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+||||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di 131 (284)
T 3kk8_A 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNL 131 (284)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCC
Confidence 5678999999999999999999999999999999998875 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCe---EEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGFH---PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~~---~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+||+++.++. +||+|||++...... .......||+.|+|||++.+..++.++||||||+++++|++|+.||.
T Consensus 132 kp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 132 KPENLLLASKAKGAAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp CGGGEEESSSSTTCCEEECCCTTCEECCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CHHHEEEecCCCCCcEEEeeceeeEEcccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 999999976655 999999999754322 22334679999999999999999999999999999999999999996
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....... . ..+.... .....+. .......+.+|+.+||+.+|.+||++.++++.
T Consensus 209 ~~~~~~~---~---~~~~~~~---~~~~~~~-----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 209 DEDQHRL---Y---AQIKAGA---YDYPSPE-----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CSSHHHH---H---HHHHHTC---CCCCTTT-----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCchhHH---H---HHHHhcc---ccCCchh-----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 5432111 1 0000000 0000110 01223568899999999999999999999984
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=280.67 Aligned_cols=217 Identities=21% Similarity=0.318 Sum_probs=157.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..++||||++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|||
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 125 (324)
T 3mtl_A 53 LLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRD 125 (324)
T ss_dssp HHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESS
T ss_pred HHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCC
Confidence 3678899999999999999999999999997 699999876 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+||+++.++.+||+|||+++..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 126 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 126 LKPQNLLINERGELKLADFGLARAKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp CCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCHHHEEECCCCCEEEccCcccccccCC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999753322 222334568999999999876 5689999999999999999999999976
Q ss_pred CCCCCcchhhhh-hhhc-------cccccccccccCCccCCC----CChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLVTW-ARPL-------FNDRRKFSKLADPRLEGR----YPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~~~-~~~~-------~~~~~~~~~~~d~~l~~~----~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.........+.. .... ......+.....+..... ........+.+|+.+||+.||.+|||+.|+++.
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 204 STVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 543221111100 0000 000000000000000000 001223567899999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=297.08 Aligned_cols=204 Identities=27% Similarity=0.350 Sum_probs=165.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+.+..|+||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+|||
T Consensus 237 iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrD 311 (576)
T 2acx_A 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRD 311 (576)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccC
Confidence 356789999999999999999999999999999999999762 2345999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||+.++.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 312 LKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 312 LKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred CchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999999998653322 233457999999999999989999999999999999999999999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
........ ....+.... ..++......+.+|+.+||+.||.+|| ++.||++.
T Consensus 389 ~~~~~~~~--i~~~i~~~~------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 389 KKKIKREE--VERLVKEVP------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp SSCCCHHH--HHHHHHHCC------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ccchhHHH--HHHHhhccc------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 43221111 111111000 112223346788999999999999999 78888764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=283.69 Aligned_cols=221 Identities=28% Similarity=0.382 Sum_probs=165.4
Q ss_pred cCCCCCCCccceeeEEEeCC--eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++...+ ..++||||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ |+||
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 169 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR---YIHR 169 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHH---STTSSCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---Eecc
Confidence 56889999999999986643 78999999999999999976 2346999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||||+||+++.++.+||+|||++......... .......++..|+|||++.+..++.++||||||+++++|++|..|+.
T Consensus 170 dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 170 DLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp CCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred CCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999865433221 11233457788999999999999999999999999999999998875
Q ss_pred CCCCCCcchhhhhhhhccc---cccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 159 STRPHGEQNLVTWARPLFN---DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..... +......... ....+...+........+......+.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus 250 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 250 SPPAE----FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp SHHHH----HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH----HHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 32100 0000000000 0000000000001111122344678899999999999999999999999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=273.40 Aligned_cols=201 Identities=26% Similarity=0.404 Sum_probs=157.6
Q ss_pred CcCCCCCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
+|++++||||+++++++.. ....++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ ++|
T Consensus 78 ~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i 152 (290)
T 1t4h_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 152 (290)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCE
Confidence 3678999999999999875 3568999999999999999975 356899999999999999999999986 349
Q ss_pred EeCCCCCCcEEEc-CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 77 IYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 77 vHrdik~~Nill~-~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
+||||||+||+++ .++.+||+|||++..... .......||+.|+|||++. ..++.++||||||+++|+|++|+.
T Consensus 153 ~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~ 227 (290)
T 1t4h_A 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEY 227 (290)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EECCCCHHHEEEECCCCCEEEeeCCCcccccc----cccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCC
Confidence 9999999999997 788999999999965322 2234456999999999876 458999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
||....... .+. ...... .....+ +......+.+|+..||+.+|.+||++.+|++.
T Consensus 228 pf~~~~~~~--~~~---~~~~~~------~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 228 PYSECQNAA--QIY---RRVTSG------VKPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTTTCSSHH--HHH---HHHTTT------CCCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCcCcHH--HHH---HHHhcc------CCcccc----CCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 996543211 111 110000 000001 11122468899999999999999999999863
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=286.44 Aligned_cols=223 Identities=19% Similarity=0.229 Sum_probs=169.8
Q ss_pred cCCCCCCCccceeeEEEeCC--eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++.+.. ..++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||
T Consensus 61 l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 136 (396)
T 4eut_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLRENG---IVHR 136 (396)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECC
T ss_pred HHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEC
Confidence 56789999999999998755 77999999999999999976322 234999999999999999999999999 9999
Q ss_pred CCCCCcEEE----cCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc--------CCCCccccEEEehHHH
Q 020529 80 DFKSSNILL----EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT--------GQLTVKSDVYSFGVVF 147 (325)
Q Consensus 80 dik~~Nill----~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDvwSlGvvl 147 (325)
||||+|||+ +.++.+||+|||+++..... .......||+.|+|||++.. ..++.++|||||||++
T Consensus 137 Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il 213 (396)
T 4eut_A 137 NIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213 (396)
T ss_dssp CCCGGGEEEEECTTSCEEEEECCGGGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHH
T ss_pred CcCHHHEEEeecCCCceeEEEecCCCceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHH
Confidence 999999999 77788999999999764332 12334569999999999875 5678899999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhhhhhhhcccccc-c----ccc--------ccCCccCCCCChHHHHHHHHHHHHchhhCC
Q 020529 148 LELITGRKAIDSTRPHGEQNLVTWARPLFNDRR-K----FSK--------LADPRLEGRYPIRGLYQALAVASMCIQEQA 214 (325)
Q Consensus 148 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~----~~~--------~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p 214 (325)
|||++|+.||.......... .....+..... . +.. ..+......++......+.+++..||+.||
T Consensus 214 ~el~tg~~Pf~~~~~~~~~~--~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP 291 (396)
T 4eut_A 214 YHAATGSLPFRPFEGPRRNK--EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291 (396)
T ss_dssp HHHHHSSCSEECTTCTTTCH--HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCT
T ss_pred HHHHHCCCCCCCCCcccchH--HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccCh
Confidence 99999999997543322111 00111111000 0 000 001111223345667788899999999999
Q ss_pred CCCCCHHHHHHHHHhhhcc
Q 020529 215 ATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 215 ~~RPs~~evl~~L~~~~~~ 233 (325)
.+||++.++++.+..+...
T Consensus 292 ~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 292 EKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp TTSCCHHHHHHHHHHHHTC
T ss_pred hhhccHHHHHHHHHHHhhc
Confidence 9999999999999888764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=285.82 Aligned_cols=216 Identities=21% Similarity=0.263 Sum_probs=161.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivHr 79 (325)
+|++++||||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.+++.||.|||+. + |+||
T Consensus 84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~ 156 (360)
T 3eqc_A 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHR 156 (360)
T ss_dssp GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCS
T ss_pred HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcC
Confidence 46788999999999999999999999999999999999976 34699999999999999999999996 8 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
||||+||+++.++.++|+|||++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 157 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 157 DVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CCSGGGEEECTTCCEEECCCCCCHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred CccHHHEEECCCCCEEEEECCCCccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999864321 122345789999999999999999999999999999999999999976
Q ss_pred CCCCCcchhhhhh---------hhccc-------------cccc----cccccCCccCCCCChHHHHHHHHHHHHchhhC
Q 020529 160 TRPHGEQNLVTWA---------RPLFN-------------DRRK----FSKLADPRLEGRYPIRGLYQALAVASMCIQEQ 213 (325)
Q Consensus 160 ~~~~~~~~~~~~~---------~~~~~-------------~~~~----~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~ 213 (325)
............. ..... .... +...................+.+|+.+||+.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 312 (360)
T 3eqc_A 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 312 (360)
T ss_dssp CCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSS
T ss_pred CCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcC
Confidence 4322110000000 00000 0000 00000000000001112456889999999999
Q ss_pred CCCCCCHHHHHHHH
Q 020529 214 AATRPLIGDVVTAL 227 (325)
Q Consensus 214 p~~RPs~~evl~~L 227 (325)
|.+|||+.++++.-
T Consensus 313 P~~Rpt~~ell~hp 326 (360)
T 3eqc_A 313 PAERADLKQLMVHA 326 (360)
T ss_dssp TTTSCCHHHHHTSH
T ss_pred hhhCCCHHHHhhCh
Confidence 99999999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=273.06 Aligned_cols=196 Identities=26% Similarity=0.358 Sum_probs=162.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+||||
T Consensus 68 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 140 (284)
T 2vgo_A 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDI 140 (284)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCC
T ss_pred HhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCC
Confidence 5678999999999999999999999999999999999976 346999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++...... ......|++.|+|||++.+..++.++||||||+++++|++|..||....
T Consensus 141 ~p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 216 (284)
T 2vgo_A 141 KPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216 (284)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CHHHEEEcCCCCEEEecccccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999998653321 2334568999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... ...+... +. .++......+.+++.+||+.+|.+||++.++++.
T Consensus 217 ~~~~------~~~~~~~--------~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 217 HTET------HRRIVNV--------DL----KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp HHHH------HHHHHTT--------CC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred HhHH------HHHHhcc--------cc----CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 2111 1111110 00 1122234567899999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=283.99 Aligned_cols=216 Identities=25% Similarity=0.389 Sum_probs=159.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|..++.. ...+++..++.++.+++.||.|||+.+ |+||||
T Consensus 78 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dl 150 (331)
T 4aaa_A 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDI 150 (331)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCc
Confidence 5678999999999999999999999999998888888754 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.+||+|||+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 151 kp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (331)
T 4aaa_A 151 KPENILVSQSGVVKLCDFGFARTLAAP--GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228 (331)
T ss_dssp CGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ChheEEEcCCCcEEEEeCCCceeecCC--ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999754322 1223445689999999999875 7899999999999999999999999765
Q ss_pred CCCCcchh-hhh-------hhhccccccccccccCCccCCCCC-----hHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNL-VTW-------ARPLFNDRRKFSKLADPRLEGRYP-----IRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~-~~~-------~~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
........ ... ....+.....+.....+.+....+ ......+.+|+.+||+.||.+||++.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 229 SDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp SHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred CcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 33211100 000 000001111111111111111111 1234678899999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=274.79 Aligned_cols=214 Identities=28% Similarity=0.398 Sum_probs=159.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDL----PPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
+|++++||||+++++++...+..++||||+++++|.+++... ......+++..++.++.|++.||.|||+.+ |
T Consensus 66 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i 142 (303)
T 2vwi_A 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---Q 142 (303)
T ss_dssp CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---C
Confidence 467889999999999999999999999999999999998642 112456999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCC---CCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHh
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK---SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~ellt 152 (325)
+||||||+||+++.++.+||+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++
T Consensus 143 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 222 (303)
T 2vwi_A 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222 (303)
T ss_dssp CCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHH
T ss_pred CCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999875433221 112234569999999999876 568999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhcccccccc-ccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKF-SKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|+.||........... . ........ ....++.... .....+.+|+.+||+.||.+||++.++++.
T Consensus 223 g~~pf~~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 223 GAAPYHKYPPMKVLML--T---LQNDPPSLETGVQDKEMLK----KYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SSCTTTTSCGGGHHHH--H---HTSSCCCTTC-----CCCC----CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCCccCchhhHHHH--H---hccCCCccccccccchhhh----hhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 9999976543221100 0 00000000 0111111112 223568899999999999999999999863
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=276.88 Aligned_cols=212 Identities=23% Similarity=0.305 Sum_probs=154.2
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~ 140 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPE 140 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGG
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHH
Confidence 4799999999999999999999999999999999976 356999999999999999999999999 999999999
Q ss_pred cEEEcCCCe---EEEecCCCCccCCCCCC-----CCccccccCCcCccCchhhcc-----CCCCccccEEEehHHHHHHH
Q 020529 85 NILLEEGFH---PKLSDFGLAKLGPVGDK-----SHVSTRVMGTYGYCAPEYAMT-----GQLTVKSDVYSFGVVFLELI 151 (325)
Q Consensus 85 Nill~~~~~---~kL~Dfgla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~ksDvwSlGvvl~ell 151 (325)
|||++.++. +||+|||++........ ........||+.|+|||++.. ..++.++|||||||++|+|+
T Consensus 141 Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~ 220 (316)
T 2ac3_A 141 NILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220 (316)
T ss_dssp GEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHH
T ss_pred HEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHH
Confidence 999988776 99999999875432211 111223559999999999875 45789999999999999999
Q ss_pred hCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCCh----HHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 152 TGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPI----RGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 152 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~----~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+|+.||.................... ...+..+..... .++. .....+.+|+.+||+.||.+||++.|+++.
T Consensus 221 ~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 221 SGYPPFVGRCGSDCGWDRGEACPACQ-NMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HSSCSCCCCCCSCSCC----CCHHHH-HHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HCCCCCcccccccccccccccchhHH-HHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 99999977543321100000000000 000000000000 0111 123568899999999999999999999873
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=280.38 Aligned_cols=198 Identities=24% Similarity=0.336 Sum_probs=163.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 95 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dl 167 (335)
T 2owb_A 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDL 167 (335)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCC
Confidence 5678999999999999999999999999999999999875 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 168 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 168 KLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CchhEEEcCCCCEEEeeccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 9999999999999999999997643222 22344679999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.... ...+.... . ..+......+.+|+.+||+.||.+||++.++++.
T Consensus 246 ~~~~------~~~~~~~~--------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 246 LKET------YLRIKKNE--------Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp HHHH------HHHHHHTC--------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HHHH------HHHHhcCC--------C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2111 01111000 0 0111223467899999999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=291.86 Aligned_cols=145 Identities=25% Similarity=0.359 Sum_probs=120.8
Q ss_pred CcCCCCCCCccceeeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
+|++++||||++++++|... ...|+||||+ +++|.+++.. ...+++..+..++.||+.||+|||+.+
T Consensus 105 ~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~--- 176 (458)
T 3rp9_A 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG--- 176 (458)
T ss_dssp HHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 36678999999999998443 5789999998 5899999975 456999999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC-------------------------CccccccCCcCccCchhh-
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-------------------------HVSTRVMGTYGYCAPEYA- 129 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~- 129 (325)
|+||||||+||||+.++.+||+|||+++........ ...+...||+.|+|||++
T Consensus 177 iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 999999999999999999999999999865322111 123445789999999986
Q ss_pred ccCCCCccccEEEehHHHHHHHhC
Q 020529 130 MTGQLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 130 ~~~~~~~ksDvwSlGvvl~elltg 153 (325)
....++.++|||||||++|||++|
T Consensus 257 ~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 257 LQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred CCCCCCcHhHHHHHHHHHHHHHHh
Confidence 456799999999999999999993
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=274.23 Aligned_cols=199 Identities=24% Similarity=0.333 Sum_probs=163.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl 141 (294)
T 2rku_A 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDL 141 (294)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999875 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++++|++|+.||....
T Consensus 142 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 219 (294)
T 2rku_A 142 KLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219 (294)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ChHhEEEcCCCCEEEEeccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997643222 22344668999999999999899999999999999999999999997643
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
.... . ....... . ..+......+.+++.+||+.+|.+||++.++++.-
T Consensus 220 ~~~~--~----~~~~~~~--------~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 220 LKET--Y----LRIKKNE--------Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp HHHH--H----HHHHTTC--------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred HHHH--H----HHHhhcc--------C----CCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 2111 0 0111000 0 11112235678999999999999999999999853
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=286.39 Aligned_cols=201 Identities=21% Similarity=0.287 Sum_probs=150.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++. .+..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 194 l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDl 265 (419)
T 3i6u_A 194 LKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDL 265 (419)
T ss_dssp HHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 56789999999999985 4567999999999999998865 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCC---eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc---CCCCccccEEEehHHHHHHHhCCC
Q 020529 82 KSSNILLEEGF---HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 82 k~~Nill~~~~---~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
||+|||++.++ .+||+|||+++.... ........||+.|+|||++.. ..++.++|||||||++|+|++|..
T Consensus 266 kp~NIll~~~~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 266 KPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp CGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred ChHhEEEecCCCcceEEEeecccceecCC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999996544 599999999986432 223345679999999999853 578899999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
||........ +...... .. ....+... ......+.+|+.+||+.||.+||++.++++.
T Consensus 343 pf~~~~~~~~--~~~~i~~---~~----~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 343 PFSEHRTQVS--LKDQITS---GK----YNFIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp SSCCCSSSCC--HHHHHHT---TC----CCCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCcchHH--HHHHHhc---CC----CCCCchhh----cccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 9976432211 1111000 00 00000000 1123578899999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=279.09 Aligned_cols=209 Identities=22% Similarity=0.304 Sum_probs=161.8
Q ss_pred cCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCeE
Q 020529 2 LSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA--NPPVI 77 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~--~~~iv 77 (325)
|++++||||+++++++.+ ....++||||+++++|.+++.........+++..++.++.+++.||+|||+.+ ..+|+
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iv 138 (279)
T 2w5a_A 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 138 (279)
T ss_dssp HHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------C
T ss_pred HHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeE
Confidence 567899999999998854 57889999999999999999764444556999999999999999999999876 23499
Q ss_pred eCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 78 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 78 Hrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||||||+||+++.++.+||+|||+++..... ........||+.|+|||++.+..++.++||||||+++|+|++|..||
T Consensus 139 H~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 216 (279)
T 2w5a_A 139 HRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 216 (279)
T ss_dssp CCCCSGGGEEECSSSCEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred EeccchhhEEEcCCCCEEEecCchheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999999999999999998754321 11223456899999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
...... .+.. .+... . -+ ..+......+.+++.+||+.+|.+||++.+|++.+..
T Consensus 217 ~~~~~~---~~~~---~i~~~--~-----~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 217 TAFSQK---ELAG---KIREG--K-----FR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp CCSSHH---HHHH---HHHHT--C-----CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred cccCHH---HHHH---HHhhc--c-----cc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 765321 1111 11100 0 00 1122234578899999999999999999999986643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=276.58 Aligned_cols=203 Identities=25% Similarity=0.299 Sum_probs=151.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivHrd 80 (325)
++.++||||+++++++.+.+..++||||++ ++|.+++.........+++..++.++.|++.||+|||++ + |+|||
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~d 135 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRD 135 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCC
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCC
Confidence 567899999999999999999999999997 688888765333456799999999999999999999998 8 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhh----ccCCCCccccEEEehHHHHHHHhCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA----MTGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
|||+||+++.++.+||+|||+++..... .......||+.|+|||++ .+..++.++||||||+++++|++|+.|
T Consensus 136 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 212 (290)
T 3fme_A 136 VKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212 (290)
T ss_dssp CSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCS
T ss_pred CCHHHEEECCCCCEEEeecCCccccccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999754322 223334699999999996 556789999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|....... ..+..... .. .+.. .+......+.+++.+||+.+|.+|||+.++++.
T Consensus 213 ~~~~~~~~-~~~~~~~~----~~-------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 213 YDSWGTPF-QQLKQVVE----EP-------SPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp SCCCSCHH-HHHHHHHH----SC-------CCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ccccCchH-HHHHHHhc----cC-------CCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 97532211 11111100 00 0000 011223568899999999999999999999883
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-37 Score=275.10 Aligned_cols=200 Identities=26% Similarity=0.346 Sum_probs=163.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++.. ..+++..++.++.+++.||.|||+.+ |+|+||
T Consensus 74 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 145 (303)
T 3a7i_A 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDI 145 (303)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCC
Confidence 5678999999999999999999999999999999999953 46999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++...... ........||+.|+|||++.+..++.++||||||+++++|++|..||....
T Consensus 146 ~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 146 KAANVLLSEHGEVKLADFGVAGQLTDT--QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECBTT--BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ChheEEECCCCCEEEeecccceecCcc--ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 999999999999999999999754322 122344678999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~ 228 (325)
... ..... .....+.+.. .....+.+|+..||+.+|.+||++.+|++..-
T Consensus 224 ~~~---~~~~~----------~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 224 PMK---VLFLI----------PKNNPPTLEG----NYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp HHH---HHHHH----------HHSCCCCCCS----SCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred HHH---HHHHh----------hcCCCCCCcc----ccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 211 11000 0001111222 22356889999999999999999999998654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=301.14 Aligned_cols=208 Identities=26% Similarity=0.381 Sum_probs=165.4
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++|+||||+++++++.+ +..++||||+.+++|.+++... ....+++..++.|+.||+.||+|||+++ |+|||
T Consensus 315 ~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrD 388 (535)
T 2h8h_A 315 VMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 388 (535)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCC
Confidence 3678899999999999876 6789999999999999999641 1245899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||||+.++.+||+|||+++...... ........++..|+|||++....++.++|||||||++|||++ |+.||..
T Consensus 389 lkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 389 LRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp CSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred CCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999997643211 111223456788999999999999999999999999999999 8999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
..... +..... .. .....+......+.+|+.+||+.+|.+||++.+|++.|+.+..
T Consensus 468 ~~~~~---~~~~i~----~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 468 MVNRE---VLDQVE----RG----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp CCHHH---HHHHHH----TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred CCHHH---HHHHHH----cC----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 43211 111110 00 0011122334578899999999999999999999999987754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=274.95 Aligned_cols=202 Identities=24% Similarity=0.308 Sum_probs=163.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++...+..++||||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ |+|+||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl 151 (314)
T 3com_A 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDI 151 (314)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCc
Confidence 5678999999999999999999999999999999999864 2456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||+++.++.++|+|||++...... ........||+.|+|||++.+..++.++||||||+++|+|++|..||....
T Consensus 152 ~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 152 KAGNILLNTEGHAKLADFGVAGQLTDT--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECBTT--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred CHHHEEECCCCCEEEeecccchhhhhh--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999754322 222344578999999999999999999999999999999999999997543
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..... . ... ....+.+ ..+......+.+|+.+||+.||.+||++.++++.
T Consensus 230 ~~~~~--~----~~~-------~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 230 PMRAI--F----MIP-------TNPPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp HHHHH--H----HHH-------HSCCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred hHHHH--H----HHh-------cCCCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 21100 0 000 0000000 1122234578899999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=273.44 Aligned_cols=195 Identities=18% Similarity=0.210 Sum_probs=154.1
Q ss_pred CCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 3 SLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 3 ~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
.++ +||||+++++++.+.+..++||||+++++|.+++.........+++..++.++.|++.||+|||+++ |+||||
T Consensus 65 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Di 141 (289)
T 1x8b_A 65 AVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDI 141 (289)
T ss_dssp HHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCC
Confidence 345 8999999999999999999999999999999999763322366999999999999999999999999 999999
Q ss_pred CCCcEEEcCC-------------------CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEE
Q 020529 82 KSSNILLEEG-------------------FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVY 141 (325)
Q Consensus 82 k~~Nill~~~-------------------~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvw 141 (325)
||+||+++.+ ..++|+|||++...... ....||+.|+|||++.+. .++.++|||
T Consensus 142 kp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~ 215 (289)
T 1x8b_A 142 KPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIF 215 (289)
T ss_dssp SGGGEEEC--------------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHH
T ss_pred CHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHH
Confidence 9999999844 47999999999764322 224589999999999876 567899999
Q ss_pred EehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 142 SFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 142 SlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
|||+++++|++|.+++.... ....... ...+. .+......+.+|+.+||+.||.+||++.
T Consensus 216 slG~il~~l~~~~~~~~~~~-----~~~~~~~-----------~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~ 275 (289)
T 1x8b_A 216 ALALTVVCAAGAEPLPRNGD-----QWHEIRQ-----------GRLPR----IPQVLSQEFTELLKVMIHPDPERRPSAM 275 (289)
T ss_dssp HHHHHHHHHTTCCCCCSSSH-----HHHHHHT-----------TCCCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHhcCCCCCcchh-----HHHHHHc-----------CCCCC----CCcccCHHHHHHHHHHhCCCcccCCCHH
Confidence 99999999999987763321 1111000 00011 1222345788999999999999999999
Q ss_pred HHHHH
Q 020529 222 DVVTA 226 (325)
Q Consensus 222 evl~~ 226 (325)
++++.
T Consensus 276 ~ll~h 280 (289)
T 1x8b_A 276 ALVKH 280 (289)
T ss_dssp HHHTC
T ss_pred HHhhC
Confidence 99863
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=273.81 Aligned_cols=201 Identities=23% Similarity=0.299 Sum_probs=159.0
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+||||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 134 (283)
T 3bhy_A 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDL 134 (283)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCC
Confidence 5678999999999999999999999999999999999975 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCC----eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 82 KSSNILLEEGF----HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 82 k~~Nill~~~~----~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||+||+++.++ .++|+|||++....... ......|++.|+|||++.+..++.++||||||+++++|++|..||
T Consensus 135 ~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 135 KPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211 (283)
T ss_dssp SGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCC
Confidence 99999998877 89999999997543221 223456899999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
........ +... ... .....+... ......+.+++.+||+.+|.+||++.++++.
T Consensus 212 ~~~~~~~~--~~~~----~~~----~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 212 LGETKQET--LTNI----SAV----NYDFDEEYF----SNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp CCSSHHHH--HHHH----HTT----CCCCCHHHH----TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred CCcchHHH--HHHh----Hhc----ccCCcchhc----ccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 76432111 1000 000 000000000 1223568899999999999999999999984
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-37 Score=281.10 Aligned_cols=204 Identities=25% Similarity=0.327 Sum_probs=161.8
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+++ +||||+++++++......++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 112 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~D 184 (355)
T 1vzo_A 112 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRD 184 (355)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 3456 799999999999999999999999999999999975 346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC--CCCccccEEEehHHHHHHHhCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|||+|||++.++.+||+|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 185 lkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 185 IKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp CCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CCHHHEEECCCCcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 99999999999999999999997543221 2223446799999999999863 47899999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTAL 227 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~L 227 (325)
........ .......... . ..++......+.+|+.+||+.||.+|| ++.++++..
T Consensus 264 ~~~~~~~~--~~~~~~~~~~--------~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 264 VDGEKNSQ--AEISRRILKS--------E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CTTSCCCH--HHHHHHHHHC--------C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred cCCccchH--HHHHHHHhcc--------C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 65432221 1111111111 0 112223345688999999999999999 999998865
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=288.47 Aligned_cols=214 Identities=22% Similarity=0.307 Sum_probs=155.3
Q ss_pred cCCCC-CCCccceeeEEEeCC--eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 2 LSLLH-HSNLVNLIGYCADGD--QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 2 L~~l~-Hpniv~l~~~~~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
|+.+. ||||+++++++...+ ..|+||||+. ++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|
T Consensus 62 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH 132 (388)
T 3oz6_A 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLH 132 (388)
T ss_dssp HHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEe
Confidence 45665 999999999997544 7899999997 799999965 35899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCC-------------------CCCccccccCCcCccCchhhcc-CCCCccc
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGD-------------------KSHVSTRVMGTYGYCAPEYAMT-GQLTVKS 138 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~ks 138 (325)
|||||+|||++.++.+||+|||+++...... .....+...||+.|+|||++.+ ..++.++
T Consensus 133 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 212 (388)
T 3oz6_A 133 RDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI 212 (388)
T ss_dssp CCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHH
T ss_pred CCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChh
Confidence 9999999999999999999999997643211 1112344679999999999986 6789999
Q ss_pred cEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccc-ccccccccc------------------CCccCCCC-----
Q 020529 139 DVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN-DRRKFSKLA------------------DPRLEGRY----- 194 (325)
Q Consensus 139 DvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~------------------d~~l~~~~----- 194 (325)
|||||||+++||++|++||...........+ ....-. ....+..+. .......+
T Consensus 213 DiwSlG~il~ell~g~~pf~~~~~~~~~~~i--~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (388)
T 3oz6_A 213 DMWSLGCILGEILCGKPIFPGSSTMNQLERI--IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKN 290 (388)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhh
Confidence 9999999999999999999765432111110 000000 000000000 00000000
Q ss_pred -------ChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 195 -------PIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 195 -------~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.......+.+|+.+||+.||.+|||+.|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred hcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 00123568899999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=278.08 Aligned_cols=202 Identities=18% Similarity=0.221 Sum_probs=157.4
Q ss_pred CCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 3 SLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 3 ~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++ +||||+++++++.+....++||||+.+++|.+++.. .....+++..++.++.|++.||+|||+.+ |+||||
T Consensus 83 ~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Di 157 (327)
T 3lm5_A 83 ELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDL 157 (327)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcC
Confidence 445 679999999999999999999999999999999864 22456999999999999999999999999 999999
Q ss_pred CCCcEEEcC---CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEE---GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~---~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+||+++. ++.+||+|||+++..... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 158 kp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (327)
T 3lm5_A 158 KPQNILLSSIYPLGDIKIVDFGMSRKIGHA---CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234 (327)
T ss_dssp CGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ChHHEEEecCCCCCcEEEeeCccccccCCc---cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999987 789999999999764322 12334679999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
........ .. +.... .. ... .........+.+|+..||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~--~~----i~~~~---~~-~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 235 GEDNQETY--LN----ISQVN---VD-YSE----ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp CSSHHHHH--HH----HHHTC---CC-CCT----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred CCCchHHH--HH----HHhcc---cc-cCc----hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 64321110 00 00000 00 000 1111234568899999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=301.19 Aligned_cols=197 Identities=24% Similarity=0.348 Sum_probs=162.8
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|..+ +||||+++++++.+.+..||||||+++|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+|||
T Consensus 395 l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrD 467 (674)
T 3pfq_A 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRD 467 (674)
T ss_dssp HTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCC
T ss_pred HHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecc
Confidence 3444 899999999999999999999999999999999976 356999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||+.++++||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 468 LKp~NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~ 545 (674)
T 3pfq_A 468 LKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 545 (674)
T ss_dssp CCSTTEEECSSSCEEECCCTTCEECCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CChhhEEEcCCCcEEEeecceeeccccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999999853322 22345578999999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH-----HHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI-----GDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~-----~evl~ 225 (325)
.... ....+.... ..++......+.+|+..||+.||.+||++ .||++
T Consensus 546 ~~~~------~~~~i~~~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 546 DEDE------LFQSIMEHN------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp SHHH------HHHHHHSSC------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CHHH------HHHHHHhCC------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 3211 111111111 11223344678899999999999999997 66654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=287.08 Aligned_cols=193 Identities=15% Similarity=0.162 Sum_probs=150.2
Q ss_pred cCCCCCCCcccee-------eEEEeCC-----------------eeEEEEecCCCCCHHHHhccCC---CCCCCCCHHHH
Q 020529 2 LSLLHHSNLVNLI-------GYCADGD-----------------QRLLVYEFMPLGSLEDHLHDLP---PDKEALDWNTR 54 (325)
Q Consensus 2 L~~l~Hpniv~l~-------~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~---~~~~~l~~~~~ 54 (325)
|++++|||||+++ +++.+.+ ..|+||||+ +|+|.+++.... .....+++..+
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~ 208 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHAR 208 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHH
Confidence 5677999999998 6666553 278999999 589999997521 11233556899
Q ss_pred HHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC--
Q 020529 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-- 132 (325)
Q Consensus 55 ~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-- 132 (325)
+.|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++... .......| +.|+|||++.+.
T Consensus 209 ~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~g-~~y~aPE~~~~~~~ 279 (377)
T 3byv_A 209 LQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-----ARVVSSVS-RGFEPPELEARRAT 279 (377)
T ss_dssp HHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETT-----CEEECCCC-TTCCCHHHHHHHTS
T ss_pred HHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecC-----CcccCCCC-cCccChhhhccccc
Confidence 999999999999999999 9999999999999999999999999997522 23344567 999999999887
Q ss_pred ---------CCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHH
Q 020529 133 ---------QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQAL 203 (325)
Q Consensus 133 ---------~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 203 (325)
.++.++|||||||++|||++|+.||............ ... .. .....+.
T Consensus 280 ~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~----------------~~~--~~----~~~~~~~ 337 (377)
T 3byv_A 280 ISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI----------------FRS--CK----NIPQPVR 337 (377)
T ss_dssp THHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGG----------------GSS--CC----CCCHHHH
T ss_pred ccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhh----------------hhh--cc----CCCHHHH
Confidence 8999999999999999999999999764432211100 000 01 1235688
Q ss_pred HHHHHchhhCCCCCCCHHHHHHH
Q 020529 204 AVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 204 ~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+|+.+||+.||.+||++.++++.
T Consensus 338 ~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 338 ALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=272.82 Aligned_cols=204 Identities=25% Similarity=0.328 Sum_probs=159.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ |+|+||
T Consensus 73 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 148 (295)
T 2clq_A 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDI 148 (295)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCC
Confidence 567899999999999999999999999999999999997632 2345789999999999999999999999 999999
Q ss_pred CCCcEEEcC-CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC--CCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~-~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+||+++. ++.+||+|||++....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.
T Consensus 149 ~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 149 KGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp SGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred ChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 999999987 8899999999997643221 1233456899999999997654 7899999999999999999999996
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....... ..+..... ...+ ..+......+.+|+.+||+.+|.+||++.++++.
T Consensus 227 ~~~~~~~---~~~~~~~~--------~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 227 ELGEPQA---AMFKVGMF--------KVHP----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp GGSSHHH---HHHHHHHH--------CCCC----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred CCCchhH---HHHhhccc--------cccc----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 4322110 00000000 0111 1122334578899999999999999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-37 Score=289.84 Aligned_cols=212 Identities=24% Similarity=0.290 Sum_probs=153.2
Q ss_pred cCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
|+.++||||+++++++... ...|+||||++ ++|.+.+.. .+++..+..++.|++.||+|||+.+
T Consensus 115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~-~~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~--- 184 (464)
T 3ttj_A 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--- 184 (464)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS-EEHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999999654 35799999997 567777743 3899999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|+||||||+|||++.++.+||+|||+++.... ....+...||+.|+|||++.+..++.++|||||||+++||++|+.
T Consensus 185 iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 261 (464)
T 3ttj_A 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261 (464)
T ss_dssp CCCCCCCGGGEEECTTSCEEECCCCCC--------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cccCCCChHhEEEeCCCCEEEEEEEeeeecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999975432 223445679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhh-h--------h-------hhhccccc-----cccccccCCccCCCCC---hHHHHHHHHHHHHchh
Q 020529 156 AIDSTRPHGEQNLV-T--------W-------ARPLFNDR-----RKFSKLADPRLEGRYP---IRGLYQALAVASMCIQ 211 (325)
Q Consensus 156 p~~~~~~~~~~~~~-~--------~-------~~~~~~~~-----~~~~~~~d~~l~~~~~---~~~~~~~~~l~~~cl~ 211 (325)
||.+.........+ . + ....+... ..+...+...+..... ......+.+|+.+||+
T Consensus 262 pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~ 341 (464)
T 3ttj_A 262 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 341 (464)
T ss_dssp SSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcC
Confidence 99765322110000 0 0 00000000 0000111110000000 0125678999999999
Q ss_pred hCCCCCCCHHHHHHH
Q 020529 212 EQAATRPLIGDVVTA 226 (325)
Q Consensus 212 ~~p~~RPs~~evl~~ 226 (325)
.||.+|||+.|+++.
T Consensus 342 ~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 342 IDPAKRISVDDALQH 356 (464)
T ss_dssp SSTTTSCCHHHHHTS
T ss_pred CChhhCCCHHHHhcC
Confidence 999999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=290.76 Aligned_cols=201 Identities=24% Similarity=0.305 Sum_probs=160.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||++++++|.+....|+||||+.+++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||
T Consensus 89 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 161 (494)
T 3lij_A 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRD 161 (494)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 36789999999999999999999999999999999998875 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC---CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEG---FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~---~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+|||++.. +.+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||
T Consensus 162 lkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf 237 (494)
T 3lij_A 162 LKPENLLLESKEKDALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237 (494)
T ss_dssp CSGGGEEESCSSTTCCEEECCCTTCEECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CChhhEEEeCCCCCCcEEEEECCCCeECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCC
Confidence 99999999764 45999999999764322 2234467999999999886 56899999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
........ . ..+.... .. +...... .....+.+|+.+||+.+|.+|||+.++++.
T Consensus 238 ~~~~~~~~---~---~~i~~~~---~~-~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 238 GGQTDQEI---L---RKVEKGK---YT-FDSPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCSSHHHH---H---HHHHHTC---CC-CCSGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCCCHHHH---H---HHHHhCC---CC-CCchhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 76533211 1 1111100 00 0111111 223568899999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=285.01 Aligned_cols=217 Identities=21% Similarity=0.285 Sum_probs=160.9
Q ss_pred CcCCCCCCCccceeeEEEe--------------------------------------CCeeEEEEecCCCCCHHHHhccC
Q 020529 1 MLSLLHHSNLVNLIGYCAD--------------------------------------GDQRLLVYEFMPLGSLEDHLHDL 42 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~--------------------------------------~~~~~lv~e~~~~gsL~~~l~~~ 42 (325)
+|+.++||||++++++|.. ....++||||++ ++|.+.+...
T Consensus 53 il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~ 131 (383)
T 3eb0_A 53 IMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSF 131 (383)
T ss_dssp HHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHH
T ss_pred HHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHH
Confidence 3678999999999999844 334889999997 6888877654
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEc-CCCeEEEecCCCCccCCCCCCCCccccccCCc
Q 020529 43 PPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTY 121 (325)
Q Consensus 43 ~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~-~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~ 121 (325)
......+++..+..++.|++.||+|||+.+ |+||||||+|||++ .++.+||+|||+++...... ......||+
T Consensus 132 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~ 205 (383)
T 3eb0_A 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSR 205 (383)
T ss_dssp HHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCS
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCC
Confidence 334567999999999999999999999999 99999999999997 68899999999998643322 234456899
Q ss_pred CccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhcccc--------cc-----ccccccC
Q 020529 122 GYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND--------RR-----KFSKLAD 187 (325)
Q Consensus 122 ~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~-----~~~~~~d 187 (325)
.|+|||++.+. .++.++|||||||++|||++|+.||......+. +.......-.. .. .+.....
T Consensus 206 ~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 283 (383)
T 3eb0_A 206 FYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA 283 (383)
T ss_dssp SCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCC
T ss_pred CccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCc
Confidence 99999998875 489999999999999999999999976533221 11111000000 00 0001111
Q ss_pred CccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 188 PRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 188 ~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
......++......+.+|+.+||+.+|.+|||+.|+++.
T Consensus 284 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111222334678899999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-37 Score=279.04 Aligned_cols=215 Identities=24% Similarity=0.266 Sum_probs=161.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+. ++|.+++.. ....+++..++.++.+++.||.|||+.+ |+||||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dl 138 (346)
T 1ua2_A 66 LQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDL 138 (346)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCS-EEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhhCCCCCCCeEEEEEeeCCceEEEEEcCC-CCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCC
Confidence 567899999999999999999999999997 589998865 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+|||++.++.+||+|||+++..... ........||+.|+|||++.+. .++.++|||||||++|+|++|.+||...
T Consensus 139 kp~Nil~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~ 216 (346)
T 1ua2_A 139 KPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216 (346)
T ss_dssp CGGGEEECTTCCEEECCCGGGSTTTSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEEcCCCCEEEEecccceeccCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999764322 2233446789999999998764 5889999999999999999999998765
Q ss_pred CCCCcchhhhhhhhcccc-ccccc---cccCCcc---CCCCC-----hHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFND-RRKFS---KLADPRL---EGRYP-----IRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~-~~~~~---~~~d~~l---~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
..... +.......... ..... ...+... ....+ ......+.+|+.+||+.||.+|||+.|+++.-
T Consensus 217 ~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 217 SDLDQ--LTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp SHHHH--HHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred CHHHH--HHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 32211 11111000000 00000 0000000 00011 12246788999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=287.00 Aligned_cols=217 Identities=22% Similarity=0.286 Sum_probs=157.4
Q ss_pred CcCCCCCCCccceeeEEEeCC------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+|+.++||||++++++|.... ..++||||+++ ++...+.........+++..++.++.|++.||+|||+.+
T Consensus 85 il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~-- 161 (394)
T 4e7w_A 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG-- 161 (394)
T ss_dssp HHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 367889999999999986543 37899999975 555444322223567999999999999999999999999
Q ss_pred CeEeCCCCCCcEEEc-CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHh
Q 020529 75 PVIYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 75 ~ivHrdik~~Nill~-~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~ellt 152 (325)
|+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 162 -ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 237 (394)
T 4e7w_A 162 -ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237 (394)
T ss_dssp -EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999 79999999999998643322 23345689999999998765 58999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhcccc--------c-----cccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFND--------R-----RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~--------~-----~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
|+.||........ +.......-.. . ..+.......+...++......+.+|+.+||+.||.+||+
T Consensus 238 g~~pf~~~~~~~~--l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 315 (394)
T 4e7w_A 238 GQPLFPGESGIDQ--LVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT 315 (394)
T ss_dssp SSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC
T ss_pred CCCCCCCCCHHHH--HHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC
Confidence 9999976532211 11111100000 0 0000000000000111123457899999999999999999
Q ss_pred HHHHHHH
Q 020529 220 IGDVVTA 226 (325)
Q Consensus 220 ~~evl~~ 226 (325)
+.|+++.
T Consensus 316 ~~e~l~h 322 (394)
T 4e7w_A 316 AIEALCH 322 (394)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=278.59 Aligned_cols=209 Identities=22% Similarity=0.263 Sum_probs=144.7
Q ss_pred cCCC-CCCCccceeeEEE--------eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 020529 2 LSLL-HHSNLVNLIGYCA--------DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 72 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~--------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~ 72 (325)
|+++ +||||+++++++. .....++||||+. |+|.+++..... ...+++..++.++.+++.||.|||+.+
T Consensus 79 l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ 156 (337)
T 3ll6_A 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQK 156 (337)
T ss_dssp HHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred HHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3456 4999999999994 3345799999996 899998864322 346999999999999999999999986
Q ss_pred CCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCC----------ccccccCCcCccCchhh---ccCCCCcccc
Q 020529 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH----------VSTRVMGTYGYCAPEYA---MTGQLTVKSD 139 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~ksD 139 (325)
++|+||||||+|||++.++.+||+|||+++......... ......||+.|+|||++ .+..++.++|
T Consensus 157 -~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~D 235 (337)
T 3ll6_A 157 -PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQD 235 (337)
T ss_dssp -SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHH
T ss_pred -CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHh
Confidence 349999999999999999999999999998654322111 11234589999999998 5667899999
Q ss_pred EEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC
Q 020529 140 VYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 140 vwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
||||||++|+|++|..||........ .... ..... +......+.+|+..||+.+|.+||+
T Consensus 236 v~slG~il~el~~g~~p~~~~~~~~~----------~~~~------~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps 295 (337)
T 3ll6_A 236 IWALGCILYLLCFRQHPFEDGAKLRI----------VNGK------YSIPP----HDTQYTVFHSLIRAMLQVNPEERLS 295 (337)
T ss_dssp HHHHHHHHHHHHHSSCCC----------------------------CCCCT----TCCSSGGGHHHHHHHSCSSGGGSCC
T ss_pred HHHHHHHHHHHHhCCCCCcchhHHHh----------hcCc------ccCCc----ccccchHHHHHHHHHccCChhhCcC
Confidence 99999999999999999965332110 0000 00000 0111234678999999999999999
Q ss_pred HHHHHHHHHhhhcc
Q 020529 220 IGDVVTALSYLANQ 233 (325)
Q Consensus 220 ~~evl~~L~~~~~~ 233 (325)
+.+|++.|..+...
T Consensus 296 ~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 296 IAEVVHQLQEIAAA 309 (337)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhc
Confidence 99999999988764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=291.79 Aligned_cols=201 Identities=22% Similarity=0.301 Sum_probs=161.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+....++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 79 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~D 151 (484)
T 3nyv_A 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRD 151 (484)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCC
Confidence 36789999999999999999999999999999999999975 456999999999999999999999999 99999
Q ss_pred CCCCcEEE---cCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill---~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+|||+ +.++.+||+|||+++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 152 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 227 (484)
T 3nyv_A 152 LKPENLLLESKSKDANIRIIDFGLSTHFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF 227 (484)
T ss_dssp CCGGGEEESSSSTTCCEEECCTTHHHHBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEEecCCCCCcEEEEeeeeeEEcccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCC
Confidence 99999999 56789999999999764332 22344579999999999876 6899999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....... +... +..... ....+. .......+.+|+.+||+.+|.+|||+.++++.
T Consensus 228 ~~~~~~~---~~~~---i~~~~~---~~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 228 NGANEYD---ILKK---VEKGKY---TFELPQ-----WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp CCSSHHH---HHHH---HHHCCC---CCCSGG-----GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCHHH---HHHH---HHcCCC---CCCCcc-----cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 7653221 1111 110000 000000 01234578899999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=274.66 Aligned_cols=218 Identities=22% Similarity=0.280 Sum_probs=158.3
Q ss_pred cCCCCCCCccceeeEEEe--------CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 2 LSLLHHSNLVNLIGYCAD--------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
|++++||||+++++++.. .+..++||||+. ++|.+.+.. ....+++..++.++.|++.||+|||+.+
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~- 144 (351)
T 3mi9_A 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK- 144 (351)
T ss_dssp HHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 567899999999999977 446899999997 688888765 3356999999999999999999999999
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCC--CCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHH
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK--SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~el 150 (325)
|+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 145 --ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 222 (351)
T 3mi9_A 145 --ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222 (351)
T ss_dssp --EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHH
T ss_pred --eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHH
Confidence 99999999999999999999999999976543221 122344568999999999876 4579999999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhcc-----cccc---ccccccCCccCCCCChHH------HHHHHHHHHHchhhCCCC
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLF-----NDRR---KFSKLADPRLEGRYPIRG------LYQALAVASMCIQEQAAT 216 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~-----~~~~---~~~~~~d~~l~~~~~~~~------~~~~~~l~~~cl~~~p~~ 216 (325)
++|..||...........+....... .... ....+............. ...+.+|+.+||+.||.+
T Consensus 223 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 302 (351)
T 3mi9_A 223 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302 (351)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGG
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhh
Confidence 99999998654322111111000000 0000 000000000000000011 235789999999999999
Q ss_pred CCCHHHHHHH
Q 020529 217 RPLIGDVVTA 226 (325)
Q Consensus 217 RPs~~evl~~ 226 (325)
|||+.|+++.
T Consensus 303 R~t~~e~l~h 312 (351)
T 3mi9_A 303 RIDSDDALNH 312 (351)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhCC
Confidence 9999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=289.46 Aligned_cols=201 Identities=22% Similarity=0.291 Sum_probs=158.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||+++++++.+....++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 74 ~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~D 146 (486)
T 3mwu_A 74 LLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRD 146 (486)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecc
Confidence 36778999999999999999999999999999999999875 356999999999999999999999999 99999
Q ss_pred CCCCcEEEc---CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLE---EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~---~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+|||++ .++.+||+|||+++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 147 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf 222 (486)
T 3mwu_A 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPF 222 (486)
T ss_dssp CSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CchHHEEEecCCCCCCEEEEECCcCeECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999999995 4567999999999754332 22334569999999999875 5899999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
........ . ..+..... ....+. .......+.+|+.+||+.+|.+|||+.++++.
T Consensus 223 ~~~~~~~~---~---~~i~~~~~---~~~~~~-----~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 223 YGKNEYDI---L---KRVETGKY---AFDLPQ-----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CCSSHHHH---H---HHHHHTCC---CSCSGG-----GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCCHHHH---H---HHHHhCCC---CCCCcc-----cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 76432211 1 01100000 000000 01224578899999999999999999999985
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=290.97 Aligned_cols=200 Identities=24% Similarity=0.301 Sum_probs=160.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||++++++|.+....++|||||++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||
T Consensus 100 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dl 172 (504)
T 3q5i_A 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDI 172 (504)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCC
Confidence 6788999999999999999999999999999999999875 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCC---eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEGF---HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~~---~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+|||++.++ .+||+|||++...... .......||+.|+|||++. ..++.++|||||||++|+|++|..||.
T Consensus 173 kp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 173 KPENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp SGGGEEESSTTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cHHHEEEecCCCCccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 99999998776 6999999999764332 2234456999999999987 468999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....... . ..+.... ..++.... ......+.+|+.+||+.||.+|||+.++++.
T Consensus 249 ~~~~~~~---~---~~i~~~~----~~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 249 GQNDQDI---I---KKVEKGK----YYFDFNDW----KNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CSSHHHH---H---HHHHHCC----CCCCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCHHHH---H---HHHHcCC----CCCCcccc----CCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 6532211 1 1111000 00000000 0123568899999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=284.79 Aligned_cols=213 Identities=18% Similarity=0.222 Sum_probs=165.8
Q ss_pred cCCCCC-CCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHH-SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~H-pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+.|+| ++|..+..++...+..+|||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||+++ |+|||
T Consensus 56 l~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrD 128 (483)
T 3sv0_A 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRD 128 (483)
T ss_dssp HHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---Eeecc
Confidence 456765 66666666777888999999999 8999999975 2456999999999999999999999999 99999
Q ss_pred CCCCcEEE---cCCCeEEEecCCCCccCCCCCCC-----CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh
Q 020529 81 FKSSNILL---EEGFHPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 81 ik~~Nill---~~~~~~kL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt 152 (325)
|||+|||| +.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 129 IKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ellt 208 (483)
T 3sv0_A 129 IKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLR 208 (483)
T ss_dssp CCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHh
Confidence 99999999 68899999999999865433221 12235679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhh-hhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 153 GRKAIDSTRPHGEQNLVTWA-RPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
|+.||............... .... ..... .+.. ....++.+|+..||+.+|.+||++.+|++.|+.+.
T Consensus 209 G~~Pf~~~~~~~~~~~~~~i~~~~~------~~~~~-~l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 209 GSLPWQGLKAGTKKQKYEKISEKKV------ATSIE-ALCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp SSCTTSSCCCSSHHHHHHHHHHHHH------HSCHH-HHHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred CCCCCccccchhHHHHHHHHhhccc------cccHH-HHhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 99999876543322222111 1100 00000 0111 12357889999999999999999999999998875
Q ss_pred c
Q 020529 232 N 232 (325)
Q Consensus 232 ~ 232 (325)
.
T Consensus 278 ~ 278 (483)
T 3sv0_A 278 I 278 (483)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=279.49 Aligned_cols=200 Identities=24% Similarity=0.371 Sum_probs=158.8
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+++ +||||+++++++......++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+|
T Consensus 153 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~D 225 (365)
T 2y7j_A 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRD 225 (365)
T ss_dssp HHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 3455 799999999999999999999999999999999975 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC------CCCccccEEEehHHHHHHHhCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG------QLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~ksDvwSlGvvl~elltg~ 154 (325)
|||+|||++.++.++|+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|.
T Consensus 226 lkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~ 302 (365)
T 2y7j_A 226 LKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302 (365)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCC
Confidence 99999999999999999999987644322 23446799999999998643 5889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.||....... .... +.... .....+.. ......+.+|+.+||+.||.+||++.++++
T Consensus 303 ~pf~~~~~~~---~~~~---i~~~~---~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 303 PPFWHRRQIL---MLRM---IMEGQ---YQFSSPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CSSCCSSHHH---HHHH---HHHTC---CCCCHHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCHHH---HHHH---HHhCC---CCCCCccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9996543211 1100 00000 00000000 012346889999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=268.29 Aligned_cols=197 Identities=21% Similarity=0.332 Sum_probs=152.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl 137 (276)
T 2h6d_A 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDL 137 (276)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCC
T ss_pred HhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCC
Confidence 5678999999999999999999999999999999999975 345899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||+++.++.++|+|||++...... .......|++.|+|||++.+..+ +.++||||||+++++|++|..||...
T Consensus 138 ~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 138 KPENVLLDAHMNAKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp CGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ChhhEEECCCCCEEEeecccccccCCC---cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999764322 12234568999999999988765 68999999999999999999999754
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
... .+. ..+.... . ..+......+.+++.+||+.||.+||++.+|++.
T Consensus 215 ~~~---~~~---~~~~~~~---~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 215 HVP---TLF---KKIRGGV---F---------YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp SHH---HHH---HHHHHCC---C---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred cHH---HHH---HHhhcCc---c---------cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 221 111 1111000 0 0111223567899999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=272.78 Aligned_cols=200 Identities=21% Similarity=0.296 Sum_probs=161.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~di 132 (304)
T 2jam_A 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDL 132 (304)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSC
T ss_pred HHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 5678999999999999999999999999999999999865 346899999999999999999999999 999999
Q ss_pred CCCcEEE---cCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill---~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+||++ +.++.++|+|||++..... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 133 kp~NIl~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 133 KPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp CGGGCEESSSSTTCCEEBCSCSTTCCCCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CHHHEEEecCCCCCCEEEccCCcceecCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9999999 7888999999999875322 12334568999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...... +. ..+.... .. +.. .........+.+++.+||+.||.+||++.++++.
T Consensus 209 ~~~~~~---~~---~~i~~~~---~~-~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 209 EETESK---LF---EKIKEGY---YE-FES----PFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TSCHHH---HH---HHHHHCC---CC-CCT----TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCHHH---HH---HHHHcCC---CC-CCc----cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 543211 11 1111100 00 011 1112234578899999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=285.96 Aligned_cols=217 Identities=23% Similarity=0.277 Sum_probs=158.1
Q ss_pred CcCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+|++++||||++++++|... ...++||||++ ++|.+++.........+++..++.++.||+.||+|||+.+
T Consensus 100 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~-- 176 (420)
T 1j1b_A 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-- 176 (420)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 36788999999999998542 24679999997 5777766543234567999999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCC-CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHh
Q 020529 75 PVIYRDFKSSNILLEEG-FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~-~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~ellt 152 (325)
|+||||||+||||+.+ +.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 177 -ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~ 252 (420)
T 1j1b_A 177 -ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252 (420)
T ss_dssp -EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHh
Confidence 9999999999999965 678999999998643322 23345789999999999765 78999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhcccc--------ccccccccCCccCC-----CCChHHHHHHHHHHHHchhhCCCCCCC
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFND--------RRKFSKLADPRLEG-----RYPIRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~d~~l~~-----~~~~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
|+.||....... .+.......-.. ...+....-+.+.. .++......+.+|+.+||+.||.+||+
T Consensus 253 G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t 330 (420)
T 1j1b_A 253 GQPIFPGDSGVD--QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330 (420)
T ss_dssp SSCSSCCSSHHH--HHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCCCHHH--HHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC
Confidence 999997653221 111111110000 00001111111100 011223467889999999999999999
Q ss_pred HHHHHHH
Q 020529 220 IGDVVTA 226 (325)
Q Consensus 220 ~~evl~~ 226 (325)
+.|+++.
T Consensus 331 ~~e~l~h 337 (420)
T 1j1b_A 331 PLEACAH 337 (420)
T ss_dssp HHHHHTS
T ss_pred HHHHhCC
Confidence 9999874
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=299.53 Aligned_cols=206 Identities=23% Similarity=0.339 Sum_probs=162.6
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++. .+..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||
T Consensus 445 l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDi 517 (656)
T 2j0j_A 445 MRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDI 517 (656)
T ss_dssp HHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccc
Confidence 56789999999999985 4568999999999999999976 2446999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+|||++.++.+||+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 518 kp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~ 596 (656)
T 2j0j_A 518 AARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596 (656)
T ss_dssp SGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred chHhEEEeCCCCEEEEecCCCeecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999999999999999999998653322 122234457789999999999999999999999999999997 99999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.... +.... .. .. .+ ..+......+.+|+.+||+.||.+||++.+|++.|+.+..
T Consensus 597 ~~~~---~~~~i---~~-~~------~~----~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 597 KNND---VIGRI---EN-GE------RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp CHHH---HHHHH---HH-TC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHH---HHHHH---Hc-CC------CC----CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 3221 11111 00 00 00 1122334578899999999999999999999999998764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=266.76 Aligned_cols=202 Identities=20% Similarity=0.255 Sum_probs=157.4
Q ss_pred cCCCCCCCccceeeEEE--eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCA--DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++||||+++++++. +....++||||+.++ |.+++.... ...+++..++.++.|++.||.|||+++ |+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~ 133 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHK 133 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHCC---eeec
Confidence 67889999999999984 456889999999755 877776532 456999999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC--CCccccEEEehHHHHHHHhCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||||+||+++.++.++|+|||++................||+.|+|||++.+.. ++.++||||||+++|+|++|+.||
T Consensus 134 dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (305)
T 2wtk_C 134 DIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213 (305)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999997654333333344567999999999987654 377999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
...... .....+.... . ..+......+.+++.+||+.||.+||++.++++.-
T Consensus 214 ~~~~~~------~~~~~i~~~~--------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 214 EGDNIY------KLFENIGKGS--------Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp CCSSHH------HHHHHHHHCC--------C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred CCchHH------HHHHHHhcCC--------C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 754311 1111111100 0 11112335678999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=286.36 Aligned_cols=149 Identities=25% Similarity=0.322 Sum_probs=124.5
Q ss_pred cCCCCCCCccceeeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
|++++||||+++++++... ...|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||+.+ |
T Consensus 79 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---i 150 (432)
T 3n9x_A 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---I 150 (432)
T ss_dssp HHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 6678999999999999766 57899999996 799999975 456999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC--------------------CccccccCCcCccCchhh-ccCCCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS--------------------HVSTRVMGTYGYCAPEYA-MTGQLT 135 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~ 135 (325)
+||||||+|||++.++.+||+|||+++........ ...+...||+.|+|||++ ....++
T Consensus 151 vHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~ 230 (432)
T 3n9x_A 151 IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT 230 (432)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCC
T ss_pred CCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCC
Confidence 99999999999999999999999999865432211 123556799999999986 556799
Q ss_pred ccccEEEehHHHHHHHhCCCCCC
Q 020529 136 VKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 136 ~ksDvwSlGvvl~elltg~~p~~ 158 (325)
.++|||||||++|||++|..||.
T Consensus 231 ~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 231 KSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp THHHHHHHHHHHHHHHTTCTTTC
T ss_pred cccccchHHHHHHHHHhcccccc
Confidence 99999999999999998655543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=276.85 Aligned_cols=211 Identities=18% Similarity=0.228 Sum_probs=161.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHH------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDH------LHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANP 74 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~ 74 (325)
|++++||||+++++++.+.+..++||||+++++|.++ +.. .....+++..++.++.|++.||.|||+ .+
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-- 172 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN-- 172 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC--
Confidence 6788999999999999999999999999999999998 433 124679999999999999999999999 88
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCc-cccEEEehHHHHHHHh
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTV-KSDVYSFGVVFLELIT 152 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-ksDvwSlGvvl~ellt 152 (325)
|+||||||+||+++.++.++|+|||++...... ......||+.|+|||++.+. .++. ++||||||+++++|++
T Consensus 173 -i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 247 (348)
T 2pml_X 173 -ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247 (348)
T ss_dssp -EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred -EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999764322 33456799999999999887 6666 9999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhcccccccccc----ccCCcc---CCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSK----LADPRL---EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~d~~l---~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|..||...... ..+.... ......+.. ...+.. ...........+.+|+.+||+.||.+||++.++++
T Consensus 248 g~~pf~~~~~~--~~~~~~i---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 248 NVVPFSLKISL--VELFNNI---RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SSCSSCCSSCS--HHHHHHH---TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCcH--HHHHHHH---hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999765431 1111111 100000000 000000 00001223457889999999999999999999987
Q ss_pred H
Q 020529 226 A 226 (325)
Q Consensus 226 ~ 226 (325)
.
T Consensus 323 h 323 (348)
T 2pml_X 323 H 323 (348)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=282.88 Aligned_cols=199 Identities=12% Similarity=0.011 Sum_probs=141.5
Q ss_pred CCCCcccee-------eEEEeC-----------------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHH------H
Q 020529 6 HHSNLVNLI-------GYCADG-----------------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR------M 55 (325)
Q Consensus 6 ~Hpniv~l~-------~~~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~------~ 55 (325)
+||||++++ +++... ...|+||||++ ++|.+++... ...+.+..+ +
T Consensus 122 ~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~ 197 (371)
T 3q60_A 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALH 197 (371)
T ss_dssp ----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHH
T ss_pred cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHH
Confidence 699988755 454433 33799999998 9999999762 223455566 7
Q ss_pred HHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc--CC
Q 020529 56 KIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT--GQ 133 (325)
Q Consensus 56 ~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~ 133 (325)
.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..
T Consensus 198 ~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~ 269 (371)
T 3q60_A 198 ILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTAT 269 (371)
T ss_dssp HHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEE
T ss_pred HHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCC
Confidence 88899999999999999 99999999999999999999999999985321 1224557799999999987 67
Q ss_pred CCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhC
Q 020529 134 LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQ 213 (325)
Q Consensus 134 ~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~ 213 (325)
++.++|||||||++|||++|+.||....+....... .... .......+...........+.+|+.+||+.|
T Consensus 270 ~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 340 (371)
T 3q60_A 270 FTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWK---RPSL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFD 340 (371)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCC---BCCT------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSS
T ss_pred cCccccHHHHHHHHHHHHhCCCCCCCcCcccccchh---hhhh------hhccccccchhhccCCCHHHHHHHHHHcCCC
Confidence 899999999999999999999999876443221111 0000 0000011111111133467889999999999
Q ss_pred CCCCCCHHHHHH
Q 020529 214 AATRPLIGDVVT 225 (325)
Q Consensus 214 p~~RPs~~evl~ 225 (325)
|.+||++.++++
T Consensus 341 P~~Rpt~~e~l~ 352 (371)
T 3q60_A 341 RRRRLLPLEAME 352 (371)
T ss_dssp TTTCCCHHHHTT
T ss_pred hhhCCCHHHHhc
Confidence 999999999976
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=271.65 Aligned_cols=200 Identities=23% Similarity=0.295 Sum_probs=156.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.... .++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dl 140 (322)
T 2ycf_A 69 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDL 140 (322)
T ss_dssp HHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 56789999999999997665 8999999999999999865 456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCe---EEEecCCCCccCCCCCCCCccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHHhCCC
Q 020529 82 KSSNILLEEGFH---PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 82 k~~Nill~~~~~---~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
||+||+++.++. +||+|||+++.... ........||+.|+|||++. ...++.++|||||||++|+|++|..
T Consensus 141 kp~NIl~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 141 KPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp SGGGEEESSSSSSCCEEECCCTTCEECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEEecCCCCCeEEEccCccceeccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999987664 99999999976432 12233456999999999974 4678999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
||........ +...... ... ...+... ......+.+|+.+||+.||.+||++.++++
T Consensus 218 pf~~~~~~~~--~~~~~~~---~~~----~~~~~~~----~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 218 PFSEHRTQVS--LKDQITS---GKY----NFIPEVW----AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp SSCSTTCSSC--HHHHHHH---TCC----CCCHHHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccchHHH--HHHHHHh---Ccc----ccCchhh----hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 9976543211 1111100 000 0000010 112357889999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=277.06 Aligned_cols=210 Identities=23% Similarity=0.344 Sum_probs=158.7
Q ss_pred cCCCCCCCccceeeEEEeCC------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
|+.++||||+++++++.... ..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+
T Consensus 78 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~--- 148 (367)
T 1cm8_A 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG--- 148 (367)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56789999999999997653 459999999 7999999975 35899999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+|||++.++.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||+++||++|+
T Consensus 149 ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 223 (367)
T 1cm8_A 149 IIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223 (367)
T ss_dssp EECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccCcCHHHEEEcCCCCEEEEeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986432 2334578999999999887 67999999999999999999999
Q ss_pred CCCCCCCCCCcchhh-h--------hhhhccccc-----cccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 155 KAIDSTRPHGEQNLV-T--------WARPLFNDR-----RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~-~--------~~~~~~~~~-----~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
.||...........+ . +...+.... ..+.......+. .........+.+|+.+||+.||.+|||+
T Consensus 224 ~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~ 302 (367)
T 1cm8_A 224 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTA 302 (367)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCH
Confidence 999765322111000 0 000000000 000000001110 1111234578899999999999999999
Q ss_pred HHHHHH
Q 020529 221 GDVVTA 226 (325)
Q Consensus 221 ~evl~~ 226 (325)
.++++.
T Consensus 303 ~e~l~h 308 (367)
T 1cm8_A 303 GEALAH 308 (367)
T ss_dssp HHHHHS
T ss_pred HHHhcC
Confidence 999874
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=274.07 Aligned_cols=216 Identities=24% Similarity=0.280 Sum_probs=157.7
Q ss_pred cCCCCCCCccceeeEEEeCCe-------eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--cCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQ-------RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH--DKA 72 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~-------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH--~~~ 72 (325)
|+.++||||++++++|..... .++||||++ ++|...+.........+++..++.++.+++.||.||| +.+
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ 151 (360)
T 3e3p_A 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN 151 (360)
T ss_dssp HHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCS-CBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC
T ss_pred HHhcCCCCcccHHHhhhccccccccceeEEEEeeccc-ccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC
Confidence 356799999999999976433 789999997 5666555433234567899999999999999999999 888
Q ss_pred CCCeEeCCCCCCcEEEcC-CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC-CCccccEEEehHHHHHH
Q 020529 73 NPPVIYRDFKSSNILLEE-GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~-~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~el 150 (325)
|+||||||+|||++. ++.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|
T Consensus 152 ---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el 225 (360)
T 3e3p_A 152 ---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM 225 (360)
T ss_dssp ---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred ---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999997 8999999999998643322 233456899999999987654 89999999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhccccccccccccCC----------------ccCCCCChHHHHHHHHHHHHchhhCC
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADP----------------RLEGRYPIRGLYQALAVASMCIQEQA 214 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~----------------~l~~~~~~~~~~~~~~l~~~cl~~~p 214 (325)
++|+.||........ +..................++ ......+......+.+|+.+||+.||
T Consensus 226 l~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 303 (360)
T 3e3p_A 226 MLGEPIFRGDNSAGQ--LHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLP 303 (360)
T ss_dssp HHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSG
T ss_pred HhCCCCcCCCChHHH--HHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCc
Confidence 999999976533211 111111000000000000000 00111122346789999999999999
Q ss_pred CCCCCHHHHHHH
Q 020529 215 ATRPLIGDVVTA 226 (325)
Q Consensus 215 ~~RPs~~evl~~ 226 (325)
.+|||+.||++.
T Consensus 304 ~~Rpt~~e~l~h 315 (360)
T 3e3p_A 304 EERMKPYEALCH 315 (360)
T ss_dssp GGSCCHHHHTTS
T ss_pred cccCCHHHHhcC
Confidence 999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=272.04 Aligned_cols=211 Identities=18% Similarity=0.225 Sum_probs=157.8
Q ss_pred cCCCC-CCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 2 LSLLH-HSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 2 L~~l~-Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
|++++ ||||+++++++.+ ....++||||+.+++|.+++.. +++..++.++.|++.||+|||+.+ |+|
T Consensus 84 l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH 153 (330)
T 3nsz_A 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMH 153 (330)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence 45665 9999999999988 6678999999999999999854 899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCC-eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCC
Q 020529 79 RDFKSSNILLEEGF-HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 79 rdik~~Nill~~~~-~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
|||||+|||++.++ .+||+|||+++...... ......|+..|+|||++.+ ..++.++|||||||++++|++|+.|
T Consensus 154 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p 230 (330)
T 3nsz_A 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230 (330)
T ss_dssp CCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred CCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999776 89999999997644322 2334568999999999887 6789999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccc-------------ccccccccc--------CCccCCCCChHHHHHHHHHHHHchhhCCC
Q 020529 157 IDSTRPHGEQNLVTWARPLFN-------------DRRKFSKLA--------DPRLEGRYPIRGLYQALAVASMCIQEQAA 215 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~--------d~~l~~~~~~~~~~~~~~l~~~cl~~~p~ 215 (325)
|........ .+.......-. ....+.... ........+......+.+|+.+||+.||.
T Consensus 231 ~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 309 (330)
T 3nsz_A 231 FFHGHDNYD-QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 309 (330)
T ss_dssp SSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGG
T ss_pred cccCCchHH-HHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcc
Confidence 954332111 11110000000 000000000 00011111112356789999999999999
Q ss_pred CCCCHHHHHHH
Q 020529 216 TRPLIGDVVTA 226 (325)
Q Consensus 216 ~RPs~~evl~~ 226 (325)
+|||+.++++.
T Consensus 310 ~Rpta~e~l~h 320 (330)
T 3nsz_A 310 SRLTAREAMEH 320 (330)
T ss_dssp GSCCHHHHHTS
T ss_pred cCCCHHHHhcC
Confidence 99999999873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-36 Score=268.07 Aligned_cols=200 Identities=24% Similarity=0.304 Sum_probs=159.5
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+++ +||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+|+|
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~d 149 (298)
T 1phk_A 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRD 149 (298)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCC
Confidence 4456 499999999999999999999999999999999975 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc------cCCCCccccEEEehHHHHHHHhCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM------TGQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|||+||+++.++.+||+|||++....... ......|++.|+|||++. ...++.++||||||+++++|++|.
T Consensus 150 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 226 (298)
T 1phk_A 150 LKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 226 (298)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCC
Confidence 99999999999999999999997643222 233456899999999985 456889999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.||....... .. ..+.... .....+ ........+.+|+.+||+.||.+||++.++++
T Consensus 227 ~p~~~~~~~~---~~---~~~~~~~---~~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 227 PPFWHRKQML---ML---RMIMSGN---YQFGSP-----EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CSSCCSSHHH---HH---HHHHHTC---CCCCTT-----TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCcCccHHH---HH---HHHhcCC---cccCcc-----cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 9996543211 11 1111100 000000 01123457889999999999999999999986
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=270.65 Aligned_cols=202 Identities=22% Similarity=0.310 Sum_probs=152.5
Q ss_pred cCCCC--CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 2 LSLLH--HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 2 L~~l~--Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
|++++ ||||+++++++.+.+..++|||+ .+++|.+++.. ...+++..++.++.+++.||.|||+.+ |+||
T Consensus 80 l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 151 (313)
T 3cek_A 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHS 151 (313)
T ss_dssp HHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCC
T ss_pred HHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceec
Confidence 34554 69999999999999999999995 47999999976 456899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-----------CCCCccccEEEehHHHH
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-----------GQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~ksDvwSlGvvl~ 148 (325)
||||+||++++ +.+||+|||+++...............||+.|+|||++.+ ..++.++||||||+++|
T Consensus 152 dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 230 (313)
T 3cek_A 152 DLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230 (313)
T ss_dssp CCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred CCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence 99999999964 8999999999986543333223345679999999999875 46888999999999999
Q ss_pred HHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
+|++|..||...... .. .. ....++.....++......+.+++.+||+.+|.+||++.+|++..
T Consensus 231 el~~g~~pf~~~~~~----~~-~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 231 YMTYGKTPFQQIINQ----IS-KL----------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp HHHHSSCTTTTCCSH----HH-HH----------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHhCCCchhhHHHH----HH-HH----------HHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 999999999654221 00 00 111111111122222245788999999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=268.67 Aligned_cols=212 Identities=23% Similarity=0.374 Sum_probs=158.8
Q ss_pred CCCCCCccceeeEEE-----eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 4 LLHHSNLVNLIGYCA-----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
.++||||+++++++. .....++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+.+ |+|
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H 143 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVH 143 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cee
Confidence 358999999999987 4567899999997 79999997632 345899999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 79 RDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 79 rdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|||||+||+++.++.+||+|||+++.... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 144 ~dlkp~Nili~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 220 (326)
T 1blx_A 144 RDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 220 (326)
T ss_dssp CCCCGGGEEECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCHHHeEEcCCCCEEEecCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999975432 123344678999999999999999999999999999999999999997
Q ss_pred CCCCCCcch-hh---------hhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 159 STRPHGEQN-LV---------TWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~-~~---------~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
......... +. .|..........+.......+ ..+.......+.+|+.+||+.||.+||++.++++
T Consensus 221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 221 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchh-hhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 653221110 00 000000000000000000000 0111223457889999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=284.74 Aligned_cols=157 Identities=25% Similarity=0.348 Sum_probs=123.5
Q ss_pred CcCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhcCCC
Q 020529 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLP-----PDKEALDWNTRMKIAAGAAKGLEYLHDKAN 73 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~-----~~~~~l~~~~~~~i~~~l~~al~~LH~~~~ 73 (325)
+|++|+||||++++++|.. ....++||||+. ++|.+++.... .....+++..++.|+.||+.||+|||+.+
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~- 148 (405)
T 3rgf_A 71 LLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW- 148 (405)
T ss_dssp HHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3678899999999999954 678999999996 68888875321 12235999999999999999999999999
Q ss_pred CCeEeCCCCCCcEEE----cCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccC-CCCccccEEEehHHH
Q 020529 74 PPVIYRDFKSSNILL----EEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVF 147 (325)
Q Consensus 74 ~~ivHrdik~~Nill----~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl 147 (325)
|+||||||+|||| +.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++
T Consensus 149 --ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 226 (405)
T 3rgf_A 149 --VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIF 226 (405)
T ss_dssp --CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHH
T ss_pred --EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHH
Confidence 9999999999999 77789999999999865432111 223446799999999999874 589999999999999
Q ss_pred HHHHhCCCCCCCCC
Q 020529 148 LELITGRKAIDSTR 161 (325)
Q Consensus 148 ~elltg~~p~~~~~ 161 (325)
|+|++|+.||....
T Consensus 227 ~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 227 AELLTSEPIFHCRQ 240 (405)
T ss_dssp HHHHHSSCTTCCCC
T ss_pred HHHHhCCCCCCCcc
Confidence 99999999997654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=282.89 Aligned_cols=204 Identities=24% Similarity=0.307 Sum_probs=147.6
Q ss_pred CCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 5 LHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA---LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~---l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
.+||||+++++++.+.+..|+||||+. ++|.+++......... .++..++.++.|++.||+|||+.+ |+||||
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDL 141 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDL 141 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCC
Confidence 389999999999999999999999996 7999999764322111 133456789999999999999999 999999
Q ss_pred CCCcEEEcCC-------------CeEEEecCCCCccCCCCCCCC--ccccccCCcCccCchhhcc-------CCCCcccc
Q 020529 82 KSSNILLEEG-------------FHPKLSDFGLAKLGPVGDKSH--VSTRVMGTYGYCAPEYAMT-------GQLTVKSD 139 (325)
Q Consensus 82 k~~Nill~~~-------------~~~kL~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~ksD 139 (325)
||+|||++.+ +.+||+|||+++......... ......||+.|+|||++.+ ..++.++|
T Consensus 142 kp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D 221 (434)
T 2rio_A 142 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID 221 (434)
T ss_dssp SGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHH
T ss_pred ChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhh
Confidence 9999999654 489999999998754332211 1234579999999999976 57899999
Q ss_pred EEEehHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC
Q 020529 140 VYSFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 218 (325)
Q Consensus 140 vwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP 218 (325)
||||||++|||++ |..||....... ..+ ..... . .+.+....+......+.+|+.+||+.||.+||
T Consensus 222 iwSlG~il~ellt~g~~Pf~~~~~~~-~~i---~~~~~----~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 288 (434)
T 2rio_A 222 IFSMGCVFYYILSKGKHPFGDKYSRE-SNI---IRGIF----S-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRP 288 (434)
T ss_dssp HHHHHHHHHHHHTTSCCTTCSTTTHH-HHH---HHTCC----C-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSC
T ss_pred hHhHHHHHHHHHhCCCCCCCCchhhH-HHH---hcCCC----C-----cccccccccccchHHHHHHHHHHhhCChhhCC
Confidence 9999999999999 999996543211 111 11100 0 01111111234567889999999999999999
Q ss_pred CHHHHHH
Q 020529 219 LIGDVVT 225 (325)
Q Consensus 219 s~~evl~ 225 (325)
++.+|++
T Consensus 289 s~~eil~ 295 (434)
T 2rio_A 289 TAMKVLR 295 (434)
T ss_dssp CHHHHHT
T ss_pred CHHHHHh
Confidence 9999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=274.06 Aligned_cols=213 Identities=24% Similarity=0.299 Sum_probs=150.7
Q ss_pred cCCCCCCCccceeeEEEeCC------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
|+.++||||+++++++.... ..|+||||++ ++|.+++.. .+++..+..++.|++.||+|||+.+
T Consensus 78 l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~--- 147 (371)
T 2xrw_A 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG--- 147 (371)
T ss_dssp HHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 56789999999999997654 7899999997 688888853 4899999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|+||||||+|||++.++.+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 148 ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 224 (371)
T 2xrw_A 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224 (371)
T ss_dssp CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred eecccCCHHHEEEcCCCCEEEEEeeccccccc---ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999975432 122344678999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcch-hhh--------hh-------hhcccccc-----ccccccCCccCCCC---ChHHHHHHHHHHHHchh
Q 020529 156 AIDSTRPHGEQN-LVT--------WA-------RPLFNDRR-----KFSKLADPRLEGRY---PIRGLYQALAVASMCIQ 211 (325)
Q Consensus 156 p~~~~~~~~~~~-~~~--------~~-------~~~~~~~~-----~~~~~~d~~l~~~~---~~~~~~~~~~l~~~cl~ 211 (325)
||.......... +.. +. ........ .+...+...+.... +......+.+|+.+||+
T Consensus 225 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~ 304 (371)
T 2xrw_A 225 LFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 304 (371)
T ss_dssp SSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSC
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCc
Confidence 997643211100 000 00 00000000 00000000000000 11225678999999999
Q ss_pred hCCCCCCCHHHHHHHH
Q 020529 212 EQAATRPLIGDVVTAL 227 (325)
Q Consensus 212 ~~p~~RPs~~evl~~L 227 (325)
.||.+|||+.++++.-
T Consensus 305 ~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 305 IDASKRISVDEALQHP 320 (371)
T ss_dssp SSGGGSCCHHHHHHSH
T ss_pred CChhhCCCHHHHhCCc
Confidence 9999999999999853
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=272.30 Aligned_cols=202 Identities=27% Similarity=0.373 Sum_probs=152.1
Q ss_pred cCCC-CCCCccceeeEEEe------CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 2 LSLL-HHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
|+++ +||||+++++++.. ....++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~-- 149 (326)
T 2x7f_A 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHK-- 149 (326)
T ss_dssp HHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3455 79999999999977 468899999999999999997632 346899999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHH
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~e 149 (325)
|+|+||||+||+++.++.+||+|||++...... ........||+.|+|||++. ...++.++|||||||++|+
T Consensus 150 -ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 226 (326)
T 2x7f_A 150 -VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226 (326)
T ss_dssp -CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHH
T ss_pred -ccccCCcHHHEEEcCCCCEEEeeCcCceecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHH
Confidence 999999999999999999999999998754321 11233456899999999987 5678999999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 150 LITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|++|..||........ +. ... ....+.+. +......+.+|+.+||..+|.+||++.++++.
T Consensus 227 l~~g~~p~~~~~~~~~--~~----~~~-------~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 227 MAEGAPPLCDMHPMRA--LF----LIP-------RNPAPRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHSSCTTTTSCHHHH--HH----HHH-------HSCCCCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhCCCCCCCCcHHHH--HH----Hhh-------cCccccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 9999999965432111 00 000 00001110 11223568899999999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=280.14 Aligned_cols=147 Identities=20% Similarity=0.278 Sum_probs=130.2
Q ss_pred CCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCC
Q 020529 4 LLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKS 83 (325)
Q Consensus 4 ~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~ 83 (325)
..+||||+++++++......++||||+. ++|.+++... ....+++..++.|+.||+.||+|||+.+ |+||||||
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp 228 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKP 228 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSG
T ss_pred ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCH
Confidence 3489999999999999999999999996 7999998763 2345999999999999999999999999 99999999
Q ss_pred CcEEEcCCCe--EEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 84 SNILLEEGFH--PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 84 ~Nill~~~~~--~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
+||||+.++. +||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|.+||....
T Consensus 229 ~NILl~~~~~~~vkL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 229 ENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp GGEEESSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHeEEccCCCcceEEeecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9999999987 99999999975322 2234578999999999999999999999999999999999999997653
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=273.28 Aligned_cols=201 Identities=21% Similarity=0.326 Sum_probs=155.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.+++.||.|||+.+ |+||||
T Consensus 70 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl 143 (302)
T 2j7t_A 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDL 143 (302)
T ss_dssp HHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCC
Confidence 5678999999999999999999999999999999999865 2456999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHHHHhCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
||+||+++.++.+||+|||++...... ........||+.|+|||++. ...++.++||||||+++|+|++|..|
T Consensus 144 kp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 221 (302)
T 2j7t_A 144 KAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221 (302)
T ss_dssp SGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred CHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCC
Confidence 999999999999999999987431110 11123356899999999984 56789999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|....... .+. ...... .... ..+......+.+++..||+.+|.+||++.++++
T Consensus 222 ~~~~~~~~--~~~----~~~~~~--~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 222 HHELNPMR--VLL----KIAKSD--PPTL-------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp TTTSCHHH--HHH----HHHHSC--CCCC-------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred CccCCHHH--HHH----HHhccC--Cccc-------CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 97643211 011 000000 0000 111223457889999999999999999999876
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=276.21 Aligned_cols=209 Identities=18% Similarity=0.209 Sum_probs=157.5
Q ss_pred CCCCccceeeEEE----eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEeCC
Q 020529 6 HHSNLVNLIGYCA----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (325)
Q Consensus 6 ~Hpniv~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivHrd 80 (325)
+||||+++++++. .....|+||||+ +++|.+++... ....+++..++.|+.|++.||+|||++ + |+|||
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrD 172 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTD 172 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCC
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCC
Confidence 4899999999987 556889999999 57777776542 235699999999999999999999998 8 99999
Q ss_pred CCCCcEEEcCCC-------------------------------------------------eEEEecCCCCccCCCCCCC
Q 020529 81 FKSSNILLEEGF-------------------------------------------------HPKLSDFGLAKLGPVGDKS 111 (325)
Q Consensus 81 ik~~Nill~~~~-------------------------------------------------~~kL~Dfgla~~~~~~~~~ 111 (325)
|||+|||++.++ .+||+|||+++....
T Consensus 173 ikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---- 248 (397)
T 1wak_A 173 IKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---- 248 (397)
T ss_dssp CSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB----
T ss_pred CCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc----
Confidence 999999998775 799999999976432
Q ss_pred CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhh------------------
Q 020529 112 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWAR------------------ 173 (325)
Q Consensus 112 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~------------------ 173 (325)
......||+.|+|||++.+..++.++|||||||++|||++|+.||................
T Consensus 249 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 249 -HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp -CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred -cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence 1334568999999999999999999999999999999999999998755433211111000
Q ss_pred ---hccccccccccccCCcc---------CCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 174 ---PLFNDRRKFSKLADPRL---------EGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 174 ---~~~~~~~~~~~~~d~~l---------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
..+.....+..+.+... ....+......+.+|+.+||+.||.+|||+.+|++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00110000000000000 01234456678899999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=271.70 Aligned_cols=206 Identities=23% Similarity=0.288 Sum_probs=141.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEeC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP-PDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYR 79 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivHr 79 (325)
++.++||||+++++++.+.+..++||||+. ++|.+++.... .....+++..++.++.+++.||.|||+. + |+||
T Consensus 75 ~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~ 150 (327)
T 3aln_A 75 MRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHR 150 (327)
T ss_dssp HSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCS
T ss_pred HHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeEC
Confidence 567899999999999999999999999997 58888875311 1245699999999999999999999998 8 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhh----ccCCCCccccEEEehHHHHHHHhCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA----MTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
||||+||+++.++.+||+|||+++..... .......||+.|+|||++ .+..++.++||||||+++|+|++|..
T Consensus 151 dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (327)
T 3aln_A 151 DIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227 (327)
T ss_dssp CCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCC
T ss_pred CCCHHHEEEcCCCCEEEccCCCceecccc---cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999999999999999999999754322 122334689999999998 45678999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
||........ ........ ..+.+...........+.+|+.+||+.||.+||++.+|++.
T Consensus 228 pf~~~~~~~~-----~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 228 PYPKWNSVFD-----QLTQVVKG-------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSSCC------------CCCCCS-------CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCcchHHH-----HHHHHhcC-------CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 9976432110 00001100 00111111111234578899999999999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=272.42 Aligned_cols=206 Identities=19% Similarity=0.220 Sum_probs=138.9
Q ss_pred CCCCCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 3 SLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
+.++||||+++++++.. +...++||||+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|
T Consensus 77 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH 151 (336)
T 3fhr_A 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAH 151 (336)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 45789999999999876 45689999999999999999762 2346999999999999999999999999 999
Q ss_pred CCCCCCcEEEcC---CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 79 RDFKSSNILLEE---GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 79 rdik~~Nill~~---~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||||+||+++. ++.+||+|||+++.... .......||+.|+|||++.+..++.++||||||+++|+|++|..
T Consensus 152 ~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (336)
T 3fhr_A 152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFP 227 (336)
T ss_dssp SCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCHHHEEEEecCCCceEEEeccccceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 999999999976 45699999999975432 12334568999999999988889999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||........... ......... .....+ ........+.+|+.+||+.||.+||++.++++.-
T Consensus 228 pf~~~~~~~~~~~--~~~~~~~~~---~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 228 PFYSNTGQAISPG--MKRRIRLGQ---YGFPNP-----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp CC--------------------------CCCTT-----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred CCCCccchhhhhh--HHHhhhccc---cccCch-----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 9966433211000 000000000 000000 0112345788999999999999999999999843
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=265.50 Aligned_cols=210 Identities=17% Similarity=0.209 Sum_probs=158.2
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCc
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSN 85 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~N 85 (325)
.|++|+++++++.+.+..++||||+ +++|.+++... ...++++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 148 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPEN 148 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHH
Confidence 4567999999999999999999999 79999999762 2246899999999999999999999999 9999999999
Q ss_pred EEEcC-------------------CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHH
Q 020529 86 ILLEE-------------------GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146 (325)
Q Consensus 86 ill~~-------------------~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvv 146 (325)
||++. ++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||+
T Consensus 149 il~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 223 (339)
T 1z57_A 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCI 223 (339)
T ss_dssp EEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHH
T ss_pred EEEeccccccccCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHHHHHH
Confidence 99987 66799999999975322 2234578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCcchhhhhhhhcccc--------ccc-----------------cccccCCcc-CCCCChHHHH
Q 020529 147 FLELITGRKAIDSTRPHGEQNLVTWARPLFND--------RRK-----------------FSKLADPRL-EGRYPIRGLY 200 (325)
Q Consensus 147 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~~-----------------~~~~~d~~l-~~~~~~~~~~ 200 (325)
+|||++|..||..................... ... ......+.. ....+.....
T Consensus 224 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (339)
T 1z57_A 224 LIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303 (339)
T ss_dssp HHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHH
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHH
Confidence 99999999999765432211111000000000 000 000000000 0111234567
Q ss_pred HHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 201 QALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 201 ~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.+.+|+.+||+.||.+|||+.||++.
T Consensus 304 ~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 304 RLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHHhCcCcccccCHHHHhcC
Confidence 88999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=265.95 Aligned_cols=202 Identities=23% Similarity=0.330 Sum_probs=150.1
Q ss_pred cCCCCCCCccceeeEEEe-------------CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLLHHSNLVNLIGYCAD-------------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
|++++||||+++++++.+ ....++||||+++++|.+++.. ....+++..++.++.|++.||+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~L 132 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYI 132 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHH
Confidence 678899999999999865 4577999999999999999975 244688999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCC------------CCccccccCCcCccCchhhccC-CCC
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK------------SHVSTRVMGTYGYCAPEYAMTG-QLT 135 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~ 135 (325)
|+.+ |+||||||+||+++.++.+||+|||++........ ........||+.|+|||++.+. .++
T Consensus 133 H~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 209 (303)
T 1zy4_A 133 HSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYN 209 (303)
T ss_dssp HHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCC
T ss_pred HhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCc
Confidence 9999 99999999999999999999999999976432110 1122345689999999999864 689
Q ss_pred ccccEEEehHHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCC
Q 020529 136 VKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAA 215 (325)
Q Consensus 136 ~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~ 215 (325)
.++||||||+++|+|++ ||... .........+... ...+...++......+.+|+.+||+.||.
T Consensus 210 ~~~Di~slG~il~~l~~---p~~~~-----~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 273 (303)
T 1zy4_A 210 EKIDMYSLGIIFFEMIY---PFSTG-----MERVNILKKLRSV--------SIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273 (303)
T ss_dssp THHHHHHHHHHHHHHHS---CCSSH-----HHHHHHHHHHHST--------TCCCCTTCCTTTSHHHHHHHHHHTCSSGG
T ss_pred chhhHHHHHHHHHHHHh---ccCCc-----hhHHHHHHhcccc--------ccccCccccccchHHHHHHHHHHHhcCcc
Confidence 99999999999999998 44221 0111111111110 11111222334446688999999999999
Q ss_pred CCCCHHHHHH
Q 020529 216 TRPLIGDVVT 225 (325)
Q Consensus 216 ~RPs~~evl~ 225 (325)
+||++.++++
T Consensus 274 ~Rps~~~ll~ 283 (303)
T 1zy4_A 274 KRPGARTLLN 283 (303)
T ss_dssp GSCCHHHHHH
T ss_pred cCcCHHHHhC
Confidence 9999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=274.98 Aligned_cols=216 Identities=21% Similarity=0.278 Sum_probs=158.3
Q ss_pred cCCCCCCCccceeeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
|++++||||+++++++... ...|+||||+. ++|.+++.. ..+++..++.++.|++.||+|||+.+ |
T Consensus 79 l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---i 149 (364)
T 3qyz_A 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---V 149 (364)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999999764 46899999996 799999965 35999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCC-CCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
+||||||+|||++.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus 150 vH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 229 (364)
T 3qyz_A 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229 (364)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred ecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999976432211 112344579999999998764 45899999999999999999999
Q ss_pred CCCCCCCCCCcchhhh-hhhhcccc----------ccccccccCCccC--CCCChHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 155 KAIDSTRPHGEQNLVT-WARPLFND----------RRKFSKLADPRLE--GRYPIRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~-~~~~~~~~----------~~~~~~~~d~~l~--~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
.||...........+. ........ .........+... ..........+.+|+.+||+.||.+|||+.
T Consensus 230 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 309 (364)
T 3qyz_A 230 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 309 (364)
T ss_dssp CSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 9997654332211110 00000000 0000000000000 000012235688999999999999999999
Q ss_pred HHHHH
Q 020529 222 DVVTA 226 (325)
Q Consensus 222 evl~~ 226 (325)
++++.
T Consensus 310 e~l~h 314 (364)
T 3qyz_A 310 QALAH 314 (364)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=276.37 Aligned_cols=215 Identities=21% Similarity=0.241 Sum_probs=150.9
Q ss_pred cCCCCCCCccceeeEEEe-----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
|++++||||+++++++.. ....|+||||+. ++|.+++.. ....+++..++.++.|++.||.|||+.+ |
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i 155 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---V 155 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---C
Confidence 567899999999999854 336799999997 789888875 3456999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
+||||||+||+++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.
T Consensus 156 vH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 156 VHRDLHPGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EecCCChHHEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 99999999999999999999999999743222 22344568999999999887 678999999999999999999999
Q ss_pred CCCCCCCCCcch-hhhhhhhc-cc-----cccccccccCCccCC-------CCChHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 156 AIDSTRPHGEQN-LVTWARPL-FN-----DRRKFSKLADPRLEG-------RYPIRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 156 p~~~~~~~~~~~-~~~~~~~~-~~-----~~~~~~~~~d~~l~~-------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
||.......... +....... .. ............+.. .........+.+|+.+||+.||.+|||+.
T Consensus 233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 312 (362)
T 3pg1_A 233 LFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312 (362)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 997643221110 00000000 00 000000000000000 00112235688999999999999999999
Q ss_pred HHHHH
Q 020529 222 DVVTA 226 (325)
Q Consensus 222 evl~~ 226 (325)
++++.
T Consensus 313 ell~h 317 (362)
T 3pg1_A 313 QALRH 317 (362)
T ss_dssp HHHTS
T ss_pred HHHcC
Confidence 99863
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=278.99 Aligned_cols=202 Identities=24% Similarity=0.286 Sum_probs=148.3
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|+.+ +|||||++++++.+....|+||||+. ++|.+++... ...+.+..++.++.|++.||.|||+.+ |+|||
T Consensus 71 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrD 143 (432)
T 3p23_A 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRD 143 (432)
T ss_dssp HHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCC
Confidence 4556 89999999999999999999999996 7999999762 233455567899999999999999999 99999
Q ss_pred CCCCcEEEcC-----CCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhc---cCCCCccccEEEehHHHHHHH
Q 020529 81 FKSSNILLEE-----GFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAM---TGQLTVKSDVYSFGVVFLELI 151 (325)
Q Consensus 81 ik~~Nill~~-----~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~ksDvwSlGvvl~ell 151 (325)
|||+|||++. ...+||+|||+++........ .......||+.|+|||++. ...++.++|||||||++|||+
T Consensus 144 lKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ell 223 (432)
T 3p23_A 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVI 223 (432)
T ss_dssp CSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHH
Confidence 9999999943 236889999999865433211 2234567999999999997 456788999999999999999
Q ss_pred h-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 152 T-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 152 t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
+ |..||.......... ... ......+ ..+......+.+|+.+||+.||.+||++.+|++
T Consensus 224 t~g~~pf~~~~~~~~~~-------~~~------~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 224 SEGSHPFGKSLQRQANI-------LLG------ACSLDCL--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSCBTTBSTTTHHHHH-------HTT------CCCCTTS--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCCcchhhHHHHHH-------Hhc------cCCcccc--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 9 899985432211000 000 0000000 011233456789999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-36 Score=275.03 Aligned_cols=209 Identities=23% Similarity=0.318 Sum_probs=144.4
Q ss_pred cCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
|+.++||||+++++++... ...|+|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.+
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g--- 152 (367)
T 2fst_X 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--- 152 (367)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999998654 5679999999 6999998854 45999999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+|||++.++.+||+|||+++.... ......||..|+|||++.+ ..++.++|||||||+++||++|+
T Consensus 153 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 227 (367)
T 2fst_X 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227 (367)
T ss_dssp CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSS
T ss_pred eeeCCCCHhhEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999975322 2344678999999999887 67899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccc-cccccCC-------cc--CCCCC-----hHHHHHHHHHHHHchhhCCCCCCC
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRK-FSKLADP-------RL--EGRYP-----IRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~d~-------~l--~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
.||...........+ ....-..... +..+... .+ ....+ ......+.+|+.+||+.||.+|||
T Consensus 228 ~pf~~~~~~~~l~~i--~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t 305 (367)
T 2fst_X 228 TLFPGTDHIDQLKLI--LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305 (367)
T ss_dssp CSCCCSSHHHHHHHH--HHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCHHHHHHHH--HHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC
Confidence 999765432111100 0000000000 0000000 00 00000 012356889999999999999999
Q ss_pred HHHHHHH
Q 020529 220 IGDVVTA 226 (325)
Q Consensus 220 ~~evl~~ 226 (325)
+.++++.
T Consensus 306 ~~e~L~h 312 (367)
T 2fst_X 306 AAQALAH 312 (367)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999874
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=273.75 Aligned_cols=208 Identities=22% Similarity=0.282 Sum_probs=153.2
Q ss_pred cCCCCCCCccceeeEEEeCCee------EEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~------~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
|+.++||||+++++++...... ++||||+. ++|.+++. ..+++..++.++.+++.||+|||+.+
T Consensus 95 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~--- 164 (371)
T 4exu_A 95 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAG--- 164 (371)
T ss_dssp HHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 5678999999999999877654 99999996 79988873 34999999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+|||++.++.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++++|++|+
T Consensus 165 ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 239 (371)
T 4exu_A 165 VVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239 (371)
T ss_dssp CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CcCCCcCHHHeEECCCCCEEEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999975322 2334568999999999987 68899999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhcccccccc------------ccccCCccCCC---CChHHHHHHHHHHHHchhhCCCCCCC
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKF------------SKLADPRLEGR---YPIRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~d~~l~~~---~~~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
.||........ +.......-.....+ ........... ........+.+|+.+||+.||.+||+
T Consensus 240 ~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 317 (371)
T 4exu_A 240 TLFKGKDYLDQ--LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317 (371)
T ss_dssp CSCCCSSHHHH--HHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC
T ss_pred CCCCCCChHHH--HHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC
Confidence 99976432111 100000000000000 00000000000 01122457889999999999999999
Q ss_pred HHHHHHH
Q 020529 220 IGDVVTA 226 (325)
Q Consensus 220 ~~evl~~ 226 (325)
+.++++.
T Consensus 318 ~~ell~h 324 (371)
T 4exu_A 318 AAQALTH 324 (371)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=270.72 Aligned_cols=210 Identities=20% Similarity=0.289 Sum_probs=154.7
Q ss_pred CCCCccceeeEEEeCC----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEeCC
Q 020529 6 HHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivHrd 80 (325)
.||||+++++++...+ ..++||||+ +++|.+++.... ...+++..++.++.|++.||+|||++ + |+|||
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~D 157 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTD 157 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSC
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecC
Confidence 4999999999997654 789999999 899999997632 34599999999999999999999998 8 99999
Q ss_pred CCCCcEEEc------CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCC
Q 020529 81 FKSSNILLE------EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 81 ik~~Nill~------~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|||+|||++ ..+.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 158 ikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CChHHeEEeccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCC
Confidence 999999994 344899999999976432 123456899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcch----hhhhh-----------------hhccccccccccccCCc---------cCCCCChHHHHHHHH
Q 020529 155 KAIDSTRPHGEQN----LVTWA-----------------RPLFNDRRKFSKLADPR---------LEGRYPIRGLYQALA 204 (325)
Q Consensus 155 ~p~~~~~~~~~~~----~~~~~-----------------~~~~~~~~~~~~~~d~~---------l~~~~~~~~~~~~~~ 204 (325)
.||.......... +.... ...+............. ....++......+.+
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (373)
T 1q8y_A 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312 (373)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHH
Confidence 9998654322111 00000 00000000000000000 011234566788999
Q ss_pred HHHHchhhCCCCCCCHHHHHHH
Q 020529 205 VASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 205 l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|+.+||+.||.+|||+.+|++.
T Consensus 313 li~~~L~~dP~~Rpt~~ell~h 334 (373)
T 1q8y_A 313 FLSPMLQLDPRKRADAGGLVNH 334 (373)
T ss_dssp HHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHHhccCccccCCHHHHhhC
Confidence 9999999999999999999874
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=270.54 Aligned_cols=215 Identities=20% Similarity=0.263 Sum_probs=155.7
Q ss_pred cCCCCCCCccceeeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 2 LSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
|++++||||+++++++... ...++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+ |
T Consensus 63 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---i 133 (353)
T 2b9h_A 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---V 133 (353)
T ss_dssp HHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---e
Confidence 5678999999999998654 67899999996 799999865 35999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCC--------ccccccCCcCccCchhhcc-CCCCccccEEEehHHH
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH--------VSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVF 147 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl 147 (325)
+||||||+||+++.++.+||+|||+++......... ......||+.|+|||++.. ..++.++|||||||++
T Consensus 134 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 213 (353)
T 2b9h_A 134 IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213 (353)
T ss_dssp ECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHH
T ss_pred ecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHH
Confidence 999999999999999999999999998654321111 1223568999999998765 6789999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhh-hhhhh--------ccccc------cccccccCCccCCCCChHHHHHHHHHHHHchhh
Q 020529 148 LELITGRKAIDSTRPHGEQNLV-TWARP--------LFNDR------RKFSKLADPRLEGRYPIRGLYQALAVASMCIQE 212 (325)
Q Consensus 148 ~elltg~~p~~~~~~~~~~~~~-~~~~~--------~~~~~------~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~ 212 (325)
++|++|+.||............ ..... ..... ..+.......+. .........+.+|+.+||+.
T Consensus 214 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~ 292 (353)
T 2b9h_A 214 AELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE-KMFPRVNPKGIDLLQRMLVF 292 (353)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHH-HHSTTSCHHHHHHHHHHSCS
T ss_pred HHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchh-hhcccCCHHHHHHHHHhcCc
Confidence 9999999999765321110000 00000 00000 000000000000 00012245678999999999
Q ss_pred CCCCCCCHHHHHHH
Q 020529 213 QAATRPLIGDVVTA 226 (325)
Q Consensus 213 ~p~~RPs~~evl~~ 226 (325)
||.+||++.++++.
T Consensus 293 dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 293 DPAKRITAKEALEH 306 (353)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred CcccCCCHHHHhcC
Confidence 99999999999873
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-35 Score=266.84 Aligned_cols=209 Identities=15% Similarity=0.179 Sum_probs=154.5
Q ss_pred CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcE
Q 020529 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNI 86 (325)
Q Consensus 7 Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Ni 86 (325)
|++++.+++++...+..++||||+ +++|.+++... ....+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NI 154 (355)
T 2eu9_A 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENI 154 (355)
T ss_dssp CSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGE
T ss_pred ceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHE
Confidence 344999999999999999999999 57777777652 2346999999999999999999999999 99999999999
Q ss_pred EE-------------------cCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHH
Q 020529 87 LL-------------------EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVF 147 (325)
Q Consensus 87 ll-------------------~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl 147 (325)
|+ +.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++
T Consensus 155 ll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 229 (355)
T 2eu9_A 155 LFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCIL 229 (355)
T ss_dssp EESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred EEecccccccccccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHH
Confidence 99 6678999999999975322 22345799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCCcchhhhhhhhcccc--------cc-----------------ccccccCC-ccCCCCChHHHHH
Q 020529 148 LELITGRKAIDSTRPHGEQNLVTWARPLFND--------RR-----------------KFSKLADP-RLEGRYPIRGLYQ 201 (325)
Q Consensus 148 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~-----------------~~~~~~d~-~l~~~~~~~~~~~ 201 (325)
|||++|..||..................... .. .......+ .............
T Consensus 230 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence 9999999999764322111110000000000 00 00000000 0000111234567
Q ss_pred HHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 202 ALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 202 ~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
+.+|+.+||+.||.+|||+.+|++.
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHHHhcCChhhCcCHHHHhcC
Confidence 8899999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=261.12 Aligned_cols=200 Identities=23% Similarity=0.279 Sum_probs=157.5
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++++++.+....++||||+++++|.+++.. ...+++..++.++.+++.||.|||+.+ |+||||
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl 147 (287)
T 2wei_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDL 147 (287)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCC
Confidence 5688999999999999999999999999999999998865 346999999999999999999999999 999999
Q ss_pred CCCcEEEcCC---CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 82 KSSNILLEEG---FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 82 k~~Nill~~~---~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
||+||+++.+ +.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++++|++|..||.
T Consensus 148 ~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp CGGGEEESCSSTTCCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ChhhEEEecCCCcccEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCC
Confidence 9999999654 479999999997543322 2233458899999998865 48999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...... +. ..+..... . .+.... ......+.+++.+||+.+|.+||++.++++.
T Consensus 224 ~~~~~~---~~---~~~~~~~~---~-~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 224 GKNEYD---IL---KRVETGKY---A-FDLPQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CSSHHH---HH---HHHHHCCC---C-CCSGGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred CCCHHH---HH---HHHHcCCC---C-CCchhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 643211 11 11110000 0 000000 1223568899999999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=265.80 Aligned_cols=216 Identities=19% Similarity=0.302 Sum_probs=155.0
Q ss_pred cCCCCCCCccceeeEEE--------------eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 020529 2 LSLLHHSNLVNLIGYCA--------------DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEY 67 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~--------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~ 67 (325)
|++++||||+++++++. +....++||||+. ++|.+++.. ..+++..++.++.|++.||+|
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~ 135 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKY 135 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHH
Confidence 57889999999999873 3468899999997 799999953 468999999999999999999
Q ss_pred HhcCCCCCeEeCCCCCCcEEEc-CCCeEEEecCCCCccCCCCCC-CCccccccCCcCccCchhhcc-CCCCccccEEEeh
Q 020529 68 LHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFG 144 (325)
Q Consensus 68 LH~~~~~~ivHrdik~~Nill~-~~~~~kL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlG 144 (325)
||+.+ |+||||||+||+++ .++.+||+|||+++....... ........+|..|+|||++.. ..++.++||||||
T Consensus 136 lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 212 (320)
T 2i6l_A 136 IHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212 (320)
T ss_dssp HHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHH
T ss_pred HHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHH
Confidence 99999 99999999999997 567999999999986432211 112234557999999998876 6789999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcchhhhhhhhccccc--cccc---------cccCCcc-CCCCChHHHHHHHHHHHHchhh
Q 020529 145 VVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR--RKFS---------KLADPRL-EGRYPIRGLYQALAVASMCIQE 212 (325)
Q Consensus 145 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~---------~~~d~~l-~~~~~~~~~~~~~~l~~~cl~~ 212 (325)
+++|||++|+.||................+..... ..+. ....+.. ...........+.+|+.+||+.
T Consensus 213 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 292 (320)
T 2i6l_A 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTF 292 (320)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCS
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCC
Confidence 99999999999997654321111000000000000 0000 0000000 0000112346788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 020529 213 QAATRPLIGDVVTA 226 (325)
Q Consensus 213 ~p~~RPs~~evl~~ 226 (325)
||.+||++.++++.
T Consensus 293 dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 293 SPMDRLTAEEALSH 306 (320)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred CccccCCHHHHhCC
Confidence 99999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=264.62 Aligned_cols=201 Identities=23% Similarity=0.308 Sum_probs=148.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEeCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivHrd 80 (325)
++.++||||+++++++.+.+..++||||+ ++.+..++.. ....+++..++.++.+++.||.|||++ + |+|||
T Consensus 78 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~d 150 (318)
T 2dyl_A 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRD 150 (318)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCC
T ss_pred HHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCC
Confidence 45679999999999999999999999999 5677666643 245689999999999999999999995 8 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHHHHhCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||+||+++.++.+||+|||++...... .......||+.|+|||++. ...++.++||||||+++|+|++|+.
T Consensus 151 lkp~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 227 (318)
T 2dyl_A 151 VKPSNILLDERGQIKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQF 227 (318)
T ss_dssp CCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEECCCCCEEEEECCCchhccCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCC
Confidence 9999999999999999999998754322 1233456899999999984 4568899999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
||....... .. ........ . +.+. ........+.+|+.+||+.||.+||++.+|++.
T Consensus 228 pf~~~~~~~--~~---~~~~~~~~---~----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 228 PYKNCKTDF--EV---LTKVLQEE---P----PLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp TTTTCCSHH--HH---HHHHHHSC---C----CCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred CCCCCCccH--HH---HHHHhccC---C----CCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 997542211 11 11111110 0 0000 001123568899999999999999999999874
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=267.27 Aligned_cols=209 Identities=21% Similarity=0.313 Sum_probs=153.4
Q ss_pred cCCCCCCCccceeeEEEeCCe------eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQ------RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~------~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
|++++||||+++++++..... .|+||||+. ++|.+++. ..+++..++.++.|++.||.|||+.+
T Consensus 77 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~--- 146 (353)
T 3coi_A 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAG--- 146 (353)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 567899999999999987654 499999997 78888773 24999999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+||+++.++.+||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++++|++|+
T Consensus 147 ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 221 (353)
T 3coi_A 147 VVHRDLKPGNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221 (353)
T ss_dssp CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cccCCCCHHHEeECCCCcEEEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999975322 1334568999999999887 67899999999999999999999
Q ss_pred CCCCCCCCCCcchhh-h--------hhhhccccc-----cccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 155 KAIDSTRPHGEQNLV-T--------WARPLFNDR-----RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~-~--------~~~~~~~~~-----~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
.||............ . |........ ..+.....+.+ ..........+.+|+.+||+.||.+||++
T Consensus 222 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~ 300 (353)
T 3coi_A 222 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTA 300 (353)
T ss_dssp CSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCH
Confidence 999765422110000 0 000000000 00000000011 01112335678899999999999999999
Q ss_pred HHHHHH
Q 020529 221 GDVVTA 226 (325)
Q Consensus 221 ~evl~~ 226 (325)
.++++.
T Consensus 301 ~e~l~h 306 (353)
T 3coi_A 301 AQALTH 306 (353)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=268.01 Aligned_cols=144 Identities=23% Similarity=0.265 Sum_probs=125.5
Q ss_pred CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc--CCCCCeEeCCCCCC
Q 020529 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD--KANPPVIYRDFKSS 84 (325)
Q Consensus 7 Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~--~~~~~ivHrdik~~ 84 (325)
|+||+++++++...+..|+||||+. ++|.+++.... ...+++..+..++.|++.||.|||. .+ |+||||||+
T Consensus 115 ~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~ 188 (382)
T 2vx3_A 115 KYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPE 188 (382)
T ss_dssp GGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGG
T ss_pred ceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcc
Confidence 4469999999999999999999996 69999997632 2459999999999999999999995 56 999999999
Q ss_pred cEEEc--CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 85 NILLE--EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 85 Nill~--~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
|||++ .++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 189 NIll~~~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 189 NILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp GEEESSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cEEEecCCCCcEEEEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99994 477899999999976432 2234578999999999999999999999999999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-35 Score=265.34 Aligned_cols=186 Identities=20% Similarity=0.310 Sum_probs=153.7
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMPL-GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
.||||+++++++.+.+..++|||++.+ ++|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~ 178 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDE 178 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHH
Confidence 369999999999999999999999975 899999975 456999999999999999999999999 999999999
Q ss_pred cEEEc-CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCCCCCC
Q 020529 85 NILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRP 162 (325)
Q Consensus 85 Nill~-~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~~~~~ 162 (325)
|||++ .++.+||+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 179 NIll~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~- 253 (320)
T 3a99_A 179 NILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE- 253 (320)
T ss_dssp GEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred HEEEeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-
Confidence 99999 7889999999999764322 2334569999999999987776 788999999999999999999986421
Q ss_pred CCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 163 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.. .... .. + +......+.+|+.+||+.+|.+||++.+|++.
T Consensus 254 ----~~-------~~~~----~~----~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 ----EI-------IRGQ----VF----F----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----HH-------HHCC----CC----C----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----hh-------hccc----cc----c----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0000 00 1 11223568899999999999999999999874
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=263.30 Aligned_cols=186 Identities=22% Similarity=0.381 Sum_probs=150.3
Q ss_pred CCCCccceeeEEEeCCeeEEEEec-CCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEF-MPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
+||||+++++++.+.+..++|||| +.+++|.+++.. ...+++..++.++.+++.||.|||+.+ |+||||||+
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~ 168 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDE 168 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGG
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChh
Confidence 899999999999999999999999 789999999976 446999999999999999999999999 999999999
Q ss_pred cEEEc-CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCC-ccccEEEehHHHHHHHhCCCCCCCCCC
Q 020529 85 NILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLT-VKSDVYSFGVVFLELITGRKAIDSTRP 162 (325)
Q Consensus 85 Nill~-~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDvwSlGvvl~elltg~~p~~~~~~ 162 (325)
||+++ .++.+||+|||++...... ......||..|+|||++.+..+. .++||||||+++|+|++|+.||....
T Consensus 169 Nil~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~- 243 (312)
T 2iwi_A 169 NILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ- 243 (312)
T ss_dssp GEEEETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred hEEEeCCCCeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-
Confidence 99999 8899999999999764332 23345689999999999877664 58999999999999999999986421
Q ss_pred CCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 163 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
.. ..... .++......+.+|+.+||+.+|.+||++.++++.
T Consensus 244 ----~~-------~~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ----EI-------LEAEL------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----HH-------HHTCC------------CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----HH-------hhhcc------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00000 1112233567899999999999999999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=281.91 Aligned_cols=189 Identities=22% Similarity=0.304 Sum_probs=150.0
Q ss_pred CcCCCCCCCccceeeEEEeCCe-----eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQ-----RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
+|++++||||++++++|...+. .||||||+++++|.+++.. .+++..++.|+.||+.||.|||+++
T Consensus 132 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g--- 202 (681)
T 2pzi_A 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG--- 202 (681)
T ss_dssp GGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4678999999999999987665 6999999999999887642 6999999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|+||||||+|||++.+ .+||+|||+++..... ....||+.|+|||++.+.. +.++|||||||++++|++|..
T Consensus 203 iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~ 274 (681)
T 2pzi_A 203 LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLP 274 (681)
T ss_dssp EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCC
T ss_pred CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCC
Confidence 9999999999999986 8999999999764322 3456999999999987764 899999999999999999988
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-HHHHHHHHHhh
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-IGDVVTALSYL 230 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-~~evl~~L~~~ 230 (325)
||........ . . ..........+.+|+.+||+.||.+||+ +.++...|..+
T Consensus 275 ~~~~~~~~~~-----------------~---~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 275 TRNGRYVDGL-----------------P---E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp EETTEECSSC-----------------C---T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCcccccccc-----------------c---c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 8764211100 0 0 0000112346789999999999999996 66666666544
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=276.17 Aligned_cols=218 Identities=24% Similarity=0.290 Sum_probs=162.8
Q ss_pred cCCCCCCCccceeeEEEe------CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 2 LSLLHHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
|++++||||+++++++.. .+..++||||+++++|.+++..... ...+++..++.|+.+++.||+|||+.+
T Consensus 66 L~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~-~~~lse~~i~~I~~QLl~aL~yLHs~g--- 141 (676)
T 3qa8_A 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISSALRYLHENR--- 141 (676)
T ss_dssp HHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSC-TTCCCSSHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 567899999999998765 6778999999999999999976332 335899999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCe---EEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh
Q 020529 76 VIYRDFKSSNILLEEGFH---PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~---~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt 152 (325)
|+||||||+||+++.++. +||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++
T Consensus 142 IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt 218 (676)
T 3qa8_A 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218 (676)
T ss_dssp BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS
T ss_pred CccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 999999999999987664 9999999998643322 2344679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhhhhhhhcccccccccccc----------CC--ccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 153 GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLA----------DP--RLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------d~--~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
|..||..... ...|.......... .... .. .....+.......+.+|+..||..||.+||++
T Consensus 219 G~~Pf~~~~~-----~~~~~~~i~~~~~~-~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa 292 (676)
T 3qa8_A 219 GFRPFLPNWQ-----PVQWHGKVREKSNE-HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTD 292 (676)
T ss_dssp SCSSCCSSCH-----HHHSSTTCC-------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CC
T ss_pred CCCCCCcccc-----hhhhhhhhhcccch-hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCH
Confidence 9999965321 11221111110000 0000 00 11122344567889999999999999999999
Q ss_pred HH-----HHHHHHhhhc
Q 020529 221 GD-----VVTALSYLAN 232 (325)
Q Consensus 221 ~e-----vl~~L~~~~~ 232 (325)
.+ ..+.+..+..
T Consensus 293 ~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 293 PQNPNVGCFQALDSILS 309 (676)
T ss_dssp TTCCCCTTHHHHHHHHC
T ss_pred HHHhcCHHHHHHHHHHh
Confidence 87 4455555554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.98 E-value=1.1e-32 Score=245.74 Aligned_cols=183 Identities=13% Similarity=0.090 Sum_probs=141.7
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++||||+++++++.+.+..|+||||+++++|.+++.. . .....+.+|+.|++.||+|||+++ |+||||
T Consensus 85 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Di 155 (286)
T 3uqc_A 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSID 155 (286)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCC
T ss_pred HhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCC
Confidence 5678999999999999999999999999999999999953 2 355678999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+|||++.++.+||++++ |++ .++.++|||||||++|||++|+.||....
T Consensus 156 kp~NIll~~~g~~kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~ 206 (286)
T 3uqc_A 156 HPSRVRVSIDGDVVLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAG 206 (286)
T ss_dssp SGGGEEEETTSCEEECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCS
T ss_pred CcccEEEcCCCCEEEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 9999999999999998543 333 26899999999999999999999998754
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhccC
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~~ 234 (325)
........ ............ .+. ......+.+|+.+||+.||.+| |+.++++.|..+....
T Consensus 207 ~~~~~~~~---~~~~~~~~~~~~----~~~----~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 207 VRSGLAPA---ERDTAGQPIEPA----DID----RDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp BCCCSEEC---CBCTTSCBCCHH----HHC----TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred cchhhHHH---HHHhccCCCChh----hcc----cCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 43211000 000000000000 011 1223568899999999999999 9999999999887543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=245.63 Aligned_cols=182 Identities=19% Similarity=0.277 Sum_probs=140.8
Q ss_pred CCCCCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 3 SLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
+.++||||+++++++.. ....++||||+++++|.+++... ....+++..++.++.|++.||+|||+.+ |+|
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H 140 (299)
T 3m2w_A 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAH 140 (299)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 45699999999999987 67889999999999999999862 2346999999999999999999999999 999
Q ss_pred CCCCCCcEEEcC---CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 79 RDFKSSNILLEE---GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 79 rdik~~Nill~~---~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||||+||+++. ++.+||+|||++.... +..++.++|||||||++|||++|+.
T Consensus 141 ~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~ 196 (299)
T 3m2w_A 141 RDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYP 196 (299)
T ss_dssp CCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCC
Confidence 999999999998 7889999999986421 2346789999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCC----hHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYP----IRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~----~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||........... .. ........ ..+ ......+.+|+.+||+.||.+||++.++++.-
T Consensus 197 pf~~~~~~~~~~~---~~---------~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 197 PFYSNHGLAISPG---MK---------TRIRMGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp SCCC-------CC---SC---------CSSCTTCC--SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred CCCCCcchhhhHH---HH---------HHHhhccc--cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 9965432211000 00 00000000 011 12245788999999999999999999999853
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=252.99 Aligned_cols=172 Identities=15% Similarity=0.193 Sum_probs=134.5
Q ss_pred eeEEEEecCCCCCHHHHhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEec
Q 020529 22 QRLLVYEFMPLGSLEDHLHDL---PPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSD 98 (325)
Q Consensus 22 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~D 98 (325)
..+++|+++ +++|.+++... ......+++..++.|+.|++.||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~D 254 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECC
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEe
Confidence 457788877 69999998522 123456889999999999999999999999 99999999999999999999999
Q ss_pred CCCCccCCCCCCCCccccccCCcCccCchhh----------ccCCCCccccEEEehHHHHHHHhCCCCCCCCCCCCcchh
Q 020529 99 FGLAKLGPVGDKSHVSTRVMGTYGYCAPEYA----------MTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL 168 (325)
Q Consensus 99 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~~~~~~~ 168 (325)
||+++.... ......| +.|+|||++ ....++.++|||||||++|||++|+.||.........
T Consensus 255 FG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~-- 326 (413)
T 3dzo_A 255 FEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS-- 326 (413)
T ss_dssp GGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS--
T ss_pred ccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH--
Confidence 999875321 1344567 999999999 5556888999999999999999999999765322111
Q ss_pred hhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 169 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...+.. . ..+ ...+.+|+.+||+.+|.+||++.++++
T Consensus 327 ----~~~~~~----------~--~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 327 ----EWIFRS----------C--KNI----PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp ----GGGGSS----------C--CCC----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----HHHHhh----------c--ccC----CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 111110 0 012 256889999999999999999887754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-31 Score=243.88 Aligned_cols=174 Identities=14% Similarity=0.057 Sum_probs=129.1
Q ss_pred CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCCCCeEeCCCCCCcEEEcCCC------
Q 020529 20 GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH-DKANPPVIYRDFKSSNILLEEGF------ 92 (325)
Q Consensus 20 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH-~~~~~~ivHrdik~~Nill~~~~------ 92 (325)
....|+||||+++|++.+.+.. ..+++..++.|+.||+.||+||| +.+ |+||||||+||||+.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~ 205 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHY 205 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEE
T ss_pred cCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceee
Confidence 6789999999999977666632 45899999999999999999999 899 99999999999999887
Q ss_pred --------------eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHH-HHHHHhCCCCC
Q 020529 93 --------------HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV-FLELITGRKAI 157 (325)
Q Consensus 93 --------------~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvv-l~elltg~~p~ 157 (325)
.+||+|||+++.... ....||+.|+|||++.+.. +.++|||||+++ .+++++|..||
T Consensus 206 ~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 206 TLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp EETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred eccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCC
Confidence 899999999986432 2347999999999998766 899999998777 77788888887
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 224 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl 224 (325)
... .|.......... ...................+.+|+.+||+.+ |+.|++
T Consensus 278 ~~~---------~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 278 SNV---------LWLHYLTDKMLK-QMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHH---------HHHHHHHHHHHH-TCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred cch---------hhhhHHHHhhhh-hhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 321 111110000000 0000111111112345678999999999976 899988
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.9e-31 Score=255.40 Aligned_cols=143 Identities=19% Similarity=0.177 Sum_probs=107.2
Q ss_pred CcCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|+++ +|+||++++++++++...||||||++|++|.++|.. ..+++.. +|+.||+.||+|||++| ||||
T Consensus 294 ~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHR 363 (569)
T 4azs_A 294 FLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHD 363 (569)
T ss_dssp HHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEES
T ss_pred HHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceec
Confidence 36677 799999999999999999999999999999999976 4557664 47899999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
||||+||||+.++.+||+|||+++..... ........||++|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 364 DIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 364 DVRPWNVMVDARQHARLIDFGSIVTTPQD--CSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cCchHhEEECCCCCEEEeecccCeeCCCC--CccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 99999999999999999999999864332 223445679999999999875 467789999999998887666443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-24 Score=208.14 Aligned_cols=139 Identities=18% Similarity=0.230 Sum_probs=116.9
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++||||+++..++...+..||||||+++++|.+++.. ++.++.|++.||.|||+++ |+||||
T Consensus 393 l~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDi 457 (540)
T 3en9_A 393 LALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDL 457 (540)
T ss_dssp HHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTC
T ss_pred HHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCC
Confidence 5678999999777777788888999999999999999964 4689999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCC-----ccccccCCcCccCchhhcc--CCCCccccEEEehHHHHHHHhCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-----VSTRVMGTYGYCAPEYAMT--GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~ksDvwSlGvvl~elltg~ 154 (325)
||+|||++. .+||+|||+++......... ......||+.|+|||++.. ..|+..+|+|+..+-.++-+-++
T Consensus 458 Kp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r 535 (540)
T 3en9_A 458 TTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERR 535 (540)
T ss_dssp CTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTC
T ss_pred CHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhc
Confidence 999999998 99999999998653321111 1235679999999999987 56788899999998888887776
Q ss_pred CCC
Q 020529 155 KAI 157 (325)
Q Consensus 155 ~p~ 157 (325)
.++
T Consensus 536 ~rY 538 (540)
T 3en9_A 536 ARY 538 (540)
T ss_dssp SCC
T ss_pred ccc
Confidence 554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=6e-18 Score=150.01 Aligned_cols=96 Identities=11% Similarity=0.043 Sum_probs=76.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++ | +++.+++.. +..|+||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||
T Consensus 158 l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDl 219 (282)
T 1zar_A 158 LQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDL 219 (282)
T ss_dssp HHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCC
Confidence 34555 5 666665544 45699999999999988 421 123579999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT 131 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 131 (325)
||+|||++ ++.+||+|||+++. +..+.|||++..
T Consensus 220 kp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 220 SQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp STTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 99999999 99999999999863 344788998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=2.7e-14 Score=124.75 Aligned_cols=87 Identities=17% Similarity=0.198 Sum_probs=67.0
Q ss_pred cCCCCCCCc--cceeeEEEeCCeeEEEEecCCC-C----CHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-cCCC
Q 020529 2 LSLLHHSNL--VNLIGYCADGDQRLLVYEFMPL-G----SLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLH-DKAN 73 (325)
Q Consensus 2 L~~l~Hpni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH-~~~~ 73 (325)
|++++|+++ +.++++ ...+|||||+.+ | +|.++... .++..+..++.+++.||.||| +.+
T Consensus 124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g- 191 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE- 191 (258)
T ss_dssp HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC-
T ss_pred HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC-
Confidence 345667654 333332 356899999942 3 77776533 234567889999999999999 999
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
|+||||||+|||++. .++|+|||++..
T Consensus 192 --ivHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 192 --LVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp --EECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred --EEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999999998 899999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.12 E-value=7e-12 Score=114.86 Aligned_cols=68 Identities=18% Similarity=0.159 Sum_probs=56.0
Q ss_pred eEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCC----------
Q 020529 23 RLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGF---------- 92 (325)
Q Consensus 23 ~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~---------- 92 (325)
.+|||||++|++|.++... .....++.|++.+|.+||+.+ ||||||||.|||+++++
T Consensus 186 ~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd~~d~~~~~~ 252 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKDAEDPSSITL 252 (397)
T ss_dssp TEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEECSSCTTSEEE
T ss_pred ceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCCccccccccc
Confidence 3799999998888665421 123568899999999999999 99999999999998776
Q ss_pred eEEEecCCCCc
Q 020529 93 HPKLSDFGLAK 103 (325)
Q Consensus 93 ~~kL~Dfgla~ 103 (325)
.+.|+||+-+-
T Consensus 253 ~~~iID~~Q~V 263 (397)
T 4gyi_A 253 TPIIIXFPQMV 263 (397)
T ss_dssp EEEECCCTTCE
T ss_pred ceEEEEeCCcc
Confidence 38999998663
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.83 E-value=6.1e-09 Score=90.48 Aligned_cols=88 Identities=15% Similarity=0.111 Sum_probs=70.4
Q ss_pred CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--------------
Q 020529 7 HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA-------------- 72 (325)
Q Consensus 7 Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~-------------- 72 (325)
|.++.++++++.+.+..|+||||++|.+|.+.+.. ......++.+++.+|+.||+..
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~ 139 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRL 139 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHH
Confidence 67788999999998999999999999999876421 1123468889999999999811
Q ss_pred ------------------------------------------CCCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 73 ------------------------------------------NPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 73 ------------------------------------------~~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
.+.++|+|+++.||+++.+..+.|+||+.+.
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 140 AELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1349999999999999876566799998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.64 E-value=5.9e-08 Score=88.31 Aligned_cols=92 Identities=15% Similarity=0.256 Sum_probs=73.1
Q ss_pred CCCccceeeEEEeC---CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------
Q 020529 7 HSNLVNLIGYCADG---DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA----------- 72 (325)
Q Consensus 7 Hpniv~l~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~----------- 72 (325)
+..+++++.++.+. +..|+||||++|..+.+.. ...++...+..++.+++.+|+.||...
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~ 170 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGK 170 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSC
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCC
Confidence 45688888888776 4589999999987774321 223788889999999999999999731
Q ss_pred --------------------------------------------CCCeEeCCCCCCcEEEcCCC--eEEEecCCCCcc
Q 020529 73 --------------------------------------------NPPVIYRDFKSSNILLEEGF--HPKLSDFGLAKL 104 (325)
Q Consensus 73 --------------------------------------------~~~ivHrdik~~Nill~~~~--~~kL~Dfgla~~ 104 (325)
.+.++|+|+++.||+++.++ .+.|+||+.+..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 171 PGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 24599999999999998775 368999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.63 E-value=2.4e-08 Score=86.13 Aligned_cols=82 Identities=18% Similarity=0.172 Sum_probs=62.6
Q ss_pred ccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------
Q 020529 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA----------------- 72 (325)
Q Consensus 10 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~----------------- 72 (325)
+.++++++..++..++||||++|.+|. ... .+ ...++.+++..|..||...
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~ 144 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERA 144 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHH
Confidence 556888888878889999999988884 321 12 2356778888888888643
Q ss_pred --------------------------------------CCCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 73 --------------------------------------NPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 73 --------------------------------------~~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
...++|+|++|.||+++.+..+.|+||+.+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 145 RTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1229999999999999877667799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.53 E-value=9.5e-09 Score=91.44 Aligned_cols=128 Identities=20% Similarity=0.194 Sum_probs=83.7
Q ss_pred eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------------------
Q 020529 22 QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA----------------------------- 72 (325)
Q Consensus 22 ~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~----------------------------- 72 (325)
..|+||++++|.+|..... ..++...+..++.+++..|+.||...
T Consensus 90 ~~~~vm~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (304)
T 3sg8_A 90 MSFAGFTKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR 163 (304)
T ss_dssp CSCEEEECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred cceEEEcccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence 3489999999988875332 23677888888899999998888611
Q ss_pred --------------------------CCCeEeCCCCCCcEEEcC--CCeEEEecCCCCccCCCCCCCCc-----------
Q 020529 73 --------------------------NPPVIYRDFKSSNILLEE--GFHPKLSDFGLAKLGPVGDKSHV----------- 113 (325)
Q Consensus 73 --------------------------~~~ivHrdik~~Nill~~--~~~~kL~Dfgla~~~~~~~~~~~----------- 113 (325)
.+.++|+|+++.||+++. +..+.|+||+.+...........
T Consensus 164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~ 243 (304)
T 3sg8_A 164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGME 243 (304)
T ss_dssp TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHH
T ss_pred cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHH
Confidence 134899999999999998 45678999999875322100000
Q ss_pred -cccccCCcCccC-chhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 114 -STRVMGTYGYCA-PEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 114 -~~~~~gt~~y~a-PE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
...+...+++.. |+..... ....+.|+++.+++.+.+|..+|
T Consensus 244 ~~~~~l~~Y~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 244 FVSKILNHYKHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHTCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHcCCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 000111111222 2322111 22357899999999999998765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=1.9e-05 Score=68.45 Aligned_cols=86 Identities=21% Similarity=0.200 Sum_probs=62.8
Q ss_pred ccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------
Q 020529 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA----------------- 72 (325)
Q Consensus 10 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~----------------- 72 (325)
+.++++++.+.+..++|||+++|.++.+.... .......++.+++..|+.||...
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~ 153 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQA 153 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhH
Confidence 67788999999999999999998888766532 11122345555666666666311
Q ss_pred --------------------------------------CCCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 73 --------------------------------------NPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 73 --------------------------------------~~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
.+.++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 154 QSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1238999999999999987777899999875
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=8.2e-05 Score=65.97 Aligned_cols=89 Identities=16% Similarity=0.147 Sum_probs=61.4
Q ss_pred ccceeeEEE-eCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC----------------
Q 020529 10 LVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA---------------- 72 (325)
Q Consensus 10 iv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~---------------- 72 (325)
+.+.+.++. ..+..++||+|++|..|....- ..++...+..++.+++..|+.||...
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~ 147 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKN 147 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHH
Confidence 556666664 3456789999999988876321 12455566666666666666666422
Q ss_pred -----------------------------------------CCCeEeCCCCCCcEEEcC---CCe-EEEecCCCCcc
Q 020529 73 -----------------------------------------NPPVIYRDFKSSNILLEE---GFH-PKLSDFGLAKL 104 (325)
Q Consensus 73 -----------------------------------------~~~ivHrdik~~Nill~~---~~~-~kL~Dfgla~~ 104 (325)
.+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 148 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 148 KILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 234799999999999987 344 58999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00011 Score=66.42 Aligned_cols=30 Identities=17% Similarity=0.341 Sum_probs=25.5
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
+.++|+|+.+.||+++++..+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence 459999999999999965457899999875
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.24 E-value=0.00054 Score=57.09 Aligned_cols=100 Identities=14% Similarity=0.083 Sum_probs=66.7
Q ss_pred CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCC
Q 020529 33 GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 112 (325)
Q Consensus 33 gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~ 112 (325)
-||.++|.. ...++++.++|.++.|.+.+|.-+-....+ ..+=+.|..|+|..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc---------
Confidence 379999987 567899999999999999998876221111 1333557899999999988864 1110
Q ss_pred ccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhC
Q 020529 113 VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 113 ~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg 153 (325)
.....+.|||... ...+.+.-|||||++||.-+--
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 0122356888653 3456788899999999988764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.21 E-value=0.0068 Score=53.78 Aligned_cols=30 Identities=23% Similarity=0.319 Sum_probs=26.8
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
..+||+|+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 449999999999999888889999999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.19 E-value=0.01 Score=52.63 Aligned_cols=92 Identities=13% Similarity=0.186 Sum_probs=56.0
Q ss_pred CCccceeeEEEeCCeeEEEEecCCCCCHH-----------HHhccCCC-C-----------------CCCCCHHHHH---
Q 020529 8 SNLVNLIGYCADGDQRLLVYEFMPLGSLE-----------DHLHDLPP-D-----------------KEALDWNTRM--- 55 (325)
Q Consensus 8 pniv~l~~~~~~~~~~~lv~e~~~~gsL~-----------~~l~~~~~-~-----------------~~~l~~~~~~--- 55 (325)
..++++++++...+..++||||+++..+. ..||.... . ...-+|....
T Consensus 91 v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~ 170 (312)
T 3jr1_A 91 INVPLVYGIGNSQGHSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSEN 170 (312)
T ss_dssp SBCCCEEEEEECSSEEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHH
T ss_pred CCcceEEEEeecCCceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHH
Confidence 45778888888888899999999987542 12343221 0 0012454321
Q ss_pred HHH----------------HHHHHHH-HHHhc-CCCCCeEeCCCCCCcEEEcCCCeEEEecCC
Q 020529 56 KIA----------------AGAAKGL-EYLHD-KANPPVIYRDFKSSNILLEEGFHPKLSDFG 100 (325)
Q Consensus 56 ~i~----------------~~l~~al-~~LH~-~~~~~ivHrdik~~Nill~~~~~~kL~Dfg 100 (325)
++. ..++.-+ ..|.. ...+.+||+|+.+.||+++.++ +.|+|+.
T Consensus 171 Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 171 RIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp THHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 111 1122222 23432 2246699999999999999887 8899974
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.46 E-value=0.039 Score=48.16 Aligned_cols=30 Identities=17% Similarity=0.142 Sum_probs=25.2
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 44899999999999 5566789999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.12 E-value=0.021 Score=52.63 Aligned_cols=29 Identities=10% Similarity=0.244 Sum_probs=26.0
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
.++|+|+++.||+++.++ +.|+||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 399999999999998876 99999998864
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=94.28 E-value=0.057 Score=47.79 Aligned_cols=32 Identities=34% Similarity=0.409 Sum_probs=27.3
Q ss_pred CCeEeCCCCCCcEEEcCC----CeEEEecCCCCccC
Q 020529 74 PPVIYRDFKSSNILLEEG----FHPKLSDFGLAKLG 105 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~----~~~kL~Dfgla~~~ 105 (325)
..++|+|+.+.||+++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 459999999999999874 67899999988653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.57 E-value=0.08 Score=46.59 Aligned_cols=29 Identities=24% Similarity=0.252 Sum_probs=25.0
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 3489999999999999 4 899999988754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.75 E-value=0.048 Score=47.94 Aligned_cols=43 Identities=23% Similarity=0.247 Sum_probs=30.9
Q ss_pred HHHHHHHHhcC----CCCCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 61 AAKGLEYLHDK----ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 61 l~~al~~LH~~----~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
+...+..|.+. ....+||+|+.+.||+++.+..+.|+||+.+.
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 34445555431 12349999999999999887666899998774
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=92.36 E-value=0.11 Score=46.32 Aligned_cols=31 Identities=16% Similarity=0.151 Sum_probs=27.3
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.64 E-value=0.39 Score=39.73 Aligned_cols=83 Identities=10% Similarity=0.131 Sum_probs=60.0
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCC-CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCCCC
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMP-LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSS 84 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik~~ 84 (325)
.||+.++. ..-.+.+...+.++.-+ +-++.. +. .++...+++++.+|+....+++.. +|--|.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecc
Confidence 68888876 45555666555555443 223333 33 278899999999999988555433 68889999
Q ss_pred cEEEcCCCeEEEecCCCC
Q 020529 85 NILLEEGFHPKLSDFGLA 102 (325)
Q Consensus 85 Nill~~~~~~kL~Dfgla 102 (325)
||+++.++.+++.=.|+-
T Consensus 109 NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp GEEECTTSCEEESCCEET
T ss_pred eEEEcCCCCEEEEEccCc
Confidence 999999999999866653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=91.59 E-value=0.17 Score=47.17 Aligned_cols=16 Identities=31% Similarity=0.177 Sum_probs=14.6
Q ss_pred CCeEeCCCCCCcEEEc
Q 020529 74 PPVIYRDFKSSNILLE 89 (325)
Q Consensus 74 ~~ivHrdik~~Nill~ 89 (325)
..++|+|+.+.|||++
T Consensus 290 ~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 290 IVLCHCDLLSSNIINT 305 (458)
T ss_dssp EEEECSCCCGGGEEEC
T ss_pred eeEEecCCCCCcEEee
Confidence 3599999999999998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=91.02 E-value=0.11 Score=46.67 Aligned_cols=29 Identities=21% Similarity=0.255 Sum_probs=24.1
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
..++|+|+.+.||+++.+. +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 3499999999999998655 8999998774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.96 E-value=0.85 Score=37.80 Aligned_cols=82 Identities=9% Similarity=0.092 Sum_probs=57.9
Q ss_pred CCCCccceeeEEEeCCeeEEEEecCC-CCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHhcCCCCCeEeCCCCC
Q 020529 6 HHSNLVNLIGYCADGDQRLLVYEFMP-LGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLE-YLHDKANPPVIYRDFKS 83 (325)
Q Consensus 6 ~Hpniv~l~~~~~~~~~~~lv~e~~~-~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~-~LH~~~~~~ivHrdik~ 83 (325)
.||++ -...-.+.+...+.++.-+ +-++. .+.. ++...+++++.+|+.... +++. -+|--|.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~~-------~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIRK-------TTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHHT-------SCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHHh-------cCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 67777 2334455666666666543 33444 3333 788999999999988776 5443 47788999
Q ss_pred CcEEEcCCCeEEEecCCCC
Q 020529 84 SNILLEEGFHPKLSDFGLA 102 (325)
Q Consensus 84 ~Nill~~~~~~kL~Dfgla 102 (325)
+||+++.++.+++.=.|+-
T Consensus 113 ~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GGEEECTTCCEEESCCEET
T ss_pred ceEEEeCCCcEEEEEcCCc
Confidence 9999999999999866653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=90.88 E-value=0.11 Score=47.30 Aligned_cols=30 Identities=23% Similarity=0.225 Sum_probs=25.3
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
+.++|+|+.+.||+++.+. +.|+||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCCC-eEEEeCccccc
Confidence 3499999999999998764 89999987753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.18 E-value=0.12 Score=47.80 Aligned_cols=30 Identities=30% Similarity=0.330 Sum_probs=24.2
Q ss_pred CCeEeCCCCCCcEEEcCC----------------------------CeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEG----------------------------FHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~----------------------------~~~kL~Dfgla~ 103 (325)
..++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~ 306 (429)
T 1nw1_A 249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS 306 (429)
T ss_dssp EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence 349999999999999875 578899998774
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=89.35 E-value=0.19 Score=45.58 Aligned_cols=30 Identities=27% Similarity=0.228 Sum_probs=26.3
Q ss_pred CCeEeCCCCCCcEEEcCC----CeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEG----FHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~----~~~kL~Dfgla~ 103 (325)
..++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 359999999999999876 689999998874
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.71 E-value=0.29 Score=44.64 Aligned_cols=28 Identities=32% Similarity=0.361 Sum_probs=24.2
Q ss_pred eEeCCCCCCcEEE------cCCCeEEEecCCCCc
Q 020529 76 VIYRDFKSSNILL------EEGFHPKLSDFGLAK 103 (325)
Q Consensus 76 ivHrdik~~Nill------~~~~~~kL~Dfgla~ 103 (325)
++|+|+.+.||++ +++..+.|+||.++.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 445679999999875
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=86.34 E-value=0.75 Score=39.52 Aligned_cols=26 Identities=23% Similarity=0.249 Sum_probs=21.4
Q ss_pred CCCeEeCCCCCCcEEEcCCCeEEEecC
Q 020529 73 NPPVIYRDFKSSNILLEEGFHPKLSDF 99 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~~~kL~Df 99 (325)
.+.+||+|+.+.||+++.++ +.|+|-
T Consensus 187 ~p~LvHGDlw~gNvl~~~~g-~~~iDp 212 (288)
T 3f7w_A 187 PPARIHGDLWNGNVLWQDDG-AVVIDP 212 (288)
T ss_dssp CCEEECSCCSGGGEEEETTE-EEECSC
T ss_pred CCeeeecCCCCCcEEEcCCC-eEEEec
Confidence 46799999999999999887 456663
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=83.66 E-value=0.52 Score=43.38 Aligned_cols=29 Identities=14% Similarity=0.263 Sum_probs=25.5
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
..++|+|+.+.||+ +.++.+.|+||..+.
T Consensus 262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred ceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 34899999999999 778889999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 325 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-58 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 8e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-47 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-46 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-46 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-44 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-44 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-40 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-39 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-39 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-34 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-33 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-33 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-30 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-29 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-29 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-26 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-23 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-18 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-07 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 6e-58
Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 22/234 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L H N++ +GY Q +V ++ SL HLH + + + + IA
Sbjct: 57 VLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQ 112
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A+G++YLH K +I+RD KS+NI L E K+ DFGLA + SH ++ G+
Sbjct: 113 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 121 YGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 177
+ APE + +SDVY+FG+V EL+TG+ + + + L
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229
Query: 178 DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231
D K ++ + + C++++ RPL ++ ++ LA
Sbjct: 230 DLSKVRSNCPKAMK------------RLMAECLKKKRDERPLFPQILASIELLA 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-48
Identities = 56/255 (21%), Positives = 95/255 (37%), Gaps = 28/255 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
+L H N++ I + Q LV ++ GSL D+L+ + + +K
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIK 104
Query: 57 IAAGAAKGLEYLHDKA-----NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK- 110
+A A GL +LH + P + +RD KS NIL+++ ++D GLA
Sbjct: 105 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 164
Query: 111 -SHVSTRVMGTYGYCAPEYAMT------GQLTVKSDVYSFGVVFLELITGRKAIDST--- 160
+GT Y APE + ++D+Y+ G+VF E+
Sbjct: 165 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 224
Query: 161 -RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALA-VASMCIQEQAATRP 218
P+ + + KL P + R+ + +A + C A R
Sbjct: 225 QLPYYDLVPSDPSVEEMRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 219 LIGDVVTALSYLANQ 233
+ LS L+ Q
Sbjct: 284 TALRIKKTLSQLSQQ 298
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 8e-48
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 27/229 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L + ++ E+M GSL D L P L N + +AA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A+G+ ++ ++ I+RD +++NIL+ + K++DFGLA+L ++
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFP 173
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE--QNLVTWARPLFND 178
+ APE G T+KSDV+SFG++ E++T + + E QNL R + D
Sbjct: 174 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD 233
Query: 179 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227
+ + + +C +E+ RP + + L
Sbjct: 234 --NCPE----------------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 2e-47
Identities = 42/168 (25%), Positives = 71/168 (42%), Gaps = 10/168 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L + +V G + + E M GSL+ L + K++
Sbjct: 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIA 112
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
KGL YL +K +++RD K SNIL+ KL DFG++ ++ +GT
Sbjct: 113 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGT 166
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL 168
Y +PE +V+SD++S G+ +E+ GR I + +
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-47
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 23/231 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L G C + LV+EFM G L D+L T + +
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLD 109
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+G+ YL + VI+RD + N L+ E K+SDFG+ + D+ ST
Sbjct: 110 VCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFP 165
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
+ +PE + + KSDV+SFGV+ E+ + K R + E + D
Sbjct: 166 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDIS 216
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231
+L PRL + + C +E+ RP ++ L+ +A
Sbjct: 217 TGFRLYKPRLAST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 6e-47
Identities = 56/246 (22%), Positives = 90/246 (36%), Gaps = 37/246 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-------------------D 41
M L H N+VNL+G C L++E+ G L ++L +
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 42 LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGL 101
D L + + A AKG+E+L K ++RD + N+L+ G K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 102 AKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161
A+ V + APE G T+KSDV+S+G++ E+ +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 221
P F KL + P + + C + RP
Sbjct: 271 PVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315
Query: 222 DVVTAL 227
++ + L
Sbjct: 316 NLTSFL 321
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 2e-46
Identities = 57/248 (22%), Positives = 91/248 (36%), Gaps = 32/248 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD--------------LPPDK 46
+ L +H N+VNL+G C G L++ E+ G L + L + D+
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 47 EALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGP 106
ALD + + AKG+ +L K I+RD + NILL G K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 107 VGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 166
V + APE T +SDV+S+G+ EL + + P +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 167 NLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226
F K+ P + + C RP +V
Sbjct: 257 ---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 227 LSYLANQT 234
+ +++
Sbjct: 302 IEKQISES 309
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 5e-46
Identities = 48/227 (21%), Positives = 89/227 (39%), Gaps = 23/227 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L G C ++ E+M G L ++L + +++
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKD 108
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+ +EYL K ++RD + N L+ + K+SDFGL++ D+ S
Sbjct: 109 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFP 164
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
+ PE M + + KSD+++FGV+ E+ + K + E
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---------TAEHIA 215
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227
+ +L P L + + C E+A RP +++ +
Sbjct: 216 QGLRLYRPHLASE-------KVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 9e-46
Identities = 47/228 (20%), Positives = 88/228 (38%), Gaps = 23/228 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLL--VYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+L L H N+V D L V E+ G L + +++ LD +++
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 59 AGAAKGLEYLHDK--ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
L+ H + V++RD K +N+ L+ + KL DFGLA++ + + +
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKA 173
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 176
+GT Y +PE KSD++S G + EL P + A +
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELAGKIR 227
Query: 177 NDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 224
+ R+ RY + + + + + RP + +++
Sbjct: 228 EGKF-------RRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-45
Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 27/234 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+++ L HSNLV L+G + L +V E+M GSL D+L + L + +K +
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSL 110
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
+ +EYL ++RD + N+L+ E K+SDFGL K + S
Sbjct: 111 DVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKL 162
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 179
+ APE + + KSDV+SFG++ E+ + + P+ L +
Sbjct: 163 PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGY 217
Query: 180 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233
+ P V C AA RP + L ++
Sbjct: 218 K-------MDAPDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-44
Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 25/241 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR-LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
++ H N+++L+G C + L+V +M G L + + + +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGL 137
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKL--GPVGDKSHVSTRV 117
AKG+++L + ++RD + N +L+E F K++DFGLA+ D H T
Sbjct: 138 QVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 177
+ A E T + T KSDV+SFGV+ EL+T P+ + N L
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQ 249
Query: 178 DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDP 237
RR L P V C +A RP ++V+ +S + +
Sbjct: 250 GRR----LLQPEYCPD-------PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298
Query: 238 N 238
+
Sbjct: 299 H 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (384), Expect = 1e-44
Identities = 50/250 (20%), Positives = 86/250 (34%), Gaps = 39/250 (15%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD------------------- 41
+++ + N+V L+G CA G L++E+M G L + L
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 42 -LPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFG 100
P L ++ IA A G+ YL ++RD + N L+ E K++DFG
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFG 185
Query: 101 LAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160
L++ D + PE + T +SDV+++GVV E+ +
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245
Query: 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220
H E + + L + +C + A RP
Sbjct: 246 MAHEE----VIYYVRDGNILACPENCPLEL------------YNLMRLCWSKLPADRPSF 289
Query: 221 GDVVTALSYL 230
+ L +
Sbjct: 290 CSIHRILQRM 299
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-44
Identities = 55/224 (24%), Positives = 84/224 (37%), Gaps = 29/224 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ S L H N++ L GY D + L+ E+ PLG++ L L D
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITE 114
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A L Y H K VI+RD K N+LL K++DFG + P S T + GT
Sbjct: 115 LANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGT 167
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
Y PE K D++S GV+ E + G+ P + +
Sbjct: 168 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEF 221
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 224
F A + S ++ + RP++ +V+
Sbjct: 222 TFPDFVTE------------GARDLISRLLKHNPSQRPMLREVL 253
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 5e-44
Identities = 57/245 (23%), Positives = 94/245 (38%), Gaps = 34/245 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHD------------LPPDKEA 48
+ L HH N++NL+G C L E+ P G+L D L
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
L + AA A+G++YL K I+RD + NIL+ E + K++DFGL++ V
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 109 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL 168
K T + A E T SDV+S+GV+ E+++ P+
Sbjct: 181 VK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTC 232
Query: 169 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228
L R P+ + + C +E+ RP ++ +L+
Sbjct: 233 AELYEKLPQGYR-----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
Query: 229 YLANQ 233
+ +
Sbjct: 282 RMLEE 286
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 5e-44
Identities = 50/225 (22%), Positives = 89/225 (39%), Gaps = 25/225 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ +L+H N+V G+ +G+ + L E+ G L D + + +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQ 111
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
G+ YLH + +RD K N+LL+E + K+SDFGLA + ++ + ++ GT
Sbjct: 112 LMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 121 YGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ-NLVTWARPLFND 178
Y APE + DV+S G+V ++ G D ++ + + N
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP 228
Query: 179 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 223
+K LA+ + E + R I D+
Sbjct: 229 WKKIDS----------------APLALLHKILVENPSARITIPDI 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 9e-44
Identities = 54/242 (22%), Positives = 93/242 (38%), Gaps = 28/242 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ H N+++L G +++ EFM GSL+ L + + G
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF---TVIQLVGMLRG 136
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRV--- 117
A G++YL + ++RD + NIL+ K+SDFGL++ T
Sbjct: 137 IAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG 193
Query: 118 MGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 177
+ APE + T SDV+S+G+V E+++ + RP+ + +
Sbjct: 194 KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYWDMTNQDVINAIEQ 248
Query: 178 DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQTYDP 237
D R P+ + C Q+ RP G +V L + +P
Sbjct: 249 DYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR---NP 294
Query: 238 NS 239
NS
Sbjct: 295 NS 296
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (377), Expect = 1e-43
Identities = 53/234 (22%), Positives = 95/234 (40%), Gaps = 22/234 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ + H NLV L+G C ++ EFM G+L D+L + + + + +A
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQ 123
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+ +EYL K I+RD + N L+ E K++DFGL++L GD
Sbjct: 124 ISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFP 179
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
+ APE + ++KSDV++FGV+ E+ T + D
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLS 223
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQT 234
+ +L + P + + C Q + RP ++ A + ++
Sbjct: 224 QVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 277
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 1e-43
Identities = 51/229 (22%), Positives = 87/229 (37%), Gaps = 30/229 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR----LLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
ML L H N+V + +LV E M G+L+ +L +
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----MKIKVLRS 116
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVST 115
KGL++LH + PP+I+RD K NI + K+ D GLA L ++ +
Sbjct: 117 WCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAK 171
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 175
V+GT + APE + DVY+FG+ LE+ T + +
Sbjct: 172 AVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--------- 221
Query: 176 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 224
+ ++ + + + + CI++ R I D++
Sbjct: 222 ------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 1e-42
Identities = 52/229 (22%), Positives = 90/229 (39%), Gaps = 26/229 (11%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L + +V LIG C + +LV E G L L +E + + ++
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMG 119
+ G++YL +K ++RD + N+LL + K+SDFGL+K LG +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP-HGEQNLVTWARPLFND 178
+ APE + + +SDV+S+GV E ++ + +P + A
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQGK 229
Query: 179 RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227
R + P L A+ S C + RP V +
Sbjct: 230 RMECPPECPPELY------------ALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 5e-42
Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 25/228 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L + +V +IG C + + +LV E LG L +L + +++
Sbjct: 61 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH----VKDKNIIELVHQ 115
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMG 119
+ G++YL + ++RD + N+LL + K+SDFGL+K L + T
Sbjct: 116 VSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 179
+ APE + + KSDV+SFGV+ E + + +P+ L
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGE 227
Query: 180 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227
R P + + ++C RP V L
Sbjct: 228 R-------MGCPAGCPR----EMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 8e-42
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 23/231 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ H N++ L G + +++ E+M G+L+ L + + + G
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRG 118
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMG 119
A G++YL N ++RD + NIL+ K+SDFGL++ L + ++ ++
Sbjct: 119 IAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 179
+ APE + T SDV+SFG+V E++T + + E
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------------- 221
Query: 180 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230
K + P+ + C Q++ A RP D+V+ L L
Sbjct: 222 --VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-41
Identities = 42/192 (21%), Positives = 73/192 (38%), Gaps = 14/192 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L+ H N+V L+ + ++ EF G+++ + +L + L + +
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQ 118
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
L YLHD +I+RD K+ NIL KL+DFG++ +GT
Sbjct: 119 TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--RTIQRRDSFIGT 173
Query: 121 YGYCAPEYAMTGQL-----TVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWARP 174
+ APE M K+DV+S G+ +E+ P + P
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP 233
Query: 175 LFNDRRKFSKLA 186
++S
Sbjct: 234 TLAQPSRWSSNF 245
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-40
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 23/227 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ L H LV L + +V E+M GSL D L + L + +AA
Sbjct: 65 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQ 121
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A G+ Y+ ++RD +++NIL+ E K++DFGLA+L ++
Sbjct: 122 IASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFP 177
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
+ APE A+ G+ T+KSDV+SFG++ EL T + G N + R
Sbjct: 178 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY----PGMVNREVLDQVERGYRM 233
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227
L + C +++ RP + L
Sbjct: 234 PCPPECPESL------------HDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-40
Identities = 51/233 (21%), Positives = 99/233 (42%), Gaps = 23/233 (9%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+++ + + ++ L+G C +L + + MP G L D++ + K+ + +
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQ 119
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
AKG+ YL D+ +++RD + N+L++ H K++DFGLAKL +K + +
Sbjct: 120 IAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
+ A E + T +SDV+S+GV EL+T +P+
Sbjct: 177 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDG-----------IPAS 220
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233
+ S + + P + C A +RP +++ S +A
Sbjct: 221 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (353), Expect = 7e-40
Identities = 51/227 (22%), Positives = 79/227 (34%), Gaps = 32/227 (14%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
L L H N + G LV E+ + + K+ L + G
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHG 123
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
A +GL YLH +I+RD K+ NILL E KL DFG A + + +GT
Sbjct: 124 ALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANSFVGT 174
Query: 121 YGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFN 177
+ APE + GQ K DV+S G+ +EL + + + +
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL 234
Query: 178 DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVV 224
+S+ C+Q+ RP ++
Sbjct: 235 QSGHWSE----------------YFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-39
Identities = 48/187 (25%), Positives = 80/187 (42%), Gaps = 11/187 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++ + N+VN + GD+ +V E++ GSL D + + D +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-----EGQIAAVCRE 124
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+ LE+LH VI+RD KS NILL KL+DFG + + + ++GT
Sbjct: 125 CLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGT 179
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGE-QNLVTWARPLFNDR 179
+ APE K D++S G++ +E+I G + P + T P +
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 180 RKFSKLA 186
K S +
Sbjct: 240 EKLSAIF 246
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 2e-39
Identities = 56/243 (23%), Positives = 92/243 (37%), Gaps = 31/243 (12%)
Query: 1 MLSLLHHSNLVNLIGYCA-DGDQRLLVYEFMPLGSLEDHLHD------------LPPDKE 47
++ + HH N+VNL+G C G +++ EF G+L +L K+
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 48 ALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPV 107
L + + AKG+E+L + I+RD + NILL E K+ DFGLA+
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 108 GDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQN 167
+ APE T++SDV+SFGV+ E+ + P+
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVK 241
Query: 168 LVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227
+ + + R P + C + + RP ++V L
Sbjct: 242 IDEEFCRRLKEGTRM----------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291
Query: 228 SYL 230
L
Sbjct: 292 GNL 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 6e-39
Identities = 45/190 (23%), Positives = 72/190 (37%), Gaps = 13/190 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++S L H V L D ++ + G L ++ + D A
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS----FDETCTRFYTAE 116
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
LEYLH +I+RD K NILL E H +++DFG AK+ K + +GT
Sbjct: 117 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 173
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
Y +PE SD+++ G + +L+ G P N + +
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKLEY 227
Query: 181 KFSKLADPRL 190
F + P+
Sbjct: 228 DFPEKFFPKA 237
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 7e-39
Identities = 56/228 (24%), Positives = 83/228 (36%), Gaps = 23/228 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ L H NL+ L G ++ V E PLGSL D L + T + A
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQ 119
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV-STRVMG 119
A+G+ YL K I+RD + N+LL K+ DFGL + P D +V
Sbjct: 120 VAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 179
+ +CAPE T + SD + FGV E+ T + P N + +
Sbjct: 177 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEG 231
Query: 180 RKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227
+ + D + V C + RP + L
Sbjct: 232 ERLPRPEDCPQD----------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 1e-37
Identities = 48/233 (20%), Positives = 92/233 (39%), Gaps = 25/233 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA------LDWNTR 54
++ + ++V L+G + G L++ E M G L+ +L L P +
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 114
+++A A G+ YL+ ++RD + N ++ E F K+ DFG+ + D
Sbjct: 136 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 174
+ + + +PE G T SDV+SFGVV E+ T +
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQ 237
Query: 175 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227
++ + + + L P + MC Q RP ++++++
Sbjct: 238 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-37
Identities = 58/246 (23%), Positives = 93/246 (37%), Gaps = 31/246 (12%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEA 48
M + H N++NL+G C ++ E+ G+L ++L P +E
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 49 LDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVG 108
L + A A+G+EYL K I+RD + N+L+ E K++DFGLA+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 109 DKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNL 168
D +T + APE T +SDV+SFGV+ E+ T P+ +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-----SPYPGVPV 243
Query: 169 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALS 228
+ L R P + + C + RP +V L
Sbjct: 244 EELFKLLKEGHR-----------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 229 YLANQT 234
+ T
Sbjct: 293 RIVALT 298
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 4e-37
Identities = 50/233 (21%), Positives = 87/233 (37%), Gaps = 24/233 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ H ++V LIG + + ++ E LG L L K +LD + + A
Sbjct: 61 TMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQ 116
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+ L YL K ++RD + N+L+ KL DFGL++ + +++
Sbjct: 117 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLP 172
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
+ APE + T SDV+ FGV E++ G +N R +R
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV----KPFQGVKNNDVIGRIENGERL 228
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233
P L ++ + C + RP ++ LS + +
Sbjct: 229 PMPPNCPPTLY------------SLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 125 bits (314), Expect = 7e-34
Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 11/156 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+S+L H LVNL D ++ +++YEFM G L + + D + + + ++
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQ 132
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
KGL ++H+ ++ D K NI+ + KL DFGL D
Sbjct: 133 VCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTT 186
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
GT + APE A + +D++S GV+ L++G
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-33
Identities = 45/178 (25%), Positives = 73/178 (41%), Gaps = 9/178 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ H L ++ + V E++ G L H+ D + AA
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK----FDLSRATFYAAE 111
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
GL++LH K ++YRD K NILL++ H K++DFG+ K +GD GT
Sbjct: 112 IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGT 166
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 178
Y APE + + D +SFGV+ E++ G+ + + P +
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR 224
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 122 bits (307), Expect = 2e-33
Identities = 48/229 (20%), Positives = 79/229 (34%), Gaps = 30/229 (13%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ + H N++ L LV++ M G L D+L +K L KI
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRA 118
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+ + LH +++RD K NILL++ + KL+DFG + D V GT
Sbjct: 119 LLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGT 172
Query: 121 YGYCAPEYAMTGQL------TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARP 174
Y APE + D++S GV+ L+ G P + + R
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLRM 226
Query: 175 LFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 223
+ + +F + S + Q R +
Sbjct: 227 IMSGNYQFGSPEWDDYSD--------TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 124 bits (311), Expect = 2e-33
Identities = 45/170 (26%), Positives = 71/170 (41%), Gaps = 12/170 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
++S +V + D+ + + M G L HL EA AA
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA----DMRFYAAE 115
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
GLE++H++ V+YRD K +NILL+E H ++SD GLA +GT
Sbjct: 116 IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGT 168
Query: 121 YGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV 169
+GY APE G +D +S G + +L+ G + + +
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 122 bits (308), Expect = 5e-33
Identities = 37/156 (23%), Positives = 71/156 (45%), Gaps = 11/156 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+++ LHH L+NL D + +L+ EF+ G L D + + + +
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQ 135
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLE--EGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
A +GL+++H+ +++ D K NI+ E + K+ DFGLA + +
Sbjct: 136 ACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTT 189
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
T + APE + +D+++ GV+ L++G
Sbjct: 190 ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-33
Identities = 30/181 (16%), Positives = 73/181 (40%), Gaps = 11/181 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L++ H N+++L ++ ++++EF+ + + ++ L+ +
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILL--EEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
+ L++LH + + D + NI+ K+ +FG A+ GD + +
Sbjct: 111 VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LF 164
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFND 178
Y APE ++ +D++S G + L++G + + A F++
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224
Query: 179 R 179
Sbjct: 225 E 225
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 120 bits (301), Expect = 1e-32
Identities = 50/223 (22%), Positives = 87/223 (39%), Gaps = 26/223 (11%)
Query: 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
+ L+H +V + G +V E++ +L D +H P + ++
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIE 115
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVST 115
+ A A + L + H +I+RD K +NI++ K+ DFG+A+ + G+ +
Sbjct: 116 VIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
Query: 116 RVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPL 175
V+GT Y +PE A + +SDVYS G V E++TG P + V+ A
Sbjct: 173 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQH 226
Query: 176 FNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 218
+ L AV + + R
Sbjct: 227 VREDPIPPSARHEGLSA--------DLDAVVLKALAKNPENRY 261
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (302), Expect = 2e-32
Identities = 41/190 (21%), Positives = 68/190 (35%), Gaps = 13/190 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L + H N+V L G L+ + + G L D + +K ++
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQ 115
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
++YLHD + L+E +SDFGL+K+ D V + GT
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGT 172
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
GY APE + D +S GV+ L+ G P ++N +
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEY 226
Query: 181 KFSKLADPRL 190
+F +
Sbjct: 227 EFDSPYWDDI 236
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (292), Expect = 5e-31
Identities = 50/179 (27%), Positives = 75/179 (41%), Gaps = 12/179 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
MLS++ H ++ + G D Q ++ +++ L L + AA
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIE----GGELFSLLRKSQRFPNPVAKFYAAE 112
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
LEYLH K +IYRD K NILL++ H K++DFG AK P V+ + GT
Sbjct: 113 VCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGT 164
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 179
Y APE T D +SFG++ E++ G + + A F
Sbjct: 165 PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 223
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-30
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 12/210 (5%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N++ L+ LV++FM D + + L +
Sbjct: 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLM 108
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+GLEYLH +++RD K +N+LL+E KL+DFGLAK G + T + T
Sbjct: 109 TLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVT 163
Query: 121 YGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLV--TWARPLFN 177
Y APE ++ V D+++ G + EL+ + + + T P
Sbjct: 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223
Query: 178 DRRKFSKLADPRLEGRYPIRGLYQALAVAS 207
L D +P L+ + A
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAG 253
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 5e-29
Identities = 46/235 (19%), Positives = 79/235 (33%), Gaps = 19/235 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSL--EDHLHDLPPDKEALDWNTRMKIA 58
L H N+V L C + + + + + + T +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 122
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVM 118
+GL++LH V++RD K NIL+ KL+DFGLA++ T V+
Sbjct: 123 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 176
Query: 119 GTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPH----------GEQNL 168
T Y APE + D++S G +F E+ + + G
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 169 VTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDV 223
W R + R+ F + +E ++ + C+ A R
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 6e-29
Identities = 35/161 (21%), Positives = 56/161 (34%), Gaps = 15/161 (9%)
Query: 1 MLSLLHHSNLVNLIGYC----ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMK 56
++V ++ A L+V E + G L + D +
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASE 115
Query: 57 IAAGAAKGLEYLHDKANPPVIYRDFKSSNILL---EEGFHPKLSDFGLAKLGPVGDKSHV 113
I + ++YLH + +RD K N+L KL+DFG AK +
Sbjct: 116 IMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT- 171
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
T Y APE + D++S GV+ L+ G
Sbjct: 172 --TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 6e-29
Identities = 37/161 (22%), Positives = 59/161 (36%), Gaps = 13/161 (8%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR------LLVYEFMPLGSLEDHLHDLPPDKEALDWNTR 54
++ L H N+V L + ++ LV +++P H K+ L
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH-YSRAKQTLPVIYV 124
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHV 113
+ L Y+H + +RD K N+LL + KL DFG AK +
Sbjct: 125 KLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEPN 179
Query: 114 STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ + Y T DV+S G V EL+ G+
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 6e-29
Identities = 42/183 (22%), Positives = 70/183 (38%), Gaps = 14/183 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L + H N++ L + +L+ E + L D +KE+L +
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVA----GGELFDFLAEKESLTEEEATEFLKQ 121
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILL----EEGFHPKLSDFGLAKLGPVGDKSHVSTR 116
G+ YLH + + D K NI+L K+ DFGLA D +
Sbjct: 122 ILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKN 175
Query: 117 VMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLF 176
+ GT + APE L +++D++S GV+ L++G V+ F
Sbjct: 176 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 177 NDR 179
D
Sbjct: 236 EDE 238
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 107 bits (269), Expect = 7e-28
Identities = 28/164 (17%), Positives = 55/164 (33%), Gaps = 17/164 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
L + + N+ + +G +LV + + L T A
Sbjct: 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG----PSLEDLLDLCGRKFSVKTVAMAAKQ 109
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHP-----KLSDFGLAKLGPVGDKS---- 111
++ +H+K ++YRD K N L+ + DFG+ K
Sbjct: 110 MLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIP 166
Query: 112 -HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ GT Y + + + + + D+ + G VF+ + G
Sbjct: 167 YREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS 210
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-27
Identities = 38/176 (21%), Positives = 64/176 (36%), Gaps = 18/176 (10%)
Query: 6 HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGL 65
S ++ L+ + D +L+ E L D ++ AL + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQD---LFDFITERGALQEELARSFFWQVLEAV 123
Query: 66 EYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYC 124
+ H+ V++RD K NIL+ KL DFG L K V T GT Y
Sbjct: 124 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYS 176
Query: 125 APEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 179
PE+ + + V+S G++ +++ G P + + F R
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVFFRQR 226
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-27
Identities = 39/156 (25%), Positives = 68/156 (43%), Gaps = 6/156 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L H N++ + + ++ + L+ L + L +
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQ 117
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK-LGPVGDKSHVSTRVMG 119
+GL+Y+H V++RD K SN+LL K+ DFGLA+ P D + T +
Sbjct: 118 ILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 120 TYGYCAPEYAMTGQLTVKS-DVYSFGVVFLELITGR 154
T Y APE + + KS D++S G + E+++ R
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 104 bits (259), Expect = 1e-26
Identities = 36/197 (18%), Positives = 76/197 (38%), Gaps = 8/197 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L HSN+V L + +LV+E + + + L+ T
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQ 108
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
G+ Y HD+ V++RD K N+L+ K++DFGLA+ + + + ++
Sbjct: 109 LLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTL 164
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
+ + + + D++S G +F E++ G + + N +
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKN 224
Query: 181 KFSKLADPRLEGRYPIR 197
+ P+ + + +
Sbjct: 225 WPNVTELPKYDPNFTVY 241
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 102 bits (256), Expect = 5e-26
Identities = 40/227 (17%), Positives = 74/227 (32%), Gaps = 26/227 (11%)
Query: 1 MLSLLHHSNLVNLIGYC-ADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAA 59
+ ++ + I +C A+GD ++V E + + T + +A
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLAD 110
Query: 60 GAAKGLEYLHDKANPPVIYRDFKSSNIL---LEEGFHPKLSDFGLAKL-----GPVGDKS 111
+EY+H K I+RD K N L ++G + DFGLAK
Sbjct: 111 QMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167
Query: 112 HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTW 171
+ + GT Y + + + + + D+ S G V + G + ++
Sbjct: 168 RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-- 225
Query: 172 ARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP 218
K L YP + + C + +P
Sbjct: 226 ----ERISEKKMSTPIEVLCKGYPS----EFATYLNFCRSLRFDDKP 264
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 7e-26
Identities = 49/190 (25%), Positives = 68/190 (35%), Gaps = 15/190 (7%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L H L L D+ V E+ G L HL A
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAE 113
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
LEYLH + V+YRD K N++L++ H K++DFGL K G GT
Sbjct: 114 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI--SDGATMKTFCGT 168
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
Y APE D + GVV E++ GR P Q+ + +
Sbjct: 169 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEI 222
Query: 181 KFSKLADPRL 190
+F + P
Sbjct: 223 RFPRTLSPEA 232
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 7e-26
Identities = 37/195 (18%), Positives = 72/195 (36%), Gaps = 7/195 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L+H N+V L+ ++ LV+EF+ + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS---ALTGIPLPLIKSYLFQ 110
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+GL + H V++RD K N+L+ KL+DFGLA+ V + + V+
Sbjct: 111 LLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTL 166
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
+ + D++S G +F E++T R + + ++
Sbjct: 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVV 226
Query: 181 KFSKLADPRLEGRYP 195
+ P + +P
Sbjct: 227 WPGVTSMPDYKPSFP 241
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.2 bits (246), Expect = 2e-24
Identities = 40/165 (24%), Positives = 67/165 (40%), Gaps = 18/165 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQR--------LLVYEFMPLGSLEDHLHDLPPDKEALDWN 52
+L LL H N+VNLI C LV++F + L +
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLS 117
Query: 53 TRMKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH 112
++ GL Y+H +++RD K++N+L+ KL+DFGLA+ + S
Sbjct: 118 EIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 174
Query: 113 VS--TRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGR 154
+ T + T Y PE + + D++ G + E+ T
Sbjct: 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.9 bits (240), Expect = 6e-24
Identities = 41/214 (19%), Positives = 74/214 (34%), Gaps = 8/214 (3%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L L H N+V L + LV+EF +D LD
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
KGL + H + V++RD K N+L+ KL++FGLA+ + + + S V+
Sbjct: 110 LLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTL 165
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDRR 180
+ + D++S G +F EL + + +Q +
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEE 225
Query: 181 KFSKLADPRLEGRYPIRGLYQALAVASMCIQEQA 214
++ + YP+ +L +
Sbjct: 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG 259
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 3e-23
Identities = 33/154 (21%), Positives = 59/154 (38%), Gaps = 7/154 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L + H N++ L+ + +F + E L + +
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQ 129
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
KGL Y+H +RD K N+ + E K+ DFGLA+ S ++ V+
Sbjct: 130 MLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTR 182
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ + T D++S G + E+ITG+
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.0 bits (238), Expect = 4e-23
Identities = 40/179 (22%), Positives = 69/179 (38%), Gaps = 12/179 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L ++ LV L D +V E++ G + HL + AA
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR----FSEPHARFYAAQ 149
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
EYLH +IYRD K N+L+++ + +++DFG AK + + GT
Sbjct: 150 IVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGT 201
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRPHGEQNLVTWARPLFNDR 179
APE ++ D ++ GV+ E+ G + +P + + F
Sbjct: 202 PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 93.8 bits (232), Expect = 2e-22
Identities = 32/170 (18%), Positives = 63/170 (37%), Gaps = 17/170 (10%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRL--LVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIA 58
+ +L N++ L D R LV+E + + L
Sbjct: 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT-------DYDIRFYM 135
Query: 59 AGAAKGLEYLHDKANPPVIYRDFKSSNILL-EEGFHPKLSDFGLAKLGPVGDKSHVSTRV 117
K L+Y H +++RD K N+++ E +L D+GLA+ G +
Sbjct: 136 YEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVR 189
Query: 118 MGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDSTRPHGEQ 166
+ + + PE + Q+ D++S G + +I ++ + +Q
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.7 bits (219), Expect = 9e-21
Identities = 44/156 (28%), Positives = 64/156 (41%), Gaps = 10/156 (6%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+ + LV L + L+ +++ G L HL +
Sbjct: 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----FTEHEVQIYVGE 137
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
LE+LH +IYRD K NILL+ H L+DFGL+K V D++ + GT
Sbjct: 138 IVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGT 193
Query: 121 YGYCAPEYAMTGQ--LTVKSDVYSFGVVFLELITGR 154
Y AP+ G D +S GV+ EL+TG
Sbjct: 194 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.9 bits (201), Expect = 3e-18
Identities = 31/154 (20%), Positives = 57/154 (37%), Gaps = 7/154 (4%)
Query: 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
+L + H N++ L+ + + L + + L + +
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 129
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGT 120
+GL+Y+H +RD K SN+ + E K+ DFGLA+ ++ V
Sbjct: 130 ILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATR 182
Query: 121 YGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
+ D++S G + EL+TGR
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.1 bits (199), Expect = 6e-18
Identities = 43/229 (18%), Positives = 86/229 (37%), Gaps = 35/229 (15%)
Query: 1 MLSLLHHSNLVNLIGYCA------DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTR 54
++ ++H N+++L+ + LV E M + +L
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERM 121
Query: 55 MKIAAGAAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVS 114
+ G+++LH + +I+RD K SNI+++ K+ DFGLA+ S +
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMM 175
Query: 115 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR----------------KAID 158
T + T Y APE + D++S G + E++ + + +
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLG 235
Query: 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVAS 207
+ P + L R +R K++ L P+L + + +
Sbjct: 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 284
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.9 bits (193), Expect = 3e-17
Identities = 30/155 (19%), Positives = 59/155 (38%), Gaps = 4/155 (2%)
Query: 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLH-DLPPDKEALDWNTRMKIAAG 60
+ ++++ L+ + + + E+ L + + +I+
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMG 119
GL+Y+H + +I+ D K N+L+E L +A LG T +
Sbjct: 134 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 120 TYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154
T Y +PE + +D++S + ELITG
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 46.3 bits (109), Expect = 9e-07
Identities = 11/103 (10%), Positives = 28/103 (27%), Gaps = 19/103 (18%)
Query: 5 LHHSNLVNLIGYCA----DGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAG 60
L L G + ++ E + L ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV-----------RVENPDEVLDM 111
Query: 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103
+ + + + +++ D N+L+ E + DF +
Sbjct: 112 ILEEVAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 325 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.97 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.62 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.79 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.06 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.38 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 91.39 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 84.45 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=339.02 Aligned_cols=214 Identities=28% Similarity=0.457 Sum_probs=164.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||++++++.+ +..++|||||++|+|.+++.. ....+++..++.|+.|++.||+|||+++ |||||
T Consensus 57 ~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrD 129 (276)
T d1uwha_ 57 VLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRD 129 (276)
T ss_dssp HHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---Eeccc
Confidence 4688999999999999764 568999999999999999975 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC---CCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG---QLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+||||+.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||+||+.||
T Consensus 130 lKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp CCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred cCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence 9999999999999999999999875544444445567899999999998643 5789999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
......... ... +.. ....|.+ ...+......+.+|+.+||+.+|.+|||+.+|++.|+.+...
T Consensus 210 ~~~~~~~~~--~~~----~~~-----~~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 210 SNINNRDQI--IFM----VGR-----GYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp TTCCCHHHH--HHH----HHH-----TSCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCChHHHH--HHH----Hhc-----CCCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 765432111 111 100 0111111 011222345788999999999999999999999999988753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=337.66 Aligned_cols=203 Identities=24% Similarity=0.371 Sum_probs=165.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||++++++.+++..|+|||||++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+|||
T Consensus 56 ~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrD 128 (271)
T d1nvra_ 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRD 128 (271)
T ss_dssp HHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCc
Confidence 36789999999999999999999999999999999999965 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+|||++.++.+||+|||+++...........+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||..
T Consensus 129 iKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~ 208 (271)
T d1nvra_ 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208 (271)
T ss_dssp CCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence 999999999999999999999987544443344556789999999999988876 6789999999999999999999976
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
...... .+..+... . ... .........+.+|+.+||+.||++|||+.||++
T Consensus 209 ~~~~~~-~~~~~~~~-----~---~~~------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 209 PSDSCQ-EYSDWKEK-----K---TYL------NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp SSTTSH-HHHHHHTT-----C---TTS------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CChHHH-HHHHHhcC-----C---CCC------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 543211 11111100 0 000 001122356789999999999999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-47 Score=340.73 Aligned_cols=209 Identities=23% Similarity=0.379 Sum_probs=161.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+.+..++|||||++|+|.+++.. ....+++.+++.|+.||+.||+|||+++ |+|||
T Consensus 80 ~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrD 153 (299)
T d1jpaa_ 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRD 153 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCc
Confidence 47889999999999999999999999999999999998875 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCc---cccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHV---STRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKA 156 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p 156 (325)
|||+||||+.++.+||+|||+++.......... .....||+.|+|||++.+..++.++|||||||++|||+| |+.|
T Consensus 154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~P 233 (299)
T d1jpaa_ 154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233 (299)
T ss_dssp CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCC
Confidence 999999999999999999999986543322211 223457899999999999999999999999999999998 8999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
|...... .+...+.. . .....+......+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 234 f~~~~~~---~~~~~i~~----~----------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 234 YWDMTNQ---DVINAIEQ----D----------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTTCCHH---HHHHHHHT----T----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHc----C----------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 9765322 11111110 0 0111222344678899999999999999999999999998765
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-47 Score=342.03 Aligned_cols=208 Identities=25% Similarity=0.407 Sum_probs=168.8
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC-------------------CCCCCCHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP-------------------DKEALDWNTRMKIAAGA 61 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~l~~~~~~~i~~~l 61 (325)
|+++ +|||||+++++|.+.+..++|||||++|+|.++++..+. ....+++..++.++.|+
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 173 (325)
T d1rjba_ 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173 (325)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence 4455 899999999999999999999999999999999976432 12458999999999999
Q ss_pred HHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEE
Q 020529 62 AKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVY 141 (325)
Q Consensus 62 ~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvw 141 (325)
+.||+|||+++ ||||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||
T Consensus 174 ~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Diw 250 (325)
T d1rjba_ 174 AKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVW 250 (325)
T ss_dssp HHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceecc
Confidence 99999999999 999999999999999999999999999875544443344556789999999999999999999999
Q ss_pred EehHHHHHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 142 SFGVVFLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 142 SlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
||||++|||+| |+.||....... .+.... ... .....|......+.+|+.+||+.||++|||+
T Consensus 251 S~Gvil~emlt~g~~Pf~~~~~~~--~~~~~~----~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~ 314 (325)
T d1rjba_ 251 SYGILLWEIFSLGVNPYPGIPVDA--NFYKLI----QNG----------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSF 314 (325)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSH--HHHHHH----HTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred chhHHHHHHHhCCCCCCCCCCHHH--HHHHHH----hcC----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 99999999997 899997654321 111111 111 1111222334678899999999999999999
Q ss_pred HHHHHHHH
Q 020529 221 GDVVTALS 228 (325)
Q Consensus 221 ~evl~~L~ 228 (325)
+||++.|.
T Consensus 315 ~ei~~~L~ 322 (325)
T d1rjba_ 315 PNLTSFLG 322 (325)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHh
Confidence 99999985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=331.90 Aligned_cols=207 Identities=26% Similarity=0.410 Sum_probs=158.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++|||||+++++|.+.+..++||||+++|+|.+++.. ....+++..++.|+.|++.||+|||+.+ |+||||
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDl 127 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDL 127 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTC
T ss_pred HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeeccc
Confidence 5788999999999999999999999999999999999876 3456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhC-CCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITG-RKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg-~~p~~~~ 160 (325)
||+|||+++++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|+ .+|+...
T Consensus 128 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 128 AARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp SGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred chhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 99999999999999999999986543322 223446789999999999999999999999999999999995 5555432
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.. ..+...... . ..... |.....++.+|+.+||+.||++|||+++|++.|+.+.+
T Consensus 207 ~~---~~~~~~i~~----~---~~~~~-------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 207 SN---SEVVEDIST----G---FRLYK-------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CH---HHHHHHHHH----T---CCCCC-------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CH---HHHHHHHHh----c---CCCCC-------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 21 111111110 0 11111 12233578899999999999999999999999998865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=329.70 Aligned_cols=196 Identities=27% Similarity=0.421 Sum_probs=164.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||++++++.+.+..|+|||||++|+|.+++.. ...+++..+..++.|++.||+|||+++ |+|||
T Consensus 59 il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrD 131 (263)
T d2j4za1 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRD 131 (263)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeee
Confidence 36789999999999999999999999999999999999975 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 132 iKp~Nill~~~~~~kl~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 132 IKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp CCGGGEEECTTSCEEECCCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eccccceecCCCCEeecccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 9999999999999999999999764322 234567999999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
..... ...+..... .+|......+.+|+.+||+.||.+|||+.||++
T Consensus 208 ~~~~~------~~~i~~~~~------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 208 TYQET------YKRISRVEF------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp SHHHH------HHHHHTTCC------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHH------HHHHHcCCC------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 32211 111111110 112223457889999999999999999999986
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=330.35 Aligned_cols=205 Identities=23% Similarity=0.376 Sum_probs=164.7
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+ +..+|||||+++|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+|||
T Consensus 61 il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrD 132 (277)
T d1xbba_ 61 VMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRD 132 (277)
T ss_dssp HHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCC
Confidence 3678999999999999965 457899999999999999976 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~ 158 (325)
|||+||||+.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 133 lKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 133 LAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 9999999999999999999999865433222 22334578999999999999999999999999999999998 899997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
...... +.... ... .....|......+.+|+.+||+.||.+|||+++|++.|+..
T Consensus 213 ~~~~~~---~~~~i----~~~----------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 213 GMKGSE---VTAML----EKG----------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp TCCHHH---HHHHH----HTT----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCHHH---HHHHH----HcC----------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 653221 11111 110 00112223345788999999999999999999999988654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.1e-46 Score=331.31 Aligned_cols=210 Identities=23% Similarity=0.353 Sum_probs=169.7
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+++..++|||||++|+|.+++... ....+++..++.|+.|++.||+|||+++ |+|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrD 140 (287)
T d1opja_ 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRD 140 (287)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCc
Confidence 367899999999999999999999999999999999999752 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||+.++.+||+|||+++..... .........|++.|+|||++.+..++.++|||||||++|||++|..|+...
T Consensus 141 lKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 141 LAARNCLVGENHLVKVADFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp CSGGGEEECGGGCEEECCCCCTTTCCSS-SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cccCeEEECCCCcEEEccccceeecCCC-CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 9999999999999999999999864332 223344456899999999999999999999999999999999976665432
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
... ..+..... .......+......+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 220 ~~~--~~~~~~i~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 220 IDL--SQVYELLE--------------KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCH--HHHHHHHH--------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred chH--HHHHHHHh--------------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 211 11111111 011112223344678899999999999999999999999987643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-46 Score=330.52 Aligned_cols=201 Identities=25% Similarity=0.360 Sum_probs=165.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+.+..|+|||||++|+|.+++.. ..+++..+..++.|++.||+|||+++ |+|||
T Consensus 70 il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrD 141 (293)
T d1yhwa1 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRD 141 (293)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccC
Confidence 36789999999999999999999999999999999998864 35999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 142 iKp~NILl~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 142 IKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCST--TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CcHHHeEECCCCcEeeccchhheeeccc--cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 9999999999999999999999864332 22345567999999999999999999999999999999999999999754
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..... +. ...... .+.+ ..+......+.+|+.+||+.||.+|||+.|+++.
T Consensus 220 ~~~~~--~~----~~~~~~-------~~~~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 220 NPLRA--LY----LIATNG-------TPEL--QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CHHHH--HH----HHHHHC-------SCCC--SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CHHHH--HH----HHHhCC-------CCCC--CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 32211 11 111100 0000 1122334678899999999999999999999763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=330.23 Aligned_cols=207 Identities=24% Similarity=0.358 Sum_probs=167.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+ +..|+|||||++|+|.+++.. .+..+++..++.++.|++.||+|||+++ |+|||
T Consensus 62 il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrD 134 (285)
T d1u59a_ 62 IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRD 134 (285)
T ss_dssp HHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCc
Confidence 3678999999999999965 467999999999999999865 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCC-CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKS-HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~ 158 (325)
|||+||||+.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 135 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~ 214 (285)
T d1u59a_ 135 LAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK 214 (285)
T ss_dssp CSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCC
Confidence 9999999999999999999999865433221 22334568999999999999999999999999999999998 899997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
...... +.... .... ....|...+..+.+|+.+||+.+|++||++.+|++.|+...
T Consensus 215 ~~~~~~---~~~~i----~~~~----------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 215 KMKGPE---VMAFI----EQGK----------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp TCCTHH---HHHHH----HTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHHH---HHHHH----HcCC----------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 654321 11111 1110 01112233457889999999999999999999999998654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=333.35 Aligned_cols=206 Identities=23% Similarity=0.337 Sum_probs=153.3
Q ss_pred CcCCCCCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC--CCCe
Q 020529 1 MLSLLHHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA--NPPV 76 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~--~~~i 76 (325)
+|++++|||||++++++.+ .+..|+|||||++|+|.+++.........+++..++.++.|++.||.|||+++ ..+|
T Consensus 56 il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~I 135 (269)
T d2java1 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 135 (269)
T ss_dssp HTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----
T ss_pred HHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCE
Confidence 4788999999999999865 45679999999999999998754334567999999999999999999999864 2349
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
+||||||+||||+.++.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 136 iHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~P 213 (269)
T d2java1 136 LHRDLKPANVFLDGKQNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 213 (269)
T ss_dssp ----CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred EeCcCchhhcCcCCCCcEEEeeccceeecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCC
Confidence 99999999999999999999999999864322 2233457799999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|....... +. ..+... .+ + ..+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus 214 f~~~~~~~---~~---~~i~~~--~~-----~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 214 FTAFSQKE---LA---GKIREG--KF-----R----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCCSSHHH---HH---HHHHHT--CC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCHHH---HH---HHHHcC--CC-----C----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 97643211 11 111100 00 1 112223457889999999999999999999975
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=332.47 Aligned_cols=201 Identities=23% Similarity=0.305 Sum_probs=163.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+.+..|+|||||++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||
T Consensus 61 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrD 133 (288)
T d1uu3a_ 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRD 133 (288)
T ss_dssp HHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCc
Confidence 36789999999999999999999999999999999999875 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||+++++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 134 iKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (288)
T d1uu3a_ 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 213 (288)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence 99999999999999999999998765444444455677999999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
..... ...+..... .++.....++.+|+.+||+.||.+|||++|++..
T Consensus 214 ~~~~~------~~~i~~~~~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 214 NEYLI------FQKIIKLEY------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp SHHHH------HHHHHTTCC------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CHHHH------HHHHHcCCC------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 32111 111111110 1122334578899999999999999999998654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=324.11 Aligned_cols=200 Identities=26% Similarity=0.401 Sum_probs=158.1
Q ss_pred CcCCCCCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 1 MLSLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
+|++++|||||+++++|.+ ....|+||||+++|+|.+++.. ...+++..++.++.|++.||+|||+++ ++|
T Consensus 61 il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~I 135 (270)
T d1t4ha_ 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPI 135 (270)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCC
T ss_pred HHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCE
Confidence 4788999999999999865 3467999999999999999976 456999999999999999999999976 459
Q ss_pred EeCCCCCCcEEEc-CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 77 IYRDFKSSNILLE-EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 77 vHrdik~~Nill~-~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
+||||||+||||+ +++.+||+|||+++.... .......||+.|+|||++.+ .++.++|||||||++|||++|+.
T Consensus 136 iHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~ 210 (270)
T d1t4ha_ 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 210 (270)
T ss_dssp CCSCCCGGGEEESSTTSCEEECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EeCCcChhhceeeCCCCCEEEeecCcceeccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCC
Confidence 9999999999996 578999999999975322 23345679999999998865 69999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
||....... .+.. .+... ...+.+ +.....++.+|+.+||+.||++|||+.|+++
T Consensus 211 Pf~~~~~~~--~~~~---~i~~~------~~~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 211 PYSECQNAA--QIYR---RVTSG------VKPASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TTTTCSSHH--HHHH---HHTTT------CCCGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCcccHH--HHHH---HHHcC------CCCccc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 997543211 1111 11100 000011 1112346789999999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=334.63 Aligned_cols=214 Identities=22% Similarity=0.300 Sum_probs=162.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcC-CCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDK-ANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~-~~~~ivHr 79 (325)
+|++++|||||+++++|.+.++.|+||||+++|+|.+++.. ...+++..+..++.|++.||.|||++ + |+||
T Consensus 57 il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHR 129 (322)
T d1s9ja_ 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHR 129 (322)
T ss_dssp GGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCS
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcc
Confidence 57899999999999999999999999999999999999975 45699999999999999999999974 8 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
||||+||||+.++.+||+|||+|+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 130 DiKP~NILl~~~~~vkl~DFGla~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 130 DVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp CCSGGGEEECTTCCEEECCCCCCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ccCHHHeeECCCCCEEEeeCCCccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999975321 123456899999999999999999999999999999999999999976
Q ss_pred CCCCCcchhhhh-hhhcc------------------ccc-------cccccccCCccCCCCC-hHHHHHHHHHHHHchhh
Q 020529 160 TRPHGEQNLVTW-ARPLF------------------NDR-------RKFSKLADPRLEGRYP-IRGLYQALAVASMCIQE 212 (325)
Q Consensus 160 ~~~~~~~~~~~~-~~~~~------------------~~~-------~~~~~~~d~~l~~~~~-~~~~~~~~~l~~~cl~~ 212 (325)
............ ..... ... .......... ....+ ...+.++.+|+.+||+.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~~L~~ 284 (322)
T d1s9ja_ 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP-PPKLPSGVFSLEFQDFVNKCLIK 284 (322)
T ss_dssp CCTTHHHHHC------------------------------CCCCHHHHHHHHHTSC-CCCCCBTTBCHHHHHHHHHHTCS
T ss_pred CCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccC-CccCccccCCHHHHHHHHHHcCC
Confidence 443211000000 00000 000 0000000000 00001 11245788999999999
Q ss_pred CCCCCCCHHHHHHH
Q 020529 213 QAATRPLIGDVVTA 226 (325)
Q Consensus 213 ~p~~RPs~~evl~~ 226 (325)
||.+|||+.|+++.
T Consensus 285 dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 285 NPAERADLKQLMVH 298 (322)
T ss_dssp STTTSCCHHHHHTS
T ss_pred ChhHCcCHHHHhhC
Confidence 99999999999884
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=329.77 Aligned_cols=202 Identities=22% Similarity=0.326 Sum_probs=162.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||++++++.+.+..++|||||++|+|.+++.. ...++++..+..++.|++.||.|||+++ |+|||
T Consensus 62 il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrD 135 (288)
T d2jfla1 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRD 135 (288)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEee
Confidence 36789999999999999999999999999999999999765 2456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhc-----cCCCCccccEEEehHHHHHHHhCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAM-----TGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||+|||++.++.+||+|||+++.... .........||+.|+|||++. ...++.++|||||||++|||++|+.
T Consensus 136 iKp~NIll~~~~~~Kl~DFG~a~~~~~--~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~ 213 (288)
T d2jfla1 136 LKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 213 (288)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECHH--HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSC
T ss_pred cChhheeECCCCCEEEEechhhhccCC--CcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCC
Confidence 999999999999999999999864321 111234567999999999984 4567899999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
||........ +.. +.... .... ..+......+.+|+.+||+.||.+|||+.|+++
T Consensus 214 Pf~~~~~~~~--~~~----i~~~~--~~~~-------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 214 PHHELNPMRV--LLK----IAKSE--PPTL-------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp TTTTSCGGGH--HHH----HHHSC--CCCC-------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCHHHH--HHH----HHcCC--CCCC-------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9976543221 111 11100 0000 112233467889999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=326.51 Aligned_cols=210 Identities=23% Similarity=0.362 Sum_probs=162.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+.+..++||||+.+++|.+++.. ....+++..++.++.|++.||+|||+.+ |+|||
T Consensus 62 il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrD 135 (283)
T d1mqba_ 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRD 135 (283)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCc
Confidence 36789999999999999999999999999999999998876 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCC-CCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+||||+.++.+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+++..|+..
T Consensus 136 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 136 LAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp CCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 999999999999999999999986543322 2233445689999999999999999999999999999999997555433
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.... ..+..... . ......+......+.+|+.+||+.+|++||++.+|++.|+.+..
T Consensus 216 ~~~~--~~~~~~i~----~----------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 216 ELSN--HEVMKAIN----D----------GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TCCH--HHHHHHHH----T----------TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCH--HHHHHHHh----c----------cCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 2211 11111111 0 01112222344678899999999999999999999999998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-45 Score=327.32 Aligned_cols=202 Identities=23% Similarity=0.322 Sum_probs=153.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||++++++.+++..|+|||||+||+|.+++.. ...+++..+..++.|++.||+|||+++ |+|||
T Consensus 60 il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrD 132 (307)
T d1a06a_ 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRD 132 (307)
T ss_dssp HHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEE
Confidence 36789999999999999999999999999999999999975 557999999999999999999999999 99999
Q ss_pred CCCCcEEEc---CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLE---EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~---~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+|||+. +++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 133 iKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf 209 (307)
T d1a06a_ 133 LKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 209 (307)
T ss_dssp CCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ecccceeecccCCCceEEEeccceeEEccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCC
Confidence 999999994 5789999999999854322 2234467999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....... +. ..+...... +. ...+...+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 210 ~~~~~~~---~~---~~i~~~~~~----~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 210 YDENDAK---LF---EQILKAEYE----FD----SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCSSHHH---HH---HHHHTTCCC----CC----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCHHH---HH---HHHhccCCC----CC----CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 7643211 11 111111100 11 11112234578899999999999999999999863
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=324.55 Aligned_cols=208 Identities=25% Similarity=0.374 Sum_probs=163.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||++++++.+ +..++||||+++|+|.+++... ....+++..++.|+.||+.||.|||+++ |+|||
T Consensus 61 ~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrD 134 (272)
T d1qpca_ 61 LMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRD 134 (272)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCc
Confidence 3678899999999998864 5679999999999999987642 2235999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||++++.+||+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+||..|+...
T Consensus 135 iKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~ 213 (272)
T d1qpca_ 135 LRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (272)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cchhheeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999998754322 22334567899999999999999999999999999999999965554332
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
... ..+...... ...+ ..+......+.+|+.+||+.+|++|||+.+|++.|+.+-
T Consensus 214 ~~~--~~~~~~i~~----------~~~~----~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 214 MTN--PEVIQNLER----------GYRM----VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCH--HHHHHHHHT----------TCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCH--HHHHHHHHh----------cCCC----CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 111 111111110 0011 112233456889999999999999999999999998654
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=317.95 Aligned_cols=204 Identities=22% Similarity=0.366 Sum_probs=168.4
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
+++++|||||+++++|.+++..++||||+++|+|.+++.. ....+++..+++++.|++.||+|||+.+ |+||||
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dl 126 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDL 126 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCC
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccc
Confidence 6788999999999999999999999999999999999765 3556899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~~ 160 (325)
||+||+++.++.+||+|||+++...... ........||+.|+|||++....++.++|||||||++|||+| |+.||...
T Consensus 127 k~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~ 205 (258)
T d1k2pa_ 127 AARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205 (258)
T ss_dssp SGGGEEECTTCCEEECCCSSCCBCSSSS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred cceeEEEcCCCcEEECcchhheeccCCC-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC
Confidence 9999999999999999999997654332 223445679999999999999999999999999999999998 89999766
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
.... +.. .+.. . .... .|......+.+|+.+||+.||++|||+.+|++.|..
T Consensus 206 ~~~~---~~~---~i~~-~---~~~~-------~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 206 TNSE---TAE---HIAQ-G---LRLY-------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHH---HHH---HHHT-T---CCCC-------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CHHH---HHH---HHHh-C---CCCC-------CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 4322 111 1110 0 0111 122233578899999999999999999999998854
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-45 Score=325.94 Aligned_cols=197 Identities=27% Similarity=0.343 Sum_probs=160.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+++..|+|||||.+|+|..++.. +.++++..++.++.||+.||.|||+++ |+|||
T Consensus 68 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrD 140 (309)
T d1u5ra_ 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRD 140 (309)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccC
Confidence 47889999999999999999999999999999999877654 457999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc---CCCCccccEEEehHHHHHHHhCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT---GQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
|||+||||+.++.+||+|||+++... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||
T Consensus 141 iKp~NILl~~~~~~Kl~DFG~a~~~~------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf 214 (309)
T d1u5ra_ 141 VKAGNILLSEPGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (309)
T ss_dssp CSGGGEEEETTTEEEECCCTTCBSSS------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CCcceEEECCCCCEEEeecccccccC------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCC
Confidence 99999999999999999999997532 2334679999999999864 46899999999999999999999999
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
........ + ..+... ..+.+. +......+.+|+.+||+.||.+|||+.|+++.
T Consensus 215 ~~~~~~~~--~----~~i~~~-------~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 215 FNMNAMSA--L----YHIAQN-------ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp TTSCHHHH--H----HHHHHS-------CCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCHHHH--H----HHHHhC-------CCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 75432111 1 011110 001111 11223578899999999999999999999863
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=318.94 Aligned_cols=207 Identities=23% Similarity=0.337 Sum_probs=158.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|. .+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+|||
T Consensus 61 ~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrD 133 (273)
T d1mp8a_ 61 TMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRD 133 (273)
T ss_dssp HHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccc
Confidence 367899999999999996 4678999999999999998765 3556999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||+++.++.+||+|||+++...... ........||+.|+|||++....++.++|||||||++|||++ |.+||..
T Consensus 134 lKp~NIll~~~~~~Kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 134 IAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp CSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cchhheeecCCCcEEEccchhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 99999999999999999999998643322 223445668999999999999999999999999999999998 8999977
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
...... ..... ... .+ ..+......+.+|+.+||+.||.+|||+.+|++.|+.+.+
T Consensus 213 ~~~~~~---~~~i~----~~~------~~----~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 213 VKNNDV---IGRIE----NGE------RL----PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp CCGGGH---HHHHH----TTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHH---HHHHH----cCC------CC----CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 644321 11110 000 00 1122334678899999999999999999999999987754
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-44 Score=324.74 Aligned_cols=208 Identities=25% Similarity=0.406 Sum_probs=166.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.++ ..+++++|+.+++|.+++.. ....+++..++.++.||+.||+|||+++ |+|||
T Consensus 64 ~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrD 136 (317)
T d1xkka_ 64 VMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRD 136 (317)
T ss_dssp HHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCc
Confidence 36788999999999999875 46778899989999998876 4567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~~ 159 (325)
|||+||||+.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||+.
T Consensus 137 lKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 137 LAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp CCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred chhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 999999999999999999999987655444444455679999999999999999999999999999999998 7899876
Q ss_pred CCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 160 TRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.........+ .... ....+......+.+|+.+||+.||.+|||+.+|++.|..+..
T Consensus 217 ~~~~~~~~~i-------~~~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 217 IPASEISSIL-------EKGE----------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp SCGGGHHHHH-------HHTC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHHHHHHH-------HcCC----------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 5432211111 1100 011122334578899999999999999999999999988754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.8e-44 Score=324.33 Aligned_cols=203 Identities=23% Similarity=0.289 Sum_probs=164.2
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++|+|||||+++++|.+.+..|||||||++|+|.+++.. ....+++..++.|+.||+.||+|||+++ |||||
T Consensus 76 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrD 149 (350)
T d1koaa2 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLD 149 (350)
T ss_dssp HHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---Ceeee
Confidence 36788999999999999999999999999999999999965 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcC--CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 81 FKSSNILLEE--GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 81 ik~~Nill~~--~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|||+|||++. ++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus 150 iKp~NIll~~~~~~~vkL~DFG~a~~~~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp CCGGGEEESSTTSCCEEECCCTTCEECCTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred echhHeeeccCCCCeEEEeecchheecccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 9999999954 578999999999864322 23445679999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....... ...+...... +... ........+.+|+.+||+.||.+|||++|+++.
T Consensus 227 ~~~~~~~------~~~i~~~~~~----~~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 227 GENDDET------LRNVKSCDWN----MDDS----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CSSHHHH------HHHHHHTCCC----SCCG----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCHHHH------HHHHHhCCCC----CCcc----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 6432211 1111111100 0111 111224578899999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.8e-44 Score=326.23 Aligned_cols=203 Identities=21% Similarity=0.275 Sum_probs=165.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++|+|||||+++++|.+.+..|||||||++|+|.+++.. ...++++..++.|+.||+.||+|||+++ |+|||
T Consensus 79 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRD 152 (352)
T d1koba_ 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLD 152 (352)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 47889999999999999999999999999999999988765 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEc--CCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 81 FKSSNILLE--EGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 81 ik~~Nill~--~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|||+||||+ .++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|+||+.||.
T Consensus 153 iKp~NILl~~~~~~~vkL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 153 IKPENIMCETKKASSVKIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp CCGGGEEESSTTCCCEEECCCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cccccccccccCCCeEEEeecccceecCCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 999999997 5789999999999865432 23455679999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...... +. ..+...... +.. .........+.+|+.+||+.||.+|||+.|+++.
T Consensus 230 ~~~~~~---~~---~~i~~~~~~----~~~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 230 GEDDLE---TL---QNVKRCDWE----FDE----DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSHHH---HH---HHHHHCCCC----CCS----STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCHHH---HH---HHHHhCCCC----CCc----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 543211 11 111111000 011 1112234578899999999999999999999763
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=319.98 Aligned_cols=210 Identities=26% Similarity=0.390 Sum_probs=172.4
Q ss_pred CC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhc
Q 020529 4 LL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHD 70 (325)
Q Consensus 4 ~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~LH~ 70 (325)
++ +|||||+++++|.+++..++||||+.+|+|.+++..... ....+++.+++.++.|++.||+|||+
T Consensus 74 ~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~ 153 (299)
T d1fgka_ 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 153 (299)
T ss_dssp HHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh
Confidence 44 899999999999999999999999999999999976432 23568999999999999999999999
Q ss_pred CCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHH
Q 020529 71 KANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 71 ~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~el 150 (325)
.+ ||||||||+|||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||
T Consensus 154 ~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~el 230 (299)
T d1fgka_ 154 KK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230 (299)
T ss_dssp TT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHh
Confidence 99 999999999999999999999999999876554444445567799999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHh
Q 020529 151 IT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSY 229 (325)
Q Consensus 151 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~ 229 (325)
++ |.+||....... +... +.... ....+......+.+|+.+||+.||++|||+.||++.|+.
T Consensus 231 l~~g~~p~~~~~~~~---~~~~----i~~~~----------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~ 293 (299)
T d1fgka_ 231 FTLGGSPYPGVPVEE---LFKL----LKEGH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293 (299)
T ss_dssp HTTSCCSSTTCCHHH---HHHH----HHTTC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ccCCCCCCCCCCHHH---HHHH----HHcCC----------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 98 688886544221 1111 11110 111122334578899999999999999999999999998
Q ss_pred hhcc
Q 020529 230 LANQ 233 (325)
Q Consensus 230 ~~~~ 233 (325)
+.+.
T Consensus 294 i~a~ 297 (299)
T d1fgka_ 294 IVAL 297 (299)
T ss_dssp HHHH
T ss_pred Hhhc
Confidence 8653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=320.63 Aligned_cols=209 Identities=26% Similarity=0.355 Sum_probs=160.8
Q ss_pred CCCCCccceeeEEEeC-CeeEEEEecCCCCCHHHHhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhcC
Q 020529 5 LHHSNLVNLIGYCADG-DQRLLVYEFMPLGSLEDHLHDLPP------------DKEALDWNTRMKIAAGAAKGLEYLHDK 71 (325)
Q Consensus 5 l~Hpniv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~------------~~~~l~~~~~~~i~~~l~~al~~LH~~ 71 (325)
.+||||+.+++++.+. ...++|||||++|+|.++++.... ....+++..++.++.|++.||+|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4899999999998764 468999999999999999975321 134589999999999999999999999
Q ss_pred CCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHH
Q 020529 72 ANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELI 151 (325)
Q Consensus 72 ~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ell 151 (325)
+ ||||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ell 230 (299)
T d1ywna1 154 K---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230 (299)
T ss_dssp T---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHH
Confidence 9 9999999999999999999999999998755544444455678999999999999999999999999999999999
Q ss_pred hCC-CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 152 TGR-KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 152 tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
||. +||....... .+.. .+.... .+ ..+.....++.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 231 t~~~~p~~~~~~~~--~~~~----~~~~~~------~~----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 231 SLGASPYPGVKIDE--EFCR----RLKEGT------RM----RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp TTSCCSSTTCCCSH--HHHH----HHHHTC------CC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHH--HHHH----HHhcCC------CC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 874 5676543221 1111 111110 01 11222345688999999999999999999999999987
Q ss_pred hc
Q 020529 231 AN 232 (325)
Q Consensus 231 ~~ 232 (325)
.+
T Consensus 295 lq 296 (299)
T d1ywna1 295 LQ 296 (299)
T ss_dssp HH
T ss_pred Hh
Confidence 54
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-43 Score=319.53 Aligned_cols=199 Identities=26% Similarity=0.328 Sum_probs=165.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++||||++++++|.+.+..|+|||||++|+|.+++.. ...+++..++.++.|++.||+|||+++ |||||
T Consensus 58 il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRD 130 (337)
T d1o6la_ 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRD 130 (337)
T ss_dssp HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCC
T ss_pred HHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccc
Confidence 46789999999999999999999999999999999999976 556999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+|||++.+|.+||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 131 lKP~NILl~~~g~vkl~DFG~a~~~~~~--~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 131 IKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CCGGGEEECTTSCEEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCHHHeEecCCCCEEEeecccccccccC--CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 9999999999999999999999864332 22344577999999999999999999999999999999999999999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
.... + ...+..... .+|...+.++.+|+.+||+.||.+||+ +.++++.
T Consensus 209 ~~~~---~---~~~i~~~~~------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 209 DHER---L---FELILMEEI------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp SHHH---H---HHHHHHCCC------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred CHHH---H---HHHHhcCCC------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 4221 1 111111111 112233456889999999999999995 7888763
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=314.21 Aligned_cols=206 Identities=27% Similarity=0.377 Sum_probs=160.7
Q ss_pred CcCCCCCCCccceeeEEEe-CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++|||||+++++|.+ .+..++||||+++|+|.+++... ....+++.++++|+.||+.||+|||+.+ |+||
T Consensus 53 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~ 127 (262)
T d1byga_ 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 127 (262)
T ss_dssp HHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eecc
Confidence 4688999999999999865 45689999999999999999651 1235899999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~ 158 (325)
||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+..++.++|||||||++|||+| |++||.
T Consensus 128 dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~ 202 (262)
T d1byga_ 128 DLAARNVLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 202 (262)
T ss_dssp CCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred ccchHhheecCCCCEeecccccceecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999999975322 2233568899999999999999999999999999999998 688876
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
..... .+..+.... .....+......+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 203 ~~~~~---~~~~~i~~~--------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 203 RIPLK---DVVPRVEKG--------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp TSCGG---GHHHHHTTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHH---HHHHHHHcC--------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 64322 222221110 01112223335788999999999999999999999999988653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=316.41 Aligned_cols=208 Identities=25% Similarity=0.352 Sum_probs=159.1
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|++++|||||+++++|.+ +..++||||+++|+|..++... ....+++..++.++.+|+.||+|||+.+ |+||||
T Consensus 66 l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~Dl 139 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDL 139 (285)
T ss_dssp HHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred HHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccc
Confidence 678999999999999854 5679999999999999998652 2345999999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTR 161 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~ 161 (325)
||+||||+.++.+||+|||+++...... ........||+.|+|||++..+.++.++|||||||++|||++|..|+....
T Consensus 140 Kp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~ 218 (285)
T d1fmka3 140 RAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218 (285)
T ss_dssp SGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred cceEEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999998643322 223445679999999999999999999999999999999999765554322
Q ss_pred CCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 162 PHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.. ..+...+... ..+ ..+......+.+|+.+||+.||++||++.+|+++|+....
T Consensus 219 ~~--~~~~~~i~~~----------~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 219 VN--REVLDQVERG----------YRM----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CH--HHHHHHHHTT----------CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CH--HHHHHHHHhc----------CCC----CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 11 1111111110 011 1122334578899999999999999999999999987554
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=314.63 Aligned_cols=201 Identities=23% Similarity=0.302 Sum_probs=163.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+.+..|||||||++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||
T Consensus 66 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrD 138 (293)
T d1jksa_ 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFD 138 (293)
T ss_dssp HHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecc
Confidence 36788999999999999999999999999999999999976 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCC----eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCC
Q 020529 81 FKSSNILLEEGF----HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 81 ik~~Nill~~~~----~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
|||+|||++.++ .+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 139 iKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 139 LKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccceEEEecCCCcccceEecchhhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence 999999998776 5999999999764332 233456789999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
|......... ..+......+. +.. +...+..+.+|+.+||+.||.+|||++|+++
T Consensus 216 f~~~~~~~~~------~~i~~~~~~~~----~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 216 FLGDTKQETL------ANVSAVNYEFE----DEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp SCCSSHHHHH------HHHHTTCCCCC----HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHH------HHHHhcCCCCC----chh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9764322111 11111100000 000 1122356789999999999999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.7e-43 Score=314.73 Aligned_cols=196 Identities=29% Similarity=0.416 Sum_probs=164.0
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||++++++.+.+..|+|||||.||+|..++.. ...+++..+..++.||+.||+|||+++ |+|||
T Consensus 57 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrD 129 (316)
T d1fota_ 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRD 129 (316)
T ss_dssp HHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccc
Confidence 46789999999999999999999999999999999999976 556899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 130 iKp~NILl~~~g~vkL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 130 LKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp CCGGGEEECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred cCchheeEcCCCCEEEecCccceEecc-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 999999999999999999999986432 234567999999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~~ 226 (325)
..... ...+..... .++......+.+++.+||+.||.+|| +++++++.
T Consensus 205 ~~~~~------~~~i~~~~~------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 205 NTMKT------YEKILNAEL------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp SHHHH------HHHHHHCCC------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CHHHH------HHHHHcCCC------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 32211 111111111 11222335688999999999999996 89999864
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-44 Score=318.34 Aligned_cols=211 Identities=23% Similarity=0.419 Sum_probs=168.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC--------------------CCCCCCHHHHHHHHHH
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--------------------DKEALDWNTRMKIAAG 60 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ 60 (325)
+|++++||||++++++|...+..++||||+.+|+|.+++..... ....+++..++.|+.|
T Consensus 69 il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 148 (301)
T d1lufa_ 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQ 148 (301)
T ss_dssp HHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHH
T ss_pred HHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHH
Confidence 36789999999999999999999999999999999999965321 2345899999999999
Q ss_pred HHHHHHHHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccE
Q 020529 61 AAKGLEYLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDV 140 (325)
Q Consensus 61 l~~al~~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDv 140 (325)
++.||+|||+.+ ||||||||+||||+.++.+||+|||+++...............||+.|+|||++.+..++.++||
T Consensus 149 i~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDV 225 (301)
T d1lufa_ 149 VAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225 (301)
T ss_dssp HHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhh
Confidence 999999999999 99999999999999999999999999986544444444556678999999999999999999999
Q ss_pred EEehHHHHHHHhCC-CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC
Q 020529 141 YSFGVVFLELITGR-KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 141 wSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
|||||++|||++|. +||......+ +...+ . ... .. ..+...+.++.+|+..||+.+|.+|||
T Consensus 226 wS~Gvvl~ell~~~~~p~~~~~~~e---~~~~v---~-~~~-~~---------~~p~~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 226 WAYGVVLWEIFSYGLQPYYGMAHEE---VIYYV---R-DGN-IL---------ACPENCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp HHHHHHHHHHHTTTCCTTTTSCHHH---HHHHH---H-TTC-CC---------CCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccchhhHHHHHccCCCCCCCCCHHH---HHHHH---H-cCC-CC---------CCCccchHHHHHHHHHHcCCChhHCcC
Confidence 99999999999995 5676543221 11111 1 110 00 112233457889999999999999999
Q ss_pred HHHHHHHHHhhh
Q 020529 220 IGDVVTALSYLA 231 (325)
Q Consensus 220 ~~evl~~L~~~~ 231 (325)
+.||+++|+.+.
T Consensus 289 ~~ev~~~L~~i~ 300 (301)
T d1lufa_ 289 FCSIHRILQRMC 300 (301)
T ss_dssp HHHHHHHHHHTT
T ss_pred HHHHHHHHHHhc
Confidence 999999998864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.3e-43 Score=320.82 Aligned_cols=199 Identities=23% Similarity=0.270 Sum_probs=162.8
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|+.++|||||+++++|.+.+..|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||+++ ||||||
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDl 133 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDL 133 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceee
Confidence 5678899999999999999999999999999999999976 456899999999999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
||+||||+.++.+||+|||+++..... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||...
T Consensus 134 KP~NILl~~~g~iKl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 134 KPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp SGGGEEECSSSCEEECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ccceeEEcCCCcEEEeeeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999864322 2344679999999999975 46899999999999999999999999765
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVTA 226 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~~ 226 (325)
.......+.. ...... + ..+......+.+|+.+||+.||.+||+ ++|+++.
T Consensus 210 ~~~~~~~~~~---~~~~~~--------~----~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 210 KTKDKHEIDR---MTLTMA--------V----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp CSSCHHHHHH---HSSSCC--------C----CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred CHHHHHHHHH---hcccCC--------C----CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 4332221111 111110 0 112223456889999999999999999 6888764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-43 Score=312.80 Aligned_cols=226 Identities=23% Similarity=0.278 Sum_probs=166.0
Q ss_pred cCCCCCCCccceeeEEEeCC----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----
Q 020529 2 LSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA----- 72 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~----- 72 (325)
+++++|||||+++++|.+.+ ..++|||||++|+|.++++. ..++|..++.++.+++.||+|||+..
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~ 125 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQG 125 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTC
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence 56789999999999997654 67999999999999999975 35999999999999999999999741
Q ss_pred CCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC--CccccccCCcCccCchhhccCC------CCccccEEEeh
Q 020529 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTGQ------LTVKSDVYSFG 144 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~ksDvwSlG 144 (325)
..+|+||||||+||||+.++.+||+|||+++........ .......||+.|+|||++.... ++.++||||||
T Consensus 126 ~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~G 205 (303)
T d1vjya_ 126 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMG 205 (303)
T ss_dssp BCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHH
T ss_pred CCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhH
Confidence 123999999999999999999999999999865443221 1234567999999999987653 57789999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCcchhhh----hhhhccccccccccccCCccCCCC-ChHHHHHHHHHHHHchhhCCCCCCC
Q 020529 145 VVFLELITGRKAIDSTRPHGEQNLVT----WARPLFNDRRKFSKLADPRLEGRY-PIRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 145 vvl~elltg~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
|++|||+||..|+............. +....... ........|.+...+ +.+....+.+|+.+||+.||.+|||
T Consensus 206 vvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 284 (303)
T d1vjya_ 206 LVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK-VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284 (303)
T ss_dssp HHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH-HHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred HHHHHHhhCCCCCCcccccccchhhcccccchHHHHHH-HHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC
Confidence 99999999998875433222111000 00000000 000111122221111 2234567889999999999999999
Q ss_pred HHHHHHHHHhhhcc
Q 020529 220 IGDVVTALSYLANQ 233 (325)
Q Consensus 220 ~~evl~~L~~~~~~ 233 (325)
+.||++.|+.+...
T Consensus 285 ~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 285 ALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999988754
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-43 Score=312.65 Aligned_cols=207 Identities=26% Similarity=0.362 Sum_probs=163.6
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+ +..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++ |+|||
T Consensus 64 ~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrD 136 (273)
T d1u46a_ 64 AMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRD 136 (273)
T ss_dssp HHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---Eeeee
Confidence 3678899999999999975 467899999999999998875 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCC-ccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh-CCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSH-VSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT-GRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt-g~~p~~ 158 (325)
|||+||+|+.++.+||+|||+++......... ......|++.|+|||++.+..++.++|||||||++|||+| |+.||.
T Consensus 137 ikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~ 216 (273)
T d1u46a_ 137 LAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216 (273)
T ss_dssp CCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998754433222 2334567889999999999999999999999999999998 899997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
...... ...+ +..... ....+...+..+.+|+.+||+.||++|||+.+|++.|.+.
T Consensus 217 ~~~~~~---~~~~---i~~~~~----------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 217 GLNGSQ---ILHK---IDKEGE----------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TCCHHH---HHHH---HHTSCC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CcCHHH---HHHH---HHhCCC----------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 543221 1111 111110 0011222335688999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-43 Score=314.02 Aligned_cols=209 Identities=26% Similarity=0.379 Sum_probs=167.6
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------------PDKEALDWNTRMKIAAGAAKGLEYL 68 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~~~l~~~~~~~i~~~l~~al~~L 68 (325)
|+++ +|||||+++++|.+.+..++||||+++|+|.++++... .....+++..++.++.||+.||.||
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 6677 79999999999999999999999999999999997531 2346799999999999999999999
Q ss_pred hcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHH
Q 020529 69 HDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 69 H~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ 148 (325)
|+.+ |+||||||+|||++.++.+||+|||+++..... .......||..|+|||.+....++.++|||||||++|
T Consensus 144 H~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ 217 (309)
T d1fvra_ 144 SQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLW 217 (309)
T ss_dssp HHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred hcCC---ccccccccceEEEcCCCceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHH
Confidence 9999 999999999999999999999999999753322 2233456899999999999999999999999999999
Q ss_pred HHHhCC-CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHH
Q 020529 149 ELITGR-KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTAL 227 (325)
Q Consensus 149 elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L 227 (325)
||++|. +||....... +...+ .. . .....+......+.+|+.+||+.||++|||+.||++.|
T Consensus 218 ell~~~~~p~~~~~~~~---~~~~i---~~-~----------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L 280 (309)
T d1fvra_ 218 EIVSLGGTPYCGMTCAE---LYEKL---PQ-G----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 280 (309)
T ss_dssp HHHTTSCCTTTTCCHHH---HHHHG---GG-T----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhcCCCCCCCCCHHH---HHHHH---Hh-c----------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999975 5665543221 11111 10 0 00111223346788999999999999999999999999
Q ss_pred Hhhhcc
Q 020529 228 SYLANQ 233 (325)
Q Consensus 228 ~~~~~~ 233 (325)
+.+...
T Consensus 281 ~~i~~~ 286 (309)
T d1fvra_ 281 NRMLEE 286 (309)
T ss_dssp HHHHHS
T ss_pred HHHHhc
Confidence 998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-43 Score=313.08 Aligned_cols=211 Identities=26% Similarity=0.399 Sum_probs=168.3
Q ss_pred CcCCCCCCCccceeeEEEe-CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeC
Q 020529 1 MLSLLHHSNLVNLIGYCAD-GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYR 79 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHr 79 (325)
+|++++||||+++++++.+ +...++|||||++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||
T Consensus 81 ~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHr 154 (311)
T d1r0pa_ 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHR 154 (311)
T ss_dssp HHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred HHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccC
Confidence 3678999999999999876 4688999999999999999876 4556889999999999999999999999 9999
Q ss_pred CCCCCcEEEcCCCeEEEecCCCCccCCCCCCC--CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 80 DFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 80 dik~~Nill~~~~~~kL~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||||+||||++++.+||+|||+++........ .......||+.|+|||++....++.++||||||+++|||+||..||
T Consensus 155 DLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~ 234 (311)
T d1r0pa_ 155 DLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234 (311)
T ss_dssp CCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCC
Confidence 99999999999999999999999865433222 2234467899999999999999999999999999999999988777
Q ss_pred CCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhcc
Q 020529 158 DSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLANQ 233 (325)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~~ 233 (325)
...... ..+..+. .... .... |......+.+|+.+||+.||++||++.||++.|+.+...
T Consensus 235 ~~~~~~--~~~~~~i---~~g~----~~~~-------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 235 YPDVNT--FDITVYL---LQGR----RLLQ-------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CC--------CHHHH---HTTC----CCCC-------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCH--HHHHHHH---HcCC----CCCC-------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 543211 1111111 1110 1111 112235688999999999999999999999999998754
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-43 Score=316.39 Aligned_cols=212 Identities=27% Similarity=0.407 Sum_probs=170.9
Q ss_pred cCCC-CCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCC--------------CCCCCCHHHHHHHHHHHHHHHH
Q 020529 2 LSLL-HHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPP--------------DKEALDWNTRMKIAAGAAKGLE 66 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~l~~~~~~~i~~~l~~al~ 66 (325)
++++ +|||||+++++|.+.+..++|||||++|+|.++++.... ....+++..++.++.|++.||+
T Consensus 80 ~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ 159 (311)
T d1t46a_ 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (311)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 3445 799999999999999999999999999999999976431 2346999999999999999999
Q ss_pred HHhcCCCCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHH
Q 020529 67 YLHDKANPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVV 146 (325)
Q Consensus 67 ~LH~~~~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvv 146 (325)
|||+++ +|||||||+||+++.++.++|+|||+++...............||+.|+|||++....++.++|||||||+
T Consensus 160 ~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~ 236 (311)
T d1t46a_ 160 FLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236 (311)
T ss_dssp HHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHH
Confidence 999999 99999999999999999999999999987665554555566789999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 147 FLELIT-GRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 147 l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
+|||+| |.+|+........ +..... . ......+......+.+|+.+||+.||.+|||+.+|++
T Consensus 237 l~ellt~g~p~~~~~~~~~~--~~~~i~----~----------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 237 LWELFSLGSSPYPGMPVDSK--FYKMIK----E----------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTTTCCSSTTCCSSHH--HHHHHH----H----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHH--HHHHHh----c----------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999998 5555655433211 111111 0 0111112223457889999999999999999999999
Q ss_pred HHHhhhc
Q 020529 226 ALSYLAN 232 (325)
Q Consensus 226 ~L~~~~~ 232 (325)
+|+....
T Consensus 301 ~L~~~i~ 307 (311)
T d1t46a_ 301 LIEKQIS 307 (311)
T ss_dssp HHHHHHH
T ss_pred HHHHhhc
Confidence 9987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.9e-42 Score=305.52 Aligned_cols=209 Identities=22% Similarity=0.300 Sum_probs=159.2
Q ss_pred cCCCCCCCccceeeEEEeCC----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 2 LSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
|++++|||||++++++...+ ..|+||||++|++|.+++.. ..++++.+++.|+.|++.||+|||+.+ |+
T Consensus 61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ii 133 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---II 133 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cc
Confidence 67899999999999987643 47999999999999999876 456999999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCeEEEecCCCCccCCCCCC-CCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCC
Q 020529 78 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 78 Hrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p 156 (325)
||||||+|||++.++.++|+|||+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.|
T Consensus 134 HrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~P 213 (277)
T d1o6ya_ 134 HRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 213 (277)
T ss_dssp CCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred CccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCC
Confidence 999999999999999999999999875433222 2233456799999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-CHHHHHHHHHhhh
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-LIGDVVTALSYLA 231 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-s~~evl~~L~~~~ 231 (325)
|....... .....+.......... ....+..+.+++.+||+.||.+|| ++.+++..|..+.
T Consensus 214 f~~~~~~~------~~~~~~~~~~~~~~~~--------~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 214 FTGDSPVS------VAYQHVREDPIPPSAR--------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCCSSHHH------HHHHHHHCCCCCGGGT--------SSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCcCHHH------HHHHHHhcCCCCCchh--------ccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 97643221 1111111111111111 112235788999999999999999 8999999887664
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=314.94 Aligned_cols=206 Identities=19% Similarity=0.209 Sum_probs=159.5
Q ss_pred CCCCCCCccceeeEEEe----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 3 SLLHHSNLVNLIGYCAD----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
+.++|||||+++++|.+ ....|+|||||+||+|.+++... ....+++..+..|+.|++.||+|||+.+ |+|
T Consensus 60 ~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiH 134 (335)
T d2ozaa1 60 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAH 134 (335)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccc
Confidence 34589999999999875 46789999999999999999752 2346999999999999999999999999 999
Q ss_pred CCCCCCcEEEcC---CCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCC
Q 020529 79 RDFKSSNILLEE---GFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRK 155 (325)
Q Consensus 79 rdik~~Nill~~---~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~ 155 (325)
|||||+|||++. .+.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.
T Consensus 135 RDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 135 RDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp CCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred ccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCC
Confidence 999999999975 5679999999998644322 2345679999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 156 AIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
||............ ...+... . ..+........+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 212 Pf~~~~~~~~~~~~--~~~i~~~-----~---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 212 PFYSNHGLAISPGM--KTRIRMG-----Q---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp SCEETTCC----------CCCSC-----S---SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCCHHHHHHHH--HHHHhcC-----C---CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 99765432211100 0000000 0 000000011234678899999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-43 Score=314.93 Aligned_cols=196 Identities=26% Similarity=0.390 Sum_probs=162.6
Q ss_pred CCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCCC
Q 020529 3 SLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDFK 82 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdik 82 (325)
+.++|||||++++++.+++..||||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+|||||
T Consensus 58 ~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDik 130 (320)
T d1xjda_ 58 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLK 130 (320)
T ss_dssp HHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCC
T ss_pred HhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 357999999999999999999999999999999999976 456899999999999999999999999 9999999
Q ss_pred CCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCCCC
Q 020529 83 SSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSTRP 162 (325)
Q Consensus 83 ~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~~~ 162 (325)
|+|||++.++++||+|||+++..... ....+...||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 131 p~NiL~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 131 LDNILLDKDGHIKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp GGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccceeecCCCceeccccchhhhcccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999864332 2334456799999999999999999999999999999999999999976532
Q ss_pred CCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH-HHHH
Q 020529 163 HGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG-DVVT 225 (325)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~-evl~ 225 (325)
... . ..+.... + .+|......+.+|+.+||+.||.+||++. +|++
T Consensus 209 ~~~---~---~~i~~~~--------~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 209 EEL---F---HSIRMDN--------P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHH---H---HHHHHCC--------C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHH---H---HHHHcCC--------C----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 211 1 1111111 1 11222335688999999999999999995 6754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-42 Score=306.45 Aligned_cols=200 Identities=24% Similarity=0.272 Sum_probs=161.6
Q ss_pred cCCCC-CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|++++ ||||+++++++.+++..|||||||++|+|.+++.. ..++++..++.++.||+.||+|||+++ |+|||
T Consensus 63 l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrD 135 (277)
T d1phka_ 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRD 135 (277)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---Ccccc
Confidence 45665 99999999999999999999999999999999975 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc------CCCCccccEEEehHHHHHHHhCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT------GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|||+|||++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+
T Consensus 136 lkp~Nill~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 136 LKPENILLDDDMNIKLTDFGFSCQLDPG---EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cccceEEEcCCCCeEEccchheeEccCC---CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCC
Confidence 9999999999999999999999865432 23345679999999999864 34688999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.||......... ..+...... . ........+.++.+|+.+||+.+|.+|||+.||++
T Consensus 213 ~Pf~~~~~~~~~------~~i~~~~~~---~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 213 PPFWHRKQMLML------RMIMSGNYQ---F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CSSCCSSHHHHH------HHHHHTCCC---C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCCCCCCHHHHH------HHHHhCCCC---C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999765322111 111111100 0 01111233467889999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-42 Score=314.34 Aligned_cols=195 Identities=23% Similarity=0.281 Sum_probs=163.1
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||++++++.+....++||||+.+|+|..++.. ...+++..++.++.||+.||.|||+.+ |||||
T Consensus 94 il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRD 166 (350)
T d1rdqe_ 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRD 166 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHHcCCCcEeecccccccccccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCc
Confidence 47889999999999999999999999999999999999976 456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDST 160 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~~~ 160 (325)
|||+||||+.++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||+||+.||...
T Consensus 167 IKP~NILl~~~g~ikL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 241 (350)
T d1rdqe_ 167 LKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCHHHcccCCCCCEEeeeceeeeeccc-----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc
Confidence 999999999999999999999986432 233467999999999999999999999999999999999999999764
Q ss_pred CCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCC-----CHHHHHH
Q 020529 161 RPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRP-----LIGDVVT 225 (325)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RP-----s~~evl~ 225 (325)
.... ....+..... ..+.....++.+|+.+||+.||.+|+ ++.++++
T Consensus 242 ~~~~------~~~~i~~~~~------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 242 QPIQ------IYEKIVSGKV------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SHHH------HHHHHHHCCC------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHH------HHHHHhcCCC------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 3211 1111111110 11122345788999999999999994 8999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=308.38 Aligned_cols=217 Identities=21% Similarity=0.217 Sum_probs=160.8
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||++++++.+++..|+||||+.++++..++.. ...+++..+..++.|++.||+|||+++ |+|||
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrD 125 (299)
T d1ua2a_ 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRD 125 (299)
T ss_dssp HHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eeccc
Confidence 36788999999999999999999999999987777666543 556899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+|||++.++.+||+|||+++...... .......||+.|+|||++... .++.++|||||||++|||++|..||..
T Consensus 126 iKp~NIli~~~~~~KL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 126 LKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp CCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcceEEecCCCccccccCccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 99999999999999999999997643322 223345799999999998755 579999999999999999999999976
Q ss_pred CCCCCcchhh-hhh----hhccccccccccccCCccCCCCC-----hHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNLV-TWA----RPLFNDRRKFSKLADPRLEGRYP-----IRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~~-~~~----~~~~~~~~~~~~~~d~~l~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....+....+ ... ...+...........-......+ ......+.+|+.+||+.||++|||+.|+++.
T Consensus 204 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 5332211000 000 00000000000000000000011 1223578899999999999999999999863
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=310.15 Aligned_cols=212 Identities=23% Similarity=0.352 Sum_probs=170.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLP------PDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+|++++|||||+++++|...+..++||||+++|+|.+++.... .....+++..+.+++.+++.||.|||+++
T Consensus 76 il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~-- 153 (308)
T d1p4oa_ 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-- 153 (308)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--
Confidence 4788999999999999999999999999999999999986421 12345899999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCC
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+|||++.++++||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||.
T Consensus 154 -ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~ 232 (308)
T d1p4oa_ 154 -FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232 (308)
T ss_dssp -CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTS
T ss_pred -eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCC
Confidence 9999999999999999999999999998654443333445567899999999999999999999999999999999985
Q ss_pred -CCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhhc
Q 020529 155 -KAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLAN 232 (325)
Q Consensus 155 -~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~~ 232 (325)
.||....... +...+.. .. . ...+......+.+|+.+||+.+|++|||+.+|++.|+...+
T Consensus 233 ~~p~~~~~~~~------~~~~i~~-~~----~------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 233 EQPYQGLSNEQ------VLRFVME-GG----L------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCTTTTSCHHH------HHHHHHT-TC----C------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCCCCHHH------HHHHHHh-CC----C------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 6665543211 1111111 00 0 01112233578899999999999999999999999976644
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-42 Score=309.18 Aligned_cols=203 Identities=15% Similarity=0.249 Sum_probs=163.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+.+..|||||||+|++|.+++.. ....+++..++.|+.||+.||+|||+.+ |+|||
T Consensus 54 il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrD 127 (321)
T d1tkia_ 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFD 127 (321)
T ss_dssp HHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCccc
Confidence 36789999999999999999999999999999999999975 2346999999999999999999999999 99999
Q ss_pred CCCCcEEEcCC--CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCCC
Q 020529 81 FKSSNILLEEG--FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~--~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|||+|||++.+ ..+||+|||+++..... .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.
T Consensus 128 lKp~NIll~~~~~~~ikl~DFG~~~~~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~ 204 (321)
T d1tkia_ 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp CCGGGEEESSSSCCCEEECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ccccceeecCCCceEEEEcccchhhccccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCC
Confidence 99999999854 48999999999864322 23345678999999999999999999999999999999999999997
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....... ...+......+. ..... .....+.+|+.+||+.||.+|||+.|+++.
T Consensus 205 ~~~~~~~------~~~i~~~~~~~~----~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 205 AETNQQI------IENIMNAEYTFD----EEAFK----EISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CSSHHHH------HHHHHHTCCCCC----HHHHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHH------HHHHHhCCCCCC----hhhcc----CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 6532211 111111110100 00000 123467899999999999999999999874
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=301.80 Aligned_cols=218 Identities=20% Similarity=0.242 Sum_probs=159.9
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||++++++.+++..|+||||+. +++.+++... ....+++..++.++.|++.||.|||+++ |||||
T Consensus 54 il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~-~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrD 127 (298)
T d1gz8a_ 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRD 127 (298)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEEeccccccccceeEEEeecC-Cchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccc
Confidence 4789999999999999999999999999996 5555555331 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC-CCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+|||++.++.+||+|||+++..... ........||+.|+|||++.... ++.++|||||||++|+|++|+.||..
T Consensus 128 iKpeNIl~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 128 LKPQNLLINTEGAIKLADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp CCGGGEEECTTSCEEECSTTHHHHHCCC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCchheeecccCcceeccCCcceeccCC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 9999999999999999999999764332 22344457999999999887765 57899999999999999999999976
Q ss_pred CCCCCcchh-hhhh----hhcccccccccc---ccCCccCCCC---ChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQNL-VTWA----RPLFNDRRKFSK---LADPRLEGRY---PIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~~~-~~~~----~~~~~~~~~~~~---~~d~~l~~~~---~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
......... .... ............ .......... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 206 DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 532211000 0000 000000000000 0000000000 01223578899999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-41 Score=300.72 Aligned_cols=214 Identities=21% Similarity=0.300 Sum_probs=158.2
Q ss_pred CCCCCCCccceeeEEEe-----CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeE
Q 020529 3 SLLHHSNLVNLIGYCAD-----GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVI 77 (325)
Q Consensus 3 ~~l~Hpniv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~iv 77 (325)
+.++||||++++++|.. ....+++|||+.++++...... ....+++..+..++.|++.||+|||+++ |+
T Consensus 65 ~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---iv 138 (305)
T d1blxa_ 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VV 138 (305)
T ss_dssp HHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred hhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EE
Confidence 34589999999999853 3477999999987766555443 3566999999999999999999999999 99
Q ss_pred eCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCCCCC
Q 020529 78 YRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAI 157 (325)
Q Consensus 78 Hrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~~p~ 157 (325)
||||||+|||++.++.+||+|||+++.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 139 HrDiKp~NILi~~~~~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 139 HRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCCCGGGEEECTTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred ecCCCccEEEEcCCCCeeecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCC
Confidence 999999999999999999999999875322 23345677999999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhh----------hhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 158 DSTRPHGEQNLVT----------WARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 158 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
...........+. |..........+..... .....+.......+.+|+.+||+.||.+|||+.|+++.
T Consensus 216 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 216 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA-QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCC-CCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccc-cchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 7654322111100 00000000000000000 00001112234567899999999999999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-41 Score=298.88 Aligned_cols=190 Identities=21% Similarity=0.299 Sum_probs=154.7
Q ss_pred cCCCC--CCCccceeeEEEeCCeeEEEEecCCC-CCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 2 LSLLH--HSNLVNLIGYCADGDQRLLVYEFMPL-GSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 2 L~~l~--Hpniv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
|++++ |||||++++++.+.+..++||||+.+ +++.+++.. ...+++..++.++.|++.||+|||+++ |+|
T Consensus 61 l~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiH 133 (273)
T d1xwsa_ 61 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLH 133 (273)
T ss_dssp HHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 34454 99999999999999999999999975 578888765 456999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCC-CeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCC-CccccEEEehHHHHHHHhCCCC
Q 020529 79 RDFKSSNILLEEG-FHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQL-TVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 79 rdik~~Nill~~~-~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDvwSlGvvl~elltg~~p 156 (325)
|||||+|||++.+ +.+||+|||+++..... ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.|
T Consensus 134 rDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~P 209 (273)
T d1xwsa_ 134 RDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 209 (273)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCC
Confidence 9999999999854 79999999999764322 2345679999999999988765 6779999999999999999999
Q ss_pred CCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 157 IDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|.... .+ .... . .+ +...+.++.+|+.+||+.||.+|||+.|+++.
T Consensus 210 f~~~~-----~i-------~~~~----~----~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 210 FEHDE-----EI-------IRGQ----V----FF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp CCSHH-----HH-------HHCC----C----CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCch-----HH-------hhcc----c----CC----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 96421 11 1000 0 01 11223568899999999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.1e-40 Score=292.52 Aligned_cols=216 Identities=20% Similarity=0.249 Sum_probs=157.3
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|++++|||||+++++|.+.+..+++|||+.++.+..+... ...+++..+..++.||+.||+|||+.+ |||||
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrD 125 (286)
T d1ob3a_ 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRD 125 (286)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred HHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecC
Confidence 57899999999999999999999999999986666666543 567999999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+|||++.++.+||+|||++....... .......|++.|+|||++... .++.++|||||||+++||++|+.||..
T Consensus 126 iKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 126 LKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp CCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCceeeEcCCCCEEecccccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 99999999999999999999997643322 223445689999999998764 568999999999999999999999976
Q ss_pred CCCCCcchhhhhh-----hhccccccccccc------cCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHH
Q 020529 160 TRPHGEQNLVTWA-----RPLFNDRRKFSKL------ADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVT 225 (325)
Q Consensus 160 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~------~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~ 225 (325)
.........+... ...+......... ..+.............+.+|+.+||+.||++|||+.|+++
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 204 VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 5322111000000 0000000000000 0000001111123457889999999999999999999975
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-39 Score=294.87 Aligned_cols=219 Identities=22% Similarity=0.241 Sum_probs=155.6
Q ss_pred CcCCCCCCCccceeeEEEeC------CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADG------DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+|++++||||++++++|... .+.+||||||+++ +...+.........+++..+..++.||+.||+|||+++
T Consensus 66 il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~-- 142 (350)
T d1q5ka_ 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG-- 142 (350)
T ss_dssp HHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--
T ss_pred HHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--
Confidence 36789999999999998543 3578999999755 44333322223567999999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCC-eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHh
Q 020529 75 PVIYRDFKSSNILLEEGF-HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~-~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~ellt 152 (325)
|+||||||+||||+.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 143 -IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~ 218 (350)
T d1q5ka_ 143 -ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 218 (350)
T ss_dssp -EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -CcccCCCcceEEEecCCCceeEecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhh
Confidence 99999999999999775 89999999997643322 2334579999999998875 468999999999999999999
Q ss_pred CCCCCCCCCCCCcchhh-h--------hhhhcccc--ccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHH
Q 020529 153 GRKAIDSTRPHGEQNLV-T--------WARPLFND--RRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIG 221 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~-~--------~~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ 221 (325)
|+.||...........+ . +....... ...+...................+.+|+.+||+.||.+|||+.
T Consensus 219 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~ 298 (350)
T d1q5ka_ 219 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298 (350)
T ss_dssp TSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHH
Confidence 99999765422111100 0 00000000 0000110000011111122345688999999999999999999
Q ss_pred HHHHH
Q 020529 222 DVVTA 226 (325)
Q Consensus 222 evl~~ 226 (325)
|+++.
T Consensus 299 e~L~H 303 (350)
T d1q5ka_ 299 EACAH 303 (350)
T ss_dssp HHHTS
T ss_pred HHhcC
Confidence 99864
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-38 Score=281.35 Aligned_cols=213 Identities=19% Similarity=0.217 Sum_probs=159.0
Q ss_pred cCCCCCCCccce-eeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHHSNLVNL-IGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~Hpniv~l-~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+++++|+|++.. ..++.+.+..++||||+ +++|...+.. ....+++.++..++.|++.||+|||+++ |+|||
T Consensus 56 ~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrD 128 (299)
T d1ckia_ 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRD 128 (299)
T ss_dssp HHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSC
T ss_pred HHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeecc
Confidence 567776665554 55567788999999999 5777777655 3556999999999999999999999999 99999
Q ss_pred CCCCcEEEc---CCCeEEEecCCCCccCCCCCCC-----CccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHh
Q 020529 81 FKSSNILLE---EGFHPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELIT 152 (325)
Q Consensus 81 ik~~Nill~---~~~~~kL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~ellt 152 (325)
|||+|||++ .+..++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 129 iKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~t 208 (299)
T d1ckia_ 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 208 (299)
T ss_dssp CCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHh
Confidence 999999985 4557999999999875433221 12345679999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchhh-hhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhhh
Q 020529 153 GRKAIDSTRPHGEQNLV-TWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYLA 231 (325)
Q Consensus 153 g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~~ 231 (325)
|+.||............ .+...... ...+.+...+ +.++.+|+..|++.+|.+||++.++.+.|+.+.
T Consensus 209 g~~P~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~----p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 209 GSLPWQGLKAATKRQKYERISEKKMS-------TPIEVLCKGY----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp SSCTTCCCC-------HHHHHHHHHH-------SCHHHHTTTS----CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred CCCcccccchHHHHHHHHHhhcccCC-------CChhHhccCC----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 99999775543322211 11111000 0001111122 256789999999999999999999999888764
Q ss_pred c
Q 020529 232 N 232 (325)
Q Consensus 232 ~ 232 (325)
.
T Consensus 278 ~ 278 (299)
T d1ckia_ 278 H 278 (299)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=4.1e-38 Score=279.71 Aligned_cols=215 Identities=17% Similarity=0.211 Sum_probs=167.2
Q ss_pred cCCCC-CCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLH-HSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
++.|+ |+|++.+++++.++...++||||+ +++|.+++.. ....+++.++..++.|++.||+|||+++ |+|||
T Consensus 54 ~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrD 126 (293)
T d1csna_ 54 YKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRD 126 (293)
T ss_dssp HHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCC
T ss_pred HHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceecc
Confidence 34564 599999999999999999999999 6999999876 3456999999999999999999999999 99999
Q ss_pred CCCCcEEEcC-----CCeEEEecCCCCccCCCCCCC-----CccccccCCcCccCchhhccCCCCccccEEEehHHHHHH
Q 020529 81 FKSSNILLEE-----GFHPKLSDFGLAKLGPVGDKS-----HVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLEL 150 (325)
Q Consensus 81 ik~~Nill~~-----~~~~kL~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~el 150 (325)
|||+|||++. ++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHH
Confidence 9999999964 568999999999875432211 123456799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHHHHhh
Q 020529 151 ITGRKAIDSTRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTALSYL 230 (325)
Q Consensus 151 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~L~~~ 230 (325)
++|+.||.................. . ....-+.+...+| .++.+++..|+..+|++||++..+.+.|..+
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~i~~~---~---~~~~~~~l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~ 276 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQKYERIGEK---K---QSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276 (293)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHH---H---HHSCHHHHTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred HhCCCcCCCccchhHHHHHHHHHhc---c---CCCChHHhcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 9999999865443322211111000 0 0000011112222 4678899999999999999999999988877
Q ss_pred hcc
Q 020529 231 ANQ 233 (325)
Q Consensus 231 ~~~ 233 (325)
..+
T Consensus 277 ~~~ 279 (293)
T d1csna_ 277 LER 279 (293)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-38 Score=289.03 Aligned_cols=211 Identities=22% Similarity=0.313 Sum_probs=157.7
Q ss_pred CcCCCCCCCccceeeEEEeCC------eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGD------QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+|++++|||||+++++|...+ +.|+||||+ +.+|..+++. ..+++..++.++.|++.||+|||+++
T Consensus 70 il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~-- 141 (346)
T d1cm8a_ 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG-- 141 (346)
T ss_dssp HHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 367899999999999997654 569999999 6788888754 45999999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhC
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITG 153 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg 153 (325)
|+||||||+|||++.++.+||+|||+++.... ..+...||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 142 -IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g 215 (346)
T d1cm8a_ 142 -IIHRDLKPGNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215 (346)
T ss_dssp -EECCCCCGGGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHS
T ss_pred -CcccccCcchhhcccccccccccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHC
Confidence 99999999999999999999999999986432 23456799999999998764 568999999999999999999
Q ss_pred CCCCCCCCCCCcchhhhhhhhc--------cc------cccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC
Q 020529 154 RKAIDSTRPHGEQNLVTWARPL--------FN------DRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~--------~~------~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
+.||.................. .. ....+.......+. .........+.+|+.+||+.||.+|||
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~t 294 (346)
T d1cm8a_ 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVT 294 (346)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCC
T ss_pred cCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcC
Confidence 9999765322111000000000 00 00000011001110 011122356789999999999999999
Q ss_pred HHHHHHH
Q 020529 220 IGDVVTA 226 (325)
Q Consensus 220 ~~evl~~ 226 (325)
+.|+++.
T Consensus 295 a~eiL~H 301 (346)
T d1cm8a_ 295 AGEALAH 301 (346)
T ss_dssp HHHHHHS
T ss_pred HHHHhcC
Confidence 9999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-38 Score=283.54 Aligned_cols=219 Identities=21% Similarity=0.251 Sum_probs=155.0
Q ss_pred CcCCCCCCCccceeeEEEe--------CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Q 020529 1 MLSLLHHSNLVNLIGYCAD--------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA 72 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~ 72 (325)
+|++++||||+++++++.. .+..++||||+.++.+..+.. ....+++..+..++.|++.||.|||+.+
T Consensus 62 il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~ 137 (318)
T d3blha1 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK 137 (318)
T ss_dssp HHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccCC
Confidence 3678999999999999855 346799999998666655543 3556899999999999999999999999
Q ss_pred CCCeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCC--CccccccCCcCccCchhhccC-CCCccccEEEehHHHHH
Q 020529 73 NPPVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKS--HVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLE 149 (325)
Q Consensus 73 ~~~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~e 149 (325)
|+||||||+|||++.++.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++||
T Consensus 138 ---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~e 214 (318)
T d3blha1 138 ---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAE 214 (318)
T ss_dssp ---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred ---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeee
Confidence 999999999999999999999999999765432221 122345699999999998765 68999999999999999
Q ss_pred HHhCCCCCCCCCCCCcchhhhhhhhccccc-------cccccccCCccCCCCChH-------HHHHHHHHHHHchhhCCC
Q 020529 150 LITGRKAIDSTRPHGEQNLVTWARPLFNDR-------RKFSKLADPRLEGRYPIR-------GLYQALAVASMCIQEQAA 215 (325)
Q Consensus 150 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~d~~l~~~~~~~-------~~~~~~~l~~~cl~~~p~ 215 (325)
|++|+.||...................... ...............+.. ....+.+|+.+||+.||+
T Consensus 215 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~ 294 (318)
T d3blha1 215 MWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPA 294 (318)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTT
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChh
Confidence 999999997643322211111100000000 000000000000000111 123567899999999999
Q ss_pred CCCCHHHHHHH
Q 020529 216 TRPLIGDVVTA 226 (325)
Q Consensus 216 ~RPs~~evl~~ 226 (325)
+|||+.|+++.
T Consensus 295 ~R~sa~elL~H 305 (318)
T d3blha1 295 QRIDSDDALNH 305 (318)
T ss_dssp TSCCHHHHHHS
T ss_pred HCcCHHHHHcC
Confidence 99999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-38 Score=282.99 Aligned_cols=202 Identities=25% Similarity=0.344 Sum_probs=160.5
Q ss_pred cCCCCC-CCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 2 LSLLHH-SNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 2 L~~l~H-pniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
|++++| |||+++++++.+....++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 82 l~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrD 154 (322)
T d1vzoa_ 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRD 154 (322)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCC
T ss_pred HHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEecc
Confidence 567755 8999999999999999999999999999999976 445788999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC--CCCccccEEEehHHHHHHHhCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG--QLTVKSDVYSFGVVFLELITGRKAID 158 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDvwSlGvvl~elltg~~p~~ 158 (325)
|||+||||+.++.+||+|||+++...... ........|++.|+|||.+.+. .++.++|||||||+||+|++|+.||.
T Consensus 155 iKp~Nill~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 155 IKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CCccceeecCCCCEEEeeccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999997643322 2233456799999999999765 46889999999999999999999998
Q ss_pred CCCCCCcchhhhhhhhccccccccccccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCC-----HHHHHH
Q 020529 159 STRPHGEQNLVTWARPLFNDRRKFSKLADPRLEGRYPIRGLYQALAVASMCIQEQAATRPL-----IGDVVT 225 (325)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs-----~~evl~ 225 (325)
........... ....... .+ .++......+.+|+.+||+.||.+||+ +.|+++
T Consensus 234 ~~~~~~~~~~i--~~~~~~~--------~~----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 234 VDGEKNSQAEI--SRRILKS--------EP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CTTSCCCHHHH--HHHHHHC--------CC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCHHHHHHHH--HHhcccC--------CC----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 76543322111 1111100 01 112234467889999999999999994 788875
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=287.77 Aligned_cols=217 Identities=20% Similarity=0.269 Sum_probs=156.0
Q ss_pred CcCCCCCCCccceeeEEEeCC----eeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCe
Q 020529 1 MLSLLHHSNLVNLIGYCADGD----QRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPV 76 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~i 76 (325)
+|++|+||||+++++++.... ..+++++|+.+++|.+++.. ..+++..++.++.|++.||+|||+++ |
T Consensus 59 il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---i 130 (345)
T d1pmea_ 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---V 130 (345)
T ss_dssp HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---C
Confidence 467899999999999997643 23444455668999999965 35999999999999999999999999 9
Q ss_pred EeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCC-CCccccccCCcCccCchhhcc-CCCCccccEEEehHHHHHHHhCC
Q 020529 77 IYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDK-SHVSTRVMGTYGYCAPEYAMT-GQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 77 vHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|||||||+||||+.++.+||+|||+++....... ........||+.|+|||++.. ..++.++||||+||++|+|++|+
T Consensus 131 iHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~ 210 (345)
T d1pmea_ 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210 (345)
T ss_dssp ECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCC
Confidence 9999999999999999999999999976433221 122345679999999999854 46789999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhcccccc---------ccccccCCccCCCCC-----hHHHHHHHHHHHHchhhCCCCCCCH
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRR---------KFSKLADPRLEGRYP-----IRGLYQALAVASMCIQEQAATRPLI 220 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~d~~l~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPs~ 220 (325)
.||....................... .......+. ....+ .....++.+|+.+||+.||.+|||+
T Consensus 211 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta 289 (345)
T d1pmea_ 211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPH-KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289 (345)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCC-CCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCc-cCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCH
Confidence 99976543211111100000000000 000000000 00011 0112468899999999999999999
Q ss_pred HHHHHH
Q 020529 221 GDVVTA 226 (325)
Q Consensus 221 ~evl~~ 226 (325)
.|+++.
T Consensus 290 ~e~L~h 295 (345)
T d1pmea_ 290 EQALAH 295 (345)
T ss_dssp HHHHTS
T ss_pred HHHhcC
Confidence 999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-37 Score=274.51 Aligned_cols=217 Identities=18% Similarity=0.205 Sum_probs=161.5
Q ss_pred CcCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCC
Q 020529 1 MLSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRD 80 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrd 80 (325)
+|+.++||||++++++|.+....++|++++.+++|..++.. ...+++..+..++.|++.||+|||+++ |+|||
T Consensus 54 il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrD 126 (292)
T d1unla_ 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRD 126 (292)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HHHhcCcCCEEeeccccccccceeEEeeecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---Eeeec
Confidence 46789999999999999999999999999999888888765 566899999999999999999999999 99999
Q ss_pred CCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCC-CCccccEEEehHHHHHHHhCCCCCCC
Q 020529 81 FKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQ-LTVKSDVYSFGVVFLELITGRKAIDS 159 (325)
Q Consensus 81 ik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDvwSlGvvl~elltg~~p~~~ 159 (325)
|||+|||++.++.+||+|||.++...... .......+++.|+|||++.... ++.++|||||||+++||++|+.||..
T Consensus 127 iKP~NIli~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 127 LKPQNLLINRNGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp CSGGGEEECTTCCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ccCcccccccCCceeeeecchhhcccCCC--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 99999999999999999999998654332 2233445788899999987665 68999999999999999999999754
Q ss_pred CCCCCcc-h-hhhhhhhc----ccccccccc------ccCCccCCCCChHHHHHHHHHHHHchhhCCCCCCCHHHHHHH
Q 020529 160 TRPHGEQ-N-LVTWARPL----FNDRRKFSK------LADPRLEGRYPIRGLYQALAVASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 160 ~~~~~~~-~-~~~~~~~~----~~~~~~~~~------~~d~~l~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~evl~~ 226 (325)
....... . +....... +........ .................+.+|+.+||+.||.+|||+.||++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 3221110 0 00000000 000000000 000000111122334578899999999999999999999763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.4e-37 Score=280.61 Aligned_cols=211 Identities=16% Similarity=0.215 Sum_probs=154.4
Q ss_pred cCCC-CCCCccceeeEEEe--CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEe
Q 020529 2 LSLL-HHSNLVNLIGYCAD--GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIY 78 (325)
Q Consensus 2 L~~l-~Hpniv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivH 78 (325)
|+++ .||||++++++|.. ....++|||||.+++|..+. ..+++..+..++.||+.||+|||+++ |+|
T Consensus 83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~g---IvH 152 (328)
T d3bqca1 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMG---IMH 152 (328)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcc---ccc
Confidence 5667 49999999999974 45689999999999997664 24999999999999999999999999 999
Q ss_pred CCCCCCcEEEcCCC-eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCCCC
Q 020529 79 RDFKSSNILLEEGF-HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGRKA 156 (325)
Q Consensus 79 rdik~~Nill~~~~-~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~~p 156 (325)
|||||+|||++.++ .+||+|||+++...... ......||+.|+|||.+.+. .++.++|||||||+++||++|+.|
T Consensus 153 rDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~p 229 (328)
T d3bqca1 153 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229 (328)
T ss_dssp CCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccccccceEEcCCCCeeeecccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCC
Confidence 99999999998654 69999999997643322 23456789999999998775 479999999999999999999999
Q ss_pred CCCCCCCCcch--hh---------hhhhh-ccccccccccccCCc--------cCCCCChHHHHHHHHHHHHchhhCCCC
Q 020529 157 IDSTRPHGEQN--LV---------TWARP-LFNDRRKFSKLADPR--------LEGRYPIRGLYQALAVASMCIQEQAAT 216 (325)
Q Consensus 157 ~~~~~~~~~~~--~~---------~~~~~-~~~~~~~~~~~~d~~--------l~~~~~~~~~~~~~~l~~~cl~~~p~~ 216 (325)
|.......... +. .+... .......+....... ...........++.+|+.+||+.||.+
T Consensus 230 f~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 309 (328)
T d3bqca1 230 FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 309 (328)
T ss_dssp SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGG
T ss_pred CCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhH
Confidence 97654321110 00 00000 000000000000000 000111123457889999999999999
Q ss_pred CCCHHHHHH
Q 020529 217 RPLIGDVVT 225 (325)
Q Consensus 217 RPs~~evl~ 225 (325)
|||++|+++
T Consensus 310 R~ta~e~L~ 318 (328)
T d3bqca1 310 RLTAREAME 318 (328)
T ss_dssp SCCHHHHHT
T ss_pred CcCHHHHhc
Confidence 999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-37 Score=281.56 Aligned_cols=213 Identities=24% Similarity=0.285 Sum_probs=150.2
Q ss_pred CcCCCCCCCccceeeEEEe------CCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCAD------GDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANP 74 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~ 74 (325)
+|++++|||||+++++|.. ....|+|||||. +++.+.+. ..+++..++.++.|++.||.|||+.+
T Consensus 69 il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~-~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g-- 139 (355)
T d2b1pa1 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG-- 139 (355)
T ss_dssp HHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS-EEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHhcCCCCeeEEEEEEecccccccCceeEEEEeccc-hHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc--
Confidence 3678899999999999953 368899999996 45555553 34899999999999999999999999
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCC
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+|||++.++.++++|||+++.... ....+...||+.|+|||++.+..++.++||||+||++++|++|+
T Consensus 140 -iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~ 215 (355)
T d2b1pa1 140 -IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215 (355)
T ss_dssp -CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred -cccccCCccccccccccceeeechhhhhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCC
Confidence 99999999999999999999999999875432 23345567899999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcchhh---------hhh-------hhccccc-----cccccccCCccCCCC---ChHHHHHHHHHHHHch
Q 020529 155 KAIDSTRPHGEQNLV---------TWA-------RPLFNDR-----RKFSKLADPRLEGRY---PIRGLYQALAVASMCI 210 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~---------~~~-------~~~~~~~-----~~~~~~~d~~l~~~~---~~~~~~~~~~l~~~cl 210 (325)
.||...........+ .+. ....... ......+........ .......+.+|+.+||
T Consensus 216 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL 295 (355)
T d2b1pa1 216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295 (355)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence 999754321110000 000 0000000 000111111111111 1234567899999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 020529 211 QEQAATRPLIGDVVTA 226 (325)
Q Consensus 211 ~~~p~~RPs~~evl~~ 226 (325)
+.||++|||++||++.
T Consensus 296 ~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 296 VIDPAKRISVDDALQH 311 (355)
T ss_dssp CSSTTTSCCHHHHHTS
T ss_pred cCChhHCcCHHHHhcC
Confidence 9999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-36 Score=276.53 Aligned_cols=211 Identities=20% Similarity=0.277 Sum_probs=151.1
Q ss_pred CcCCCCCCCccceeeEEEeC-----CeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCC
Q 020529 1 MLSLLHHSNLVNLIGYCADG-----DQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPP 75 (325)
Q Consensus 1 iL~~l~Hpniv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ 75 (325)
+|++++|||||++++++... ...++|++|+.+|+|.+++.. ..+++..+..++.||+.||+|||+++
T Consensus 70 il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g--- 141 (348)
T d2gfsa1 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD--- 141 (348)
T ss_dssp HHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 46789999999999998643 344666777789999999953 45999999999999999999999999
Q ss_pred eEeCCCCCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccC-CCCccccEEEehHHHHHHHhCC
Q 020529 76 VIYRDFKSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTG-QLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 76 ivHrdik~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDvwSlGvvl~elltg~ 154 (325)
|+||||||+|||++.++.+|++|||++.... .......||+.|+|||+..+. .++.++|||||||++|+|++|+
T Consensus 142 iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~ 216 (348)
T d2gfsa1 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216 (348)
T ss_dssp CCCCCCCGGGEEECTTCCEEECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CcccccCCccccccccccccccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCC
Confidence 9999999999999999999999999986432 233446789999999987765 4689999999999999999999
Q ss_pred CCCCCCCCCCcchhhhhhhhcccccccc---------ccccCCc-cCCCCC-----hHHHHHHHHHHHHchhhCCCCCCC
Q 020529 155 KAIDSTRPHGEQNLVTWARPLFNDRRKF---------SKLADPR-LEGRYP-----IRGLYQALAVASMCIQEQAATRPL 219 (325)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~d~~-l~~~~~-----~~~~~~~~~l~~~cl~~~p~~RPs 219 (325)
.||...........+. .......... ....... .....+ ......+.+|+.+||+.||.+|||
T Consensus 217 ~pF~~~~~~~~~~~i~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t 294 (348)
T d2gfsa1 217 TLFPGTDHIDQLKLIL--RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 294 (348)
T ss_dssp CSCCCSSHHHHHHHHH--HHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCHHHHHHHHH--HhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC
Confidence 9997643221111110 0000000000 0000000 000000 122356789999999999999999
Q ss_pred HHHHHHH
Q 020529 220 IGDVVTA 226 (325)
Q Consensus 220 ~~evl~~ 226 (325)
+.|+++.
T Consensus 295 a~elL~H 301 (348)
T d2gfsa1 295 AAQALAH 301 (348)
T ss_dssp HHHHHTS
T ss_pred HHHHhcC
Confidence 9999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.97 E-value=9.4e-32 Score=245.14 Aligned_cols=212 Identities=19% Similarity=0.224 Sum_probs=146.0
Q ss_pred CCCCCccceeeEEEe--CCeeEEEEecCCCCC-HHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhc-CCCCCeEeCC
Q 020529 5 LHHSNLVNLIGYCAD--GDQRLLVYEFMPLGS-LEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHD-KANPPVIYRD 80 (325)
Q Consensus 5 l~Hpniv~l~~~~~~--~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~-~~~~~ivHrd 80 (325)
+.||||+++++++.. ....+++++++..+. ....... .....+++..+..++.|++.||.|||+ .+ |+|||
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrD 151 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTD 151 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSC
T ss_pred cCcCceEEEEEEeeeccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---ccccc
Confidence 358999999999864 356667776664443 3332222 234568999999999999999999997 77 99999
Q ss_pred CCCCcEEEcCCC------eEEEecCCCCccCCCCCCCCccccccCCcCccCchhhccCCCCccccEEEehHHHHHHHhCC
Q 020529 81 FKSSNILLEEGF------HPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGR 154 (325)
Q Consensus 81 ik~~Nill~~~~------~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDvwSlGvvl~elltg~ 154 (325)
|||+||||+.++ .++|+|||.+..... ......||+.|+|||++....++.++||||+||++++|++|+
T Consensus 152 lKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~ 226 (362)
T d1q8ya_ 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226 (362)
T ss_dssp CSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CChhHeeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCC
Confidence 999999997664 499999999875322 234467999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCcch----hhhhhhhccc-------cccccccccC---------C----------ccCCCCChHHHHHHHH
Q 020529 155 KAIDSTRPHGEQN----LVTWARPLFN-------DRRKFSKLAD---------P----------RLEGRYPIRGLYQALA 204 (325)
Q Consensus 155 ~p~~~~~~~~~~~----~~~~~~~~~~-------~~~~~~~~~d---------~----------~l~~~~~~~~~~~~~~ 204 (325)
.||.......... +......+-. ........++ . ......+......+.+
T Consensus 227 ~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 306 (362)
T d1q8ya_ 227 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306 (362)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHH
Confidence 9997543322111 1111000000 0000000000 0 0011223456778999
Q ss_pred HHHHchhhCCCCCCCHHHHHHH
Q 020529 205 VASMCIQEQAATRPLIGDVVTA 226 (325)
Q Consensus 205 l~~~cl~~~p~~RPs~~evl~~ 226 (325)
|+.+||+.||.+|||+.|+++.
T Consensus 307 ll~~mL~~dP~~Rpta~e~L~H 328 (362)
T d1q8ya_ 307 FLSPMLQLDPRKRADAGGLVNH 328 (362)
T ss_dssp HHGGGGCSSTTTCBCHHHHHTC
T ss_pred HHHHHCCCChhHCcCHHHHhcC
Confidence 9999999999999999999863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.62 E-value=3.2e-17 Score=134.85 Aligned_cols=118 Identities=11% Similarity=0.063 Sum_probs=83.2
Q ss_pred cCCCCCCCccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCCCCCeEeCCC
Q 020529 2 LSLLHHSNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKANPPVIYRDF 81 (325)
Q Consensus 2 L~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~~~~ivHrdi 81 (325)
|.++.|+|++..+++. ..+++|||+++..+.+ ++......++.+++.+|+|||+.+ |+||||
T Consensus 68 l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDi 129 (191)
T d1zara2 68 LQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDL 129 (191)
T ss_dssp HHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred HHHccCCCcceEEEec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccC
Confidence 4567899998887653 2479999998765433 233345678999999999999999 999999
Q ss_pred CCCcEEEcCCCeEEEecCCCCccCCCCCCCCccccccCCcCccCch-----hhccCCCCccccEEEehHHHH
Q 020529 82 KSSNILLEEGFHPKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPE-----YAMTGQLTVKSDVYSFGVVFL 148 (325)
Q Consensus 82 k~~Nill~~~~~~kL~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~ksDvwSlGvvl~ 148 (325)
||+|||++++ .++|+|||++........ ..|+... .+....|+.++|+||+.--++
T Consensus 130 KP~NILv~~~-~~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 130 SQYNVLVSEE-GIWIIDFPQSVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp STTSEEEETT-EEEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred ChhheeeeCC-CEEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 9999999965 589999999865321110 0111111 012356788999999765443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.79 E-value=3.3e-05 Score=64.43 Aligned_cols=85 Identities=15% Similarity=0.133 Sum_probs=58.9
Q ss_pred ccceeeEEEeCCeeEEEEecCCCCCHHHHhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhcCC-----------------
Q 020529 10 LVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEALDWNTRMKIAAGAAKGLEYLHDKA----------------- 72 (325)
Q Consensus 10 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~----------------- 72 (325)
+.+++.++.+++..++||++++|..+.+.... . .. ...++.+++..++.||+..
T Consensus 72 vP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~----~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~ 142 (263)
T d1j7la_ 72 VPKVLHFERHDGWSNLLMSEADGVLCSEEYED----E--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL 142 (263)
T ss_dssp CCCEEEEEEETTEEEEEEECCSSEEHHHHTTT----C--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHH
T ss_pred CCcEEEEEecCCceEEEEEecccccccccccc----c--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhH
Confidence 56778888888999999999998887654421 0 11 1223444455555555210
Q ss_pred ---------------------------------------CCCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 73 ---------------------------------------NPPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 73 ---------------------------------------~~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
.+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1238999999999999987667799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.06 E-value=0.00042 Score=57.06 Aligned_cols=29 Identities=28% Similarity=0.248 Sum_probs=25.3
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
.++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 38999999999999987677899998774
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.38 E-value=0.0022 Score=56.62 Aligned_cols=29 Identities=24% Similarity=0.238 Sum_probs=25.4
Q ss_pred CeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 75 PVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 75 ~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
.++|+|+.+.|||++++. ++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 499999999999998765 89999988754
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.95 E-value=0.023 Score=47.80 Aligned_cols=30 Identities=27% Similarity=0.222 Sum_probs=26.4
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAK 103 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~ 103 (325)
.++||+|+.++||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 349999999999999988777899999774
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=91.39 E-value=0.11 Score=43.79 Aligned_cols=29 Identities=28% Similarity=0.374 Sum_probs=23.6
Q ss_pred CCeEeCCCCCCcEEEcCCCeEEEecCCCCcc
Q 020529 74 PPVIYRDFKSSNILLEEGFHPKLSDFGLAKL 104 (325)
Q Consensus 74 ~~ivHrdik~~Nill~~~~~~kL~Dfgla~~ 104 (325)
..+||+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 458999999999999743 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=84.45 E-value=0.19 Score=43.49 Aligned_cols=15 Identities=33% Similarity=0.499 Sum_probs=13.4
Q ss_pred eEeCCCCCCcEEEcC
Q 020529 76 VIYRDFKSSNILLEE 90 (325)
Q Consensus 76 ivHrdik~~Nill~~ 90 (325)
++|+|+.+.||++.+
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 689999999999854
|